{
    "000078.SZ": {
        "short_name": "SHN NEPTUNUS BIO",
        "long_name": "Shenzhen Neptunus Bioengineering Co., Ltd.",
        "summary": "Shenzhen Neptunus Bioengineering Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anti-tumor, cardiovascular disease, and other disease. The company was founded in 1992 and is based in Shenzhen, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shenzhen",
        "zipcode": "518057",
        "website": "http://www.neptunus.com",
        "market_cap": "Small Cap"
    },
    "000100.KS": {
        "short_name": "Yuhan",
        "long_name": "Yuhan Corporation",
        "summary": "Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal injury; ETC products in the areas of cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, and neuro systems; anti-infective, anti-cancer, and hormone and other products; and analgesics, anti-rheumatics, and anesthetics. It also offers OTC products, including vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, dermatology and analgesics drugs, and others; and household and healthcare products, such as bleaches, detergents, pesticides, and oral care products. In addition, the company engages in dental business and offers implants, dental equipment/consumable, and dental care products. Additionally, the company manufactures and sells medical supplies for livestock, aquatic animals, and household pets.  Further, it provides contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.yuhan.co.kr",
        "market_cap": "Mid Cap"
    },
    "000105.KS": {
        "short_name": "Yuhan(1P)",
        "long_name": "Yuhan Corporation",
        "summary": "Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal injury; ETC products in the areas of cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, and neuro systems; anti-infective, anti-cancer, and hormone and other products; and analgesics, anti-rheumatics, and anesthetics. It also offers OTC products, including vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, dermatology and analgesics drugs, and others; and household and healthcare products, such as bleaches, detergents, pesticides, and oral care products. In addition, the company engages in dental business and offers implants, dental equipment/consumable, and dental care products. Additionally, the company manufactures and sells medical supplies for livestock, aquatic animals, and household pets.  Further, it provides contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.yuhan.co.kr",
        "market_cap": "Small Cap"
    },
    "000153.SZ": {
        "short_name": "ANHUI FENGYUAN PHA",
        "long_name": "Anhui Fengyuan Pharmaceutical Co., Ltd.",
        "summary": "Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells biological pharmacy, chemical pharmacy, and traditional Chinese medicines primarily in China. The company offers antipyretic-analgesic, cardiovascular, antibiotic, nervous system, anti-tumor, antiulcer, and hormone drugs, as well as nutraceuticals. It also provides general medicines for vitamin and mineral deficiency; medicines for resisting parasitic diseases and microorganisms; coenzymes; and antiviral and uterine contractive medicines. In addition, the company offers sedative-hypnotic drugs; drugs for curing mesenteric stress syndrome; drugs for lowering blood pressure; and drugs for curing benign prostatic hyperplasia. It also exports its products to Europe, North America, Africa, Southeast Asia, and Central Asia. The company is based in Hefei, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Hefei",
        "zipcode": null,
        "website": "http://www.bbcayy.com",
        "market_cap": "Small Cap"
    },
    "000220.KS": {
        "short_name": "YuyuPharma",
        "long_name": "Yuyu Pharma, Inc.",
        "summary": "Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants. It also provides non-prescription drugs and health supplements. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.yuyu.co.kr",
        "market_cap": "Micro Cap"
    },
    "000225.KS": {
        "short_name": "YuyuPharma(1P)",
        "long_name": "Yuyu Pharma, Inc.",
        "summary": "Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants. It also provides non-prescription drugs and health supplements. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.yuyu.co.kr",
        "market_cap": "Micro Cap"
    },
    "000227.KS": {
        "short_name": "YuyuPharma(2PB)",
        "long_name": "Yuyu Pharma, Inc.",
        "summary": "Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants. It also provides non-prescription drugs and health supplements. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.yuyu.co.kr",
        "market_cap": "Micro Cap"
    },
    "000230.KS": {
        "short_name": "ILDONG HOLDINGS",
        "long_name": "Ildong Holdings Co., Ltd.",
        "summary": "Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It also engages in the research and manufacture of health foods and ingredients, as well as offers hyaluronic acid for use in drugs, medical devices, and cosmetics; and various medical devices for beauty, cosmetic-surgery, and antiaging applications. In addition, the company distributes medical devices, quasi drugs, health supplements, food products, beverages, cosmetics, sanitary ware, and other healthcare products through online. Further, it offers beauty and cosmetic surgery services; and pharmaceutical SI consulting, system development and deployment, RFID and barcode systems, and other solutions, as well as engages in advertising business. The company was formerly known as Ildong Pharmaceutical Co., Ltd. and changed its name to Ildong Holdings Co., Ltd. in August 2016. Ildong Holdings Co., Ltd. was founded in 1941 and is based in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.ildongholdings.co.kr",
        "market_cap": "Micro Cap"
    },
    "000403.SZ": {
        "short_name": "PACIFIC SHUANGLIN",
        "long_name": "Pacific Shuanglin Bio-pharmacy Co., LTD",
        "summary": "Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), human rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, tianqi analgesic cream, musk herd cream, musk bone paste, anti-inflammatory analgesic cream, dieshangling plasters, and medical gauzes. The company is also involved in the development of porcine pulmonary surfactants, shaqifang compounds, a1-protease inhibitors, human coagulation factor VIII products, and human fibrinogens. In addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; real estate development; and electronic product information consultation, as well as in the provision of electricity. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. is based in Taiyuan, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Taiyuan",
        "zipcode": "030006",
        "website": null,
        "market_cap": "Mid Cap"
    },
    "000513.SZ": {
        "short_name": "LIVZON PHARMACEUTI",
        "long_name": "Livzon Pharmaceutical Group Inc.",
        "summary": "Livzon Pharmaceutical Group Inc. engages in the research, development, production, and distribution of pharmaceutical products in the People's Republic of China. Its products include Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitropin for injection to treat anovulation and sufferers; Perospirone Hydrochloride for the treatment of schizophrenia; Anti-viral Granules to treat upper respiratory tract infection and influenza; and Shenqi Fuzheng Injection for the treatment of weakness and tiredness, lassitude, spontaneous sweating, vertigo, and for the patients of lung cancer and stomach cancer. The company also offers active pharmaceutical ingredients (APIs) and intermediates, such as diagnostic kit for IgM/IgG antibody to coronavirus; and diagnostic reagents and equipment, including diagnostic kit for human immunodeficiency virus antibody, diagnostic kit for anti-nuclear antibody panel, and diagnostic kit for tuberculosis specific infected T cells. In addition, it provides biologic products, traditional Chinese drug medicine, biochemical drugs, microbiological preparations, antibiotics, and pharmaceutical raw materials. The company also exports its products. Livzon Pharmaceutical Group Inc. was founded in 1985 and is based in Zhuhai, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Zhuhai",
        "zipcode": "519090",
        "website": "http://www.livzon.com.cn",
        "market_cap": "Mid Cap"
    },
    "000520.KS": {
        "short_name": "SamilPharm",
        "long_name": "Samil Pharmaceutical Co.,Ltd",
        "summary": "Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.samil-pharm.com",
        "market_cap": "Micro Cap"
    },
    "000538.SZ": {
        "short_name": "YUNNAN BAIYAO GRP",
        "long_name": "Yunnan Baiyao Group Co.,Ltd",
        "summary": "Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China and internationally. It provides health products, drugs, medical instruments, Chinese medicine resources, and tea. The company offers its products under the Yunnan Baiyao, Yunfeng, Tong Qiaoqiao, Yunjian, Life, Jinkoujian, Langjian, Yangyuanqing, Caizhiji, Baiyao Health, Leopard Seven, Qiancaotang, Qiancao Meizi, and Tianzihong brand names. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Kunming",
        "zipcode": "650500",
        "website": "http://www.yunnanbaiyao.com.cn",
        "market_cap": "Large Cap"
    },
    "000566.SZ": {
        "short_name": "HAINAN HAIYAO CO",
        "long_name": "Hainan Haiyao Co., Ltd.",
        "summary": "Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products in China. The company develops approximately 132 products in various forms, such as general medicines, powder formulations, capsules, granules, tablets, injections, APIs, etc. in various anti-infection, anti-tumor, nervous system, digestive system, and sandan. It also produces vitamin C products, sterile raw materials, and pharmaceutical intermediates and chemicals, as well as REZ-1 digital cochlear products; and provides software platform, software products, and their related information services based on mobile Internet and cloud services for medical, health, and other industries. The company also exports its products to Vietnam, India, Cambodia, Singapore, Malaysia, and other Southeast Asia. Hainan Haiyao Co., Ltd. was founded in 1965 and is based in Haikou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Haikou",
        "zipcode": "570311",
        "website": "http://www.haiyao.com.cn",
        "market_cap": "Small Cap"
    },
    "000597.SZ": {
        "short_name": "NORTHEAST PHARMACE",
        "long_name": "Northeast Pharmaceutical Group Co., Ltd.",
        "summary": "Northeast Pharmaceutical Group Co., Ltd. provides chemical synthetic and bio-fermentation APIs, and medicinal and micro-ecological preparation products in China. It offers various nutritional products, such as Vitamin C, L-Carnitine, and other products; API products comprising fosfomycin, anti-aids, and other products; and chemical products, including chemical and pharmaceutical intermediates, chiral separation reagent products, etc. The company also provides digestives, narcotic medicines, cardiovascular, cerebrovascular medicines, etc. In addition, it engages in medical distribution business. Northeast Pharmaceutical Group Co., Ltd. was founded in 1993 and is based in Shenyang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shenyang",
        "zipcode": null,
        "website": "http://www.nepharm.com",
        "market_cap": "Small Cap"
    },
    "000623.SZ": {
        "short_name": "JILIN AODONG PHARM",
        "long_name": "Jilin Aodong Pharmaceutical Group Co., Ltd.",
        "summary": "Jilin Aodong Pharmaceutical Group Co., Ltd. produces and sells pharmaceutical products in China. The company offers various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, syrups, spirits, and ointments, as well as enzymes, biochemical medicine, and plant chemical medicine. It also provides healthcare products. In addition, the company engages in highway construction and toll collection businesses. The company was founded in 1957 and is headquartered in Dunhua, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Dunhua",
        "zipcode": "133700",
        "website": "http://www.jlaod.com",
        "market_cap": "Mid Cap"
    },
    "000627.SZ": {
        "short_name": "HUBEI BIOCAUSE PH",
        "long_name": "Hubei Biocause Pharmaceutical Co., Ltd.",
        "summary": "Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses. It is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. The company also exports its products to the United States, the European Union, and internationally. The company is based in Jingmen, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Jingmen",
        "zipcode": null,
        "website": "http://www.biocause.com",
        "market_cap": "Mid Cap"
    },
    "000640.KS": {
        "short_name": "Donga Socio Holdings",
        "long_name": "Dong-A Socio Holdings Co., Ltd.",
        "summary": "Dong-A Socio Holdings Co., Ltd. engages in the pharmaceutical business in South Korea and internationally. It offers DA-3801 (Gonadopin) for the treatment of controlled ovarian hyper-stimulation in ART and ovulation induction in anovulatory women; and DA-3031 (Dulastin) for the treatment of neutropenia. The company also develops DA-3880 that completed Phase I in European Union and Phase III in Japan for the treatment of anemia; DMB-3111, which completed Phase I in Japan and Phase III in European Union for the treatment of breast cancer; DMB-3113, a Phase I product for the treatment of rheumatoid arthritis; DA-3131 for the treatment of age-related macular degeneration; and DA-3115 for the treatment of psoriasis. Dong-A Socio Holdings Co., Ltd. was founded in 1932 and is based in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.donga.co.kr",
        "market_cap": "Small Cap"
    },
    "000650.SZ": {
        "short_name": "RENHE PHARMACY CO",
        "long_name": "Renhe Pharmacy Co., Ltd.",
        "summary": "Renhe Pharmacy Co., Ltd. produces and sells pharmaceutical products. It offers Chinese and western medicines; chemical drugs; dietary supplements; and active pharmaceutical ingredients. It also provides health related products, such as oral solid and liquid dosages, large and small volume injections, lotions for external use, liniments, suppositories, and ointments; and eye drops, bulk medicines, hard and soft capsules, and granules tablets. The company was founded in 1996 and is based in Nanchang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Nanchang",
        "zipcode": "330038",
        "website": "http://www.renheyaoye.com",
        "market_cap": "Small Cap"
    },
    "000661.SZ": {
        "short_name": "CHANGCHUN HIGH NEW",
        "long_name": "Changchun High & New Technology Industry (Group) Inc.",
        "summary": "Changchun High & New Technology Industry (Group) Inc., together with its subsidiaries, manufactures and sells biopharmaceuticals and proprietary Chinese medicines in China. It also engages in real estate development, property management, and real estate leasing services. The company was founded in 1993 and is based in Changchun, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Changchun",
        "zipcode": "130021",
        "website": "http://www.cchn.com.cn",
        "market_cap": "Large Cap"
    },
    "000739.SZ": {
        "short_name": "APELOA PHARMACEUTI",
        "long_name": "Apeloa Pharmaceutical Co.,Ltd",
        "summary": "Apeloa Pharmaceutical Co.,Ltd researches and develops, produces, and sells pharmaceutical products in China and internationally. It provides products in the cardio-cerebrovascular, anti-infection, anti-viral, anti-tumor, and other treatment areas. The company offers preparations, raw material intermediates, and veterinary drugs primarily under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. It also provides contract research and development, and production services for pharmaceutical companies. The company is headquartered in Dongyang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Dongyang",
        "zipcode": "322118",
        "website": "http://www.apeloa.com",
        "market_cap": "Mid Cap"
    },
    "000756.SZ": {
        "short_name": "SHANDONG XINHUA PH",
        "long_name": "Shandong Xinhua Pharmaceutical Company Limited",
        "summary": "Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical Bulk Drugs, Preparations, and Chemical Intermediates and Other products. It offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for central nervous system diseases; and other drugs under the brand of Xinhua. The company also provides prepared Chinese herbal medicine for decoction, traditional Chinese medicines, chemical raw materials, chemical preparations, antibiotics, biochemical medicines, chemical bulk drugs, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc. In addition, it offers raw materials and intermediates, powders for injection and tablets, and bulk pharmaceutical and intermediates; tablets, hard capsules, granules, and dry suspension; imports and exports goods and technologies; designs medical projects; develops and sells real estate; and health products research and development activities. Additionally, the company engages in the certification and import and export business; electrical equipment engineering; and installation and testing of chemical equipment and electrical equipment, as well as sales of mechanical, hardware, and electrical equipment. It also provides contract manufacturing services of APIs and pharmaceutical intermediates, as well as OTC and generic products; and internet data services, internet sales, and internet information services for pharmaceuticals and medical devices, etc. The company operates in the People's Republic of China, the Americas, Europe, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Zibo",
        "zipcode": "255086",
        "website": "http://www.xhzy.com",
        "market_cap": "Small Cap"
    },
    "000766.SZ": {
        "short_name": "TONGHUA GH PHARMAC",
        "long_name": "Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd",
        "summary": "Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products primarily focus on the rheumatism, digestion, cancer, and gynecology fields. The company offers traditional Chinese medicines, such as gynecological, rheumatic and bone pain, urology, detoxification, cardio-cerebral, digestive, respiratory, diabetes, and pediatric medication products, as well as anti-tumor drugs, prescription and OTC drugs, and Western medicines. The company offers its products in the form of capsules, tablets, injections, liquids, etc. Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. was founded in 1990 and is based in Tonghua, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Tonghua",
        "zipcode": "134001",
        "website": "http://www.thjm.cn",
        "market_cap": "Small Cap"
    },
    "000788.SZ": {
        "short_name": "PKU HEALTHCARE COR",
        "long_name": "PKU HealthCare Corp.,Ltd.",
        "summary": "PKU HealthCare Corp.,Ltd. researches, develops, manufactures, and exports pharmaceutical preparations in western China. The company offers various products, including anti-microbials, anti-tumor, cardiovascular, anti-allergy, nonsteroidal anti-inflammatory products, as well as blood sugar products, regulatory immune anti-tumor, digestive system, and blood volume expanders. It also provides treatment of mental disorders and other products. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013. PKU HealthCare Corp.,Ltd. was founded in 1965 and is based in Chongqing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Chongqing",
        "zipcode": "401121",
        "website": "http://www.pku-hc.com",
        "market_cap": "Small Cap"
    },
    "000790.SZ": {
        "short_name": "CHENGDU HUASUN TEC",
        "long_name": "Chengdu Huasun Technology Group Inc., Ltd.",
        "summary": "Chengdu Huasun Technology Group Inc., Ltd. manufactures and sells medicines, bio-pharmaceutical products, and building steel structures. The company manufactures modern Chinese medicines, traditional Chinese medicines, and chemical medicines; and sells drugs. It also engages in the research and development, production, and sale of biological products and biotechnology drugs; and medicines for the treatment of cardiovascular and cerebrovascular diseases. In addition, the company designs, produces, installs, and services steel structure buildings. The company was formerly known as Chengdu Taihe Health Technology Group Inc., Ltd. and changed its name to Chengdu Huasun Technology Group Inc., Ltd. in April 2020. Chengdu Huasun Technology Group Inc., Ltd. was founded in 1998 and is based in Chengdu, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Chengdu",
        "zipcode": null,
        "website": "http://www.thjkjt.com",
        "market_cap": "Small Cap"
    },
    "000915.SZ": {
        "short_name": "SHANDONG WIT DYNE",
        "long_name": "Shandong Shanda Wit Science and Technology Co., Ltd.",
        "summary": "Shandong Shanda Wit Science and Technology Co., Ltd. engages in the pharmaceutical and environment protection businesses in China. Its medical products include azithromycin granules, licorice zinc granules, combined calcium carbonate, vitamin AD drops, epalat tablet, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company's environmental products comprise deep disc filters, sulfuric acid diluents, industrial wastewater treatment solutions, chlorine dioxide generators, chlorine dioxide preparation devices, and power plant flue gas desulfurization and denitrification total contracting devices, as well as involved in the planning and construction of constructed wetland. Its environmental products also consists of optional equipment and raw materials; chlorine dioxide disinfectants, compounds, and composites; gas exhaust treatment; and solid waste treatment. The company also provides information products comprising DLP splicing display units, LCD splicing display units, image stitching processors, industrial automation control products, and communication products; and modified asphalt products, rubber asphalt non - curing waterproof materials, and asphalt anti \u00c2\u0096 corrosion products. In addition, it is involved in the design and installation of display, communications, and industrial control system; system integration; research, development, and production of high-performance road modified and waterproof asphalt products; property rental and management activities; and provision of education services. Shandong Shanda Wit Science and Technology Co., Ltd. was founded in 1993 and is based in Jinan, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Jinan",
        "zipcode": "250061",
        "website": "http://www.sd-wit.com",
        "market_cap": "Small Cap"
    },
    "000919.SZ": {
        "short_name": "JINLING PHARMACEUT",
        "long_name": "Jinling Pharmaceutical Company Limited",
        "summary": "Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products in China. The company offers Mailuoning injection for the treatment of thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and sequelae, multiple arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, thrombophlebitis, etc.; ferrous succinate tablets for the prevention and treatment of iron deficiency anemia; and lentinan injection for treatment of malignant tumors. It also provides medical health care services. Jinling Pharmaceutical Company Limited is based in Nanjing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Nanjing",
        "zipcode": "210058",
        "website": "http://www.jlyy000919.com",
        "market_cap": "Small Cap"
    },
    "000963.SZ": {
        "short_name": "HUADONG MEDICINE",
        "long_name": "Huadong Medicine Co., Ltd",
        "summary": "Huadong Medicine Co., Ltd. produces and sells various pharmaceutical products in China. The company offers Chinese patent drugs, immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, and antibiotic drugs. Its products include gastrointestinal agents, APIs, and other products. The company also engages in the production and management of traditional Chinese and western raw medicines and preparations, and health care products; sale of biological products as a proxy; wholesale of TCM materials, TCM decoction pieces, chemical preparations, etc.; warehousing and storage business; and research, development, production, and sale of aesthetic medicine products. Huadong Medicine Co., Ltd. was founded in 1993 and is headquartered in Hangzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Hangzhou",
        "zipcode": "310011",
        "website": "http://www.eastchinapharm.com",
        "market_cap": "Large Cap"
    },
    "000989.SZ": {
        "short_name": "JIUZHITANG CO.LTD",
        "long_name": "Jiuzhitang Co., Ltd.",
        "summary": "Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. The company offers shuxuetong injections, Angong Niuhuang Wan, Danxi granules, and Gastrodia Uncaria for cardiovascular and cerebrovascular disease; Guizhi Fuling pills, Buxue Shengru granules, and hemostasis and analgesia products for gynecological disease; Schicon for respiratory disease; and Jiaqi Ganzian granules, Jianwei Yuyang tablets, Jienchang Ning, and Chidan yellowing products for digestive disease. It also provides non-prescription drugs for treating nourishing QI and blood, cardiovascular and cerebrovascular, urinary system, pediatric, gynecological, skeletal muscle, respiratory, dermatology, nervous system, ENT, digestive system, and tumor diseases. Jiuzhitang Co., Ltd. was founded in 1999 and is headquartered in Beijing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Beijing",
        "zipcode": "100026",
        "website": "http://www.hnjzt.com",
        "market_cap": "Small Cap"
    },
    "000999.SZ": {
        "short_name": "CHINA RESOURCES SA",
        "long_name": "China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.",
        "summary": "China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in the People's Republic of China and internationally. It also provides related health services. The company offers OTC products, including cold, skin, gastrointestinal, cough relieving, orthopedics, and pediatrics drugs; prescription drug products in traditional Chinese medicine, tumors, cardiovascular and cerebrovascular, digestive system, orthopedics, and pediatrics; Chinese medicine injections; formula granules; and anti-infective drugs. It sells its products under 999 family medicine brands, Sanjiuweitai series, 999 Ganmaoling series, 999 dermatitis series, and other products. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. The company was founded in 1999 and is based in Shenzhen, the People's Republic of China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources (Holdings) Co., Ltd.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shenzhen",
        "zipcode": "518110",
        "website": "http://www.999.com.cn",
        "market_cap": "Mid Cap"
    },
    "002001.SZ": {
        "short_name": "ZHEJIANG NHU CO",
        "long_name": "Zhejiang NHU Company Ltd.",
        "summary": "Zhejiang NHU Company Ltd. engages in the production and sale of nutritional products, aroma chemicals, and polymer materials in China. The company offers nutrition products, comprising feed and food additives, such as vitamin E, vitamin A, vitamin C, DL-Methionine, vitamin D3, D-Biotin, coenzyme Q10, carotenoids, etc.; and aroma chemicals, including linalool series, citral series, leaf alcohol series, methyl dihydro jasmonate, raspberry ketone, ligustral, etc. for daily chemicals, food, and medicine fields. Zhejiang NHU Company Ltd. was founded in 1999 and is based in Xinchang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Xinchang",
        "zipcode": "312500",
        "website": "http://www.cnhu.com",
        "market_cap": "Large Cap"
    },
    "002004.SZ": {
        "short_name": "HUAPONT-LIFE SCIEN",
        "long_name": "Huapont Life Sciences Co., Ltd.",
        "summary": "Huapont Life Sciences Co., Ltd. engages in the pharmaceutical and agrochemical businesses in China and internationally. It is involved in the research and development, production, sale, and services of pesticide intermediates, original drugs, and preparations. The company also offers medicines for skin and other applications, as well as provides medical services. The company was formerly known as Huapont-Nutrichem Co., Ltd. and changed its name to Huapont Life Sciences Co., Ltd. in September 2015. Huapont Life Sciences Co., Ltd. was founded in 2001 and is based in Chongqing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Chongqing",
        "zipcode": "401121",
        "website": "http://www.huapont.com.cn",
        "market_cap": "Mid Cap"
    },
    "002020.SZ": {
        "short_name": "ZHEJIANG JINGXIN P",
        "long_name": "Zhejiang Jingxin Pharmaceutical Co., Ltd.",
        "summary": "Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China and internationally. The company offers APIs, antihypertensive products, antibiotics, quinolones, gastrointestinal promotions, antidiabetics, antipileptics, antihistamines, H+ pump depressants, antihyper cholesterolemia products, histamine H2 receptor blokades, antihyper cholesterolemirs, antidepressants, cephalosporin products, and biopharma products. It also provides diagnostic medical displays, surgical medical displays, clinical medical displays, medical large screens, medical integrated machines, ultrasonic medical displays, and other products. The company was formerly known as Zhejiang Jingxin Pharmaceutical Factory and changed its name to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000. Zhejiang Jingxin Pharmaceutical Co., Ltd. was founded in 1974 and is headquartered in Xinchang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Xinchang",
        "zipcode": "312500",
        "website": "http://www.jingxinpharm.com",
        "market_cap": "Small Cap"
    },
    "002099.SZ": {
        "short_name": "ZHEJIANG HISOAR PH",
        "long_name": "Zhejiang Hisoar Pharmaceutical Co., Ltd.",
        "summary": "Zhejiang Hisoar Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells fine chemicals and special raw drugs in China and internationally. It offers antibiotic, anti-virus, cardiovascular, sugar-reducing, and other materials; and medicine intermediates, and other customized and processed products, such as clindamycin, 4-AA Iso-carbapenem series, thiamphenicol, florfenicol, voglibose, eclindamycin, 4-AA iso-carbapenem, thiamphenicol, florfenicol, voglibose, etc. It also exports its products. The company was founded in 1966 and is based in Taizhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Taizhou",
        "zipcode": "318000",
        "website": "http://www.hisoar.com",
        "market_cap": "Small Cap"
    },
    "002107.SZ": {
        "short_name": "SHANDONG WOHUA PHA",
        "long_name": "Shandong Wohua Pharmaceutical Co., Ltd.",
        "summary": "Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. It offers Xinkeshu tablets, Naoxueshu oral solutions, Tongluo Huayu capsules, oral liquids, and Zhenju Jiangya tablets for cardiovascular and cerebrovascular; respiratory system drugs; medicines for women and children; urinary system drugs; heat purging fire drugs; digestive system drugs; anti-rheumatic drugs; and drugs for soothe the nerves. The company is based in Weifang, China. Shandong Wohua Pharmaceutical Co., Ltd. is a subsidiary of Beijing Zhongzheng Wanrong Investment(Group) Co., Ltd.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Weifang",
        "zipcode": "261205",
        "website": "http://www.wohua.cn",
        "market_cap": "Small Cap"
    },
    "002118.SZ": {
        "short_name": "JILIN ZIXIN PHARMA",
        "long_name": "Jilin Zixin Pharmaceutical Industrial Co.,Ltd.",
        "summary": "Jilin Zixin Pharmaceutical Industrial Co.,Ltd researches, develops, produces, and sells Chinese medicines, gene sequencers, and supporting reagents in China. It provides ginseng products; prescription products; OTC drugs; and other products. Jilin Zixin Pharmaceutical Industrial Co.,Ltd was founded in 1998 and is based in Changchun, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Changchun",
        "zipcode": "130041",
        "website": "http://www.jilinzixin.com.cn",
        "market_cap": "Small Cap"
    },
    "002219.SZ": {
        "short_name": "HENGKANG MEDICAL G",
        "long_name": "Hengkang Medical Group Co.,Ltd",
        "summary": "Hengkang Medical Group Co.,Ltd provides medical services, pharmaceuticals, health care, and daily products in China and internationally. It operates hospitals. The company also manufactures pharmaceutical products in the areas of pain, cold, cough, gynecology, cardiovascular, digestive, and urinary systems. In addition, it offers Chinese herbal medicines, infusion, and hemostasis products, as well as daily care products, including toothpaste and toothbrush. The company was formerly known as Gansu Duyiwei Biological Pharmaceutical Co., Ltd. and changed its name to Hengkang Medical Group Co.,Ltd in January 2014. Hengkang Medical Group Co.,Ltd. was founded in 2001 and is based in Chengdu, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Chengdu",
        "zipcode": "610063",
        "website": "http://www.hkmg.com",
        "market_cap": "Small Cap"
    },
    "002262.SZ": {
        "short_name": "JIANGSU NHWA PHARM",
        "long_name": "Jiangsu Nhwa Pharmaceutical Co., LTD",
        "summary": "Jiangsu Nhwa Pharmaceutical Co., LTD produces and sells central nervous system drugs in China and internationally. It offers drugs in the anesthesia, psychiatry, and neurological categories. The company also provides APIs in the areas of central nervous system, anesthetic and sedative, anti-fungal, and others. In addition, it is developing various cardiovascular products, such as Iptakalim, an anti-hypertension drug. The company has a collaborative research agreement with the Ann Romney Center for Neurologic Diseases at Brigham, and Women's Hospital and Biodextris to develop a novel immuno-stimulatory therapy for neurologic disorders. Jiangsu Nhwa Pharmaceutical Co., LTD was founded in 1978 and is based in Xuzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Xuzhou",
        "zipcode": "221009",
        "website": "http://www.nhwa-group.com",
        "market_cap": "Mid Cap"
    },
    "002317.SZ": {
        "short_name": "GUANGDONG ZHONGSHE",
        "long_name": "Guangdong Zhongsheng Pharmaceutical Co., Ltd.",
        "summary": "Guangdong Zhongsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company offers Chinese and chemical medicines. It is also involved in the research and development of products in the fields of ophthalmology, cardiovascular, cerebrovascular, respiratory, digestive, diabetes, tumor, and senile degenerative diseases. The company was founded in 1979 and is based in Dongguan, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Dongguan",
        "zipcode": null,
        "website": "http://www.zspcl.com",
        "market_cap": "Small Cap"
    },
    "002332.SZ": {
        "short_name": "ZHEJIANG XIANJU PH",
        "long_name": "Zhejiang Xianju Pharmaceutical Co.,Ltd.",
        "summary": "Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide. It offers active pharmaceutical ingredients, such as steroid drugs, and male and female hormones; intermediates; and finished formulations in the form of tablets, capsules, granules, soft capsules, powder inhalations, creams, gels, injections, and powder-injections. The company was founded in 1972 and is based in Xianju, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Xianju",
        "zipcode": "317300",
        "website": "http://en.xjpharma.com/",
        "market_cap": "Mid Cap"
    },
    "002349.SZ": {
        "short_name": "NANTONG JINGHUA PH",
        "long_name": "Nantong Jinghua Pharmaceutical Co., Ltd.",
        "summary": "Nantong Jinghua Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs. The company was founded in 1957 and is based in Nantong, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Nantong",
        "zipcode": "226407",
        "website": "http://www.jinghuapharm.com",
        "market_cap": "Small Cap"
    },
    "002365.SZ": {
        "short_name": "QIANJIANG YONGAN P",
        "long_name": "Qianjiang Yongan Pharmaceutical Co., Ltd.",
        "summary": "Qianjiang Yongan Pharmaceutical Co., Ltd. manufactures and sells taurine in China and internationally. The company was founded in 2001 and is based in Qianjiang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Qianjiang",
        "zipcode": "433132",
        "website": "http://www.chinataurine.com",
        "market_cap": "Small Cap"
    },
    "002370.SZ": {
        "short_name": "ZHEJIANG YATAI PHA",
        "long_name": "Zhejiang Yatai Pharmaceutical Co., Ltd.",
        "summary": "Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers tablets, capsules, patches, powder injections, and troches. It also provides chemical agents and raw materials, and diagnostic reagents, as well as pharmaceutical research and development outsourcing services. Zhejiang Yatai Pharmaceutical Co., Ltd. was founded in 1989 and is based in Shaoxing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shaoxing",
        "zipcode": "312030",
        "website": "http://en.ytyaoye.com",
        "market_cap": "Small Cap"
    },
    "002390.KS": {
        "short_name": "HANDOK",
        "long_name": "HANDOK Inc.",
        "summary": "Handok Inc. operates as an integrated pharmaceutical company. The company provides ETC and OTC drugs, medical devices, and in-vitro diagnostics instruments and devices. It focuses on various therapeutic areas, such as oncology, diabetes and metabolic disorders, CNS orphan diseases, eye disorders, and other disease areas. The company also offers healthcare products comprising food supplements under the NatureSet and Culturelle brands; food and beverages; and medical nutrition products. The company was formerly known as Handok Pharmaceuticals Co., Ltd and changed its name to Handok Inc. in July 2013. Handok Inc. was founded in 1954 and is based in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": "06235",
        "website": "http://www.handok.co.kr",
        "market_cap": "Small Cap"
    },
    "002390.SZ": {
        "short_name": "GUIZHOU XINBANG PH",
        "long_name": "Guizhou Xinbang Pharmaceutical Co., Ltd.",
        "summary": "Guizhou Xinbang Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of Chinese herbal medicines and biological drugs in China and internationally. It offers cardiovascular and cerebrovascular, digestive system, endocrine, tumor and immune regulation, blood system, rheumatism and rheumatoid, urinary system, antipyretic analgesic, cold medication, gynecological treatment, and anti-infective drugs. The company was founded in 1995 and is headquartered in Guiyang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Guiyang",
        "zipcode": "550018",
        "website": "http://www.xinbang.com",
        "market_cap": "Mid Cap"
    },
    "002393.SZ": {
        "short_name": "TIANJIN LISHENG PH",
        "long_name": "Tianjin Lisheng Pharmaceutical Co.,Ltd.",
        "summary": "Tianjin Lisheng Pharmaceutical Co.,Ltd. researches and develops medicines. The company offers raw materials, drugs, and medicinal plastic bottles. It also exports its products. The company was founded in 1951 and is based in Tianjin, China. Tianjin Lisheng Pharmaceutical Co.,Ltd. is a subsidiary of Tianjin Pharmaceutical Holdings Ltd.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Tianjin",
        "zipcode": "300385",
        "website": "http://www.lishengpharma.com",
        "market_cap": "Small Cap"
    },
    "002412.SZ": {
        "short_name": "HUNAN HANSEN PHARM",
        "long_name": "Hunan Hansen Pharmaceutical Co., Ltd.",
        "summary": "Hunan Hansen Pharmaceutical Co., Ltd. produces and sells Chinese and western medicines in China and internationally. It provides medicines in injection, oral liquid, tablet, capsule, granule, syrup, ointment, tincture, pill, and other forms. The company is based in Yiyang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Yiyang",
        "zipcode": "413000",
        "website": "http://www.hansenzy.com",
        "market_cap": "Small Cap"
    },
    "002424.SZ": {
        "short_name": "GUIZHOU BAILING GR",
        "long_name": "Guizhou Bailing Group Pharmaceutical Co., Ltd.",
        "summary": "Guizhou Bailing Group Pharmaceutical Co., Ltd. researches, develops, produces, and sells Chinese medicines in China. The company provides medicines in the form of tablets, capsules, granules, syrups, pills, powders, tinctures, sprays, and ointments for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases. Guizhou Bailing Group Pharmaceutical Co., Ltd. was founded in 2005 and is based in Anshun, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Anshun",
        "zipcode": null,
        "website": "http://www.gzbl.com",
        "market_cap": "Small Cap"
    },
    "002433.SZ": {
        "short_name": "GUANGDONG TAIANTAN",
        "long_name": "Guangdong Taiantang Pharmaceutical Co., Ltd.",
        "summary": "Guangdong Taiantang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of traditional Chinese medicines in China. It offers medicines for the areas, including reproductive male, reproductive gynecology, cardiovascular, dermatology, pediatrics, respiratory, replenishment, digestive hepatobiliary, rheumatology, and health and other areas. Goangdong Taiantang Pharmaceutical Co., Ltd. was founded in 1995 and is headquartered in Shanghai, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shanghai",
        "zipcode": null,
        "website": "http://www.pibao.cn",
        "market_cap": "Small Cap"
    },
    "002437.SZ": {
        "short_name": "HARBIN GLORIA PHAR",
        "long_name": "Harbin Gloria Pharmaceuticals Co., Ltd",
        "summary": "Harbin Gloria Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products primarily in the People's Republic of China. It offers cardiac cerebrovascular medication, skeletal muscle system, vitamins and minerals, urinary system medication, antitumor medication, anti-infective drugs, respiratory medication, antihistamine, peptic, and other products. Harbin Gloria Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Harbin, the People's Republic of China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Harbin",
        "zipcode": "150025",
        "website": "http://www.gloria.cc",
        "market_cap": "Small Cap"
    },
    "002550.SZ": {
        "short_name": "CHANGZHOU QIANHONG",
        "long_name": "Changzhou Qianhong Biopharma CO.,LTD",
        "summary": "Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with the focus on polysaccharides and enzymes in China. The company provides various API products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; kallidinogenase kallikrein for use in the treatment of microcirculation disorders; and heparinoid. It also offers a range of preparations, such as nadroparin calcium PFS, enoxaparin sodium PFS, dalteparin sodium PFS, and asparaginase and heparin sodium injections for use as anticoagulants. In addition, the company exports its products. Changzhou Qianhong Biopharma CO.,LTD was founded in 1971 and is based in Changzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Changzhou",
        "zipcode": "213022",
        "website": "http://www.qhsh.com.cn",
        "market_cap": "Small Cap"
    },
    "002620.KS": {
        "short_name": "JEIL PHARMA HOLDINGS",
        "long_name": "Jeil Pharma Holdings Inc",
        "summary": "Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. Jeil Pharma Holdings Inc was founded in 1959 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": "06543",
        "website": "http://www.jeilpharm.co.kr",
        "market_cap": "Small Cap"
    },
    "002626.SZ": {
        "short_name": "XIAMEN KINGDOMWAY",
        "long_name": "Xiamen Kingdomway Group Company",
        "summary": "Xiamen Kingdomway Group Company engages in the manufacturing and sale of the nutrition and health resources in China and internationally. It offers a series of raw material products, including coenzyme Q10, VA, VD3, microalgae DHA, and plant ARA, as well as provides dietary supplements and sports nutrition products. The company was formerly known as Xiamen Jindawei Vitamin Co., Ltd. Xiamen Kingdomway Group Company was founded in 1997 and is based in Xiamen, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Xiamen",
        "zipcode": null,
        "website": "http://www.kingdomway.com",
        "market_cap": "Mid Cap"
    },
    "002644.SZ": {
        "short_name": "LANZHOU FOCI PHARM",
        "long_name": "LanZhou Foci Pharmaceutical Co.,Ltd.",
        "summary": "LanZhou Foci Pharmaceutical Co.,Ltd., a pharmaceutical company, manufactures and sells traditional Chinese medicines in China. It provides its products in various dosage forms, including pills, tablets, granules, capsules, concentrated decoctions, mixtures, oral liquids, syrups, and medicinal wines under the Min Shan and Foci brands. The company also engages in researching activities for the development of new herbal drugs. It also exports its products to approximately 27 countries, which include the United States, Canada, Japan, Singapore, Indonesia, Thailand, Malaysia, New Zealand, Australia, Russia, Ukraine, Hong Kong, etc. The company was founded in 1929 and is based in Lanzhou, China. LanZhou Foci Pharmaceutical Co.,Ltd. is a subsidiary of Lanzhou Foci Pharmaceutical Factory.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Lanzhou",
        "zipcode": null,
        "website": "http://www.fczy.com",
        "market_cap": "Small Cap"
    },
    "002688.SZ": {
        "short_name": "JINHE BIOTECHNOLOG",
        "long_name": "Jinhe Biotechnology CO., LTD.",
        "summary": "Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. The company offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pheumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well as bacterial diseases, including paratyphoid and cholera. It also exports its products to the United States, South-east Asia, Latin America, Europe, etc. The company is based in Dalian, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Dalian",
        "zipcode": "116023",
        "website": "http://www.jinhe.com.cn",
        "market_cap": "Small Cap"
    },
    "002693.SZ": {
        "short_name": "HAINAN SHUANGCHENG",
        "long_name": "Hainan Shuangcheng Pharmaceuticals Co., Ltd.",
        "summary": "Hainan Shuangcheng Pharmaceuticals Co., Ltd. researches, develops, manufactures, and markets synthesized peptide drugs and active pharmaceutical ingredients worldwide. It offers somatostatin, thymosin, clindamycin hydrochloride, thymopentin, L-carnitine, uranin hydrobromide, inosine, cyclophosphine adenosine, motidine, scopolamine, and sodium ferulate for injections, as well as vitamin B6. The company was founded in 2000 and is based in Haikou, the People's Republic of China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Haikou",
        "zipcode": "570311",
        "website": "http://www.shuangchengmed.com",
        "market_cap": "Micro Cap"
    },
    "002720.KS": {
        "short_name": "Kukje Pharma",
        "long_name": "Kukje Pharma Co., Ltd.",
        "summary": "Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, and other ETC products. The company was founded in 1959 and is headquartered in Seongnam, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seongnam-si",
        "zipcode": null,
        "website": "http://www.kukjepharm.co.kr",
        "market_cap": "Micro Cap"
    },
    "002728.SZ": {
        "short_name": "TEYI PHARMACEUTICA",
        "long_name": "Teyi Pharmaceutical Group Co.,Ltd",
        "summary": "Teyi Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of proprietary Chinese medicines, and chemical preparations, raw materials, and products in China. The company offers cough and phlegm, kidney, anti- infection, cardiovascular, and digestive system drugs. Its chemical raw materials and products include aluminum magnesium carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, strontium and tannic acid, and zinc sulfate. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co., Ltd. in November 2016. Teyi Pharmaceutical Group Co., Ltd. is based in Taishan, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Taishan",
        "zipcode": "529200",
        "website": "http://www.tczy.com.cn",
        "market_cap": "Small Cap"
    },
    "002737.SZ": {
        "short_name": "SUNFLOWER PHARMACE",
        "long_name": "Sunflower Pharmaceutical Group Co.,Ltd",
        "summary": "Sunflower Pharmaceutical Group Co.,Ltd develops, manufactures, and sells Chinese pharmaceuticals in China. The company produces Chinese patent medicines, chemicals, biological medicines, and health care medicines. Its products include children's medicines, digestive medicines, flu medicines, gynecologic medicines, liver and gallbladder gastrointestinal medicines, cold medicines, rheumatic medicines, heart and brain vascular medicines, geriatrics and chronic disease medicines, cardiovascular medicines, etc. under the Sun Flower and Little Sun Flower brands. The company was founded in 2005 and is based in Harbin, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Harbin",
        "zipcode": null,
        "website": "http://www.kuihuayaoye.com",
        "market_cap": "Small Cap"
    },
    "002750.SZ": {
        "short_name": "KUNMING LONGJIN PH",
        "long_name": "Kunming Longjin Pharmaceutical Co., Ltd.",
        "summary": "Kunming Longjin Pharmaceutical Co., Ltd. develops, produces, and sells natural botanicals and chemical freeze-dried powder injections in China. It offers Chinese, biochemical, chemical, cardio-cerebral vascular, and digestive system medicines; immune system and first aid medications; and vitamins, minerals, and enteral and parenteral nutrition products. The company was founded in 1996 and is based in Kunming, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Kunming",
        "zipcode": "650503",
        "website": "http://www.longjin.com.cn",
        "market_cap": "Small Cap"
    },
    "002773.SZ": {
        "short_name": "CHENGDU KANGHONG P",
        "long_name": "Chengdu Kanghong Pharmaceuticals Group Co., Ltd",
        "summary": "Chengdu Kanghong Pharmaceuticals Group Co., Ltd engages in the research, development, production, and sale of biological products, Chinese medicines, and chemical drugs in China. It offers ophthalmic system, central nervous system, digestive system, and other system drugs. The company was founded in 1996 and is headquartered in Chengdu, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Chengdu",
        "zipcode": null,
        "website": "http://www.cnkh.com",
        "market_cap": "Mid Cap"
    },
    "002793.SZ": {
        "short_name": "LUOXIN PHARMACEUTI",
        "long_name": "Luoxin Pharmaceuticals Group Stock Co., Ltd.",
        "summary": "Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers medical treatment and health services. The company was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and changed its name to Luoxin Pharmaceuticals Group Stock Co., Ltd. in April 2020. Luoxin Pharmaceuticals Group Stock Co., Ltd. is based in Linyi, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shanghai",
        "zipcode": "201210",
        "website": "http://www.luoxin.cn",
        "market_cap": "Mid Cap"
    },
    "002817.SZ": {
        "short_name": "ANHUI HUANGSHAN CA",
        "long_name": "Anhui Huangshan Capsule Co., Ltd.",
        "summary": "Anhui Huangshan Capsule Co., Ltd. manufactures and sells vacant hard capsules. It offers entersoluble vacant gelatin capsules, vegetable entersoluble capsules, vacant gelatin capsules, colon soluble vacant gelatin capsules, vegetable capsules, and pulluan capsules. The company was founded in 1989 and is based in Jingde, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Jingde",
        "zipcode": "242605",
        "website": "http://www.hsjn.com",
        "market_cap": "Micro Cap"
    },
    "002864.SZ": {
        "short_name": "SHAANXI PANLONG PH",
        "long_name": "Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd",
        "summary": "Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells drugs and GAP cultivation of medicinal materials in China. It offers orthopedic, cardio-cerebrovascular, digestive, supplement category, respiratory, Chinese anti-inflammatory, pediatric, gynecology, hepatobiliary, and specialty drugs. The company was founded in 1992 and is headquartered in Xi'an, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Xi'an",
        "zipcode": "710025",
        "website": "http://www.pljt.com",
        "market_cap": "Small Cap"
    },
    "002880.SZ": {
        "short_name": "SHENZHEN WEIGUANG",
        "long_name": "Shenzhen Weiguang Biological Products Co., Ltd.",
        "summary": "Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human albumin, intravenous immunoglobulin (pH4), freeze-dried intravenous human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies patient immunoglobulin, tetanus human immunoglobulin, histamine human immunoglobulin, and human fibrinogen, as well as a total of 9 varieties and 21 specifications. Shenzhen Weiguang Biological Products Co., Ltd. was founded in 1985 and is based in Shenzhen, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shenzhen",
        "zipcode": "518107",
        "website": "http://www.szwg.com",
        "market_cap": "Small Cap"
    },
    "002900.SZ": {
        "short_name": "HARBIN MEDISAN PHA",
        "long_name": "Harbin Medisan Pharmaceutical Co., Ltd.",
        "summary": "Harbin Medisan Pharmaceutical Co., Ltd. researches, develops, produces, and sells chemical formulations in China. It offers Araxetan, alanyl glutamine, brain protein hydrolyzate, ligustrazine hydrochloride, bone peptide, Yanhuning, glucose, and sodium chloride injections, as well as rice nitrogen tablets, valsartan dispersible tablets, and other drugs for use in the various indications comprising nervous system, cardiovascular and cerebrovascular, musculoskeletal, systemic anti-infective, regulating water, electrolyte and acid-base balance, nutritional supplements, and other medical fields. The company was founded in 1996 and is based in Harbin, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Harbin",
        "zipcode": "150025",
        "website": "http://www.medisan.com.cn",
        "market_cap": "Small Cap"
    },
    "002907.SZ": {
        "short_name": "CHONGQING PHARSCIN",
        "long_name": "Chongqing Pharscin Pharmaceutical Co., Ltd.",
        "summary": "Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, hard capsules, soft capsules, powder injections, freeze-dried powder injections, small volume injections, API synthesis, and botanical drug extractions. It provides its products in the areas of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. The company is headquartered in Chongqing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Chongqing",
        "zipcode": "401120",
        "website": "http://www.pharscin.com",
        "market_cap": "Small Cap"
    },
    "002923.SZ": {
        "short_name": "ZHUHAI RUNDU PHARM",
        "long_name": "Zhuhai Rundu Pharmaceutical Co., Ltd.",
        "summary": "Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the research and development, production, and marketing of pharmaceutical ingredients for cardiovascular, gastrointestinal, CNS, and anesthesia. It offers APIs, intermediates, and pellets, as well as formulations in the forms of capsules, tablets, and injections. The company serves in the United States, Germany, Spain, Holland, Slovenia, Argentina, Brazil, Honduras, Japan, Korea, India, Jordan, Syria, Saudi Arabia, Algeria, Tunisia, Egypt, etc. Zhuhai Rundu Pharmaceutical Co., Ltd. was founded in 1997 and is based in Zhuhai, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Zhuhai",
        "zipcode": "519041",
        "website": "http://www.rdpharma.cn",
        "market_cap": "Small Cap"
    },
    "002940.SZ": {
        "short_name": "ZHEJIANG ANGLIKANG",
        "long_name": "Zhejiang AngLiKang Pharmaceutical CO.,LTD.",
        "summary": "Zhejiang Anglikang Pharmaceutical Co., Ltd. produces and sells bulk pharmaceutical materials, pharmaceutic preparations, and medical empty capsules. The company offers pharmaceutical preparations, such as Levamlodipine Besylate, Levofloxacin Hydrochloride, Nifedipine sustain-released, Cefaclor sustained-release, Cefpodoxime Proxetil tablets, as well as Cefaclor capsules and granules. It also provides APLs, including Cefradine, Cefalexin, Cefradine sterile with L-arginine, Cefadroxil, Cefaclor, Cefixime, Doxofylline, Oryzanol, Telmisartan, and 7-Amino-3-methyl-3-cephem-4-carboxylic acid, as well as Ketoleucine, Ketovaine, D, L-Ketoisoleucine, D, L-a-Hydroxymethionine, and Ketone phenylalanine calcium. The company was founded in 2001 and is based in Shengzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shengzhou",
        "zipcode": "312400",
        "website": "http://www.alkpharm.com",
        "market_cap": "Small Cap"
    },
    "003000.KS": {
        "short_name": "BukwangPharm",
        "long_name": "Bukwang Pharmaceutical Co., Ltd.",
        "summary": "Bukwang Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It manufactures oral solid dosage forms, injections, oral solutions, external-use solutions, and ointments. The company offers products in various therapeutic areas, including liver disease treatments, such as Levovir and Legalon; diabetic complication products comprising Dexid and Thioctacid; CNS disorder drugs consisting of Lonasen, Ixel, and Orfil; and respiratory disease treatments, which comprise Azeptin and Asima. It also provides OTC products; toothpastes, and hair and skin care goods; and nutritional supplements. In addition, the company offers products for antihistamines, hepatitis and gastrointestinal, sedative and antidote, anti-cancer, thyroid and osteoporosis, diabetes, obstetrics, urinogenital, cardiovascular, dermatology, obesity, pain relief, and muscle relaxant. Further, it provides products for bruises, skin and mucous membrane, rhinitis, cold symptoms, cough, phlegm and asthma, rheumatoid arthritis, osteoarthritis, pain caused by cold and fever, dysmenorrhea, NSAIDs, inflammation, joint inflammation, tinea pedis, infected wounds, dermatitis, antivirals-herpes, eczema, diarrhea, dyspepsia, sense of distension, anti-histamine, anti-ulcer, constipation, anemia, pregnant multivitamins, candidiasis, athlete's foot, onychomycosis, stomatitis, pimple, acne, physical fatigue, neuralgia, myalgia, and arthralgia. Additionally, the company offers medicines for period of lactation, rickets, night blindness, varicose vein, and sputum; and quasi drugs and medical devices, as well as health functional food. It also develops anti-diabetes compound with Melior Pharmaceuticals; and anti-cancer drugs with LSK BioPartners, as well as cell therapies using adult stem cells, as well as holds a license for a novel candidate to treat movement disorder in Parkinson's disease patients. The company was founded in 1960 and is based in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": "06955",
        "website": "http://www.bukwang.co.kr",
        "market_cap": "Small Cap"
    },
    "003060.KS": {
        "short_name": "Aprogen pharmaceuticals",
        "long_name": "Aprogen pharmaceuticals,Inc.",
        "summary": "Aprogen pharmaceuticals,Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-viral, anti-ulcerant, anti-epliepsy products; external agents; anti-cancer drugs; amino-acid nutrient transfusion agents; and cosmetics. The company was formerly known as Schnell Biopharmaceuticals, Inc. and changed its name to Aprogen pharmaceuticals,Inc. in April 2017. Aprogen pharmaceuticals,Inc. was founded in 1960 and is headquartered in Seongnam, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seongnam-si",
        "zipcode": null,
        "website": "http://en.aprogen-pharm.com/index.do",
        "market_cap": "Small Cap"
    },
    "003120.KS": {
        "short_name": "IlsungPharm",
        "long_name": "Ilsung Pharmaceuticals Co., Ltd.",
        "summary": "Ilsung Pharmaceuticals Co., Ltd. operates as a pharmaceutical company in South Korea. It offers antibiotics, analgesics, neuromuscular blocker, anesthetics, antipyretics, and cardiovascular system products. The company was founded in 1954 and is based in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.ilsung-ph.co.kr",
        "market_cap": "Micro Cap"
    },
    "003220.KS": {
        "short_name": "Daewonpharm",
        "long_name": "Daewon Pharmaceutical Co., Ltd.",
        "summary": "Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells medicine and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis uses. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 45 countries primarily in Asia, Central and South America, the Middle East, etc. The company was founded in 1958 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.daewonpharm.com",
        "market_cap": "Micro Cap"
    },
    "003520.KS": {
        "short_name": "YUNGJIN PHARM",
        "long_name": "Yungjin Pharm. Co., Ltd.",
        "summary": "Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea. It provides cephalosporin, general, and calcium APIs; antibiotic, central nervous system, cardiovascular, endocrine, respiratory, analgesic and anti-inflammatory, anti-histamine, anti-fungal, nutrition, and urinary formulations, as well as vitamins and supplements, and cosmetics; and tonic drinks. The company was founded in 1952 and is based in Seoul, South Korea. Yungjin Pharm. Co., Ltd. is a subsidiary of KT&G Corporation.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.yungjin.co.kr",
        "market_cap": "Small Cap"
    },
    "003850.KS": {
        "short_name": "BoryungPharm",
        "long_name": "Boryung Pharmaceutical Co., Ltd.",
        "summary": "Boryung Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in South Korea. The company offers cardiovascular products, antibiotics, anticancer products, amino acids and cosmetics, gastrointestinal products, and API's. It also exports its products to approximately 50 countries on 6 continents, including Japan, China, the Southeast Asia, the Middle East, Europe, South America, and Africa. The company was formerly known as Boryung Drugs Co., Ltd. and changed its name to Boryung Pharmaceutical Co., Ltd. in February 1966. Boryung Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": "03127",
        "website": "http://www.boryung.co.kr",
        "market_cap": "Small Cap"
    },
    "005500.KS": {
        "short_name": "SamjinPharm",
        "long_name": "Samjin Pharmaceuticals Co., Ltd.",
        "summary": "Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company's products include SA001, a clinical Phase II product for the treatment of dry eye syndrome; SJ-3366 for HIV that is in preclinical/clinical stage; and SJ-3902, SJP1601, SJP1604, SJP1803/1804, and SJP004, which are preclinical stage products for the treatment of cancer, AMD, and CNS disorders. Its products also comprise SJP1602, SJP1610, SJP1702, SJP1801, and SJP005 that are in biological testing stage for the treatment of cancer, RA, diabetes, and Alzheimer's; and SJP003, which is in clinical stage for the treatment of anti-coagulation disease. The company was founded in 1968 and is headquartered in Seoul, Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": "04054",
        "website": "http://www.samjinpharm.co.kr",
        "market_cap": "Micro Cap"
    },
    "007570.KS": {
        "short_name": "IlyangPharm",
        "long_name": "Ilyang Pharmaceutical Co.,Ltd",
        "summary": "Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages. In addition, the company offers pharmaceutical raw materials products, such as aluminum hydroxide gel, dried aluminum hydroxide gel, magnesium hydroxide, magnesium hydroxide gel, aluminum hydroxide-magnesium carbonate co-dried gel, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, aluminum phosphate gel, aluminum magnesium metasilicate, aluminum magnesium silicate, aluminum magnesium silicopolydrate, magaldrate, magaldrate wet gel, dihydroxy aluminum sodium carbonate, magnesium carbonate, aluminum magnesium hydroxide, synthetic aluminum silicate, and other products. Ilyang Pharmaceutical Co.,Ltd also exports its products to approximately 14 countries. The company was formerly known as Il-Yang Pharm. Ind. Co. and changed its name to Ilyang Pharmaceutical Co., Ltd. in May 1991. Ilyang Pharmaceutical Co.,Ltd was founded in 1946 and is headquartered in Yongin, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Yongin",
        "zipcode": "17096",
        "website": "http://www.ilyang.co.kr",
        "market_cap": "Small Cap"
    },
    "007575.KS": {
        "short_name": "IlyangPharm(1P)",
        "long_name": "Ilyang Pharmaceutical Co.,Ltd",
        "summary": "Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages. In addition, the company offers pharmaceutical raw materials products, such as aluminum hydroxide gel, dried aluminum hydroxide gel, magnesium hydroxide, magnesium hydroxide gel, aluminum hydroxide-magnesium carbonate co-dried gel, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, aluminum phosphate gel, aluminum magnesium metasilicate, aluminum magnesium silicate, aluminum magnesium silicopolydrate, magaldrate, magaldrate wet gel, dihydroxy aluminum sodium carbonate, magnesium carbonate, aluminum magnesium hydroxide, synthetic aluminum silicate, and other products. Ilyang Pharmaceutical Co.,Ltd also exports its products to approximately 14 countries. The company was formerly known as Il-Yang Pharm. Ind. Co. and changed its name to Ilyang Pharmaceutical Co., Ltd. in May 1991. Ilyang Pharmaceutical Co.,Ltd was founded in 1946 and is headquartered in Yongin, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Yongin",
        "zipcode": "17096",
        "website": "http://www.ilyang.co.kr",
        "market_cap": "Small Cap"
    },
    "008490.KS": {
        "short_name": "SUHEUNG",
        "long_name": "Suheung Co., Ltd.",
        "summary": "Suheung Co., Ltd. produces and sells empty hard capsules for use in pharmaceutical and nutraceutical applications. The company also offers contract manufacturing services for various dosage types and packaging combinations. It also provides OEM services for paintballs. Suheung Co., Ltd. was founded in 1973 and is based in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": "130-845",
        "website": "http://www.suheung.com",
        "market_cap": "Small Cap"
    },
    "009290.KS": {
        "short_name": "KwangdongPharm",
        "long_name": "Kwang Dong Pharmaceutical Co., Ltd.",
        "summary": "Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of antitussive expectorants, ophthalmic, liver disease agents, mineral preparations, vitamins, circulating system, and nutritious tonics; and ETC drugs in the areas of oral hypoglycemic agents, anti-arteriosclerotic agents, metabolic drugs, vitamins, digestive organ agents, circulating systems, immunosuppressants, obesity drugs, urinary genital and anal drugs, appetite suppressants, neuropsychiatric solvents, antispasmodics, antitussive expectorants, anti-vertigo drugs, antivirals agents, anti-malignant-tumor agents, and vasodilator, as well as antiepileptic, antihistaminic, antipyretic, analgesic, and anti-inflammatory agents. The company also provides general supplements, OTC drinks, consumer drinks, functional drinks, and traditional health foods. In addition, it engages in the operation of hospitals; and the retail and wholesale of products through discount stores, TV home shopping, and Internet shopping malls. Further, the company operates as a MRO total service provider for the raw/intermediate materials and consumables under various business models, such as the construction purchase service and overseas local purchase service. Kwang Dong Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.ekdp.com",
        "market_cap": "Small Cap"
    },
    "009420.KS": {
        "short_name": "HANALL BIOPHARMA",
        "long_name": "Hanall Biopharma Co.,Ltd",
        "summary": "Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes, osteoporosis, chronic kidney failure, hypothyroidism, vitamin D-resistant rickets, osteomalacia, erectile dysfunction, prostatic hyperplasia, candidiasis, various fungal infections, prostate cancer, formal, constipation, thin stools, bloating, bowel abnormal fermentation, and hemorrhoids. The company was founded in 1973 and is based in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.hanall.co.kr",
        "market_cap": "Small Cap"
    },
    "016580.KS": {
        "short_name": "WhaninPharm",
        "long_name": "Whan In Pharm Co.,Ltd.",
        "summary": "Whan In Pharm Co.,Ltd., a pharmaceutical company, develops, manufactures, markets, and sells therapeutic products in South Korea. It offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": "05855",
        "website": "http://www.whanin.com",
        "market_cap": "Micro Cap"
    },
    "017180.KS": {
        "short_name": "Myungmoon Pharm",
        "long_name": "MYUNGMOON Pharm co.,Ltd",
        "summary": "MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics, urogentital agents, adrenocortical hormone products, oncology agents, other preparations, fillers, and anti-obesity agents for pharmacotherapy. The company also provides OTC products, such as antinausants, genitourinary system products, anti gum disease products, hepatics, parasiticides, cathartic, oral disease products, antidiarrheal agents, digestive system products, cold drugs, calcium products, nasal sprays, multiple vitamin products, eye nutrition products, eye drops, blood circulation products, circulatory solvents, skin external preparations, and topical analgesic products. In addition, it offers health supplements, quasi drugs, and blended juices. MYUNGMOON Pharm co.,Ltd was founded in 1983 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": "06258",
        "website": "http://www.mmpharm.co.kr",
        "market_cap": "Micro Cap"
    },
    "019170.KS": {
        "short_name": "ShinpoongPharm",
        "long_name": "Shin Poong Pharm.Co.,Ltd.",
        "summary": "Shin Poong Pharm.Co.,Ltd. manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products. It also provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; and over the counter products. The company also exports its products to approximately 50 countries. Shin Poong Pharm.Co.,Ltd. was founded in 1962 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": "06246",
        "website": "http://shinpoong.co.kr",
        "market_cap": "Mid Cap"
    },
    "019175.KS": {
        "short_name": "ShinpoongPharm(1P)",
        "long_name": "Shin Poong Pharm.Co.,Ltd.",
        "summary": "Shin Poong Pharm.Co.,Ltd. manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products. It also provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; and over the counter products. The company also exports its products to approximately 50 countries. Shin Poong Pharm.Co.,Ltd. was founded in 1962 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": "06246",
        "website": "http://shinpoong.co.kr",
        "market_cap": "Mid Cap"
    },
    "0239.HK": {
        "short_name": "PAK FAH YEOW",
        "long_name": "Pak Fah Yeow International Limited",
        "summary": "Pak Fah Yeow International Limited, an investment holding company, together with its subsidiaries, manufactures, markets, and distributes healthcare products under the Hoe Hin brand name in the People's Republic of China, Hong Kong, Macau, Southeast Asia, North America, the United Kingdom, and internationally. It operates through three segments: Healthcare, Property Investments, and Treasury Investments. The company offers white flower embrocation medicated oils, strain relief products, and ointments under the under the Hoe Hin brand name, as well as F\u00c3\u00bazai 239, a floral-scented white flower embrocation. In addition, it invests in commercial, industrial, residential, and car park properties; and provides advertising agency services. The company was founded in 1927 and is headquartered in Wan Chai, Hong Kong.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Wan Chai",
        "zipcode": null,
        "website": "http://www.pakfahyeow.com",
        "market_cap": "Micro Cap"
    },
    "0455.HK": {
        "short_name": "TIANDA PHARMA",
        "long_name": "Tianda Pharmaceuticals Limited",
        "summary": "Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese and western medicines and biochemical drugs, etc., such as cardio-cerebrovascular drugs, pediatric drugs, anti-flu and respiratory system drugs, anti-infection drugs, detoxification agents, and other pharmaceutical products. The company offers its health care products under the Herb Valley brand name. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; property holding business; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Central",
        "zipcode": null,
        "website": "http://www.tiandapharma.com",
        "market_cap": "Micro Cap"
    },
    "0460.HK": {
        "short_name": "SIHUAN PHARM",
        "long_name": "Sihuan Pharmaceutical Holdings Group Ltd.",
        "summary": "Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company offers cardio-cerebral vascular system, digestive system, metabolism, anti-infective, respiratory, neurology, and other drugs. It also engages in the marketing of pharmaceutical products; manufacture of pharmaceutical materials and medical instruments; project preparation for the manufacture of pharmaceutical products; promotion of technology, biotechnology, and consulting services; and construction of medical projects, as well as the provision of information support, research and development, business and development, and general hospital and hospital management services. In addition, the company invests in property; constructs environmental protection projects; and wholesales chemical raw materials and medical devices. The company was founded in 2001 and is based in Wanchai, Hong Kong.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Wan Chai",
        "zipcode": null,
        "website": "http://www.sihuanpharm.com",
        "market_cap": "Mid Cap"
    },
    "0503.HK": {
        "short_name": "LANSEN PHARMA",
        "long_name": "Lansen Pharmaceutical Holdings Limited",
        "summary": "Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally. It operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. The company offers specialist medicines and Chinese medicine generic drugs; cosmetic products; and plant extracts and healthcare products. It also engages in research, development, and industrialization of industrial enzyme preparations, molecular biology tool enzymes, and bioactive factors for cosmetics and biological skincare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Ningbo",
        "zipcode": "315174",
        "website": "http://www.lansen.com.cn",
        "market_cap": "Micro Cap"
    },
    "0570.HK": {
        "short_name": "TRAD CHI MED",
        "long_name": "China Traditional Chinese Medicine Holdings Co. Limited",
        "summary": "China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of Chinese medicine and pharmaceutical products in the People's Republic of China. The company offers granules, finished drugs, decoction pieces, and healthcare products. It is also involved in the cultivation of Chinese medicinal herbs; preparation of traditional Chinese medicines; trading of pharmaceutical products; provision of traditional Chinese medical consultation services; and retail of pharmaceuticals and decoction. The company also provides logistics and warehouse, and property leasing services. The company sells its products to hospitals and retail pharmacies. The company was formerly known as China Traditional Chinese Medicine Co. Limited and changed its name to China Traditional Chinese Medicine Holdings Co. Limited in July 2016. China Traditional China Traditional Chinese Medicine Holdings Co. Limited is headquartered in Foshan, China.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Foshan",
        "zipcode": null,
        "website": "http://www.china-tcm.com.cn",
        "market_cap": "Mid Cap"
    },
    "063160.KS": {
        "short_name": "CKDBio",
        "long_name": "CKD Bio Corp.",
        "summary": "CKD Bio Corp. manufactures and distributes drug substances based on fermentation, synthesis, and biotechnology in South Korea. It offers drug substances in the areas of antibiotic, \u00c3\u009f-lactamase inhibitors, immunosuppressants, anticancer drugs, obesity treatment drugs, dry eye, antivirus, antituberculosis, antihyperlipidemics, and probiotics. The company also provides contract research and development, and manufacturing services for active pharmaceutical ingredients and intermediates, and probiotics. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": "03742",
        "website": "http://www.ckdbio.com",
        "market_cap": "Micro Cap"
    },
    "069620.KS": {
        "short_name": "DAEWOONG PHARM",
        "long_name": "Daewoong pharmaceutical Co.,Ltd.",
        "summary": "Daewoong pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": "135-715",
        "website": "http://www.daewoong.com",
        "market_cap": "Small Cap"
    },
    "0719.HK": {
        "short_name": "SHANDONG XINHUA",
        "long_name": "Shandong Xinhua Pharmaceutical Company Limited",
        "summary": "Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical Bulk Drugs, Preparations, and Chemical Intermediates and Other products. It offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for central nervous system diseases; and other drugs under the brand of Xinhua. The company also provides prepared Chinese herbal medicine for decoction, traditional Chinese medicines, chemical raw materials, chemical preparations, antibiotics, biochemical medicines, chemical bulk drugs, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc. In addition, it offers raw materials and intermediates, powders for injection and tablets, and bulk pharmaceutical and intermediates; tablets, hard capsules, granules, and dry suspension; imports and exports goods and technologies; designs medical projects; develops and sells real estate; and health products research and development activities. Additionally, the company engages in the certification and import and export business; electrical equipment engineering; and installation and testing of chemical equipment and electrical equipment, as well as sales of mechanical, hardware, and electrical equipment. It also provides contract manufacturing services of APIs and pharmaceutical intermediates, as well as OTC and generic products; and internet data services, internet sales, and internet information services for pharmaceuticals and medical devices, etc. The company operates in the People's Republic of China, the Americas, Europe, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Zibo",
        "zipcode": "255086",
        "website": "http://www.xhzy.com",
        "market_cap": "Small Cap"
    },
    "0858.HK": {
        "short_name": "EXTRAWELL PHAR",
        "long_name": "Extrawell Pharmaceutical Holdings Limited",
        "summary": "Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, and sells pharmaceutical products in the People's Republic of China. It operates through Manufacturing, Trading, and Gene Development segments. The company offers transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system; and Wisk for the treatment of II-III degree of radio-injury of skin, normal common burn, actinic dermatitis, various infectious ulcers, and oral ulcers, as well as for trauma and post operation wound healing. It also provides ZhouBang, a thromboxane synthetase inhibitor to prevent the coagulation of platelets and facilitate relaxation of blood vessels. In addition, the company is involved in the marketing and distribution of imported pharmaceutical products, including GM-1 to treat lesions of central nervous system caused due to vascular or traumatic events, and Parkinson's disease; Millibar for the treatment of high blood pressure; and Skin-Cap for use in the treatment of psoriasis, dandruff, dermatitis, atopic dermatitis, eczema, and tinea. Further, it engages in the commercial exploitation and development of genome-related technology; provision of agency services; property investment business; and holds gene invention rights. The company is headquartered in Quarry Bay, Hong Kong.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Quarry Bay",
        "zipcode": null,
        "website": "http://www.extrawell.com.hk",
        "market_cap": "Nano Cap"
    },
    "0874.HK": {
        "short_name": "BAIYUNSHAN PH",
        "long_name": "Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited",
        "summary": "Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and chemical raw material intermediates in the People's Republic of China and internationally. It operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. The company is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, ganoderma spore oil capsules, lozenges, tortoise herb jelly, etc. In addition, it invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services. As of December 31, 2020, the company had 141 retail chain pharmacy outlets, which included 27 Cai Zhi Lin pharmacy outlets, 33 Jian Min pharmacy outlets, 36 GPC Prescription Pharmacy outlets, and 24 Hainan Guangyao Chenfei Pharmaceutical Chain outlets, as well as 21 retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Guangzhou",
        "zipcode": "510130",
        "website": "http://www.gybys.com.cn",
        "market_cap": "Mid Cap"
    },
    "0897.HK": {
        "short_name": "WAI YUEN TONG",
        "long_name": "Wai Yuen Tong Medicine Holdings Limited",
        "summary": "Wai Yuen Tong Medicine Holdings Limited, an investment holding company, manufactures, processes, and retails traditional Chinese medicine, western pharmaceutical products, and health food and personal products in Hong Kong, Mainland China, Macau, and internationally. The company offers Chinese medicines and health food products under the Wai Yuen Tong brand name; and western pharmaceutical and personal care products under the Madame Pearl's and Pearl's brands. It also engages in the investment, holding, and selling of properties; provision of financial services; and agricultural produce exchange market operation. It operates approximately 55 retail stores in Hong Kong. The company was founded in 1897 and is headquartered in Kowloon Bay, Hong Kong. Wai Yuen Tong Medicine Holdings Limited is a subsidiary of Rich Time Strategy Limited.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Kowloon Bay",
        "zipcode": null,
        "website": "http://www.wyth.net",
        "market_cap": "Micro Cap"
    },
    "08HH.SG": {
        "short_name": "Shanghai Fos.Pharm.(Gr.)Co.LtdR",
        "long_name": "Shanghai Fosun Pharmaceutical (Group) Co., Ltd.",
        "summary": "Shanghai Fosun Pharmaceutical (Group) Co., Ltd. researches, develops, manufactures, trades, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing and Research and Development, Healthcare Service, Medical Devices and Medical Diagnosis, Pharmaceutical Distribution and Retail, and Other business Operations. It offers pharmaceutical products in the areas of metabolic and digestive system; antitumor; anti-infective; central nervous system drugs; cardiovascular system; blood system; vaccines; and APIs and intermediates. The company also provides medical diagnosis and medical device products in the field of in vitro diagnostics, the products involve clinical chemistry, clinical immunity, molecular diagnostics, gene chip technology, clinical microbiology, and other fields of laboratory medicine. In addition, it offers medical services in various hospitals. The company was formerly known as Shanghai Fosun Industrial Co. Ltd. and changed its name to Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in December 2004. The company was founded in 1994 and is based in Shanghai, China.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "China",
        "state": null,
        "city": "Shanghai",
        "zipcode": "200233",
        "website": "http://www.fosunpharma.com",
        "market_cap": "Large Cap"
    },
    "0911.HK": {
        "short_name": "QIANHAI HEALTH",
        "long_name": "Qianhai Health Holdings Limited",
        "summary": "Qianhai Health Holdings Limited, an investment holding company, engages in the sale of health products in Hong Kong. It operates through Health-Care Products and Electronic Component Products segments. The company offers Chinese herbal medicines, and skin-care and other health-care products to wholesalers and retailers. It offers American ginseng, an herbaceous perennial plant, which includes cultivated and wild ginseng; and ginseng wine. The company is also involved in the sale of information technology components, such as central processing units and semi-conductors. In addition, it engages in the property and other assets holding, and property leasing activities; and money lending business through the provision of secured and unsecured loans. The company was formerly known as Hang Fat Ginseng Holdings Company Limited and changed its name to Qianhai Health Holdings Limited in September 2016. The company was founded in 1989 and is based in Sheung Wan, Hong Kong. Qianhai Health Holdings Limited is a subsidiary of Explorer Rosy Limited.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Sheung Wan",
        "zipcode": null,
        "website": "http://www.qianhaihealth.com.hk",
        "market_cap": "Nano Cap"
    },
    "0C8.F": {
        "short_name": "CATALENT INC.  DL-,01",
        "long_name": "Catalent, Inc.",
        "summary": "Catalent, Inc., together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral vector gene therapy; formulation, development, and manufacturing for parenteral dose forms, including prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. It has a collaboration with the Janssen Pharmaceutical Companies; Arcturus Therapeutics Holdings Inc.; and BrainStorm Cell Therapeutics Inc. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NJ",
        "city": "Somerset",
        "zipcode": "08873",
        "website": "http://www.catalent.com",
        "market_cap": "Large Cap"
    },
    "0EH.F": {
        "short_name": "TOLERANZIA AB",
        "long_name": "Toleranzia AB",
        "summary": "Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate for treating myasthenia gravis, an autoimmune nerve and muscle disease. It also intends to develop TOL3 drug candidate to treat ANCA vasculitis, an autoimmune blood vessel disease. The company is headquartered in Gothenburg, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Gothenburg",
        "zipcode": "411 26",
        "website": "http://www.toleranzia.com",
        "market_cap": "Nano Cap"
    },
    "0HC.F": {
        "short_name": "MOJAVE BRANDS INC.",
        "long_name": "Mojave Brands Inc.",
        "summary": "Mojave Brands Inc. does not have significant operations. Previously, it was engaged in the manufacturing, processing, and sale of cannabis extracts. The company was formerly known as Mojave Jane Brands Inc. and changed its name to Mojave Brands Inc. in March 2020. Mojave Brands Inc. is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 3P3",
        "website": "http://www.mojavejane.com",
        "market_cap": "Nano Cap"
    },
    "0IGA.F": {
        "short_name": "TELIGENT INC.  DL-,01",
        "long_name": "Teligent, Inc.",
        "summary": "Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The company's topical semi-solid and liquid products are used in various applications that range from cosmetics and cosmeceuticals; and the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. It sells its products through national chain drug stores, drug wholesalers, distributors, and group purchasing organizations. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NJ",
        "city": "Buena",
        "zipcode": "08310",
        "website": "http://www.teligent.com",
        "market_cap": "Micro Cap"
    },
    "0JS.F": {
        "short_name": "MEDMEN ENTERPRISES",
        "long_name": "MedMen Enterprises Inc.",
        "summary": "MedMen Enterprises Inc., through its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, distributes, and retails recreational and medicinal cannabis under the [statemade], LuxLyte, and MedMen Red brand names. It operates 25 retail stores in 6 states. MedMen Enterprises Inc. was founded in 2010 and is headquartered in Culver City, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "CA",
        "city": "Culver City",
        "zipcode": "90232",
        "website": "http://www.medmen.com",
        "market_cap": "Micro Cap"
    },
    "0JS.SG": {
        "short_name": "MedMen Enterprises Inc. Registe",
        "long_name": "MedMen Enterprises Inc.",
        "summary": "MedMen Enterprises Inc., through its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, distributes, and retails recreational and medicinal cannabis under the [statemade], LuxLyte, and MedMen Red brand names. It operates 25 retail stores in 6 states. MedMen Enterprises Inc. was founded in 2010 and is headquartered in Culver City, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "United States",
        "state": "CA",
        "city": "Culver City",
        "zipcode": "90232",
        "website": "http://www.medmen.com",
        "market_cap": "Micro Cap"
    },
    "0NN.F": {
        "short_name": "AVICANNA INC.",
        "long_name": "Avicanna Inc.",
        "summary": "Avicanna Inc., a biopharmaceutical company, focuses on the research, development, cultivation, manufacture, and commercialization of plant-derived cannabinoid-based products and extracts for the use in medical, consumer health, and pharmaceutical industries internationally. The company provides pharmaceutical grade cannabinoids, including tetrahydrocannabinol (THC), cannabidiol (CBD), cannabigerol (CBG), and other rare cannabinoids; active pharmaceutical ingredients (APIs); feminized seeds; and bulk formulations under the Aureus Santa Marta brand. It also offers CBD based derma-cosmetic consumer products, such as beauty treatment, moisture and protection, and specialized care products under the Pura Earth brand; and medical cannabis/phyto-therapeutic products for the medical or homeopathic use under the Rho Phyto brand. In addition, the company provides pharmaceutical products focusing on skin disorders, including epidermolysis bullosa, eczema, and general skin problems comprising acne, erythema, and dryness; and neurological disorders, such as neuropathic pain, epilepsy, Parkinson's disease and multiple sclerosis, and nociceptive pain resulting from inflammatory and joint disorders, as well as a topical cream for rare genetic skin disorders. Avicanna has research collaboration with Dr. Christine Allen'sResearch Group for the development of a cannabinoid-based pharmaceutical for the treatment of COVID-19 induced lung inflammation. Avicanna Inc.was founded in 2016 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5G 1V2",
        "website": "http://www.avicanna.com",
        "market_cap": "Nano Cap"
    },
    "0OG.F": {
        "short_name": "ORGANIGRAM HLDGS INC.",
        "long_name": "OrganiGram Holdings Inc.",
        "summary": "Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "NB",
        "city": "Moncton",
        "zipcode": "E1E 3X3",
        "website": "http://www.organigram.ca",
        "market_cap": "Small Cap"
    },
    "0OP.F": {
        "short_name": "OPTINOSE INC.  DL-,001",
        "long_name": "OptiNose, Inc.",
        "summary": "OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase 3b clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "PA",
        "city": "Yardley",
        "zipcode": "19067",
        "website": "http://www.optinose.com",
        "market_cap": "Micro Cap"
    },
    "0P0.F": {
        "short_name": "AERIE PHARMACEUTIC.DL-001",
        "long_name": "Aerie Pharmaceuticals, Inc.",
        "summary": "Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma, ocular surface, and retinal diseases in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma. The company is also developing AR-15512 to treat signs and symptoms of dry eye; and AR-1105, AR-13503 SR, and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM. Aerie Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Durham, North Carolina.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NC",
        "city": "Durham",
        "zipcode": "27703",
        "website": "http://www.aeriepharma.com",
        "market_cap": "Small Cap"
    },
    "0QT0.F": {
        "short_name": "GUARDI.HEALTH NEW DL-,001",
        "long_name": "Guardion Health Sciences, Inc.",
        "summary": "Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "CA",
        "city": "San Diego",
        "zipcode": "92128",
        "website": "http://www.guardionhealth.com",
        "market_cap": "Nano Cap"
    },
    "0VH.F": {
        "short_name": "OVATION SCIENCE I",
        "long_name": "Ovation Science Inc.",
        "summary": "Ovation Science Inc. engages in the production of cannabis or hemp products in Canada. The company's Invisicare is a patented drug delivery technology for use in topical and transdermal skin products containing hemp seed oil and cannabis products under the Ovation brand. It holds sublicenses for cannabis based products in Canada and in the United States; and Lighthouse for licensed dispensaries in the United States. The company was founded in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2T6",
        "website": "http://ovationscience.com",
        "market_cap": "Nano Cap"
    },
    "0VZ1.F": {
        "short_name": "ACREAGE HLDGS INC.CL.E SV",
        "long_name": "Acreage Holdings, Inc.",
        "summary": "Acreage Holdings, Inc., formerly High Street Capital Partners, is a principal investment firm specializing in cannabis industry. Acreage Holdings, Inc. was founded in 2014 and is based in New York, New York.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10017",
        "website": "http://www.acreageholdings.com",
        "market_cap": "Small Cap"
    },
    "0VZ2.F": {
        "short_name": "ACREAGE HLDGS INC.CL.D SV",
        "long_name": "Acreage Holdings, Inc.",
        "summary": "Acreage Holdings, Inc., formerly High Street Capital Partners, is a principal investment firm specializing in cannabis industry. Acreage Holdings, Inc. was founded in 2014 and is based in New York, New York.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10017",
        "website": "http://www.acreageholdings.com",
        "market_cap": "Micro Cap"
    },
    "0ZF1.F": {
        "short_name": "GOODNESS GROWTH HLDGS INC",
        "long_name": "Vireo Health International, Inc.",
        "summary": "Vireo Health International Inc. operates as a physician-led cannabis company in the United States. It cultivates cannabis; manufactures pharmaceutical-grade cannabis extracts; and sells its products through its network of Green Goods and other retail locations, and third-party dispensaries. The company grows and/or processes cannabis in eight markets and operates 16 dispensaries. Vireo Health International Inc. is headquartered in Minneapolis, Minnesota.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "MN",
        "city": "Minneapolis",
        "zipcode": "55408",
        "website": "http://www.vireohealth.com",
        "market_cap": "Micro Cap"
    },
    "102460.KS": {
        "short_name": "REYON",
        "long_name": "REYON Pharmaceutical Co., Ltd.",
        "summary": "REYON Pharmaceutical Co., Ltd. manufactures and sells finished medicines and APIs in South Korea and internationally. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; migraine drugs; miscellaneous cardiovascular system drugs; neuromuscular disorder related drugs; nootropics and neurotonics; NSAIDs; respiratory stimulants; skeletal muscle relaxants; and vasodilators. REYON Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://reyonpharm.co.kr",
        "market_cap": "Small Cap"
    },
    "10E.F": {
        "short_name": "APHRIA INC.",
        "long_name": "Tilray, Inc.",
        "summary": "Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Leamington",
        "zipcode": "N8H 1M8",
        "website": "http://aphriainc.com",
        "market_cap": "Mid Cap"
    },
    "11L1.F": {
        "short_name": "CANOPY GROWTH",
        "long_name": "Canopy Growth Corporation",
        "summary": "Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. As of February 14, 2020, it operated 28 cannabis retail stores under the Tweed or Tokyo Smoke name. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Smiths Falls",
        "zipcode": "K7A 0A8",
        "website": "http://www.canopygrowth.com",
        "market_cap": "Mid Cap"
    },
    "128940.KS": {
        "short_name": "HanmiPharm",
        "long_name": "Hanmi Pharm. Co., Ltd.",
        "summary": "Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": "05545",
        "website": "http://www.hanmipharm.com",
        "market_cap": "Mid Cap"
    },
    "1349.HK": {
        "short_name": "FUDANZHANGJIANG",
        "long_name": "Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.",
        "summary": "Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells bio-pharmaceutical products. It offers genetic engineering platform drugs, including CD30-MMAE, which is in clinical trial Phase I for tumors; Trop 2 antibody-conjugated drug that is in pre-clinical studies for triple negative breast cancer, bladder and gastric cancer, and other tumors; and HER2 antibody-drug conjugate, which is in pre-clinical study for tumors. The company also provides photodynamic technical platform drugs, such as hemoporfin for port wine stain, which is in Phase IV clinical trial; aminolevulinic acid, which is in Phase II clinical trials for cervical diseases infected by HPV; and aminolevulinic acid that is in Phase I clinical trials for acne, as well as completed pre-clinical study for brain gliomas. In addition, it offers nano technical platform drugs comprising Nanoparticle Albumin-bound Paclitaxel that is in pre-clinical studies for tumors, as well as developing Doxorubicin liposome for tumors. Further, the company offers oral solid preparation technology, which includes obeticholic acid for Hepatobiliary disease; and JAK1 inhibitor that is in Phase I clinical trial for rheumatoid arthritis. Additionally, it researches and develops pharmaceutical and medical devices; medical diagnostic products; provides related services; and sells daily necessities, and clinical laboratory analysis instruments and software. It also engages in the technology development, transfer, consulting, and promotion activities; and production of freeze-dried powder injections and APIs, as well as invests in overseas medical projects. The company was founded in 1996 and is based in Shanghai, the People's Republic of China.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Shanghai",
        "zipcode": "201210",
        "website": "http://www.fd-zj.com",
        "market_cap": "Small Cap"
    },
    "135A.F": {
        "short_name": "SCYNEXIS INC.  DL-,001",
        "long_name": "SCYNEXIS, Inc.",
        "summary": "SCYNEXIS, Inc., a biotechnology company, delivers therapies for the treatment fungal infections in the United States. It is developing its lead product candidate, ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company develops ibrexafungerp, which has completed Phase II clinical trials for the treatment of vulvovaginal candidiasis. It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NJ",
        "city": "Jersey City",
        "zipcode": "07302-6548",
        "website": "http://www.scynexis.com",
        "market_cap": "Micro Cap"
    },
    "136.F": {
        "short_name": "ADAMAS PAHRMACEUT.DL-,001",
        "long_name": "Adamas Pharmaceuticals, Inc.",
        "summary": "Adamas Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of medicines for patients suffering from chronic neurologic disorders in the United States. It offers GOCOVRI, an extended release capsule for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications, as well as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing OFF episodes; and OSMOLEX ER, an extended release tablet to treat Parkinson's disease and drug-induced extrapyramidal reactions in adult patients. The company is also developing ADS-4101, which has completed two Phase 1b studies for treating partial onset seizures in patients with epilepsy. In addition, it offers NAMZARIC and NAMENDA XR, a memantine hydrochloride extended release and donepezil hydrochloride capsules for the treatment of moderate to severe dementia of an Alzheimer's type. The company was formerly known as NeuroMolecular Pharmaceuticals, Inc. and changed its name to Adamas Pharmaceuticals, Inc. in July 2007. Adamas Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "CA",
        "city": "EmeryVille",
        "zipcode": "94608",
        "website": "http://www.adamaspharma.com",
        "market_cap": "Micro Cap"
    },
    "1498.HK": {
        "short_name": "PURAPHARM",
        "long_name": "PuraPharm Corporation Limited",
        "summary": "PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mailand China, and internationally. The company operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. It offers holistic products under the PuraGold, Haveron, CardioClear, PuraPharm Lingzhi, and Arashi Kuni names; and various therapeutic products under the Nong's, Oncozac, and Immuzac names for Chinese medicine practitioners. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules (CCMG) products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it researches, develops, and trades in modernized Chinese medicines; and provides Chinese medical diagnostic services. The company sells its products to hospitals, medical institutions, and medicine practitioners, as well as operates an online store. As of December 31, 2019, the company operated 67 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Central, Hong Kong.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Central",
        "zipcode": null,
        "website": "http://www.purapharm.com",
        "market_cap": "Nano Cap"
    },
    "14K.F": {
        "short_name": "SUNDIAL GROWERS INC.",
        "long_name": "Sundial Growers Inc.",
        "summary": "Sundial Growers Inc. engages in production and marketing of cannabis products for the adult-use market in Canada. It produces and distributes inhalable products, such as flower, pre-rolls, and vapes. The company offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. Sundial Growers Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2R 1P3",
        "website": "http://www.sundialgrowers.com",
        "market_cap": "Small Cap"
    },
    "1513.HK": {
        "short_name": "LIVZON PHARMA",
        "long_name": "Livzon Pharmaceutical Group Inc.",
        "summary": "Livzon Pharmaceutical Group Inc. engages in the research, development, production, and distribution of pharmaceutical products in the People's Republic of China. Its products include Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitropin for injection to treat anovulation and sufferers; Perospirone Hydrochloride for the treatment of schizophrenia; Anti-viral Granules to treat upper respiratory tract infection and influenza; and Shenqi Fuzheng Injection for the treatment of weakness and tiredness, lassitude, spontaneous sweating, vertigo, and for the patients of lung cancer and stomach cancer. The company also offers active pharmaceutical ingredients (APIs) and intermediates, such as diagnostic kit for IgM/IgG antibody to coronavirus; and diagnostic reagents and equipment, including diagnostic kit for human immunodeficiency virus antibody, diagnostic kit for anti-nuclear antibody panel, and diagnostic kit for tuberculosis specific infected T cells. In addition, it provides biologic products, traditional Chinese drug medicine, biochemical drugs, microbiological preparations, antibiotics, and pharmaceutical raw materials. The company also exports its products. Livzon Pharmaceutical Group Inc. was founded in 1985 and is based in Zhuhai, China.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Zhuhai",
        "zipcode": "519090",
        "website": "http://www.livzon.com.cn",
        "market_cap": "Mid Cap"
    },
    "1558.HK": {
        "short_name": "HEC PHARM",
        "long_name": "YiChang HEC ChangJiang Pharmaceutical Co., Ltd.",
        "summary": "YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Yichang",
        "zipcode": null,
        "website": "http://cj.hec.cn",
        "market_cap": "Small Cap"
    },
    "1652.HK": {
        "short_name": "FUSEN PHARM",
        "long_name": "Fusen Pharmaceutical Company Limited",
        "summary": "Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products under the Fusen brand in the People's Republic of China. It offers over the counter and prescription based proprietary Chinese medicine (PCM) products in various dosage forms. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and other PCM and western medicine products, such as Chaihu injection, as well as flunarizine hydrochloride capsules, compound ferrous sulfate granules, and clarithromycin sustained release tablets. In addition, it researches, develops, produces, and sells various PCMs and chemical medicines for the treatments of cold and fever, cardiovascular and gynecological diseases, and anemia. Further, the company offers business management and consulting services. The company was founded in 2003 and is headquartered in Nanyang, China.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Nanyang",
        "zipcode": null,
        "website": "http://www.fusenyy.com",
        "market_cap": "Small Cap"
    },
    "1681.HK": {
        "short_name": "CONSUN PHARMA",
        "long_name": "Consun Pharmaceutical Group Limited",
        "summary": "Consun Pharmaceutical Group Limited, an investment holding company, researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People's Republic of China. The company operates in two segments, Consun Pharmaceutical and Yulin Pharmaceutical. It offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi particles to treat proteinuria; Gadopentetate Dimeglumine injections for magnetic resonance image diagnostics of nervous centralis, stomach, chest, pelvic cavity, and extremities, as well as for renal function assessment; and Iopamidol injections used for neuroradiology, angiography, and urography. The company also provides Yuanli Kang, an iron-dextrin oral solution; Yibao Yua, an erythromycin estolate suspension; Yuantong Ning, a cetirizine hydrochloride oral solution; and Zhixueling capsules to treat hysteromyoma bleeding, prolonged lochiorrhea, intermenstrual bleeding, bleeding after use of a contraceptive ring, hemorrhoidal bleeding, and epistaxis. In addition, it offers Gyn Antidysmenorrheic tablets for the treatment of irregular menstruation, irregular period during perimenopause, and abdominal pain during menstruation due to hepatic depression and blood deficiency; and Antibacterial Fujie lotion for staphylococcus aureus, Candida albicans, and escherichia coli in the feminine vaginal. Further, the company provides bone-setting liquid; Yunxiang analgesic tincture for treatment of rheumatism, common cold, headache, stomachache, cardiodynia, and pain in gastral cavity and chilblain; Sanqi Chuangchun capsules for activating blood circulation and dispersing blood stasis; Shiduqing capsules and tablets, and Paeonol ointment for skin disease. Additionally, it offers hepatobiliary, gastroenterology, and other medicines. The company was founded in 1997 and is headquartered in Guangzhou, the People's Republic of China.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Guangzhou",
        "zipcode": null,
        "website": "http://www.chinaconsun.com",
        "market_cap": "Small Cap"
    },
    "1707.TW": {
        "short_name": "GRAPE KING BIO LTD",
        "long_name": "Grape King Bio Ltd",
        "summary": "Grape King Bio Ltd produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan, China, and internationally. It operates through Multi-Level Marketing, Distributors, and Original Equipment Manufacturer (OEM) segments. The company offers mushroom mycelium products, such as ganoderma lucidum, agaricus blazei, antrodia cinnamomea, cordyceps sinensis, and coriolus versicolor; probiotics, including enterococcus, bifidobacterium, lactobacillus, pediococcus, streptococcus, saccharomyces, and clostridium; and enzymes. It also provides OEM, original design manufacturing, formulation design, research and development, and raw material supply services. The company was founded in 1969 and is headquartered in Taoyuan, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TAI",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taoyuan City",
        "zipcode": "324",
        "website": "http://www.grapeking.com.tw",
        "market_cap": "Small Cap"
    },
    "1731.TW": {
        "short_name": "MAYWUFA CO",
        "long_name": "Maywufa Company Ltd.",
        "summary": "Maywufa Company Ltd. manufactures and sells hair and skin care products under the Maywufa brand in Taiwan. It offers hair color creams; health care products and food supplements; and mother and baby skin care products under the mustela brand. The company also provides pharmaceuticals and medical devices, such as PG2 Lyophilized injection for treatment of cancer-related fatigue; AmCad-UT Detection device, an ultrasound CAD for thyroid cancer detection; and Bio-Three tablets for the treatment of mild diarrhea, abdominal pain, and constipation. In addition, it sells and distributes pharmaceutical products; and operates and manages pharmacy chain under the Pharmacy Franchise name. Maywufa Company Ltd. was founded in 1976 and is headquartered in Taipei City, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TAI",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taipei",
        "zipcode": "105",
        "website": "http://www.maywufa.com.tw",
        "market_cap": "Micro Cap"
    },
    "1789.TW": {
        "short_name": "SCINOPHARM TAIWAN LTD",
        "long_name": "ScinoPharm Taiwan, Ltd.",
        "summary": "ScinoPharm Taiwan, Ltd., together with its subsidiaries, researches and develops, produces, and sells CGMP active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, the United States, Europe, India, rest of Asia, and internationally. The company offers custom synthesis services for biochemistry molecules, such as peptides and nucleic acids; generic API manufacturing services; and outsourcing services. It also provides CRAM services, such as chemistry skill, analytical and regulatory, chemical process development, clinical drug substance, and consulting services for the development and manufacturing of clinical, small-scale, and commercial-stage APIs and intermediates. In addition, the company develops peptide synthesis technologies. Further, it develops and manufactures western medicines and other chemical materials, albumin medicines, oligonucleotide medicines, injections, and new small molecule drugs, as well as provides biological technology services and technical services. The company has a strategic alliance with Baxter International Inc. to develop, manufacture, and commercialize of antiemetic drug in chemotherapy for cancer. ScinoPharm Taiwan, Ltd. was founded in 1997 and is headquartered in Tainan, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TAI",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Tainan City",
        "zipcode": "74144",
        "website": "http://www.scinopharm.com",
        "market_cap": "Small Cap"
    },
    "1795.TW": {
        "short_name": "LOTUS PHARMACEUTICAL CO",
        "long_name": "Lotus Pharmaceutical Co., Ltd.",
        "summary": "Lotus Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells medicines in Taiwan, Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, and central nervous system disease. The company also sells and markets a portfolio of over-the-counter medicines. In addition, it engages in wholesale of cosmetics; retail of clinical machines; biotech technological services; and related consulting services. Lotus Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Taipei City, Taiwan. Lotus Pharmaceutical Co., Ltd. is a subsidiary of Alvogen Emerging Markets Holdings Limited.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TAI",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taipei",
        "zipcode": "110",
        "website": "http://www.lotuspharm.com.tw",
        "market_cap": "Small Cap"
    },
    "1796.TWO": {
        "short_name": "GENEFERM BIOTECHNOLOGY CO LTD",
        "long_name": "GeneFerm Biotechnology Co., Ltd.",
        "summary": "GeneFerm Biotechnology Co., Ltd. develops, manufactures, markets, and sells fermented products in Taiwan and internationally. The company offers a range of raw materials, such as fermented microbial, fungi, and fruits and vegetables products; probiotics; and herbal extracts and animal derived peptides and powders. It also provides ODM, as well as fermentation toll manufacturing services to companies for the development and manufacture of dietary supplements, functional foods, health food products, and various applications. The company was founded in 1999 and is based in Taipei City, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taipei City",
        "zipcode": "11503",
        "website": "http://www.geneferm.com",
        "market_cap": "Nano Cap"
    },
    "17K.F": {
        "short_name": "KINDRED BIOSCIENC.DL-0001",
        "long_name": "Kindred Biosciences, Inc.",
        "summary": "Kindred Biosciences, Inc., a commercial-stage biopharmaceutical company, engages in developing therapies for pets. Its product pipeline focuses on biologics for a range of indications primarily in dogs and cats. The company offers Mirataz, a mirtazapine transdermal ointment for the management of weight loss in cats; and Zimeta, a dipyrone injection for the control of fever in horses. It also develops KIND-016, a monoclonal antibody for the treatment of atopic dermatitis in dogs; KIND-032, a monoclonal antibody targeting interleukin-4 (IL-4) receptor for the treatment of atopic dermatitis in dogs; KIND-025 a canine fusion protein targeting IL-4 and IL-13 for atopic dermatitis in dogs; KIND-030, a monoclonal antibody targeting canine parvovirus for the prophylactic indication in dogs; KIND-509, an antibody for canine inflammatory bowel disease in dogs; KIND-510a, a long-acting feline recombinant erythropoietin being developed for the management of non-regenerative anemia in cats; and KIND-511, an anti-tumor necrosis factor treatment for newborn foals. The company was incorporated in 2012 and is headquartered in Burlingame, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "CA",
        "city": "Burlingame",
        "zipcode": "94010",
        "website": "http://www.kindredbio.com",
        "market_cap": "Micro Cap"
    },
    "185750.KS": {
        "short_name": "CHONGKUNDANG",
        "long_name": "Chong Kun Dang Pharmaceutical Corp.",
        "summary": "Chong Kun Dang pharmaceutical Corp. engages in the manufacturing, marketing, and selling of medicines in South Korea and internationally. It provides prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetics; over-the-counter drugs, such as Penzal, Prefemine, and Modcol, as well as consumer health products, such as insecticides, hair dye, etc.; and healthcare supplements with preventive benefits. The company also exports its products. Chong Kun Dang pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.ckdpharm.com",
        "market_cap": "Small Cap"
    },
    "1AZ.F": {
        "short_name": "ICANIC BRANDS CO. INC.",
        "long_name": "Icanic Brands Company Inc.",
        "summary": "Icanic Brands Company Inc. provides life enhancement products in Canada. The company owns license for X-Sprays, a brand of life enhancement products administered through an oral spray delivery system. It markets and sells dietary supplements for nonmedical use primarily cannabinoid and cannabis-infused sprays, as well as non-cannabis infused sprays. The company was formerly known as Integrated Cannabis Company, Inc. and changed its name to Icanic Brands Company Inc. in February 2020. Icanic Brands Company Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1H2",
        "website": "http://www.icaninc.com",
        "market_cap": "Micro Cap"
    },
    "1BUP.F": {
        "short_name": "GTEC HLDGS LTD",
        "long_name": "GTEC Holdings Ltd.",
        "summary": "GTEC Holdings Ltd., doing business as GTEC Cannabis Co, cultivates, markets, and distributes cannabis products in Canada. The company brand portfolio includes BLK MKT, Tenzo, Pristine, GreenTec, Cognoscente, and Treehugger. It sells its products through medical and recreational sales channels, as well as through its GreenTec medical website and various licensed partners. The company was founded in 2017 and is headquartered in Kelowna, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Kelowna",
        "zipcode": "V1Y 7T2",
        "website": "http://www.gtec.co",
        "market_cap": "Micro Cap"
    },
    "1D5A.F": {
        "short_name": "PLX PHARMA INC.  DL -,001",
        "long_name": "PLx Pharma Inc.",
        "summary": "PLx Pharma Inc., a specialty pharmaceutical company, focuses on developing the PLxGuard drug delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system, which provides patients with vascular disease and diabetic patients who are candidates for aspirin therapy based on physician recommendation, with fast, reliable, and predictable platelet inhibition as compared to enteric-coated aspirin, as well as reduces the risk of stomach erosions and ulcers as compared with immediate-release aspirin, after seven days of treatment. Its product pipeline also includes other oral nonsteroidal anti-inflammatory drugs using the PLxGuard drug delivery system, such as PL1200 Ibuprofen 200 mg and PL1200 Ibuprofen 400 mg, which are in Phase I clinical stage for pain and inflammation, as well as PL1100 Ibuprofen 400 mg. PLx Pharma Inc. was founded in 2002 and is headquartered in Sparta, New Jersey.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NJ",
        "city": "Sparta",
        "zipcode": "07871",
        "website": "http://plxpharma.com",
        "market_cap": "Micro Cap"
    },
    "1JS.F": {
        "short_name": "SHIELD THERAPEUT. LS-,015",
        "long_name": "Shield Therapeutics plc",
        "summary": "Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of late-stage pharmaceuticals to treat unmet medical needs. The company's lead product is Ferric Maltol, marketed in the European Union as Feraccru, a non-salt based novel therapy for the treatment of iron deficiency anemia in patients with inflammatory bowel disease. Its advanced pipeline asset is PT20, a novel therapy that has completed its Phase II pivotal study for the treatment of hyperphosphatemia in patients with chronic kidney disease. The company also develops PT30 to treat hypo-allergenic IV iron therapy; and PT40, the first generic version of iron sucrose. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Gateshead",
        "zipcode": "NE8 3DF",
        "website": "http://www.shieldtherapeutics.com",
        "market_cap": "Micro Cap"
    },
    "1JV1.F": {
        "short_name": "GNOMESTAR CRAFT INC.",
        "long_name": "Gnomestar Craft Inc.",
        "summary": "Gnomestar Craft Inc. operates as a licensed stage company for producing medical marijuana in Canada. The company was formerly known as Vodis Pharmaceuticals Inc. and changed its name to Gnomestar Craft Inc. in December 2020. Gnomestar Craft Inc. was incorporated in 2011 and is based in Delta, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Delta",
        "zipcode": "V4G 1B5",
        "website": "http://www.gnomestarcannabis.com",
        "market_cap": "Nano Cap"
    },
    "1LP.F": {
        "short_name": "LANSEN PHARMAC.HLD.DL-,01",
        "long_name": "Lansen Pharmaceutical Holdings Limited",
        "summary": "Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally. It operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. The company offers specialist medicines and Chinese medicine generic drugs; cosmetic products; and plant extracts and healthcare products. It also engages in research, development, and industrialization of industrial enzyme preparations, molecular biology tool enzymes, and bioactive factors for cosmetics and biological skincare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "China",
        "state": null,
        "city": "Ningbo",
        "zipcode": "315174",
        "website": "http://www.lansen.com.cn",
        "market_cap": "Micro Cap"
    },
    "1N9.F": {
        "short_name": "NEUTRISCI INTL",
        "long_name": "NeutriSci International Inc.",
        "summary": "NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada. Its products include Neuenergy, an energy chewable tablet that provides focus and mental clarity; and BluScience, a nutraceutical product. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with Cryopharm Corporation and Nutritional High International Inc. NeutriSci International Inc. was founded in 2009 and is headquartered in Calgary, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2G 4X7",
        "website": "http://www.neutrisci.com",
        "market_cap": "Nano Cap"
    },
    "1OA.F": {
        "short_name": "BLUEBERRIES MEDICAL",
        "long_name": "Blueberries Medical Corp.",
        "summary": "Blueberries Medical Corp. engages in the growth, cultivation, development, production, and supply of medicinal cannabis and related products in Colombia. The company offers medicinal-grade cannabis oil extracts and related products. Blueberries Medical Corp. is headquartered in Bogot\u00c3\u00a1, Colombia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Colombia",
        "state": null,
        "city": "Bogot\u00c3\u00a1",
        "zipcode": null,
        "website": "http://blueberriesmed.com",
        "market_cap": "Nano Cap"
    },
    "1PG.MU": {
        "short_name": "AKER BIOMARINE ASA  NK 6",
        "long_name": "Aker BioMarine AS",
        "summary": "Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates in two segments, Ingredients and Brands. The company provides krill oil products, including omega-3s, phospholipids, choline, and astaxanthin under the Superba, Kori, NKO, and K\u00c2\u00b7REAL brands. It also offers Qrill aqua nutrient-rich feed ingredients for aquaculture; and QRILL pet, a functional ingredient for pet food. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste into products, such as shopping baskets and food trays. Aker BioMarine AS has an agreement with Medical Food Solutions Research to develop pharmaceutical therapies for brain and eye health based on Lysoveta. The company is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MUN",
        "market": "dr_market",
        "country": "Norway",
        "state": null,
        "city": "Lysaker",
        "zipcode": "1327",
        "website": "http://www.akerbiomarine.com",
        "market_cap": "Small Cap"
    },
    "1R8.F": {
        "short_name": "RADIUS HEALTH INC.DL-0001",
        "long_name": "Radius Health, Inc.",
        "summary": "Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine and other therapeutics. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a short-wear-time transdermal patch that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone receptor-positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "MA",
        "city": "Boston",
        "zipcode": "02210",
        "website": "http://www.radiuspharm.com",
        "market_cap": "Small Cap"
    },
    "1TM.F": {
        "short_name": "MITHRA PHARMACEUTIC.AIW",
        "long_name": "Mithra Pharmaceuticals SA",
        "summary": "Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial is a combined oral contraceptive; Donesta, which is in phase III clinical trial for vasomotor menopausal symptoms relief; and PeriNesta, an oral treatment for perimenopause. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications; and Tibelia, a solution for treating menopause and osteoporosis. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Li\u00c3\u00a8ge, Belgium.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Belgium",
        "state": null,
        "city": "Li\u00c3\u00a8ge",
        "zipcode": "4000",
        "website": "http://www.mithra.com",
        "market_cap": "Small Cap"
    },
    "1V70.F": {
        "short_name": "VINERGY CAPITAL INC.",
        "long_name": "Vinergy Capital Inc.",
        "summary": "Vinergy Capital Inc. does not have significant operations. Previously, it was engaged in the development of cannabis products. The company was formerly known as Vinergy Cannabis Capital Inc. and changed its name to Vinergy Capital Inc. in March 2021. Vinergy Capital Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1T2",
        "website": "http://vinergycapital.com",
        "market_cap": "Nano Cap"
    },
    "1WZA.F": {
        "short_name": "THOUGHTFUL BRANDS INC.",
        "long_name": "Thoughtful Brands Inc.",
        "summary": "Mota Ventures Corp., together with its subsidiaries, operates in the cannabidiol (CBD) e-commerce business. It provides CBD hemp-oil formulations and cosmetics. The company offers its products under the Nature's Exclusive, First Class, and Sativida brands in the United States and Europe. Mota Ventures Corp. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 3T5",
        "website": "http://www.thoughtful-brands.com",
        "market_cap": "Nano Cap"
    },
    "1X8.F": {
        "short_name": "CRESO PHARMA LTD",
        "long_name": "Creso Pharma Limited",
        "summary": "Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates and harvests cannabis plants, as well as supplies dried cannabis plant retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions in humans; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. The company also offers nutraceutical products, such as cannaQIX, a hemp oil-derived food supplement under the Cannamics brand. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Australia",
        "state": "WA",
        "city": "Nedlands",
        "zipcode": "6009",
        "website": "http://www.cresopharma.com",
        "market_cap": "Micro Cap"
    },
    "2005.HK": {
        "short_name": "SSY GROUP",
        "long_name": "SSY Group Limited",
        "summary": "SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Wan Chai",
        "zipcode": null,
        "website": "http://www.ssygroup.com.hk",
        "market_cap": "Mid Cap"
    },
    "2070.SR": {
        "short_name": "Saudi Pharmaceutical Industries",
        "long_name": "Saudi Pharmaceutical Industries and Medical Appliances Corporation",
        "summary": "Saudi Pharmaceutical Industries and Medical Appliances develops, manufactures, and markets medicinal products and pharmaceutical formulations in the Kingdom of Saudi Arabia, Egypt, the Middle East, Morocco, and Algeria. The company is also involved in the manufacturing of basic chemical substances and products; medicines for human use, including cosmetics; and wholesale and retail of medicines and related products. In addition, it develops, manufactures, and sells pharmaceutical products and medical appliances; operates and maintains healthcare facilities. Further, the company engages in the research and development of medical science. The company was founded in 1986 and is headquartered in Buraydah, the Kingdom of Saudi Arabia.",
        "currency": "SAR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SAU",
        "market": "sr_market",
        "country": "Saudi Arabia",
        "state": null,
        "city": "Buraydah",
        "zipcode": null,
        "website": "http://www.spimaco.com.sa",
        "market_cap": "Small Cap"
    },
    "214390.KS": {
        "short_name": "KYONGBO",
        "long_name": "Kyongbo Pharmaceutical Co., Ltd",
        "summary": "Kyongbo Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients in South Korea. The company offers general, cephalosporins, and anti-cancer APIs; prescription drugs, including anesthetic, cardiovascular, digestive, and antibiotics; and OTC drugs. It also exports its products to 30 countries worldwide. The company was formerly known as Kyongbo Chemical Co. Ltd. and changed its name to Kyongbo Pharmaceutical Co., Ltd in March 2002. Kyongbo Pharmaceutical Co., Ltd was founded in 1987 and is headquartered in Asan, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Asan",
        "zipcode": null,
        "website": "http://www.kbpharma.co.kr",
        "market_cap": "Micro Cap"
    },
    "2196.HK": {
        "short_name": "FOSUN PHARMA",
        "long_name": "Shanghai Fosun Pharmaceutical (Group) Co., Ltd.",
        "summary": "Shanghai Fosun Pharmaceutical (Group) Co., Ltd. researches, develops, manufactures, trades, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing and Research and Development, Healthcare Service, Medical Devices and Medical Diagnosis, Pharmaceutical Distribution and Retail, and Other business Operations. It offers pharmaceutical products in the areas of metabolic and digestive system; antitumor; anti-infective; central nervous system drugs; cardiovascular system; blood system; vaccines; and APIs and intermediates. The company also provides medical diagnosis and medical device products in the field of in vitro diagnostics, the products involve clinical chemistry, clinical immunity, molecular diagnostics, gene chip technology, clinical microbiology, and other fields of laboratory medicine. In addition, it offers medical services in various hospitals. The company was formerly known as Shanghai Fosun Industrial Co. Ltd. and changed its name to Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in December 2004. The company was founded in 1994 and is based in Shanghai, China.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Shanghai",
        "zipcode": "200233",
        "website": "http://www.fosunpharma.com",
        "market_cap": "Large Cap"
    },
    "2348.HK": {
        "short_name": "DAWNRAYS PHARMA",
        "long_name": "Dawnrays Pharmaceutical (Holdings) Limited",
        "summary": "Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. The company operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. It offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics; and system specific medicines for various therapeutic areas comprising cardiovascular system, anti-allergic, anti-HBV, digestive system, urinary system, anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wanchai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Wan Chai",
        "zipcode": null,
        "website": "http://www.dawnrays.com",
        "market_cap": "Small Cap"
    },
    "23N.F": {
        "short_name": "NUVO PHARMACEUTICALS INC.",
        "long_name": "Nuvo Pharmaceuticals Inc.",
        "summary": "Nuvo Pharmaceuticals Inc. provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticarial; Cambia, a nonsteroidal anti-inflammatory drug for migraine; Suvexx/Treximet migraine medicine; NeoVisc viscosupplement for knee osteoarthritis; and Resultz/FullMarks/LAUSBUB for head lice infestations. The company also provides Bezalip SR for patients with high cholesterol or high levels of triglycerides; Proferrin, an iron supplement for the prevention and treatment of iron deficiency; Fiorinal 1 and Fiorinal C1 for the relief of tension-type headaches; Viskazide and Visken antihypertensive agents; Collatamp G for surgical implantation during surgery; PegaLAX, a laxative for the treatment of occasional constipation and irregularity; Mutaflor, a probiotic for the management and relief of chronic constipation and associated abdominal pain and cramps; MoviPrep for the cleansing of the colon in preparation for colonoscopy; Uracyst for mild to severe GAG layer damage of the urinary bladder; and Soriatane to treat psoriasis and other keratinization disorders. In addition, it offers Pennsaid and Pennsaid 2% topical treatments for osteoarthritic pain; Vimovo for relief of arthritis symptoms; SYNERA/RAPYDAN topical patches used to help prevent pain associated with needle sticks and other superficial skin procedures; Yosprala for the prevention of heart attacks and strokes; and Heated Lidocaine/Tetracaine Patch, a topical patch applied prior to painful medical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was founded in 1983 and is headquartered in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5N 6J5",
        "website": "http://www.miravohealthcare.com",
        "market_cap": "Nano Cap"
    },
    "249420.KS": {
        "short_name": "ILDONG PHARM",
        "long_name": "Ildong Pharmaceutical Co., Ltd.",
        "summary": "Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system applications. It also provides raw material drugs; health foods and foods; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products. In addition, the company manages licenses and provides contract manufacturing services. It also exports its products to approximately 20 countries worldwide. Ildong Pharmaceutical Co., Ltd. a strategic collaboration with Evotec SE to accelerate the development of various Ildong's proprietary projects through access to Evotec's INDiGO platform. The company was founded in 1941 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.ildong.com",
        "market_cap": "Small Cap"
    },
    "2633.HK": {
        "short_name": "JACOBSON PHARMA",
        "long_name": "Jacobson Pharma Corporation Limited",
        "summary": "Jacobson Pharma Corporation Limited, through its subsidiaries, manufactures and trades in generic drugs and proprietary medicines in Hong Kong, China, Macau, Singapore, and internationally. The company offers generic drugs for various therapeutic categories, including respiratory, cardiovascular, central nervous system, gastrointestinal, scar treatment, and oral anti-diabetics, anti-infective, diltiazem controlled release, dihydrocodeine, perindopril tablets. propranolol oral solution, mesalazine enteric coated tablets 500mg and finasteride tablets dermatological, and anti-allergic drugs. It also provides proprietary Chinese medicines, such as Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan/Shiling oil, and Col-gan tablet. In addition, it trades in medical supplies. Jacobson Pharma Corporation Limited sells its products to hospitals and clinics, and registered pharmacies, as well as to doctors in private and retail outlets, and trading companies. The company was incorporated and is headquartered in Kwun Tong, Hong Kong. Jacobson Pharma Corporation Limited is a subsidiary of Kingshill Development Limited.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Kwun Tong",
        "zipcode": null,
        "website": "http://www.jacobsonpharma.com",
        "market_cap": "Micro Cap"
    },
    "271980.KS": {
        "short_name": "JEIL PHARM",
        "long_name": "Jeil Pharmaceutical Co.,Ltd",
        "summary": "Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gatrointestinal, cardiovascular, neuropyschiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, etc. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea. Jeil Pharmaceutical Co.,Ltd operates independently of Jeil Pharma Holdings Inc as of June 2, 2017.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": "06543",
        "website": "http://www.jeilpharm.co.kr",
        "market_cap": "Small Cap"
    },
    "2877.HK": {
        "short_name": "SHINEWAY PHARM",
        "long_name": "China Shineway Pharmaceutical Group Limited",
        "summary": "China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections in various therapeutic areas, including cardio-cerebrovascular, antiviral, orthopedics, pediatrics, gynecology, neurology, gastroenterology, ophthalmology, oncology, and immunology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Shijiazhuang",
        "zipcode": "051430",
        "website": "http://www.shineway.com",
        "market_cap": "Small Cap"
    },
    "293480.KS": {
        "short_name": "Hana Pharm",
        "long_name": "Hana Pharm Co., Ltd.",
        "summary": "Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1958 and is headquartered in Seoul, South Korea.",
        "currency": "KRW",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "KSC",
        "market": "kr_market",
        "country": "South Korea",
        "state": null,
        "city": "Seoul",
        "zipcode": null,
        "website": "http://www.hanaph.co.kr",
        "market_cap": "Small Cap"
    },
    "29A.F": {
        "short_name": "AMPHASTAR PHARMA.DL-,0001",
        "long_name": "Amphastar Pharmaceuticals, Inc.",
        "summary": "Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers procainamide for documented ventricular arrhythmias; neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; medroxyprogesterone acetate injectable suspension for the prevention of pregnancy; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block, as well as manufactures and distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "CA",
        "city": "Rancho Cucamonga",
        "zipcode": "91730",
        "website": "http://www.amphastar.com",
        "market_cap": "Small Cap"
    },
    "2DT.F": {
        "short_name": "AMNEAL PHMCTCLS, INC.",
        "long_name": "Amneal Pharmaceuticals, Inc.",
        "summary": "Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers licensed, owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinson's disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NJ",
        "city": "Bridgewater",
        "zipcode": "08807",
        "website": "http://www.amneal.com",
        "market_cap": "Small Cap"
    },
    "2HQ.DE": {
        "short_name": "TILRAY INC. CL.2 DL-,0001",
        "long_name": "Tilray, Inc.",
        "summary": "As of May 3, 2021, Tilray, Inc. was acquired by Aphria Inc., in a reverse merger transaction. Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, clinics, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, Germany, Israel, New Zealand, Portugal, Spain, Africa, Switzerland, the United States, Malta, and the United Kingdom. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "GER",
        "market": "de_market",
        "country": "Canada",
        "state": "BC",
        "city": "Nanaimo",
        "zipcode": "V9X IJ2",
        "website": "http://www.tilray.com",
        "market_cap": "Mid Cap"
    },
    "2IA.F": {
        "short_name": "IANTHUS CAPITAL HLDGS INC",
        "long_name": "iAnthus Capital Holdings, Inc.",
        "summary": "iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 31 dispensaries and 10 cultivation and/or processing facilities in 9 states. The company is headquartered in New York, New York.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10170",
        "website": "http://www.ianthus.com",
        "market_cap": "Nano Cap"
    },
    "2IV.F": {
        "short_name": "INDIVIOR PLC  DL 0,10",
        "long_name": "Indivior PLC",
        "summary": "Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company is also involved in finance activities. It operates in approximately 40 countries worldwide. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "VA",
        "city": "North Chesterfield",
        "zipcode": "23235",
        "website": "http://www.indivior.com",
        "market_cap": "Small Cap"
    },
    "2IVA.F": {
        "short_name": "INDIVIOR PLC ADR/5  DL 2",
        "long_name": "Indivior PLC",
        "summary": "Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company is also involved in finance activities. It operates in approximately 40 countries worldwide. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "VA",
        "city": "North Chesterfield",
        "zipcode": "23235",
        "website": "http://www.indivior.com",
        "market_cap": "Small Cap"
    },
    "2J6.F": {
        "short_name": "MPX INTERNATIONAL CORP.",
        "long_name": "MPX International Corporation",
        "summary": "MPX International Corporation, a cannabis company, focuses on the medical and adult-use cannabis markets in Canada and Switzerland. It focuses on producing and distributing three principal types of products, such as cannabis flowers, cannabis extract and related products, and cannabis derivatives under the Strain Rec and Salus Bioharma brands. The company was founded in 2015 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M2N 6P4",
        "website": "http://mpxinternationalcorp.com",
        "market_cap": "Nano Cap"
    },
    "2J6.MU": {
        "short_name": "MPX INTERNATIONAL CORP.",
        "long_name": "MPX International Corporation",
        "summary": "MPX International Corporation, a cannabis company, focuses on the medical and adult-use cannabis markets in Canada and Switzerland. It focuses on producing and distributing three principal types of products, such as cannabis flowers, cannabis extract and related products, and cannabis derivatives under the Strain Rec and Salus Bioharma brands. The company was founded in 2015 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MUN",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M2N 6P4",
        "website": "http://mpxinternationalcorp.com",
        "market_cap": "Nano Cap"
    },
    "2J6.SG": {
        "short_name": "MPX International Corp. Registe",
        "long_name": "MPX International Corporation",
        "summary": "MPX International Corporation, a cannabis company, focuses on the medical and adult-use cannabis markets in Canada and Switzerland. It focuses on producing and distributing three principal types of products, such as cannabis flowers, cannabis extract and related products, and cannabis derivatives under the Strain Rec and Salus Bioharma brands. The company was founded in 2015 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M2N 6P4",
        "website": "http://mpxinternationalcorp.com",
        "market_cap": "Nano Cap"
    },
    "2MT.F": {
        "short_name": "ATHENEX INC.",
        "long_name": "Athenex, Inc.",
        "summary": "Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral Paclitaxel, an oral dosage form, which is in Phase III trial for metastatic breast cancer, as well as various clinical studies in advanced malignancies and gastric cancer; and Oral Irinotecan and Encequidar, a potent anticancer drug that is in a Phase I study for the treatment of metastatic colorectal cancer, glioblastoma, lung, ovarian, cervical, upper gastrointestinal, and pancreatic cancer. Its Orascovery product candidates also comprise Oral Docetaxel and Encequidar, a potent anticancer drug, which is in Phase I clinical study for breast, lung, prostate, gastric, and head and neck cancers; Oral Topotecan and Encequidar, a potent anticancer drug that is Phase I clinical trial to treat lung, ovarian, and cervical cancer; and Oral Eribulin and Encequidar, an anticancer intravenous drug to treat certain patients with breast cancer and liposarcoma. In addition, the company offers Src Kinase product candidates comprising Tirbanibulin ointments for actinic keratosis, skin cancers, and psoriasis; Tirbanibulin Oral for solid and liquid tumors; and KX2-361 for glioblastoma multiforme. Further, it is developing dual absorption enhancers to inhibit the P-gp transporter and the cytochrome P450 enzymes within the gastrointestinal tract; T Cell Receptor Engineered T Cell, a cell-based immunotherapy; and PT01 (Pegtomarginase), an arginine deprivation therapy product. The company was formerly known as Kinex Pharmaceuticals LLC and changed its name to Athenex, Inc. in August 2015. Athenex, Inc. was incorporated in 2003 and is headquartered in Buffalo, New York.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NY",
        "city": "Buffalo",
        "zipcode": "14203",
        "website": "http://www.athenex.com",
        "market_cap": "Small Cap"
    },
    "2PQ.F": {
        "short_name": "ORGANOGENESIS HLDGS",
        "long_name": "Organogenesis Holdings Inc.",
        "summary": "Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic allograft wound covering and surgical barrier for application in the care of chronic and acute wounds or surgical implantation in spine, orthopedic, and sports medicine applications; Apligraf, a bioengineered bi-layered skin substitute for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft, a dermal substitute for the treatment of DFUs; NuShield, a dehydrated placental tissue wound covering and surgical barrier applied to the target tissue to support native healing; and PuraPly Antimicrobial, an antimicrobial barrier skin substitute to treat chronic and acute wounds. Its surgical and sports medicine products comprise NuCel, a surgically implanted allograft used primarily in spinal and orthopedic surgical applications; ReNu, a cryopreserved suspension used to support healing of soft tissues; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company's pipeline products include PuraPly XT and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; Novachor, a chorionic membrane wound covering; TransCyte, a bioengineered tissue for the treatment of partial thickness burns; and Gintuit, a bioengineered bi-layered living cellular tissue for the treatment of mucogingival conditions in adults. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales force and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "MA",
        "city": "Canton",
        "zipcode": "02021",
        "website": "http://organogenesis.com",
        "market_cap": "Small Cap"
    },
    "2RH.F": {
        "short_name": "REDHILL B.S.ADR 10/IL-,01",
        "long_name": "RedHill Biopharma Ltd.",
        "summary": "RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 1/2a study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis, and has completed Phase 2 studies for irritable bowel syndrome with diarrhea; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and Phase 2a study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; and RHB-106, an encapsulated formulation for bowel preparation, which has completed Phase 2a study. The company was incorporated in 2009 and is headquartered in Tel Aviv, Israel.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Israel",
        "state": null,
        "city": "Tel Aviv",
        "zipcode": "6473921",
        "website": "http://www.redhillbio.com",
        "market_cap": "Small Cap"
    },
    "2UO1.F": {
        "short_name": "HAPPINESS BIOT.GRP -,0005",
        "long_name": "Happiness Biotech Group Limited",
        "summary": "Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powder, cordyceps mycelia, ejiao solution, American ginseng, and other products. It also offers a range of ganoderma lucidum products, such as essence oil, cleansing milk, shampoo, shower gel, and nourishing cream products under the Cai Zhi Ning brand, as well as edible fungi. In addition, the company provides disinfectants, non-medical face masks, and COVID-19 anti-body testing kits. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. Happiness Biotech Group Limited was founded in 2004 and is headquartered in Nanping, the People's Republic of China.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "China",
        "state": null,
        "city": "Nanping",
        "zipcode": "353200",
        "website": "http://www.happ.org.cn",
        "market_cap": "Nano Cap"
    },
    "2VV.F": {
        "short_name": "ZENABIS GLOBAL INC.",
        "long_name": "Zenabis Global Inc.",
        "summary": "Zenabis Global Inc. engages in the cultivation and sale of medical and adult-use recreational cannabis in Canada and internationally. The company produces and markets strains of dried cannabis under the Zenabis, Namaste, and Re-\u00c3\u00bcp brands; and various oil-based cannabis products. It has 111,200 kg of licensed cannabis cultivation space in three licensed facilities in Canada. The company is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2X8",
        "website": "http://www.zenabis.com",
        "market_cap": "Micro Cap"
    },
    "2VX.F": {
        "short_name": "THE FLOWR CORP.",
        "long_name": "The Flowr Corporation",
        "summary": "The Flowr Corporation cultivates, produces, and sells cannabis in Canada. It also has operations in Canada, Europe, and Australia. The company is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 3E4",
        "website": "http://www.flowr.ca",
        "market_cap": "Micro Cap"
    },
    "300016.SZ": {
        "short_name": "BEIJING BEILU PHAR",
        "long_name": "Beijing Beilu Pharmaceutical Co., Ltd.",
        "summary": "Beijing Beilu Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. The company's products include contrast agents, central nervous system products, and oral anti-diabetic drugs. Beijing Beilu Pharmaceutical Co., Ltd. also produces precision medicine. The company was founded in 1992 and is based in Beijing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Beijing",
        "zipcode": "100082",
        "website": "http://www.beilu.com.cn",
        "market_cap": "Small Cap"
    },
    "300026.SZ": {
        "short_name": "TIANJIN CHASE SUN",
        "long_name": "Tianjin Chase Sun Pharmaceutical Co.,Ltd",
        "summary": "Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and marketing of various pharmaceutical products in China. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet based therapy. It is also involved in the research and development of various drugs in the areas of sepsis, pulmonary hypertension, leukemia, cardiovascular and cerebrovascular diseases, arthritis, ischemic stroke, HCV, vascular disease, psychosis, and chemotherapy, as well as anesthesia drugs and immunomodulators. The company was founded in 1996 and is based in Tianjin, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Tianjin",
        "zipcode": "10200536",
        "website": "http://www.chasesun.cn",
        "market_cap": "Small Cap"
    },
    "300039.SZ": {
        "short_name": "SHANGHAI KAIBAO PH",
        "long_name": "Shanghai Kaibao Pharmaceutical CO.,Ltd",
        "summary": "Shanghai Kaibao Pharmaceutical CO.,Ltd researches, develops, produces, and sells modern Chinese medicines primarily in China. The company's primary product is Tanreqing injection that clears heat and detoxifies; relieves cough and removes phlegm; and for treatment of pneumonia, acute and chronic bronchitis, and upper respiratory tract infection. It also provides Kaibao Chuanxiong capsules; Kaibao Weiyuan tablets; And Kaibao pressure-release sustained release tablets. In addition, the company offers western medicines in various dosage forms, such as lyophilized powder injection, small volume injection, tablet, capsule, granule, pill, cream, and other dosage forms. Its western medicines comprise Kaixilai freeze-dried powder, tiopronin sodium, ginseng capsule, and Shanhaidan, alopecia areata, as well as Yuanman brand health win. The company is also developing Youxinding Capsule for treatment of depressions, which is in phase II clinical study; classic Fangding Guiyou soft capsule that is in phase III clinical study; Shufeng analgesic capsule for the treatment of migraine, which is in phase III clinical study; Huadan Anshen mixture for anti-insomnia that is in phase III clinical study; and Tanzheqing series of products, which is in phase III clinical study. Shanghai Kaibao Pharmaceutical CO.,Ltd was founded in 2000 and is based in Shanghai, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shanghai",
        "zipcode": "201401",
        "website": "http://www.xykb.com",
        "market_cap": "Small Cap"
    },
    "300086.SZ": {
        "short_name": "HONZ PHARMACEUTICA",
        "long_name": "Honz Pharmaceutical Co., Ltd.",
        "summary": "Honz Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pediatric medicines in China. It offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal and digestive, cough, anti-flu, antipyretic, anti-infection, anti-fungal, antipyretic-analgesic, and endocrine. The company markets its products through a network of agents and sales terminals. The company was formerly known as HaiNan Honz Pharmaceutical Co.,Ltd. and changed its name to Honz Pharmaceutical Co., Ltd. in November 2016. Honz Pharmaceutical Co., Ltd. is headquartered in Guangzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Guangzhou",
        "zipcode": null,
        "website": "http://www.honz.com.cn",
        "market_cap": "Small Cap"
    },
    "300110.SZ": {
        "short_name": "HUAREN PHARMACEUTI",
        "long_name": "Huaren Pharmaceutical Co., Ltd.",
        "summary": "Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. The company offers non-PVC double tube double valves, single tube single valves, and single tube double valve soft bags, as well as plastic and glass bottles. It also provides sodium lactate ringer injection, compound sodium chloride injection, glucose injection, sodium chloride injection, sterilized injection water, physiological sodium chloride solution, and mannitol injection products. In addition, the company offers various medical devices, such as incision pull-open fixators, disposable casing puncture device, disposable specimen pickup device, and devices for endoscopy; disposable slip pads, disposable backflow drainage bags, and sterile drainage bags; and abdominal dialysis external short tubes, iodine liquid protection cap, disposable abdominal drainage bags, and various types of rubber plugs, as well as pre-sealing pistons, conveyor plugs for infusion bags, dosing plugs for infusion bags, and polycarbonate for injections to fold plugs. Further, it provides injections for various diseases categories, which include the circulatory system, nervous system, blood volume extender, blood purification, anti-hepatitis and hepatitis assisted drugs, and hemostatic and anti-infective class; and retention needle and accessory products. Huaren Pharmaceutical Co., Ltd. was founded in 1998 and is based in Qingdao, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Qingdao",
        "zipcode": "266100",
        "website": "http://www.qdhuaren.com",
        "market_cap": "Small Cap"
    },
    "300119.SZ": {
        "short_name": "TIANJIN RINGPU BIO",
        "long_name": "Tianjin Ringpu Bio-Technology Co., Ltd.",
        "summary": "Tianjin Ringpu Bio-Technology Co., Ltd. develops, manufactures, and sells animal health products in China. It provides approximately 280 varieties of animal health products, including chemical drugs, biological products, feed additives, and plant extracts for poultry, livestock, pets, and aquatic animals. The company was founded in 1998 and is based in Tianjin, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Tianjin",
        "zipcode": "300308",
        "website": "http://www.ringpu.com",
        "market_cap": "Mid Cap"
    },
    "300142.SZ": {
        "short_name": "WALVAX BIOTECHNOLO",
        "long_name": "Walvax Biotechnology Co., Ltd.",
        "summary": "Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others. It provides Group A, C meningococcal polysaccharide conjugate vaccine for infants below or equal to 2 years preventing diseases, such as cerebrospinal meningitis and septicemia; Group A and C meningococcal polysaccharide vaccine for in adults and children over the age of 2 years and adults to prevent disease caused by the bacterium Neisseria meningitidis group A or group C; and Group ACYW135 meningococcal polysaccharide vaccine for children above 2 years old to prevent epidemic cerebrospinal meningitis caused by Neisseria meningitidis group A, C, Y, and W135. The company also offers haemophilus influenzae type b conjugate vaccine for children from the age of 2 months to 5 years for the prevention of infectious diseases, including meningitis, pneumonia, septicemia, cellulitis, arthritis, epiglottitis, etc. In addition, it provides diphtheria, tetanus, and acellular pertussis combined vaccine for the prevention of diphtheria, tetanus, and pertussis for individuals from the age of 3 months to 6 years; and 23-valent pneumococcal polysaccharide vaccine for children above 2 years old to prevent pneumococcal disease caused by 23 serotypes. Walvax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Kunming, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Kunming",
        "zipcode": "650106",
        "website": "http://www.walvax.com",
        "market_cap": "Large Cap"
    },
    "300158.SZ": {
        "short_name": "SHANXI ZHENDONG PH",
        "long_name": "Shanxi Zhendong Pharmaceutical Co.,Ltd",
        "summary": "Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, researches, develops, manufactures, and markets pharmaceutical products and Chinese medicines in China. It offers cancer drugs, cardiovascular drugs, infectious disease drugs, and respiratory drugs; antibiotics, antitumor drugs, vitamins, etc.; Chinese medicines; calcium preparations; and active pharmaceutical ingredients, as well as sells gastrointestinal drugs. The company offers its products in various dosage forms, such as large volume injections, small volume injections, powder injections, lyophilized powders, tablets, hard capsules, granules, dry suspensions, ointments, psychotropic substances, and other formulations Shanxi Zhendong Pharmaceutical Co.,Ltd is based in Changzhi, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Changzhi",
        "zipcode": "047100",
        "website": "http://www.zdjt.com",
        "market_cap": "Small Cap"
    },
    "300194.SZ": {
        "short_name": "FUAN PHARMACEUTICA",
        "long_name": "Fuan Pharmaceutical (Group) Co., Ltd.",
        "summary": "Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells pharmaceutical intermediates, bulk drugs, and formulations in the People's Republic of China. It offers APIs and intermediates, as well as formulations, such as anti-infective, cardiovascular, digestive, leaflet, and other products. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. Fuan Pharmaceutical (Group) Co., Ltd. was founded in 2004 and is based in Chongqing, the People's Republic of China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Chongqing",
        "zipcode": "401254",
        "website": "http://www.fapharm.com",
        "market_cap": "Small Cap"
    },
    "300199.SZ": {
        "short_name": "HYBIO PHARMACEUTIC",
        "long_name": "Hybio Pharmaceutical Co., Ltd.",
        "summary": "Hybio Pharmaceutical Co., Ltd., a peptide pharmaceutical company, engages in the research and development, manufacture, and sale of polypeptide drugs in the People's Republic of China and internationally. Its peptide finished dosage products include digestive system agents, immune modulators, PTH and Ca metabolic modulators, hormone and endocrine modulators, FD for circulatory and blood systems, antiviral agents, and hemostatic products. The company also provides custom and GMP peptides; and a range of peptide APIs. Hybio Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Shenzhen, the People's Republic of China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shenzhen",
        "zipcode": "518057",
        "website": "http://www.hybio.com.cn",
        "market_cap": "Small Cap"
    },
    "300239.SZ": {
        "short_name": "BAOTOU DONGBAO BIO",
        "long_name": "Baotou Dongbao Bio-Tech Co.,Ltd",
        "summary": "Baotou Dongbao Bio-Tech Co., Ltd. engages in the research and development, production, and sale of gelatin and collagen products in the People's Republic of China and internationally. It offers food additive and pharmaceutical gelatin, as well as collagen peptide. The company was founded in 1997 and is based in Baotou, the People's Republic of China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Baotou",
        "zipcode": "014030",
        "website": "http://www.dongbaoshengwu.com",
        "market_cap": "Small Cap"
    },
    "300267.SZ": {
        "short_name": "HUNAN ER-KANG PHAR",
        "long_name": "Hunan Er-Kang Pharmaceutical Co., Ltd",
        "summary": "Hunan Er-Kang Pharmaceutical Co., Ltd manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally. Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets. Its conventional pharmaceutical excipients include pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprise hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate and its series products. The company was founded in 2003 and is based in Liuyang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Liuyang",
        "zipcode": null,
        "website": "http://www.hnerkang.com",
        "market_cap": "Small Cap"
    },
    "300436.SZ": {
        "short_name": "FUJIAN COSUNTER PH",
        "long_name": "Fujian Cosunter Pharmaceutical Co., Ltd.",
        "summary": "Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. The company offers crude drugs and solid preparations in the form of tablets, capsules, granules, medicinal teas, etc. for use in the treatment of hepatitis B virus. Its products include Adefovir Dipivoxil and Lamivudine tablets, as well as Entecavir and Tenofovir Disoproxil Fumarate capsules. The company was founded in 2001 and is based in Fuzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Fuzhou",
        "zipcode": "350003",
        "website": "http://www.cosunter.com",
        "market_cap": "Small Cap"
    },
    "300452.SZ": {
        "short_name": "ANHUI SUNHERE PHAR",
        "long_name": "Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.",
        "summary": "Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. manufactures and sells pharmaceutical excipients and professional medicines in China. The company provides cellulose, starch, povidone, stearic acid, coating powder, resin, food additive, and other products. It also exports its products to Europe, the United States, Southeast Asia, and internationally. The company is based in Huainan, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Huainan",
        "zipcode": "232007",
        "website": "http://www.shanhe01.com",
        "market_cap": "Small Cap"
    },
    "300519.SZ": {
        "short_name": "ZHEJIANG XINGUANG",
        "long_name": "Zhejiang Xinguang Pharmaceutical Co., Ltd.",
        "summary": "Zhejiang Xinguang Pharmaceutical Co., Ltd. produces and sells pharmaceutical products in China. The company offers pharmaceutical products in the areas of cardiovascular, orthopedics, health food, respiratory system, digestive system, and urinary system; and products for the removal of heat and toxic substances, as well as tonic and other products. It offers its products in the form of oral solution, troche, capsule, granule, syrup, and bulks. Zhejiang Xinguang Pharmaceutical Co., Ltd. was founded in 1970 and is based in Shengzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shengzhou",
        "zipcode": null,
        "website": "http://www.xgpharma.com",
        "market_cap": "Small Cap"
    },
    "300534.SZ": {
        "short_name": "GANSU LONGSHENRONG",
        "long_name": "Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd",
        "summary": "Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd researches, develops, produces, and sells traditional Chinese medicines. It offers Yuan Hu Zhitong dropping pills for abdominal pain, stomach pain, hypochondriac pain, and headache, as well as to regulate qi and promote blood; Ma Xing Zhi cough capsules for acute and chronic bronchitis and wheezing; Qiwei Wenyang capsules; Xiaoshuan Tongluo and Compound Danshen tablets to promote blood circulation; Astragalus Angelica capsules for radiation hazards; and Citrate bismuth bacteriostatic gels. The company also provides Berberine citrate films for the treatment of cervical erosion; Shu Xinning tablets to improve coronary blood circulation, as well as treat hypertension, coronary heart disease, and angina pectoris; Sanqi injury pills for bruises, rheumatism, joint pain, acute and chronic contusion, and neuralgia; and anti-inflammatory and gallbladder tablets for heat, dampness, and daring treatment. In addition, it offers Pediatric Qingfei Zhike tablets for the treatment of heat, cough, and phlegm; pediatric clearing spirit tablets; and Suanzaoren oil drop pills to regulate blood lipids. The company was founded in 2002 and is based in Lanzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Lanzhou",
        "zipcode": null,
        "website": "http://www.lsrfzy.com",
        "market_cap": "Micro Cap"
    },
    "300558.SZ": {
        "short_name": "BETTA PHARMACEUTIC",
        "long_name": "Betta Pharmaceuticals Co., Ltd.",
        "summary": "Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of malignant tumors, diabetes, and cardio-cerebrovascular diseases in China. The company offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer. It is also developing CM082 for treating malignant tumor and eye-ground maculopathy. The company has agreement with Amgen Inc. for marketing Vectibix, an anti-tumor drug in China. Betta Pharmaceuticals Co., Ltd. was founded in 2003 and is headquartered in Hangzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Hangzhou",
        "zipcode": null,
        "website": "http://www.bettapharma.com",
        "market_cap": "Mid Cap"
    },
    "300584.SZ": {
        "short_name": "NANJING HICIN PHAR",
        "long_name": "Nanjing Hicin Pharmaceutical Co., Ltd.",
        "summary": "Nanjing Hicin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, marketing, and sale of pharmaceutical preparations and synthetic chemicals in China. The company offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. It also provides technical transferring services. The company also exports APIs; omeprazole sodium and cefepime hydrochloride for injections; and lansoprazole tablets to South-Asian countries, South-American countries, and European countries. Nanjing Hicin Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Nanjing",
        "zipcode": "210009",
        "website": "http://www.hicin.cn",
        "market_cap": "Small Cap"
    },
    "300601.SZ": {
        "short_name": "SHENZHEN KANGTAI B",
        "long_name": "Shenzhen Kangtai Biological Products Co., Ltd.",
        "summary": "Shenzhen Kangtai Biological Products Co., Ltd. develops, produces, and sells various types of human vaccines in China. The company's products include cell-free whitebait type b haemophilus combined vaccine, measles rubella combined with live attenuated vaccine, haemophilus influenzae type b conjugate vaccine, recombinant hepatitis B vaccine, hepatitis B vaccine, and other products. Shenzhen Kangtai Biological Products Co., Ltd. has an agreement between YTB and Yong Tai Berhad in relation to the development and commercialization of Covid-19 inactivated vaccine in Malaysia. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is based in Shenzhen, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shenzhen",
        "zipcode": null,
        "website": "http://www.biokangtai.com",
        "market_cap": "Large Cap"
    },
    "300630.SZ": {
        "short_name": "HAINAN POLY PHARM",
        "long_name": "Hainan Poly Pharm. Co., Ltd.",
        "summary": "Hainan Poly Pharm. Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. The company offers APIs. The company offers formulations in various therapeutic areas, which include anti-allergy, non-steroid anti-inflammatory, antibiotic, and digestive drugs. Its products include desloratadine preparations in anti-allergy drugs, diclofenac preparations in non-steroidal anti-inflammatory drugs, azithromycin for injection and clarithromycin preparations in antibiotic drugs, and trimebutine maleate preparations in digestive drugs. Hainan Poly Pharm. Co., Ltd. was founded in 1992 and is based in Haikou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Haikou",
        "zipcode": null,
        "website": "http://english.hnpoly.com",
        "market_cap": "Mid Cap"
    },
    "300636.SZ": {
        "short_name": "JIANGXI SYNERGY PH",
        "long_name": "Jiangxi Synergy Pharmaceutical Co., Ltd.",
        "summary": "Jiangxi Synergy Pharmaceutical Co., Ltd. manufactures and sells APIs worldwide. It offers APIs, liquid crystal compounds, and intermediates. The company was founded in 2004 and is headquartered in Yichun, the People's Republic of China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Yichun",
        "zipcode": "330700",
        "website": "http://www.jxsynergy.com",
        "market_cap": "Small Cap"
    },
    "300683.SZ": {
        "short_name": "WUHAN HITECK BIOLO",
        "long_name": "Wuhan Hiteck Biological Pharma Co., Ltd.",
        "summary": "Wuhan Hiteck Biological Pharma Co., Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of biological engineering products and freeze-dried powder injection primarily in China. Its products include Jinlujie 20ug, a mouse nerve growth factor for injection; and recombinant allosteric human tumor necrosis factor, which is in phase III clinical trial used for the treatment of apoptosis. The company offers its products in the field of nervous system and oncology. Wuhan Hiteck Biological Pharma Co., Ltd. is based in Wuhan, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Wuhan",
        "zipcode": "430056",
        "website": "http://www.hiteck.com.cn",
        "market_cap": "Small Cap"
    },
    "300702.SZ": {
        "short_name": "ZHEJIANG TIANYU PH",
        "long_name": "Zhejiang Tianyu Pharmaceutical Co., Ltd.",
        "summary": "Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of cardiovascular, anti-diabetic, anti-atherosclerosis, anticoagulant, and anti-asthmatic series. It also provides fine chemicals and CMO services. The company was founded in 1993 and is based in Taizhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Taizhou",
        "zipcode": "318020",
        "website": "http://www.tianyupharm.com",
        "market_cap": "Mid Cap"
    },
    "300723.SZ": {
        "short_name": "YIPINHONG PHARMACE",
        "long_name": "Yipinhong Pharmaceutical Co.,Ltd",
        "summary": "Yipinhong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. It offers anti-infection, pediatric, cardiovascular, genitourinary, respiratory, liver and digestion, and dermatological products, as well as anti-inflammatory and analgesic products. The company was founded in 2002 and is headquartered in Guangzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Guangzhou",
        "zipcode": "510623",
        "website": "http://www.gdyph.com",
        "market_cap": "Small Cap"
    },
    "300725.SZ": {
        "short_name": "PHARMABLOCK SCIENC",
        "long_name": "PharmaBlock Sciences (Nanjing), Inc.",
        "summary": "PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services to pharmaceutical research and development, and commercial production. It offers scaffolds and building blocks; custom synthesis services; and process research and development, as well as manufactures key intermediates and RSMs. The company was founded in 2006 and is based in Nanjing, the People's Republic of China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHZ",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Nanjing",
        "zipcode": "210032",
        "website": "http://www.pharmablock.com",
        "market_cap": "Mid Cap"
    },
    "3054.TW": {
        "short_name": "LIWANLI INNOVATION CO LTD",
        "long_name": "LIWANLI Innovation Co., Ltd.",
        "summary": "LIWANLI Innovation Co., Ltd. operates in the biomedical science industry. The company provides products in the areas of nutrition and healthcare. It offers Vigoway and powder collection products for male, female, elderly, and children audience. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015. LIWANLI Innovation Co., Ltd. was founded in 1991 and is based in New Taipei City, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TAI",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "New Taipei City",
        "zipcode": "235",
        "website": "http://www.liwanli.com.tw",
        "market_cap": "Micro Cap"
    },
    "31R.F": {
        "short_name": "REVIVE THERAPEUTICS LTD",
        "long_name": "Revive Therapeutics Ltd.",
        "summary": "Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers novel cannabinoid-centric treatments for liver diseases, inflammatory diseases, and skin disorders. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and coronavirus disease; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocybin oral formulations for the treatment of depression, anxiety, etc.; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. Revive Therapeutics Ltd. has a research collaboration agreement with PharmaTher Inc. for the development of psilocybin in the treatment of cancer and the discovery of other uses of undisclosed psychedelic compounds; and with North Carolina State University for the development of a novel biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform, as well as a research agreement with the University of California, San Francisco to explore the use of Bucillamine as a treatment for severe COVID-19. The company was incorporated in 2012 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 1P1",
        "website": "http://www.revivethera.com",
        "market_cap": "Micro Cap"
    },
    "3341.T": {
        "short_name": "NIHON CHOUZAI CO LTD",
        "long_name": "Nihon Chouzai Co.,Ltd.",
        "summary": "Nihon Chouzai Co., Ltd. engages in the management of health insurance dispensing chain pharmacies in Japan. The company also manufactures and sells generic drugs to medical institutions and other pharmacies. In addition, it offers temporary staffing services for pharmacist; and employment services for physicians and registered sales personnel, and other healthcare professionals. Further, the company provides studies and research services for pharmaceutical companies and organizations; information and consulting services for industries associated with pharmaceuticals and healthcare; and other services. Nihon Chouzai Co., Ltd. was founded in 1980 and is headquartered in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "100-6737",
        "website": "http://www.nicho.co.jp",
        "market_cap": "Small Cap"
    },
    "354.F": {
        "short_name": "COLLEGIUM PHARMAC.DL-,001",
        "long_name": "Collegium Pharmaceutical, Inc.",
        "summary": "Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "MA",
        "city": "Stoughton",
        "zipcode": "02072",
        "website": "http://www.collegiumpharma.com",
        "market_cap": "Small Cap"
    },
    "3692.HK": {
        "short_name": "HANSOH PHARMA",
        "long_name": "Hansoh Pharmaceutical Group Company Limited",
        "summary": "Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals and active pharmaceutical ingredients in the People's Republic of China. The company provides products for therapeutic areas, including central nervous system diseases, oncology, anti-infectives, diabetes, and cardiovascular, as well as gastrointestinal area. Its principal products include Mailingda, a category 1.1 drug for the treatment of chronic myelogenous leukemia; and Ameile, Hansoh Xinfu, Pulaile, Zefei, Xinwei, Xinmei, Xintai, Tanneng, Afatinib Dimaleate, Sunitinib Malate, Oulanning, Ameining, Ailanning, Zetan, Hengjie, Hengsen, Fulaimei, Fulaidi, Fulairui, Ruibote, Zexin, Ruiyisheng, Empagliflozin, and Saxagliptin, which are generic drugs. The company serves pharmaceutical product distributors. It has a strategic collaboration with Viela Bio, Inc. to develop and commercialize inebilizumab for the treatment of autoimmune diseases and hematologic cancers; and strategic collaboration and license agreement with EQRx, INC. to research, develop, manufacture, and commercialize Almonertinib. The company was founded in 1995 and is headquartered in Lianyungang, the People's Republic of China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Lianyungang",
        "zipcode": "222069",
        "website": "http://www.hspharm.com",
        "market_cap": "Large Cap"
    },
    "3705.TW": {
        "short_name": "YUNGSHIN GLOBAL HOLDING CORPORA",
        "long_name": "YungShin Global Holding Corporation",
        "summary": "YungShin Global Holding Corporation, through its subsidiaries, produces and sells pharmaceutical products. The company offers medicines and feed additives for swine, ruminants, poultry, pets, and aquatics; APIs, API intermediates, and specialty chemicals, as well as CRO and CMO services; herbal products; health foods; and beauty care products. It also operates EYES testing laboratories for food safety testing; and offers western medicines, agricultural products, chemical intermediates, and over-the-counter medicines. In addition, the company imports and exports pharmaceuticals, APIs, bio-products, and functional food materials; exports medicine-manufacturing machines and components, and medicine/food ingredients, as well as related materials, such as ampoules and vials; imports tablet-analysis equipment; and operates a nursing home for senior care. It operates in Taiwan, China, the United States, Japan, Malaysia, Hong Kong, Singapore, Thailand, Indonesia, Cambodia, and South Africa. The company was founded in 1952 and is based in Taipei, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TAI",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taipei",
        "zipcode": "10541",
        "website": "http://www.yungshingroup.com",
        "market_cap": "Small Cap"
    },
    "3737.HK": {
        "short_name": "ZHONGZHIPHARM",
        "long_name": "Zhongzhi Pharmaceutical Holdings Limited",
        "summary": "Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands. The company is also involved in the operation of chain and online pharmacies; manufacture and sale of food and Chinese herbs; and property management. As of December 31, 2020, it operated 366 self-operated chain pharmacies, including 325 medical insurance designated pharmacies located in Zhongshan in the Guangdong Province under the Zeus brand. The company was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited is a subsidiary of Crystal Talent Investment Group Limited.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Zhongshan",
        "zipcode": null,
        "website": "http://www.zeus.cn",
        "market_cap": "Micro Cap"
    },
    "38G.F": {
        "short_name": "SPROUTLY CDA INC.",
        "long_name": "Sproutly Canada Inc.",
        "summary": "Sproutly Canada Inc. produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumable markets in Canada. It offers its products under the Caliber brand name. The company is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6B 2T5",
        "website": "http://www.sproutly.ca",
        "market_cap": "Nano Cap"
    },
    "39H.F": {
        "short_name": "SPEAKEASY CANNAB.CLUB",
        "long_name": "Speakeasy Cannabis Club Ltd.",
        "summary": "Speakeasy Cannabis Club Ltd. focuses on producing medical cannabis in Canada. It owns approximately 290 acres of land in Rock Creek, British Columbia. The company is headquartered in Rock Creek, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Rock Creek",
        "zipcode": "V0H 1Y0",
        "website": "http://speakeasygrowers.com",
        "market_cap": "Micro Cap"
    },
    "39L.F": {
        "short_name": "PETIQ INC. CL. A  DL-,001",
        "long_name": "PetIQ, Inc.",
        "summary": "PetIQ, Inc. operates as a pet medication and wellness company. It operates in two segments, Products and Services. The company offers Rx pet medications, which include heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and co-develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers across 41 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "ID",
        "city": "Eagle",
        "zipcode": "83616",
        "website": "http://www.petiq.com",
        "market_cap": "Small Cap"
    },
    "39N.F": {
        "short_name": "MATICA ENTERPRISES INC.",
        "long_name": "Matica Enterprises Inc.",
        "summary": "Matica Enterprises Inc. engages in the medical marijuana business. It offers IONIC MIST, a spray mist that captures and neutralizes cannabis smoke odours. The company was formerly known as Matica Graphite Inc. and changed its name to Matica Enterprises Inc. in July 2014. Matica Enterprises Inc. is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 1Y2",
        "website": "http://www.maticaenterprises.com",
        "market_cap": "Nano Cap"
    },
    "3D7.F": {
        "short_name": "WILLOW BIOSCIENCES",
        "long_name": "Willow Biosciences Inc.",
        "summary": "Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. is headquartered in Calgary, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2R 0Y6",
        "website": "http://www.willowbio.com",
        "market_cap": "Micro Cap"
    },
    "3IP.F": {
        "short_name": "HARROW HEALTH INC. NEW",
        "long_name": "Harrow Health, Inc.",
        "summary": "Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and Visionology, a membership-based online eye health and medication platform. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was founded in 1998 and is headquartered in San Diego, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "TN",
        "city": "Nashville",
        "zipcode": "37205",
        "website": "http://www.harrowinc.com",
        "market_cap": "Micro Cap"
    },
    "3K70.F": {
        "short_name": "SILO WELLNESS INC.",
        "long_name": "Silo Wellness Inc.",
        "summary": "FlyOverture Equity Inc. doing business as Silo Wellness, engages in producing plant and fungal-based compounds for natural wellness. It offers psilocybin nasal spray made from cannabis. FlyOverture Equity Inc. was formerly known as Eighteen Fifty Equity, Inc. The company was founded in 2018 and is headquartered in Springfield, Oregon.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "OR",
        "city": "Springfield",
        "zipcode": "97478",
        "website": "http://www.silowellness.com",
        "market_cap": null
    },
    "3KF.F": {
        "short_name": "AUXLY CANNABIS GRP",
        "long_name": "Auxly Cannabis Group Inc.",
        "summary": "Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. The company engages in the cultivation of cannabis; and development and distribution of cannabis products. It offers products, such as soft chews, vape cartridges, vape pens, pre-rolled cannabis, chocolates, and cannabis oil spray and oil drops through retail stores under the Kolab Project, Foray, and Dosecan brand names. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M6J 0C2",
        "website": "http://auxly.com",
        "market_cap": "Micro Cap"
    },
    "3KY.F": {
        "short_name": "HANSOH PHARMAC. HD-,00001",
        "long_name": "Hansoh Pharmaceutical Group Company Limited",
        "summary": "Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals and active pharmaceutical ingredients in the People's Republic of China. The company provides products for therapeutic areas, including central nervous system diseases, oncology, anti-infectives, diabetes, and cardiovascular, as well as gastrointestinal area. Its principal products include Mailingda, a category 1.1 drug for the treatment of chronic myelogenous leukemia; and Ameile, Hansoh Xinfu, Pulaile, Zefei, Xinwei, Xinmei, Xintai, Tanneng, Afatinib Dimaleate, Sunitinib Malate, Oulanning, Ameining, Ailanning, Zetan, Hengjie, Hengsen, Fulaimei, Fulaidi, Fulairui, Ruibote, Zexin, Ruiyisheng, Empagliflozin, and Saxagliptin, which are generic drugs. The company serves pharmaceutical product distributors. It has a strategic collaboration with Viela Bio, Inc. to develop and commercialize inebilizumab for the treatment of autoimmune diseases and hematologic cancers; and strategic collaboration and license agreement with EQRx, INC. to research, develop, manufacture, and commercialize Almonertinib. The company was founded in 1995 and is headquartered in Lianyungang, the People's Republic of China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "China",
        "state": null,
        "city": "Lianyungang",
        "zipcode": "222069",
        "website": "http://www.hspharm.com",
        "market_cap": "Large Cap"
    },
    "3N9.F": {
        "short_name": "AMRYT PHARMA PLC  LS -,06",
        "long_name": "Amryt Pharma plc",
        "summary": "Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy. It also develops FILSUVEZ drug candidate, which is in Phase 3 EASE trial for the treatment of severe epidermolysis bullosa (EB), a rare and genetic skin disease; and AP103 that is in preclinical stage for the treatment of patients with recessive dystrophic EB, a subset of EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Ireland",
        "state": null,
        "city": "Dublin",
        "zipcode": "4",
        "website": "http://www.amrytpharma.com",
        "market_cap": "Small Cap"
    },
    "3N9A.F": {
        "short_name": "AMRYT PHARMA PLC SP.ADR/5",
        "long_name": "Amryt Pharma plc",
        "summary": "Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy. It also develops FILSUVEZ drug candidate, which is in Phase 3 EASE trial for the treatment of severe epidermolysis bullosa (EB), a rare and genetic skin disease; and AP103 that is in preclinical stage for the treatment of patients with recessive dystrophic EB, a subset of EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Ireland",
        "state": null,
        "city": "Dublin",
        "zipcode": "4",
        "website": "http://www.amrytpharma.com",
        "market_cap": "Small Cap"
    },
    "3TP.F": {
        "short_name": "ACERUS PHARMACEUTICALS",
        "long_name": "Acerus Pharmaceuticals Corporation",
        "summary": "Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Elegant vaginal moisturizer, which provides comfort to women suffering from vaginal dryness; and Elegant pH, a pH balanced vaginal product; and Tefina, a clinical stage product for women with female sexual dysfunction. In addition, the company provides TriVair technology platform for pulmonary and nasal dosing. Acerus Pharmaceuticals Corporation sells products through its salesforce in the United States; and through a network of distributors internationally. The company was formerly known as Trimel Pharmaceuticals Corporation and changed its name to Acerus Pharmaceuticals Corporation in September 2015. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5L 1J9",
        "website": "http://www.aceruspharma.com",
        "market_cap": "Nano Cap"
    },
    "3Z6.F": {
        "short_name": "NATTOPHARMA ASA  NK 3",
        "long_name": "NattoPharma ASA",
        "summary": "As of March 23, 2021, NattoPharma ASA operates as a subsidiary of Compagnie Des Levures Lesaffre SA.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Norway",
        "state": null,
        "city": "Oslo",
        "zipcode": "0283",
        "website": "http://www.nattopharma.com",
        "market_cap": "Micro Cap"
    },
    "40M.F": {
        "short_name": "NANEXA AB",
        "long_name": "Nanexa AB (publ)",
        "summary": "Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "75450",
        "website": "http://www.nanexa.com",
        "market_cap": "Nano Cap"
    },
    "4105.TWO": {
        "short_name": "TTY BIOPHARM COMPANY LIMITED",
        "long_name": "TTY Biopharm Company Limited",
        "summary": "TTY Biopharm Company Limited, a pharmaceutical company, develops and markets branded generics in Taiwan and internationally. It offers oncology drugs, such as Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Folina inj, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, and Zobonic for anti-cancer therapies. The company also provides anti-infection drugs, including Brosym, Colimycin, Cubicin, Lipo-AB, Metacin, Cepiro, and FlucelvaxQuad. In addition, it offers healthcare related drugs, such as Algitab, Alginos, Bio-Cal Plus, and Sulfin for gastrointestinal, bone, and metabolic healthcare. The company also holds a license to develop and commercialize Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic. The company was founded in 1960 and is headquartered in Taipei, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taipei",
        "zipcode": "11503",
        "website": "http://eng.tty.com.tw",
        "market_cap": "Small Cap"
    },
    "4108.TW": {
        "short_name": "PHYTOHEALTH CORP.",
        "long_name": "PhytoHealth Corporation",
        "summary": "PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B drugs, and dietary supplements in Asia. Its products include PG2 Lyophilized injection for the treatment of cancer related fatigue; EnerCharge, which is used in enhancing physical strength, maintaining good spirits, and enhancing health maintenance activities; NatoCleanse capsules, which helps to reduce the risk of cardiovascular diseases; ReyeasCleanse health food capsules; and EnerCharge, an energy drink. The company also offers precision medical equipment and instruments; and computer-aided diagnosis development and authorization services. PhytoHealth Corporation was founded in 1998 and is based in Taipei, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TAI",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taipei",
        "zipcode": "105",
        "website": "http://www.phytohealth.com.tw",
        "market_cap": "Micro Cap"
    },
    "4114.TWO": {
        "short_name": "SYNMOSA BIOPHARMA CORP",
        "long_name": "Synmosa Biopharma Corporation",
        "summary": "Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand in Taiwan. It offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology. The company provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, and other forms. It also offers contract manufacturing services. The company also exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua. Synmosa Biopharma Corporation was incorporated in 1980 and is based in Taipei City, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taipei",
        "zipcode": "114",
        "website": "http://www.synmosa.com.tw",
        "market_cap": "Micro Cap"
    },
    "4117.TWO": {
        "short_name": "GBC",
        "long_name": "General Biologicals Corporation",
        "summary": "General Biologicals Corporation engages in manufacturing and selling in-vitro diagnostic devices and pharmaceuticals in Taiwan and internationally. It offers real-time PCR products, including IVD kits and genesis products for breast cancer; ELISA Products comprising KIWI products; RIA products for gastrin, hepatitis, and thyroid, as well as vitamin products; rapid tests consisting of blood glucose monitoring systems, and cardiac and tumor markers, as well as products related to drug abuse, fertility hormones, and infectious diseases; lab ware products; and raw materials that comprise antibodies and antigens. The company also provides protein drugs for oral candidiasis; and point of care products for liver fibrosis and breast cancer indications. In addition, it offers products for use in clinics and laboratories for preventives and cancer diagnosis, including skin and oral care, breast cancer and liver related, and advanced cancer diagnosis products, as well as healthcare and education services. General Biologicals Corporation was founded in 1984 and is headquartered in Hsinchu City, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Hsinchu City",
        "zipcode": "30076",
        "website": "http://www.gbc.com.tw",
        "market_cap": "Micro Cap"
    },
    "4119.TW": {
        "short_name": "SCI PHARMTECH INC",
        "long_name": "SCI Pharmtech, Inc.",
        "summary": "SCI Pharmtech, Inc. develops, produces, and sells active pharmaceutical ingredients, intermediates, and custom products worldwide. Its active pharmaceutical ingredients include Articaine HCl, Atomoxetine HCl, Bisoprolol Fumarate, Brinzolamide, Clindamycin Palmitate HCl, Divalproex Sodium, Duloxetine HCl, Hydroxychloroquine sulfate, Loxoprofen Sodium, Methylphenidate HCl, Pentobarbital Sodium, Probucol, Propafenone HCl, Sodium Valproate, Thiopental, Valproic Acid, Adenine, Cannabidiol, and Dexmethylphenidate HCl. The company's intermediate products comprise Azetidin-3-ol hydrogenchloride, Diethyl Isobutyl Malonate, Diethyl dipropylmalonate, Diethyl ethyl(1-methylbutyl)malonate, Pyrogallolaldehyde, Benzhydrylamine, 1-Benzhydrylazetidin-3-ol, 1-(2-Hydroxyphenyl)-3-phenylpropan-1-one, N-Methyl-4-piperidinol, Ritalinic acid, d-Ritalinic acid HCl, (1R, 2S)-1 Phenyl-2-(pyrrolldin-1-yl)propan-1-ol HCl, and (1R, 2S)-1 Phenyl-2-(pyrrolldin-1-yl)propan-1-ol. Its intermediate products also consists of (S)-3-(methylmino)-1-(2-thi-enyl)propan-1-ol, (R)-3-(Methylamino)-1-phenylpropanol, (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol, Menthadienol, 5-pentylbenzene-1,3-diol Olivetol, Methyl 2,4-dihydroxy-6-pentylbenzoate, and Ethyl 2,4-dihydroxy-6-pentylbenzoate Ethyl Olivetolate. The company also provides custom manufacturing services. SCI Pharmtech, Inc. was founded in 1987 and is based in Taoyuan City, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TAI",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taoyuan City",
        "zipcode": "33856",
        "website": "http://www.sci-pharmtech.com.tw",
        "market_cap": "Micro Cap"
    },
    "4127.TWO": {
        "short_name": "TIEN LIANG BIOTECH CO LTD",
        "long_name": "Tien Liang BioTech Co., Ltd.",
        "summary": "Tien Liang BioTech Co., Ltd. produces and sells pharmaceutical products in Taiwan and internationally. The company pills for cough, lumbar bone soreness cloth, and stool and gastric problems, as well as liver, bladder, bone pain. It also provides hair removal and skin cream; pain coagulation gel and spray; alcohol, cranberry, and deep-sea oil capsules; pumpkin seed oil; soaps; and liqueur amine-based acid. Tien Liang BioTech Co., Ltd. was founded in 1960 and is based in New Taipei City, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "New Taipei City",
        "zipcode": null,
        "website": "http://www.tlb.com.tw",
        "market_cap": "Nano Cap"
    },
    "4172.TWO": {
        "short_name": "InnoPharmax",
        "long_name": "InnoPharmax Inc.",
        "summary": "InnoPharmax Inc., a specialty pharmaceutical company, develops and commercializes products for the treatment of infectious diseases, immunology, oncology, and other specialties in Taiwan. The company offers anti-infection agents, including Bestnem, an imipenem and cilastatin sodium solution that is used intravenous in the treatment of various infections caused by susceptible organisms, such as lower respiratory tract, skin and skin structure, intra-abdominal, gynecologic, or bone and joint infections; and various complicated or uncomplicated urinary tract infections, septicemia, or endocarditis caused by susceptible organisms. It also provides gadopentetate dimeglumine, a contrast medium for magnetic resonance imaging (MRI) of the body after intravenous administration; and gadodiamide, a contrast medium for cranial and spinal MRI, as well as for general MRI of the body after intravenous administration. In addition, the company offers oncology agents comprising Innomustine for the treatment of hodgkin's disease, non-hodgkin's lymphoma, and plasmocytoma, as well as chronic lymphocytic leukemia and breast cancer; and immunological agents that include Cyclosporine A, an immuno-suppresant with a low aqueous solubility used for the inhibition of graft rejection in organ transplant recipients, as well as inpheno tablets. Further, it is developing oncology, cardiovascular, CNS, urology, and contrast agents, as well as agents for metabolic disorders and drugs for rare diseases. The company was founded in 2005 and is based in Taipei City, Taiwan. InnoPharmax Inc. is a subsidiary of Synmosa Biopharma Corporation.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taipei City",
        "zipcode": "11492",
        "website": "http://www.innopharmax.com",
        "market_cap": "Nano Cap"
    },
    "4191.TWO": {
        "short_name": "PHD",
        "long_name": "Pharmadax Inc.",
        "summary": "Pharmadax Inc. engages in the pharmaceutical research and development business in Taiwan, the Unites States, China, and internationally. It primarily focuses on the development of oral solid controlled-release technology pellets. The company offers Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets, as well as contract development and/or contract manufacturing services for solid orals. It provides its products for a range of therapeutic areas, including schizophrenia, hypertension, diabetes, cold, Parkinson's disease, ADHD, chronic hepatitis, overactive bladder, and muscle relaxant. The company was founded in 2008 and is headquartered in New Taipei City, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "New Taipei City",
        "zipcode": "23553",
        "website": "http://www.pharmadax.com",
        "market_cap": "Micro Cap"
    },
    "4502.T": {
        "short_name": "TAKEDA PHARMACEUTICAL CO LTD",
        "long_name": "Takeda Pharmaceutical Company Limited",
        "summary": "Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, rest of Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc., Sosei Group Corporation, and LogicBio Therapeutics, Inc.; strategic collaboration with Prometheus Biosciences, Inc; a license and research agreement with The University of Texas MD Anderson Cancer Center; a research collaboration agreements with Enzyre BV and Cerevance; a collaboration agreement with Artisan Bio, Inc.; and a multi-target rare disease collaboration with Evox Therapeutics Ltd., as well as licensing agreement with ProThera Biologics Inc. It also has a strategic alliance with Egle Therapeutics SAS and Evotec SE; a strategic partnership with Neurocrine Biosciences, Inc.; Carmine Therapeutics and HemoShear Therapeutics, LLC; strategic collaboration with KSQ Therapeutics to research, develop, and commercialize immune-based therapies for cancer; and strategic collaboration with Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "103-8668",
        "website": "http://www.takeda.com",
        "market_cap": "Large Cap"
    },
    "4506.T": {
        "short_name": "SUMITOMO DAINIPPON PHARMA CO LT",
        "long_name": "Sumitomo Dainippon Pharma Co., Ltd.",
        "summary": "Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, diagnostics, and others. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, depression, type 2 diabetes, systemic fungal infection, pruritus, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides atypical antipsychotic, antiepileptic, carbapenem antibiotic, and gastroprokine products; and Anderson-Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, and seasonings, such as soups or bouillons; and chemical product materials consisting of pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, primarily dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. Sumitomo Dainippon Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application (CiRA); Kyoto University; and Aikomi Co., Ltd., as well as a joint development agreement with SanBio, Inc. It also has a strategic research collaboration agreement with Gain Therapeutics, Inc. for the research and development of structurally targeted allosteric regulators to restore functional activity of defective lysosomal enzymes in rare genetic and demyelinating diseases. The company was formerly known as Dainippon Sumitomo Pharma Co., Ltd. and changed its name to Sumitomo Dainippon Pharma Co., Ltd. in June 2014. Sumitomo Dainippon Pharma Co., Ltd. was founded in 1897 and is headquartered in Osaka, Japan. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Osaka",
        "zipcode": "541-0045",
        "website": "http://www.ds-pharma.com",
        "market_cap": "Mid Cap"
    },
    "4507.T": {
        "short_name": "SHIONOGI & CO",
        "long_name": "Shionogi & Co., Ltd.",
        "summary": "Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. Its primary products Tivicay for HIV treatment; Mulpleta for the treatment of thrombocytopenia; Xofluza, an influenza drug; Symproic for opioid-induced constipation treatment; and Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment. The company also offers antibody detection kits for COVID-19. Shionogi & Co., Ltd. has collaboration agreements with InveniAI, LLC.; Hsiri Therapeutics Inc.; Nagasaki University; Roche Group to develop and commercialize Xofluza; and Nagasaki University and The Kitasato Institute to develop antimalarial drugs and vaccines. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Osaka",
        "zipcode": "541-0045",
        "website": "http://www.shionogi.com",
        "market_cap": "Large Cap"
    },
    "4512.T": {
        "short_name": "WAKAMOTO PHARMACEUTICAL CO",
        "long_name": "Wakamoto Pharmaceutical Co.,Ltd.",
        "summary": "Wakamoto Pharmaceutical Co., Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong Wakamoto, a gastrointestinal drug for digestion, intestinal regulation, and nutritional supplementation. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943. Wakamoto Pharmaceutical Co., Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "103-8330",
        "website": "http://www.wakamoto-pharm.co.jp",
        "market_cap": "Micro Cap"
    },
    "4516.T": {
        "short_name": "NIPPON SHINYAKU CO",
        "long_name": "Nippon Shinyaku Co., Ltd.",
        "summary": "Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Switzerland, and internationally. The company operates through Pharmaceuticals and Functional Food segments. It offers drugs for urological diseases, inflammation and allergies, hematologic malignancies, cardiovascular and metabolic diseases, gastrointestinal disorders, and other diseases. The company's products include Zalutia for urinary disorder caused by benign prostatic; Eviprostat for prostatic hypertrophy; Bladderon for pollakisuria; Estracyt for prostate cancer; Cialis for erectile dysfunction; Vidaza for myelodysplastic syndrome; Cylocide for solid tumor and acute leukemia; CylocideN for relapsed and refractory acute leukemia and malignant lymphoma; Gazyva for humanized anti-CD20 monoclonal antibody; Defiterio sinusoidal obstruction syndrome; and Trisenox and Amnolake for relapsed and refractory acute promyelocytic leukemia. Nippon Shinyaku Co., Ltd.'s products also comprise Uptravi, Adcirca, and Opsumit for pulmonary arterial hypertension; VILTEPSO for muscular dystrophy; Lunabel LD and Lunabel ULD for dysmenorrhea; Erizas, a dry powder inhaler solution for allergic rhinitis; Azunol Gargle liquid, a gargling solution containing azulene; Isobide for oral osmotic diuresis/meniere's disease; Cephadol for vertigo; Livostin for allergic rhinitis and conjunctivitis; Regtect for maintaining alcohol abstinence; and Onetram and Tramal for cancer and chronic pain. In addition, it researches, develops, and markets drugs in the areas of gynecology, otorhinolaryngology, and orthopedics. Further, the company provides functional foods, such as health food ingredients, preservatives, protein preparations, supplements, and spice and condiments. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Kyoto",
        "zipcode": "601-8550",
        "website": "http://www.nippon-shinyaku.co.jp",
        "market_cap": "Mid Cap"
    },
    "4517.T": {
        "short_name": "BIOFERMIN PHARMACEUTICAL CO",
        "long_name": "Biofermin Pharmaceutical Co., Ltd.",
        "summary": "Biofermin Pharmaceutical Co., Ltd. manufactures and sells drugs and quasi-drugs in Japan. It offers drugs for the treatment of diarrhea, constipation, and stomach digestion; and veterinary medicines, pesticides and other chemicals, cosmetics, medical equipment, foods, beverages, food additives, feeds, feed additives, and various tests. The company was formerly known as Kobe hygiene Laboratory Co., Ltd. and changed its name to Biofermin Pharmaceutical Co., Ltd. in March 1949. The company was founded in 1917 and is headquartered in Kobe, Japan. Biofermin Pharmaceutical Co., Ltd. is a subsidiary of Taisho Pharmaceutical Co., Ltd.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Kobe",
        "zipcode": "650-0021",
        "website": "http://www.biofermin.co.jp",
        "market_cap": "Small Cap"
    },
    "4521.T": {
        "short_name": "KAKEN PHARMACEUTICAL",
        "long_name": "Kaken Pharmaceutical Co., Ltd.",
        "summary": "Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. It offers pharmaceutical products and medical devices, such as Clenafin, a topical treatment for onychomycosis; Artz, an anti-osteoarthritis agent; Seprafilm, a semitransparent film-type absorbable adhesion barrier, which is applied to damaged tissue; Fiblast, a spray-on drug for the treatment of pressure ulcers and other skin ulcers; Regroth, a medicinal product for periodontal regeneration; and Hernicore for the treatment of lumbar disc herniation. The company also provides Adofeed, a pain- and inflammation-relieving plaster; Ebrantil for the treatment of dysuria and hypertension; Procylin, an oral-use prostaglandin I2 analog; Lipidil, an anti-hyperlipidemia agent; Mentax, an anti-trichophyton agent; and Loxoprofen Na Tape, a pain-relieving and anti-inflammatory plaster. In addition, it offers Ropion, a pain relief injection; and agrochemicals and animal health products, including Polyoxins that is used as fungicide; Pentoxazone, a rice herbicide; and Salinomycin, an anti-coccidial feed additive for chicken. Further, the company is developing BBI-4000 that has completed phase III clinical trial for primary axillary hyperhidrosis; KMW-1, which is in phase III clinical trial for the removal of eschar with thermal burns; KAR for treatment of hide lice infestation; and KP-607, which is in phase II clinical trial for the treatment of onychomycosis. Additionally, it is involved in the rental of Bunkyo Green Court, a commercial complex. The company offers its products under the Mentax Lotrimin Ultra, Mentax Butena, Mentax, Kaifen, Fiblast, and Jublia brands. It has license agreements with Corbus Pharmaceuticals Holdings, Inc. and Arbor Pharmaceuticals, LLC. Kaken Pharmaceutical Co., Ltd. was founded in 1917 and is headquartered in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "113-8650",
        "website": "http://www.kaken.co.jp",
        "market_cap": "Small Cap"
    },
    "4523.T": {
        "short_name": "EISAI CO",
        "long_name": "Eisai Co., Ltd.",
        "summary": "Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. Eisai Co., Ltd. has a research collaboration agreement with Wren Therapeutics Ltd. for the discovery of small molecules that target synuclein for the potential treatment of synucleinopathies, including Parkinson's disease and dementia with Lewy bodies; and a collaboration with BioLabs for the launch of the Eisai Innovation Center BioLabs, a shared lab and office space for start-ups to innovate in the field of neurological diseases. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was founded in 1941 and is headquartered in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "112-8088",
        "website": "http://www.eisai.co.jp",
        "market_cap": "Large Cap"
    },
    "4524.T": {
        "short_name": "MORISHITA JINTAN",
        "long_name": "Morishita Jintan Co., Ltd.",
        "summary": "Morishita Jintan Co., Ltd. produces and distributes pharmaceuticals, quasi drugs, medical devices, and food products in Japan. It operates through Healthcare Business and Capsule Business divisions. The Healthcare Business division manufactures and sells Jintan branded products, as well as engages in OEM/ODM of dietary supplements, cosmetics, foods, etc. The Capsule Business division is involved in the OEM/ODM of pharmaceuticals, foods, etc., as well as the development of industrial use capsules. The company was founded in 1893 and is headquartered in Osaka, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Osaka",
        "zipcode": "540-8566",
        "website": "http://www.jintan.co.jp",
        "market_cap": "Micro Cap"
    },
    "4530.T": {
        "short_name": "HISAMITSU PHARMACEUTICAL CO INC",
        "long_name": "Hisamitsu Pharmaceutical Co., Inc.",
        "summary": "Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. The company provides analgesic / anti-inflammatory patches; athlete's foot / ringworm remedy products; allergy-only rhinitis drugs; eye drops; high cholesterol improving drugs; acne remedies; cooling sheets; and supporters for knee, waist, elbow, calf and ankle. It also provides cooling sprays; bactericidal antibacterial spray and deodorant spray; ship fixing sheet; adhesive plasters for magnetic products; skin care products; sweat sheet; massage roller gel and oil spray; thermal equipment, and dietary supplements. The company offers its products under the Salon pass, Salonship, Air Salon Pass, Fatus, Butena Rock, Allegra, Direct pasting, Choleston, Life Cera, Deco Deco Cool, Children Robin Eye Plus. Eye cool, MSM, and other brand names. It sells its products in North America, Central and South America, Asia, Oceania, the Middle East, Africa, and Europe. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tosu",
        "zipcode": "841-0017",
        "website": "http://www.hisamitsu.co.jp",
        "market_cap": "Mid Cap"
    },
    "4534.T": {
        "short_name": "MOCHIDA PHARMACEUTICAL CO",
        "long_name": "Mochida Pharmaceutical Co., Ltd.",
        "summary": "Mochida Pharmaceutical Co., Ltd. produces and sells pharmaceuticals, skincare products, and diagnostics solutions in Japan. The company provides cardiovascular, analgesic, gastrointestinal, neurological, anti-infective, antidiabetics, and anticancer products, as well as hormone and biological preparations, and biosimilars; diagnostic reagents, such as reagents for fertility/infertility and other reagents; and face and body care, hair care, and skincare products, as well as dermatology, psychiatry, obstetrics, and gynecology products. It also developing drugs for the treatment of intractable diseases. The company has collaboration agreements with Amarin Corporation plc for the development and commercialization of ethyl icosapentate products; and Gene Techno Science Co., Ltd. to develop new regenerative medicine for the treatment of digestive rare and intractable diseases, such as congenital isolated hypoganglionosis. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "162-0845",
        "website": "http://www.mochida.co.jp",
        "market_cap": "Small Cap"
    },
    "4538.T": {
        "short_name": "FUSO PHARMACEUTICAL INDUSTRIES",
        "long_name": "Fuso Pharmaceutical Industries,Ltd.",
        "summary": "Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceutical products in Japan. It primarily offers dialysates for artificial kidneys. The company was founded in 1937 and is headquartered in Osaka, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Osaka",
        "zipcode": "541-0045",
        "website": "http://www.fuso-pharm.co.jp",
        "market_cap": "Micro Cap"
    },
    "4539.T": {
        "short_name": "NIPPON CHEMIPHAR CO",
        "long_name": "Nippon Chemiphar Co., Ltd.",
        "summary": "Nippon Chemiphar Co., Ltd., together with its subsidiaries, manufactures, markets, imports, exports, and sells, ethical pharmaceuticals and diagnostic agents in Japan and internationally. It offers diagnostic products, such as IgE NC, a diagnostic kit that provides results and reveals total IgE levels, as well as 57 individual allergen reagents; and DP3000, a device for allergen-specific IgE measurements. The company also develops NC-2400, a PPAR-delta agonist; NC-2500, a novel advanced xanthine oxidoreductase inhibitor for the treatment of hyperuricemia/gout; and NC-2600, a P2X4 receptor antagonist for the treatment of neuropathic pain. In addition, it develops NC-2700, a novel urate transporter 1 inhibitor that enhance excretion urate to urine; NC-2800, a delta opioid receptor agonist for the treatment of depression/anxiety; Uralyt-U, an alkalization therapeutic drug; Soleton, an analgesic and anti-inflammatory drug; and Calvan, a hypertension therapeutic drug. Further, the company provides quasi-drugs, nutrients, health foods, cosmetics, and various type of creams. It distributes its generic pharmaceuticals through wholesalers to hospitals and pharmacies. The company was formerly known as Hitachi Chemical Co., Ltd. and changed its name to Nippon Chemiphar Co., Ltd. in 1970. Nippon Chemiphar Co., Ltd. was founded in 1950 and is headquartered in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "101-0032",
        "website": "http://www.chemiphar.co.jp",
        "market_cap": "Micro Cap"
    },
    "4540.T": {
        "short_name": "TSUMURA & CO",
        "long_name": "Tsumura & Co.",
        "summary": "Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines, as well as Kampo powdered extracts; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "107-8521",
        "website": "http://www.tsumura.co.jp",
        "market_cap": "Mid Cap"
    },
    "4541.T": {
        "short_name": "NICHI-IKO PHARMACEUTICAL CO",
        "long_name": "Nichi-Iko Pharmaceutical Co., Ltd.",
        "summary": "Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, imports, and distributes various pharmaceutical products. It primarily focuses on the production of generic drugs. The company offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin ? antagonist, angiotensin ? antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products. It also provides treatments for circulatory, digestive, respiratory, central and peripheral nervous systems, and others. In addition, the company engages in the packaging design business. Further, it exports its products. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was founded in 1965 and is headquartered in Toyama, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Toyama",
        "zipcode": "930-8583",
        "website": "http://www.nichiiko.co.jp",
        "market_cap": "Small Cap"
    },
    "4547.T": {
        "short_name": "KISSEI PHARMACEUTICAL CO",
        "long_name": "Kissei Pharmaceutical Co., Ltd.",
        "summary": "Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products primarily in Japan. It offers Urief and Urief OD tablets for the treatment of dysuria; Glufast, Glubes, and Marizev tablets for type 2 diabetes; Darbepoetin Alfa BS and Epoetin Alfa BS injections for the treatment of renal anemia; Beova tablets for overactive bladder treatment; P-TOL chewable tablets for treating hyperphosphatemia; and Minirin Melt OD tablets for nocturia due to nocturnal polyuria in males, central diabetes insipidus, and nocturnal enuresis resulted from decrease of urine osmolality. The company's products in pipeline include KPS-0373 that has completed Phase III clinical trial to treat spinocerebellar ataxia; CCX168, which has completed Phase III clinical trial for the treatment of microscopic polyangiitis and granulomatosis with polyangiitis; AJM300, which is in Phase III clinical trial to treat ulcerative colitis; R788 that is in Phase III clinical trial to treat chronic idiopathic thrombocytopenic purpura; and MR13A9, which is in Phase III clinical trial to treat uremic pruritus in dialysis patients. It is also developing KLH-2109 for treating endometriosis and uterine fibroids; KDT-3594 for the treatment of Parkinson's disease; Silodosin for dysuria associated with benign prostatic hyperplasia; Mitiglinide for type 2 diabetes mellitus; and Bedoradrine for the treatment of acute exacerbation of asthma. In addition, it develops and sells protein controlled and energy supply foods; and purchases and sells related materials, as well as offers system development and information processing, construction contracting, equipment and facility management, and information gathering and development support services. The company was formerly known as Kissei Yakuhin Kogyo Co., Ltd. and changed its name to Kissei Pharmaceutical Co., Ltd. in October 1964. The company was founded in 1946 and is headquartered in Matsumoto, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Matsumoto",
        "zipcode": "399-8710",
        "website": "http://www.kissei.co.jp",
        "market_cap": "Small Cap"
    },
    "4551.T": {
        "short_name": "TORII PHARMACEUTICAL CO",
        "long_name": "Torii Pharmaceutical Co., Ltd.",
        "summary": "Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CEDARTOLEN, a sublingual immunotherapy drug. Torii Pharmaceutical Co., Ltd. markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "103-8439",
        "website": "http://www.torii.co.jp",
        "market_cap": "Small Cap"
    },
    "4553.T": {
        "short_name": "TOWA PHARMACEUTICAL CO",
        "long_name": "Towa Pharmaceutical Co., Ltd.",
        "summary": "Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 drug products. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Osaka",
        "zipcode": "571-8580",
        "website": "http://www.towayakuhin.co.jp",
        "market_cap": "Small Cap"
    },
    "4559.T": {
        "short_name": "ZERIA PHARMACEUTICAL",
        "long_name": "Zeria Pharmaceutical Co., Ltd.",
        "summary": "Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn's disease, and gastritis and ulcers; zinc containing anti-ulcerants; oral bowel cleansing agents; laxatives; therapeutic agents for hypophosphatemia; long-acting calcium channel blockers; oral NSAID; anti-leukopenia after radiotherapy products; sclerosing agent for varicose veins; anti-inflammatory topical blood circulation enhancers; non-steroidal anti-inflammatory ophthalmic solutions; absorbable topical hemostat products; and proton pump inhibitors. In addition, it offers consumer healthcare products, such as nutritional health drugs, cold remedies, ophthalmic solutions, anti-inflammatory/analgesics, hemorroidal remedies, dermal remedies, quasi-drugs/cosmetics, nutrient tonics, and food for specified health uses. The company was formerly known as Zeria Yakusho Kenkyusho Co., Ltd. and changed its name to Zeria Pharmaceutical Co., Ltd. in May 1970. Zeria Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "103-8351",
        "website": "http://www.zeria.co.jp",
        "market_cap": "Small Cap"
    },
    "4569.T": {
        "short_name": "KYORIN HOLDINGS INC",
        "long_name": "KYORIN Holdings, Inc.",
        "summary": "KYORIN Holdings, Inc., through its subsidiaries, researches and develops, produces, and sells ethical, generic, and over-the-counter drugs in Japan and internationally. It operates through Ethical Pharmaceutical Business and Consumer Healthcare Business segments. The company's products primarily include Flutiform, a drug for the treatment of asthma; Lasvic, an oral quinolone synthetic antibacterial agent; Desalex, an antiallergic agent; Kipres, a product for the treatment of bronchial asthma and allergic rhinitis; NASONEX, an allergic rhinitis therapeutic agent; Uritos and Beova, which are therapeutic agents for overactive bladder; Pentasa, a remedy for ulcerative colitis/Crohn's disease; Mucodyne, a mucoregulan drug; and MONTELUKAST KM, which are generic drugs for the treatment of bronchial asthma and allergic rhinitis. It also provides Milton, a baby bottle disinfectant; Rubysta, a disinfectant cleaner; hand hygiene and skincare products; and prescription medicines and quasi-drugs, diagnostics, and industrial chemicals. In addition, the company is involved in the discovery and evaluation of candidate compounds; and research and analysis of other companies' technologies and collection of information concerning clinical trials business. Further, its pipeline products include KRP-AM1977Y, a quinolone synthetic antibacterial agent; KRP-116D for the treatment of interstitial cystitis; KRP-108P for the treatment of bronchial asthma; and Ad-SGE-REIC for treating Malignant pleural mesothelioma. Additionally, the company's out-licensed products in pipeline comprise FPR2 agonist program and KRP-203. KYORIN Holdings, Inc. was founded in 1923 and is headquartered in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "101-8311",
        "website": "http://www.kyorin-gr.co.jp/en",
        "market_cap": "Small Cap"
    },
    "4574.T": {
        "short_name": "TAIKO PHARMACEUTICAL CO LTD",
        "long_name": "Taiko Pharmaceutical Co.,Ltd.",
        "summary": "Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs, including gastrointestinal drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; and quasi-drugs, such as Trumpet Intestinal Regulator BF for stomach distention, loose stools, and constipation. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as LISPASS Cleverin generator, a machine which emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. In addition, the company manufactures and sells bath additives and pyroligneous acids for horticultural use. It operates in Japan, China, Hong Kong, Taiwan, Thailand, Malaysia, Vietnam, Mongolia, the United States, and Canada. Taiko Pharmaceutical Co.,Ltd. was founded in 1946 and is headquartered in Osaka, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Osaka",
        "zipcode": "550-0005",
        "website": "http://www.seirogan.co.jp",
        "market_cap": "Small Cap"
    },
    "4577.T": {
        "short_name": "DAITO PHARMACEUTICAL CO.LTD",
        "long_name": "Daito Pharmaceutical Co.,Ltd.",
        "summary": "Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was founded in 1942 and is headquartered in Toyama, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Toyama",
        "zipcode": "939-8567",
        "website": "http://www.daitonet.co.jp",
        "market_cap": "Small Cap"
    },
    "4581.T": {
        "short_name": "TAISHO PHARMACEUTICAL HLDG CO L",
        "long_name": "Taisho Pharmaceutical Holdings Co., Ltd.",
        "summary": "Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) drugs and prescription pharmaceutical products in Japan and internationally. It operates through Self-Medication Operation Group and Prescription Pharmaceutical Operation Group segments. The Self-Medication Operation Group segment offers OTC drugs, quasi-drugs, food products, and general medical and hygiene supplies, such as Lipovitan series of energy drinks; the Pabron series of cold remedies and sinus treatments; the RiUP series of hair re-growth treatment products; the Taisho Kampo series of gastrointestinal treatment products; the Colac series of laxative products; the Naron series and other products for antipyretic analgesics; the Preser series of hemorrhoid treatment products; Hapacol, Efferalgan, Dafalgan, and Tempra for antipyretic analgesics; Counterpain topical anti-inflammatory analgesics; Vitacilina, a dermatological treatment product; and VICKS, a cough suppressant throat lozenges and medicated drops. This segment also engages in the real estate leasing and facility management, and hotel management operations. The Prescription Pharmaceutical Operation Group segment offers ethical drugs, including Edirol, an active vitamin D3 osteoporosis agent; Clarith, a macrolide antibiotic; Palux, a peripheral vasodilator; Bonviva, a bisphosphonate osteoporosis agent; Lusefi, a type 2 diabetes mellitus agent; and LOQOA, a transdermal anti-inflammatory analgesic. This segment has various products under development primarily in therapeutic areas, such as central nervous system, infectious, and metabolic diseases, as well as orthopedic disorders. The company also offers raw materials for pharmaceuticals and quasi-drugs; and supplies health foods and skin care products. Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is headquartered in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "170-8655",
        "website": "http://www.taisho-holdings.co.jp",
        "market_cap": "Mid Cap"
    },
    "4582.T": {
        "short_name": "SYMBIO PHARMACEUTICALS LTD",
        "long_name": "SymBio Pharmaceuticals Limited",
        "summary": "SymBio Pharmaceuticals Limited engages in the research and development, manufacturing, and marketing of pharmaceutical drugs in the areas of oncology and hematology. It primarily develops anti-cancer agents. The company's Treakisym SyB L-0501, an anti-cancer agent, which is marketed for the treatment of non-Hodgkin's lymphoma, multiple myeloma, and chronic lymphocytic leukemia under the TREAKISYM name; and is in the Phase III clinical trial to treat relapsed/refractory diffuse large B-cell lymphoma. It also develops SyB L-1701, a ready-to-dilute formulation; and SyB L-1702, a rapid infusion liquid formulation. In addition, the company develops SyB L-1101, an intravenous formulation, which is in Phase III clinical trial for the treatment of higher-risk myelodysplastic syndromes (HR-MDS); and SyB C-1101, an oral formulation that is in Phase II/III clinical trial in combination with azacitidine to treat HR-MDS. Further, it develops SyB V-1901, an antiviral drug for the treatment of infectious diseases. The company primarily operates in Japan, South Korea, China, Hong Kong, Taiwan, and Singapore. SymBio Pharmaceuticals Limited was founded in 2005 and is based in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "105-0001",
        "website": "http://www.symbiopharma.com",
        "market_cap": "Small Cap"
    },
    "4586.T": {
        "short_name": "MEDRX CO LTD",
        "long_name": "MedRx Co., Ltd",
        "summary": "MedRx Co., Ltd, a pharmaceutical company, develops pharmaceutical drugs based on the transdermal absorption system in Japan. It develops medicines based on Ionic liquid transdermal system. The company's products pipeline include MRX-4TZT, which is in phase II; MRX-5LBT, which is phase III; MRX-10XT, which is in phase I; and MRX-7MLL, which is in pre-clinical stage. It also offers micro needle patches for delivery of vaccines and/or APIs through skin, as well as adhesive skin patches. The company was founded in 2002 and is headquartered in Higashikagawa, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Higashikagawa",
        "zipcode": "769-2712",
        "website": "http://www.medrx.co.jp",
        "market_cap": "Nano Cap"
    },
    "4595.T": {
        "short_name": "MIZUHO MEDY CO LTD",
        "long_name": "Mizuho Medy Co.,Ltd.",
        "summary": "Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products primarily in Japan. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. The company also operates in the United States, Belgium, France, China, South Korea, Singapore, and Taiwan. Mizuho Medy Co.,Ltd. was founded in 1977 and is headquartered in Tosu, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tosu",
        "zipcode": "841-0048",
        "website": "http://www.mizuho-m.co.jp",
        "market_cap": "Micro Cap"
    },
    "4597.T": {
        "short_name": "SOLASIA PHARMA K K",
        "long_name": "Solasia Pharma K.K.",
        "summary": "Solasia Pharma K.K. develops and commercializes drugs in the field of oncology in Japan and other Asian countries. The company offers SP-03 (episil oral liquid) for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy for cancer; and SP-01 (Sancuso), a transdermal delivery system that delivers granisetron, an anti-emetic into the patient's bloodstream for the treatment of chemotherapy induced nausea and vomiting. It is also developing SP-02 (Darinaparsin), a mitochondrial-targeted agent that has completed phase III clinical study to treat various hematologic and solid cancers; and SP-04 (PledOx), an intracellular superoxide removing agent, which is in phase IIb clinical trials for chemotherapy induced peripheral neuropathy. In addition, the company is developing SP-05 (Arfolitixorin) that is in phase III clinical study for the enhancement of antitumor efficacy of fluorouracil, including the treatment for pancreatic cancer, breast cancer, stomach cancer, and head and neck cancers. Solasia Pharma K.K. was founded in 2006 and is based in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "105-0011",
        "website": "http://www.solasia.co.jp",
        "market_cap": "Micro Cap"
    },
    "4746.TW": {
        "short_name": "FORMOSA LABORATORIES INC",
        "long_name": "Formosa Laboratories, Inc.",
        "summary": "Formosa Laboratories, Inc. produces and sells active pharmaceutical ingredients (APIs) worldwide. The company offers APIs in the areas of anticancers, anti-inflammatory and analgesic agents, MRI enhancing agents, polymeric drugs, CNS agents, immunomodulators, respiratory agents, steroids, vitamin D derivatives, and antibiotics. It also provides contract development and manufacturing services; solutions for manufacturing antibody-drug conjugates; and injectable manufacturing services. The company was founded in 1995 and is based in Taoyuan City, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TAI",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taoyuan City",
        "zipcode": "33842",
        "website": "http://www.formosalab.com",
        "market_cap": "Small Cap"
    },
    "484.F": {
        "short_name": "SATIVA WELLNESS GROUP INC",
        "long_name": "Sativa Wellness Group Inc.",
        "summary": "Sativa Wellness Group Inc. operates as a CBD wellness company. The company engages in the cultivation and extraction of cannabinoids. It also sells CBD products to wholesale and online retail markets, as well as white label CBD products for third party brands. The company is based in North Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "North Vancouver",
        "zipcode": "V7M 3J3",
        "website": "http://www.sativawellnessgroup.com",
        "market_cap": "Nano Cap"
    },
    "4883.T": {
        "short_name": "MODALIS THERAPEUTICS CORP",
        "long_name": "Modalis Therapeutics Corporation",
        "summary": "Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. It is developing therapies for orphan genetic diseases using its proprietary CRISPR-GNDM technology that enables the locus specific modulation of gene expression or histone modification without the need for double-stranded DNA cleavage, gene editing, or base editing. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corporation was founded in 2016 and is headquartered in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "103-0026",
        "website": "http://modalistx.com",
        "market_cap": "Small Cap"
    },
    "4886.T": {
        "short_name": "ASKA PHARMACEUTICAL HOLDINGS CO",
        "long_name": "ASKA Pharmaceutical Holdings Co.,Ltd.",
        "summary": "ASKA Pharmaceutical Holdings Co., Ltd. engages in the manufacture, sale, and import/export of pharmaceuticals, veterinary medicines, quasi-drugs, foods, and medical devices in Japan. The company offers Altat for the treatment of peptic ulcer and gastritis; Prostal drugs for the treatment of prostatic hypertrophy and cancer; Lipidil for the treatment of hyperlipidemia; Thyradin, a drug for the treatment of thyroid disease; Ange, an oral contraceptive agent; and Menoaid Combipatch, a climacteric syndrome treatment. It is also developing L-105 for the treatment of hepatic encephalopathy; AKP-501, a fertility treatment with follicle stimulating hormone preparation of recombinant DNA as an active agent; and CDB-2914, a uterine leiomyomata treatment. The company was founded in 1920 and is headquartered in Tokyo, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "108-8532",
        "website": "http://www.aska-pharma.co.jp",
        "market_cap": "Small Cap"
    },
    "4887.T": {
        "short_name": "SAWAI GROUP HOLDINGS CO LTD",
        "long_name": "Sawai Group Holdings Co., Ltd.",
        "summary": "Sawai Group Holdings Co., Ltd., together with subsidiaries, manufactures, sells, imports, and exports pharmaceutical products in Japan and the United States. The company offers drugs in various formulations, including tablets, oral dispersing tablets, capsules, granules, injections, tapes, ophthalmic/nasal solutions, syrups, etc. in the therapeutic areas of cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, chemotherapeutics, vitamins, anti-cancer, etc. It serves hospitals, general practitioners, and dispensing pharmacies. Sawai Group Holdings Co., Ltd. was founded in 1929 and is headquartered in Osaka, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Osaka",
        "zipcode": "532-0003",
        "website": "http://www.sawai.co.jp",
        "market_cap": "Small Cap"
    },
    "4A5.F": {
        "short_name": "FAGRON N.V. PORT.",
        "long_name": "Fagron NV",
        "summary": "Fagron NV, a pharmaceutical compounding company, provides personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients. It prepares personalized ready-to-use medication in its sterile and non-sterile compounding facilities. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it offers pharmaceutical raw materials, equipment, and supplies that pharmacists need to prepare medication in the pharmacy. Further, the company develops, manufactures, and supplies mixing equipment that pharmacists can use for the compounding of semi-solid dermatological formulations. It has operations in Europe, the Americas, the Middle East, and Africa, as well as Asia and the Pacific. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Belgium",
        "state": null,
        "city": "Nazareth",
        "zipcode": "9810",
        "website": "http://www.fagron.com",
        "market_cap": "Small Cap"
    },
    "4K9.F": {
        "short_name": "CANAFARMA HEMP PROD.CORP.",
        "long_name": "CanaFarma Hemp Products Corp.",
        "summary": "CanaFarma Hemp Products Corp. engages in growing, manufacturing, processing, and selling hemp oil in the United States. The company offers hemp-based products, such as chewing gum and tincture under the YOOFORIC brand. It offers its products online. The company is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6Z 1S4",
        "website": "http://www.canafarmacorp.com",
        "market_cap": "Nano Cap"
    },
    "4KH.F": {
        "short_name": "KHIRON LIFE SCIENCES",
        "long_name": "Khiron Life Sciences Corp.",
        "summary": "Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and CBD (cannabidiol) medical cannabis. It also operates a network of health centers under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2B5",
        "website": "http://www.khiron.ca",
        "market_cap": "Micro Cap"
    },
    "4UU.F": {
        "short_name": "DIURNAL GROUP PLC LS -,05",
        "long_name": "Diurnal Group plc",
        "summary": "Diurnal Group plc operates as a specialty pharma company worldwide. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. The company offers Alkindi, a replacement therapy for paediatric adrenal insufficiency in Europe. It also develops Chronocort, which completed Phase III clinical trials targeting congenital adrenal hyperplasia and adrenal insufficiency. The company's early stage pipeline products comprise Native Oral Testosterone, a replacement treatment for patients suffering from hypogonadism; siRNA, a short interfering RNA oligonucleotide therapy for patients suffering from adrenocorticotropin-dependent Cushing's syndrome; and T3 modified, a modified-release preparation of T3 (levothyroxine) hormone for patients suffering from hypothyroidism. Diurnal Group plc was incorporated in 2015 and is headquartered in Cardiff, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Cardiff",
        "zipcode": "CF14 4UJ",
        "website": "http://www.diurnal.co.uk",
        "market_cap": "Micro Cap"
    },
    "4VV.F": {
        "short_name": "JUVA LIFE INC.",
        "long_name": "Juva Life Inc.",
        "summary": "Juva Life Inc. engages in the cultivation, research, manufacturing, distribution, and sale of pharmacy-grade medical and recreational cannabis products in California. The company was founded in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3E8",
        "website": "http://www.juvalife.com",
        "market_cap": "Micro Cap"
    },
    "4WE.F": {
        "short_name": "WEEDMD INC.",
        "long_name": "WeedMD Inc.",
        "summary": "WeedMD Inc. produces, distributes, and sells medical-grade cannabis in Canada. It offers dried cannabis, cannabis plants and seeds, cannabis oil, edibles, extracts and topicals, and others, as well as cannabis flower products. The company sells its products directly to medical patients and strategic relationships across the seniors' market, as well as through supply agreements with Shoppers Drug Mart and six provincial distribution agencies under the Color Cannabis, Saturday, Starseed, and WeedMD brand names. WeedMD Inc. is headquartered in Aylmer, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Aylmer",
        "zipcode": "N5H 2M8",
        "website": "http://www.weedmd.com",
        "market_cap": "Micro Cap"
    },
    "4XM.F": {
        "short_name": "PAC ROOTS CANNABIS CORP.",
        "long_name": "Pac Roots Cannabis Corp.",
        "summary": "Pac Roots Cannabis Corp. cultivates and sells marijuana for medicinal purposes. The company was incorporated in 2012 and is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2E9",
        "website": "http://pacroots.ca",
        "market_cap": "Nano Cap"
    },
    "4XT.DE": {
        "short_name": "XPHYTO THERAPEUTICS",
        "long_name": "XPhyto Therapeutics Corp.",
        "summary": "XPhyto Therapeutics Corp., through its subsidiaries, operates as a biopharma, diagnostics, and cannabis science company in Canada and Germany. It is involved in the production, cultivation, extraction, isolation, formulation, delivery, and sale of medicinal cannabis. The company also provides contract development and consulting services. XPhyto Therapeutics Corp. has development, technology purchase and license agreement with 3a-Diagnostics GmbH for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a's pathogen specific biosensors and XPhyto's oral dissolvable drug delivery platform. XPhyto Therapeutics Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "GER",
        "market": "de_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6J 3B1",
        "website": "http://www.xphyto.com",
        "market_cap": "Micro Cap"
    },
    "4XT.F": {
        "short_name": "XPHYTO THERAPEUTICS",
        "long_name": "XPhyto Therapeutics Corp.",
        "summary": "XPhyto Therapeutics Corp., through its subsidiaries, operates as a biopharma, diagnostics, and cannabis science company in Canada and Germany. It is involved in the production, cultivation, extraction, isolation, formulation, delivery, and sale of medicinal cannabis. The company also provides contract development and consulting services. XPhyto Therapeutics Corp. has development, technology purchase and license agreement with 3a-Diagnostics GmbH for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a's pathogen specific biosensors and XPhyto's oral dissolvable drug delivery platform. XPhyto Therapeutics Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6J 3B1",
        "website": "http://www.xphyto.com",
        "market_cap": "Micro Cap"
    },
    "4YX.F": {
        "short_name": "RED LIGHT HOLLAND CORP.",
        "long_name": "Red Light Holland Corp.",
        "summary": "Red Light Holland Corp. engages in the production, cultivation, and sale of magic truffles to the legal recreational market in the Netherlands. It sells its products under the iMicrodose brand name through smart shops operators and an advanced e-commerce platform, iMicrodose.nl. The company was incorporated in 1982 and is based in Toronto, Ontario.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 2V9",
        "website": "http://www.redlighttruffles.com",
        "market_cap": "Micro Cap"
    },
    "5EA.F": {
        "short_name": "ELANCO ANIMAL HEALTH.",
        "long_name": "Elanco Animal Health Incorporated",
        "summary": "Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "IN",
        "city": "Greenfield",
        "zipcode": "46140",
        "website": "http://www.elanco.com",
        "market_cap": "Large Cap"
    },
    "5J2.F": {
        "short_name": "GABATHER AB (PUBL) SK-,44",
        "long_name": "Gabather AB (publ)",
        "summary": "Gabather AB (publ) develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics; anti-depressants and anxiolytics; analgesics; and cognition-enhancing treatments, including Alzheimer's disease. The company was founded in 2014 and is based in Malm\u00c3\u00b6, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Malm\u00c3\u00b6",
        "zipcode": "211 20",
        "website": "http://www.gabather.com",
        "market_cap": "Nano Cap"
    },
    "5V51.F": {
        "short_name": "AVIVAGEN INC.",
        "long_name": "Avivagen Inc.",
        "summary": "Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers products based on its OxC-Beta technology, such as OxC-beta Livestock, a premix for livestock feeds; and Vivamune Health Chews supplements for companion animals. It has operations in Mexico and Latin America. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen Inc.in May 2012. Avivagen Inc. was founded in 2005 and is headquartered in Ottawa, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Ottawa",
        "zipcode": "K1A 0R6",
        "website": "http://www.avivagen.com",
        "market_cap": "Nano Cap"
    },
    "600079.SS": {
        "short_name": "HUMANWELL HEALTHCARE (GROUP) CO",
        "long_name": "Humanwell Healthcare (Group) Co.,Ltd.",
        "summary": "Humanwell Healthcare (Group) Co.,Ltd. provides healthcare solutions in the Asia Pacific, North America, Africa, and internationally. The company offers anesthetic/analgesic products; women's health products for unplanned pregnancy, emergency contraception, and birth control; consumer healthcare products for women; and CNS drugs for bronchitis, migraine, dysmenorrhea, neuralgia, epilepsy, acute and chronic cerebrovascular diseases, and brain injury and peripheral vascular diseases. It also provides herbal medicines for cold and flu, rheumatoid arthritis, skin care, hepatitis, urinary tract infection, and hypomnesis; anti-infection drugs; OTC medicines for digestive disorders, cold and flu, anti-inflammation, anti-infection, and nutritional supplements; and other products targeting cardiovascular, gastrointestinal, and reproductive diseases. The company was formerly known as Wuhan Humanwell Healthcare (Group) Co., Ltd. and changed its name to Humanwell Healthcare (Group) Co.,Ltd. in March 2013. Humanwell Healthcare (Group) Co.,Ltd. was founded in 1993 and is based in Wuhan, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Wuhan",
        "zipcode": "430075",
        "website": "http://www.humanwell.com.cn",
        "market_cap": "Mid Cap"
    },
    "600080.SS": {
        "short_name": "GINWA ENTERPRISE GROUP",
        "long_name": "Ginwa Enterprise (Group) Inc.",
        "summary": "Ginwa Enterprise (Group) Inc. researches, develops, produces, and sells proprietary Chinese, biological, and chemical medicines in China. It offers orthopedic, immune, pediatric, antibiotic, digestive system, gynecological, cardiovascular, antipyretic, analgesic, antiviral, and other products. The company provides its products in the form of capsules, powders, and tablets. Ginwa Enterprise (Group) Inc. is based in Xi'an, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Xi'an",
        "zipcode": null,
        "website": "http://www.ginwa.com.cn",
        "market_cap": "Small Cap"
    },
    "600085.SS": {
        "short_name": "BEIJING TONGRENTANG CO",
        "long_name": "Beijing Tongrentang Co., Ltd",
        "summary": "Beijing Tongrentang Co., Ltd engages in the scientific research, production, sale, and distribution of Chinese medicines in China and internationally. It covers 28 product formulations, such as pills, powders, wines and capsules, oral liquids, and dripping pills with the original powder preparation in the areas of cardiovascular, cerebrovascular, and gynecological diseases, as well as anti-depressive new drugs. The company sells its products under the brand names of Angong Niuhuang Wan, Tongren Dahuo Wan Pills, Tongren Niuhuang Qingxin Pills, Zi Xuesan, National wine, Tongren Wuji Baifeng Pills, Zhuanggu medicinal liquor, Bureau Fang Zhibao, Reconstituted pill, and Yufeng Ningxin Dropping Pills. The company was founded in 1669 and is based in Beijing, China. Beijing Tongrentang Co., Ltd is a subsidiary of China Beijing Tongrentang (Group) Co., Ltd.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Beijing",
        "zipcode": "100062",
        "website": "http://www.tongrentanggf.com",
        "market_cap": "Mid Cap"
    },
    "600129.SS": {
        "short_name": "CHONGQING TAIJI IND",
        "long_name": "Chongqing Taiji Industry(Group) Co.,Ltd",
        "summary": "Chongqing Taiji Industry(Group) Co.,Ltd operates in the pharmaceutical industry in China and internationally. It researches, develops, produces, and sells Chinese medicine and health products. The company offers its products in various dosage forms, including tablets, oral liquids, syrups, dripping pills, granules, capsules, tinctures, powders, etc. It offers its products in various areas, such as digestive system, respiratory system, cardiovascular and cerebrovascular, pediatrics and gynecology, systemic anti-infective drugs, analgesia and antibiotics, orthopedics, cold clearing and cough relief, and endocrine and nervous system drugs. The company is based in Chongqing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Chongqing",
        "zipcode": "408000",
        "website": "http://www.taiji.com",
        "market_cap": "Small Cap"
    },
    "600195.SS": {
        "short_name": "CHINA ANIMAL HUSBANDRY INDUSTRY",
        "long_name": "China Animal Husbandry Industry Co., Ltd.",
        "summary": "China Animal Husbandry Industry Co., Ltd. manufactures and sells animal health and nutrition products in China. The company offers veterinary drugs and vaccines, veterinary biological products, and feed and feed additives. It also trades in raw materials. The company was founded in 1998 and is based in Beijing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Beijing",
        "zipcode": "100070",
        "website": "http://www.cahic.com",
        "market_cap": "Small Cap"
    },
    "600196.SS": {
        "short_name": "SHANGHAI FOSUN PHARMACEUTICAL G",
        "long_name": "Shanghai Fosun Pharmaceutical (Group) Co., Ltd.",
        "summary": "Shanghai Fosun Pharmaceutical (Group) Co., Ltd. researches, develops, manufactures, trades, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing and Research and Development, Healthcare Service, Medical Devices and Medical Diagnosis, Pharmaceutical Distribution and Retail, and Other business Operations. It offers pharmaceutical products in the areas of metabolic and digestive system; antitumor; anti-infective; central nervous system drugs; cardiovascular system; blood system; vaccines; and APIs and intermediates. The company also provides medical diagnosis and medical device products in the field of in vitro diagnostics, the products involve clinical chemistry, clinical immunity, molecular diagnostics, gene chip technology, clinical microbiology, and other fields of laboratory medicine. In addition, it offers medical services in various hospitals. The company was formerly known as Shanghai Fosun Industrial Co. Ltd. and changed its name to Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in December 2004. The company was founded in 1994 and is based in Shanghai, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shanghai",
        "zipcode": "200233",
        "website": "http://www.fosunpharma.com",
        "market_cap": "Large Cap"
    },
    "600211.SS": {
        "short_name": "TIBET RHODIOLA PHARMACEUTICAL H",
        "long_name": "Tibet Rhodiola Pharmaceutical Holding Co.",
        "summary": "Tibet Rhodiola Pharmaceutical Holding Co. engages in the research and development, production, and sale of pharmaceuticals in China. The company offers Tibetan medicines, botanical medicine products, chemical medicine products, and biological products. Tibet Rhodiola Pharmaceutical Holding Co. was founded in 1999 and is based in Lhasa, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Lhasa",
        "zipcode": "850000",
        "website": "http://www.xzyy.cn",
        "market_cap": "Mid Cap"
    },
    "600216.SS": {
        "short_name": "ZHEJIANG MEDICINE",
        "long_name": "Zhejiang Medicine Co., Ltd.",
        "summary": "Zhejiang Medicine Co., Ltd. produces and sells fat-soluble vitamins, quasi-vitamins, quinolone antibiotics, anti-drug-resistant antibiotics, and other products. The company offers anti-infective drugs, glucosidase inhibitors, and immune suppressants; and human and animal nutrition products. It also provides glycopeptides medicines, natural drugs, and feed additives; and vitamin D3 oil, various vitamin products, and vitamin APIs, as well as biological medicines, pharmaceutical intermediates, and biological pesticides. In addition, the company offers nutriceuticals, such as high-purity synthetic and natural vitamin E, biotin, vitamin A and its derivatives, vitamin d3, and \u00c3\u009f-carotene; anti-drug-resistant antibiotics, cardiovascular products, and antiviral products, including oncology and anti-infective drugs; nutriceutical soft capsules; and drug products, such as oral solid dosage forms and large volume injections. Further, it engages in the wholesale and retail of medical drugs and apparatus, medical instruments, healthcare products, and food. The company was founded in 1954 and is based in Shaoxing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shaoxing",
        "zipcode": "312366",
        "website": "http://www.china-zmc.com",
        "market_cap": "Mid Cap"
    },
    "600222.SS": {
        "short_name": "HENAN TALOPH PHARMACEUTICAL STO",
        "long_name": "Henan Taloph Pharmaceutical Stock Co.,Ltd",
        "summary": "Henan Taloph Pharmaceutical Stock Co., Ltd. researches, produces, and sells Chinese and western medicines in China. It primarily offers its products in the forms of oral liquids, tablets, capsules, fluids, and other forms. The company's principal products include Huperzine A tablets, phenoxybenzamine hydrochloride tablets, pazufloxacin mesylate sodium chloride injections, and various infusion products. It serves hospitals, pharmacies, and patients. The company was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. Henan Taloph Pharmaceutical Stock Co., Ltd. is based in Zhengzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Zhengzhou",
        "zipcode": "450001",
        "website": "http://www.taloph.com",
        "market_cap": "Small Cap"
    },
    "600252.SS": {
        "short_name": "GUANGXI WUZHOU ZHONGHENG GROUP ",
        "long_name": "Guangxi Wuzhou Zhongheng Group Co.,Ltd",
        "summary": "Guangxi Wuzhou Zhongheng Group Co., Ltd. researches, develops, manufactures, and sells pharmaceuticals in China. The company offers pills, capsules, and injections and tablets for cardiovascular and cerebrovascular diseases, bruises, gynecological diseases, and respiratory diseases. It also produces health food products under the DOUBLE MONEY brand, as well as health-care functional beverages, smokable turtle pastes, jelly-type turtle paste, etc. The company is based in Wuzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Wuzhou",
        "zipcode": "543000",
        "website": "http://www.wz-zhongheng.com",
        "market_cap": "Small Cap"
    },
    "600267.SS": {
        "short_name": "ZHEJIANG HISUN PHARMACEUTICAL C",
        "long_name": "Zhejiang Hisun Pharmaceutical Co., Ltd.",
        "summary": "Zhejiang Hisun Pharmaceutical Co., Ltd. manufactures and supplies pharmaceutical products in China. It provides active pharmaceutical ingredients and finished dosage form products. The company offers products in the areas of anti-tumor, cardiovascular, anti-infective, liver care, orthopedics, anticancer, anti-parasitic, immunosuppressant, etc.; and weight loss, anti-viral, anti-TB, veterinary pharma, and others. It also provides product consultation and CMO/CRO manufacturing services. The company was founded in 1956 and is headquartered in Taizhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Taizhou",
        "zipcode": "318000",
        "website": "http://www.hisunpharm.com",
        "market_cap": "Mid Cap"
    },
    "600277.SS": {
        "short_name": "ELION CLEAN ENERGY CO LTD",
        "long_name": "Elion Energy Company Limited",
        "summary": "Elion Energy Company Limited manufactures and distributes chemical products in China. It produces and markets polyvinyl chloride, synthetic new materials, caustic soda, liquid chlorine, and other products. The company also focuses on clean energy and environmental protection businesses. Elion Energy Company Limited was founded in 1999 and is based in Beijing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Beijing",
        "zipcode": "100026",
        "website": "http://www.elion.cn",
        "market_cap": "Small Cap"
    },
    "600285.SS": {
        "short_name": "HENAN LINGRUI PHARMACEUTICAL",
        "long_name": "Henan Lingrui Pharmaceutical Co., Ltd.",
        "summary": "Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering approximately 100 product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is based in Xinyang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Xinyang",
        "zipcode": "465550",
        "website": "http://www.lingrui.com",
        "market_cap": "Small Cap"
    },
    "600332.SS": {
        "short_name": "GUANGZHOU BAIYUNSHAN PHARMACEUT",
        "long_name": "Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited",
        "summary": "Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and chemical raw material intermediates in the People's Republic of China and internationally. It operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. The company is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, ganoderma spore oil capsules, lozenges, tortoise herb jelly, etc. In addition, it invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services. As of December 31, 2020, the company had 141 retail chain pharmacy outlets, which included 27 Cai Zhi Lin pharmacy outlets, 33 Jian Min pharmacy outlets, 36 GPC Prescription Pharmacy outlets, and 24 Hainan Guangyao Chenfei Pharmaceutical Chain outlets, as well as 21 retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Guangzhou",
        "zipcode": "510130",
        "website": "http://www.gybys.com.cn",
        "market_cap": "Mid Cap"
    },
    "600351.SS": {
        "short_name": "YABAO PHARMACEUTICAL GROUP CO L",
        "long_name": "Yabao Pharmaceutical Group Co., Ltd",
        "summary": "Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, raw materials, pharmaceutical packaging materials, and health care products in China and internationally. The company offers products for children's medication, gynecological, cardiovascular, cerebrovascular, pediatric, and elderly chronic diseases. It provides children's medication drugs under the Ding Gui brand name; gynecological drugs under the 100 Yu brand name; and cardiovascular and cerebrovascular drugs under the Ya Bao brand name. The company offers plastic bottles, cartons, and other pharmaceutical packaging materials. The company offers its products in the form of injections, tablets, capsules, granules, pills, patches, freeze-dried powders, mixtures, suppositories, and solutions. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is headquartered in Beijing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Beijing",
        "zipcode": "100176",
        "website": "http://www.yabao.com.cn",
        "market_cap": "Small Cap"
    },
    "600380.SS": {
        "short_name": "JOINCARE PHARMACEUTICAL GROUP I",
        "long_name": "Joincare Pharmaceutical Group Industry Co.,Ltd.",
        "summary": "Joincare Pharmaceutical Group Industry Co., Ltd. researches, develops, produces, sells, and services medicine and health products primarily in China. It also offers proprietary Chinese medicines, testing reagents, monoclonal antibodies, APIs, and chemical preparations. In addition, the company offers traditional Chinese medicine and health food, such as Taitai Oral Liquid, Jingxin Oral Liquid, Dysmenorrhea Oral Liquid, Zhengyuan Dan, Hanlin Qingzhi Capsule, Yike Post, Kungfu V Effervescent Tablets, etc.; Chinese medicine decoction pieces; pharmaceutical products; and Eagle brand health products, which includes American Ginseng series, deer essence, Ganoderma lucidum series, vitamin series, etc. Further, it supplies the intermediates F9 and 4AA; and provides genetic diagnostic reagents for food safety, human major infectious disease prevention and control, animal disease prevention and control, entry and exit inspection, and quarantine. Additionally, the company offers various evaluation devices for the effectiveness of inhalation preparations, respiratory simulators for different populations, dynamic laser diffraction particle size analyzers for inhalation preparations, and other professional analytical instruments, such as HPLC; and food additives, as well as engages in business investment and other businesses. Joincare Pharmaceutical Group Industry Co., Ltd. was founded in 1992 and is headquartered in Shenzhen, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shenzhen",
        "zipcode": null,
        "website": "http://www.joincare.com",
        "market_cap": "Mid Cap"
    },
    "600420.SS": {
        "short_name": "SHANGHAI SHYNDEC PHARMACEUTICAL",
        "long_name": "Shanghai Shyndec Pharmaceutical Co., Ltd.",
        "summary": "Shanghai Shyndec Pharmaceutical Co., Ltd. manufactures drug preparation products in China and internationally. It focuses on anti-infection, cardiovascular and cerebrovascular, anti-tumor, leptin drugs, metabolism, and endocrine areas. Shanghai Shyndec Pharmaceutical Co., Ltd. was founded in 1996 and is based in Shanghai, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shanghai",
        "zipcode": "200040",
        "website": "http://www.shyndec.com",
        "market_cap": "Small Cap"
    },
    "600422.SS": {
        "short_name": "KPC PHARMACEUTICALS INC",
        "long_name": "KPC Pharmaceuticals, Inc.",
        "summary": "KPC Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria. The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, and health foods; Amoxicillin, Cefaclor, Alfacalcidol, Artz, Snaplets, and Ribavirin spray products; glycyrrhizic acid; and GLP-1, a long-acting hypoglycemic drug. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. KPC Pharmaceuticals, Inc. was founded in 1951 and is based in Kunming, the People's Republic of China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Kunming",
        "zipcode": "650106",
        "website": "http://www.kpc.com.cn",
        "market_cap": "Small Cap"
    },
    "600479.SS": {
        "short_name": "ZHUZHOU QIANJIN PHARMACEUTICAL ",
        "long_name": "ZhuZhou QianJin Pharmaceutical Co.,Ltd",
        "summary": "ZhuZhou QianJin Pharmaceutical Co.,Ltd produces and sells pharmaceutical products in China. The company offers gynecology, pediatrics, beauty, antimicrobial, circulatory, endocrine, specialty, digestive, nervous, and cardiovascular products. It also provides health pillows and ginger tea; hygiene products; and wine. The company is based in Zhuzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Zhuzhou",
        "zipcode": "412000",
        "website": "http://www.qjyy.com",
        "market_cap": "Small Cap"
    },
    "600488.SS": {
        "short_name": "TIANJIN TIANYAO PHARMACEUTICAL ",
        "long_name": "Tianjin Tianyao Pharmaceuticals Co., Ltd.",
        "summary": "Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research, manufacture, and export of pharmaceutical APIs in Asia. It primarily provides corticosteroid, cardio cerebrovascular, and analgesic APIs and formulations. The company offers bulk drugs, including dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinlone acetonide acetate, prednisone acetate, prednisone, prednisolone, flucinonide, halcinonide, triamcinolone acetonide, clobetasol propionate, betamethasone, methylprednisolone hydrocortisone acetate, methylprednisolone, and triamcinolone. The company is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE : 600488) operates as a subsidiary of Jinhushen Biomedical Technology Co., Ltd.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Tianjin",
        "zipcode": "300462",
        "website": "http://www.kingyork.biz/tianyaoyaoyeen",
        "market_cap": "Small Cap"
    },
    "600511.SS": {
        "short_name": "CHINA NATIONAL MEDICINES CORP",
        "long_name": "China National Medicines Corporation Ltd.",
        "summary": "China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical and healthcare products in China. The company also provides logistics and warehousing services; and operates a B2B e-commerce platform. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Beijing",
        "zipcode": "100077",
        "website": "http://www.cncm.com.cn",
        "market_cap": "Mid Cap"
    },
    "600513.SS": {
        "short_name": "JIANGSU LIANHUAN PHARMACEUTICAL",
        "long_name": "Jiangsu Lianhuan Pharmaceutical Co., Ltd.",
        "summary": "Jiangsu Lianhuan Pharmaceutical Co., Ltd. manufactures and sells chemical raw materials, preparations, and organic intermediates in China. The company offers urinary system drugs, antihistamines, cardiovascular drugs, steroid hormones, antibiotics, and other products. Its products portfolio comprises eplet, terfenadine, ebastine tablets, felodipine tablets, felodipine sustained-release capsules, simvastatin tablets, danazol capsules and suppositories, metformin gliclazide tablets, lumbrokinase capsules, balofloxacin tablets, and sertraline hydrochloride; and APIs. It exports its products to approximately 20 countries, such as Europe, the United States, Southeast Asia, and Australia. The company was founded in 2000 and is based in Yangzhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Yangzhou",
        "zipcode": "225009",
        "website": "http://www.lhpharma.com",
        "market_cap": "Small Cap"
    },
    "600518.SS": {
        "short_name": "KANGMEI PHARMACEUTICAL CO LTD",
        "long_name": "Kangmei Pharmaceutical Co., Ltd.",
        "summary": "Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese medicines in China. It also offers chemical medicines and food products; and operates hospitals and Chinese medicine pharmacies. The company was founded in 1997 and is headquartered in Puning, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Puning",
        "zipcode": "515300",
        "website": "http://www.kangmei.com.cn",
        "market_cap": "Mid Cap"
    },
    "600521.SS": {
        "short_name": "ZHEJIANG HUAHAI PHARMACEUTICAL ",
        "long_name": "Zhejiang Huahai Pharmaceutical Co., Ltd.",
        "summary": "Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products. It also engages in packaging components business, such as high-density polyethylene bottles and polypropylene caps. In addition, the company provides contract manufacturing and other services. Further, it is involved in import and export trade services. Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Linhai",
        "zipcode": "317024",
        "website": "http://www.huahaipharm.com",
        "market_cap": "Mid Cap"
    },
    "600530.SS": {
        "short_name": "SHANGHAI JIAODA ONLLY CO. LTD.",
        "long_name": "Shanghai Jiaoda Onlly Co.,Ltd",
        "summary": "Shanghai Jiaoda Onlly Co., Ltd., together with its subsidiaries, engages in the health-care food business in China. Its health-care food products are used for gastrointestinal function, heart and brain condition improvement, fatigue, and blood lipid and blood sugar, and other health needs. The company also develops commercial residential building projects; offers finance services to small and micro enterprises, and individual clients; and provides natural organic products and technical services for industries involved in natural medicine, functional food, food additives, natural cosmetics, essence, and flavors. Shanghai Jiaoda Onlly Co., Ltd. was founded in 1990 and is based in Shanghai, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shanghai",
        "zipcode": "200030",
        "website": "http://www.onlly.com.cn",
        "market_cap": "Small Cap"
    },
    "600535.SS": {
        "short_name": "TASLY PHARMACEUTICAL GROUP CO L",
        "long_name": "Tasly Pharmaceutical Group Co., Ltd",
        "summary": "Tasly Pharmaceutical Group Co., Ltd. engages in biological medicine, health, and medical service businesses in China. It offers herbal and chemical medicines, health products, pharmaceutical substances and APIs, herbal extracts, concentrated herbal granules, and tea series products. The company also provides cosmetic series products, including moisture lotions, moisture creams, eye creams, and face washing foams; daily hygiene products, such as sanitary and carefree pads, honey-propolis soaps, and pollen soaps; and medical equipment, which include massage tappers, massage cushions, and circulation machines. It also exports its products to the United States, Russia, and countries in Europe, Africa, and rest of Asia. Tasly Pharmaceutical Group Co., Ltd. was founded in 1994 and is based in Tianjin, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Tianjin",
        "zipcode": "300410",
        "website": "http://www.tasly.com",
        "market_cap": "Mid Cap"
    },
    "600557.SS": {
        "short_name": "JIANGSU KANION PHARMACEUTICAL C",
        "long_name": "Jiangsu Kanion Pharmaceutical Co.,Ltd.",
        "summary": "Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. The company was founded in 1975 and is based in Lianyungang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Lianyungang",
        "zipcode": null,
        "website": "http://www.kanion.com",
        "market_cap": "Small Cap"
    },
    "600566.SS": {
        "short_name": "HUBEI JUMPCAN PHARMACEUTICAL CO",
        "long_name": "Hubei Jumpcan Pharmaceutical Co., Ltd.",
        "summary": "Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis. The company was formerly known as Hubei Hongcheng General Machinery Co., Ltd and changed its name to Hubei Jumpcan Pharmaceutical Co., Ltd. in March 2015. Hubei Jumpcan Pharmaceutical Co., Ltd. is based in Taixing, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Taixing",
        "zipcode": "225441",
        "website": "http://www.jumpcan.com",
        "market_cap": "Mid Cap"
    },
    "600568.SS": {
        "short_name": "ZHONG ZHU HEALTHCARE HOLDING CO",
        "long_name": "Zhongzhu Healthcare Holding Co.,Ltd",
        "summary": "Zhongzhu Healthcare Holding Co.,Ltd constructs and develops real estate properties in China. It also produces ophthalmic drugs; researches and develops natural botanical drugs. In addition, it researches and develops drugs, such as recombinant human endostatin adenovirus injection, which is an anticancer gene therapy; Genistein capsule for the treatment of postmenopausal osteoporosis; and motherwort that is primarily a gynecological drug. Further, the company offers medical instruments, including radiation therapy, hyperthermia, phototherapy, and ultrasound diagnosis, as well as develops imaging breast tumor detection systems. Additionally, it offers medical services. The company was formerly known as Zhongzhu Holding Co., Ltd. and changed its name to Zhongzhu Healthcare Holding Co.,Ltd in June 2016. Zhongzhu Healthcare Holding Co.,Ltd was founded in 1970 and is headquartered in Qianjiang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Qianjiang",
        "zipcode": null,
        "website": "http://www.zz600568.com",
        "market_cap": "Small Cap"
    },
    "600594.SS": {
        "short_name": "GUIZHOU YIBAI PHARMACEUTICAL CO",
        "long_name": "Guizhou Yibai Pharmaceutical Co., Ltd.",
        "summary": "Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatism, digestive system, pediatric, gynecological, anti-infection, anti-inflammatory, analgesic, and other diseases. The company was founded in 1995 and is based in Guiyang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Guiyang",
        "zipcode": "550008",
        "website": "http://www.gzcci.com",
        "market_cap": "Small Cap"
    },
    "600664.SS": {
        "short_name": "HARBIN PHARMACEUTICAL GROUP CO ",
        "long_name": "Harbin Pharmaceutical Group Co., Ltd.",
        "summary": "Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and trade of pharmaceuticals in China and internationally. The company operates through seven segments: Antibiotics, Small-Molecular Drug Preparations, OTC and Healthcare Products, Modern Chinese Medicines, Biopharmaceuticals, Animal Vaccines, and Medicine Circulations. It offers a series of penicillin and cephalosporin products, as well as intermediates. The company's lead products include Shuang Huanglian freeze-dried injection; Danshen freeze-dried injection; Shuang Huanglian powder for injection; roxithromycin dispersible tablets; belladonna, sulfamethoxazole, and trimerhoprim tablets; pediatric paracetamol, atificial cow-bezoar, and chlorphenamine maleate granules; Shuanghuanglian oral liquid; and ceftriaxone sodium for injection. Its lead products also comprise amoxicillin capsules, cefotiam hydrochloride for injection, panax ginseng extract, cefepime hydrochloride for injection, cefoperazone sodium for injection, and amoxicillin sodium and clavulanate potassium for injection; cefuroxime, ceftazidime, cefotaxime sodium, and ceftriaxone sodium for injection; and ampicillin capsules. The company is based in Harbin, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Harbin",
        "zipcode": "150070",
        "website": "http://www.hayao.com",
        "market_cap": "Small Cap"
    },
    "600781.SS": {
        "short_name": "FUREN GROUP PHARMACEUTICAL CO L",
        "long_name": "FUREN Group Pharmaceutical Co., Ltd.",
        "summary": "FUREN Group Pharmaceutical Co., Ltd. primarily engages in the manufacture and distribution of pharmaceuticals in Henan Province and Shanghai, China. The company produces traditional Chinese medicines, such as capsules, tablets, granules, gels, injections, oral liquids, and others. It provides granules for heart attacks; capsules for diabetes and hyperlipidemia; and others. It is also involved in warehousing and trading businesses. The company was founded in 1996 and is based in Shanghai, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shanghai",
        "zipcode": "200031",
        "website": "http://www.shfuren.cn",
        "market_cap": "Small Cap"
    },
    "600789.SS": {
        "short_name": "SHANDONG LUKANG PHARMACEUTICAL ",
        "long_name": "Shandong Lukang Pharmaceutical Co.,Ltd.",
        "summary": "Shandong Lukang Pharmaceutical Co.,Ltd. manufactures and sells bio-pharmaceuticals and antibiotics in China. The company offers human and animal active pharmaceutical ingredients; human and animal preparations; bio-pesticides; herbal medicines; and amino acid. It is also involved in the sewage treatment, odor control, sewage facilities management, environmental protection material production and sale, and management of water disposal. The company exports its products to approximately 40 countries in Asia, Europe, Africa, and the United States. The company was formerly known as Jining Antibiotic Factory and changed its name to Shandong Lukang Pharmaceutical Co.,Ltd. in October 1993. Shandong Lukang Pharmaceutical Co.,Ltd. was founded in 1966 and is based in Jining, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Jining",
        "zipcode": "272021",
        "website": "http://www.lkpc.com",
        "market_cap": "Small Cap"
    },
    "600829.SS": {
        "short_name": "HPGC RENMINTONGTAI PHARMACEUTIC",
        "long_name": "HPGC Renmintongtai Pharmaceutical Corporation",
        "summary": "HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese medicines, Chinese herbal medicine, chemical preparations, antibiotics, biological products, and biochemical drugs, as well as medical equipment and health products. It also provides logistics services, including warehousing and distribution; and hospital services comprising medical treatment, scientific research, prevention, health care, rehabilitation, blood purification, and renal disease treatment. In addition, the company offers Chinese and Western medicines, Chinese herbal medicines, nourishing health care products, medical equipment, cosmetics, and daily necessities through an e-commerce platform. It operates 319 chain stores in Heilongjiang Province. The company was founded in 1950 and is headquartered in Harbin, China. HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Harbin",
        "zipcode": "150071",
        "website": "http://www.hyrmtt.com.cn",
        "market_cap": "Small Cap"
    },
    "600976.SS": {
        "short_name": "JIANMIN PHARMACEUTICAL GROUP CO",
        "long_name": "Jianmin Pharmaceutical Group Co., Ltd.",
        "summary": "Jianmin Pharmaceutical Group Co., Ltd. manufactures and sells Chinese medicines in China. It offers pediatric drugs under the Jianmin, Longmu, and Yekaitai brands. The company is based in Wuhan, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Wuhan",
        "zipcode": null,
        "website": "http://www.whjm.com",
        "market_cap": "Small Cap"
    },
    "600993.SS": {
        "short_name": "MAYINGLONG PHARMACEUTICAL GP CO",
        "long_name": "Mayinglong Pharmaceutical Group Co., LTD.",
        "summary": "Mayinglong Pharmaceutical Group Co., Ltd. engages in the manufacture, wholesale, and retail of pharmaceutical products primarily in China. It offers hemorrhoid, gynecological, cough, skin, cosmeceutical, and other products, as well as drugstore and merchants varieties. The company provides its products in various dosage forms comprising ointments, suppositories, tablets, lotions and granules, and creams. It also operates hospitals. Mayinglong Pharmaceutical Group Co., Ltd. was founded in 1582 and is based in Wuhan, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Wuhan",
        "zipcode": "430064",
        "website": "http://www.mayinglong.cn",
        "market_cap": "Small Cap"
    },
    "603079.SS": {
        "short_name": "ZHEJIANG SHENGDA BIO-PHARM CO L",
        "long_name": "Zhejiang Shengda Bio-Pharm Co., Ltd.",
        "summary": "Zhejiang Shengda Bio-Pharm Co., Ltd. engages in the research, development, production, and sale of food and feed additives worldwide. The company offers vitamins, such as biotin and folic acid, etc.; biological fresh-keeping agents, including nisin and natamycin; and intermediate APIs. It also produces natural food preservatives. The company is based in Tiantai, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Tiantai",
        "zipcode": "317200",
        "website": "http://www.sd-pharm.com",
        "market_cap": "Small Cap"
    },
    "603139.SS": {
        "short_name": "SHAANXI KANGHUI PHARMACEUTICAL ",
        "long_name": "Shaanxi Kanghui Pharmaceutical Co., Ltd.",
        "summary": "Shaanxi Kanghui Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory, urinary system, gastrointestinal liver and gallbladder, and other drugs in the form of tablets, capsules, granules, and oral liquids. The company is based in Xianyang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Xianyang",
        "zipcode": "712000",
        "website": "http://www.sxkh.com",
        "market_cap": "Micro Cap"
    },
    "603168.SS": {
        "short_name": "ZHEJIANG SHAPUAISI PHARM CO LTD",
        "long_name": "Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.",
        "summary": "Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antipyretic and analgesic, antibacterial anti-inflammatory, endocrine, liver disease adjuvant, cardiovascular, detoxification, diuretic row stone, gynecology, infusion, and jianweixiaosh categories. It offers its products in injections, oral solutions, eye drops, tablets, capsules, suppositories, granules, medicine raw materials, rinsing agents, mixtures, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 1978 and is based in Pinghu, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Pinghu",
        "zipcode": null,
        "website": "http://www.zjspas.com",
        "market_cap": "Small Cap"
    },
    "603367.SS": {
        "short_name": "CISEN PHARMACEUTICAL CO LTD",
        "long_name": "Cisen Pharmaceutical Co., Ltd.",
        "summary": "Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells chemical drug preparations and health care products in China and internationally. The company's chemical drug preparations include liver disease drugs, antitumor and auxiliary drugs, nutrition preparations, contrast agents, antibiotics, digestive system agents, polypropylene ampoules, and external preparations, as well as sedation anesthesia, cardiovascular, cough and asthma, immunomodulator, infusion, and therapeutic infusion products. It also engages in the formulation, development, manufacturing, and marketing of generic pharmaceutical products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. is based in Jining, the People's Republic of China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Jining",
        "zipcode": "272073",
        "website": "http://www.lkcisen.com",
        "market_cap": "Small Cap"
    },
    "603456.SS": {
        "short_name": "ZHEJIANG JIUZHOU PHARMACEUTICAL",
        "long_name": "Zhejiang Jiuzhou Pharmaceutical Co., Ltd",
        "summary": "Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, and cardiovascular drugs. The company also provides asymmetric catalysts and lithium battery materials. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is based in Taizhou, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Taizhou",
        "zipcode": "318000",
        "website": "http://www.jiuzhoupharma.com",
        "market_cap": "Mid Cap"
    },
    "603520.SS": {
        "short_name": "ZHEJIANG STARRY PHARMACEUTICAL ",
        "long_name": "Zhejiang Starry Pharmaceutical Co., Ltd.",
        "summary": "Zhejiang Starry Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and marketing of active ingredient and intermediate X-CT non-ionic contrast agents, and fluoroquinolones in China and internationally. Its contrast medium products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, gadobenate dimeglumine, iodixanol, gadopentetate dimeglumine, and gadoterate meglumine; and fluoroquinolones products comprise levofloxacin hemihydrate, levofloxacin HCL, levofloxacin acid ester, levofloxacin acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is based in Xianju, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Xianju",
        "zipcode": "317300",
        "website": "http://www.starrypharm.com",
        "market_cap": "Mid Cap"
    },
    "603538.SS": {
        "short_name": "NINGBO MENOVO PHARMACEUTICAL CO",
        "long_name": "Ningbo Menovo Pharmaceutical Co., Ltd.",
        "summary": "Ningbo Menovo Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products. It offers APIs, intermediates, and formulations for the treatment of cardiovascular, central nervous, respiratory, antitumor, anti-infection, digestive, geriatric, and antiviral diseases. The company was founded in 2004 and is headquartered in Ningbo, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Ningbo",
        "zipcode": "315040",
        "website": "http://www.menovopharm.com",
        "market_cap": "Small Cap"
    },
    "603567.SS": {
        "short_name": "HEILONGJIANG ZBD PHARMACEUTICAL",
        "long_name": "Heilongjiang ZBD Pharmaceutical Co., Ltd.",
        "summary": "Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Hulin",
        "zipcode": null,
        "website": "http://www.zbdzy.com",
        "market_cap": "Mid Cap"
    },
    "603669.SS": {
        "short_name": "LIONCO PHARMACEUTICAL GROUP CO",
        "long_name": "Lionco Pharmaceutical Group Co., Ltd.",
        "summary": "Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China. The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular and cerebrovascular, detoxification, anti-tumor, and other products. It also operates research institutes that specialize in the research of chemical drugs, natural medicines, and biological drugs. Lionco Pharmaceutical Group Co., Ltd. was founded in 2003 and is based in Shannan, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shannan",
        "zipcode": "856000",
        "website": "http://www.lingkang.com.cn",
        "market_cap": "Small Cap"
    },
    "603676.SS": {
        "short_name": "TIBET WEIXINKANG MEDICINE CO LT",
        "long_name": "Tibet Weixinkang Medicine Co., Ltd.",
        "summary": "Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company's products include parenteral nutrition vitamins, electrolyte supplements, intravenous iron supplements, antibiotics, and medicine for digestive system and liver diseases. It also offers injection multivitamins, potassium magnesium aspartate for injection, iron sucrose injection, potassium aspartate injection, etc. The company was formerly known as Weixinkang Medicine Youxian Gongsi and changed its name to Tibet Weixinkang Medicine Co., Ltd. in 2015. Tibet Weixinkang Medicine Co., Ltd. was founded in 2006 and is headquartered in Lhasa, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Lhasa",
        "zipcode": null,
        "website": "http://www.wxkpharma.com",
        "market_cap": "Small Cap"
    },
    "603707.SS": {
        "short_name": "NANJING KING-FRIEND BIOCHEMICAL",
        "long_name": "Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd",
        "summary": "Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd manufactures and sells heparin sodium and low molecular weight heparin products for pharmaceutical companies in the People's Republic of China. It offers enoxaparin sodium, dalteparin sodium, and naqu heparin calcium injections. The company also exports its products primarily to the European and American countries. The company was founded in 2000 and is based in Nanjing, the People's Republic of China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Nanjing",
        "zipcode": "210061",
        "website": "http://www.nkf-pharma.com",
        "market_cap": "Mid Cap"
    },
    "603858.SS": {
        "short_name": "SHANDONG BUCHANG PHARMACEUTICAL",
        "long_name": "Shandong Buchang Pharmaceuticals Co., Ltd.",
        "summary": "Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China. Shandong Buchang Pharmaceuticals Co., Ltd. is a subsidiary of Shanghai Zhangjiang (Group) Co., Ltd.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Heze",
        "zipcode": "274000",
        "website": "http://www.buchang.com",
        "market_cap": "Mid Cap"
    },
    "603998.SS": {
        "short_name": "HUNAN FANGSHENG PHARMACEUTICAL ",
        "long_name": "Hunan Fangsheng Pharmaceutical Co., Ltd.",
        "summary": "Hunan Fangsheng Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. The company offers cardio-cerebrovascular, pediatric, gynecological, orthopedics, traumatology, anti-infective, oncology, digestive system, urinary system, heat-clearing and detoxifying, and other drugs. It is also involved in the wholesale of pharmaceutical products and medical devices; provision of biotechnology related research, consulting, technical transfer, and other technology based services; and research and industrialization of individualized medicine laboratory technology. The company was founded in 2002 and is based in Changsha, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Changsha",
        "zipcode": null,
        "website": "http://www.fangsheng.com.cn",
        "market_cap": "Small Cap"
    },
    "6185.HK": {
        "short_name": "CANSINOBIO-B",
        "long_name": "CanSino Biologics Inc.",
        "summary": "CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides; and DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. It also develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; TB Booster for the BCG-vaccinated population; and Ad5-nCov, a recombinant novel coronavirus disease vaccine. In addition, the company is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CSB012 to treat adenovirus; CSB013 for ZIKA virus; CSB105 to treat meningitis; CSB016 for treating shingles; and CSB107 for polio. It has a collaboration with The National Research Council of Canada to advance vaccine against COVID-19; and co-development agreement with Precision NanoSystems, Inc. to develop a mRNA lipid nanoparticle vaccine against COVID-19. CanSino Biologics Inc. was founded in 2009 and is headquartered in Tianjin, the People's Republic of China.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Tianjin",
        "zipcode": null,
        "website": "http://www.cansinotech.com",
        "market_cap": "Large Cap"
    },
    "6472.TWO": {
        "short_name": "BORA PHARMACEUTICALS CO LTD",
        "long_name": "Bora Pharmaceuticals Co., LTD.",
        "summary": "Bora Pharmaceuticals Co., LTD. engages in the research, development, production, marketing, sale, and distribution of pharmaceutical products worldwide. It manufactures and sells generic, brand, and over-the-counter (OTC) drugs. The company is involved in contract development and manufacturing; consumer healthcare and OTC; and prescription drugs businesses. It also provides clinical and commercial manufacturing services, including solvent manufacturing; solid and liquid dosage forms; extrusion spheronization; immediate and extended release; core, sugar-coated, and film-coated tablets; fixed-dose combination products; and granules, and liquids sachet/stick pack filling. In addition, the company offers pharmaceutical development services, such as liquid and solid dosage forms, and immediate and modified release, analytical method development and validation; packaging and serialization services, which include bottle and blister packaging, and sachets; and raw materials and finished products testing, and analytical techniques services, as well as method verification, validation, and transfer. Further, it provides OTC medicines, foods and vitamins supplements; and skincare products. Additionally, the company also offers market analysis, drug and regulatory related services, price development, GDP warehousing, distribution, packaging, marketing planning, and sales services. The company's sales and distribution network comprises medical centers, hospitals, clinics, pharmacies, drug stores, CVS, and specialty channels. Bora Pharmaceuticals Co., LTD. was founded in 2007 and is based in Taipei, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taipei",
        "zipcode": "114",
        "website": "http://www.bora-corp.com",
        "market_cap": "Small Cap"
    },
    "6496.TWO": {
        "short_name": "EXCELSIOR BIOPHARMA INC",
        "long_name": "Excelsior Biopharma Inc.",
        "summary": "Excelsior Biopharma Inc. develops pharmaceutical products in Taiwan. The company offers prescription drugs, over-the-counter drugs, medical devices, healthcare food products, medical supplies, and skin products. It provides its products for the therapeutic areas, such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics and gynecology, anesthesiology, orthopedics, neonatology, oncology, pulmonary medicine, nephology, and others, etc. The company also offers test kits under the Actim name to detect inflected C-reactive protein, influenza virus, colorectal cancer, acute pancreatitis, preterm birth, and early water-breaking. In addition, it provides oral care products, including oral cleansing toothpaste, mouthwash and gel; and health food and cosmetic products. Excelsior Biopharma Inc. also exports its products. The company was formerly known as Excelsior Enterprise Co., Ltd. Excelsior Biopharma Inc. was founded in 1988 and is headquartered in Taipei City, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taipei",
        "zipcode": null,
        "website": "http://www.excelsiorgroup.com.tw",
        "market_cap": "Nano Cap"
    },
    "6576.TWO": {
        "short_name": "FORESEE PHARMACEUTICALS CO LTD",
        "long_name": "Foresee Pharmaceuticals Co., Ltd.",
        "summary": "Foresee Pharmaceuticals Co., Ltd., clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in Taiwan and Europe. The company's stabilized injectable formulation pipeline includes FP-001, which completed Phase III clinical study for the treatment of advanced stage prostate cancer; FP-004 that is in preclinical stage to treat opioids use disorder; FP-011 and FP-014, a long-acting sustained release dosage form for the treatment of breast cancer/prostate cancer; FP-015, for the treatment of neurological diseases; and FP-002 for the treatment of acromegaly, as well as FP-008 for the treatment of diabetic retinopathy. Its new chemical entity pipeline products consists of FP-020 to treat alport syndrome; FP-025, a selective matrix metalloproteinase-12 inhibitor, which is in Phase II clinical trial for the treatment of asthama, chronic obstructive pulmonary diseases, and emphysema or sarcoidosis; and FP-045, a small molecule mitochondrial aldehyde dehydrogenase 2 that completed Phase I clinical study for the treatment of peripheral arterial disease, fanconi anemia, and cardiorenal metabolic diseases. The company's strategic partners include Pierre Fabre Medicament Production and ScinoPharm. Foresee Pharmaceuticals Co., Ltd. was founded in 2013 and is headquartered in Taipei, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taipei",
        "zipcode": "115",
        "website": "http://www.foreseepharma.com",
        "market_cap": "Small Cap"
    },
    "6620.TWO": {
        "short_name": "Handa Pharma",
        "long_name": "Handa Pharmaceuticals, Inc.",
        "summary": "Handa Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China. It is developing various general delivery systems, including matrix system, reservoir system, matrix plus reservoir system, osmotic pump system, and colon delivery system. The company also develops modified release dosage forms, such as orally disintegrating tablets, modified release orally disintegrating tablets, modified release suspension systems, and ophthalmic modified release systems. In addition, it develops 505(b)2 and generic drugs. The company is headquartered in Tainan City, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Tainan City",
        "zipcode": "74147",
        "website": "http://www.handapharma.com.tw",
        "market_cap": "Micro Cap"
    },
    "6621.TWO": {
        "short_name": "UniPharma",
        "long_name": "UniPharma Co., Ltd.",
        "summary": "UniPharma Co., Ltd. engages in the brand drug development activities. The company offers adhesion reduction, neurology, cardiovascular, and anesthesia solutions; and antidotes, as well as medical devices and in vitro-diagnostic products. It also develops bio-markers for the diagnosis of neurological disease; and operates a laboratory for neurological bio-markers. The company was founded in 1998 and is based in Taipei, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taipei",
        "zipcode": "11494",
        "website": "http://www.uni-pharma.com",
        "market_cap": "Nano Cap"
    },
    "6677.TWO": {
        "short_name": "Anxo",
        "long_name": "Anxo Pharmaceutical Co., Ltd.",
        "summary": "Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. It offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, gastroenterology, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. The company was founded in 2003 and is headquartered in Taipei, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taipei",
        "zipcode": "10489",
        "website": "http://www.anxo.com.tw",
        "market_cap": "Nano Cap"
    },
    "6817.TWO": {
        "short_name": "WINSTON",
        "long_name": "Winston Medical Supply Co.,Ltd",
        "summary": "Winston Medical Supply Co.,Ltd. engages in the development, manufacture, and distribution of pharmaceuticals, nutrition supplements, and cosmeceutical products. It offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations, which are in oral dosage forms, such as powders, troches, tables, film coated tablets, chewables, and capsules for the treatment of colds, gastrointestinal issues, or other indications. The company was founded in 1974 and is based in Tainan City, Taiwan. As of January 2014, Winston Medical Supply Co., Ltd. operates as a subsidiary of Medigen Biotechnology Corp.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Tainan City",
        "zipcode": "71072",
        "website": "http://www.winston.com.tw",
        "market_cap": "Micro Cap"
    },
    "688185.SS": {
        "short_name": "CANSINO BIOLOGICS INC",
        "long_name": "CanSino Biologics Inc.",
        "summary": "CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides; and DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. It also develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; TB Booster for the BCG-vaccinated population; and Ad5-nCov, a recombinant novel coronavirus disease vaccine. In addition, the company is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CSB012 to treat adenovirus; CSB013 for ZIKA virus; CSB105 to treat meningitis; CSB016 for treating shingles; and CSB107 for polio. It has a collaboration with The National Research Council of Canada to advance vaccine against COVID-19; and co-development agreement with Precision NanoSystems, Inc. to develop a mRNA lipid nanoparticle vaccine against COVID-19. CanSino Biologics Inc. was founded in 2009 and is headquartered in Tianjin, the People's Republic of China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Tianjin",
        "zipcode": null,
        "website": "http://www.cansinotech.com",
        "market_cap": "Large Cap"
    },
    "688321.SS": {
        "short_name": "SHENZHEN CHIPSCREEN BIOSCIENCES",
        "long_name": "Shenzhen Chipscreen Biosciences Co., Ltd.",
        "summary": "Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shenzhen",
        "zipcode": "518057",
        "website": "http://www.chipscreen.com",
        "market_cap": "Mid Cap"
    },
    "688505.SS": {
        "short_name": "SHANGHAI FUDAN-ZHANGJIAN BIO-PH",
        "long_name": "Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.",
        "summary": "Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells bio-pharmaceutical products. It offers genetic engineering platform drugs, including CD30-MMAE, which is in clinical trial Phase I for tumors; Trop 2 antibody-conjugated drug that is in pre-clinical studies for triple negative breast cancer, bladder and gastric cancer, and other tumors; and HER2 antibody-drug conjugate, which is in pre-clinical study for tumors. The company also provides photodynamic technical platform drugs, such as hemoporfin for port wine stain, which is in Phase IV clinical trial; aminolevulinic acid, which is in Phase II clinical trials for cervical diseases infected by HPV; and aminolevulinic acid that is in Phase I clinical trials for acne, as well as completed pre-clinical study for brain gliomas. In addition, it offers nano technical platform drugs comprising Nanoparticle Albumin-bound Paclitaxel that is in pre-clinical studies for tumors, as well as developing Doxorubicin liposome for tumors. Further, the company offers oral solid preparation technology, which includes obeticholic acid for Hepatobiliary disease; and JAK1 inhibitor that is in Phase I clinical trial for rheumatoid arthritis. Additionally, it researches and develops pharmaceutical and medical devices; medical diagnostic products; provides related services; and sells daily necessities, and clinical laboratory analysis instruments and software. It also engages in the technology development, transfer, consulting, and promotion activities; and production of freeze-dried powder injections and APIs, as well as invests in overseas medical projects. The company was founded in 1996 and is based in Shanghai, the People's Republic of China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Shanghai",
        "zipcode": "201210",
        "website": "http://www.fd-zj.com",
        "market_cap": "Mid Cap"
    },
    "688566.SS": {
        "short_name": "JIANGSU JIBEIER PHARMACEUTICAL ",
        "long_name": "JiangsuJibeier Pharmaceutical Co., Ltd.",
        "summary": "Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research, development, production, and sale of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products cover various therapeutic areas, such as improving white blood cells, enhancing immunity, treating joint diseases, anti-hypertension, anti-eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach diseases, and other diseases. The company was founded in 2001 and is based in Zhenjiang, China.",
        "currency": "CNY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SHH",
        "market": "cn_market",
        "country": "China",
        "state": null,
        "city": "Zhenjiang",
        "zipcode": "212000",
        "website": "http://www.jibeier.com.cn",
        "market_cap": "Small Cap"
    },
    "6896.HK": {
        "short_name": "GOLDEN THROAT",
        "long_name": "Golden Throat Holdings Group Company Limited",
        "summary": "Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China. It offers Golden Throat lozenges over-the-counter medicine to relive symptoms of sore, dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat lozenge series products that include Dule lozenges and sugar-free Dule lozenges in various flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn; Yinxingye tablet that are designed to facilitate blood circulation, remove blood stasis, and dredge energy channels; and herbal vegetable beverages for soothing voice and relieving sore throats. The company also exports its products to the United States, Canada, Russia, Japan, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and Africa. Golden Throat Holdings Group Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Liuzhou",
        "zipcode": null,
        "website": "http://www.goldenthroat.com",
        "market_cap": "Micro Cap"
    },
    "6AP.F": {
        "short_name": "NEOLEUKIN TERAP. -,000001",
        "long_name": "Neoleukin Therapeutics, Inc.",
        "summary": "Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "WA",
        "city": "Seattle",
        "zipcode": "98102",
        "website": "http://www.neoleukin.com",
        "market_cap": "Small Cap"
    },
    "6CQ.F": {
        "short_name": "CRESCO LABS INC. SUB. VTG",
        "long_name": "Cresco Labs Inc.",
        "summary": "Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; flowers, popcorns, shakes, pre-rolls, and vapes under the High Supply brand; flowers, vapes, and edibles under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, ingestibles, sublingual oils, and transdermal patches under the Remedi brand, as well as cannabis products made from plants under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. It owns and operates 24 dispensaries, as well as has 5 retail licenses. The company is headquartered in Chicago, Illinois.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "IL",
        "city": "Chicago",
        "zipcode": "60654",
        "website": "http://www.crescolabs.com",
        "market_cap": "Mid Cap"
    },
    "6FN.F": {
        "short_name": "KLARIA PHARMA HOLDING AB",
        "long_name": "Klaria Pharma Holding AB (publ.)",
        "summary": "Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy. The company's clinical phase products include Epinephrine/Adrenaline for the treatment of acute allergic reaction; Naloxone for opioid overdose; and Ketamine for acute pain and depression. It also focuses on the commercialization of cannabis/cannabinoids, including THC and CBD for medical and recreational applications. The company was founded in 2014 and is based in Uppsala, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "754 50",
        "website": "http://www.klaria.com",
        "market_cap": "Nano Cap"
    },
    "6I7.F": {
        "short_name": "LABOMAR S.P.A.",
        "long_name": "Labomar S.p.A.",
        "summary": "Labomar S.p.A. researches, develops, manufactures, and sells food supplements, medical devices, cosmetics, and pharmaceutical products in Italy, France, Poland, Spain, North America, and internationally. It offers food supplements for various therapeutic areas, including immune systems, gastroenterology, cough and cold, neurology, oncology, eyesight wellness, sport, dermatology, inside beauty, cardiology, orthopedics, pediatrics, detoxing, and metabolic syndrome; and vitamins, minerals, and antioxidants. The company also provides medical devices for the use in gynaecology, cough and cold, gastroenterology, wound healing, metabolic syndrome, proctology, detoxing, and oral wound care therapeutic areas; and foods for special medical purposes, such as gastroenterology, endocrinology, and dysphagia. In addition, it offers cosmetics for inside beauty, skin cleanser, skincare, haircare, oral wound care, sun care, dermatology, acne rosacea, acne, atopic dertmatitis, and bruises therapeutic areas; and probiotic food supplements. Further, the company provides contract development and manufacturing services. Labomar S.p.A. offers its products in the form of tablets, capsules, liquids, powders, and semi solids. It has a commercial agreement with Bayer for the development and production of the references in various pharmaceutical flavors and forms. The company was founded in 1998 and is headquartered in Istrana, Italy. Labomar S.p.A. is a subsidiary of LBM Holding S.r.l.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Italy",
        "state": "TV",
        "city": "Istrana",
        "zipcode": "31036",
        "website": "http://labomar.com",
        "market_cap": "Micro Cap"
    },
    "6ZY.F": {
        "short_name": "ZYNERBA PHARMACEUTIC.INC.",
        "long_name": "Zynerba Pharmaceuticals, Inc.",
        "summary": "Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It improves the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "PA",
        "city": "Devon",
        "zipcode": "19333",
        "website": "http://zynerba.com",
        "market_cap": "Micro Cap"
    },
    "71U.F": {
        "short_name": "SAWAI GROUP HOLDINGS CO.",
        "long_name": "Sawai Group Holdings Co., Ltd.",
        "summary": "Sawai Group Holdings Co., Ltd., together with subsidiaries, manufactures, sells, imports, and exports pharmaceutical products in Japan and the United States. The company offers drugs in various formulations, including tablets, oral dispersing tablets, capsules, granules, injections, tapes, ophthalmic/nasal solutions, syrups, etc. in the therapeutic areas of cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, chemotherapeutics, vitamins, anti-cancer, etc. It serves hospitals, general practitioners, and dispensing pharmacies. Sawai Group Holdings Co., Ltd. was founded in 1929 and is headquartered in Osaka, Japan.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Japan",
        "state": null,
        "city": "Osaka",
        "zipcode": "532-0003",
        "website": "http://www.sawai.co.jp",
        "market_cap": "Small Cap"
    },
    "73M0.F": {
        "short_name": "MEDAVAIL HOLDINGS DL-,001",
        "long_name": "MedAvail Holdings, Inc",
        "summary": "MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology. The company provides turnkey services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations. It also operates SpotRx, a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery. MedAvail Holdings, Inc. is based in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5N 5M4",
        "website": "http://www.medavail.com",
        "market_cap": "Small Cap"
    },
    "74HA.F": {
        "short_name": "HEXO CORP.",
        "long_name": "HEXO Corp.",
        "summary": "HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Kanata",
        "zipcode": "K2K 2X2",
        "website": "http://www.hexocorp.com",
        "market_cap": "Small Cap"
    },
    "7561.TWO": {
        "short_name": "Bioray Biotech",
        "long_name": "Bioray Biotech Co., Ltd",
        "summary": "BioRay Biotech Co., Ltd. engages in the development and manufacture of biological agents. Its biological agents include functional probiotics, medicinal fungi, and immune cell preparations. The company was founded in 1994 is based in Pingtung, Taiwan.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Pingtung",
        "zipcode": "90846",
        "website": "http://www.bio-ray.com.tw",
        "market_cap": "Nano Cap"
    },
    "761.F": {
        "short_name": "PHARMANUTRA S.P.A.",
        "long_name": "Pharmanutra S.p.A.",
        "summary": "Pharmanutra S.p.A., a pharmaceutical company, engages in the research, design, development, and marketing of nutraceutical supplements and medical devices in Europe, Asia, the United States, and Africa. The company also manufactures and distributes active ingredients for the pharmaceutical, food, and dietary supplement industry; and develops and distributes drugs, medical devices, OTC products, and nutritional supplements with focus on the pediatric area. Its products primarily include Apportal, Sideral Folic 30, UltraMag, Cetilar, Gestalys DHA, Sideral Forte, CardioSideral, Bonecal, Novomega, and Dikappa2. The company distributes and sells its products through sales representatives and wholesalers to pharmacies and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Italy",
        "state": "PI",
        "city": "Pisa",
        "zipcode": "56122",
        "website": "http://www.pharmanutra.it",
        "market_cap": "Small Cap"
    },
    "7CI.F": {
        "short_name": "CRONOS GRP INC.",
        "long_name": "Cronos Group Inc.",
        "summary": "Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5V 2H1",
        "website": "http://www.thecronosgroup.com",
        "market_cap": "Mid Cap"
    },
    "7HR.F": {
        "short_name": "ZOETIC INT. PLC  LS-,01",
        "long_name": "Zoetic International Plc",
        "summary": "Zoetic International Plc, a vertically integrated CBD company, researches, develops, produces, and sells cannabidiol (CBD) consumer products and other hemp derivatives in the United States and the United Kingdom. The company offers oral CBD tinctures and CBD gummies, as well as softgel, massage oil, and skincare products. Its CBD products are used for pharmaceutical and tobacco replacement applications. The company was formerly known as Highlands Natural Resources plc and changed its name to Zoetic International Plc in September 2019. Zoetic International Plc was founded in 2014 and is headquartered in London, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "W1W 8DH",
        "website": "http://zoeticinternational.com",
        "market_cap": "Micro Cap"
    },
    "7LV.F": {
        "short_name": "THE VALENS CO.",
        "long_name": "The Valens Company Inc.",
        "summary": "The Valens Company Inc., engages in the development and manufacturing of cannabinoid based products. The company operates through Cannabis Operations and Analytical Testing segments. The Cannabis Operation segment provides extraction, post processing, and white label manufacturing under the standard processing and standard cultivation license issued by Health Canada. The Analytical Testing segment offers testing services for cannabis products under an analytical testing license provided by Health Canada. The company offers CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, formulation, and white-label product development services. Further, it produces dried cannabis and hemp biomass products. Additionally, the company provides range of products, including tinctures, two-piece caps, soft gels, oral sprays and vape pens, as well as beverages, concentrates, topicals, edibles, injectables, natural health products. It also offers analytical testing services to third party licensed producers in the cannabis space. The company offers a CBD-forward iced tea under the BASECAMP; and THC-forward citrus water under the SUMMIT brand names. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5V 2J6",
        "website": "http://www.thevalenscompany.com",
        "market_cap": "Small Cap"
    },
    "8049.HK": {
        "short_name": "JILIN CHANGLONG",
        "long_name": "Jilin Province Huinan Changlong Bio-pharmacy Company Limited",
        "summary": "Jilin Province Huinan Changlong Bio-pharmacy Company Limited engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People's Republic of China. It offers tablets, capsules, bulk drugs, pills, Chinese medicine pretreatment and extraction products, powders for injections, lyophilized powder for injections, small volume injection solutions, APIs, and granules. The company markets its products under the Changlong and Qing Tong brands. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Tonghua, China.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Tonghua",
        "zipcode": "135100",
        "website": "http://www.jlchanglong.com",
        "market_cap": "Micro Cap"
    },
    "82P.F": {
        "short_name": "PACIRA BIOSCIENC. DL-,001",
        "long_name": "Pacira BioSciences, Inc.",
        "summary": "Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a bupivacaine liposome injectable suspension, administered at the time of surgery to control pain and reduce or eliminate the use of opioids for acute postsurgical pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Parsippany, New Jersey.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NJ",
        "city": "Parsippany",
        "zipcode": "07054",
        "website": "http://www.pacira.com",
        "market_cap": "Mid Cap"
    },
    "8329.HK": {
        "short_name": "NEP INTERLONG",
        "long_name": "Shenzhen Neptunus Interlong Bio-technique Company Limited",
        "summary": "Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, researches, develops, produces, and sells medicines in the People's Republic of China. It is also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology products and in vitro diagnostic reagents. In addition, the company manufactures herbal medicines, generic drugs, and transfusion products, as well as medical devices. It serves approximately 500 medical organizations. The company is based in Shenzhen, the People's Republic of China. Shenzhen Neptunus Interlong Bio-technique Company Limited is a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "China",
        "state": null,
        "city": "Shenzhen",
        "zipcode": "518000",
        "website": "http://www.interlong.com",
        "market_cap": "Micro Cap"
    },
    "8432.TWO": {
        "short_name": "TSH BIOPHARM CORPORATION LIMITE",
        "long_name": "TSH Biopharm Corporation Limited",
        "summary": "TSH Biopharm Corporation Limited develops and markets medicines for chronic diseases in Taiwan. It offers products for cardiovascular, central nervous, gastrointestinal, and others, as well as liquid-biopsy diagnosis. The company is headquartered in Taipei city, Taiwan. TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited.",
        "currency": "TWD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TWO",
        "market": "tw_market",
        "country": "Taiwan",
        "state": null,
        "city": "Taipei",
        "zipcode": "11503",
        "website": "http://www.tshbiopharm.com",
        "market_cap": "Micro Cap"
    },
    "84S.F": {
        "short_name": "SLANG WORLDWIDE I",
        "long_name": "SLANG Worldwide Inc.",
        "summary": "SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company worldwide. It owns, licenses, and/or markets 11 brands which serve flower, inhalable concentrates, and ingestibles, including edibles and pressed pills. The company was formerly known as Fire Cannabis Inc. and changed its name to SLANG Worldwide Inc. in November 2018. SLANG Worldwide Inc. was incorporated in 2017 and is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M4M 3G3",
        "website": "http://www.slangww.com",
        "market_cap": "Micro Cap"
    },
    "8622.HK": {
        "short_name": "HUAKANG BIOMED",
        "long_name": "Huakang Biomedical Holdings Company Limited",
        "summary": "Huakang Biomedical Holdings Company Limited, a medical device company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China. It offers male and female fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; and auxiliary reproductive supplies and equipment. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is headquartered in Wan Chai, Hong Kong.",
        "currency": "HKD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "HKG",
        "market": "hk_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Wan Chai",
        "zipcode": null,
        "website": "http://www.huakangbiomedical.com",
        "market_cap": "Nano Cap"
    },
    "8CB.F": {
        "short_name": "CANNARA BIOTECH INC.",
        "long_name": "Cannara Biotech Inc.",
        "summary": "Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. It also offers hemp based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Montreal, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "QC",
        "city": "Montreal",
        "zipcode": "H4N 3M9",
        "website": "http://cannara.ca",
        "market_cap": "Micro Cap"
    },
    "8JM.F": {
        "short_name": "VETOQUINOL INH.  EO 2,50",
        "long_name": "Vetoquinol SA",
        "summary": "Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of pain management, anti-infective, cardiology-nephrology, care and hygiene, antiparasiticides, behavior, internal medicine, and reproduction for cats, dogs, cattle, and pigs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "France",
        "state": null,
        "city": "Lure",
        "zipcode": "70204",
        "website": "http://www.vetoquinol.com",
        "market_cap": "Small Cap"
    },
    "8MV.F": {
        "short_name": "BIOHARVEST SCIENCES INC",
        "long_name": "BioHarvest Sciences Inc.",
        "summary": "BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the necessity to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V7X 1M8",
        "website": "http://www.bioharvest.com",
        "market_cap": "Micro Cap"
    },
    "8OO.F": {
        "short_name": "HEMPFUSION WELLNES INC.",
        "long_name": "Hempfusion Wellness Inc.",
        "summary": "Hempfusion Wellness Inc., a health and wellness supplement company, manufactures, markets, and sells hemp-based cannabidiol (CBD) and probiotic products in the United States. Its products include tinctures, capsules, and topical creams and gel products under the HempFusion brand; probiotic enzymes and digestive capsules, and topical products under the Probulin brand; and HF Labs and Biome Research branded products that are versions of its hemp extract-based and probiotic products. The company sells its products through its e-commerce websites and doctor practitioners, as well as through a various food, drug, mass, and convenience market retailers. Hempfusion Wellness Inc. was founded in 2015 and is headquartered in Denver, Colorado.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "CO",
        "city": "Denver",
        "zipcode": "80202",
        "website": "http://www.hempfusion.com",
        "market_cap": "Micro Cap"
    },
    "9273.T": {
        "short_name": "KOA SHOJI HOLDINGS CO LTD",
        "long_name": "Koa Shoji Holdings Co.,Ltd.",
        "summary": "Koa Shoji Holdings Co.,Ltd., through its subsidiaries, engages in import and sale of generic APIs/intermediates in Japan. It is also involved in the manufacture of various injections; OTC drugs, primarily various vitamins; and generic drugs. In addition, the company engages in contract manufacturing of pharmaceuticals; and packaging of pharmaceutical products. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquartered in Yokohama, Japan.",
        "currency": "JPY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JPX",
        "market": "jp_market",
        "country": "Japan",
        "state": null,
        "city": "Yokohama",
        "zipcode": "223-0061",
        "website": "http://www.koashoji-hd.com",
        "market_cap": "Micro Cap"
    },
    "9SO.F": {
        "short_name": "SOLASIA PHARMA K.K.  O.N.",
        "long_name": "Solasia Pharma K.K.",
        "summary": "Solasia Pharma K.K. develops and commercializes drugs in the field of oncology in Japan and other Asian countries. The company offers SP-03 (episil oral liquid) for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy for cancer; and SP-01 (Sancuso), a transdermal delivery system that delivers granisetron, an anti-emetic into the patient's bloodstream for the treatment of chemotherapy induced nausea and vomiting. It is also developing SP-02 (Darinaparsin), a mitochondrial-targeted agent that has completed phase III clinical study to treat various hematologic and solid cancers; and SP-04 (PledOx), an intracellular superoxide removing agent, which is in phase IIb clinical trials for chemotherapy induced peripheral neuropathy. In addition, the company is developing SP-05 (Arfolitixorin) that is in phase III clinical study for the enhancement of antitumor efficacy of fluorouracil, including the treatment for pancreatic cancer, breast cancer, stomach cancer, and head and neck cancers. Solasia Pharma K.K. was founded in 2006 and is based in Tokyo, Japan.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "105-0011",
        "website": "http://www.solasia.co.jp",
        "market_cap": "Micro Cap"
    },
    "A061.F": {
        "short_name": "VIBE GROWTH CORP.",
        "long_name": "Vibe Growth Corporation",
        "summary": "Vibe Growth Corporation engages in the cultivation, production, retail, and distribution of cannabis for recreation and medicinal use in the United States, Canada, and internationally. The company operates through four segments: Dispensaries, Cultivation, Real Estate, and Canada. It operates 5 dispensaries and a cannabis greenhouse cultivation, as well as sells its products online under the Vibe By California brand. The company was formerly known as Vibe Bioscience Ltd. and changed its name to Vibe Growth Corporation in October 2020. Vibe Growth Corporation is headquartered in Sacramento, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "CA",
        "city": "Sacramento",
        "zipcode": "95826",
        "website": "http://www.vibebycalifornia.com",
        "market_cap": "Micro Cap"
    },
    "A491.F": {
        "short_name": "ISRACANN BIOSCIENCES INC.",
        "long_name": "Isracann Biosciences Inc.",
        "summary": "Isracann Biosciences Inc., together with its subsidiaries, cultivates and produces medical cannabis in Israel and internationally. It also provides property development, facility design and construction, cultivation and processing, administrative, and technology licensing services. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V7X 1L3",
        "website": "http://www.isracann.com",
        "market_cap": "Nano Cap"
    },
    "A8D.F": {
        "short_name": "AB SCIENCE S.A.  EO-,01",
        "long_name": "AB Science S.A.",
        "summary": "AB Science S.A., a clinical-stage pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases. The company is also developing AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase II clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was founded in 2001 and is headquartered in Paris, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "France",
        "state": null,
        "city": "Paris",
        "zipcode": "75008",
        "website": "http://www.ab-science.com",
        "market_cap": "Small Cap"
    },
    "A9K.F": {
        "short_name": "HALO COLLECTIVE INC.",
        "long_name": "Halo Collective Inc.",
        "summary": "Halo Collective Inc. operates as a cannabis cultivation, manufacturing, and distribution company that grows, extracts, and processes cannabis flower, oils, and concentrates in the United States. The company also offers edible products, including single piece chews and a syrup-based drink in California and, Oregon. In addition, it markets branded and private label products. The company sells its cannabis products principally to dispensaries under Hush, Mojave, and Exhale brands. It serves licensed retailers and wholesalers. Halo Collective Inc. has a strategic partnership with High Tide Inc; and with OG DNA Genetics Inc to develop genetics in Oregon. The company was formerly known as Halo Labs Inc. and changed its name to Halo Collective Inc. in January 2021. Halo Collective Inc. was founded in 2016 and is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 2M5",
        "website": "http://www.haloco.com",
        "market_cap": "Micro Cap"
    },
    "AARTIDRUGS.NS": {
        "short_name": "AARTI DRUGS LTD",
        "long_name": "Aarti Drugs Limited",
        "summary": "Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally. It offers active pharmaceutical ingredients in various therapeutic categories, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheimer's treatment, sedatives, vitamins, and alcoholism treatment. The company also provides pharmaceutical intermediate products comprising tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, raloxifene, and zolpidem; and specialty chemical products, such as benzene sulphonamide, benzene sulphonic acid, benzene sulphonic acid methyl ester, benzene sulphonyl chloride, cipro Q acid, levofloxacin Q acid, methyl nicotinate, N-methyl methane sulphonamide, diphenyl sulphone, norofloxacin Q acid, ofloxacin Q acid, ortho para toluene sulphonamide, ortho/para toluene sulphonic acid methyl ester, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, para toluene sulphonamide, para toluene sulphonic acid methyl ester, para toluene sulphonyl chloride, and sodium benezene sulfinate. In addition, its products under development comprise Acamprosate for alcoholism; Dabigatran for use as an anticoagulant; Sevelamer for antihyperphosphatemia; Colsevelam for anti-cholestrol treatment; Drondarone and Olmesartan for the treatment of cardiovascular diseases; Valasartan for use as cardiprotectant; and Sitagliptin for use as an antidiabetic. Additionally, the company offers contract manufacturing services. Aarti Drugs Limited was founded in 1984 and is headquartered in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400 022",
        "website": "http://www.aartidrugs.co.in",
        "market_cap": "Small Cap"
    },
    "AB.PA": {
        "short_name": "AB SCIENCE",
        "long_name": "AB Science S.A.",
        "summary": "AB Science S.A., a clinical-stage pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases. The company is also developing AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase II clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was founded in 2001 and is headquartered in Paris, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PAR",
        "market": "fr_market",
        "country": "France",
        "state": null,
        "city": "Paris",
        "zipcode": "75008",
        "website": "http://www.ab-science.com",
        "market_cap": "Small Cap"
    },
    "ABSCF": {
        "short_name": "AB SCIENCE",
        "long_name": "AB Science S.A.",
        "summary": "AB Science S.A., a clinical-stage pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases. The company is also developing AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase II clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was founded in 2001 and is headquartered in Paris, France.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "France",
        "state": null,
        "city": "Paris",
        "zipcode": "75008",
        "website": "http://www.ab-science.com",
        "market_cap": "Small Cap"
    },
    "ABTI": {
        "short_name": "ALTEROLA BIOTECH INC",
        "long_name": "Alterola Biotech, Inc.",
        "summary": "Alterola Biotech, Inc., together with its subsidiaries, focus on the development of cannabinoid, cannabinoid-like, non-cannabinoid pharmaceutical active pharmaceutical ingredients (APIs), and pharmaceutical medicines made from cannabinoid in United Kingdom and worldwide. The company focuses on developing food-grade ingredients, regulated pharmaceuticals, and regulated food products. In addition, it focuses on the development of bulk ingredients for supply into the cosmetic sector. The company was formerly known as Jedediah Resources Corp. and changed its name to Alterola Biotech, Inc. in July 2010. Alterola Biotech, Inc. was incorporated in 2008 and is based in Birkenhead, the United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Birkenhead",
        "zipcode": "CH41 5AR",
        "website": "http://www.alterolabiotech.com",
        "market_cap": "Small Cap"
    },
    "AC4.F": {
        "short_name": "AUSTRALIS CAPITAL INC.",
        "long_name": "Australis Capital Inc.",
        "summary": "Australis Capital Inc. is a venture capital specializing in early-stage but not limited to equity positions and/or debt in both public and private companies, financings in exchange for royalties or other distribution streams, and control share acquisitions and buyouts. It seeks to identify and invest in United States and abroad in cannabis and real estate assets. Australis Capital Inc. is based in Las Vegas, Nevada and additional offices in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89119",
        "website": "http://www.ausa-corp.com/",
        "market_cap": "Nano Cap"
    },
    "AC6.F": {
        "short_name": "ALZECURE PHARMA AB",
        "long_name": "AlzeCure Pharma AB (publ)",
        "summary": "AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of diseases and conditions that affect the central nervous system. The company is developing five drug candidates based on the NeuroRestore and Alzstatin research platforms. Its pipeline drug candidates include ACD855, which is in Phase I clinical trial for sleep disruptions, traumatic brain injuries, and Alzheimer's disease; ACD856, ACD679, and ACD680 for Alzheimer's disease; ACD857 for eye/ear indications; VR1 that is in Phase I clinical trial for neuropathic pain; and TrkA-NAM for osteoarthritic pain. The company was founded in 2012 and is based in Huddinge, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Huddinge",
        "zipcode": "141 57",
        "website": "http://www.alzecurepharma.se",
        "market_cap": "Nano Cap"
    },
    "AC8.AX": {
        "short_name": "AUSCANN FPO",
        "long_name": "AusCann Group Holdings Ltd",
        "summary": "AusCann Group Holdings Ltd, a pharmaceutical company, researches, develops, cultivates, produces, and distributes cannabinoid-based pharmaceuticals in Australia and internationally. It offers hard-shell capsules using Neuvis technology for the treatment of chronic neuropathic pain. The company is based in West Perth, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "WA",
        "city": "West Perth",
        "zipcode": "6005",
        "website": "http://auscann.com.au",
        "market_cap": "Nano Cap"
    },
    "ACB": {
        "short_name": "Aurora Cannabis Inc.",
        "long_name": "Aurora Cannabis Inc.",
        "summary": "Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "Canada",
        "state": "AB",
        "city": "Edmonton",
        "zipcode": "T9E 0V6",
        "website": "http://auroramj.com",
        "market_cap": "Small Cap"
    },
    "ACB.TO": {
        "short_name": "AURORA CANNABIS INC",
        "long_name": "Aurora Cannabis Inc.",
        "summary": "Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "AB",
        "city": "Edmonton",
        "zipcode": "T9E 0V6",
        "website": "http://auroramj.com",
        "market_cap": "Small Cap"
    },
    "ACCA": {
        "short_name": "ACACIA DIVERSIFIED HOLDINGS INC",
        "long_name": "Acacia Diversified Holdings, Inc.",
        "summary": "Acacia Diversified Holdings, Inc. engages in the extraction and processing of high-CBD/low-THC content medical grade hemp oils from medical hemp plants in the United States. The company is also involved in the research and development of botanicals endocannabinoid nutraceuticals product line; and retail and wholesale distribution of medicinal hemp products and dietary supplements. In addition, it offers consumer products under the EUFLORIA brand name for the distribution channels. The company was formerly known as Acacia Automotive, Inc. and changed its name to Acacia Diversified Holdings, Inc. in October 2012. Acacia Diversified Holdings, Inc. was incorporated in 1984 and is based in Clearwater, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Clearwater",
        "zipcode": "33760",
        "website": "http://www.acaciadiversifiedholdings.com",
        "market_cap": "Nano Cap"
    },
    "ACNNF": {
        "short_name": "AUSCANN GROUP HOLDINGS LTD",
        "long_name": "AusCann Group Holdings Ltd",
        "summary": "AusCann Group Holdings Ltd, a pharmaceutical company, researches, develops, cultivates, produces, and distributes cannabinoid-based pharmaceuticals in Australia and internationally. It offers hard-shell capsules using Neuvis technology for the treatment of chronic neuropathic pain. The company is based in West Perth, Australia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Australia",
        "state": "WA",
        "city": "West Perth",
        "zipcode": "6005",
        "website": "http://auscann.com.au",
        "market_cap": "Nano Cap"
    },
    "ACRDF": {
        "short_name": "ACREAGE HOLDINGS INC",
        "long_name": "Acreage Holdings, Inc.",
        "summary": "Acreage Holdings, Inc., formerly High Street Capital Partners, is a principal investment firm specializing in cannabis industry. Acreage Holdings, Inc. was founded in 2014 and is based in New York, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10017",
        "website": "http://www.acreageholdings.com",
        "market_cap": "Micro Cap"
    },
    "ACRHF": {
        "short_name": "ACREAGE HOLDINGS INC",
        "long_name": "Acreage Holdings, Inc.",
        "summary": "Acreage Holdings, Inc., formerly High Street Capital Partners, is a principal investment firm specializing in cannabis industry. Acreage Holdings, Inc. was founded in 2014 and is based in New York, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10017",
        "website": "http://www.acreageholdings.com",
        "market_cap": "Small Cap"
    },
    "ACRX": {
        "short_name": "AcelRx Pharmaceuticals, Inc.",
        "long_name": "AcelRx Pharmaceuticals, Inc.",
        "summary": "AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company's lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. It also develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood City, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NGM",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Redwood City",
        "zipcode": "94063",
        "website": "http://www.acelrx.com",
        "market_cap": "Micro Cap"
    },
    "ACUR": {
        "short_name": "ACURA PHARMACEUTICALS INC",
        "long_name": "Acura Pharmaceuticals, Inc.",
        "summary": "Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was incorporated in 1935 and is based in Palatine, Illinois.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "IL",
        "city": "Palatine",
        "zipcode": "60067",
        "website": "http://www.acurapharm.com",
        "market_cap": "Nano Cap"
    },
    "ACUS": {
        "short_name": "ACUSPHERE INC",
        "long_name": "Acusphere, Inc.",
        "summary": "Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "MA",
        "city": "Watertown",
        "zipcode": "02472",
        "website": "http://www.acusphere.com",
        "market_cap": "Nano Cap"
    },
    "ADMP": {
        "short_name": "Adamis Pharmaceuticals Corporat",
        "long_name": "Adamis Pharmaceuticals Corporation",
        "summary": "Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's product candidates comprise Symjepi Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products consisting of fluticasone for the treatment of asthma; beclomethasone, a metered dose inhaler product for the asthma; and naloxone injection product candidates for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "San Diego",
        "zipcode": "92130",
        "website": "http://www.adamispharmaceuticals.com",
        "market_cap": "Micro Cap"
    },
    "ADMS": {
        "short_name": "Adamas Pharmaceuticals, Inc.",
        "long_name": "Adamas Pharmaceuticals, Inc.",
        "summary": "Adamas Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of medicines for patients suffering from chronic neurologic disorders in the United States. It offers GOCOVRI, an extended release capsule for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications, as well as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing OFF episodes; and OSMOLEX ER, an extended release tablet to treat Parkinson's disease and drug-induced extrapyramidal reactions in adult patients. The company is also developing ADS-4101, which has completed two Phase 1b studies for treating partial onset seizures in patients with epilepsy. In addition, it offers NAMZARIC and NAMENDA XR, a memantine hydrochloride extended release and donepezil hydrochloride capsules for the treatment of moderate to severe dementia of an Alzheimer's type. The company was formerly known as NeuroMolecular Pharmaceuticals, Inc. and changed its name to Adamas Pharmaceuticals, Inc. in July 2007. Adamas Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NGM",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "EmeryVille",
        "zipcode": "94608",
        "website": "http://www.adamaspharma.com",
        "market_cap": "Micro Cap"
    },
    "ADVT": {
        "short_name": "ADVANTIS CORPORATION",
        "long_name": "Advantis Corp.",
        "summary": "Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions. Advantis Corp. was formerly known as Ramoil Management, Ltd. and changed its name to Advantis Corp. in December 2015. Advantis Corp. is based in Newport Beach, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Newport Beach",
        "zipcode": "92660",
        "website": "http://www.advantiscorp.com",
        "market_cap": "Nano Cap"
    },
    "AEQ.F": {
        "short_name": "AEQUUS PHARMACEUTICALS",
        "long_name": "Aequus Pharmaceuticals Inc.",
        "summary": "Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistitan, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Tacrolimus IR, an immunosuppressant for the treatment and prevention of acute rejection following organ transplantation; Evolve dry eye products for various symptoms involved with dry eye disease and blepharitis, including discomfort, stinging, burning, and dryness; and preservative free ophthalmic product. Its development stage product includes Topiramate XR and Oxcarbazepine XR extended-release oral tablets for the treatment of epilepsy; AQS1303, a transdermal pyridoxine/doxylamine for the treatment of nausea and vomiting of pregnancy; and AQS1304, a cannabinoid-based therapeutics for neurological disorders. The company has collaboration agreements with Sandoz Canada, Inc. for the promotion of Vistitan; Supernus Pharmaceuticals, Inc. for marketing of extended-release anti-epileptic drugs; and Medicom Healthcare Ltd. to focus on preservative free therapies in ophthalmology. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1S4",
        "website": "http://www.aequuspharma.ca",
        "market_cap": "Nano Cap"
    },
    "AERI": {
        "short_name": "Aerie Pharmaceuticals, Inc.",
        "long_name": "Aerie Pharmaceuticals, Inc.",
        "summary": "Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma, ocular surface, and retinal diseases in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma. The company is also developing AR-15512 to treat signs and symptoms of dry eye; and AR-1105, AR-13503 SR, and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM. Aerie Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Durham, North Carolina.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "NC",
        "city": "Durham",
        "zipcode": "27703",
        "website": "http://www.aeriepharma.com",
        "market_cap": "Small Cap"
    },
    "AFP.AX": {
        "short_name": "AFT PHARM FPO NZX",
        "long_name": "AFT Pharmaceuticals Limited",
        "summary": "AFT Pharmaceuticals Limited develops, licenses, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers approximately 130 prescription and non-prescription products for use in the areas of allergy, eye care, first aid, fungal, pain management, and skin care, as well as supplements. It is also involved in the distribution of pharmaceuticals. The company was founded in 1997 and is headquartered in Auckland, New Zealand.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "New Zealand",
        "state": null,
        "city": "Auckland",
        "zipcode": "0622",
        "website": "http://www.aftpharm.com",
        "market_cap": "Small Cap"
    },
    "AFT.NZ": {
        "short_name": "AFT Pharmaceuticals Ltd Ordinar",
        "long_name": "AFT Pharmaceuticals Limited",
        "summary": "AFT Pharmaceuticals Limited develops, licenses, distributes, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail and oral care, pain management, skin care, and other products, as well as supplements. The company was incorporated in 1997 and is headquartered in Auckland, New Zealand.",
        "currency": "NZD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NZE",
        "market": "nz_market",
        "country": "New Zealand",
        "state": null,
        "city": "Auckland",
        "zipcode": "0622",
        "website": "http://www.aftpharm.com",
        "market_cap": "Small Cap"
    },
    "AGFAF": {
        "short_name": "AGRAFLORA ORGANICS INTERNATIONA",
        "long_name": "AgraFlora Organics International Inc.",
        "summary": "AgraFlora Organics International Inc. operates in the cannabis industry in Canada and the Republic of Colombia. The company was formerly known as PUF Ventures Inc. and changed its name to AgraFlora Organics International Inc. in November 2018. The company was incorporated in 2004 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2T7",
        "website": "http://agraflora.com",
        "market_cap": "Nano Cap"
    },
    "AGH.AX": {
        "short_name": "ALTHEA FPO",
        "long_name": "Althea Group Holdings Limited",
        "summary": "Althea Group Holdings Limited cultivates, produces, supplies, imports, and exports pharmaceutical grade medicinal cannabis in Australia, the United Kingdom, and Canada. It also offers a range of education, access, and management services to support eligible patients, healthcare professionals, and pharmacies in navigating medicinal cannabis treatment pathways through Concierge, an online service, as well as Medic, an online education. Althea Group Holdings Limited was founded in 2017 and is based in Melbourne, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Melbourne",
        "zipcode": "3000",
        "website": "http://www.althea.life",
        "market_cap": "Micro Cap"
    },
    "AGOL": {
        "short_name": "ANDINA GOLD CORP",
        "long_name": "Andina Gold Corp.",
        "summary": "Andina Gold Corp. focuses on gold exploration activities. The company was formerly known as Redwood Green Corp. and changed its name to Andina Gold Corp. in October 2020. Andina Gold Corp. was incorporated in 2011 and is based in Englewood, Colorado.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CO",
        "city": "Englewood",
        "zipcode": "80204",
        "website": "http://www.redwoodgreencorp.com",
        "market_cap": "Nano Cap"
    },
    "AGRA.CN": {
        "short_name": "AgraFlora",
        "long_name": "AgraFlora Organics International Inc.",
        "summary": "AgraFlora Organics International Inc. operates in the cannabis industry in Canada and the Republic of Colombia. The company was formerly known as PUF Ventures Inc. and changed its name to AgraFlora Organics International Inc. in November 2018. The company was incorporated in 2004 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2T7",
        "website": "http://agraflora.com",
        "market_cap": "Nano Cap"
    },
    "AGRX": {
        "short_name": "Agile Therapeutics, Inc.",
        "long_name": "Agile Therapeutics, Inc.",
        "summary": "Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NCM",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "Princeton",
        "zipcode": "08540",
        "website": "http://www.agiletherapeutics.com",
        "market_cap": "Micro Cap"
    },
    "AGY.L": {
        "short_name": "ALLERGY THERAPEUTICS PLC ORD 0.",
        "long_name": "Allergy Therapeutics plc",
        "summary": "Allergy Therapeutics plc engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, Acarovac MPL, Venomil, Synbiotics, Penicillin Diagnostics, and Peanut. The company also develops allergy vaccines for grass, tree, and house dust mite, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Worthing",
        "zipcode": "BN14 8SA",
        "website": "http://www.allergytherapeutics.com",
        "market_cap": null
    },
    "AGYTF": {
        "short_name": "ALLERGY THERAPEUTICS",
        "long_name": "Allergy Therapeutics plc",
        "summary": "Allergy Therapeutics plc engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, Acarovac MPL, Venomil, Synbiotics, Penicillin Diagnostics, and Peanut. The company also develops allergy vaccines for grass, tree, and house dust mite, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Worthing",
        "zipcode": "BN14 8SA",
        "website": "http://www.allergytherapeutics.com",
        "market_cap": "Large Cap"
    },
    "AH.TO": {
        "short_name": "ALEAFIA HEALTH INC",
        "long_name": "Aleafia Health Inc.",
        "summary": "Aleafia Health Inc. operates as an integrated cannabis health and wellness services company in Canada and internationally. It produces a portfolio of products, including dried flower and pre-rolls, as well as oil drops and capsules, oral sprays, and cannabis-infused sublingual strips. The company offers its products under the Kin Slips, Emblem, and Symbl brands. It also operates a network of 25 medical cannabis clinics under the Canabo Clinics brand name; and education centers. The company was incorporated in 2007 and is headquartered in Concord, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Concord",
        "zipcode": "L4K 1G4",
        "website": "http://www.aleafiahealth.com",
        "market_cap": "Micro Cap"
    },
    "AIDA": {
        "short_name": "AIDA PHARMA INC",
        "long_name": "Aida Pharmaceuticals, Inc.",
        "summary": "Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Hangzhou",
        "zipcode": "310016",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "AION.CN": {
        "short_name": "AionTherapeutic",
        "long_name": "Aion Therapeutic Inc.",
        "summary": "Aion Therapeutic Inc. researches, grows, harvests, and markets medical cannabis products in Canada. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was founded in 2011 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M2N 5W9",
        "website": "http://www.aiontherapeutic.com",
        "market_cap": "Nano Cap"
    },
    "AIP.JO": {
        "short_name": "Adcock Ingram Hldgs Ltd",
        "long_name": "Adcock Ingram Holdings Limited",
        "summary": "Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products primarily in Southern Africa, India, and rest of Africa. It offers a portfolio of over the counter products, prescription medicines, and consumer products, as well as instrument and surgical products. The company also provides pharmaceutical products in a range of therapeutic classes, such as women's health, cannabidiol, antiretroviral, dermatology, central nervous system, respiratory, ophthalmology, generics, cardiovascular, pain, gastroenterology, energy supplements, colds and flu, personal care, feminine hygiene, digestive well-being, allergies, baby care, cough, food and nutrition supplements, vitamins, and minerals supplements. In addition, it manufactures and supplies hospital and critical care products, including intravenous solutions, renal dialysis systems, and blood collection products. The company serves private and public sectors. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.",
        "currency": "ZAc",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JNB",
        "market": "za_market",
        "country": "South Africa",
        "state": null,
        "city": "Midrand",
        "zipcode": "1682",
        "website": "http://www.adcock.co.za",
        "market_cap": null
    },
    "AJANTPHARM.NS": {
        "short_name": "AJANTA PHARMA",
        "long_name": "Ajanta Pharma Limited",
        "summary": "Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory and general health products, dermatology, ophthalmology, and pain management areas. It also provides multivitamins, antibiotics, eye drops, cough syrups, etc. The company serves in India, Africa, rest of Asia, the United States, and internationally. It supplies its products to government bodies, including armed forces, government hospitals, canteens, stores department, etc. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400067",
        "website": "http://www.ajantapharma.com",
        "market_cap": "Mid Cap"
    },
    "AKBM.OL": {
        "short_name": "AKER BIOMARINE ASA",
        "long_name": "Aker BioMarine AS",
        "summary": "Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates in two segments, Ingredients and Brands. The company provides krill oil products, including omega-3s, phospholipids, choline, and astaxanthin under the Superba, Kori, NKO, and K\u00c2\u00b7REAL brands. It also offers Qrill aqua nutrient-rich feed ingredients for aquaculture; and QRILL pet, a functional ingredient for pet food. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste into products, such as shopping baskets and food trays. Aker BioMarine AS has an agreement with Medical Food Solutions Research to develop pharmaceutical therapies for brain and eye health based on Lysoveta. The company is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.",
        "currency": "NOK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "OSL",
        "market": "no_market",
        "country": "Norway",
        "state": null,
        "city": "Lysaker",
        "zipcode": "1327",
        "website": "http://www.akerbiomarine.com",
        "market_cap": "Small Cap"
    },
    "ALBERTDAVD.NS": {
        "short_name": "ALBERT DAVID",
        "long_name": "Albert David Limited",
        "summary": "Albert David Limited manufactures and sells pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenteral, oral/enteral, topical agents, and vision care problems. The company also exports its products to Latin American, South East Asian, and various African countries. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Kolkata",
        "zipcode": "700001",
        "website": "http://www.albertdavidindia.com",
        "market_cap": "Nano Cap"
    },
    "ALEAF": {
        "short_name": "ALEAFIA HEALTH INC",
        "long_name": "Aleafia Health Inc.",
        "summary": "Aleafia Health Inc. operates as an integrated cannabis health and wellness services company in Canada and internationally. It produces a portfolio of products, including dried flower and pre-rolls, as well as oil drops and capsules, oral sprays, and cannabis-infused sublingual strips. The company offers its products under the Kin Slips, Emblem, and Symbl brands. It also operates a network of 25 medical cannabis clinics under the Canabo Clinics brand name; and education centers. The company was incorporated in 2007 and is headquartered in Concord, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Concord",
        "zipcode": "L4K 1G4",
        "website": "http://www.aleafiahealth.com",
        "market_cap": "Micro Cap"
    },
    "ALEMBICLTD.NS": {
        "short_name": "ALEMBIC LTD",
        "long_name": "Alembic Limited",
        "summary": "Alembic Limited manufactures and markets fermentation and chemistry based active pharmaceuticals ingredients (API). The company operates through API and Real Estate segments. It is also involved in the construction and leasing of residential and commercial real estate projects; provision of project management and marketing consultancy services; and wind power generation business. The company also exports its products. Alembic Limited was founded in 1907 and is based in Vadodara, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Vadodara",
        "zipcode": "390003",
        "website": "http://www.alembiclimited.com",
        "market_cap": "Small Cap"
    },
    "ALID": {
        "short_name": "ALLIED CORP",
        "long_name": "Allied Corp.",
        "summary": "Allied Corp., a medical cannabis production company, engages in the research, development, and production of cannabinoid health solutions in the United States. It offers hemp derived natural health products, including Liberty, a hemp derived cannabidiol (CBD) tincture; and Tactical Hydration, a CBD infused electrolyte replacement drink under the Tactical Relief brand. The company also provides Hydro Sport, a CBD-infused rehydration drink under the Equilibrium Bio brand; anti-aging cosmetics and topicals infused with CBD under the MaXXa brand; and anti-aging, anti-pain, and anti-inflammation skin care products under the Buds Pure Naturals brand. In addition, it is developing ALID 12, a pharma product, which is in Phase I clinical trial for treating post-traumatic stress disorder in Colombia. The company is headquartered in Kelowna, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Kelowna",
        "zipcode": "V1Y 2E4",
        "website": "http://allied.health",
        "market_cap": "Micro Cap"
    },
    "ALIM": {
        "short_name": "Alimera Sciences, Inc.",
        "long_name": "Alimera Sciences, Inc.",
        "summary": "Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NGM",
        "market": "us_market",
        "country": "United States",
        "state": "GA",
        "city": "Alpharetta",
        "zipcode": "30005",
        "website": "http://www.alimerasciences.com",
        "market_cap": "Micro Cap"
    },
    "ALKEM.NS": {
        "short_name": "ALKEM LAB LTD",
        "long_name": "Alkem Laboratories Limited",
        "summary": "Alkem Laboratories Limited, a pharmaceutical company, develops, manufactures, and sells pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, diabetology, cardiology, gastroenterology, osteoporosis, central nervous system, oncology, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain relief/analgesic, anti-diabetic, and neurology products. It also provides pregnancy detection kits and condoms. Alkem Laboratories Limited was founded in 1973 and is headquartered in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400013",
        "website": "http://www.alkemlabs.com",
        "market_cap": "Mid Cap"
    },
    "ALM.MC": {
        "short_name": "ALMIRALL S.A.",
        "long_name": "Almirall, S.A.",
        "summary": "Almirall, S.A., a pharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines worldwide. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, cutaneous T-cell lymphoma, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications; and for central nervous system, cardiovascular, and gastrointestinal diseases. Its products include Actikerall, Solaraze, Cordran Tape, Skilarence, Ilumetri, Seysara, Almax, Crestor, Provisacor, Sativex, Ebastel, Aczone, Tazorac, Azelex, and Veltin. Almirall, S.A. has a strategic research collaboration with Evotec AG to discover and develop first-in-class therapeutics in the field of dermatology diseases; collaborative research and license agreement with X-Chem, Inc. for the development of oral compounds for patients suffering from dermatological diseases; research collaboration with Iktos in the area of artificial intelligence for new drug design; multi-target research collaboration with the University of Dundee to develop novel targeted protein degraders medicines; and collaboration with Popit to provide a novel support solution for patients with psoriasis. It also has a strategic partnership with Tyris Therapeutics to develop gene therapies for the treatment of rare genetic dermatology diseases; and Happify Health to develop evidence-supported digital therapeutics solutions for psoriasis patients. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MCE",
        "market": "es_market",
        "country": "Spain",
        "state": null,
        "city": "Barcelona",
        "zipcode": "08022",
        "website": "http://www.almirall.com",
        "market_cap": "Mid Cap"
    },
    "ALPA.NS": {
        "short_name": "ALPA LABORATORIES",
        "long_name": "Alpa Laboratories Limited",
        "summary": "Alpa Laboratories Limited engages in manufacturing, marketing, and selling pharmaceutical finished dosage forms in India. It offers ethical, generic, and over the counter products in various finished dosage forms, including liquid injections, dry powder injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human use; and boluses, injections, and intra-mammary infusions for veterinary use. The company provides its products in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, anti protozoans, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. Alpa Laboratories Limited sells its products through distributors, as well as retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to various countries in South and Central America, Africa, and Asia, including CIS countries comprising Russia, Ukraine, Kazakhstan, etc. Alpa Laboratories Limited was incorporated in 1988 and is based in Indore, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Indore",
        "zipcode": "453446",
        "website": "http://www.alpalabs.in",
        "market_cap": "Nano Cap"
    },
    "ALZCUR.ST": {
        "short_name": "AlzeCure Pharma AB",
        "long_name": "AlzeCure Pharma AB (publ)",
        "summary": "AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of diseases and conditions that affect the central nervous system. The company is developing five drug candidates based on the NeuroRestore and Alzstatin research platforms. Its pipeline drug candidates include ACD855, which is in Phase I clinical trial for sleep disruptions, traumatic brain injuries, and Alzheimer's disease; ACD856, ACD679, and ACD680 for Alzheimer's disease; ACD857 for eye/ear indications; VR1 that is in Phase I clinical trial for neuropathic pain; and TrkA-NAM for osteoarthritic pain. The company was founded in 2012 and is based in Huddinge, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Huddinge",
        "zipcode": "141 57",
        "website": "http://www.alzecurepharma.se",
        "market_cap": "Nano Cap"
    },
    "AMHD": {
        "short_name": "HLK BIOTECH HOLDING GROUP INC",
        "long_name": "HLK Biotech Holding Group, Inc.",
        "summary": "HLK Biotech Holding Group, Inc., through its subsidiaries, produces and sells biodiesel. It also acquires real estate properties. The company was formerly known as Amelot Holdings, Inc. and changed its name to HLK Biotech Holding Group, Inc. in February 2018. HLK Biotech Holding Group, Inc. is headquartered in Norfolk, Virginia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "VA",
        "city": "Norfolk",
        "zipcode": "23517",
        "website": "http://www.amelotholdings.com",
        "market_cap": "Nano Cap"
    },
    "AMPH": {
        "short_name": "Amphastar Pharmaceuticals, Inc.",
        "long_name": "Amphastar Pharmaceuticals, Inc.",
        "summary": "Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers procainamide for documented ventricular arrhythmias; neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; medroxyprogesterone acetate injectable suspension for the prevention of pregnancy; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block, as well as manufactures and distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Rancho Cucamonga",
        "zipcode": "91730",
        "website": "http://www.amphastar.com",
        "market_cap": "Small Cap"
    },
    "AMRUTANJAN.NS": {
        "short_name": "AMRUTANJAN HEALTH",
        "long_name": "Amrutanjan Health Care Limited",
        "summary": "Amrutanjan Health Care Limited produces and sells ayurvedic pain balms in India. It operates through OTC products, Beverages, and Others segments. The company offers pain management products, including pain balms and roll-ons; and back pain roll-ons and lotions, body pain gels, and joint muscle sprays, as well as non-steroidal anti-inflammatory drugs. It also provides congestion management products, such as cold rubs, cough syrups, nasal inhalers, and mints. In addition, the company offers sanitary napkins for women. Further, it provides corn caps; hand sanitizers; and juice drinks under the Fruitnik and Fruitnik Electro+ brand names, as well as operates a pain management center. It also exports its products to Gulf, African, South East, and Asian countries. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Chennai",
        "zipcode": "600004",
        "website": "http://www.amrutanjan.com",
        "market_cap": "Micro Cap"
    },
    "AMRX": {
        "short_name": "Amneal Pharmaceuticals, Inc.",
        "long_name": "Amneal Pharmaceuticals, Inc.",
        "summary": "Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers licensed, owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinson's disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "Bridgewater",
        "zipcode": "08807",
        "website": "http://www.amneal.com",
        "market_cap": "Small Cap"
    },
    "AMYT.L": {
        "short_name": "AMRYT PHARMA PLC ORD 6P",
        "long_name": "Amryt Pharma plc",
        "summary": "Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy. It also develops FILSUVEZ drug candidate, which is in Phase 3 EASE trial for the treatment of severe epidermolysis bullosa (EB), a rare and genetic skin disease; and AP103 that is in preclinical stage for the treatment of patients with recessive dystrophic EB, a subset of EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "Ireland",
        "state": null,
        "city": "Dublin",
        "zipcode": "4",
        "website": "http://www.amrytpharma.com",
        "market_cap": null
    },
    "AMYT": {
        "short_name": "Amryt Pharma plc",
        "long_name": "Amryt Pharma plc",
        "summary": "Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy. It also develops FILSUVEZ drug candidate, which is in Phase 3 EASE trial for the treatment of severe epidermolysis bullosa (EB), a rare and genetic skin disease; and AP103 that is in preclinical stage for the treatment of patients with recessive dystrophic EB, a subset of EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Ireland",
        "state": null,
        "city": "Dublin",
        "zipcode": "4",
        "website": "http://www.amrytpharma.com",
        "market_cap": "Small Cap"
    },
    "ANAS": {
        "short_name": "ALTERNATURALS INC",
        "long_name": "Alternaturals, Inc.",
        "summary": "Alternaturals, Inc. manufactures and distributes supplements and all-natural remedies that are alternatives to prescription drugs. Its products include Focamine, an all-natural focus, attention, and concentration promoter for people suffering from ADHD; and Sombium, an alternative sleep aid. The company was formerly known as Premier Mortgage Resources, Inc. and changed its name to Alternaturals, Inc. in May 2014. The company was founded in 1995 and is based in Grandville, Michigan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "New Windsor",
        "zipcode": "12553",
        "website": "http://alternaturals.com",
        "market_cap": "Nano Cap"
    },
    "ANIP": {
        "short_name": "ANI Pharmaceuticals, Inc.",
        "long_name": "ANI Pharmaceuticals, Inc.",
        "summary": "ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "MN",
        "city": "Baudette",
        "zipcode": "56623",
        "website": "http://www.anipharmaceuticals.com",
        "market_cap": "Small Cap"
    },
    "ANP.AX": {
        "short_name": "ANTISENSE FPO",
        "long_name": "Antisense Therapeutics Limited",
        "summary": "Antisense Therapeutics Limited, a biopharmaceutical company, engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d that has completed Phase IIa for the treatment of multiple sclerosis, Duchennes Muscular Dystrophy, multiple sclerosis, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Therapeutics Limited is based in Toorak, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Toorak",
        "zipcode": "3142",
        "website": "http://www.antisense.com.au",
        "market_cap": "Micro Cap"
    },
    "ANTCF": {
        "short_name": "AION THERAPEUTIC INC",
        "long_name": "Aion Therapeutic Inc.",
        "summary": "Aion Therapeutic Inc. researches, grows, harvests, and markets medical cannabis products in Canada. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was founded in 2011 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M2N 5W9",
        "website": "http://www.aiontherapeutic.com",
        "market_cap": "Nano Cap"
    },
    "AOLS": {
        "short_name": "AEOLUS PHARMACEUTICALS INC",
        "long_name": "Aeolus Pharmaceuticals, Inc.",
        "summary": "Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which is developed against the pulmonary sub-syndrome of acute radiation syndrome; and for use as a medical countermeasure for exposure to chemical vesicants and nerve agents. The company is also developing AEOL 11114B, AEOL 11203, and AEOL 11207 for the treatment of Parkinson's disease, as well as AEOL 20415 for treating infectious diseases. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Mission Viejo",
        "zipcode": "92691",
        "website": "http://www.aeoluspharma.com",
        "market_cap": "Nano Cap"
    },
    "AOXG": {
        "short_name": "AOXING PHARMACEUTICAL CO INC",
        "long_name": "Aoxing Pharmaceutical Company, Inc.",
        "summary": "Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang, China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Shijiazhuang",
        "zipcode": null,
        "website": "http://axzyen.icm.cn",
        "market_cap": "Nano Cap"
    },
    "APH.AX": {
        "short_name": "APHEMP FPO",
        "long_name": "Australian Primary Hemp Limited",
        "summary": "Australian Primary Hemp Limited manufactures and distributes hemp products under the Australian Primary Hemp brand to retail, wholesale, and white label customers in Australia. The company offers hemp seeds, cold pressed hemp oil, hemp fiber powder, hemp flour, hemp protein powder, hemp and bush balm mint hand sanitizers, hemp boost, hemp balance, and hemp and honey nut bars. It is also involved in the cultivation and production of hemp; handling various areas of hemp seed selection, farming, processing, and distribution; hemp contract packaging; and bulk and retail sale of edible hemp products. The company was founded in 2016 and is headquartered in Geelong, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Geelong",
        "zipcode": "3220",
        "website": "http://www.ausprimaryhemp.com.au",
        "market_cap": "Nano Cap"
    },
    "APH.L": {
        "short_name": "ALLIANCE PHARMA PLC ORD 1P",
        "long_name": "Alliance Pharma plc",
        "summary": "Alliance Pharma plc operates as a pharmaceutical company in the United Kingdom, Republic of Ireland, Mainland Europe, the United States, and internationally. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It owns or licenses the rights to approximately 80 pharmaceutical and consumer healthcare products. The company also offers medical devices, food supplements, and cosmetics. In addition, the company provides its products under the Kelo-Cote, Nizoral, MacuShield, Vamousse, Flamma Franchise, Aloclair, Hydromol, Forceval, Optiflo, Oxyplastine, Ashton & Parsons, and Ametop brand names. Alliance Pharma plc was founded in 1996 and is headquartered in Chippenham, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Chippenham",
        "zipcode": "SN15 2BB",
        "website": "http://www.alliancepharmaceuticals.com",
        "market_cap": null
    },
    "APHA": {
        "short_name": "Aphria Inc.",
        "long_name": "Tilray, Inc.",
        "summary": "Tilray Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The company offers cannabis-lifestyle and consumer packaged goods; and hemp-based foods and alcoholic beverages. It offers medical cannabis in extracts and dried flower forms; and cannabis extracts, including purified oil drops and capsules. The company supplies cannabis extract products to patients, physicians, pharmacies, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company was formerly known as Aphria Inc. and changed its name to Tilray, Inc. Tilray Inc. is based in Leamington, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Leamington",
        "zipcode": "N8H 1M8",
        "website": "http://www.tilray.com",
        "market_cap": "Mid Cap"
    },
    "APHA.TO": {
        "short_name": "APHRIA INC",
        "long_name": "Aphria Inc.",
        "summary": "Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Leamington",
        "zipcode": "N8H 1M8",
        "website": "http://aphriainc.com",
        "market_cap": "Mid Cap"
    },
    "APLLTD.NS": {
        "short_name": "ALEMBIC PHARMACEUT",
        "long_name": "Alembic Pharmaceuticals Limited",
        "summary": "Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (API) and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardio-diabetic, gynecology, acute, gastroenterology, ophthalmology, dermatology, urology, orthopedics, cancer, inflammation, autoimmune diseases, anti-infective, cold and cough, and metabolic disorders, as well as hospital care and animal health. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Vadodara",
        "zipcode": "390003",
        "website": "http://www.alembicpharmaceuticals.com",
        "market_cap": "Mid Cap"
    },
    "APN.JO": {
        "short_name": "Aspen Pharmacare Hldgs Ltd",
        "long_name": "Aspen Pharmacare Holdings Limited",
        "summary": "Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anaesthetics and muscle relaxants under the Anaesthetics brand; cytotoxic medicines under the Regional brand; and injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It is also involved in the contract and supply of chemical and biochemical active pharmaceutical ingredients and finished dose form pharmaceuticals for third parties. The company offers products in the form of oral solid dose, injectables, liquids, semi-solids, steriles, biologicals, and active pharmaceutical ingredients. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.",
        "currency": "ZAc",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JNB",
        "market": "za_market",
        "country": "South Africa",
        "state": null,
        "city": "Durban",
        "zipcode": null,
        "website": "http://www.aspenpharma.com",
        "market_cap": null
    },
    "APNHF": {
        "short_name": "ASPEN PHARMACARE HLDGS",
        "long_name": "Aspen Pharmacare Holdings Limited",
        "summary": "Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anaesthetics and muscle relaxants under the Anaesthetics brand; cytotoxic medicines under the Regional brand; and injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It is also involved in the contract and supply of chemical and biochemical active pharmaceutical ingredients and finished dose form pharmaceuticals for third parties. The company offers products in the form of oral solid dose, injectables, liquids, semi-solids, steriles, biologicals, and active pharmaceutical ingredients. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "South Africa",
        "state": null,
        "city": "Durban",
        "zipcode": null,
        "website": "http://www.aspenpharma.com",
        "market_cap": "Mid Cap"
    },
    "APNHY": {
        "short_name": "ASPEN PHARMACARE HLDGS",
        "long_name": "Aspen Pharmacare Holdings Limited",
        "summary": "Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anaesthetics and muscle relaxants under the Anaesthetics brand; cytotoxic medicines under the Regional brand; and injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It is also involved in the contract and supply of chemical and biochemical active pharmaceutical ingredients and finished dose form pharmaceuticals for third parties. The company offers products in the form of oral solid dose, injectables, liquids, semi-solids, steriles, biologicals, and active pharmaceutical ingredients. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "South Africa",
        "state": null,
        "city": "Durban",
        "zipcode": null,
        "website": "http://www.aspenpharma.com",
        "market_cap": "Mid Cap"
    },
    "APPB": {
        "short_name": "APPLIED BIOSCIENCES CORP",
        "long_name": "Applied Biosciences Corp.",
        "summary": "Applied Biosciences Corp. focuses on the development and commercialization of novel, synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It is focused on investment and partnership opportunities under the Applied BioSciences brand in the medical, scientific, nutraceutical, and health and wellness markets. The company also produces health and wellness products, including creams, balms, tinctures, concentrates, and edibles under the Remedi, Remedi Plus, Herbal Pet, MTN CBD, Champ Organics, and Equine Care names. It focuses on various areas of the medical, scientific, bioceutical, hemp, and CBD industry. In addition, the company provides lab testing services. It delivers consumer and OTC THC-free CBD products to its customers in the United States and internationally. Applied Biosciences Corp. was incorporated in 2014 and is based in New York, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10022",
        "website": "http://www.appliedbiocorp.com",
        "market_cap": "Nano Cap"
    },
    "AQS.V": {
        "short_name": "AEQUUS PHARMACEUTICALS INC",
        "long_name": "Aequus Pharmaceuticals Inc.",
        "summary": "Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistitan, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Tacrolimus IR, an immunosuppressant for the treatment and prevention of acute rejection following organ transplantation; Evolve dry eye products for various symptoms involved with dry eye disease and blepharitis, including discomfort, stinging, burning, and dryness; and preservative free ophthalmic product. Its development stage product includes Topiramate XR and Oxcarbazepine XR extended-release oral tablets for the treatment of epilepsy; AQS1303, a transdermal pyridoxine/doxylamine for the treatment of nausea and vomiting of pregnancy; and AQS1304, a cannabinoid-based therapeutics for neurological disorders. The company has collaboration agreements with Sandoz Canada, Inc. for the promotion of Vistitan; Supernus Pharmaceuticals, Inc. for marketing of extended-release anti-epileptic drugs; and Medicom Healthcare Ltd. to focus on preservative free therapies in ophthalmology. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1S4",
        "website": "http://www.aequuspharma.ca",
        "market_cap": "Nano Cap"
    },
    "AQST": {
        "short_name": "Aquestive Therapeutics, Inc.",
        "long_name": "Aquestive Therapeutics, Inc.",
        "summary": "Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "Warren",
        "zipcode": "07059",
        "website": "http://www.aquestive.com",
        "market_cap": "Micro Cap"
    },
    "AQSZF": {
        "short_name": "AEQUUS PHARMACEUTICALS INC",
        "long_name": "Aequus Pharmaceuticals Inc.",
        "summary": "Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistitan, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Tacrolimus IR, an immunosuppressant for the treatment and prevention of acute rejection following organ transplantation; Evolve dry eye products for various symptoms involved with dry eye disease and blepharitis, including discomfort, stinging, burning, and dryness; and preservative free ophthalmic product. Its development stage product includes Topiramate XR and Oxcarbazepine XR extended-release oral tablets for the treatment of epilepsy; AQS1303, a transdermal pyridoxine/doxylamine for the treatment of nausea and vomiting of pregnancy; and AQS1304, a cannabinoid-based therapeutics for neurological disorders. The company has collaboration agreements with Sandoz Canada, Inc. for the promotion of Vistitan; Supernus Pharmaceuticals, Inc. for marketing of extended-release anti-epileptic drugs; and Medicom Healthcare Ltd. to focus on preservative free therapies in ophthalmology. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1S4",
        "website": "http://www.aequuspharma.ca",
        "market_cap": "Nano Cap"
    },
    "ARAH.F": {
        "short_name": "ALEAFIA HEALTH INC.",
        "long_name": "Aleafia Health Inc.",
        "summary": "Aleafia Health Inc. operates as an integrated cannabis health and wellness services company in Canada and internationally. It produces a portfolio of products, including dried flower and pre-rolls, as well as oil drops and capsules, oral sprays, and cannabis-infused sublingual strips. The company offers its products under the Kin Slips, Emblem, and Symbl brands. It also operates a network of 25 medical cannabis clinics under the Canabo Clinics brand name; and education centers. The company was incorporated in 2007 and is headquartered in Concord, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Concord",
        "zipcode": "L4K 1G4",
        "website": "http://www.aleafiahealth.com",
        "market_cap": "Micro Cap"
    },
    "AREV.CN": {
        "short_name": "AREVNanoTec",
        "long_name": "AREV NanoTec Brands Inc.",
        "summary": "AREV NanoTec Brands Inc., an integrated cannabis company, produces and delivers functional compounds and ingredients in Canada. The company's ingredients and formulations are used in products that are targeted for sale in the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical markets. Its products addresses the areas of health, which include anxiety, pain management, insomnia, central nervous system, and disorders and libido. The company was formerly known as AREV Brands International Ltd. and changed its name to AREV NanoTec Brands Inc. in March 2020. AREV NanoTec Brands Inc. was incorporated in 2005 and is based in Coquitlam, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Coquitlam",
        "zipcode": "V3K 6R2",
        "website": "http://www.arevbrands.com",
        "market_cap": "Nano Cap"
    },
    "AREVF": {
        "short_name": "AREV NANOTEC BRANDS INC",
        "long_name": "AREV NanoTec Brands Inc.",
        "summary": "AREV NanoTec Brands Inc., an integrated cannabis company, produces and delivers functional compounds and ingredients in Canada. The company's ingredients and formulations are used in products that are targeted for sale in the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical markets. Its products addresses the areas of health, which include anxiety, pain management, insomnia, central nervous system, and disorders and libido. The company was formerly known as AREV Brands International Ltd. and changed its name to AREV NanoTec Brands Inc. in March 2020. AREV NanoTec Brands Inc. was incorporated in 2005 and is based in Coquitlam, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Coquitlam",
        "zipcode": "V3K 6R2",
        "website": "http://www.arevbrands.com",
        "market_cap": "Nano Cap"
    },
    "ASC.JO": {
        "short_name": "Ascendis Health Ltd",
        "long_name": "Ascendis Health Limited",
        "summary": "Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa, Cyprus, Spain, Hungary, Romania, and internationally. It operates through Consumer Health, Pharma, and Medical segments. The company offers body and skin products, as well as over-the-counter, and complementary and alternative consumer products; and supplies medical devices and consumables. It also exports its products to approximately 171 countries. Ascendis Health Limited was founded in 2008 and is based in Johannesburg, South Africa.",
        "currency": "ZAc",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JNB",
        "market": "za_market",
        "country": "South Africa",
        "state": null,
        "city": "Johannesburg",
        "zipcode": "2191",
        "website": "http://www.ascendishealth.com",
        "market_cap": null
    },
    "ASIA.CN": {
        "short_name": "AsiaGrBiotech",
        "long_name": "Asia Green Biotechnology Corp.",
        "summary": "Asia Green Biotechnology Corp., an early stage international agri-technology company, focuses on the development, evaluation, testing, application, and supply of products derived from proprietary organic hybridization technology in Asia. It focuses on planting, growing, and harvesting new and valuable strains of hemp and related crops. Asia Green Biotechnology Corp. has an agreement with Pathway Rx Inc. and PNW Biosciences Inc. for the clinical development and commercialization of the cannabis sativa varieties for prevention and treatment of COVID-19 and other infectious diseases. The company was formerly known as Asia Cannabis Corp. and changed its name to Asia Green Biotechnology Corp. in April 2020. The company was incorporated in 2017 and is based in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2N 3E5",
        "website": "http://www.asiagreenbiotechnology.com",
        "market_cap": "Nano Cap"
    },
    "ASP.TO": {
        "short_name": "ACERUS PHARMACEUTICALS CORP",
        "long_name": "Acerus Pharmaceuticals Corporation",
        "summary": "Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Elegant vaginal moisturizer, which provides comfort to women suffering from vaginal dryness; and Elegant pH, a pH balanced vaginal product; and Tefina, a clinical stage product for women with female sexual dysfunction. In addition, the company provides TriVair technology platform for pulmonary and nasal dosing. Acerus Pharmaceuticals Corporation sells products through its salesforce in the United States; and through a network of distributors internationally. The company was formerly known as Trimel Pharmaceuticals Corporation and changed its name to Acerus Pharmaceuticals Corporation in September 2015. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5L 1J9",
        "website": "http://www.aceruspharma.com",
        "market_cap": "Micro Cap"
    },
    "ASPCF": {
        "short_name": "ACERUS PHARMACEUTICALS CORP",
        "long_name": "Acerus Pharmaceuticals Corporation",
        "summary": "Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Elegant vaginal moisturizer, which provides comfort to women suffering from vaginal dryness; and Elegant pH, a pH balanced vaginal product; and Tefina, a clinical stage product for women with female sexual dysfunction. In addition, the company provides TriVair technology platform for pulmonary and nasal dosing. Acerus Pharmaceuticals Corporation sells products through its salesforce in the United States; and through a network of distributors internationally. The company was formerly known as Trimel Pharmaceuticals Corporation and changed its name to Acerus Pharmaceuticals Corporation in September 2015. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5L 1J9",
        "website": "http://www.aceruspharma.com",
        "market_cap": "Micro Cap"
    },
    "ASRT": {
        "short_name": "Assertio Holdings, Inc.",
        "long_name": "Assertio Holdings, Inc.",
        "summary": "Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. The company's pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; moderate to severe ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, an NSAID for relief of mild to moderate acute pain; and SPRIX, an NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "IL",
        "city": "Lake Forest",
        "zipcode": "60045",
        "website": "http://www.assertiotx.com",
        "market_cap": "Micro Cap"
    },
    "ASTRAZEN.NS": {
        "short_name": "ASTREZENECA PHARMA",
        "long_name": "AstraZeneca Pharma India Limited",
        "summary": "AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and distributes pharmaceutical products in India and internationally. It manufactures and sells medicines under the Brilinta, Axcer, Forxiga, Oxra, Gledepa, Xigduo, Symbicort, Onglyza, Kombiglyze, Tagrisso, Lynparza, Zoladex, QTERN, and Imfinzi brand names. The company offers products in the areas of cardiovascular, renal, metabolic, oncology, antidiabetic, respiratory, inflammation, and autoimmunity diseases. It also provides clinical trial services. The company was founded in 1979 and is headquartered in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Bengaluru",
        "zipcode": "560045",
        "website": "http://www.astrazeneca.com/india",
        "market_cap": "Small Cap"
    },
    "ASZ1.F": {
        "short_name": "ALIMERA SCIENCES  DL-,01",
        "long_name": "Alimera Sciences, Inc.",
        "summary": "Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "GA",
        "city": "Alpharetta",
        "zipcode": "30005",
        "website": "http://www.alimerasciences.com",
        "market_cap": "Micro Cap"
    },
    "ATHJF": {
        "short_name": "ANTISENSE THERAPEUTICS",
        "long_name": "Antisense Therapeutics Limited",
        "summary": "Antisense Therapeutics Limited, a biopharmaceutical company, engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d that has completed Phase IIa for the treatment of multiple sclerosis, Duchennes Muscular Dystrophy, multiple sclerosis, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Therapeutics Limited is based in Toorak, Australia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Toorak",
        "zipcode": "3142",
        "website": "http://www.antisense.com.au",
        "market_cap": "Micro Cap"
    },
    "ATNX": {
        "short_name": "Athenex, Inc.",
        "long_name": "Athenex, Inc.",
        "summary": "Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral Paclitaxel, an oral dosage form, which is in Phase III trial for metastatic breast cancer, as well as various clinical studies in advanced malignancies and gastric cancer; and Oral Irinotecan and Encequidar, a potent anticancer drug that is in a Phase I study for the treatment of metastatic colorectal cancer, glioblastoma, lung, ovarian, cervical, upper gastrointestinal, and pancreatic cancer. Its Orascovery product candidates also comprise Oral Docetaxel and Encequidar, a potent anticancer drug, which is in Phase I clinical study for breast, lung, prostate, gastric, and head and neck cancers; Oral Topotecan and Encequidar, a potent anticancer drug that is Phase I clinical trial to treat lung, ovarian, and cervical cancer; and Oral Eribulin and Encequidar, an anticancer intravenous drug to treat certain patients with breast cancer and liposarcoma. In addition, the company offers Src Kinase product candidates comprising Tirbanibulin ointments for actinic keratosis, skin cancers, and psoriasis; Tirbanibulin Oral for solid and liquid tumors; and KX2-361 for glioblastoma multiforme. Further, it is developing dual absorption enhancers to inhibit the P-gp transporter and the cytochrome P450 enzymes within the gastrointestinal tract; T Cell Receptor Engineered T Cell, a cell-based immunotherapy; and PT01 (Pegtomarginase), an arginine deprivation therapy product. The company was formerly known as Kinex Pharmaceuticals LLC and changed its name to Athenex, Inc. in August 2015. Athenex, Inc. was incorporated in 2003 and is headquartered in Buffalo, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "Buffalo",
        "zipcode": "14203",
        "website": "http://www.athenex.com",
        "market_cap": "Small Cap"
    },
    "ATTBF": {
        "short_name": "ABATTIS BIOCEUTICALS CORP",
        "long_name": "Abattis Bioceuticals Corp.",
        "summary": "Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2M6",
        "website": "http://www.abattis.com",
        "market_cap": "Nano Cap"
    },
    "AUROPHARMA.NS": {
        "short_name": "AUROBINDO PHARMA",
        "long_name": "Aurobindo Pharma Limited",
        "summary": "Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of various pharmaceutical products in India. The company primarily offers oral solids, injectables, over the counter drugs, and dietary supplements, as well as active pharmaceutical ingredients and finished dosage forms for central nervous system, cardiovascular, anti-retroviral, anti-diabetics, anti-allergies, gastroenterology, antibiotics, dermatology, respiratory, and oncology, as well as specialty generic formulations. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, transdermal patches, inhalers, vaccines, and depot injections. The company also exports its products to approximately 155 countries. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine UB-612 for India and UNICEF. Aurobindo Pharma Limited was founded in 1986 and is headquartered in Hyderabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Hyderabad",
        "zipcode": "500084",
        "website": "http://www.aurobindo.com",
        "market_cap": "Mid Cap"
    },
    "AUSA.CN": {
        "short_name": "AustralisCap",
        "long_name": "Australis Capital Inc.",
        "summary": "Australis Capital Inc. is a venture capital specializing in early-stage but not limited to equity positions and/or debt in both public and private companies, financings in exchange for royalties or other distribution streams, and control share acquisitions and buyouts. It seeks to identify and invest in United States and abroad in cannabis and real estate assets. Australis Capital Inc. is based in Las Vegas, Nevada and additional offices in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89119",
        "website": "http://www.ausa-corp.com/",
        "market_cap": "Nano Cap"
    },
    "AUSAF": {
        "short_name": "AUSTRALIS CAP INC",
        "long_name": "Australis Capital Inc.",
        "summary": "Australis Capital Inc. is a venture capital specializing in early-stage but not limited to equity positions and/or debt in both public and private companies, financings in exchange for royalties or other distribution streams, and control share acquisitions and buyouts. It seeks to identify and invest in United States and abroad in cannabis and real estate assets. Australis Capital Inc. is based in Las Vegas, Nevada and additional offices in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89119",
        "website": "http://www.ausa-corp.com/",
        "market_cap": "Nano Cap"
    },
    "AVCN.TO": {
        "short_name": "AVICANNA INC",
        "long_name": "Avicanna Inc.",
        "summary": "Avicanna Inc., a biopharmaceutical company, focuses on the research, development, cultivation, manufacture, and commercialization of plant-derived cannabinoid-based products and extracts for the use in medical, consumer health, and pharmaceutical industries internationally. The company provides pharmaceutical grade cannabinoids, including tetrahydrocannabinol (THC), cannabidiol (CBD), cannabigerol (CBG), and other rare cannabinoids; active pharmaceutical ingredients (APIs); feminized seeds; and bulk formulations under the Aureus Santa Marta brand. It also offers CBD based derma-cosmetic consumer products, such as beauty treatment, moisture and protection, and specialized care products under the Pura Earth brand; and medical cannabis/phyto-therapeutic products for the medical or homeopathic use under the Rho Phyto brand. In addition, the company provides pharmaceutical products focusing on skin disorders, including epidermolysis bullosa, eczema, and general skin problems comprising acne, erythema, and dryness; and neurological disorders, such as neuropathic pain, epilepsy, Parkinson's disease and multiple sclerosis, and nociceptive pain resulting from inflammatory and joint disorders, as well as a topical cream for rare genetic skin disorders. Avicanna has research collaboration with Dr. Christine Allen'sResearch Group for the development of a cannabinoid-based pharmaceutical for the treatment of COVID-19 induced lung inflammation. Avicanna Inc.was founded in 2016 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5G 1V2",
        "website": "http://www.avicanna.com",
        "market_cap": "Nano Cap"
    },
    "AVCNF": {
        "short_name": "AVICANNA INC",
        "long_name": "Avicanna Inc.",
        "summary": "Avicanna Inc., a biopharmaceutical company, focuses on the research, development, cultivation, manufacture, and commercialization of plant-derived cannabinoid-based products and extracts for the use in medical, consumer health, and pharmaceutical industries internationally. The company provides pharmaceutical grade cannabinoids, including tetrahydrocannabinol (THC), cannabidiol (CBD), cannabigerol (CBG), and other rare cannabinoids; active pharmaceutical ingredients (APIs); feminized seeds; and bulk formulations under the Aureus Santa Marta brand. It also offers CBD based derma-cosmetic consumer products, such as beauty treatment, moisture and protection, and specialized care products under the Pura Earth brand; and medical cannabis/phyto-therapeutic products for the medical or homeopathic use under the Rho Phyto brand. In addition, the company provides pharmaceutical products focusing on skin disorders, including epidermolysis bullosa, eczema, and general skin problems comprising acne, erythema, and dryness; and neurological disorders, such as neuropathic pain, epilepsy, Parkinson's disease and multiple sclerosis, and nociceptive pain resulting from inflammatory and joint disorders, as well as a topical cream for rare genetic skin disorders. Avicanna has research collaboration with Dr. Christine Allen'sResearch Group for the development of a cannabinoid-based pharmaceutical for the treatment of COVID-19 induced lung inflammation. Avicanna Inc.was founded in 2016 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5G 1V2",
        "website": "http://www.avicanna.com",
        "market_cap": "Nano Cap"
    },
    "AVDL": {
        "short_name": "Avadel Pharmaceuticals plc",
        "long_name": "Avadel Pharmaceuticals plc",
        "summary": "Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. The company's lead product candidate is FT218, a formulation of sodium oxybate which is in a Phase 3 clinical trial for the treatment excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Ireland",
        "state": null,
        "city": "Dublin",
        "zipcode": "2",
        "website": "http://www.avadel.com",
        "market_cap": "Small Cap"
    },
    "AWK1.F": {
        "short_name": "AVADEL PHARM. SPONS.ADR/1",
        "long_name": "Avadel Pharmaceuticals plc",
        "summary": "Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. The company's lead product candidate is FT218, a formulation of sodium oxybate which is in a Phase 3 clinical trial for the treatment excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Ireland",
        "state": null,
        "city": "Dublin",
        "zipcode": "2",
        "website": "http://www.avadel.com",
        "market_cap": "Small Cap"
    },
    "AWY.F": {
        "short_name": "ANTISENSE THERAPEUTICS",
        "long_name": "Antisense Therapeutics Limited",
        "summary": "Antisense Therapeutics Limited, a biopharmaceutical company, engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d that has completed Phase IIa for the treatment of multiple sclerosis, Duchennes Muscular Dystrophy, multiple sclerosis, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Therapeutics Limited is based in Toorak, Australia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Toorak",
        "zipcode": "3142",
        "website": "http://www.antisense.com.au",
        "market_cap": "Micro Cap"
    },
    "AXRX": {
        "short_name": "AMEXDRUG CORPORATION",
        "long_name": "Amexdrug Corporation",
        "summary": "Amexdrug Corporation, a pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. It is also involved in the research, development, manufacture, and sale of pharmaceutical drugs, cosmetics, and medical devices. The company operates in two segments, Distribution and Health and Beauty Products. In addition, it engages in the distribution of prescription and over-the-counter drugs, non-drug products, and health and beauty products; and private manufacturing and labeling activities. Further, the company manufactures and sells facial and body creams, arthritic pain relief medications, and hair and nail care products to pharmacies, beauty salons, beauty supply stores, and other fine shops. Amexdrug Corporation markets its products under the Sponix name. The company distributes its products through its subsidiaries primarily to independent pharmacies and secondarily to small-sized pharmacy chains, alternative care facilities, and other wholesalers and retailers in the state of California. The company was formerly known as Harlyn Products, Inc. and changed its name to Amexdrug Corporation in April 2000 to reflect the change in its business to the sale of pharmaceutical products. Amexdrug Corporation was founded in 1963 and is based in Commerce, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Commerce",
        "zipcode": "90040",
        "website": "http://www.amexdrug.com",
        "market_cap": "Nano Cap"
    },
    "AYR-A.CN": {
        "short_name": "Ayr Wellness",
        "long_name": "Ayr Wellness Inc.",
        "summary": "Ayr Wellness Inc., a vertically-integrated cannabis multi-state operator, cultivates, extracts, manufactures, distributes, and retails cannabis products and branded cannabis packaged goods. The company's cannabis and cannabis products include concentrates, edibles, and vaporizer products. It also provides administrative, consulting, and operations support services to licensed cannabis companies. In addition, Ayr Wellness Inc. operates medical retail dispensaries. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in New York, New York.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10022",
        "website": "http://www.ayrwellness.com",
        "market_cap": "Small Cap"
    },
    "AYRWF": {
        "short_name": "AYR WELLNESS INC",
        "long_name": "Ayr Wellness Inc.",
        "summary": "Ayr Wellness Inc., a vertically-integrated cannabis multi-state operator, cultivates, extracts, manufactures, distributes, and retails cannabis products and branded cannabis packaged goods. The company's cannabis and cannabis products include concentrates, edibles, and vaporizer products. It also provides administrative, consulting, and operations support services to licensed cannabis companies. In addition, Ayr Wellness Inc. operates medical retail dispensaries. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in New York, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10022",
        "website": "http://www.ayrwellness.com",
        "market_cap": "Small Cap"
    },
    "AYUR.CN": {
        "short_name": "AyurcannHolding",
        "long_name": "Ayurcann Holdings Corp.",
        "summary": "Ayurcann Inc. offers customized post-harvest outsourcing solutions to licensed cannabis producers. It offers end-to-end full outsourcing solutions, including extraction, refinement, formulation, packaging, fulfillment, and distribution. The company was founded in 2018 and is based in Thornhill, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Thornhill",
        "zipcode": "L4J 2L1",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "B6E.F": {
        "short_name": "SWEDISH ORPHAN BIOVIT.SK1",
        "long_name": "Swedish Orphan Biovitrum AB (publ)",
        "summary": "Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin associated periodic syndrome, rheumatoid arthritis, and still's disease; Orfadin to treat hereditary tyrosinaemia type-1; and Synagis for serious lower respiratory tract infection. The company It also provides other products, such as Akynzeo, Aloxi, Ammonul, Betapred, Caphosol, Fibclot, IVheBex, and Willfact. In addition, it develops drug substance for ReFacto AF/Xyntha for Pfizer; BIVV001 for haemophilia A; and Nirsevimab for respiratory syncytial virus. The company has a strategic collaboration with Apellis Pharmaceuticals Inc. to develop pegcetacoplan for the treatment of multiple rare diseases, including paroxysmal nocturnal hemoglobinuria. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Solna",
        "zipcode": "112 76",
        "website": "http://www.sobi.com",
        "market_cap": "Mid Cap"
    },
    "BAFNAPH.NS": {
        "short_name": "Bafna Pharmaceuticals Ltd",
        "long_name": "Bafna Pharmaceuticals Limited",
        "summary": "Bafna Pharmaceuticals Limited manufactures and sells generic pharmaceutical products in India. It also exports its products. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Chennai",
        "zipcode": "600001",
        "website": "http://www.bafnapharma.com",
        "market_cap": "Nano Cap"
    },
    "BALPHARMA.NS": {
        "short_name": "BAL PHARMA",
        "long_name": "Bal Pharma Limited",
        "summary": "Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; and cardiac care products under the Secremet and Servace brands. The company also offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, etc.; and various formulations. In addition, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company exports its products to Europe, Latin America, Africa, the Far East, the Middle East, and internationally. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Bengaluru",
        "zipcode": "560052",
        "website": "http://www.balpharma.com",
        "market_cap": "Nano Cap"
    },
    "BAMM.CN": {
        "short_name": "BodyandMindInc",
        "long_name": "Body and Mind Inc.",
        "summary": "Body and Mind Inc. cultivates, produces, processes, distributes, and retails medical and recreational cannabis in Nevada, California, Arkansas, and Ohio. The company offers packaged and grinded flower buds; concentrates; disposable pen vaporizers; distillate oil cartridges; and distillate infused edible products. It produces and sells cannabis flowers, oil extracts, and edibles under the Body and Mind brand name. The company also operates ShowGrow San Diego dispensary; and manages ShowGrow Long Beach dispensary. In addition, it is involved in the production of marijuana extract products, such as distillate oils, ice waxes, dry sifts, shatters, edibles, and topicals. The company was formerly known as Deploy Technologies Inc. and changed its name to Body and Mind Inc. in November 2017. Body and Mind Inc. was founded in 1998 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2M6",
        "website": "http://www.bamcannabis.com",
        "market_cap": "Nano Cap"
    },
    "BBM.CN": {
        "short_name": "BlueberriesMed",
        "long_name": "Blueberries Medical Corp.",
        "summary": "Blueberries Medical Corp. engages in the growth, cultivation, development, production, and supply of medicinal cannabis and related products in Colombia. The company offers medicinal-grade cannabis oil extracts and related products. Blueberries Medical Corp. is headquartered in Bogot\u00c3\u00a1, Colombia.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Colombia",
        "state": null,
        "city": "Bogot\u00c3\u00a1",
        "zipcode": null,
        "website": "http://blueberriesmed.com",
        "market_cap": "Nano Cap"
    },
    "BBRRF": {
        "short_name": "BLUEBERRIES MEDICAL CORP",
        "long_name": "Blueberries Medical Corp.",
        "summary": "Blueberries Medical Corp. engages in the growth, cultivation, development, production, and supply of medicinal cannabis and related products in Colombia. The company offers medicinal-grade cannabis oil extracts and related products. Blueberries Medical Corp. is headquartered in Bogot\u00c3\u00a1, Colombia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Colombia",
        "state": null,
        "city": "Bogot\u00c3\u00a1",
        "zipcode": null,
        "website": "http://blueberriesmed.com",
        "market_cap": "Nano Cap"
    },
    "BBT.CN": {
        "short_name": "Benchmark Botan",
        "long_name": "Benchmark Botanics Inc.",
        "summary": "Benchmark Botanics Inc. cultivates and produces pharmaceutical grade medical and recreational cannabis. It serves the medical, pharmaceutical, and recreational markets in Canada. The company is headquartered in Richmond, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Richmond",
        "zipcode": "V7B 1C3",
        "website": "http://www.benchmarkbotanics.com",
        "market_cap": "Nano Cap"
    },
    "BBW.F": {
        "short_name": "BENCHMARK BOTANICS INC.",
        "long_name": "Benchmark Botanics Inc.",
        "summary": "Benchmark Botanics Inc. cultivates and produces pharmaceutical grade medical and recreational cannabis. It serves the medical, pharmaceutical, and recreational markets in Canada. The company is headquartered in Richmond, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Richmond",
        "zipcode": "V7B 1C3",
        "website": "http://www.benchmarkbotanics.com",
        "market_cap": "Micro Cap"
    },
    "BD5.F": {
        "short_name": "BIODELIVERY SCIE. DL-,001",
        "long_name": "BioDelivery Sciences International, Inc.",
        "summary": "BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NC",
        "city": "Raleigh",
        "zipcode": "27612",
        "website": "http://www.bdsi.com",
        "market_cap": "Small Cap"
    },
    "BDSI": {
        "short_name": "BioDelivery Sciences Internatio",
        "long_name": "BioDelivery Sciences International, Inc.",
        "summary": "BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "NC",
        "city": "Raleigh",
        "zipcode": "27612",
        "website": "http://www.bdsi.com",
        "market_cap": "Small Cap"
    },
    "BFK.SI": {
        "short_name": "Pharmesis Intl",
        "long_name": "Pharmesis International Ltd.",
        "summary": "Pharmesis International Ltd., an investment holding company, researches, develops, produces, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People's Republic of China. The company provides prescribed products and over-the-counter drugs. It offers western medicine products under the brand name of Kinna, including Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Compound Procaine hydrochloride to treat arteriosclerosi, menopausal symptoms, dyspepsia, and adynamia; Lianpushuangqing for acute inflammation; AFenKa to treat migraine, pain, headache, nasosinusitis, cold, muscle pain, menstrual pain, toothache, and arthritis; Xiao Shi Jian Pi to treat flatus, inappetency, dyspepsy, and spleen weakness; and Xiao Luo Tong for the rheumatoid arthritis and other rheumatic diseases treatment. The company also provides TCM formulated products under the Longlife brand name comprising Gulin Gansu for acute and chronic hepatitis treatment; Er Ding granules to treat jaundice, and clear heat and toxics; and Kang Gu Zeng Sheng for boosting the functions of kidney, as well as for increasing blood circulation and alleviating pain. In addition, it offers health supplement products, such as Mei Li Wei Ta to combat aging process and support bone health for women; Hao Xiu Xi to enhance sleep and regulate blood fats; Hao Zhuang Tai to regulate blood fats and fight fatique; and Qianlieman'an for promoting healthy prostate function and colon health, and supporting urinary function, as well as SHULINGHOU for the treatment of acute and chronic pharyngitis, laryngitis, sore throat, and hoarseness. Further, the company engages in the wholesale of chemical drugs, biological raw products, TCM products, antibiotics, and antibiotic agents. Pharmesis International Ltd. was founded in 1996 and is headquartered in the Chengdu, People's Republic of China.",
        "currency": "SGD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SES",
        "market": "sg_market",
        "country": "China",
        "state": null,
        "city": "Chengdu",
        "zipcode": null,
        "website": "http://www.pharmesis.com",
        "market_cap": "Nano Cap"
    },
    "BGAIF": {
        "short_name": "BIOGAIA AG",
        "long_name": "BioGaia AB (publ)",
        "summary": "BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates in Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylori\u00c2\u0096the gastric ulcer bacterium; and low bone density. The company offers its products under the brand name of BioGaia. The company was founded in 1990 and is headquartered in Stockholm, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "112 27",
        "website": "http://www.biogaia.com",
        "market_cap": "Small Cap"
    },
    "BGL.F": {
        "short_name": "BIOGAIA AB  B  SK 1",
        "long_name": "BioGaia AB (publ)",
        "summary": "BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates in Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylori\u00c2\u0096the gastric ulcer bacterium; and low bone density. The company offers its products under the brand name of BioGaia. The company was founded in 1990 and is headquartered in Stockholm, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "112 27",
        "website": "http://www.biogaia.com",
        "market_cap": "Small Cap"
    },
    "BHC": {
        "short_name": "Bausch Health Companies Inc.",
        "long_name": "Bausch Health Companies Inc.",
        "summary": "Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "Canada",
        "state": "QC",
        "city": "Laval",
        "zipcode": "H7L 4A8",
        "website": "http://www.bauschhealth.com",
        "market_cap": "Mid Cap"
    },
    "BHC.TO": {
        "short_name": "BAUSCH HEALTH COMPANIES INC",
        "long_name": "Bausch Health Companies Inc.",
        "summary": "Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "QC",
        "city": "Laval",
        "zipcode": "H7L 4A8",
        "website": "http://www.bauschhealth.com",
        "market_cap": "Large Cap"
    },
    "BHHKF": {
        "short_name": "BENCHMARK BOTANICS INC",
        "long_name": "Benchmark Botanics Inc.",
        "summary": "Benchmark Botanics Inc. cultivates and produces pharmaceutical grade medical and recreational cannabis. It serves the medical, pharmaceutical, and recreational markets in Canada. The company is headquartered in Richmond, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Richmond",
        "zipcode": "V7B 1C3",
        "website": "http://www.benchmarkbotanics.com",
        "market_cap": "Nano Cap"
    },
    "BHNG.CN": {
        "short_name": "BhangInc",
        "long_name": "Bhang Inc.",
        "summary": "Bhang Inc. operates as a cannabis consumer packaged goods brand company in the United States. Its portfolio of products include cannabis; hempderived cannabidiol; and terpene products, including chocolates, pre-rolls, vapes, gums, beverages, and gummies. The company was founded in 2010 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 3S1",
        "website": "http://www.bhangnation.com",
        "market_cap": "Nano Cap"
    },
    "BHNGF": {
        "short_name": "BHANG INC",
        "long_name": "Bhang Inc.",
        "summary": "Bhang Inc. operates as a cannabis consumer packaged goods brand company in the United States. Its portfolio of products include cannabis; hempderived cannabidiol; and terpene products, including chocolates, pre-rolls, vapes, gums, beverages, and gummies. The company was founded in 2010 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 3S1",
        "website": "http://www.bhangnation.com",
        "market_cap": "Nano Cap"
    },
    "BHSC.CN": {
        "short_name": "BioHarvestSci",
        "long_name": "BioHarvest Sciences Inc.",
        "summary": "BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the necessity to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V7X 1M8",
        "website": "http://www.bioharvest.com",
        "market_cap": "Micro Cap"
    },
    "BIEI": {
        "short_name": "PREMIER BIOMEDICAL INC",
        "long_name": "Premier Biomedical, Inc.",
        "summary": "Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "PA",
        "city": "Jackson Center",
        "zipcode": "16133",
        "website": "http://www.premierbiomedical.com",
        "market_cap": "Nano Cap"
    },
    "BILZ.CN": {
        "short_name": "IgniteIntlBr",
        "long_name": "Ignite International Brands, Ltd.",
        "summary": "Ignite International Brands, Ltd. operates in cannabis industry in the United States and Canada. It offers joints, beverages, drops, oil tinctures, topicals, pet products, and vape products under the IGNITE brand name. The company is headquartered in Vaughan, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "L4K 4B6",
        "website": "http://www.ignite.co",
        "market_cap": "Micro Cap"
    },
    "BILZF": {
        "short_name": "IGNITE INTERNATIONAL BRANDS LTD",
        "long_name": "Ignite International Brands, Ltd.",
        "summary": "Ignite International Brands, Ltd. operates in cannabis industry in the United States and Canada. It offers joints, beverages, drops, oil tinctures, topicals, pet products, and vape products under the IGNITE brand name. The company is headquartered in Vaughan, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "L4K 4B6",
        "website": "http://www.ignite.co",
        "market_cap": "Micro Cap"
    },
    "BIO.CN": {
        "short_name": "BiomeGrowInc",
        "long_name": "Biome Grow Inc.",
        "summary": "Biome Grow Inc., through its subsidiaries, cultivates, produces, and distributes cannabis at Antigonish, Nova Scotia. The company is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5G 1V2",
        "website": "http://www.biomegrow.com",
        "market_cap": "Nano Cap"
    },
    "BIOFILCHEM.NS": {
        "short_name": "BIOFIL CHEMICALS &",
        "long_name": "Biofil Chemicals and Pharmaceuticals Limited",
        "summary": "Biofil Chemicals and Pharmaceuticals Limited engages in the pharmaceutical and chemical businesses primarily in India. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic dippers and caps. It also provides job work service for manufacturing of pharmaceuticals. The company was founded in 1985 and is based in Indore, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Indore",
        "zipcode": "452015",
        "website": "http://www.biofilgroup.net",
        "market_cap": "Nano Cap"
    },
    "BIOG-B.ST": {
        "short_name": "BioGaia AB ser. B",
        "long_name": "BioGaia AB (publ)",
        "summary": "BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates in Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylori\u00c2\u0096the gastric ulcer bacterium; and low bone density. The company offers its products under the brand name of BioGaia. The company was founded in 1990 and is headquartered in Stockholm, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "112 27",
        "website": "http://www.biogaia.com",
        "market_cap": "Small Cap"
    },
    "BIOGY": {
        "short_name": "BIOGAIA AG",
        "long_name": "BioGaia AB (publ)",
        "summary": "BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates in Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylori\u00c2\u0096the gastric ulcer bacterium; and low bone density. The company offers its products under the brand name of BioGaia. The company was founded in 1990 and is headquartered in Stockholm, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "112 27",
        "website": "http://www.biogaia.com",
        "market_cap": "Small Cap"
    },
    "BIOIF": {
        "short_name": "BIOME GROW INC",
        "long_name": "Biome Grow Inc.",
        "summary": "Biome Grow Inc., through its subsidiaries, cultivates, produces, and distributes cannabis at Antigonish, Nova Scotia. The company is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5G 1V2",
        "website": "http://www.biomegrow.com",
        "market_cap": "Nano Cap"
    },
    "BIOVF": {
        "short_name": "SWEDISH ORPHAN BIOVITRUM AB",
        "long_name": "Swedish Orphan Biovitrum AB (publ)",
        "summary": "Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin associated periodic syndrome, rheumatoid arthritis, and still's disease; Orfadin to treat hereditary tyrosinaemia type-1; and Synagis for serious lower respiratory tract infection. The company It also provides other products, such as Akynzeo, Aloxi, Ammonul, Betapred, Caphosol, Fibclot, IVheBex, and Willfact. In addition, it develops drug substance for ReFacto AF/Xyntha for Pfizer; BIVV001 for haemophilia A; and Nirsevimab for respiratory syncytial virus. The company has a strategic collaboration with Apellis Pharmaceuticals Inc. to develop pegcetacoplan for the treatment of multiple rare diseases, including paroxysmal nocturnal hemoglobinuria. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "state": null,
        "city": "Solna",
        "zipcode": "112 76",
        "website": "http://www.sobi.com",
        "market_cap": "Mid Cap"
    },
    "BIOYF": {
        "short_name": "BIOSYENT INC",
        "long_name": "BioSyent Inc.",
        "summary": "BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX 150, an oral hematinic; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; and FeraMAX Pd Therapeutic 150 for the prevention and treatment of iron deficiency anemia. It also offers Cathejell, a product indicated for surface anesthesia and lubrication during various procedures, including cystoscopy, catheterization, endourethral operation, endoscopy, proctoscopy, rectoscopy, and tracheal intubation, as well as used for the symptomatic treatment of pain in connection with cystitis and urethritis;  ; Aguettant System for pre-filled syringes that are used for various injectable medications in hospital and acute care settings; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by menopause, stress, and chemotherapy; Proktis-M, a rectal suppository for the healing of the anus and rectum; and Cysview, an adjunct to white-light cystoscopy for the detection and management of non-muscle invasive papillary bladder cancer. In addition, it provides Combogesic for moderate acute pain and reduction of fever in adults; Protect-It, a non-chemical food-safe grain insecticide product used as a preventative treatment against insect infestations in stored grains; and Tibella, a hormone replacement therapy to treat vasomotor symptoms due to estrogen deficiency. The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BioSyent Inc. is headquartered in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5N 6M1",
        "website": "http://www.biosyent.com",
        "market_cap": "Micro Cap"
    },
    "BKIT": {
        "short_name": "BIOHEMP INTERNATIONAL INC",
        "long_name": "BioHemp International, Inc.",
        "summary": "BioHemp International, Inc. focuses on operating in the fast-growing consumer hemp and cannabidiol (CBD) market through a strategic rollup of CBD distributors. It focuses on the creation of distribution platform for CBD providers. The company was formerly known as Blake Insomnia Therapeutics, Inc. and changed its name to BioHemp International, Inc. in June 2019. BioHemp International, Inc. was founded in 2012 and is based in New York, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10001",
        "website": "http://www.biohempinternational.com",
        "market_cap": "Nano Cap"
    },
    "BKUH": {
        "short_name": "BAKHU HOLDINGS CORPORATION",
        "long_name": "Bakhu Holdings, Corp.",
        "summary": "Bakhu Holdings, Corp. focuses on the production, manufacturing, and sale of cannabis and byproducts in the United States, Canada, Mexico, the Caribbean, and internationally. It also focuses on cannabis-related research, teaching, and education for medical and other purposes. The company was formerly known as Planet Resources, Corp. and changed its name to Bakhu Holdings, Corp. in May 2009. Bakhu Holdings, Corp. was founded in 2008 and is based in Long Beach, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Long Beach",
        "zipcode": "90831",
        "website": "http://www.bakhuholdings.com",
        "market_cap": "Small Cap"
    },
    "BKZ.SI": {
        "short_name": "Suntar Eco-City",
        "long_name": "Suntar Eco-City Limited",
        "summary": "Suntar Eco-City Limited, an investment holding company, engages in the eco-tourism and property development activities in the People's Republic of China. It is also involved in the medical research and development activities; sale of healthcare products and nanophase materials; and provision of technical and investment consulting services. The company was formerly known as Reyphon Agriceutical Limited and changed its name to Suntar Eco-City Limited in June 2012. The company was founded in 2006 and is based in Singapore. Suntar Eco-City Limited is a subsidiary of Suntar Investment Pte. Ltd.",
        "currency": "SGD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SES",
        "market": "sg_market",
        "country": "Singapore",
        "state": null,
        "city": "Singapore",
        "zipcode": "569059",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "BLAU3.SA": {
        "short_name": "BLAU        ON      NM",
        "long_name": "Blau Farmac\u00eautica S.A.",
        "summary": "Blau Farmac\u00c3\u00aautica S.A., a pharmaceutical company, engages in the production and sale of biological medications in the United States, Colombia, Chile, Peru, Argentina, Uruguay, and Brazil. Its medications cover various therapeutic classes, such as oncology, hematology, nephrology, rheumatology, infectology, anesthesiology, intensive care, general practice, and others. The company was founded in 1987 and is based in Cotia, Brazil.",
        "currency": "BRL",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SAO",
        "market": "br_market",
        "country": "Brazil",
        "state": "SP",
        "city": "Cotia",
        "zipcode": "06705-030",
        "website": "http://www.blau.com.br",
        "market_cap": null
    },
    "BLEVF": {
        "short_name": "BELEAVE INC",
        "long_name": "Beleave Inc.",
        "summary": "Beleave Inc. operates as a medical cannabis company in Canada. The company cultivates and sells medical and recreational cannabis products. It also operates a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner. The company sells its products through operating stores and online. Beleave Inc. is headquartered in Oakville, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Oakville",
        "zipcode": "L6H 0H2",
        "website": "http://beleave.com",
        "market_cap": "Nano Cap"
    },
    "BLISSGVS.NS": {
        "short_name": "BLISS GVS PHARMA",
        "long_name": "Bliss GVS Pharma Limited",
        "summary": "Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. The company offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. It also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, the company offers therapeutic products consisting of anti-bacterial, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. It also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400072",
        "website": "http://www.blissgvs.com",
        "market_cap": "Micro Cap"
    },
    "BLLXF": {
        "short_name": "PLANTFUEL LIFE INC",
        "long_name": "PlantFuel Life Inc.",
        "summary": "Sire Bioscience Inc., together with its subsidiaries, invests in, cultivates, produces, and sells various hemp and cannabis products in Canada. It offers cannabidiol (CBD) based wellness products, oils, and edibles, as well as animal and pet related CBD products under the yumz, MEDIflower, BIONIC,FUSIONS, PURPLEK, INFUSIONS, Voila, Karma, CANNA BANANA, cancan, FUR BABY, CBDTECH, and LEAFBELIEF. The company is headquartered in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5N 6C4",
        "website": "http://www.sirebioscience.com",
        "market_cap": "Nano Cap"
    },
    "BMCS": {
        "short_name": "BIOTECH MEDICS INC",
        "long_name": "BioTech Medics, Inc.",
        "summary": "BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer. In addition, the company develops and sells nutraceutical products, such as BioBody Balance, a liquid vitamin concentrate; and BioBody Energy Spray, a caffeine and alcohol free natural vitamin energy spray. It offers its nutraceutical products through gross retail sales. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "TX",
        "city": "Southlake",
        "zipcode": "76092-0114",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "BMK.L": {
        "short_name": "BENCHMARK HOLDINGS PLC ORD 0.1P",
        "long_name": "Benchmark Holdings plc",
        "summary": "Benchmark Holdings plc, together with its subsidiaries, provides technical services, products, and specialist knowledge that support the development of food and farming industries worldwide. The company operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers salmon breeding technologies and production facilities to the harnesses industry to provide a range of genetic merit ova. The Advanced Nutrition segment manufactures and offers nutrition and health products to the aquaculture industry. The Health segment provides health products to aquaculture market. Benchmark Holdings plc was founded in 2000 and is based in Sheffield, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Sheffield",
        "zipcode": "S35 1QN",
        "website": "http://www.benchmarkplc.com",
        "market_cap": null
    },
    "BMMJ": {
        "short_name": "BODY AND MIND INC",
        "long_name": "Body and Mind Inc.",
        "summary": "Body and Mind Inc. cultivates, produces, processes, distributes, and retails medical and recreational cannabis in Nevada, California, Arkansas, and Ohio. The company offers packaged and grinded flower buds; concentrates; disposable pen vaporizers; distillate oil cartridges; and distillate infused edible products. It produces and sells cannabis flowers, oil extracts, and edibles under the Body and Mind brand name. The company also operates ShowGrow San Diego dispensary; and manages ShowGrow Long Beach dispensary. In addition, it is involved in the production of marijuana extract products, such as distillate oils, ice waxes, dry sifts, shatters, edibles, and topicals. The company was formerly known as Deploy Technologies Inc. and changed its name to Body and Mind Inc. in November 2017. Body and Mind Inc. was founded in 1998 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2M6",
        "website": "http://www.bamcannabis.com",
        "market_cap": "Nano Cap"
    },
    "BNIGF": {
        "short_name": "BERONI GROUP LTD",
        "long_name": "Beroni Group Limited",
        "summary": "Beroni Group Limited, together with its subsidiaries, develops and sells smoking control products, air purifiers, water filters, cosmetics, and health care products and supplements in China and Japan. It operates through Nicobloc, Fogibloc Air Purifier, Olansi Water Filter, MRET Water Activator, Health Supplements, Cosmetic products, and Cell Therapies segments. The company's products include NicoBloc, a smoking cessation/harm reduction product; Fogibloc, an air purifier system; and lung cleansing health supplements. It also offers cosmetic products, such as V show rejuvenation liquids, hyaluronic acid moisturizing silk masks, and avocado poly-peptide intensive treatment silk masks. In addition, the company provides fruit and vegetable detoxification machines, and multifunctional dust mite controllers. Further, it offers medical drugs, health foods, supplements, cosmetic products, and household goods under Vitatreal brand and third party brands through its wholesale network to chemists, clinics, dentists, supermarkets, and other retail outlets, as well as its Website. The company has a strategic cooperation agreement with Tianjin University in China to develop a medical solution for the coronavirus. The company was founded in 2014 and is based in Tianjin, the People's Republic of China. Beroni Group Limited is a subsidiary of Beroni Technology Ltd.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Tianjin",
        "zipcode": "300380",
        "website": "http://www.beronigroup.com",
        "market_cap": "Micro Cap"
    },
    "BOI.PA": {
        "short_name": "BOIRON",
        "long_name": "Boiron SA",
        "summary": "Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat flu like symptoms, such as fever, chills, headaches, and muscle aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and S\u00c3\u00a9datif PC to treat anxiety and emotional, and minor sleep disorders. The company's branded homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Hom\u00c3\u00a9optic to treat eye discomfort and irritation due to various causes for adults and children; Hom\u00c3\u00a9ovox for vocal disorders; and Arnigel Roll-on for the treatment of benign trauma in the absence of open wounds. In addition, it provides dietary supplement; Dermoplasmine, a lip balm stick; Reformulation of the Hom\u00c3\u00a9odent; Mag' Nuit, a dietary supplement; Osmobiotic to protect from gastric acid; Boc\u00c3\u00a9al, a throat spray homeopathic medicine for moderate sore throats with no fever, mouth sores, and small mouth lesions; Cocyntal to treat colic in infants and newborns; and hand sanitizer products, as well as physiological serum used to clean children's and babies' eyes and noses. The company offers its products through distribution centers, pharmacy chains, wholesalers, drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PAR",
        "market": "fr_market",
        "country": "France",
        "state": null,
        "city": "Messimy",
        "zipcode": "69510",
        "website": "http://www.boiron.fr",
        "market_cap": "Small Cap"
    },
    "BON.F": {
        "short_name": "BOIRON SA INH.  EO 1",
        "long_name": "Boiron SA",
        "summary": "Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat flu like symptoms, such as fever, chills, headaches, and muscle aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and S\u00c3\u00a9datif PC to treat anxiety and emotional, and minor sleep disorders. The company's branded homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Hom\u00c3\u00a9optic to treat eye discomfort and irritation due to various causes for adults and children; Hom\u00c3\u00a9ovox for vocal disorders; and Arnigel Roll-on for the treatment of benign trauma in the absence of open wounds. In addition, it provides dietary supplement; Dermoplasmine, a lip balm stick; Reformulation of the Hom\u00c3\u00a9odent; Mag' Nuit, a dietary supplement; Osmobiotic to protect from gastric acid; Boc\u00c3\u00a9al, a throat spray homeopathic medicine for moderate sore throats with no fever, mouth sores, and small mouth lesions; Cocyntal to treat colic in infants and newborns; and hand sanitizer products, as well as physiological serum used to clean children's and babies' eyes and noses. The company offers its products through distribution centers, pharmacy chains, wholesalers, drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "France",
        "state": null,
        "city": "Messimy",
        "zipcode": "69510",
        "website": "http://www.boiron.fr",
        "market_cap": "Small Cap"
    },
    "BQST": {
        "short_name": "BIOQUEST CORP",
        "long_name": "BioQuest Corp.",
        "summary": "BioQuest Corp. produces and sells a range of CBD products in the retail, direct, and Internet markets in the United States. The company was formerly known as Select-TV Solutions, Inc. and changed its name to BioQuest Corp. in November 2019. BioQuest Corp. was founded in 2011 and is headquartered in Newport Beach, California. As of October 10, 2019, BioQuest Corp. operates as a subsidiary of Pillar Marketing Group, Inc.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Newport Beach",
        "zipcode": "92660",
        "website": "http://www.bioquestcorp.com",
        "market_cap": "Nano Cap"
    },
    "BR1C.F": {
        "short_name": "SIRE BIOSCIENCE INC.",
        "long_name": "PlantFuel Life Inc.",
        "summary": "Sire Bioscience Inc., together with its subsidiaries, invests in, cultivates, produces, and sells various hemp and cannabis products in Canada. It offers cannabidiol (CBD) based wellness products, oils, and edibles, as well as animal and pet related CBD products under the yumz, MEDIflower, BIONIC,FUSIONS, PURPLEK, INFUSIONS, Voila, Karma, CANNA BANANA, cancan, FUR BABY, CBDTECH, and LEAFBELIEF. The company is headquartered in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5N 6C4",
        "website": "http://www.sirebioscience.com",
        "market_cap": "Nano Cap"
    },
    "BRCK-U.CN": {
        "short_name": "BellRockBran",
        "long_name": "BellRock Brands Inc.",
        "summary": "BellRock Brands Inc. develops, markets, and sells cannabis products in the United States, Canada, and internationally. It offers cannabis infused adult-use topicals, confections, edibles, beverages, and concentrates, as well as transdermal patches, tinctures, capsules, lotions, creams, other topicals, vapes, and cosmetic serums. The company also provides branded hemp-infused products for humans and pets. Its brands include Mary's Medicinals, Mary's Nutritionals, Mary's Methods, Mary's Tails, Beezle, Dixie, Synergy, Mindset, Aceso, Therabis, D\u00c3\u00a9fonc\u00c3\u00a9, and Rebel Coast. The company was formerly known as Dixie Brands Inc. and changed its name to BellRock Brands Inc. in October 2020. BellRock Brands Inc. is headquartered in Denver, Colorado.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "CO",
        "city": "Denver",
        "zipcode": "80239",
        "website": "http://www.bellrockbrands.com",
        "market_cap": "Micro Cap"
    },
    "BROOKS.NS": {
        "short_name": "BROOKS LAB LTD",
        "long_name": "Brooks Laboratories Limited",
        "summary": "Brooks Laboratories Limited manufactures and sells pharmaceuticals on contract basis in India and internationally. The company was founded in 2002 and is based in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400093",
        "website": "http://www.brookslabs.net",
        "market_cap": "Nano Cap"
    },
    "BSFA.F": {
        "short_name": "ANI PHARMACEUT.  DL-,0001",
        "long_name": "ANI Pharmaceuticals, Inc.",
        "summary": "ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "MN",
        "city": "Baudette",
        "zipcode": "56623",
        "website": "http://www.anipharmaceuticals.com",
        "market_cap": "Small Cap"
    },
    "BSFA.SG": {
        "short_name": "ANI Pharmaceuticals Inc. Regist",
        "long_name": "ANI Pharmaceuticals, Inc.",
        "summary": "ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "United States",
        "state": "MN",
        "city": "Baudette",
        "zipcode": "56623",
        "website": "http://www.anipharmaceuticals.com",
        "market_cap": "Small Cap"
    },
    "BSPK": {
        "short_name": "BESPOKE EXCTRACTS INC",
        "long_name": "Bespoke Extracts, Inc.",
        "summary": "Bespoke Extracts, Inc. provides hemp-derived cannabidiol (CBD) products. The company offers CBD formulations, including manuka honey and in the form of lotions and balms; and markets CBD extracts in capsule form, topicals, and gummies. Bespoke Extracts, Inc. market its products as dietary supplements through its direct-to-consumers e-commerce store bespokeextracts.com. The company was formerly known as DiMi Telematics International, Inc. and changed its name to Bespoke Extracts, Inc. in March 2017. Bespoke Extracts, Inc. is headquartered in Sunny Isles Beach, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Sunny Isles Beach",
        "zipcode": "33160",
        "website": "http://www.bespokeextracts.com",
        "market_cap": "Nano Cap"
    },
    "BSPM": {
        "short_name": "Biostar Pharmaceuticals, Inc.",
        "long_name": "Biostar Pharmaceuticals, Inc.",
        "summary": "Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Xianyang",
        "zipcode": "712000",
        "website": "http://biostarpharmaceuticals.com",
        "market_cap": "Nano Cap"
    },
    "BUDZ": {
        "short_name": "WEED INC",
        "long_name": "WEED, Inc.",
        "summary": "WEED, Inc., an early stage holding company, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases primarily in the United States. The company was formerly known as United Mines, Inc. and changed its name to WEED, Inc. in February 2015. WEED, Inc. was incorporated in 1999 and is headquartered in Tucson, Arizona.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "AZ",
        "city": "Tucson",
        "zipcode": "85750",
        "website": "http://weedincusa.com",
        "market_cap": "Micro Cap"
    },
    "BUGVF": {
        "short_name": "PRIMO NUTRACEUTICALS INC",
        "long_name": "Primo Nutraceuticals Inc.",
        "summary": "Primo Nutraceuticals Inc. owns and develops commercial real estate properties for the cannabis cultivation sector in Canada. It offers built out turnkey facilities equipped with infrastructure to cannabis growers and processors. It owns hemp project in Oregon state and the greenhouse campus in Washington state. The company was formerly known as Bougainville Ventures Inc. and changed its name to Primo Nutraceuticals Inc. in October 2019. Primo Nutraceuticals Inc. was incorporated in 2014 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1J9",
        "website": "http://www.primonutraceuticals.com",
        "market_cap": "Nano Cap"
    },
    "BUZZ.CN": {
        "short_name": "Pharmadrug",
        "long_name": "Pharmadrug Inc.",
        "summary": "Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also distributes medical cannabis to pharmacies in Germany and rest of the European Union. In addition, the company engages in the adult use psychedelic retail business; and researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. The company is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5K 1H1",
        "website": "http://www.pharmadrug.co",
        "market_cap": "Nano Cap"
    },
    "BVF.F": {
        "short_name": "BAUSCH HEALTH COS.",
        "long_name": "Bausch Health Companies Inc.",
        "summary": "Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "QC",
        "city": "Laval",
        "zipcode": "H7L 4A8",
        "website": "http://www.bauschhealth.com",
        "market_cap": "Large Cap"
    },
    "BXP.L": {
        "short_name": "BEXIMCO PHARMACEUTICALS LIMITED",
        "long_name": "Beximco Pharmaceuticals Limited",
        "summary": "Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesic and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was founded in 1976 and is headquartered in Dhaka, Bangladesh.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "Bangladesh",
        "state": null,
        "city": "Dhaka",
        "zipcode": "1205",
        "website": "http://www.beximcopharma.com",
        "market_cap": null
    },
    "C1P.F": {
        "short_name": "CONSUN PHARMAC.GR.HD -,10",
        "long_name": "Consun Pharmaceutical Group Limited",
        "summary": "Consun Pharmaceutical Group Limited, an investment holding company, researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People's Republic of China. The company operates in two segments, Consun Pharmaceutical and Yulin Pharmaceutical. It offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi particles to treat proteinuria; Gadopentetate Dimeglumine injections for magnetic resonance image diagnostics of nervous centralis, stomach, chest, pelvic cavity, and extremities, as well as for renal function assessment; and Iopamidol injections used for neuroradiology, angiography, and urography. The company also provides Yuanli Kang, an iron-dextrin oral solution; Yibao Yua, an erythromycin estolate suspension; Yuantong Ning, a cetirizine hydrochloride oral solution; and Zhixueling capsules to treat hysteromyoma bleeding, prolonged lochiorrhea, intermenstrual bleeding, bleeding after use of a contraceptive ring, hemorrhoidal bleeding, and epistaxis. In addition, it offers Gyn Antidysmenorrheic tablets for the treatment of irregular menstruation, irregular period during perimenopause, and abdominal pain during menstruation due to hepatic depression and blood deficiency; and Antibacterial Fujie lotion for staphylococcus aureus, Candida albicans, and escherichia coli in the feminine vaginal. Further, the company provides bone-setting liquid; Yunxiang analgesic tincture for treatment of rheumatism, common cold, headache, stomachache, cardiodynia, and pain in gastral cavity and chilblain; Sanqi Chuangchun capsules for activating blood circulation and dispersing blood stasis; Shiduqing capsules and tablets, and Paeonol ointment for skin disease. Additionally, it offers hepatobiliary, gastroenterology, and other medicines. The company was founded in 1997 and is headquartered in Guangzhou, the People's Republic of China.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "China",
        "state": null,
        "city": "Guangzhou",
        "zipcode": null,
        "website": "http://www.chinaconsun.com",
        "market_cap": "Small Cap"
    },
    "C1S.F": {
        "short_name": "CHINA SHINEWAY PHAR.HD-10",
        "long_name": "China Shineway Pharmaceutical Group Limited",
        "summary": "China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections in various therapeutic areas, including cardio-cerebrovascular, antiviral, orthopedics, pediatrics, gynecology, neurology, gastroenterology, ophthalmology, oncology, and immunology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "China",
        "state": null,
        "city": "Shijiazhuang",
        "zipcode": "051430",
        "website": "http://www.shineway.com",
        "market_cap": "Small Cap"
    },
    "C4TA.F": {
        "short_name": "AMP ALTERNATIVE MED.PROD.",
        "long_name": "AMP Alternative Medical Products Inc.",
        "summary": "AMP Alternative Medical Products Inc., through its subsidiaries, operates in the medical cannabis industry. It imports and sells EU-GMP medical cannabis for patients in Germany. The company was formerly known as AMP German Cannabis Group Inc. and changed its name to AMP Alternative Medical Products Inc. in February 2021. AMP Alternative Medical Products Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3L2",
        "website": "http://www.amp-eu.com",
        "market_cap": "Nano Cap"
    },
    "C5G.F": {
        "short_name": "OREXO AB  SK-,40",
        "long_name": "Orexo AB (publ)",
        "summary": "Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar, for the treatment of short-term insomnia. The company's development products comprise OX124, a medication for naloxone rescue; OX125, a medication for nalmefene rescue; and OX338 sublingual tablet formulation of ketorolac for treatment of moderate to severe pain. It is also developing OX-MPI program for the treatment of microvascular diseases in chronic inflammatory conditions. The company's digital therapies comprise deprexis therapy for the treatment of mild to severe depression; vorvida for alcohol use disorder; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "754 50",
        "website": "http://www.orexo.com",
        "market_cap": "Micro Cap"
    },
    "CAAOF": {
        "short_name": "INDVR BRANDS INC",
        "long_name": "INDVR Brands Inc.",
        "summary": "INDVR Brands Inc. focuses on providing management resources, and infrastructure and equipment for the production, cultivation, and dispensary operations of licensed cannabis businesses in the United States. The company offers its products under the Cannabis, The Joint, Incognito by Cannabis, Fire by Cannabis, Cannabis Prime, Fat Face Farms, Honu, and INDVR names. The company was formerly known as Cannabis One Holdings Inc. and changed its name to INDVR Brands Inc. in August 2020. INDVR Brands Inc. is headquartered in Denver, Colorado.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CO",
        "city": "Denver",
        "zipcode": "80205",
        "website": "http://cannabisone.life",
        "market_cap": "Nano Cap"
    },
    "CADILAHC.NS": {
        "short_name": "CADILA HEALTHCARE",
        "long_name": "Cadila Healthcare Limited",
        "summary": "Cadila Healthcare Limited engages in the research, development, production, marketing, and distribution of pharmaceutical products in India, the United States, and internationally. It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; animal healthcare products; and consumer wellness products. The company offers products in the therapeutic areas of pain management, neurology, dermatology, rare diseases, specialty oncology, gastroenterology, and liver diseases. It also provides consumer wellness products, such as Sugar Free and Sugarlite; Complan; EverYuth, a range of skincare products; Nycil, a prickly heat powder; Glucon-D glucose powder; Sampriti Ghee; Nutralite; and various other products. In addition, the company is developing drugs in the areas of oncology, autoimmune disease, nephrology, ophthalmology, inflammation, rheumatology, hepatology, infectious disease, etc. Further, it offers animal healthcare products for various therapeutic areas, such as anti-bacterial, NSAIDs, anti-mastitis, tonics, and poultry vaccines. The company also engages in the retail pharmacy, and manpower supply and administration activities. Cadila Healthcare Limited was founded in 1952 and is headquartered in Ahmedabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Ahmedabad",
        "zipcode": "382481",
        "website": "http://www.zyduscadila.com",
        "market_cap": "Mid Cap"
    },
    "CADMF": {
        "short_name": "CHEMESIS INTERNATIONAL INC",
        "long_name": "Chemesis International Inc.",
        "summary": "Chemesis International Inc., together with its subsidiaries, cultivates, manufactures, distributes, and retails cannabis products in California, Puerto Rico, and Colombia. It offers various types of extractions, formulations, and products specializing in BHO extraction, alcohol extraction, and CO2 extraction. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1S4",
        "website": "http://chemesis.com",
        "market_cap": "Nano Cap"
    },
    "CALT": {
        "short_name": "Calliditas Therapeutics AB",
        "long_name": "Calliditas Therapeutics AB (publ)",
        "summary": "Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing pharmaceutical products for patients with unmet medical needs. The company's lead product candidate is Nefecon, a unique formulation optimized to combine a time lag effect with a concentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy. Calliditas Therapeutics AB (publ) also intends to take Nefecon through a global Phase 3 study to commercialization. The company was founded in 2004 and is headquartered in Stockholm, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "111 22",
        "website": "http://www.calliditas.se",
        "market_cap": "Small Cap"
    },
    "CALTX.ST": {
        "short_name": "Calliditas Therapeutics AB",
        "long_name": "Calliditas Therapeutics AB (publ)",
        "summary": "Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing pharmaceutical products for patients with unmet medical needs. The company's lead product candidate is Nefecon, a novel oral formulation of budesonide potent local immunosuppressant for the treatment of the autoimmune renal disease IgA nephropathy. Calliditas Therapeutics AB (publ) also intends to take Nefecon through a global Phase 3 study to commercialization. Calliditas Therapeutics AB (publ) was founded in 2004 and is headquartered in Stockholm, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "111 22",
        "website": "http://www.calliditas.se",
        "market_cap": "Small Cap"
    },
    "CAN.AX": {
        "short_name": "CANN GROUP FPO",
        "long_name": "Cann Group Limited",
        "summary": "Cann Group Limited engages in research and development, cultivation and production, manufacturing, clinical evaluation, processing, packaging, and distribution and supply of medicinal cannabis for various diseases and medical conditions in Australia. The company was founded in 2014 and is based in Bundoora, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Bundoora",
        "zipcode": "3083",
        "website": "http://www.canngrouplimited.com",
        "market_cap": "Micro Cap"
    },
    "CANA.CN": {
        "short_name": "CannAmBr",
        "long_name": "CannAmerica Brands Corp.",
        "summary": "CannAmerica Brands Corp. owns a portfolio of brands in the medical cannabis and recreational cannabis space with licensees in the states of Colorado, Nevada, Oklahoma, Maryland, and Massachusetts. The company primarily builds and maximizes the value of its brands by promoting, marketing, and licensing brands through various distribution channels, including dispensaries, wholesalers, and distributors. It offers sweet, sour, and sweet and sour fruit juice gummies under the CannAmerica brand. The company is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2T5",
        "website": "http://www.cannamericabrands.com",
        "market_cap": "Nano Cap"
    },
    "CANB": {
        "short_name": "CAN B CORP",
        "long_name": "Can B Corp.",
        "summary": "Can B Corp. produces and sells cannabidiol (CBD) based products in the United States. It provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, and concentrates through its Website and vending machines, and other medical professionals. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in February 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "Hicksville",
        "zipcode": "11801",
        "website": "http://canbcorp.com",
        "market_cap": "Nano Cap"
    },
    "CANB.V": {
        "short_name": "CANADABIS CAPITAL INC",
        "long_name": "CanadaBis Capital Inc.",
        "summary": "CanadaBis Capital Inc. cultivates, produces, distributes, and sells cannabis and cannabis products in Canada. The company operates through three segments: wholesale, retail, and extraction and tolling. It also engages in the sale of cannabis and cannabis related products to end consumers, as well as provides cannabinoid extraction services to other licensed producers. The company is headquartered in Red Deer County, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "AB",
        "city": "Red Deer County",
        "zipcode": "T4E 3B6",
        "website": "http://www.canadabis.com",
        "market_cap": "Nano Cap"
    },
    "CANL": {
        "short_name": "CANNLABS INC",
        "long_name": "CannLabs, Inc.",
        "summary": "CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. is based in Denver, Colorado.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CO",
        "city": "Denver",
        "zipcode": "80210",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "CANN.CN": {
        "short_name": "HeritageCanna",
        "long_name": "Heritage Cannabis Holdings Corp.",
        "summary": "Heritage Cannabis Holdings Corp., through its subsidiaries, operates as a cannabinoid company that focuses on the production and sale of medical and recreational hemp-based and cannabis-based products and services in Canada and the United States. It offers extraction services; and focuses on processing, manufacturing, and distributing medical cannabis products and cannabis oils. It provides integrative approach to cannabinoid therapy for healthcare consumers and healthcare practitioners. The company was formerly known as Umbral Energy Corp. and changed its name to Heritage Cannabis Holdings Corp. in January 2018. Heritage Cannabis Holdings Corp. was incorporated in 2007 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5S 1M2",
        "website": "http://www.heritagecann.com",
        "market_cap": "Micro Cap"
    },
    "CANQF": {
        "short_name": "CANAQUEST MEDICAL CORPORATION",
        "long_name": "CanaQuest Medical Corp.",
        "summary": "CanaQuest Medical Corp. develops health products and pharmaceuticals that utilize hemps, cannabis, and algae oils. The company was formerly known as Algae Dynamics Corp. and changed its name to CanaQuest Medical Corp. in January 2019. CanaQuest Medical Corp. was founded in 2008 and is based in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5L 5S9",
        "website": "http://canaquest.com",
        "market_cap": "Nano Cap"
    },
    "CANSF": {
        "short_name": "WILLOW BIOSCIENCES INC",
        "long_name": "Willow Biosciences Inc.",
        "summary": "Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2R 0Y6",
        "website": "http://www.willowbio.com",
        "market_cap": "Micro Cap"
    },
    "CAPLIPOINT.NS": {
        "short_name": "CAPLIN POINT LABOR",
        "long_name": "Caplin Point Laboratories Limited",
        "summary": "Caplin Point Laboratories Limited develops, manufactures, markets, and exports generic pharmaceutical formulations and branded generic products in India and internationally. It provides tablets, capsules, vials, ophthalmic products, liquid orals, soft gel capsules, ointments, creams and gels, powder for injections, suppositories and ovules, dermo cosmetics, surgicals and disposables, pre-mix bag formulations, inhalers and sprays, IV infusion products, dry syrups, topicals, and other products, as well as liquid, lyophilized, and pre-filled injection syringes. The company also operates QueTenX, an e-commerce website. Caplin Point Laboratories Limited was founded in 1990 and is based in Chennai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Chennai",
        "zipcode": "600096",
        "website": "http://www.caplinpoint.net",
        "market_cap": "Small Cap"
    },
    "CASBF": {
        "short_name": "CANSINO BIOLOGICS INC",
        "long_name": "CanSino Biologics Inc.",
        "summary": "CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides; and DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. It also develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; TB Booster for the BCG-vaccinated population; and Ad5-nCov, a recombinant novel coronavirus disease vaccine. In addition, the company is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CSB012 to treat adenovirus; CSB013 for ZIKA virus; CSB105 to treat meningitis; CSB016 for treating shingles; and CSB107 for polio. It has a collaboration with The National Research Council of Canada to advance vaccine against COVID-19; and co-development agreement with Precision NanoSystems, Inc. to develop a mRNA lipid nanoparticle vaccine against COVID-19. CanSino Biologics Inc. was founded in 2009 and is headquartered in Tianjin, the People's Republic of China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Tianjin",
        "zipcode": null,
        "website": "http://www.cansinotech.com",
        "market_cap": "Large Cap"
    },
    "CAU.AX": {
        "short_name": "CRONOS FPO",
        "long_name": "Cronos Australia Limited",
        "summary": "Cronos Australia Limited operates as a medicinal cannabis company in Australia and Asia. The company operates through Medicinal Cannabis and Clinics segments. It distributes  PEACE NATURALS brand medicinal cannabis products; develops and sells medicinal cannabis products; and operates medicinal cannabis clinics. The company was incorporated in 2018 and is headquartered in South Yarra, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "VIC",
        "city": "South Yarra",
        "zipcode": "3141",
        "website": "http://www.cronosaustralia.com",
        "market_cap": "Nano Cap"
    },
    "CAVR": {
        "short_name": "CAVU RESOURCES INC",
        "long_name": "CAVU Resources Inc.",
        "summary": "CAVU Resources, Inc. operates in the information and entertainment space in the cannabis sector. It offers SoKu (Social Kush), a gamified social chat application for legal marijuana users; and MediKu (Medical Kush), a dosage tracking application for medical marijuana patients and caregivers providing personal analysis, budget managing recommendations, and costs and daily communication for result tracking. The company was formerly known as Proxity, Inc. and changed its name to CAVU Resources, Inc. in May 2009. CAVU Resources, Inc. was founded in 1995 and is based in Las Vegas, Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89146",
        "website": "http://cavuresource.com",
        "market_cap": "Nano Cap"
    },
    "CBD-U.TO": {
        "short_name": "HEMPFUSION WELLNESS INC USD",
        "long_name": "Hempfusion Wellness Inc.",
        "summary": "Hempfusion Wellness Inc., a health and wellness supplement company, manufactures, markets, and sells hemp-based cannabidiol (CBD) and probiotic products in the United States. Its products include tinctures, capsules, and topical creams and gel products under the HempFusion brand; probiotic enzymes and digestive capsules, and topical products under the Probulin brand; and HF Labs and Biome Research branded products that are versions of its hemp extract-based and probiotic products. The company sells its products through its e-commerce websites and doctor practitioners, as well as through a various food, drug, mass, and convenience market retailers. Hempfusion Wellness Inc. was founded in 2015 and is headquartered in Denver, Colorado.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "United States",
        "state": "CO",
        "city": "Denver",
        "zipcode": "80202",
        "website": "http://www.hempfusion.com",
        "market_cap": "Micro Cap"
    },
    "CBD.NZ": {
        "short_name": "Cannasouth Limited Ordinary Sha",
        "long_name": "Cannasouth Limited",
        "summary": "Cannasouth Limited, a biopharmaceutical company, engages in the research, development, production, and supply of cannabis biomass and cannabinoid medicines in New Zealand. The company was incorporated in 2018 and is based in Hamilton, New Zealand.",
        "currency": "NZD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NZE",
        "market": "nz_market",
        "country": "New Zealand",
        "state": null,
        "city": "Hamilton",
        "zipcode": "3256",
        "website": "http://www.cannasouth.co.nz",
        "market_cap": "Nano Cap"
    },
    "CBDHF": {
        "short_name": "HEMPFUSION WELLNESS INC",
        "long_name": "Hempfusion Wellness Inc.",
        "summary": "Hempfusion Wellness Inc., a health and wellness supplement company, formulates, markets, and distributes hemp-based natural supplements and probiotic products in the United States. Its products include tinctures, capsules, and topical creams and gel products under the HempFusion brand; and digestive enzymes and probiotics, and skin care products under the Probulin brand; and HF Labs and Biome Research branded products. The company sells its products through its e-commerce websites and doctor practitioners, as well as through a various food, drug, mass, and convenience market retailers. Hempfusion Wellness Inc. is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 4N7",
        "website": "http://www.hempfusion.com",
        "market_cap": "Micro Cap"
    },
    "CBDL": {
        "short_name": "CBD LIFE SCIENCES INC",
        "long_name": "CBD Life Sciences Inc.",
        "summary": "Cre8tive Works, Inc. offers financing and services for independent entertainment projects in the United States. The company engages in financing independent media productions, including feature films, documentaries, animation, television series, Webisodes, and soundtracks; assisting independent productions with marketing and distribution; and funding and/or brokering production services (e.g. studios, post-production, software, and others). It serves independent film producers. The company was formerly known as a Rangemore Film Productions Corp. and changed its name to Cre8tive Works, Inc. in December 2013. Cre8tive Works, Inc. was founded in 2006 and is headquartered in Woodlands, Texas.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "TX",
        "city": "Woodlands",
        "zipcode": "77382",
        "website": "http://www.optiumcyber.com",
        "market_cap": "Nano Cap"
    },
    "CBDN.CN": {
        "short_name": "CBDGlobalSci",
        "long_name": "CBD Global Sciences Inc.",
        "summary": "CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers provides biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "CO",
        "city": "Lakewood",
        "zipcode": "80228",
        "website": "http://www.cbdglobalsciences.com",
        "market_cap": "Nano Cap"
    },
    "CBDNF": {
        "short_name": "CBD GLOBAL SCIENCES INC",
        "long_name": "CBD Global Sciences Inc.",
        "summary": "CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers provides biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CO",
        "city": "Lakewood",
        "zipcode": "80228",
        "website": "http://www.cbdglobalsciences.com",
        "market_cap": "Nano Cap"
    },
    "CBDS": {
        "short_name": "CANNABIS SATIVA INC",
        "long_name": "Cannabis Sativa, Inc.",
        "summary": "Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. It operates through two segments, PrestoCorp and GKMP. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology; and operates as a contract manufacturer of products containing hemp-based cannabidiol (CBD). Its products under development include Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; Lip Garden, an emollient balm; and cut cream. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; owns a patented cannabis sativa plant strain known as Ecuadorian Sativa; and owns intellectual property license for use in medical marijuana edibles and lozenges. In addition, it operates iBudtender, an application for sharing information between cannabis products, patients, and businesses. Cannabis Sativa, Inc. serves CBD and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. was incorporated in 2004 and is based in Mesquite, Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Mesquite",
        "zipcode": "89027",
        "website": "http://cannabissativainc.com",
        "market_cap": "Nano Cap"
    },
    "CBDX.CN": {
        "short_name": "CanbudDistri",
        "long_name": "Canbud Distribution Corporation",
        "summary": "Canbud Distribution Corporation produces clones of cannabis and hemp cannabinoids. It offers its products under the brands My SeeBD, My SeeBN, and My SeeBG. The company was formerly known as Cannabis Clonal Corporation. Canbud Distribution Corporation was founded in 2018 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 1T1",
        "website": "http://canbudcorp.com",
        "market_cap": null
    },
    "CBDX": {
        "short_name": "CURATIVE BIOSCIENCES INC",
        "long_name": "Curative Biosciences, Inc.",
        "summary": "Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Miami",
        "zipcode": "33131",
        "website": "http://curativebio.com",
        "market_cap": "Nano Cap"
    },
    "CBDY": {
        "short_name": "TARGET GROUP INC",
        "long_name": "Target Group Inc.",
        "summary": "Target Group Inc. cultivates, processes, and distributes curated cannabis products for the adult-use medical and recreational cannabis market in Canada. Its products include cannabis flower and extract pods for vaporizer use, cannabis pre-rolls, k-cup infused coffee and tea pods, infused cannabis beverages and edibles, infused topical products, and CBD wellness products. The company also offers Wisp, a single-use pre-measured pod and vaporizer system for consumers involved in vaporizing natural herbs, including cannabis. It has a collaboration agreement with cGreen, Inc for manufacturing and distributing the patent-pending THC antidote True Focus in the United States, Europe, and the Caribbean; and distribution, collaboration, and licensing agreement with Serious Seeds B.V. The company was formerly known as Chess Supersite Corporation and changed its name to Target Group Inc. in July 2018. Target Group Inc. was incorporated in 2013 and is based in Hamilton, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Hamilton",
        "zipcode": "L8W 2E7",
        "website": "http://www.targetgroupinc.ca",
        "market_cap": "Nano Cap"
    },
    "CBGI": {
        "short_name": "CANNABUSINESS GROUP INC",
        "long_name": "The CannaBusiness Group, Inc.",
        "summary": "The CannaBusiness Group, Inc. operates as a real estate acquisition, leasing, and management company focusing on zoning issues in the United States. The company acquires commercial property or land, and leases out the facilities for customers in the agricultural, industrial, commercial, and retail sectors. It also acquires, leases, and manages a portfolio of properties. The company was formerly known as Muscle Warfare International, Inc. and changed its name to The CannaBusiness Group, Inc. in February 2014. The CannaBusiness Group, Inc. was founded in 1985 and is based in Mission Viejo, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Mission Viejo",
        "zipcode": "92691",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "CBGL": {
        "short_name": "CANNABIS GLOBAL INC",
        "long_name": "Cannabis Global, Inc.",
        "summary": "Cannabis Global, Inc. focuses on the development and commercialization of proprietary engineered technologies to deliver hemp extracts and cannabinoids to the human body. It also provides managerial services in areas of the regulated hemp and cannabis industries. The company was formerly known as MCTC Holdings, Inc. and changed its name to Cannabis Global, Inc. in December 2019. Cannabis Global, Inc. was incorporated in 2005 and is headquartered in Los Angeles, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Los Angeles",
        "zipcode": "90071",
        "website": "http://www.cannabisglobalinc.com",
        "market_cap": "Nano Cap"
    },
    "CBIA": {
        "short_name": "CANOPUS BIOPHARMA INC",
        "long_name": "Canopus BioPharma Incorporated",
        "summary": "Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Santa Monica",
        "zipcode": "90401",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "CBJ.F": {
        "short_name": "CUMBERLAND PHARMACEURIC.",
        "long_name": "Cumberland Pharmaceuticals Inc.",
        "summary": "Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ injection, for the treatment of certain serious bacterial infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. The company markets and sells its products through sales representatives and district managers. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "TN",
        "city": "Nashville",
        "zipcode": "37203",
        "website": "http://www.cumberlandpharma.com",
        "market_cap": "Nano Cap"
    },
    "CBWTF": {
        "short_name": "AUXLY CANNABIS GROUP INC",
        "long_name": "Auxly Cannabis Group Inc.",
        "summary": "Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. The company engages in the cultivation of cannabis; and development and distribution of cannabis products. It offers products, such as soft chews, vape cartridges, vape pens, pre-rolled cannabis, chocolates, and cannabis oil spray and oil drops through retail stores under the Kolab Project, Foray, and Dosecan brand names. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M6J 0C2",
        "website": "http://auxly.com",
        "market_cap": "Micro Cap"
    },
    "CCHW.CN": {
        "short_name": "ColumbiaCareInc",
        "long_name": "Columbia Care Inc.",
        "summary": "Columbia Care Inc. cultivates, manufactures, and provides cannabis-based health and wellness solutions, and derivative products. The company holds licenses in 19 jurisdictions in the United States and the European Union. It operates cultivation facilities, manufacturing facilities, and retail dispensaries. The company was founded in 2012 and is headquartered in New York, New York.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10019",
        "website": "http://www.col-care.com",
        "market_cap": "Small Cap"
    },
    "CCHWF": {
        "short_name": "COLUMBIA CARE INC",
        "long_name": "Columbia Care Inc.",
        "summary": "Columbia Care Inc. cultivates, manufactures, and provides cannabis-based health and wellness solutions, and derivative products. The company holds licenses in 19 jurisdictions in the United States and the European Union. It operates cultivation facilities, manufacturing facilities, and retail dispensaries. The company was founded in 2012 and is headquartered in New York, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10019",
        "website": "http://www.col-care.com",
        "market_cap": "Small Cap"
    },
    "CD0.F": {
        "short_name": "CANBUD DISTRIBUTION CORP.",
        "long_name": "Canbud Distribution Corporation",
        "summary": "Canbud Distribution Corporation produces clones of cannabis and hemp cannabinoids. It offers its products under the brands My SeeBD, My SeeBN, and My SeeBG. The company was formerly known as Cannabis Clonal Corporation. Canbud Distribution Corporation was founded in 2018 and is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 1T1",
        "website": "http://canbudcorp.com",
        "market_cap": null
    },
    "CDVA.CN": {
        "short_name": "CordovaCann",
        "long_name": "CordovaCann Corp.",
        "summary": "CordovaCann Corp., a cannabis-focused consumer products company, primarily provides services and investment capital to the processing, production, and retail vertical markets of the cannabis industry. As of March 8, 2021, it operated six stores under the Star Buds cannabis retail store in Alberta, Ontario, and Manitoba. The company was formerly known as LiveReel Media Corporation and changed its name to CordovaCann Corp. in January 2018. CordovaCann Corp. is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5V 0R2",
        "website": "http://www.cordovacann.com",
        "market_cap": "Nano Cap"
    },
    "CGB.AX": {
        "short_name": "CANNGLOBAL FPO",
        "long_name": "Cann Global Limited",
        "summary": "Cann Global Limited operates in medicinal cannabis and hemp food industries in Australia and internationally. The company operates through Hemp and Medical Cannabis Products, and Mining Exploration and Evaluation segments. It grows and cultivates hemp and medical cannabis products; and provides plant-based food and skin care products. The company also engages in the exploration and development of bauxite. In addition, it holds interests in the South Johnstone Project located in Queensland; and the New England Bauxite Project located in the New South Wales. The company was formerly known as Queensland Bauxite Limited and changed its name to Cann Global Limited in January 2019. Cann Global Limited was incorporated in 2007 and is based in Sydney, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Sydney",
        "zipcode": "2000",
        "website": "http://www.canngloballimited.com",
        "market_cap": "Nano Cap"
    },
    "CGC": {
        "short_name": "Canopy Growth Corporation",
        "long_name": "Canopy Growth Corporation",
        "summary": "Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. As of February 14, 2020, it operated 28 cannabis retail stores under the Tweed or Tokyo Smoke name. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Smiths Falls",
        "zipcode": "K7A 0A8",
        "website": "http://www.canopygrowth.com",
        "market_cap": "Mid Cap"
    },
    "CHM.CN": {
        "short_name": "ChemistreeTech",
        "long_name": "Chemistree Technology Inc.",
        "summary": "Chemistree Technology Inc., an investment company, operates in the cannabis sector in the United States. The company was formerly known as Whattozee Networks Inc. and changed its name to Chemistree Technology Inc. in August 2017. Chemistree Technology Inc. was incorporated in 2008 and is headquartered in North Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "North Vancouver",
        "zipcode": "V7N 4M2",
        "website": "http://www.chemistree.ca",
        "market_cap": "Nano Cap"
    },
    "CHMJF": {
        "short_name": "CHEMISTREE TECHNOLOGY INC",
        "long_name": "Chemistree Technology Inc.",
        "summary": "Chemistree Technology Inc., an investment company, operates in the cannabis sector in the United States. The company was formerly known as Whattozee Networks Inc. and changed its name to Chemistree Technology Inc. in August 2017. Chemistree Technology Inc. was incorporated in 2008 and is headquartered in North Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "North Vancouver",
        "zipcode": "V7N 4M2",
        "website": "http://www.chemistree.ca",
        "market_cap": "Nano Cap"
    },
    "CHNC": {
        "short_name": "CHINA INFRASTRUCTURE CONSTRUCTI",
        "long_name": "China Infrastructure Construction Corp.",
        "summary": "China Infrastructure Construction Corp. offers concierge medicine through its membership-based model in the Houston Metro area, Texas. The company is based in Houston, Texas.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "TX",
        "city": "Houston",
        "zipcode": "77036",
        "website": "http://www.chnc-hdh.com",
        "market_cap": "Nano Cap"
    },
    "CHOO.CN": {
        "short_name": "ChoomHldgsInc",
        "long_name": "Choom Holdings Inc.",
        "summary": "Choom Holdings Inc., through its subsidiaries, engages in the retail of cannabis. As of June 30, 2020, the company operates two medical and two coaching clinics under the name Concord Medical Centre; and 13 retail stores. The company was formerly known as Standard Graphite Corporation and changed its name to Choom Holdings Inc. in November 2017. Choom Holdings Inc. was incorporated in 2006 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6J 1T5",
        "website": "http://choomholdings.ca",
        "market_cap": "Nano Cap"
    },
    "CHOOF": {
        "short_name": "CHOOM HOLDINGS INC",
        "long_name": "Choom Holdings Inc.",
        "summary": "Choom Holdings Inc., through its subsidiaries, engages in the retail of cannabis. As of June 30, 2020, the company operates two medical and two coaching clinics under the name Concord Medical Centre; and 13 retail stores. The company was formerly known as Standard Graphite Corporation and changed its name to Choom Holdings Inc. in November 2017. Choom Holdings Inc. was incorporated in 2006 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6J 1T5",
        "website": "http://choomholdings.ca",
        "market_cap": "Nano Cap"
    },
    "CHV.CN": {
        "short_name": "Canada House",
        "long_name": "Canada House Wellness Group Inc.",
        "summary": "Canada House Wellness Group Inc., through its subsidiaries, provides medical grade cannabis products in Canada. The company offers cannabinoid therapy products and services to patients, as well as owns and operates medicinal cannabis clinics; and a licensed dispensary. It also provides a cloud-based software that links physicians, providers, and patients to data that supports treatment with medical cannabis. The company is headquartered in Pickering, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Pickering",
        "zipcode": "ON L1W",
        "website": "http://www.canadahouse.ca",
        "market_cap": "Nano Cap"
    },
    "CJH.F": {
        "short_name": "CANSINO BIOLOGICS H  YC 1",
        "long_name": "CanSino Biologics Inc.",
        "summary": "CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides; and DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. It also develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; TB Booster for the BCG-vaccinated population; and Ad5-nCov, a recombinant novel coronavirus disease vaccine. In addition, the company is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CSB012 to treat adenovirus; CSB013 for ZIKA virus; CSB105 to treat meningitis; CSB016 for treating shingles; and CSB107 for polio. It has a collaboration with The National Research Council of Canada to advance vaccine against COVID-19; and co-development agreement with Precision NanoSystems, Inc. to develop a mRNA lipid nanoparticle vaccine against COVID-19. CanSino Biologics Inc. was founded in 2009 and is headquartered in Tianjin, the People's Republic of China.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "China",
        "state": null,
        "city": "Tianjin",
        "zipcode": null,
        "website": "http://www.cansinotech.com",
        "market_cap": "Large Cap"
    },
    "CJH.SG": {
        "short_name": "CanSino Biologics Inc. Register",
        "long_name": "CanSino Biologics Inc.",
        "summary": "CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides; and DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. It also develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; TB Booster for the BCG-vaccinated population; and Ad5-nCov, a recombinant novel coronavirus disease vaccine. In addition, the company is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CSB012 to treat adenovirus; CSB013 for ZIKA virus; CSB105 to treat meningitis; CSB016 for treating shingles; and CSB107 for polio. It has a collaboration with The National Research Council of Canada to advance vaccine against COVID-19; and co-development agreement with Precision NanoSystems, Inc. to develop a mRNA lipid nanoparticle vaccine against COVID-19. CanSino Biologics Inc. was founded in 2009 and is headquartered in Tianjin, the People's Republic of China.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "China",
        "state": null,
        "city": "Tianjin",
        "zipcode": null,
        "website": "http://www.cansinotech.com",
        "market_cap": "Large Cap"
    },
    "CL.CN": {
        "short_name": "CrescoLabsInc",
        "long_name": "Cresco Labs Inc.",
        "summary": "Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; flowers, popcorns, shakes, pre-rolls, and vapes under the High Supply brand; flowers, vapes, and edibles under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, ingestibles, sublingual oils, and transdermal patches under the Remedi brand, as well as cannabis products made from plants under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. It owns and operates 24 dispensaries, as well as has 5 retail licenses. The company is headquartered in Chicago, Illinois.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "IL",
        "city": "Chicago",
        "zipcode": "60654",
        "website": "http://www.crescolabs.com",
        "market_cap": "Mid Cap"
    },
    "CLB.F": {
        "short_name": "CHRISTINA LAKE CANNABIS",
        "long_name": "Christina Lake Cannabis Corp.",
        "summary": "Christina Lake Cannabis Corp. engages in the growing, harvesting, processing, and sale of cannabis products in the British Columbia, Canada. It primarily offers cannabis oil, hemp oil, and other hemp and cannabis derived products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 21, 2018. Christina Lake Cannabis Corp. was incorporated in 2014 and is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1H2",
        "website": "http://www.christinalakecannabis.com",
        "market_cap": "Nano Cap"
    },
    "CLC.CN": {
        "short_name": "ChristinaCanna",
        "long_name": "Christina Lake Cannabis Corp.",
        "summary": "Christina Lake Cannabis Corp. engages in the growing, harvesting, processing, and sale of cannabis products in the British Columbia, Canada. It primarily offers cannabis oil, hemp oil, and other hemp and cannabis derived products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 21, 2018. Christina Lake Cannabis Corp. was incorporated in 2014 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1H2",
        "website": "http://www.christinalakecannabis.com",
        "market_cap": "Nano Cap"
    },
    "CLCFF": {
        "short_name": "CHRISTINA LAKE CANNABIS CORP",
        "long_name": "Christina Lake Cannabis Corp.",
        "summary": "Christina Lake Cannabis Corp. engages in the growing, harvesting, processing, and sale of cannabis products in the British Columbia, Canada. It primarily offers cannabis oil, hemp oil, and other hemp and cannabis derived products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 21, 2018. Christina Lake Cannabis Corp. was incorporated in 2014 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1H2",
        "website": "http://www.christinalakecannabis.com",
        "market_cap": "Nano Cap"
    },
    "CLSH.CN": {
        "short_name": "CLSHldgsUSA",
        "long_name": "CLS Holdings USA, Inc.",
        "summary": "CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. The company extracts various cannabinoids from the cannabis plants and converts into concentrates, such as oils, waxes, edibles, and shatters. Its concentrates are used for electronic cigarettes vaporization, and pharmaceutical and other purposes. The company also offers consulting services to cannabis-related businesses comprising growers, dispensaries, and laboratories; and toll processing services. CLS Holdings USA, Inc. was founded in 2014 and is based in Las Vegas, Nevada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89104",
        "website": "http://www.clsholdingsinc.com",
        "market_cap": "Nano Cap"
    },
    "CLSH": {
        "short_name": "CLS HOLDINGS USA INC",
        "long_name": "CLS Holdings USA, Inc.",
        "summary": "CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. The company extracts various cannabinoids from the cannabis plants and converts into concentrates, such as oils, waxes, edibles, and shatters. Its concentrates are used for electronic cigarettes vaporization, and pharmaceutical and other purposes. The company also offers consulting services to cannabis-related businesses comprising growers, dispensaries, and laboratories; and toll processing services. CLS Holdings USA, Inc. was founded in 2014 and is based in Las Vegas, Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89104",
        "website": "http://www.clsholdingsinc.com",
        "market_cap": "Nano Cap"
    },
    "CLTEF": {
        "short_name": "CALLIDITAS THERAPEUTICS AB",
        "long_name": "Calliditas Therapeutics AB (publ)",
        "summary": "Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing pharmaceutical products for patients with unmet medical needs. The company's lead product candidate is Nefecon, a novel oral formulation of budesonide potent local immunosuppressant for the treatment of the autoimmune renal disease IgA nephropathy. Calliditas Therapeutics AB (publ) also intends to take Nefecon through a global Phase 3 study to commercialization. Calliditas Therapeutics AB (publ) was founded in 2004 and is headquartered in Stockholm, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "111 22",
        "website": "http://www.calliditas.se",
        "market_cap": "Small Cap"
    },
    "CLVR": {
        "short_name": "Clever Leaves Holdings Inc.",
        "long_name": "Clever Leaves Holdings Inc.",
        "summary": "Clever Leaves Holdings Inc. cultivates, extracts, manufactures, and commercializes pharmaceutical-grade cannabinoid products in Colombia, Portugal, Germany, the United States, and Canada. The company operates through two segments, Cannabinoid and Non-Cannabinoid. It also engages in the formulating, manufacturing, marketing, distributing, and selling of homeopathic and other natural remedies, wellness products, detoxification products, nutraceuticals, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors. Clever Leaves Holdings Inc. is based in New York, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10017",
        "website": "http://www.cleverleaves.com",
        "market_cap": "Micro Cap"
    },
    "CM1.F": {
        "short_name": "CHEMISTREE TECHNOLOGY",
        "long_name": "Chemistree Technology Inc.",
        "summary": "Chemistree Technology Inc., an investment company, operates in the cannabis sector in the United States. The company was formerly known as Whattozee Networks Inc. and changed its name to Chemistree Technology Inc. in August 2017. Chemistree Technology Inc. was incorporated in 2008 and is headquartered in North Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "North Vancouver",
        "zipcode": "V7N 4M2",
        "website": "http://www.chemistree.ca",
        "market_cap": "Nano Cap"
    },
    "CNABQ": {
        "short_name": "UNITED CANNABIS CORPORATION",
        "long_name": "United Cannabis Corporation",
        "summary": "United Cannabis Corporation owns intellectual properties related to growth, production, manufacture, marketing, management, utilization, and distribution of medical and recreational marijuana, and marijuana infused products in the United States and the Cayman Islands. The company focuses on developing therapeutics, including Prana Bio Nutrient Medicinal products for supplement deficiencies related to the endocannabinoid system, including pain, neuropathy, arthritis, MS, IBS, autism, seizures, eczema, sleep, anxiety, head trauma, opioid dependency, and clinical endocannabinoid deficiencies; and Prana Aromatherapy Transdermal Roll-on line that provides targeted and large surface relief with combinations of aromatherapy. It also develops Epidiferphane, a therapeutic for the prevention of the negative side effects of chemotherapy, as well as therapeutics for the management of rheumatoid arthritis and treatment of brain cancer. The company was formerly known as MySkin, Inc. and changed its name to United Cannabis Corporation in May 2014. United Cannabis Corporation was founded in 2007 and is based in Golden, Colorado.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CO",
        "city": "Golden",
        "zipcode": "80401",
        "website": "http://unitedcannabis.us",
        "market_cap": "Nano Cap"
    },
    "CNFA.CN": {
        "short_name": "CanaFarma",
        "long_name": "CanaFarma Hemp Products Corp.",
        "summary": "CanaFarma Hemp Products Corp. engages in growing, manufacturing, processing, and selling hemp oil in the United States. The company offers hemp-based products, such as chewing gum and tincture under the YOOFORIC brand. It offers its products online. The company is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6Z 1S4",
        "website": "http://www.canafarmacorp.com",
        "market_cap": "Nano Cap"
    },
    "CNFHF": {
        "short_name": "CANAFARMA HEMP PRODUCTS CORP",
        "long_name": "CanaFarma Hemp Products Corp.",
        "summary": "CanaFarma Hemp Products Corp. engages in growing, manufacturing, processing, and selling hemp oil in the United States. The company offers hemp-based products, such as chewing gum and tincture under the YOOFORIC brand. It offers its products online. The company is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6Z 1S4",
        "website": "http://www.canafarmacorp.com",
        "market_cap": "Nano Cap"
    },
    "CNGGF": {
        "short_name": "CANN GROUP LTD",
        "long_name": "Cann Group Limited",
        "summary": "Cann Group Limited engages in research and development, cultivation and production, manufacturing, clinical evaluation, processing, packaging, and distribution and supply of medicinal cannabis for various diseases and medical conditions in Australia. The company was founded in 2014 and is based in Bundoora, Australia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Bundoora",
        "zipcode": "3083",
        "website": "http://www.canngrouplimited.com",
        "market_cap": "Micro Cap"
    },
    "CNNA": {
        "short_name": "CANN AMERICAN CORP",
        "long_name": "Cann American Corp.",
        "summary": "Cann American Corp., a development stage company, focuses on the development of Cannabis sativa strains for pets in various European Union countries. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was founded in 2004 and is based in Cloverdale, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Cloverdale",
        "zipcode": "95425",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "CNNC": {
        "short_name": "CANNONAU CORP",
        "long_name": "Cannonau Corp.",
        "summary": "Cannonau Corp. develops CBD based products. The company was formerly known as Pacific Blue Energy Corp. and changed its name to Cannonau Corp. in August 2019. Cannonau Corp. was founded in 2007 and is based in Skaneateles, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "Skaneateles",
        "zipcode": "13252-9318",
        "website": "http://pbec.biz",
        "market_cap": "Small Cap"
    },
    "CNNXF": {
        "short_name": "CANNAMERICA BRANDS CORP",
        "long_name": "CannAmerica Brands Corp.",
        "summary": "CannAmerica Brands Corp. owns a portfolio of brands in the medical cannabis and recreational cannabis space with licensees in the states of Colorado, Nevada, Oklahoma, Maryland, and Massachusetts. The company primarily builds and maximizes the value of its brands by promoting, marketing, and licensing brands through various distribution channels, including dispensaries, wholesalers, and distributors. It offers sweet, sour, and sweet and sour fruit juice gummies under the CannAmerica brand. The company is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2T5",
        "website": "http://www.cannamericabrands.com",
        "market_cap": "Nano Cap"
    },
    "CNPOF": {
        "short_name": "RIV CAPITAL INC",
        "long_name": "RIV Capital Inc.",
        "summary": "RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, and media and content. The firm also focuses on beverages, capsules and concentrates, edibles, dry flower / pre-rolls, vaporizers and hardware, pet products, and topicals. In agriculture and food sciences firm focuses in invest plant science, soil science, food science, animal science and environmental science. In production firm focuses in Indoor cultivation, greenhouse cultivation, outdoor cultivation, nursery cultivation and fermentation. In processing firm focuses in harvesting, extraction and purification, packaging, food and beverage processing and laboratory testing services. In pharmaceuticals and biotechnology firm focuses in pharmaceutical discovery and development, delivery method (ex: pill, soft gel, tincture), biosynthetic derived cannabinoids and other molecules, medical devices (ex: inhalers) and lab equipment. In consumer products and accessories firm focuses in edibles, beverages, inhalable, cosmetics and cannabis consumption accessories. In retail and distribution firm focuses in licensed brick and mortar retailers, pharmacies, online consumer marketplaces, delivery services, and others. The firm invests in opportunities globally. The firm prefers to invest in check sizes have ranged from CA$1 million ($0.71 million) to $40 million ($28.45 million), but more typical investment range is between CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm is focused on making minority stake investments. Firm employ diverse investment structures including debt, preferred and common equity, and production-linked royalties. RIV Capital Inc. was founded on 2017 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 3Y2",
        "website": "http://www.rivcapital.com",
        "market_cap": "Micro Cap"
    },
    "CNSC": {
        "short_name": "CANNASSIST INTL CORP",
        "long_name": "CannAssist International Corp.",
        "summary": "CannAssist International Corp. produces and sells cannabidiol (CBD) and other products. The company provides Cibidinol, a CBD product, as well as consumable and topical products in various delivery forms, including capsules, sublingual drops, films, troches, lotions, creams, sprays, powders, and suppositories. CannAssist International Corp. sells its products directly through xceptorcbd.com. The company was formerly known as Iris Grove Acquisition Corporation and changed its name to CannAssist International Corp. in May 2018. CannAssist International Corp. was incorporated in 2017 and is based in Fallbrook, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Fallbrook",
        "zipcode": "92028",
        "website": "http://xceptorcbd.com",
        "market_cap": "Nano Cap"
    },
    "CNTMF": {
        "short_name": "CANSORTIUM INC",
        "long_name": "Cansortium Inc.",
        "summary": "Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. The company engages in the cultivation, processing, retail, and distribution activities. Its medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls, cartridges, and edibles. The company provides its products under the Fluent brand name. Cansortium Inc. was incorporated in 2018 and is headquartered in Miami, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Miami",
        "zipcode": "33137",
        "website": "http://www.getfluent.com",
        "market_cap": "Micro Cap"
    },
    "CNTR.CN": {
        "short_name": "CENTRBrands",
        "long_name": "CENTR Brands Corp.",
        "summary": "CENTR Brands Corp. engages in the development and marketing of beverages infused with hemp-derived extracts and derivatives. The company primarily offers cannabidiol beverages. It offers CENTR, a CBD beverage product. CENTR Brands Corp. was founded in 2012 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6H 4J1",
        "website": "http://findyourcentr.com",
        "market_cap": "Micro Cap"
    },
    "CNTRF": {
        "short_name": "CENTR BRANDS CORP",
        "long_name": "CENTR Brands Corp.",
        "summary": "CENTR Brands Corp. engages in the development and marketing of beverages infused with hemp-derived extracts and derivatives. The company primarily offers cannabidiol beverages. It offers CENTR, a CBD beverage product. CENTR Brands Corp. was founded in 2012 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6H 4J1",
        "website": "http://findyourcentr.com",
        "market_cap": "Micro Cap"
    },
    "CNTTQ": {
        "short_name": "CANNTRUST HOLDINGS INC",
        "long_name": "CannTrust Holdings Inc.",
        "summary": "CannTrust Holdings Inc. produces and distributes medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc. was incorporated in 2015 and is based in Vaughan, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Vaughan",
        "zipcode": "L4K 1Z9",
        "website": "http://www.canntrust.ca",
        "market_cap": "Micro Cap"
    },
    "CNVCF": {
        "short_name": "BIOHARVEST SCIENCES INC",
        "long_name": "BioHarvest Sciences Inc.",
        "summary": "BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the necessity to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V7X 1M8",
        "website": "http://www.bioharvest.com",
        "market_cap": "Micro Cap"
    },
    "CNZN.TA": {
        "short_name": "CANZON ISRAEL LTD",
        "long_name": "Canzon Israel Ltd",
        "summary": "Canzon Israel Ltd manages and operates Internet sites in Israel. It offers various tools, such as forums, blogs, and video sharing platforms to users. The company also provides design and development services for Internet and mobile sectors. It serves corporations and large companies, technology product companies, and start-up customers. The company distributes its products through sales people, events, and cooperation agreements. The company was formerly known as User Trend Ltd. Canzon Israel Ltd was founded in 1999 and is based in Bnei Brak, Israel.",
        "currency": "ILA",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TLV",
        "market": "il_market",
        "country": "Israel",
        "state": null,
        "city": "Jaffa",
        "zipcode": "6249245",
        "website": null,
        "market_cap": null
    },
    "COLL": {
        "short_name": "Collegium Pharmaceutical, Inc.",
        "long_name": "Collegium Pharmaceutical, Inc.",
        "summary": "Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "MA",
        "city": "Stoughton",
        "zipcode": "02072",
        "website": "http://www.collegiumpharma.com",
        "market_cap": "Small Cap"
    },
    "COPHF": {
        "short_name": "CRESO PHARMA LTD",
        "long_name": "Creso Pharma Limited",
        "summary": "Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates and harvests cannabis plants, as well as supplies dried cannabis plant retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions in humans; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. The company also offers nutraceutical products, such as cannaQIX, a hemp oil-derived food supplement under the Cannamics brand. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Australia",
        "state": "WA",
        "city": "Nedlands",
        "zipcode": "6009",
        "website": "http://www.cresopharma.com",
        "market_cap": "Micro Cap"
    },
    "COSM": {
        "short_name": "COSMOS HOLDINGS INC",
        "long_name": "Cosmos Holdings Inc.",
        "summary": "Cosmos Holdings Inc., through its subsidiaries, operates as a pharmaceutical wholesaler primarily in the European Union. It imports, exports, and distributes branded pharmaceutical products, generic pharmaceutical products, prescription and non-prescription derivatives of cannabis products, over-the-counter medicines, cosmetics, nursery, dietary products, and vitamin supplements. It also develops nutraceutical products under the Sky Life Premium brand name. The company provides its products to wholesale drug distributors, hospitals, pharmacies, governmental agencies, and wholesalers and retail healthcare providers. It operates in Greece, Germany, the United Kingdom, Hungary, the Netherlands, Ireland, Libya, Poland, Italy, France, Denmark, Croatia, Turkey, Jordan, Indonesia, Georgia, Belgium, and Cyprus. The company was formerly known as Prime Estates and Developments, Inc. and changed its name to Cosmos Holdings Inc. in November 2013. Cosmos Holdings Inc. was incorporated in 2009 and is based in Chicago, Illinois.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "IL",
        "city": "Chicago",
        "zipcode": "60604",
        "website": "http://www.cosmosholdingsinc.com",
        "market_cap": "Micro Cap"
    },
    "CPH.AX": {
        "short_name": "CRESO FPO",
        "long_name": "Creso Pharma Limited",
        "summary": "Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates and harvests cannabis plants, as well as supplies dried cannabis plant retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions in humans; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. The company also offers nutraceutical products, such as cannaQIX, a hemp oil-derived food supplement under the Cannamics brand. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "WA",
        "city": "Nedlands",
        "zipcode": "6009",
        "website": "http://www.cresopharma.com",
        "market_cap": "Micro Cap"
    },
    "CPH.TO": {
        "short_name": "CIPHER PHARMACEUTICALS INC",
        "long_name": "Cipher Pharmaceuticals Inc.",
        "summary": "Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and Conzip/Durela (CIP- Tramadol), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products also include Trevyent, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for the treatment of onychomycosis; and DTR-001, a tattoo removal cream. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Oakville",
        "zipcode": "L6H 0M2",
        "website": "http://www.cipherpharma.com",
        "market_cap": "Nano Cap"
    },
    "CPHI": {
        "short_name": "China Pharma Holdings, Inc.",
        "long_name": "China Pharma Holdings, Inc.",
        "summary": "China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. was founded in 1993 and is based in Haikou, the People's Republic of China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASE",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Haikou",
        "zipcode": "570216",
        "website": "http://www.chinapharmaholdings.com",
        "market_cap": "Nano Cap"
    },
    "CPHRF": {
        "short_name": "CIPHER PHARMACEUTICALS INC",
        "long_name": "Cipher Pharmaceuticals Inc.",
        "summary": "Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and Conzip/Durela (CIP- Tramadol), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products also include Trevyent, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for the treatment of onychomycosis; and DTR-001, a tattoo removal cream. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Oakville",
        "zipcode": "L6H 0M2",
        "website": "http://www.cipherpharma.com",
        "market_cap": "Nano Cap"
    },
    "CPIVF": {
        "short_name": "CAPTIVA VERDE WELLNESS CORP",
        "long_name": "Captiva Verde Wellness Corp.",
        "summary": "Captiva Verde Wellness Corp. operates as a health and wellness company. The company's assets include sustainable real estate communities in California; outdoor organic cannabis cultivation in Canada; premium infused products and consumer retail partnerships across North America; and medical cannabis license product distribution in Mexico. It primarily invests in assets that contain green residential communities, disruptive manufacturing facilities, organic food production, and pharmaceutical products. The company was formerly known as Captiva Verde Land Corp. and changed its name to Captiva Verde Wellness Corp. in May 2021. Captiva Verde Wellness Corp. was incorporated in 2015 and is based in Coquitlam, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Coquitlam",
        "zipcode": "V3J 2L7",
        "website": "http://captivaverdecorp.com",
        "market_cap": "Nano Cap"
    },
    "CPIX": {
        "short_name": "Cumberland Pharmaceuticals Inc.",
        "long_name": "Cumberland Pharmaceuticals Inc.",
        "summary": "Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ injection, for the treatment of certain serious bacterial infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. The company markets and sells its products through sales representatives and district managers. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "TN",
        "city": "Nashville",
        "zipcode": "37203",
        "website": "http://www.cumberlandpharma.com",
        "market_cap": "Nano Cap"
    },
    "CPMD": {
        "short_name": "CANNAPHARMARX INC",
        "long_name": "CannaPharmaRX, Inc.",
        "summary": "CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It negotiates, acquires, and develops various cannabis cultivation projects in Canada. The company is based in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2P 5C5",
        "website": "http://www.cannapharmarx.com",
        "market_cap": "Nano Cap"
    },
    "CPTR.CN": {
        "short_name": "Captor Capital",
        "long_name": "Captor Capital Corp.",
        "summary": "Captor Capital Corp. engages in the manufacture and retail sale of cannabis products in the United States. It operates two dispensaries under the CHAI Cannabis Co. brand in Santa Cruz and Monterey, California, as well as operates an e-commerce site under the CHAI-brand. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. in June 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 1B6",
        "website": "http://captorcapital.com",
        "market_cap": "Micro Cap"
    },
    "CRDL.TO": {
        "short_name": "CARDIOL THERAPEUTICS INC",
        "long_name": "Cardiol Therapeutics Inc.",
        "summary": "Cardiol Therapeutics Inc., a clinical-stage biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, an ultra-pure and high concentration cannabidiol oral formulation for the treatment of in hospitalized COVID-19 patients with a prior history of risk factors for CVD; and has completed phase I clinical trials for the treatment of acute myocarditis and other inflammatory heart disease. The company is also developing a proprietary subcutaneous formulation of cannabidiol to achieve higher bioavailability for the treatment chronic heart failure. In addition, it develops proprietary nanotechnology to enable the distribution of water insoluble drugs within the blood circulation, enhance pharmacokinetics, and facilitate drug accumulation in the failing heart. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Oakville",
        "zipcode": "L6H 0G5",
        "website": "http://www.cardiolrx.com",
        "market_cap": "Micro Cap"
    },
    "CRFT.CN": {
        "short_name": "BCCraftSupplyCo",
        "long_name": "BC Craft Supply Co. Ltd.",
        "summary": "BC Craft Supply Co. Ltd., together with its subsidiaries, engages in the production and distribution of licensed craft cannabis and craft cannabis related products for recreational and medical purposes. The company was formerly known as Pasha Brands Ltd. and changed its name to BC Craft Supply Co. Ltd. in May 2020. BC Craft Supply Co. Ltd. is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2V6",
        "website": "http://bccraftsupply.ca",
        "market_cap": "Nano Cap"
    },
    "CRFTF": {
        "short_name": "BC CRAFT SUPPLY CO LTD",
        "long_name": "BC Craft Supply Co. Ltd.",
        "summary": "BC Craft Supply Co. Ltd., together with its subsidiaries, engages in the production and distribution of licensed craft cannabis and craft cannabis related products for recreational and medical purposes. The company was formerly known as Pasha Brands Ltd. and changed its name to BC Craft Supply Co. Ltd. in May 2020. BC Craft Supply Co. Ltd. is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2V6",
        "website": "http://bccraftsupply.ca",
        "market_cap": "Nano Cap"
    },
    "CRLBF": {
        "short_name": "CRESCO LABS INC",
        "long_name": "Cresco Labs Inc.",
        "summary": "Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; flowers, popcorns, shakes, pre-rolls, and vapes under the High Supply brand; flowers, vapes, and edibles under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, ingestibles, sublingual oils, and transdermal patches under the Remedi brand, as well as cannabis products made from plants under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. It owns and operates 24 dispensaries, as well as has 5 retail licenses. The company is headquartered in Chicago, Illinois.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "IL",
        "city": "Chicago",
        "zipcode": "60654",
        "website": "http://www.crescolabs.com",
        "market_cap": "Mid Cap"
    },
    "CRON": {
        "short_name": "Cronos Group Inc. Common Share",
        "long_name": "Cronos Group Inc.",
        "summary": "Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5V 2H1",
        "website": "http://www.thecronosgroup.com",
        "market_cap": "Mid Cap"
    },
    "CRON.TO": {
        "short_name": "CRONOS GROUP INC",
        "long_name": "Cronos Group Inc.",
        "summary": "Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5V 2H1",
        "website": "http://www.thecronosgroup.com",
        "market_cap": "Mid Cap"
    },
    "CRTPF": {
        "short_name": "CARDIOL THERAPEUTICS INC",
        "long_name": "Cardiol Therapeutics Inc.",
        "summary": "Cardiol Therapeutics Inc., a clinical-stage biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, an ultra-pure and high concentration cannabidiol oral formulation for the treatment of in hospitalized COVID-19 patients with a prior history of risk factors for CVD; and has completed phase I clinical trials for the treatment of acute myocarditis and other inflammatory heart disease. The company is also developing a proprietary subcutaneous formulation of cannabidiol to achieve higher bioavailability for the treatment chronic heart failure. In addition, it develops proprietary nanotechnology to enable the distribution of water insoluble drugs within the blood circulation, enhance pharmacokinetics, and facilitate drug accumulation in the failing heart. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Oakville",
        "zipcode": "L6H 0G5",
        "website": "http://www.cardiolrx.com",
        "market_cap": "Micro Cap"
    },
    "CSI.CN": {
        "short_name": "ChemesisIntl",
        "long_name": "Chemesis International Inc.",
        "summary": "Chemesis International Inc., together with its subsidiaries, cultivates, manufactures, distributes, and retails cannabis products in California, Puerto Rico, and Colombia. It offers various types of extractions, formulations, and products specializing in BHO extraction, alcohol extraction, and CO2 extraction. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1S4",
        "website": "http://chemesis.com",
        "market_cap": "Nano Cap"
    },
    "CSUI": {
        "short_name": "CANNABIS SUISSE CORP",
        "long_name": "Cannabis Suisse Corp.",
        "summary": "Cannabis Suisse Corp. engages in the cultivation and distribution of recreational tobacco products and medical CBD oils in Switzerland. The company sells its products through a distribution network of retailers and online shops under the Swiss4Life retail brand. The company was formerly known as Geant Corp. and changed its name to Cannabis Suisse Corp. in February 2019. Cannabis Suisse Corp. was incorporated in 2016 and is based in Dietikon, Switzerland.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Switzerland",
        "state": null,
        "city": "Dietikon",
        "zipcode": "8953",
        "website": "http://www.cannabissuissecorp.com",
        "market_cap": "Nano Cap"
    },
    "CT9.F": {
        "short_name": "CARDIOL THERAPEUTICS CL.A",
        "long_name": "Cardiol Therapeutics Inc.",
        "summary": "Cardiol Therapeutics Inc., a clinical-stage biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, an ultra-pure and high concentration cannabidiol oral formulation for the treatment of in hospitalized COVID-19 patients with a prior history of risk factors for CVD; and has completed phase I clinical trials for the treatment of acute myocarditis and other inflammatory heart disease. The company is also developing a proprietary subcutaneous formulation of cannabidiol to achieve higher bioavailability for the treatment chronic heart failure. In addition, it develops proprietary nanotechnology to enable the distribution of water insoluble drugs within the blood circulation, enhance pharmacokinetics, and facilitate drug accumulation in the failing heart. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Oakville",
        "zipcode": "L6H 0G5",
        "website": "http://www.cardiolrx.com",
        "market_cap": "Micro Cap"
    },
    "CTABF": {
        "short_name": "CANNTAB THERAPEUTICS LIMITED",
        "long_name": "Canntab Therapeutics Limited",
        "summary": "Canntab Therapeutics Limited, a biopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids, tetrahydrocannabinol, and terpenes in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Markham",
        "zipcode": "L3R 5J6",
        "website": "http://canntab.ca",
        "market_cap": "Nano Cap"
    },
    "CTLT.MX": {
        "short_name": "CATALENT INC",
        "long_name": "Catalent, Inc.",
        "summary": "Catalent, Inc., together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral vector gene therapy; formulation, development, and manufacturing for parenteral dose forms, including prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. It has a collaboration with the Janssen Pharmaceutical Companies; Arcturus Therapeutics Holdings Inc.; and BrainStorm Cell Therapeutics Inc. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.",
        "currency": "MXN",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MEX",
        "market": "mx_market",
        "country": "United States",
        "state": "NJ",
        "city": "Somerset",
        "zipcode": "08873",
        "website": "http://www.catalent.com",
        "market_cap": "Large Cap"
    },
    "CTLT": {
        "short_name": "Catalent, Inc.",
        "long_name": "Catalent, Inc.",
        "summary": "Catalent, Inc., together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral vector gene therapy; formulation, development, and manufacturing for parenteral dose forms, including prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. It has a collaboration with the Janssen Pharmaceutical Companies; Arcturus Therapeutics Holdings Inc.; and BrainStorm Cell Therapeutics Inc. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "Somerset",
        "zipcode": "08873",
        "website": "http://www.catalent.com",
        "market_cap": "Large Cap"
    },
    "CTTH": {
        "short_name": "CTT PHARMACEUTICAL HLDGS INC",
        "long_name": "CTT Pharmaceutical Holdings, Inc.",
        "summary": "CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. The company is based in Ottawa, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Ottawa",
        "zipcode": "K2P 2B4",
        "website": "http://www.cttpharmaceuticals.com",
        "market_cap": "Nano Cap"
    },
    "CTX.TO": {
        "short_name": "CRESCITA THERAPEUTICS INC",
        "long_name": "Crescita Therapeutics Inc.",
        "summary": "Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns various proprietary drug delivery platforms, including Peel, DuraPeel, and MMPE that support the development of patented formulations, which facilitate the delivery of active drugs into or through the skin. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination with MMPE technology to treat plaque psoriasis; and CTX-102, a Phase I topical formulation utilizing MMPE technology to treat an undisclosed dermatological skin condition. Its non-prescription skincare products comprise skincare products, such as facial creams, cleansers, exfoliants, masks, serums, and suncare products for aging, acne, rosacea, pigmentation, dehydration, and sensitivity under the Laboratoire Dr Renaud brand; a line of dermocosmetic products for anti-aging medical procedures under the Pro-Derm brand; skincare products primarily for the Asian consumers under Dermazulene brand; and a line of products to target and treat various skincare concerns under the Alyria brand. The company has a development and licensing agreement with Sundial Growers Inc. to develop cannabis and hemp topicals; a commercialization license agreement with Cantabria Labs Inc.; and a development and commercialization license agreement with Taro Pharmaceuticals Inc. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "QC",
        "city": "Laval",
        "zipcode": "H7V 0A3",
        "website": "http://www.crescitatherapeutics.com",
        "market_cap": "Nano Cap"
    },
    "CURA.CN": {
        "short_name": "CuraleafHoldnc.",
        "long_name": "Curaleaf Holdings, Inc.",
        "summary": "Curaleaf Holdings, Inc. operates as an integrated medical and wellness cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers oil-based formulations, such as vaporizing, cartridges, tinctures, and capsules; and ground-flower. The company also provides hemp-based CBD products. As of March 9, 2021, it operated 101 dispensaries, 23 cultivation sites, and 30 processing sites in 23 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "MA",
        "city": "Wakefield",
        "zipcode": "01880",
        "website": "http://www.curaleaf.com",
        "market_cap": "Mid Cap"
    },
    "CURLF": {
        "short_name": "CURALEAF HOLDINGS  INC",
        "long_name": "Curaleaf Holdings, Inc.",
        "summary": "Curaleaf Holdings, Inc. operates as an integrated medical and wellness cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers oil-based formulations, such as vaporizing, cartridges, tinctures, and capsules; and ground-flower. The company also provides hemp-based CBD products. As of March 9, 2021, it operated 101 dispensaries, 23 cultivation sites, and 30 processing sites in 23 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "MA",
        "city": "Wakefield",
        "zipcode": "01880",
        "website": "http://www.curaleaf.com",
        "market_cap": "Large Cap"
    },
    "CURR": {
        "short_name": "CURE PHARMACEUTICAL HOLDING COR",
        "long_name": "CURE Pharmaceutical Holding Corp.",
        "summary": "CURE Pharmaceutical Holding Corp., together with its subsidiaries, operates as an integrated drug delivery and development company in the United States and internationally. It focuses on the development and manufacture of drug formulation and drug delivery technologies in novel dosage forms to enhance drug efficacy, safety, and patient adherence. The company operates through two business segments: Cure and Sera Labs. It offers pharmaceutical and wellness products, including CUREfilm Blue, a sildenafil oral thin film for the treatment of erectile dysfunction; cannabinoid products with optimized pharmacokinetic profiles using microCURE and CUREfilm technology under the CUREfilm Canna name; and CUREfilm Anti-Viral, an orally bio-available anti-viral of an existing therapeutic leveraging existing pre-clinical/clinical safety and toxicity data. The company also provides CUREfilm Central Nervous System, a novel dosage form to treat disease states utilizing its proprietary CUREfilm dosage form, as well as to treat mental health disorders, such as depression, PTSD, addiction disorders, obsessive compulsive disorders, and anxiety. It sells wellness products through direct to consumer and wholesale channels. CURE Pharmaceutical Holding Corp. has a collaboration with Canopy Growth Corporation for the production and sale of medical cannabis. The company was founded in 2011 and is based in Oxnard, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Oxnard",
        "zipcode": "93033",
        "website": "http://www.curepharmaceutical.com",
        "market_cap": "Nano Cap"
    },
    "CVGR.CN": {
        "short_name": "CityViewGreen",
        "long_name": "City View Green Holdings Inc.",
        "summary": "City View Green Holdings Inc. intends to produce cannabis-infused food, oils, distillates, and water-soluble products for the food and beverage markets. The company is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M4M 3P1",
        "website": "http://www.cityviewgreen.ca",
        "market_cap": "Nano Cap"
    },
    "CVGRF": {
        "short_name": "CITY VIEW GREEN HOLDINGS INC",
        "long_name": "City View Green Holdings Inc.",
        "summary": "City View Green Holdings Inc. intends to produce cannabis-infused food, oils, distillates, and water-soluble products for the food and beverage markets. The company is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M4M 3P1",
        "website": "http://www.cityviewgreen.ca",
        "market_cap": "Nano Cap"
    },
    "CVHIF": {
        "short_name": "VENTURA CANNABIS AND WELLNESS C",
        "long_name": "Ventura Cannabis & Wellness Corporation",
        "summary": "Ventura Cannabis & Wellness Corporation operates as a vertically integrated cannabis product company in California. The company was formerly known as BLVD Centers Corporation and changed its name to Ventura Cannabis & Wellness Corporation in February 2019. The company was incorporated in 2013 and is headquartered in Los Angeles, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Los Angeles",
        "zipcode": "90017",
        "website": "http://www.venturacanna.com",
        "market_cap": "Nano Cap"
    },
    "CVJ.F": {
        "short_name": "CANN GROUP LTD",
        "long_name": "Cann Group Limited",
        "summary": "Cann Group Limited engages in research and development, cultivation and production, manufacturing, clinical evaluation, processing, packaging, and distribution and supply of medicinal cannabis for various diseases and medical conditions in Australia. The company was founded in 2014 and is based in Bundoora, Australia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Bundoora",
        "zipcode": "3083",
        "website": "http://www.canngrouplimited.com",
        "market_cap": "Micro Cap"
    },
    "CVSI": {
        "short_name": "CV SCIENCES INC",
        "long_name": "CV Sciences, Inc.",
        "summary": "CV Sciences, Inc. operates as a life science company in the United States. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD name in various market sectors, including nutraceutical, beauty care, and specialty foods. It serves internet sales, direct-to-consumer health and wellness stores, collectives, cooperatives, master distributors, specialty retailers, and convenience stores, as well as food, drug, and mass merchandise retailers. The Specialty Pharmaceutical segment focuses on developing and commercializing cannabinoids to treat medical indications. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "San Diego",
        "zipcode": "92121",
        "website": "http://www.cvsciences.com",
        "market_cap": "Nano Cap"
    },
    "CVT.NZ": {
        "short_name": "Comvita Limited Ordinary Shares",
        "long_name": "Comvita Limited",
        "summary": "Comvita Limited, together with its subsidiaries, engages in the manufacturing and marketing of natural health products in Australia, New Zealand, China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. It offers Manuka honey, propolis, olive leaf extract, medihoney and skincare, gourmet honey, elixirs and lozenges, royal jelly, omega 3, and cider vinegar products, as well as oral, kids, and eye health products. The company also engages in the apiary ownership and management, property ownership, and research and development activities. Comvita Limited was founded in 1974 and is based in Te Puke, New Zealand.",
        "currency": "NZD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NZE",
        "market": "nz_market",
        "country": "New Zealand",
        "state": null,
        "city": "Te Puke",
        "zipcode": "3153",
        "website": "http://www.comvita.co.nz",
        "market_cap": "Micro Cap"
    },
    "CVY.F": {
        "short_name": "CITY VIEW GREEN HOLDINGS",
        "long_name": "City View Green Holdings Inc.",
        "summary": "City View Green Holdings Inc. intends to produce cannabis-infused food, oils, distillates, and water-soluble products for the food and beverage markets. The company is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M4M 3P1",
        "website": "http://www.cityviewgreen.ca",
        "market_cap": "Nano Cap"
    },
    "CWAB.F": {
        "short_name": "CHEMESIS INTL INC.  O.N.",
        "long_name": "Chemesis International Inc.",
        "summary": "Chemesis International Inc., together with its subsidiaries, cultivates, manufactures, distributes, and retails cannabis products in California, Puerto Rico, and Colombia. It offers various types of extractions, formulations, and products specializing in BHO extraction, alcohol extraction, and CO2 extraction. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1S4",
        "website": "http://chemesis.com",
        "market_cap": "Nano Cap"
    },
    "CWBHF": {
        "short_name": "CHARLOTTES WEB HOLDINGS INC",
        "long_name": "Charlotte's Web Holdings, Inc.",
        "summary": "Charlotte's Web Holdings, Inc. produces and distributes hemp-based cannabidiol wellness products in the United States. The company offers products in the categories of tinctures, capsules, gummies, topicals, and pet products. It distributes its products under the Charlotte's Web name through its e-commerce website, third party e-commerce websites, as well as distributors, health practitioners, and various brick and mortar retailers. Charlotte's Web Holdings, Inc. has a collaboration between its CW Labs science division and the University at Buffalo's Center for Integrated Global Biomedical Sciences to advance hemp cannabinoid science through a research program; and scientific collaboration with McLean Hospital. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was incorporated in 2018 and is headquartered in Boulder, Colorado.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CO",
        "city": "Boulder",
        "zipcode": "80302",
        "website": "http://www.charlottesweb.com",
        "market_cap": "Small Cap"
    },
    "CWEB.TO": {
        "short_name": "CHARLOTTES WEB HOLDINGS INC",
        "long_name": "Charlotte's Web Holdings, Inc.",
        "summary": "Charlotte's Web Holdings, Inc. produces and distributes hemp-based cannabidiol wellness products in the United States. The company offers products in the categories of tinctures, capsules, gummies, topicals, and pet products. It distributes its products under the Charlotte's Web name through its e-commerce website, third party e-commerce websites, as well as distributors, health practitioners, and various brick and mortar retailers. Charlotte's Web Holdings, Inc. has a collaboration between its CW Labs science division and the University at Buffalo's Center for Integrated Global Biomedical Sciences to advance hemp cannabinoid science through a research program; and scientific collaboration with McLean Hospital. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was incorporated in 2018 and is headquartered in Boulder, Colorado.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "United States",
        "state": "CO",
        "city": "Boulder",
        "zipcode": "80302",
        "website": "http://www.charlottesweb.com",
        "market_cap": "Small Cap"
    },
    "CWWBF": {
        "short_name": "PLANT BASED INVESTMENT CORP",
        "long_name": "Plant-Based Investment Corp.",
        "summary": "Plant-Based Investment Corp. is a principal investment firm. The firm seeks to invest in cannabis industry. It also invests in public cannabis companies. The firm employs fundamental analysis along with a combination of bottom-up and top-down stock picking approach to create its portfolios. Cannabis Growth Opportunity Corporation is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5V 1V6",
        "website": "http://www.pbinvest.ca",
        "market_cap": "Nano Cap"
    },
    "CXRXF": {
        "short_name": "ADVANZ PHARMA CORP LTD (JY)",
        "long_name": "ADVANZ PHARMA Corp. Limited",
        "summary": "ADVANZ PHARMA Corp. Limited, a pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products worldwide. The company operates through two segments: ADVANZ PHARMA International and ADVANZ PHARMA North America. Its ADVANZ PHARMA International segment offers a portfolio of branded and generic prescription products to wholesalers, distributors, hospitals, and pharmacies. This segment's products include Brinavess for the conversion of onset atrial fibrillation to sinus rhythm in adults; Aggrastat, a reversible GP IIb/IIIa inhibitor indicated for use in patients with acute coronary syndrome; Xydalba, a semi-synthetic lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections in adults; and Zevtera/Mabelio, a cephalosporin antibiotic for the treatment of community-acquired and hospital-acquired pneumonia. The company's ADVANZ PHARMA North America segment provides Donnatal for the treatment of irritable bowel syndrome; Zonegran for the treatment of partial seizures in adults with epilepsy; Nilandron for the treatment of metastatic prostate cancer; Lanoxin for the treatment of mild to moderate heart failure and atrial fibrillation; Plaquenil for the treatment of lupus and rheumatoid arthritis; and Photofrin for the treatment of certain types of cancer. It also offers Prostaglandin E1 formulations for the treatment of erectile dysfunction and peripheral arterial occlusive disease under the Prostavasin, Viridal, Vasaprostan, and Edex brands, as well as holds licensed commercialization rights to a pre-registration drug/device combination product, Trevyent for the treatment of pulmonary arterial hypertension. It sells its products through direct sales and local distribution relationships. The company was formerly known as ADVANZ PHARMA Corp. and changed its name to ADVANZ PHARMA Corp. Limited in December 2019. ADVANZ PHARMA Corp. Limited is headquartered in London, the United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "EC4N 7BL",
        "website": "http://www.advanzpharma.com",
        "market_cap": "Small Cap"
    },
    "CXXI.CN": {
        "short_name": "C21 InvInc",
        "long_name": "C21 Investments Inc.",
        "summary": "C21 Investments Inc., an integrated cannabis company, cultivates, processes, and distributes cannabis and hemp-derived consumer products in the United States. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 Investments Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 3N9",
        "website": "http://www.cxxi.ca",
        "market_cap": "Micro Cap"
    },
    "CXXIF": {
        "short_name": "C21 INVESTMENTS INC",
        "long_name": "C21 Investments Inc.",
        "summary": "C21 Investments Inc., an integrated cannabis company, cultivates, processes, and distributes cannabis and hemp-derived consumer products in the United States. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 Investments Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 3N9",
        "website": "http://www.cxxi.ca",
        "market_cap": "Micro Cap"
    },
    "CY3B.F": {
        "short_name": "ADAMIS PHARMACEUTIC.CORP.",
        "long_name": "Adamis Pharmaceuticals Corporation",
        "summary": "Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's product candidates comprise Symjepi Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products consisting of fluticasone for the treatment of asthma; beclomethasone, a metered dose inhaler product for the asthma; and naloxone injection product candidates for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "CA",
        "city": "San Diego",
        "zipcode": "92130",
        "website": "http://www.adamispharmaceuticals.com",
        "market_cap": "Micro Cap"
    },
    "CYTH": {
        "short_name": "Cyclo Therapeutics, Inc.",
        "long_name": "Cyclo Therapeutics, Inc.",
        "summary": "Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. The company's lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was founded in 1990 and is based in Gainesville, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Gainesville",
        "zipcode": "32653",
        "website": "http://www.cyclotherapeutics.com",
        "market_cap": "Micro Cap"
    },
    "D2EA.F": {
        "short_name": "PHYTO EXTRACTIONS INC.",
        "long_name": "Phyto Extractions Inc.",
        "summary": "Adastra Labs Holdings Ltd. operates as a cannabis extraction and processing solutions company. It also offers third party analytical testing services, such as white labelling, contract processing, and cannabis testing. The company is based in Langley, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Langley",
        "zipcode": "V4W 3X8",
        "website": "http://www.adastralabs.ca",
        "market_cap": "Nano Cap"
    },
    "DB.V": {
        "short_name": "DECIBEL CANNABIS COMPANY INC",
        "long_name": "Decibel Cannabis Company Inc.",
        "summary": "Decibel Cannabis Company Inc. engages the cultivation, processing, production, and retail sale of cannabis products in Canada. It offers cannabis flower under the Qwest and Qwest Reserve brands; and cannabis pre-rolls under the Blendcraft by Qwest brand. The company is also involved in the extraction, processing, and manufacturing of various cannabis derivative products. It also sells bulk amounts of cannabis biomass to licensed producers in Canada. Decibel Cannabis Company Inc. is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2P 3S8",
        "website": "http://www.decibelcc.com",
        "market_cap": "Micro Cap"
    },
    "DBCCF": {
        "short_name": "DECIBEL CANNABIS COMPANY INC",
        "long_name": "Decibel Cannabis Company Inc.",
        "summary": "Decibel Cannabis Company Inc. engages the cultivation, processing, production, and retail sale of cannabis products in Canada. It offers cannabis flower under the Qwest and Qwest Reserve brands; and cannabis pre-rolls under the Blendcraft by Qwest brand. The company is also involved in the extraction, processing, and manufacturing of various cannabis derivative products. It also sells bulk amounts of cannabis biomass to licensed producers in Canada. Decibel Cannabis Company Inc. is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2P 3S8",
        "website": "http://www.decibelcc.com",
        "market_cap": "Micro Cap"
    },
    "DC8.F": {
        "short_name": "DURECT CORP.  DL-,001",
        "long_name": "DURECT Corporation",
        "summary": "DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops DUR-928, an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid homeostasis, inflammation, and cell survival, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; Santen Pharmaceutical Co., Ltd.; Sandoz AG; and Gilead Sciences, Inc. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "CA",
        "city": "Cupertino",
        "zipcode": "95014-4166",
        "website": "http://www.durect.com",
        "market_cap": "Small Cap"
    },
    "DC8.SG": {
        "short_name": "DURECT CORP. Registered Shares ",
        "long_name": "DURECT Corporation",
        "summary": "DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops DUR-928, an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid homeostasis, inflammation, and cell survival, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; Santen Pharmaceutical Co., Ltd.; Sandoz AG; and Gilead Sciences, Inc. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "United States",
        "state": "CA",
        "city": "Cupertino",
        "zipcode": "95014-4166",
        "website": "http://www.durect.com",
        "market_cap": "Small Cap"
    },
    "DEVA.IS": {
        "short_name": "DEVA HOLDING",
        "long_name": "Deva Holding A.S.",
        "summary": "Deva Holding A.S. manufactures and sells pharmaceutical products in Turkey. The company provides antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also offers products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, and sensory organs. In addition, the company offers animal health products and active pharmaceutical ingredients, eye drops, medical ampoules for sterile injectable products, and cologne. It also exports its products to approximately 60 countries. The company was founded in 1958 and is based in Istanbul, Turkey. Deva Holding A.S. is a subsidiary of EastPharma SARL.",
        "currency": "TRY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "IST",
        "market": "tr_market",
        "country": "Turkey",
        "state": null,
        "city": "Istanbul",
        "zipcode": "34303",
        "website": "http://www.deva.com.tr",
        "market_cap": "Small Cap"
    },
    "DFMA.F": {
        "short_name": "IKAENIK FARMS INC.",
        "long_name": "Ik\u00e4nik Farms, Inc.",
        "summary": "Ikanik Farms Inc. operates as an integrated cannabis cultivator, producer, distributor, and dispensary operator. The company is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 3C2",
        "website": "http://www.iknkbrands.com",
        "market_cap": "Micro Cap"
    },
    "DGDM": {
        "short_name": "DIGITAL DEVELOPMENT PARTNERS IN",
        "long_name": "Digital Development Partners, Inc.",
        "summary": "Digital Development Partners, Inc. manufactures and sells cannabidiol (CBD) based products from industrial hemp worldwide. It offers CBD Oils and CBD-infused personal care products; gummies and pet treat; CBD-infused body butter and lip balms; bath bombs; and hand sanitizer gel and spray products under the Grizzly Creek Naturals brand name. The company also manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites. It also sells its products online through the grizzlycreeknaturals.com website. The company is based in Flower Mound, Texas.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "TX",
        "city": "Flower Mound",
        "zipcode": "75022",
        "website": "http://www.digitaldevelopmentpartners.com",
        "market_cap": "Nano Cap"
    },
    "DIOD.ME": {
        "short_name": "DIOD PJSC",
        "long_name": "DIOD Maker of Eco-Friendly Equipment and Nutrition Public Joint Stock Company",
        "summary": "DIOD Maker of Eco-Friendly Equipment and Nutrition Public Joint Stock Company researches, develops, manufactures, and sells nutritional supplements, pharmaceuticals, active cosmetics, and health equipment for home use. The company offers dihydroquercetine that is used in the production of nutritional supplements, drugs, cosmetics, and food additives; biologically active food additives; healthy cosmetics and skin care products; clinical nutrition products; and medical and environmental technology products. It also provides medicines to cure and prevent the development of socially important vascular and coronary diseases, inflammatory joint diseases, and weight-related problems, as well as diseases related to male and female reproductive health. The company markets its products primarily under the Capilar, Arthro-Active, Phase 2, Stella, Viardo, Iod-Active, and Selenium-Active brand names. It sells its products through wholesalers and foreign partners in Russia, Belarus, Ukraine, Kazakhstan, Georgia, Armenia, Serbia, Montenegro, Moldova, Latvia, the Czech Republic, Bulgaria, and internationally. DIOD Maker of Eco-Friendly Equipment and Nutrition Public Joint Stock Company was founded in 1931 and is based in Moscow, Russia.",
        "currency": "RUB",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MCX",
        "market": "ru_market",
        "country": "Russia",
        "state": null,
        "city": "Moscow",
        "zipcode": "115114",
        "website": "http://www.diod.ru",
        "market_cap": "Nano Cap"
    },
    "DIVISLAB.NS": {
        "short_name": "DIVI'S LABORATORIE",
        "long_name": "Divi's Laboratories Limited",
        "summary": "Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates for in the United States, Asia, Europe, and internationally. The company also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. In addition, it exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was founded in 1990 and is headquartered in Hyderabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Hyderabad",
        "zipcode": "500032",
        "website": "http://www.divislabs.com",
        "market_cap": "Large Cap"
    },
    "DKSC": {
        "short_name": "DAKSHIDIN CORP",
        "long_name": "Dakshidin Corporation, Inc.",
        "summary": "Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBD/cannabis-based medical product company. It cultivates cannabis; and operates an online sales portal for CBD products. The company also manages distribution channel programs in the retail distribution, reselling, and direct sales market segments. Dakshidin Corporation, Inc. was formerly known as Avrada, Inc. and changed its name to Dakshidin Corporation, Inc. in February 2007. The company is based in Miami, Florida with additional offices in Las Vegas, Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Miami",
        "zipcode": "33172-3652",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "DLTNF": {
        "short_name": "DELTA 9 CANNABIS INC",
        "long_name": "Delta 9 Cannabis Inc.",
        "summary": "Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis and related merchandise and devices. As of April 14, 2021, it owned and operated 12 retail stores under the Delta 9 Cannabis Store brand. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "MB",
        "city": "Winnipeg",
        "zipcode": "R3L 2V9",
        "website": "http://www.delta9.ca",
        "market_cap": "Nano Cap"
    },
    "DMP.DE": {
        "short_name": "DERMAPHARM HLDG INH O.N.",
        "long_name": "Dermapharm Holding SE",
        "summary": "Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three divisions: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, enzymes, dermatologics, systemic corticoids, women's healthcare, pain treatment, and ophthalmologics primarily under the Dekristol, Allergovit, and Tromcardin brands. In addition, the company provides medical devices under the bite away and Herpotherm names; food supplements under the H\u00c3\u00bcbner brand; and Azedil, a nasal spray and eye drop product to treat acute hay fever symptoms. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. It serves pharmaceutical wholesalers, pharmacies, hospitals, and health food stores. The company was founded in 1991 and is headquartered in Gr\u00c3\u00bcnwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "GER",
        "market": "de_market",
        "country": "Germany",
        "state": null,
        "city": "Gr\u00c3\u00bcnwald",
        "zipcode": "82031",
        "website": "http://www.dermapharm.de",
        "market_cap": "Mid Cap"
    },
    "DMP.F": {
        "short_name": "DERMAPHARM HLDG INH O.N.",
        "long_name": "Dermapharm Holding SE",
        "summary": "Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three divisions: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, enzymes, dermatologics, systemic corticoids, women's healthcare, pain treatment, and ophthalmologics primarily under the Dekristol, Allergovit, and Tromcardin brands. In addition, the company provides medical devices under the bite away and Herpotherm names; food supplements under the H\u00c3\u00bcbner brand; and Azedil, a nasal spray and eye drop product to treat acute hay fever symptoms. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. It serves pharmaceutical wholesalers, pharmacies, hospitals, and health food stores. The company was founded in 1991 and is headquartered in Gr\u00c3\u00bcnwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Gr\u00c3\u00bcnwald",
        "zipcode": "82031",
        "website": "http://www.dermapharm.de",
        "market_cap": "Mid Cap"
    },
    "DN.TO": {
        "short_name": "DELTA 9 CANNABIS INC",
        "long_name": "Delta 9 Cannabis Inc.",
        "summary": "Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis and related merchandise and devices. As of April 14, 2021, it owned and operated 12 retail stores under the Delta 9 Cannabis Store brand. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "MB",
        "city": "Winnipeg",
        "zipcode": "R3L 2V9",
        "website": "http://www.delta9.ca",
        "market_cap": "Nano Cap"
    },
    "DNL.L": {
        "short_name": "DIURNAL GROUP PLC ORD GBP0.05",
        "long_name": "Diurnal Group plc",
        "summary": "Diurnal Group plc operates as a specialty pharma company worldwide. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. The company offers Alkindi, a replacement therapy for paediatric adrenal insufficiency in Europe. It also develops Chronocort, which completed Phase III clinical trials targeting congenital adrenal hyperplasia and adrenal insufficiency. The company's early stage pipeline products comprise Native Oral Testosterone, a replacement treatment for patients suffering from hypogonadism; siRNA, a short interfering RNA oligonucleotide therapy for patients suffering from adrenocorticotropin-dependent Cushing's syndrome; and T3 modified, a modified-release preparation of T3 (levothyroxine) hormone for patients suffering from hypothyroidism. Diurnal Group plc was incorporated in 2015 and is headquartered in Cardiff, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Cardiff",
        "zipcode": "CF14 4UJ",
        "website": "http://www.diurnal.co.uk",
        "market_cap": null
    },
    "DNPUF": {
        "short_name": "SUMITOMO DAINIPPON PHARMA CO LT",
        "long_name": "Sumitomo Dainippon Pharma Co., Ltd.",
        "summary": "Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, diagnostics, and others. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, depression, type 2 diabetes, systemic fungal infection, pruritus, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides atypical antipsychotic, antiepileptic, carbapenem antibiotic, and gastroprokine products; and Anderson-Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, and seasonings, such as soups or bouillons; and chemical product materials consisting of pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, primarily dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. Sumitomo Dainippon Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application (CiRA); Kyoto University; and Aikomi Co., Ltd., as well as a joint development agreement with SanBio, Inc. It also has a strategic research collaboration agreement with Gain Therapeutics, Inc. for the research and development of structurally targeted allosteric regulators to restore functional activity of defective lysosomal enzymes in rare genetic and demyelinating diseases. The company was formerly known as Dainippon Sumitomo Pharma Co., Ltd. and changed its name to Sumitomo Dainippon Pharma Co., Ltd. in June 2014. Sumitomo Dainippon Pharma Co., Ltd. was founded in 1897 and is headquartered in Osaka, Japan. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Japan",
        "state": null,
        "city": "Osaka",
        "zipcode": "541-0045",
        "website": "http://www.ds-pharma.com",
        "market_cap": "Mid Cap"
    },
    "DPA.F": {
        "short_name": "DAITO PHARMACEUTICAL",
        "long_name": "Daito Pharmaceutical Co.,Ltd.",
        "summary": "Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was founded in 1942 and is headquartered in Toyama, Japan.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Japan",
        "state": null,
        "city": "Toyama",
        "zipcode": "939-8567",
        "website": "http://www.daitonet.co.jp",
        "market_cap": "Small Cap"
    },
    "DPM.F": {
        "short_name": "SUMITOMO DAINIPPON PHARMA",
        "long_name": "Sumitomo Dainippon Pharma Co., Ltd.",
        "summary": "Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, diagnostics, and others. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, depression, type 2 diabetes, systemic fungal infection, pruritus, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides atypical antipsychotic, antiepileptic, carbapenem antibiotic, and gastroprokine products; and Anderson-Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, and seasonings, such as soups or bouillons; and chemical product materials consisting of pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, primarily dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. Sumitomo Dainippon Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application (CiRA); Kyoto University; and Aikomi Co., Ltd., as well as a joint development agreement with SanBio, Inc. It also has a strategic research collaboration agreement with Gain Therapeutics, Inc. for the research and development of structurally targeted allosteric regulators to restore functional activity of defective lysosomal enzymes in rare genetic and demyelinating diseases. The company was formerly known as Dainippon Sumitomo Pharma Co., Ltd. and changed its name to Sumitomo Dainippon Pharma Co., Ltd. in June 2014. Sumitomo Dainippon Pharma Co., Ltd. was founded in 1897 and is headquartered in Osaka, Japan. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Japan",
        "state": null,
        "city": "Osaka",
        "zipcode": "541-0045",
        "website": "http://www.ds-pharma.com",
        "market_cap": "Mid Cap"
    },
    "DRREDDY.NS": {
        "short_name": "DR REDDYS LABS",
        "long_name": "Dr. Reddy's Laboratories Limited",
        "summary": "Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosage with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. It also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Proprietary Products segment focuses on the research, development, and manufacture of differentiated formulations for dermatology and neurology therapeutic areas. The company also engages in developing therapies in the fields of oncology and inflammation. As of March 31, 2020, it had four late stage projects at various stages of development. The company's therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. It has collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists; and partnership with Department of Biotechnology - Biotechnology Industry Research Assistance Council for Sputnik V vaccine clinical trials in India. The company was founded in 1984 and is headquartered in Hyderabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Hyderabad",
        "zipcode": "500034",
        "website": "http://www.drreddys.com",
        "market_cap": "Large Cap"
    },
    "DRRX": {
        "short_name": "DURECT Corporation",
        "long_name": "DURECT Corporation",
        "summary": "DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops DUR-928, an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid homeostasis, inflammation, and cell survival, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; Santen Pharmaceutical Co., Ltd.; Sandoz AG; and Gilead Sciences, Inc. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NCM",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Cupertino",
        "zipcode": "95014-4166",
        "website": "http://www.durect.com",
        "market_cap": "Small Cap"
    },
    "DUTV": {
        "short_name": "DIGITAL UTILITIES VENTURES INC",
        "long_name": "Digital Utilities Ventures, Inc.",
        "summary": "Digital Utilities Ventures, Inc., through its wholly owned subsidiary, Torq Communications, Inc., provides real time video transport system for the Internet. It offers The New Last Mile, a first live Internet to TV/cell phone broadcasting system. The company is headquartered in Fort Lauderdale, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Fort Lauderdale",
        "zipcode": "33311",
        "website": "http://www.duventures.com",
        "market_cap": "Nano Cap"
    },
    "DVAX": {
        "short_name": "Dynavax Technologies Corporatio",
        "long_name": "Dynavax Technologies Corporation",
        "summary": "Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "EmeryVille",
        "zipcode": "94608",
        "website": "http://www.dynavax.com",
        "market_cap": "Small Cap"
    },
    "DVL.F": {
        "short_name": "ALLIANCE PHARMA  LS-,01",
        "long_name": "Alliance Pharma plc",
        "summary": "Alliance Pharma plc operates as a pharmaceutical company in the United Kingdom, Republic of Ireland, Mainland Europe, the United States, and internationally. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It owns or licenses the rights to approximately 80 pharmaceutical and consumer healthcare products. The company also offers medical devices, food supplements, and cosmetics. In addition, the company provides its products under the Kelo-Cote, Nizoral, MacuShield, Vamousse, Flamma Franchise, Aloclair, Hydromol, Forceval, Optiflo, Oxyplastine, Ashton & Parsons, and Ametop brand names. Alliance Pharma plc was founded in 1996 and is headquartered in Chippenham, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Chippenham",
        "zipcode": "SN15 2BB",
        "website": "http://www.alliancepharmaceuticals.com",
        "market_cap": "Small Cap"
    },
    "DVLA.JK": {
        "short_name": "Darya-Varia Laboratoria Tbk.",
        "long_name": "PT Darya-Varia Laboratoria Tbk",
        "summary": "PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia and internationally. It operates in three segments: Prescription Drugs, Consumer Health Products, and Export and Toll Manufacturing Services. It provides various prescription and consumer health products in antibiotic, antiparasit, antiseptic, anti-fungal, cough and cold, cardiology, central nervous system, gastro-hepatology, somatic, vitamin and food supplement, women healthcare, ear healthcare, and derma medic areas. The company was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk is a subsidiary of Blue Sphere Singapore Pte. Ltd.",
        "currency": "IDR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JKT",
        "market": "id_market",
        "country": "Indonesia",
        "state": null,
        "city": "Jakarta",
        "zipcode": "12430",
        "website": "http://www.darya-varia.com",
        "market_cap": "Micro Cap"
    },
    "DVLP": {
        "short_name": "GOLDEN DEVELOPING SOLUTIONS INC",
        "long_name": "Golden Developing Solutions, Inc.",
        "summary": "Golden Developing Solutions, Inc., through its subsidiaries, engages in the online retail of cannabidiol (CBD) products. It develops and operates an Internet website that offers CBD, hemp oil, and health/wellness related products, including vitamins, supplements, CBD based tinctures, vapes, soft-gels, and other products. The company was formerly known as Clean Hydrogen Producers, Ltd and changed its name to Golden Developing Solutions, Inc. in April 2017. Golden Developing Solutions, Inc. was incorporated in 1998 and is based in Lakeway, Texas.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "TX",
        "city": "Lakeway",
        "zipcode": "78734",
        "website": "http://goldendeveloping.com",
        "market_cap": "Nano Cap"
    },
    "DYF1.F": {
        "short_name": "DYNAVAX TECHS  DL-,001",
        "long_name": "Dynavax Technologies Corporation",
        "summary": "Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "CA",
        "city": "EmeryVille",
        "zipcode": "94608",
        "website": "http://www.dynavax.com",
        "market_cap": "Small Cap"
    },
    "E2Z.F": {
        "short_name": "ALMIRALL S.A.  EO -,12",
        "long_name": "Almirall, S.A.",
        "summary": "Almirall, S.A., a pharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines worldwide. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, cutaneous T-cell lymphoma, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications; and for central nervous system, cardiovascular, and gastrointestinal diseases. Its products include Actikerall, Solaraze, Cordran Tape, Skilarence, Ilumetri, Seysara, Almax, Crestor, Provisacor, Sativex, Ebastel, Aczone, Tazorac, Azelex, and Veltin. Almirall, S.A. has a strategic research collaboration with Evotec AG to discover and develop first-in-class therapeutics in the field of dermatology diseases; collaborative research and license agreement with X-Chem, Inc. for the development of oral compounds for patients suffering from dermatological diseases; research collaboration with Iktos in the area of artificial intelligence for new drug design; multi-target research collaboration with the University of Dundee to develop novel targeted protein degraders medicines; and collaboration with Popit to provide a novel support solution for patients with psoriasis. It also has a strategic partnership with Tyris Therapeutics to develop gene therapies for the treatment of rare genetic dermatology diseases; and Happify Health to develop evidence-supported digital therapeutics solutions for psoriasis patients. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Spain",
        "state": null,
        "city": "Barcelona",
        "zipcode": "08022",
        "website": "http://www.almirall.com",
        "market_cap": "Mid Cap"
    },
    "E8M.F": {
        "short_name": "ELIXINOL WELLNESS LTD.",
        "long_name": "Elixinol Wellness Limited",
        "summary": "Elixinol Global Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. It distributes hemp-derived cannabidiol products under the Elixinol brand. The company was incorporated in 2017 and is headquartered in Sydney, Australia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Sydney",
        "zipcode": "2000",
        "website": "http://www.elixinolglobal.com",
        "market_cap": "Nano Cap"
    },
    "EAH.L": {
        "short_name": "ECO ANIMAL HEALTH GROUP PLC ORD",
        "long_name": "ECO Animal Health Group plc",
        "summary": "ECO Animal Health Group plc, together with its subsidiaries, develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. The company was founded in 1972 and is headquartered in New Malden, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "New Malden",
        "zipcode": "KT3 4QS",
        "website": "http://www.ecoanimalhealthgroupplc.com",
        "market_cap": null
    },
    "EAPH": {
        "short_name": "EASTON PHARMACEUTICALS INC",
        "long_name": "Easton Pharmaceuticals Inc.",
        "summary": "Easton Pharmaceuticals Inc., a specialty pharmaceutical company, develops and markets various topically delivered drugs to treat cancer and other therapeutic products to treat various conditions. Its products include Nauseasol, a motion sickness gel; Skin Renou HA, an anti-aging wrinkle cream using hyaluronic acid, which keeps the skin smooth; Kenestrin Gel used for arthritis, knees, elbows, shoulders, wrist, and back pain; and Viorra, a hormone free, non-toxic, and topical gel that improves sexual functioning of women. The company was formerly known as LAM Industries, Inc. and changed its name to Easton Pharmaceuticals Inc. in March 2010. Easton Pharmaceuticals Inc. was founded in 1997 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": null,
        "website": null,
        "market_cap": "Nano Cap"
    },
    "EAST.V": {
        "short_name": "EASTWEST BIOSCIENCE INC",
        "long_name": "EastWest Bioscience Inc.",
        "summary": "EastWest Bioscience Inc., a vertically-integrated wellness company, manufactures and sells hemp nutritional products in Canada and the United States. It offers bulk CBD and CBD consumer products, such as pet, beauty and skin care, food, and CBD supplement products, as well as tinctures, nutraceuticals, and chocolate infused CBD products to wholesalers and independent resellers. The company also operates Sangster's Health Center stores that sells supplements and wellness products through its franchise locations and online ecommerce platform. In addition, it is involved in the property management business. EastWest Bioscience Inc. was founded in 2016 and is headquartered in Penticton, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V2A 3J7",
        "website": "http://www.eastwestbioscience.com",
        "market_cap": "Nano Cap"
    },
    "EASY.CN": {
        "short_name": "SpeakEasyCanna",
        "long_name": "Speakeasy Cannabis Club Ltd.",
        "summary": "Speakeasy Cannabis Club Ltd. focuses on producing medical cannabis in Canada. It owns approximately 290 acres of land in Rock Creek, British Columbia. The company is headquartered in Rock Creek, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Rock Creek",
        "zipcode": "V0H 1Y0",
        "website": "http://speakeasygrowers.com",
        "market_cap": "Micro Cap"
    },
    "EAT.CN": {
        "short_name": "NutritionalHi",
        "long_name": "Nutritional High International Inc.",
        "summary": "Nutritional High International Inc. manufactures and processes hemp and marijuana-infused cannabis oils, extracts, and edible products for medical and adult recreation use in the United States and Canada. It offers cannabis-based vaping, concentrate, and infused edible products, such as oil vape cartridges, syringes, dab jars, and mints, as well as cannabis infused chocolates under the FL\u00c3\u008f brand name. The company also distributes other branded cannabis products. Nutritional High International Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5K 1H1",
        "website": "http://www.nutritionalhigh.com",
        "market_cap": "Nano Cap"
    },
    "EBS": {
        "short_name": "Emergent Biosolutions, Inc.",
        "long_name": "Emergent BioSolutions Inc.",
        "summary": "Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response products and solutions for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs). The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers ACAM2000, a smallpox vaccine; BioThrax, an anthrax vaccine; Vaxchora, a cholera vaccine; and Vivotif, a typhoid vaccine. The company also provides NARCAN for the emergency treatment of known or suspected opioid overdose; and Reactive Skin Decontamination Lotion Kit, a medical device to remove or neutralize chemical warfare agents from the skin. In addition, it offers raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to treat inhalational anthrax; Botulism Antitoxin Heptavalent for treating botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccination; and Trobigard a combination drug-device auto injector product candidate. Further, the company is developing COVID-EIG and COVID-HIG potential treatments to COVID-19 disease; and FLU-IGIV for the treatment of Influenza A infection in hospitalized patients. Additionally, it provides contract development and manufacturing service that comprises development services, drug substance manufacturing, and drug product manufacturing in the pharmaceutical and biotechnology industries, as well as the governments and non-governmental organizations. The company has collaboration agreements with Novavax Inc.; and Johnson & Johnson. Emergent BioSolutions Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "United States",
        "state": "MD",
        "city": "Gaithersburg",
        "zipcode": "20879",
        "website": "http://www.emergentbiosolutions.com",
        "market_cap": "Mid Cap"
    },
    "ECGS": {
        "short_name": "ECO GROWTH STRATEGIES INC",
        "long_name": "Eco-Growth Strategies Inc.",
        "summary": "Eco-Growth Strategies Inc., a nutraceutical company, develops various CBD-based products. It offers CBD extraction services under the XtractionOne Plus name. The company is based in Orangevale, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Orangevale",
        "zipcode": "95662",
        "website": "http://ecogrowthstrategies.com",
        "market_cap": null
    },
    "ECOX": {
        "short_name": "ECO INNOVATION GROUP INC",
        "long_name": "Eco Innovation Group, Inc.",
        "summary": "Eco Innovation Group, Inc. focuses on the development of power booster for home and office applications that will reduce electric bills. It also provides other energy saving related technologies. Eco Innovation Group, Inc. is based in Van Nuys, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Van Nuys",
        "zipcode": "91406",
        "website": "http://www.ecoig.com",
        "market_cap": "Nano Cap"
    },
    "ECS.AX": {
        "short_name": "ECSBOTANIC FPO",
        "long_name": "ECS Botanics Holdings Ltd",
        "summary": "ECS Botanics Holdings Ltd, an agribusiness and hemp food company, cultivates and processes industrial hemp in Australia. It also supplies bulk hemp foods for cafes, whole food suppliers, food brands, or food manufacturers, as well as hemp seed to licensed operators for processing and sowing. The company is based in Launceston, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "TAS",
        "city": "Launceston",
        "zipcode": "7302",
        "website": "http://ecsbotanics.com.au",
        "market_cap": "Nano Cap"
    },
    "EDEN.CN": {
        "short_name": "EdenEmpireInc",
        "long_name": "Eden Empire Inc.",
        "summary": "Eden Empire Inc. invests in and operates in the cannabis sector. It engages in the retail sale of cannabis in Canada and the United States. Eden Empire Inc. is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V7V 4G8",
        "website": "http://myeden.ca",
        "market_cap": "Nano Cap"
    },
    "EEVVF": {
        "short_name": "EVE & CO INCORPORATED",
        "long_name": "Eve & Co Incorporated",
        "summary": "Eve & Co Incorporated, through its subsidiary, Natural MedCo Ltd., produces and sells dried cannabis, cannabis plants, and cannabis seeds in Canada. It offers cannabis for women under the EVE brand. The company is headquartered in Strathroy, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Strathroy",
        "zipcode": "N7G 3H8",
        "website": "http://www.evecannabis.ca",
        "market_cap": "Nano Cap"
    },
    "EFLI": {
        "short_name": "CELLTECH INTERNATIONAL INC",
        "long_name": "New Earth Life Sciences, Inc.",
        "summary": "New Earth Life Sciences, Inc. harvests, processes, manufactures, and sells dietary supplements. Its dietary supplements are marketed under the Wild Essentials, EDGE, and GIVE brand names. The company is based in Klamath Falls, Oregon.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "OR",
        "city": "Klamath Falls",
        "zipcode": "97601",
        "website": "http://www.newearth.com",
        "market_cap": "Nano Cap"
    },
    "EGRX": {
        "short_name": "Eagle Pharmaceuticals, Inc.",
        "long_name": "Eagle Pharmaceuticals, Inc.",
        "summary": "Eagle Pharmaceuticals, Inc., a biotechnology pharmaceutical company, focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also includes EP-4104, a dantrolene sodium for exertional heat stroke, as well as to treat organophosphate exposure; EP-5101 (PEMFEXY) for lung cancer and mesothelioma; EGL-5385-C-1701 (fulvestrant) for breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has a strategic collaboration with Tyme Technologies, Inc. to advance oral SM-88 for the treatment of patients with cancer. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "Woodcliff Lake",
        "zipcode": "07677",
        "website": "http://www.eagleus.com",
        "market_cap": "Small Cap"
    },
    "EII.F": {
        "short_name": "EISAI CO. LTD",
        "long_name": "Eisai Co., Ltd.",
        "summary": "Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. Eisai Co., Ltd. has a research collaboration agreement with Wren Therapeutics Ltd. for the discovery of small molecules that target synuclein for the potential treatment of synucleinopathies, including Parkinson's disease and dementia with Lewy bodies; and a collaboration with BioLabs for the launch of the Eisai Innovation Center BioLabs, a shared lab and office space for start-ups to innovate in the field of neurological diseases. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was founded in 1941 and is headquartered in Tokyo, Japan.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "112-8088",
        "website": "http://www.eisai.co.jp",
        "market_cap": "Large Cap"
    },
    "ELAN": {
        "short_name": "Elanco Animal Health Incorporat",
        "long_name": "Elanco Animal Health Incorporated",
        "summary": "Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "United States",
        "state": "IN",
        "city": "Greenfield",
        "zipcode": "46140",
        "website": "http://www.elanco.com",
        "market_cap": "Large Cap"
    },
    "ELIXF": {
        "short_name": "ELIXXER LTD",
        "long_name": "Elixxer Ltd.",
        "summary": "Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It focuses on invests in medical and specialty cannabis derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. is based in Montreal, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "QC",
        "city": "Montreal",
        "zipcode": "H4Z 1E9",
        "website": "http://www.elixxer.com",
        "market_cap": "Nano Cap"
    },
    "ELLXF": {
        "short_name": "ELIXINOL WELLNESS LTD",
        "long_name": "Elixinol Wellness Limited",
        "summary": "Elixinol Global Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. It distributes hemp-derived cannabidiol products under the Elixinol brand. The company was incorporated in 2017 and is headquartered in Sydney, Australia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Sydney",
        "zipcode": "2000",
        "website": "http://www.elixinolglobal.com",
        "market_cap": "Nano Cap"
    },
    "ELN.F": {
        "short_name": "ELANIX BIOTECHN.AG",
        "long_name": "Elanix Biotechnologies AG",
        "summary": "Elanix Biotechnologies AG, a tissue regeneration company, develops and commercializes products for acute wound care, dermatological, and gynecological applications, and provides cell technology services. It also owns cell banks containing various quantities of cells. The company was founded in 1966 and is headquartered in Epalinges, Switzerland.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Switzerland",
        "state": null,
        "city": "Epalinges",
        "zipcode": "1066",
        "website": "http://www.elanixbiotechnologies.ch",
        "market_cap": "Nano Cap"
    },
    "ELTP": {
        "short_name": "ELITE PHARMACEUTICALS INC",
        "long_name": "Elite Pharmaceuticals, Inc.",
        "summary": "Elite Pharmaceuticals, Inc. engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Hydromorphone HCl 8mg tablets for pains under the Dilaudid brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases. The company also provides Oxycodone HCl immediate release 5mg, 10mg, 15mg, 20mg, and 30mg tablets for pains under Roxycodone brand; Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Methadone HCl tablets for pains under the Dolophine brand; and Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets for central nervous system diseases under the Adderall brand, as well as Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; and SequestOX, an immediate release Oxycodone with Naltrexone. In addition, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, and infection. Further, the company is developing a range of abuse deterrent opioid products. It has a manufacturing and license agreement with Epic Pharma LLC; development and license agreement with SunGen Pharma, LLC; and strategic marketing alliance with Glenmark Pharmaceuticals, Inc. USA, as well as Lannett Company. Inc. The company was founded in 1984 and is headquartered in Northvale, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "Northvale",
        "zipcode": "07647",
        "website": "http://www.elitepharma.com",
        "market_cap": "Micro Cap"
    },
    "ELXR.V": {
        "short_name": "ELIXXER LTD",
        "long_name": "Elixxer Ltd.",
        "summary": "Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It focuses on invests in medical and specialty cannabis derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. is based in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "QC",
        "city": "Montreal",
        "zipcode": "H4Z 1E9",
        "website": "http://www.elixxer.com",
        "market_cap": "Nano Cap"
    },
    "EMGE": {
        "short_name": "EMERGENT HEALTH CORP",
        "long_name": "Emergent Health Corp",
        "summary": "Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "PA",
        "city": "King of Prussia",
        "zipcode": "19406",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "EMH.CN": {
        "short_name": "Emerald Heal",
        "long_name": "Emerald Health Therapeutics, Inc.",
        "summary": "Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1J8",
        "website": "http://emeraldhealth.ca",
        "market_cap": "Nano Cap"
    },
    "EMHTF": {
        "short_name": "EMERALD HEALTH THERAPEUTICS INC",
        "long_name": "Emerald Health Therapeutics, Inc.",
        "summary": "Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1J8",
        "website": "http://emeraldhealth.ca",
        "market_cap": "Nano Cap"
    },
    "EN9.F": {
        "short_name": "ENZYMATICA AB",
        "long_name": "Enzymatica AB",
        "summary": "Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and internationally. Its product includes ColdZyme mouth spray, which prevents cold and reduces the duration of illness. The company also provides ColdZyme mouth spray under the PreCold name in Iceland; ViruProtect name in Austria and Belgium; ColdGuard name in South Africa; Zerinol Virus Defense in Italy; and Psysiomer Stop Virus in France. It also offers STADAProtect, a mouth spray to protect and care oral cavity, as well as enzyme formulations. Enzymatica AB was incorporated in 2007 and is based in Lund, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Lund",
        "zipcode": "223 70",
        "website": "http://www.enzymatica.se",
        "market_cap": "Micro Cap"
    },
    "ENDP": {
        "short_name": "Endo International plc",
        "long_name": "Endo International plc",
        "summary": "Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Ireland",
        "state": null,
        "city": "Dublin",
        "zipcode": "4",
        "website": "http://www.endo.com",
        "market_cap": "Small Cap"
    },
    "ENZY.ST": {
        "short_name": "Enzymatica AB",
        "long_name": "Enzymatica AB",
        "summary": "Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and internationally. Its product includes ColdZyme mouth spray, which prevents cold and reduces the duration of illness. The company also provides ColdZyme mouth spray under the PreCold name in Iceland; ViruProtect name in Austria and Belgium; ColdGuard name in South Africa; Zerinol Virus Defense in Italy; and Psysiomer Stop Virus in France. It also offers STADAProtect, a mouth spray to protect and care oral cavity, as well as enzyme formulations. Enzymatica AB was incorporated in 2007 and is based in Lund, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Lund",
        "zipcode": "223 70",
        "website": "http://www.enzymatica.se",
        "market_cap": "Micro Cap"
    },
    "EO7.F": {
        "short_name": "ENDO INTERNATL  DL-,0001",
        "long_name": "Endo International plc",
        "summary": "Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Ireland",
        "state": null,
        "city": "Dublin",
        "zipcode": "4",
        "website": "http://www.endo.com",
        "market_cap": "Small Cap"
    },
    "EOF.AX": {
        "short_name": "ECOFIBRE FPO",
        "long_name": "Ecofibre Limited",
        "summary": "Ecofibre Limited, together with its subsidiaries, engages in breeding, growing, processing, and distributing hemp products in the United States and Australia. It offers protein powders, dehulled hemp seeds, and hemp seed oil products. The company also produces hemp nutraceutical products for human and pet consumption, as well as topical creams and salves; and develops hemp related fiber products. It sells its products through wholesalers and distributors, as well as pharmacy stores under the Ananda Food and Woolworths Macro brand names. The company was founded in 2009 and is based in Sydney, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Sydney",
        "zipcode": "2000",
        "website": "http://www.ecofibre.com",
        "market_cap": "Micro Cap"
    },
    "EOFBF": {
        "short_name": "ECOFIBRE LTD",
        "long_name": "Ecofibre Limited",
        "summary": "Ecofibre Limited, together with its subsidiaries, engages in breeding, growing, processing, and distributing hemp products in the United States and Australia. It offers protein powders, dehulled hemp seeds, and hemp seed oil products. The company also produces hemp nutraceutical products for human and pet consumption, as well as topical creams and salves; and develops hemp related fiber products. It sells its products through wholesalers and distributors, as well as pharmacy stores under the Ananda Food and Woolworths Macro brand names. The company was founded in 2009 and is based in Sydney, Australia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Sydney",
        "zipcode": "2000",
        "website": "http://www.ecofibre.com",
        "market_cap": "Micro Cap"
    },
    "EOLS": {
        "short_name": "Evolus, Inc. Common Stock",
        "long_name": "Evolus, Inc.",
        "summary": "Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was founded in 2012 and is headquartered in Newport Beach, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Newport Beach",
        "zipcode": "92660",
        "website": "http://www.evolus.com",
        "market_cap": "Small Cap"
    },
    "EPIC.CN": {
        "short_name": "LeviathanNat",
        "long_name": "Leviathan Natural Products Inc.",
        "summary": "Leviathan Natural Products Inc. engages in cultivating, processing, and distributing of cannabis and hemp products in Canada, the United States, and Colombia. The company was formerly known as Leviathan Cannabis Group Inc. and changed its name to Leviathan Natural Products Inc. in July 2020. Leviathan Natural Products Inc. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 4J6",
        "website": "http://leviathan-naturals.com",
        "market_cap": "Nano Cap"
    },
    "EPN.AX": {
        "short_name": "EPSILON FPO",
        "long_name": "Epsilon Healthcare Limited",
        "summary": "Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Sydney",
        "zipcode": "2000",
        "website": "http://www.epsilonhealthcare.com.au",
        "market_cap": "Nano Cap"
    },
    "ER4.F": {
        "short_name": "EMERGENT BIOSOLNS DL-,001",
        "long_name": "Emergent BioSolutions Inc.",
        "summary": "Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response products and solutions for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs). The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers ACAM2000, a smallpox vaccine; BioThrax, an anthrax vaccine; Vaxchora, a cholera vaccine; and Vivotif, a typhoid vaccine. The company also provides NARCAN for the emergency treatment of known or suspected opioid overdose; and Reactive Skin Decontamination Lotion Kit, a medical device to remove or neutralize chemical warfare agents from the skin. In addition, it offers raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to treat inhalational anthrax; Botulism Antitoxin Heptavalent for treating botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccination; and Trobigard a combination drug-device auto injector product candidate. Further, the company is developing COVID-EIG and COVID-HIG potential treatments to COVID-19 disease; and FLU-IGIV for the treatment of Influenza A infection in hospitalized patients. Additionally, it provides contract development and manufacturing service that comprises development services, drug substance manufacturing, and drug product manufacturing in the pharmaceutical and biotechnology industries, as well as the governments and non-governmental organizations. The company has collaboration agreements with Novavax Inc.; and Johnson & Johnson. Emergent BioSolutions Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "MD",
        "city": "Gaithersburg",
        "zipcode": "20879",
        "website": "http://www.emergentbiosolutions.com",
        "market_cap": "Mid Cap"
    },
    "ERBB": {
        "short_name": "AMERICAN GREEN INC",
        "long_name": "American Green, Inc.",
        "summary": "American Green, Inc. operates as a technology company in the medical cannabis industry in the United States. It develops retail, brand, and commercial cultivating solutions in partnership with licensed retail medical marijuana dispensaries operated under the American Green brand name. The company operates ZaZZZ, a consumer operated marijuana vending machine for automated, age-verifying dispensing of cannabis-based medicines. It also offers Jurassic Water for cannabis plants; truth lighting, a LED lighting solution; and OG tea nutrients, a specialty fertilizer product. It has collaboration agreement with Endexx Corporation to develop the Access Control Identification and Verification Vending Platform. The company was formerly known as Tranzbyte Corporation and changed its name to American Green, Inc. in May 2014. American Green, Inc. is headquartered in Tempe, Arizona.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "AZ",
        "city": "Tempe",
        "zipcode": "85284",
        "website": "http://www.americangreen.com",
        "market_cap": "Micro Cap"
    },
    "ERIS.NS": {
        "short_name": "ERIS LIFESCIENCES",
        "long_name": "Eris Lifesciences Limited",
        "summary": "Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, anti\u00c2\u0096diabetes, anti- infective, antipyretics, vitamins/nutrients, gastroenterology, acute and chronic respiratory, gynecology, pediatrics, neurology, psychiatry, arthritis, and pain/analgesics, as well as in-vitro fertilization, cancer, multi-therapy, cosmetology, and dermatology. The company also provides blood pressure monitors, infra-red thermometers, nebulizer, and pregnancy testing kits. Eris Lifesciences Limited was founded in 2007 and is based in Ahmedabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Ahmedabad",
        "zipcode": "380015",
        "website": "http://www.eris.co.in",
        "market_cap": "Small Cap"
    },
    "ERMA.ST": {
        "short_name": "Enorama Pharma AB",
        "long_name": "Enorama Pharma AB (publ)",
        "summary": "Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. It offers nicotine chewing gum for smoking cessation and medical cannabis chewing gums for non-pharma applications, as well as for other applications, such as oromucosal drug delivery and allergic rhinitis. The company is based in Malm\u00c3\u00b6, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Malm\u00c3\u00b6",
        "zipcode": null,
        "website": "http://www.enorama.se",
        "market_cap": "Nano Cap"
    },
    "ERV2.F": {
        "short_name": "MOLECULE HOLDINGS",
        "long_name": "Molecule Holdings Inc.",
        "summary": "Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages. The company is based in Lansdowne, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Lansdowne",
        "zipcode": "K0E 1L0",
        "website": "http://www.molecule.ca",
        "market_cap": "Nano Cap"
    },
    "ESALY": {
        "short_name": "EISAI CO",
        "long_name": "Eisai Co., Ltd.",
        "summary": "Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. Eisai Co., Ltd. has a research collaboration agreement with Wren Therapeutics Ltd. for the discovery of small molecules that target synuclein for the potential treatment of synucleinopathies, including Parkinson's disease and dementia with Lewy bodies; and a collaboration with BioLabs for the launch of the Eisai Innovation Center BioLabs, a shared lab and office space for start-ups to innovate in the field of neurological diseases. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was founded in 1941 and is headquartered in Tokyo, Japan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "112-8088",
        "website": "http://www.eisai.co.jp",
        "market_cap": "Large Cap"
    },
    "ETF.SG": {
        "short_name": "ELITE PHARMACEUTICALS INC. Regi",
        "long_name": "Elite Pharmaceuticals, Inc.",
        "summary": "Elite Pharmaceuticals, Inc. engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Hydromorphone HCl 8mg tablets for pains under the Dilaudid brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases. The company also provides Oxycodone HCl immediate release 5mg, 10mg, 15mg, 20mg, and 30mg tablets for pains under Roxycodone brand; Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Methadone HCl tablets for pains under the Dolophine brand; and Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets for central nervous system diseases under the Adderall brand, as well as Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; and SequestOX, an immediate release Oxycodone with Naltrexone. In addition, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, and infection. Further, the company is developing a range of abuse deterrent opioid products. It has a manufacturing and license agreement with Epic Pharma LLC; development and license agreement with SunGen Pharma, LLC; and strategic marketing alliance with Glenmark Pharmaceuticals, Inc. USA, as well as Lannett Company. Inc. The company was founded in 1984 and is headquartered in Northvale, New Jersey.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "United States",
        "state": "NJ",
        "city": "Northvale",
        "zipcode": "07647",
        "website": "http://www.elitepharma.com",
        "market_cap": "Micro Cap"
    },
    "ETST": {
        "short_name": "EARTH SCIENCE TECH INC",
        "long_name": "Earth Science Tech, Inc.",
        "summary": "Earth Science Tech, Inc., a biotechnology company, focuses on delivering nutraceuticals, bioceuticals, and dietary supplements in the areas of health, wellness, nutrition, supplement, cosmetic, and alternative medicine worldwide. The company focuses on delivering nutritional and dietary supplements for the treatment of chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, and aging. Its products include vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods, and other products. The company markets its products in a range of formulations and delivery forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs. It also offers Cannabidiol oil to retailers in the vaping industry; and cannabinoid products. In addition, the company retails health, wellness, sports nutrition, and dietary supplement products. Earth Science Tech, Inc. offers its products through its retail store located in Coral Gables, Florida, as well as through the internet. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in April 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Doral, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Doral",
        "zipcode": "33122",
        "website": "http://www.earthsciencetech.com",
        "market_cap": "Nano Cap"
    },
    "EV0.F": {
        "short_name": "EVOKE PHARMA INC.DL-,0001",
        "long_name": "Evoke Pharma, Inc.",
        "summary": "Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "CA",
        "city": "Solana Beach",
        "zipcode": "92075",
        "website": "http://www.evokepharma.com",
        "market_cap": "Nano Cap"
    },
    "EVE.V": {
        "short_name": "EVE AND CO INCORPORATED",
        "long_name": "Eve & Co Incorporated",
        "summary": "Eve & Co Incorporated, through its subsidiary, Natural MedCo Ltd., produces and sells dried cannabis, cannabis plants, and cannabis seeds in Canada. It offers cannabis for women under the EVE brand. The company is headquartered in Strathroy, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Strathroy",
        "zipcode": "N7G 3H8",
        "website": "http://www.evecannabis.ca",
        "market_cap": "Nano Cap"
    },
    "EVIO": {
        "short_name": "EVIO INC",
        "long_name": "EVIO, Inc.",
        "summary": "EVIO, Inc., together with its subsidiaries, provides analytical testing and advisory services to cannabis industry in the United States. The company's consulting services include advisory, product formulation, and licensing and compliance services. It also offers various testing services comprise cannabinoid potency testing, terpene analysis, pesticide testing, residual solvent screening, visual inspections, biological contaminant testing, and other services. EVIO, Inc. is headquartered in Henderson, Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Henderson",
        "zipcode": "89052",
        "website": "http://eviolabs.com",
        "market_cap": "Nano Cap"
    },
    "EVL.F": {
        "short_name": "EVOLUS INC.  DL-,00001",
        "long_name": "Evolus, Inc.",
        "summary": "Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was founded in 2012 and is headquartered in Newport Beach, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "CA",
        "city": "Newport Beach",
        "zipcode": "92660",
        "website": "http://www.evolus.com",
        "market_cap": "Small Cap"
    },
    "EVOK": {
        "short_name": "Evoke Pharma, Inc.",
        "long_name": "Evoke Pharma, Inc.",
        "summary": "Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Solana Beach",
        "zipcode": "92075",
        "website": "http://www.evokepharma.com",
        "market_cap": "Micro Cap"
    },
    "EVOTF": {
        "short_name": "EVOTEC SE",
        "long_name": "Evotec SE",
        "summary": "Evotec SE provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. The company's EVT Execute segment offers drug discovery services, such as target identification and validation, hit identification, sample management, chemistry, drug metabolism and pharmacokinetics, research informatics and in silico drug discovery, proteomics and metabolomics, bio-reagents, in vitro biology, in vivo pharmacology, biomarkers, and antibody discovery; INDiGO, a program for accelerating drug development; integrated chemistry, manufacturing, and control services; integrated drug discovery services; and integrated pre-clinical development services. Its EVT Innovate segment is involved in developing drug discovery projects, assets, and platforms. The company's portfolio of research and development programs include diabetes and diabetic complications, fibrosis, immunology, infectious and inflammatory diseases, kidney and liver diseases, oncological and rare diseases, pain, respiratory diseases, and women's health. Evotec SE was founded in 1993 and is headquartered in Hamburg, Germany.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Germany",
        "state": null,
        "city": "Hamburg",
        "zipcode": "22419",
        "website": "http://www.evotec.com",
        "market_cap": "Mid Cap"
    },
    "EVRRF": {
        "short_name": "MOLECULE HOLDINGS INC",
        "long_name": "Molecule Holdings Inc.",
        "summary": "Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages. The company is based in Lansdowne, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Lansdowne",
        "zipcode": "K0E 1L0",
        "website": "http://www.molecule.ca",
        "market_cap": "Nano Cap"
    },
    "EVT.DE": {
        "short_name": "EVOTEC SE  INH O.N.",
        "long_name": "Evotec SE",
        "summary": "Evotec SE provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. The company's EVT Execute segment offers drug discovery services, such as target identification and validation, hit identification, sample management, chemistry, drug metabolism and pharmacokinetics, research informatics and in silico drug discovery, proteomics and metabolomics, bio-reagents, in vitro biology, in vivo pharmacology, biomarkers, and antibody discovery; INDiGO, a program for accelerating drug development; integrated chemistry, manufacturing, and control services; integrated drug discovery services; and integrated pre-clinical development services. Its EVT Innovate segment is involved in developing drug discovery projects, assets, and platforms. The company's portfolio of research and development programs include diabetes and diabetic complications, fibrosis, immunology, infectious and inflammatory diseases, kidney and liver diseases, oncological and rare diseases, pain, respiratory diseases, and women's health. Evotec SE was founded in 1993 and is headquartered in Hamburg, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "GER",
        "market": "de_market",
        "country": "Germany",
        "state": null,
        "city": "Hamburg",
        "zipcode": "22419",
        "website": "http://www.evotec.com",
        "market_cap": "Mid Cap"
    },
    "EVT.F": {
        "short_name": "EVOTEC SE  INH O.N.",
        "long_name": "Evotec SE",
        "summary": "Evotec SE provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. The company's EVT Execute segment offers drug discovery services, such as target identification and validation, hit identification, sample management, chemistry, drug metabolism and pharmacokinetics, research informatics and in silico drug discovery, proteomics and metabolomics, bio-reagents, in vitro biology, in vivo pharmacology, biomarkers, and antibody discovery; INDiGO, a program for accelerating drug development; integrated chemistry, manufacturing, and control services; integrated drug discovery services; and integrated pre-clinical development services. Its EVT Innovate segment is involved in developing drug discovery projects, assets, and platforms. The company's portfolio of research and development programs include diabetes and diabetic complications, fibrosis, immunology, infectious and inflammatory diseases, kidney and liver diseases, oncological and rare diseases, pain, respiratory diseases, and women's health. Evotec SE was founded in 1993 and is headquartered in Hamburg, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Hamburg",
        "zipcode": "22419",
        "website": "http://www.evotec.com",
        "market_cap": "Mid Cap"
    },
    "EVT.VI": {
        "short_name": "EVOTEC SE",
        "long_name": "Evotec SE",
        "summary": "Evotec SE provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. The company's EVT Execute segment offers drug discovery services, such as target identification and validation, hit identification, sample management, chemistry, drug metabolism and pharmacokinetics, research informatics and in silico drug discovery, proteomics and metabolomics, bio-reagents, in vitro biology, in vivo pharmacology, biomarkers, and antibody discovery; INDiGO, a program for accelerating drug development; integrated chemistry, manufacturing, and control services; integrated drug discovery services; and integrated pre-clinical development services. Its EVT Innovate segment is involved in developing drug discovery projects, assets, and platforms. The company's portfolio of research and development programs include diabetes and diabetic complications, fibrosis, immunology, infectious and inflammatory diseases, kidney and liver diseases, oncological and rare diseases, pain, respiratory diseases, and women's health. Evotec SE was founded in 1993 and is headquartered in Hamburg, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VIE",
        "market": "at_market",
        "country": "Germany",
        "state": null,
        "city": "Hamburg",
        "zipcode": "22419",
        "website": "http://www.evotec.com",
        "market_cap": "Mid Cap"
    },
    "EVTA.F": {
        "short_name": "EVOTEC SE ADR/2 O.N.",
        "long_name": "Evotec SE",
        "summary": "Evotec SE provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. The company's EVT Execute segment offers drug discovery services, such as target identification and validation, hit identification, sample management, chemistry, drug metabolism and pharmacokinetics, research informatics and in silico drug discovery, proteomics and metabolomics, bio-reagents, in vitro biology, in vivo pharmacology, biomarkers, and antibody discovery; INDiGO, a program for accelerating drug development; integrated chemistry, manufacturing, and control services; integrated drug discovery services; and integrated pre-clinical development services. Its EVT Innovate segment is involved in developing drug discovery projects, assets, and platforms. The company's portfolio of research and development programs include diabetes and diabetic complications, fibrosis, immunology, infectious and inflammatory diseases, kidney and liver diseases, oncological and rare diseases, pain, respiratory diseases, and women's health. Evotec SE was founded in 1993 and is headquartered in Hamburg, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Hamburg",
        "zipcode": "22419",
        "website": "http://www.evotec.com",
        "market_cap": "Mid Cap"
    },
    "EVTCY": {
        "short_name": "EVOTEC SE",
        "long_name": "Evotec SE",
        "summary": "Evotec SE provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. The company's EVT Execute segment offers drug discovery services, such as target identification and validation, hit identification, sample management, chemistry, drug metabolism and pharmacokinetics, research informatics and in silico drug discovery, proteomics and metabolomics, bio-reagents, in vitro biology, in vivo pharmacology, biomarkers, and antibody discovery; INDiGO, a program for accelerating drug development; integrated chemistry, manufacturing, and control services; integrated drug discovery services; and integrated pre-clinical development services. Its EVT Innovate segment is involved in developing drug discovery projects, assets, and platforms. The company's portfolio of research and development programs include diabetes and diabetic complications, fibrosis, immunology, infectious and inflammatory diseases, kidney and liver diseases, oncological and rare diseases, pain, respiratory diseases, and women's health. Evotec SE was founded in 1993 and is headquartered in Hamburg, Germany.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Germany",
        "state": null,
        "city": "Hamburg",
        "zipcode": "22419",
        "website": "http://www.evotec.com",
        "market_cap": "Mid Cap"
    },
    "EXDI": {
        "short_name": "EXACTUS INC",
        "long_name": "Exactus, Inc.",
        "summary": "Exactus, Inc. produces and supplies hemp and hemp-derived products in the United States. It provides cannabidiol (CBD) feminized genetics, high cannabigerol (CBG) feminized genetics, hemp-derived specialty ingredients, and white-label products to the cosmetic, wellness, food, beverage, pharmaceutical, and pet industries. The company's specialty ingredients include CBD, CBG, CBN, and CBC isolates; CBD and CBG distillates; CBD water-soluble; CBD and CBG biomass; CBD AND CBG flowers; and CBD crude oil. It also provides a range of custom manufactured specialty cannabinoid products, such as skincare products, pain creams, tinctures, bath bombs, soft gels, balms, pet products, supplements, and other products. The company is based in Delray Beach, Florida. Exactus, Inc. is a subsidiary of Ceed2Med, LLC.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Delray Beach",
        "zipcode": "33483",
        "website": "http://www.exactushemp.com",
        "market_cap": "Nano Cap"
    },
    "EXL.AX": {
        "short_name": "ELIXINOL FPO",
        "long_name": "Elixinol Wellness Limited",
        "summary": "Elixinol Global Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. It distributes hemp-derived cannabidiol products under the Elixinol brand. The company was incorporated in 2017 and is headquartered in Sydney, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Sydney",
        "zipcode": "2000",
        "website": "http://www.elixinolglobal.com",
        "market_cap": "Nano Cap"
    },
    "EXMT": {
        "short_name": "ANYTHING TECHNOLOGIES MEDIA INC",
        "long_name": "Anything Technologies Media, Inc.",
        "summary": "Anything Technologies Media, Inc. provides media duplication/replication and fulfillment services. The company offers duplication and replication services for DVDs, Blu-ray discs, and CDs; and USB duplication and printing services. It also provides supply chain solutions fulfillment and mailing services, custom silk-screen/offset media printing and packaging, and DVD and Blu-ray authoring/encoding services; and Website hosting, design, and SEO services. The company was formerly known as Exchange Mobile Telecommunications Corp. and changed its name to Anything Technologies Media, Inc. in September 2010. Anything Technologies Media, Inc. was founded in 1997 and is based in Ione, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Ione",
        "zipcode": "95640",
        "website": "http://www.anythingtechnologiesmedia.com",
        "market_cap": "Nano Cap"
    },
    "EXP.V": {
        "short_name": "EXPERION HOLDINGS LTD",
        "long_name": "Experion Holdings Ltd.",
        "summary": "Experion Holdings Ltd., through its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada. Its products are used for adult-use, wellness and therapeutic, and medical applications. Experion Holdings Ltd. offers its products under the Citizen Stash and Kanabe brand names. The company was formerly known as Viridium Pacific Group Ltd. and changed its name to Experion Holdings Ltd. in June 2019. Experion Holdings Ltd. is headquartered in Mission, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Mission",
        "zipcode": "V2V 0A6",
        "website": "http://www.experionwellness.com",
        "market_cap": "Nano Cap"
    },
    "EXPFF": {
        "short_name": "EXPERION HOLDINGS LTD",
        "long_name": "Experion Holdings Ltd.",
        "summary": "Experion Holdings Ltd., through its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada. Its products are used for adult-use, wellness and therapeutic, and medical applications. Experion Holdings Ltd. offers its products under the Citizen Stash and Kanabe brand names. The company was formerly known as Viridium Pacific Group Ltd. and changed its name to Experion Holdings Ltd. in June 2019. Experion Holdings Ltd. is headquartered in Mission, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Mission",
        "zipcode": "V2V 0A6",
        "website": "http://www.experionwellness.com",
        "market_cap": "Nano Cap"
    },
    "F11.F": {
        "short_name": "FLOWER ONE HOLDINGS INC",
        "long_name": "Flower One Holdings Inc.",
        "summary": "Flower One Holdings Inc., through its subsidiaries, cultivates and produces cannabis for the recreational and medical cannabis markets in Nevada. It owns and operates 400,000 square-foot greenhouse for the cultivation of marijuana and 55,000 square-foot production facility in Nevada; and 25,000 square-foot indoor cultivation and a commercial kitchen in Las Vegas. The company cultivates, processes, produces, and packages dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals, and infused products; and leases a warehouse in North Las Vegas. It sells its products directly to dispensaries; wholesale cannabis products; and provision of contract cultivation, production, and packaging consumer cannabis brands. The company headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 2R9",
        "website": "http://www.flowerone.com",
        "market_cap": "Micro Cap"
    },
    "F11.MU": {
        "short_name": "FLOWER ONE HOLDINGS INC",
        "long_name": "Flower One Holdings Inc.",
        "summary": "Flower One Holdings Inc., through its subsidiaries, cultivates and produces cannabis for the recreational and medical cannabis markets in Nevada. It owns and operates 400,000 square-foot greenhouse for the cultivation of marijuana and 55,000 square-foot production facility in Nevada; and 25,000 square-foot indoor cultivation and a commercial kitchen in Las Vegas. The company cultivates, processes, produces, and packages dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals, and infused products; and leases a warehouse in North Las Vegas. It sells its products directly to dispensaries; wholesale cannabis products; and provision of contract cultivation, production, and packaging consumer cannabis brands. The company headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MUN",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 2R9",
        "website": "http://www.flowerone.com",
        "market_cap": "Micro Cap"
    },
    "FAE.MC": {
        "short_name": "FAES FARMA, S.A.",
        "long_name": "Faes Farma, S.A.",
        "summary": "Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter (OTC) drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for ulcerative colitis and Crohn's disease; Dezacor, a corticoid; Dolotren, an anti-inflammatory; Dolotren Gel; Dynamogen, an anti-anorexic; Ferroprotina, an anti-anaemic; Hidroferol; Lipofen; Positon for dermatitis; strength builder products, such as Potenciator and Surmenalit; Pruina, a laxative; Robaxisal Compuesto, a muscle relaxant and analgesic; Trausan, a citicoline; Venosmil, a venous vasoprotector; Venosmil Gel; and Yendol, an anti-flu. The company also provides Bilastine, an antihistamine molecule for the treatment of allergic rhino conjunctivitis and urticarial; Calcifediol for bone metabolism; Deflazacort to treat osteoarticular disease; Hidrosmin for venous insufficiency; and Mesalazine to treat digestion problems. It also exports its products. Faes Farma, S.A. was founded in 1933 and is headquartered in Leioa, Spain.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MCE",
        "market": "es_market",
        "country": "Spain",
        "state": null,
        "city": "Leioa",
        "zipcode": "48940",
        "website": "http://faesfarma.com",
        "market_cap": "Small Cap"
    },
    "FAGI": {
        "short_name": "FULL ALLIANCE GROUP INC",
        "long_name": "Full Alliance Group, Inc.",
        "summary": "Beverly Hills Group, Inc. operates an institution that recognizes and honors noteworthy individuals, movies, and film scores for their contributions to the motion picture industry. The company honors and commemorates movies and individuals, whether living or deceased, for their works and contributions to the history of motion pictures. It also operates a facility that exhibits rotating displays, memorabilia, portraitures, and live vignettes to entertain and educate the public about the people and processes involved in filmmaking. In addition, the company broadcasts the event on television. The company was founded in 2000 and is based in Palm Springs, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Palm Springs",
        "zipcode": "92262",
        "website": "http://motionpicturehalloffame.info",
        "market_cap": "Nano Cap"
    },
    "FAGR.BR": {
        "short_name": "FAGRON",
        "long_name": "Fagron NV",
        "summary": "Fagron NV, a pharmaceutical compounding company, provides personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients. It prepares personalized ready-to-use medication in its sterile and non-sterile compounding facilities. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it offers pharmaceutical raw materials, equipment, and supplies that pharmacists need to prepare medication in the pharmacy. Further, the company develops, manufactures, and supplies mixing equipment that pharmacists can use for the compounding of semi-solid dermatological formulations. It has operations in Europe, the Americas, the Middle East, and Africa, as well as Asia and the Pacific. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "BRU",
        "market": "be_market",
        "country": "Belgium",
        "state": null,
        "city": "Nazareth",
        "zipcode": "9810",
        "website": "http://www.fagron.com",
        "market_cap": "Small Cap"
    },
    "FCM.MI": {
        "short_name": "FRIULCHEM",
        "long_name": "Friulchem S.p.A.",
        "summary": "Friulchem S.p.A. engages in the research, development, and production of original and generic pharmaceutical products for human and veterinary fields in Italy. It offers generic cosmoceuticals and food supplements; chewable cubes for animals; and cosmetic products for pigmentation disorders. The company is based in Milan, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "MI",
        "city": "Milan",
        "zipcode": "20149",
        "website": "http://www.friulchem.com",
        "market_cap": "Nano Cap"
    },
    "FDC.NS": {
        "short_name": "FDC LTD",
        "long_name": "FDC Limited",
        "summary": "FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400102",
        "website": "http://www.fdcindia.com",
        "market_cap": "Small Cap"
    },
    "FEQ1.F": {
        "short_name": "LABORATORIO REIG J.EO 0,5",
        "long_name": "Laboratorio Reig Jofre, S.A.",
        "summary": "Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements. The company offers prescription medicines, OTCs, medical devices, and cosmetics. Its products include pharmaceutical technologies products, such as antibiotics, and injectable and other products; specialty pharmacare products, which include skin, hair, and nail health, joint health and pain, women's health, respiratory/ENT, and pediatrics; and consumer healthcare products under the Fort\u00c3\u00a9 Pharma brand. The company also provides CDMO and CMO services. It sells its products directly in 7 countries and through business partners in approximately 70 countries. The company was founded in 1929 and is based in Sant Joan Desp\u00c3\u00ad, Spain. Laboratorio Reig Jofre, S.A. is a subsidiary of Reig Jofre Investments SL.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Spain",
        "state": null,
        "city": "Barcelona",
        "zipcode": "08970",
        "website": "http://www.reigjofre.com",
        "market_cap": "Small Cap"
    },
    "FF.MI": {
        "short_name": "FINE FOODS & PHARMACEUTICALS NT",
        "long_name": "Fine Foods & Pharmaceuticals N.T.M. S.p.A.",
        "summary": "Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of pharmaceuticals, nutraceuticals, and medical devices. Its pharmaceutical products include powders and granules, tablets, coated tablets, and hard gelatin capsules; and nutraceutical products comprise soluble and effervescent powders and granules, coated tablets, and hard gelatin capsules, as well as soluble, effervescent, and chewable tablets. The company also develops and manufactures medical devices for gastrointestinal treatment, oral and throat treatment, and weight management. Fine Foods & Pharmaceuticals N.T.M. S.p.A. was founded in 1985 and is based in Verdellino, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "BG",
        "city": "Verdellino",
        "zipcode": "24040",
        "website": "http://www.finefoods.it",
        "market_cap": "Small Cap"
    },
    "FFEA.F": {
        "short_name": "FAES FARMA INH.  EO-,10",
        "long_name": "Faes Farma, S.A.",
        "summary": "Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter (OTC) drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for ulcerative colitis and Crohn's disease; Dezacor, a corticoid; Dolotren, an anti-inflammatory; Dolotren Gel; Dynamogen, an anti-anorexic; Ferroprotina, an anti-anaemic; Hidroferol; Lipofen; Positon for dermatitis; strength builder products, such as Potenciator and Surmenalit; Pruina, a laxative; Robaxisal Compuesto, a muscle relaxant and analgesic; Trausan, a citicoline; Venosmil, a venous vasoprotector; Venosmil Gel; and Yendol, an anti-flu. The company also provides Bilastine, an antihistamine molecule for the treatment of allergic rhino conjunctivitis and urticarial; Calcifediol for bone metabolism; Deflazacort to treat osteoarticular disease; Hidrosmin for venous insufficiency; and Mesalazine to treat digestion problems. It also exports its products. Faes Farma, S.A. was founded in 1933 and is headquartered in Leioa, Spain.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Spain",
        "state": null,
        "city": "Leioa",
        "zipcode": "48940",
        "website": "http://faesfarma.com",
        "market_cap": "Small Cap"
    },
    "FFNT.CN": {
        "short_name": "4FrontVentCorp",
        "long_name": "4Front Ventures Corp.",
        "summary": "4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates in two segments, THC Cannabis and CBD Wellness. It produces and sells cannabis and CBD. As of December 31, 2020, it operated 5 dispensaries in Massachusetts, Illinois, Michigan primarily under the MISSION brand name. In addition, the company sells equipment, supplies, and intellectual property to cannabis producers; imports and sale equipment and supplies; leases real estate properties to cannabis producers; offers consulting services; and operates cannabis dispensaries. 4Front Ventures Corp. was founded in 2011 and is headquartered in Phoenix, Arizona.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "AZ",
        "city": "Phoenix",
        "zipcode": "85018",
        "website": "http://4frontventures.com",
        "market_cap": "Small Cap"
    },
    "FFNTF": {
        "short_name": "4FRONT VENTURES CORP",
        "long_name": "4Front Ventures Corp.",
        "summary": "4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates in two segments, THC Cannabis and CBD Wellness. It produces and sells cannabis and CBD. As of December 31, 2020, it operated 5 dispensaries in Massachusetts, Illinois, Michigan primarily under the MISSION brand name. In addition, the company sells equipment, supplies, and intellectual property to cannabis producers; imports and sale equipment and supplies; leases real estate properties to cannabis producers; offers consulting services; and operates cannabis dispensaries. 4Front Ventures Corp. was founded in 2011 and is headquartered in Phoenix, Arizona.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "AZ",
        "city": "Phoenix",
        "zipcode": "85018",
        "website": "http://4frontventures.com",
        "market_cap": "Small Cap"
    },
    "FIOR.CN": {
        "short_name": "FioreCannabis",
        "long_name": "Fiore Cannabis Ltd.",
        "summary": "Fiore Cannabis Ltd. engages in the cultivation and production of medical and recreational marijuana in Canada and the United States. The company was formerly known as Citation Growth Corp. and changed its name to Fiore Cannabis Ltd. in November 2020. Fiore Cannabis Ltd. was incorporated in 2007 and is headquartered in Kelowna, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Kelowna",
        "zipcode": "V1Y 5Y7",
        "website": "http://fiorecannabis.com",
        "market_cap": "Nano Cap"
    },
    "FIORF": {
        "short_name": "FIORE CANNABIS LTD",
        "long_name": "Fiore Cannabis Ltd.",
        "summary": "Fiore Cannabis Ltd. engages in the cultivation and production of medical and recreational marijuana in Canada and the United States. The company was formerly known as Citation Growth Corp. and changed its name to Fiore Cannabis Ltd. in November 2020. Fiore Cannabis Ltd. was incorporated in 2007 and is headquartered in Kelowna, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Kelowna",
        "zipcode": "V1Y 5Y7",
        "website": "http://fiorecannabis.com",
        "market_cap": "Nano Cap"
    },
    "FIRE.TO": {
        "short_name": "THE SUPREME CANNABIS COMPANY IN",
        "long_name": "The Supreme Cannabis Company, Inc.",
        "summary": "The Supreme Cannabis Company, Inc. engages in the production of medical cannabis products in Canada. The company was formerly known as Supreme Pharmaceuticals Inc. and changed its name to The Supreme Cannabis Company, Inc. in December 2017. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M6J 2Z7",
        "website": "http://www.supreme.ca",
        "market_cap": "Micro Cap"
    },
    "FITX": {
        "short_name": "CREATIVE EDGE NUTRITION INC",
        "long_name": "Creative Edge Nutrition, Inc.",
        "summary": "Creative Edge Nutrition, Inc. develops and sells a portfolio of health\u00c2\u0096oriented nutrition products. The company offers products in the categories of weight loss, metabolic enhancement, recovery/well-being, muscle enhancement and stimulation, and natural line. Its products include MetaBolic Xtreme, a product for weight loss; Hyper-Infusion, a pre-workout powder to enhance endurance and strength; Alpha-Drive, a product for post cycle therapy; Amino Plex, an intra-workout recovery catalyst; Chia Plex, a product for health and well being; and Hemp Nutra Tea and Nutra Coffee additives. The company was formerly known as Laufer Bridge Enterprises Inc. and changed its name to Creative Edge Nutrition, Inc. in April 2012. Creative Edge Nutrition, Inc. is based in Madison Heights, Michigan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "MI",
        "city": "Madison Heights",
        "zipcode": "48071",
        "website": "http://www.cenergynutrition.com",
        "market_cap": "Nano Cap"
    },
    "FLOOF": {
        "short_name": "FLOWER ONE HOLDINGS INC",
        "long_name": "Flower One Holdings Inc.",
        "summary": "Flower One Holdings Inc., through its subsidiaries, cultivates and produces cannabis for the recreational and medical cannabis markets in Nevada. It owns and operates 400,000 square-foot greenhouse for the cultivation of marijuana and 55,000 square-foot production facility in Nevada; and 25,000 square-foot indoor cultivation and a commercial kitchen in Las Vegas. The company cultivates, processes, produces, and packages dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals, and infused products; and leases a warehouse in North Las Vegas. It sells its products directly to dispensaries; wholesale cannabis products; and provision of contract cultivation, production, and packaging consumer cannabis brands. The company headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 2R9",
        "website": "http://www.flowerone.com",
        "market_cap": "Micro Cap"
    },
    "FLWPF": {
        "short_name": "THE FLOWR CORPORATION",
        "long_name": "The Flowr Corporation",
        "summary": "The Flowr Corporation cultivates, produces, and sells cannabis in Canada. It also has operations in Canada, Europe, and Australia. The company is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 3E4",
        "website": "http://www.flowr.ca",
        "market_cap": "Micro Cap"
    },
    "FLWR.V": {
        "short_name": "THE FLOWR CORPORATION",
        "long_name": "The Flowr Corporation",
        "summary": "The Flowr Corporation cultivates, produces, and sells cannabis in Canada. It also has operations in Canada, Europe, and Australia. The company is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 3E4",
        "website": "http://www.flowr.ca",
        "market_cap": "Micro Cap"
    },
    "FLXN": {
        "short_name": "Flexion Therapeutics, Inc.",
        "long_name": "Flexion Therapeutics, Inc.",
        "summary": "Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions in the United States. The company offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) knee pain. It is also involved in the development of FX201, a gene therapy product candidate designed to provide on demand production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, a NaV1.7 inhibitor for the management of post-operative pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NGM",
        "market": "us_market",
        "country": "United States",
        "state": "MA",
        "city": "Burlington",
        "zipcode": "01803",
        "website": "http://www.flexiontherapeutics.com",
        "market_cap": "Small Cap"
    },
    "FONE.CN": {
        "short_name": "FlowerOneHldg",
        "long_name": "Flower One Holdings Inc.",
        "summary": "Flower One Holdings Inc., through its subsidiaries, cultivates and produces cannabis for the recreational and medical cannabis markets in Nevada. It owns and operates 400,000 square-foot greenhouse for the cultivation of marijuana and 55,000 square-foot production facility in Nevada; and 25,000 square-foot indoor cultivation and a commercial kitchen in Las Vegas. The company cultivates, processes, produces, and packages dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals, and infused products; and leases a warehouse in North Las Vegas. It sells its products directly to dispensaries; wholesale cannabis products; and provision of contract cultivation, production, and packaging consumer cannabis brands. The company headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 2R9",
        "website": "http://www.flowerone.com",
        "market_cap": "Micro Cap"
    },
    "FTEG": {
        "short_name": "FOR THE EARTH CORPORATION",
        "long_name": "For The Earth Corp.",
        "summary": "For the Earth Corporation manufactures and sells consumable household products in the United States and internationally. The company provides a range of laundry detergents, household cleansers, fabric softeners, dryer sheets, dishwashing detergents, and other cleaning products under its own and private label in retail chains. It also provides Litter To Go, a disposable cat litter box made from corrugated material that contains ready-to-use litter; and What Odor?, a biodegradable and non-toxic odor-eliminating spray, as well as other pet supplies, including treats and toys, stylish feeders, and odor/stain-eliminating solutions. For the Earth Corporation sells its products to retail customers; industrial customers comprising hotel, nursing homes, restaurants, and professional sports teams; and direct-to consumers. The company was formerly known as Medjet Inc. and changed its name to For the Earth Corporation in January 2011. For the Earth Corporation was founded in 1993 and is headquartered in Phoenix, Arizona.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "AZ",
        "city": "Phoenix",
        "zipcode": "85012",
        "website": "http://ftegco.com",
        "market_cap": "Nano Cap"
    },
    "FUEL.CN": {
        "short_name": "PlantFueLif",
        "long_name": "PlantFuel Life Inc.",
        "summary": "Sire Bioscience Inc., together with its subsidiaries, invests in, cultivates, produces, and sells various hemp and cannabis products in Canada. It offers cannabidiol (CBD) based wellness products, oils, and edibles, as well as animal and pet related CBD products under the yumz, MEDIflower, BIONIC,FUSIONS, PURPLEK, INFUSIONS, Voila, Karma, CANNA BANANA, cancan, FUR BABY, CBDTECH, and LEAFBELIEF. The company is headquartered in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5N 6C4",
        "website": "http://www.sirebioscience.com",
        "market_cap": "Nano Cap"
    },
    "FUP.F": {
        "short_name": "FUJI PHARMA CO.LTD.",
        "long_name": "Fuji Pharma Co., Ltd.",
        "summary": "Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers hormone medicines for obstetrics and gynecology therapies, as well as injectable drugs, such as radiopharmaceutical products. It also provides medical care for women; in vitro diagnostics, acute medical care products, and curative medicines; and information regarding pharmaceuticals and health. The company was founded in 1965 and is headquartered in Tokyo, Japan.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "102-0075",
        "website": "http://www.fujipharma.jp",
        "market_cap": "Micro Cap"
    },
    "FWDG": {
        "short_name": "FUTUREWORLD CORP",
        "long_name": "FutureWorld Corp.",
        "summary": "FutureWorld Corp., together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of hemp/cannabis products, services, and technologies worldwide. The company provides smart sensor technology, communication network, surveillance security, data analysis for smart cultivation, and consultation for the industrial hemp and legal medicinal marijuana. It offers personal and professional tetrahydrocannabinoil and Cannabidiol test kits; pharmaceutical grade CBD oil solutions; URVape vaporizer pens, which are oil vaporizers for the e-cigarette, cannabis, and herbal vaping industry; CaNNaLyTiX, a dashboard controller system that allows various computer systems to be integrated throughout a cultivator's infrastructures; CaNNaTRAK, the barcode and RFID tracking systems for keeping seed to sale tracking of hemp/cannabis; and SPIDer (secure perimeter intrusion detection network), a system to meet the needs of theft and malicious attacks. The company also provides SmartSense, which offers wireless security and smart sensor mesh network for precision agriculture, irrigation systems, and greenhouses for the hemp industry; SmartNergy that offers tools to analyze various aspects of a cultivator's energy usage; and CaNNaBoX machine, which operates with the swipe of a card to verify identity, age, and prescription information of a medical marijuana patient before releasing measured packages of marijuana. Its target customers include consumers via Internet sales, direct-to-consumer health and wellness stores, collectives, cooperatives, affiliate sales, and master distributors. The company was formerly known as FutureWorld Energy, Inc. and changed its name to FutureWorld Corp. in June 2014. FutureWorld Corp. was founded in 2002 and is based in Saint Petersburg, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Saint Petersburg",
        "zipcode": "33704",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "G2AB.F": {
        "short_name": "VIFOR PHARMA UNSP.ADR/0,2",
        "long_name": "Vifor Pharma AG",
        "summary": "Vifor Pharma AG, a pharmaceutical company, focuses on the development, manufacture, and commercialization of pharmaceutical products in Switzerland, rest of Europe, the United States, and internationally. The company offers Ferinject/Injectafer, a solution of ferric carboxymaltose used for the treatment of iron deficiency and iron deficiency anemia; Maltofer, an oral iron polymaltose complex for infants, children, adolescents, and pregnant woman with iron deficiency; and Mircera, a long-acting erythropoiesis-stimulating agent (ESA) to treat symptomatic anemia associated with the chronic kidney disease (CKD). It also provides Retacrit, a short-acting ESA; Venofer, an intravenous iron sucrose used in the intravenous treatment of iron deficiency; and Velphoro, a non-calcium, iron-based chewable phosphate binder for the treatment of hyperphosphatemia in adults with CKD undergoing dialysis. In addition, the company offers Rayaldee, an orally administered, extended release formulation of calcifediol for the treatment of secondary hyperparathyroidism in patients with CKD; Veltassa for the treatment of hyperkalaemia in CKD and chronic heart failure patients; and Invokana to treat diabetic kidney disease. Further, it developing Vadadustat, an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of anemia due to chronic kidney disease; Avacopan, an orally-administered, highly selective inhibitor of C5aR1 for the treatment of orphan and rare renal diseases; ANG-3777 for the treatment of delayed graft function and cardiac surgery-associated acute kidney injury; Difelikefalin for the treatment for chronic kidney disease-associated pruritus; and VIT-2763 to treat beta-thalassemia. Vifor Pharma AG has a strategic partnership with Fresenius Kabi. The company was formerly known as Galenica AG and changed its name to Vifor Pharma AG in April 2017. Vifor Pharma AG was founded in 1872 and is headquartered in Sankt Gallen, Switzerland.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Switzerland",
        "state": null,
        "city": "Sankt Gallen",
        "zipcode": "9014",
        "website": "http://www.viforpharma.com",
        "market_cap": "Mid Cap"
    },
    "GABA.ST": {
        "short_name": "Gabather AB",
        "long_name": "Gabather AB (publ)",
        "summary": "Gabather AB (publ) develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics; anti-depressants and anxiolytics; analgesics; and cognition-enhancing treatments, including Alzheimer's disease. The company was founded in 2014 and is based in Malm\u00c3\u00b6, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Malm\u00c3\u00b6",
        "zipcode": "211 20",
        "website": "http://www.gabather.com",
        "market_cap": "Nano Cap"
    },
    "GAGE.CN": {
        "short_name": "GageGrowth",
        "long_name": "Gage Growth Corp.",
        "summary": "Gage Growth Corp. provides support services to licensed Gage-branded cannabis cultivators, processors, and provisioning centers, as well as to Cookies-branded provisioning centers. It services include management, consulting, HR, financing, intellectual property, licensing, and real estate support. The company was formerly known as Wolverine Partners Corp. and changed its name to Gage Growth Corp. in October 2020. Gage Growth Corp. was incorporated in 2017 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5K 0A1",
        "website": "http://www.gageusa.com",
        "market_cap": null
    },
    "GAIA.CN": {
        "short_name": "GaiaGrowCorp",
        "long_name": "Gaia Grow Corp.",
        "summary": "Gaia Grow Corp., through its subsidiaries, focuses on the cultivation and sale of industrial hemp for medical uses in Canada. Its principal property is located in Lamont County, Alberta. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": null,
        "website": "http://www.gaiagrow.com",
        "market_cap": "Nano Cap"
    },
    "GBHPF": {
        "short_name": "GLOBAL HEMP GROUP INC",
        "long_name": "Global Hemp Group Inc.",
        "summary": "Global Hemp Group Inc. focuses on the industrial hemp industry in Canada and the United States. The company was formerly known as Arris Holdings Inc. and changed its name to Global Hemp Group Inc. in March 2014. Global Hemp Group Inc. was incorporated in 2009 and is headquartered in North Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "North Vancouver",
        "zipcode": "V7H 2Y4",
        "website": "http://globalhempgroup.com",
        "market_cap": "Nano Cap"
    },
    "GBLP": {
        "short_name": "GLOBAL PHARMATECH INC",
        "long_name": "Global Pharmatech, Inc.",
        "summary": "Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. The company's principal product line consists of XS CAPSULE (XIN-SHU) for the treatment of angina and other coronary disease; JUTAI SOFT CAPSULE, a dietary supplement; QINGXUAN ANTI-HYPERTENSION TABLET, an over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level; and YANREQING TABLET for the treatment of inflammation. It also manufactures and sells other proprietary drugs, generics, and dietary supplements used to treat symptoms ranging from headaches, coughing, and dry mouth to infections, and numbness of limbs. The company markets its products through distributors, such as wholesale companies and chain store representatives, as well as through its sales force. Global Pharmatech, Inc. was founded in 2001 and is based in Changchun, China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Changchun",
        "zipcode": "130 012",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "GCAN": {
        "short_name": "GREATER CANNABIS CO INC",
        "long_name": "The Greater Cannabis Company, Inc.",
        "summary": "The Greater Cannabis Company, Inc., a biopharmaceutical company, focuses on the development and commercialization of technology for transmucosal delivery of legal medical or recreational cannabis and cannabinoids. It intends to commercialize the technology by sublicensing or partnering with licensed producers, distributors, processors, consumer product, and pharmaceutical companies. The company was founded in 2014 and is based in Baltimore, Maryland.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "MD",
        "city": "Baltimore",
        "zipcode": "21208",
        "website": "http://www.gcanrx.com",
        "market_cap": "Nano Cap"
    },
    "GEATF": {
        "short_name": "RADIKO HOLDINGS CORP",
        "long_name": "Radiko Holdings Corp.",
        "summary": "Radiko Holdings Corp., together with its subsidiaries, focuses on cannabis industries in the United States and internationally. The company also manufactures and distributes a range of cannabis infused edibles and tinctures under the La Vida Verde brand; a range of wholesale flower, packaged flower, pre-rolls, and concentrates under the Skunk Feather brand; a range of cannabis, infused, chocolates, and edible cannabis consumables gummies, and capsules under the name the Blank Brand; and supplements under the Baseline brand. The company was formerly known as International Cannabrands Inc. and changed its name to Radiko Holdings Corp. in July 2020. The company is headquartered in Des Moines, Washington.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "WA",
        "city": "Des Moines",
        "zipcode": "98198",
        "website": "http://www.radikoholdings.com",
        "market_cap": "Nano Cap"
    },
    "GEKA.F": {
        "short_name": "GENOMMA LAB INT. FIN. B",
        "long_name": "Genomma Lab Internacional, S.A.B. de C.V.",
        "summary": "Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the research, development, and marketing of pharmaceutical, over the counter, and personal care products in Mexico, the United States, and Latin America. It offers antibacterial products under the Next-AB brand name, including disinfecting wet wipes, alcohol-based hand sanitizers, and antibacterial soaps; razor products under the Groomen brand; anti-flu medicines under the Next brand; HIV testing kits under the OraQuick brand name; and isotonic beverages under the Suerox brand, as well as gold lift creams under the Cicatricure brand. The company also provides shampoos under the Revie, Vanart, and T\u00c3\u00ado Nacho names; and cough and cold medicines under the Tukol brand. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Mexico",
        "state": "DF",
        "city": "Mexico City",
        "zipcode": "01210",
        "website": "http://www.genommalab.com",
        "market_cap": "Small Cap"
    },
    "GENH": {
        "short_name": "GENERATION HEMP INC",
        "long_name": "Generation Hemp, Inc.",
        "summary": "Generation Hemp Inc. engages in leasing industrial warehouse located in Denver, Colorado. The company was formerly known as Home Treasure Finders, Inc. and changed its name to Generation Hemp Inc. in August 2019. Generation Hemp Inc. was incorporated in 2008 and is based in Dallas, Texas.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "TX",
        "city": "Dallas",
        "zipcode": "75209",
        "website": "http://www.genhempinc.com",
        "market_cap": "Micro Cap"
    },
    "GENX": {
        "short_name": "GENEX PHARMACEUTICALS INC",
        "long_name": "Genex Pharmaceutical, Inc.",
        "summary": "Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical is headquartered in Tianjin City, the People's Republic of China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Tianjin City",
        "zipcode": "300074",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "GENX.V": {
        "short_name": "GENIX PHARMACEUTICALS CORPORATI",
        "long_name": "Genix Pharmaceuticals Corporation",
        "summary": "Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral spray; Renochlor, a dietary supplement to aid in the restoration of kidney health and kidney function; and Sucanon, an insulin sensitizer that lowers blood sugar by increasing the muscle, fat, and liver's sensitivity to insulin. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and powders. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "T8V 0Z7",
        "website": "http://www.genixpharm.com",
        "market_cap": "Nano Cap"
    },
    "GG0.F": {
        "short_name": "GAIA GROW CORP.",
        "long_name": "Gaia Grow Corp.",
        "summary": "Gaia Grow Corp., through its subsidiaries, focuses on the cultivation and sale of industrial hemp for medical uses in Canada. Its principal property is located in Lamont County, Alberta. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": null,
        "website": "http://www.gaiagrow.com",
        "market_cap": "Nano Cap"
    },
    "GGBXF": {
        "short_name": "GREEN GROWTH BRANDS INC",
        "long_name": "Green Growth Brands Inc.",
        "summary": "Green Growth Brands Inc., together with its subsidiaries, engages in the cultivation, processing, production, distribution, and retailing of cannabis and cannabidiol (CBD)-infused consumer products in the United States. It provides medical and retail marijuana products to various dispensaries; and CBD-infused personal care and beauty products, such as therapeutic, face care, body care, shower and bathroom, and sleep products through shops, e-commerce, and wholesale channels. The company offers its products under the CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne brand names. The company was formerly known as Xanthic Biopharma Inc. and changed its name to Green Growth Brands Inc. in January 2019. Green Growth Brands Inc. was founded in 1968 and is based in Columbus, Ohio.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "OH",
        "city": "Columbus",
        "zipcode": "43219",
        "website": "http://www.greengrowthbrands.com",
        "market_cap": "Nano Cap"
    },
    "GGTTF": {
        "short_name": "GTEC HOLDINGS LTD",
        "long_name": "GTEC Holdings Ltd.",
        "summary": "GTEC Holdings Ltd., doing business as GTEC Cannabis Co, cultivates, markets, and distributes cannabis products in Canada. The company brand portfolio includes BLK MKT, Tenzo, Pristine, GreenTec, Cognoscente, and Treehugger. It sells its products through medical and recreational sales channels, as well as through its GreenTec medical website and various licensed partners. The company was founded in 2017 and is headquartered in Kelowna, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Kelowna",
        "zipcode": "V1Y 7T2",
        "website": "http://www.gtec.co",
        "market_cap": "Micro Cap"
    },
    "GHG.CN": {
        "short_name": "GlobalHemp Grp",
        "long_name": "Global Hemp Group Inc.",
        "summary": "Global Hemp Group Inc. focuses on the industrial hemp industry in Canada and the United States. The company was formerly known as Arris Holdings Inc. and changed its name to Global Hemp Group Inc. in March 2014. Global Hemp Group Inc. was incorporated in 2009 and is headquartered in North Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "North Vancouver",
        "zipcode": "V7H 2Y4",
        "website": "http://globalhempgroup.com",
        "market_cap": "Nano Cap"
    },
    "GHG.F": {
        "short_name": "GLOBAL HEMP GROUP INC.",
        "long_name": "Global Hemp Group Inc.",
        "summary": "Global Hemp Group Inc. focuses on the industrial hemp industry in Canada and the United States. The company was formerly known as Arris Holdings Inc. and changed its name to Global Hemp Group Inc. in March 2014. Global Hemp Group Inc. was incorporated in 2009 and is headquartered in North Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "North Vancouver",
        "zipcode": "V7H 2Y4",
        "website": "http://globalhempgroup.com",
        "market_cap": "Nano Cap"
    },
    "GHSI": {
        "short_name": "Guardion Health Sciences, Inc.",
        "long_name": "Guardion Health Sciences, Inc.",
        "summary": "Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "San Diego",
        "zipcode": "92128",
        "website": "http://www.guardionhealth.com",
        "market_cap": "Nano Cap"
    },
    "GLDFF": {
        "short_name": "CHALICE BRANDS LIMITED",
        "long_name": "Golden Leaf Holdings Ltd.",
        "summary": "Golden Leaf Holdings Ltd., through its subsidiaries, produces, distributes, and sells cannabis oil and flower products in the United States. The company provides distillate vaporizer cartridges, ethanol extract products, and fruit chew blast products. It offers its products under the Private Stash, Jackpot, Chalice, Golden, RXO, and Elysium Fields brands. The company also engages in the ownership, administration, and leasing of real estate and intellectual properties, and capital equipment, as well as industrial hemp processing activities. In addition, it operates a network of six dispensaries under the Chalice Farms brand; and one dispensary under the Left Coast Connections brand in Oregon, as well as operates as a toll processing and white label service consultant. Golden Leaf Holdings Ltd. is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 1P1",
        "website": "http://www.goldenleafholdings.com",
        "market_cap": "Small Cap"
    },
    "GLENMARK.NS": {
        "short_name": "GLENMARK PHARM",
        "long_name": "Glenmark Pharmaceuticals Limited",
        "summary": "Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in India, North America, Latin America, Europe, and internationally. The company provides branded and generic formulations in therapeutic areas of dermatology, respiratory, and oncology; and various active pharmaceutical ingredients. Its product pipeline includes ISB 830, an OX40 antagonist monoclonal antibody, which is in Phase 2b clinical trial for the treatment of atopic dermatitis; ISC 17536, an oral transient receptor potential ankyrin-1 antagonist, which has completed Phase 2a clinical trial for the treatment of diabetic peripheral neuropathy; ISB 1302, a HER2 X CD3 beat bispecific antibody, which is in Phase 1/2 clinical trial for the treatment of metastatic HER2-positive breast cancer; and ISB 1342, a CD38 X CD3 beat bispecific antibody that is in Phase 1 clinical trial for the treatment of relapsed/refractory multiple myeloma. The company's pre-clinical stage product pipeline comprises ISB 880 for the for the treatment of anti-inflammatory therapy; ISB 1908 and ISB 1909 T-cell engagers for the treatment of oncology; ISB 1442, an innate immune engager for the treatment of oncology; ISC XXXXX, an HPK1 inhibitor for the treatment of oncology; and GRC 39815, an inhibitor of the retinoid-related orphan receptor gamma t for the treatment of chronic obstructive pulmonary disorder. It also offers Ryaltris nasal spray for allergic rhinitis. The company was founded in 1977 and is based in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400099",
        "website": "http://www.glenmarkpharma.com",
        "market_cap": "Mid Cap"
    },
    "GLH.CN": {
        "short_name": "GoldenLeaf",
        "long_name": "Golden Leaf Holdings Ltd.",
        "summary": "Golden Leaf Holdings Ltd., through its subsidiaries, produces, distributes, and sells cannabis oil and flower products in the United States. The company provides distillate vaporizer cartridges, ethanol extract products, and fruit chew blast products. It offers its products under the Private Stash, Jackpot, Chalice, Golden, RXO, and Elysium Fields brands. The company also engages in the ownership, administration, and leasing of real estate and intellectual properties, and capital equipment, as well as industrial hemp processing activities. In addition, it operates a network of six dispensaries under the Chalice Farms brand; and one dispensary under the Left Coast Connections brand in Oregon, as well as operates as a toll processing and white label service consultant. Golden Leaf Holdings Ltd. is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 1P1",
        "website": "http://www.goldenleafholdings.com",
        "market_cap": "Nano Cap"
    },
    "GLI.JO": {
        "short_name": "Go Life International Ld",
        "long_name": "Go Life International Limited",
        "summary": "Go Life International Limited, a healthcare company, distributes health products focusing on the nutraceuticals and cosmeceuticals markets in South Africa and internationally. It also offers pharmaceutical and generic products, medical consumables, and hospital equipment. In addition, the company operates four frail care centers in the Western Cape. Further, it is involved in the investment and holding activities. The company sells its products through stockists and an online shop. The company was formerly known as Go Life International PCC and changed its name to Go Life International Ltd in March 2015. Go Life International Ltd was founded in 2005 and is headquartered in Knysna, South Africa.",
        "currency": "ZAc",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JNB",
        "market": "za_market",
        "country": "South Africa",
        "state": null,
        "city": "Knysna",
        "zipcode": "6571",
        "website": "http://golife.co.za",
        "market_cap": null
    },
    "GMVP": {
        "short_name": "GRIDIRON BIONUTRIENTS INC",
        "long_name": "Gridiron BioNutrients, Inc.",
        "summary": "Gridiron BioNutrients, Inc. develops, markets, and sells cannabidiol products. The company offers capsules, oil, gummies, concentrates, water, beverages, hemp tinctures, and salves. It sells its products under the Gridiron BioNutrients and Gridiron MVP names through an online platform. Gridiron BioNutrients, Inc. was founded in 2017 and is based in Scottsdale, Arizona.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "AZ",
        "city": "Scottsdale",
        "zipcode": "85251",
        "website": "http://gridironmvp.com",
        "market_cap": "Nano Cap"
    },
    "GNHAF": {
        "short_name": "VIFOR PHARMA AG",
        "long_name": "Vifor Pharma AG",
        "summary": "Vifor Pharma AG, a pharmaceutical company, focuses on the development, manufacture, and commercialization of pharmaceutical products in Switzerland, rest of Europe, the United States, and internationally. The company offers Ferinject/Injectafer, a solution of ferric carboxymaltose used for the treatment of iron deficiency and iron deficiency anemia; Maltofer, an oral iron polymaltose complex for infants, children, adolescents, and pregnant woman with iron deficiency; and Mircera, a long-acting erythropoiesis-stimulating agent (ESA) to treat symptomatic anemia associated with the chronic kidney disease (CKD). It also provides Retacrit, a short-acting ESA; Venofer, an intravenous iron sucrose used in the intravenous treatment of iron deficiency; and Velphoro, a non-calcium, iron-based chewable phosphate binder for the treatment of hyperphosphatemia in adults with CKD undergoing dialysis. In addition, the company offers Rayaldee, an orally administered, extended release formulation of calcifediol for the treatment of secondary hyperparathyroidism in patients with CKD; Veltassa for the treatment of hyperkalaemia in CKD and chronic heart failure patients; and Invokana to treat diabetic kidney disease. Further, it developing Vadadustat, an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of anemia due to chronic kidney disease; Avacopan, an orally-administered, highly selective inhibitor of C5aR1 for the treatment of orphan and rare renal diseases; ANG-3777 for the treatment of delayed graft function and cardiac surgery-associated acute kidney injury; Difelikefalin for the treatment for chronic kidney disease-associated pruritus; and VIT-2763 to treat beta-thalassemia. Vifor Pharma AG has a strategic partnership with Fresenius Kabi. The company was formerly known as Galenica AG and changed its name to Vifor Pharma AG in April 2017. Vifor Pharma AG was founded in 1872 and is headquartered in Sankt Gallen, Switzerland.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Switzerland",
        "state": null,
        "city": "Sankt Gallen",
        "zipcode": "9014",
        "website": "http://www.viforpharma.com",
        "market_cap": "Mid Cap"
    },
    "GNHAY": {
        "short_name": "VIFOR PHARMA AG",
        "long_name": "Vifor Pharma AG",
        "summary": "Vifor Pharma AG, a pharmaceutical company, focuses on the development, manufacture, and commercialization of pharmaceutical products in Switzerland, rest of Europe, the United States, and internationally. The company offers Ferinject/Injectafer, a solution of ferric carboxymaltose used for the treatment of iron deficiency and iron deficiency anemia; Maltofer, an oral iron polymaltose complex for infants, children, adolescents, and pregnant woman with iron deficiency; and Mircera, a long-acting erythropoiesis-stimulating agent (ESA) to treat symptomatic anemia associated with the chronic kidney disease (CKD). It also provides Retacrit, a short-acting ESA; Venofer, an intravenous iron sucrose used in the intravenous treatment of iron deficiency; and Velphoro, a non-calcium, iron-based chewable phosphate binder for the treatment of hyperphosphatemia in adults with CKD undergoing dialysis. In addition, the company offers Rayaldee, an orally administered, extended release formulation of calcifediol for the treatment of secondary hyperparathyroidism in patients with CKD; Veltassa for the treatment of hyperkalaemia in CKD and chronic heart failure patients; and Invokana to treat diabetic kidney disease. Further, it developing Vadadustat, an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of anemia due to chronic kidney disease; Avacopan, an orally-administered, highly selective inhibitor of C5aR1 for the treatment of orphan and rare renal diseases; ANG-3777 for the treatment of delayed graft function and cardiac surgery-associated acute kidney injury; Difelikefalin for the treatment for chronic kidney disease-associated pruritus; and VIT-2763 to treat beta-thalassemia. Vifor Pharma AG has a strategic partnership with Fresenius Kabi. The company was formerly known as Galenica AG and changed its name to Vifor Pharma AG in April 2017. Vifor Pharma AG was founded in 1872 and is headquartered in Sankt Gallen, Switzerland.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Switzerland",
        "state": null,
        "city": "Sankt Gallen",
        "zipcode": "9014",
        "website": "http://www.viforpharma.com",
        "market_cap": "Mid Cap"
    },
    "GNMLF": {
        "short_name": "GENOMMA LAB INTERNACIONAL SAB",
        "long_name": "Genomma Lab Internacional, S.A.B. de C.V.",
        "summary": "Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the research, development, and marketing of pharmaceutical, over the counter, and personal care products in Mexico, the United States, and Latin America. It offers antibacterial products under the Next-AB brand name, including disinfecting wet wipes, alcohol-based hand sanitizers, and antibacterial soaps; razor products under the Groomen brand; anti-flu medicines under the Next brand; HIV testing kits under the OraQuick brand name; and isotonic beverages under the Suerox brand, as well as gold lift creams under the Cicatricure brand. The company also provides shampoos under the Revie, Vanart, and T\u00c3\u00ado Nacho names; and cough and cold medicines under the Tukol brand. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Mexico",
        "state": "DF",
        "city": "Mexico City",
        "zipcode": "01210",
        "website": "http://www.genommalab.com",
        "market_cap": "Small Cap"
    },
    "GNOM.CN": {
        "short_name": "GnomestarCraft",
        "long_name": "Gnomestar Craft Inc.",
        "summary": "Gnomestar Craft Inc. operates as a licensed stage company for producing medical marijuana in Canada. The company was formerly known as Vodis Pharmaceuticals Inc. and changed its name to Gnomestar Craft Inc. in December 2020. Gnomestar Craft Inc. was incorporated in 2011 and is based in Delta, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Delta",
        "zipcode": "V4G 1B5",
        "website": "http://www.gnomestarcannabis.com",
        "market_cap": "Nano Cap"
    },
    "GPFT": {
        "short_name": "GRAPEFRUIT USA INC",
        "long_name": "Grapefruit USA, Inc.",
        "summary": "Grapefruit USA, Inc. focuses on manufacturing and distribution of cannabis distillates, edibles, and cannabis products. It also offers cannabis advisory services for branding, compliance, packaging, extraction, edible manufacturing, and distribution logistics efforts. The company was formerly known as Grapefruit Boulevard Investments, Inc. and changed its name to Grapefruit USA, Inc. in January 2020. Grapefruit USA, Inc. was founded in 2017 and is based in Wilmington, Delaware.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "DE",
        "city": "Wilmington",
        "zipcode": "19801",
        "website": "http://www.grapefruitblvd.com",
        "market_cap": "Micro Cap"
    },
    "GPHG": {
        "short_name": "GLOBAL PHARM HLDGS GROUP INC",
        "long_name": "Global Pharm Holdings Group, Inc.",
        "summary": "Global Pharm Holdings Group, Inc., through its subsidiaries, engages in the distribution of pharmaceuticals-related products, Chinese herb cultivation, and preparation of raw materials for medicine in China. It distributes prescription and non-prescription drugs in the form of injections, tablets, pastes, granules, and capsules for various diseases. The company is also involved in the cultivation, processing, and sale of Chinese herbs, such as wild ginseng, chrysanthemum, salvia, angelica, wind, schisandra, rana, etc. In addition, it sells biochemical drugs, cosmetics, pre-packaged food, and medical devices. The company markets its products directly to hospitals, clinics, pharmacies and drugstores, and other healthcare institutions. Global Pharm Holdings Group, Inc. is based in Shenzhen, China. As of December 31, 2018, Global Pharm Holdings Group, Inc. operates as a subsidiary of Fortune Insight Limited.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Shenzhen",
        "zipcode": "518026",
        "website": "http://www.globalpharmholdings.com",
        "market_cap": "Nano Cap"
    },
    "GRAM-U.NE": {
        "short_name": "TPCO (THE PARENT COMPANY) HOLDI",
        "long_name": "TPCO Holding Corp.",
        "summary": "TPCO Holding Corp., cultivates, manufactures, distributes, and retails cannabis in California. The company offers approximately 17 owned and licensed brands offering 250 SKUs across various factors, such as whole flower, pre-rolls, infused pre-rolls, vaporizer cartridges, concentrates, gummies, chocolate, beverages, capsules, tinctures, lozenges, topicals, and body care products. It also offers its products through Caliva.com, a direct-to-consumer e-commerce platform. The company was formerly known as Subversive Capital Acquisition Corp. and changed its name to TPCO Holding Corp. in January 2021. TPCO Holding Corp. was incorporated in 2019 and is based in San Jose, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NEO",
        "market": "ca_market",
        "country": "United States",
        "state": "CA",
        "city": "San Jose",
        "zipcode": "95125",
        "website": "http://www.theparent.co",
        "market_cap": null
    },
    "GRAMF": {
        "short_name": "TPCO HOLDING CORP",
        "long_name": "TPCO Holding Corp.",
        "summary": "TPCO Holding Corp., cultivates, manufactures, distributes, and retails cannabis in California. The company offers approximately 17 owned and licensed brands offering 250 SKUs across various factors, such as whole flower, pre-rolls, infused pre-rolls, vaporizer cartridges, concentrates, gummies, chocolate, beverages, capsules, tinctures, lozenges, topicals, and body care products. It also offers its products through Caliva.com, a direct-to-consumer e-commerce platform. The company was formerly known as Subversive Capital Acquisition Corp. and changed its name to TPCO Holding Corp. in January 2021. TPCO Holding Corp. was incorporated in 2019 and is based in San Jose, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "San Jose",
        "zipcode": "95125",
        "website": "http://www.theparent.co",
        "market_cap": null
    },
    "GRANULES.NS": {
        "short_name": "GRANULES INDIA",
        "long_name": "Granules India Limited",
        "summary": "Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Hyderabad",
        "zipcode": "500081",
        "website": "http://www.granulesindia.com",
        "market_cap": "Small Cap"
    },
    "GRCU": {
        "short_name": "GREEN CURES & BOTANICAL DIST IN",
        "long_name": "Green Cures & Botanical Distribution Inc.",
        "summary": "Green Cures & Botanical Distribution Inc. operates various services and products in the medical marijuana and botanical industry. It focuses on the production, distribution, and management of cannabis-derived products. The company's products comprise nutritional supplements, vitamins, minerals, herbs/botanicals, sports nutrition, and specialty products. It also provides online community portals that supply public with information and resources regarding the benefits of cannabis-derived products. Green Cures & Botanical Distribution Inc. is based in Inglewood, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Inglewood",
        "zipcode": "90304",
        "website": "http://greencurescorp.com",
        "market_cap": "Nano Cap"
    },
    "GRIN.CN": {
        "short_name": "GrownRogIntInc",
        "long_name": "Grown Rogue International Inc.",
        "summary": "Grown Rogue International Inc., through with its subsidiaries, engages in the cultivation, production, and wholesale of cannabis products in Canada and the United States. The company offers flower products, such as indicas, sativas, and hybrids; and edibles, vape cartridges, pre-rolls, or concentrates. It sells its products directly to dispensaries. The company is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5V 1X2",
        "website": "http://www.grownrogue.com",
        "market_cap": "Nano Cap"
    },
    "GRLB": {
        "short_name": "GL BRANDS INC",
        "long_name": "GL Brands, Inc.",
        "summary": "GL Brands, Inc., a hemp consumer packaged goods company, engages in the development and commercialization of cannabinoid-rich products for health and well-being in the United States, Mexico, and internationally. The company offers various cannabinoid products made from organic industrial hemp, including tinctures, gel caps, edibles, topicals, vape cartridges, capsules, and beverages under the Green Lotus and IrieCBD brand names. It markets products through direct-to-store sales and direct-to-consumer models, as well as through distribution partnerships. The company was formerly known as Freedom Leaf, Inc. and changed its name to GL Brands, Inc. in November 2019. GL Brands, Inc. was incorporated in 2013 and is headquartered in Addison, Texas. On December 17, 2020, GL Brands, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "TX",
        "city": "Addison",
        "zipcode": "75001",
        "website": "http://www.glbrands.com",
        "market_cap": "Nano Cap"
    },
    "GRPS": {
        "short_name": "GOLD RIVER PRODUCTIONS INC",
        "long_name": "Gold River Productions, Inc.",
        "summary": "Gold River Productions, Inc. manufactures and sells plastic composite products in the United States. Its products are used in commercial and recreational vehicle, housing and construction, marine, and other industries. The company is based in Salt Lake City, Utah.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "UT",
        "city": "Salt Lake City",
        "zipcode": "84121",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "GRUSF": {
        "short_name": "GROWN ROGUE INTERNATIONAL INC",
        "long_name": "Grown Rogue International Inc.",
        "summary": "Grown Rogue International Inc., through with its subsidiaries, engages in the cultivation, production, and wholesale of cannabis products in Canada and the United States. The company offers flower products, such as indicas, sativas, and hybrids; and edibles, vape cartridges, pre-rolls, or concentrates. It sells its products directly to dispensaries. The company is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5V 1X2",
        "website": "http://www.grownrogue.com",
        "market_cap": "Nano Cap"
    },
    "GRYN": {
        "short_name": "GREEN HYGIENICS HLDGS INC",
        "long_name": "Green Hygienics Holdings Inc.",
        "summary": "Green Hygienics Holdings, Inc., a development stage company, intends to cultivate and process industrial hemp for extracting cannabidiol. The company was formerly known as Takedown Entertainment Inc. and changed its name to Green Hygienics Holdings Inc. in July 2012. Green Hygienics Holdings Inc. was founded in 2008 and is based in Poway, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Poway",
        "zipcode": "92064",
        "website": "http://www.greenhygienics.com",
        "market_cap": "Micro Cap"
    },
    "GS3.F": {
        "short_name": "CBD GLOBAL SCIENCES INC.",
        "long_name": "CBD Global Sciences Inc.",
        "summary": "CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers provides biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "CO",
        "city": "Lakewood",
        "zipcode": "80228",
        "website": "http://www.cbdglobalsciences.com",
        "market_cap": "Nano Cap"
    },
    "GSAC": {
        "short_name": "GELSTAT CORPORATION",
        "long_name": "GelStat Corp.",
        "summary": "GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation is headquartered in Palm City, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Palm City",
        "zipcode": "34990",
        "website": "http://www.gelstat.com",
        "market_cap": "Nano Cap"
    },
    "GSRX": {
        "short_name": "GSRX INDUSTRIES INC",
        "long_name": "GSRX Industries Inc.",
        "summary": "GSRX Industries Inc., through its subsidiaries, engages in acquiring, developing, and operating retail cannabis dispensaries. It operates five cannabis dispensaries under the Green Spirit RX name in Puerto Rico; and a dispensary under The Green Room name in California. The company also owns and operates GetPureAndNatural.com, an e-commerce site that offers a range of hemp extract products. In addition, it focuses on the extraction, manufacture, distribution, and delivery of cannabis and cannabinoid products. The company was formerly known as Green Spirit Industries Inc. and changed its name to GSRX Industries Inc. in July 2018. GSRX Industries Inc. is headquartered in Dorado, Puerto Rico.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "PR",
        "city": "Dorado",
        "zipcode": "00646",
        "website": "http://www.gsrxindustries.com",
        "market_cap": "Nano Cap"
    },
    "GTBIF": {
        "short_name": "GREEN THUMB INDUSTRIES INC",
        "long_name": "Green Thumb Industries Inc.",
        "summary": "Green Thumb Industries Inc. manufactures, distributes, and sells various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including concentrates, edibles, and topical and other cannabis products under the Rythm, Dogwalkers, The Feel Collection, incredibles, Dr. Solomon's, Beboe, and other brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of March 25, 2021, it owned and operated 55 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "IL",
        "city": "Chicago",
        "zipcode": "60654",
        "website": "http://www.gtigrows.com",
        "market_cap": "Mid Cap"
    },
    "GTEC.V": {
        "short_name": "GTEC HOLDINGS LTD",
        "long_name": "GTEC Holdings Ltd.",
        "summary": "GTEC Holdings Ltd., doing business as GTEC Cannabis Co, cultivates, markets, and distributes cannabis products in Canada. The company brand portfolio includes BLK MKT, Tenzo, Pristine, GreenTec, Cognoscente, and Treehugger. It sells its products through medical and recreational sales channels, as well as through its GreenTec medical website and various licensed partners. The company was founded in 2017 and is headquartered in Kelowna, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Kelowna",
        "zipcode": "V1Y 7T2",
        "website": "http://www.gtec.co",
        "market_cap": "Micro Cap"
    },
    "GTII.CN": {
        "short_name": "GreenThumb",
        "long_name": "Green Thumb Industries Inc.",
        "summary": "Green Thumb Industries Inc. manufactures, distributes, and sells various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including concentrates, edibles, and topical and other cannabis products under the Rythm, Dogwalkers, The Feel Collection, incredibles, Dr. Solomon's, Beboe, and other brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of March 25, 2021, it owned and operated 55 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "IL",
        "city": "Chicago",
        "zipcode": "60654",
        "website": "http://www.gtigrows.com",
        "market_cap": "Mid Cap"
    },
    "GTSIF": {
        "short_name": "LOBE SCIENCES LTD",
        "long_name": "Lobe Sciences Ltd.",
        "summary": "Lobe Sciences Ltd., a technology and services company, provides real estate, financial, management, intellectual property, and branding support for development of transformational medicine in the United States. The company intends to develop psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications. It also owns acquired brands, intellectual property, and leases office and production premises to a cannabis processor and retailer. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6B 2Z4",
        "website": "http://www.lobesciences.com",
        "market_cap": "Nano Cap"
    },
    "GU5.F": {
        "short_name": "GUANG.BAIY.PHAR.HO.H YC 1",
        "long_name": "Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited",
        "summary": "Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and chemical raw material intermediates in the People's Republic of China and internationally. It operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. The company is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, ganoderma spore oil capsules, lozenges, tortoise herb jelly, etc. In addition, it invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services. As of December 31, 2020, the company had 141 retail chain pharmacy outlets, which included 27 Cai Zhi Lin pharmacy outlets, 33 Jian Min pharmacy outlets, 36 GPC Prescription Pharmacy outlets, and 24 Hainan Guangyao Chenfei Pharmaceutical Chain outlets, as well as 21 retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "China",
        "state": null,
        "city": "Guangzhou",
        "zipcode": "510130",
        "website": "http://www.gybys.com.cn",
        "market_cap": "Mid Cap"
    },
    "GUD.TO": {
        "short_name": "KNIGHT THERAPEUTICS INC",
        "long_name": "Knight Therapeutics Inc.",
        "summary": "Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada and internationally. It offers Bijuva for the treatment of moderate to severe vasomotor symptoms associated with menopause in women with intact uterus; IMVEXXY to treat postmenopausal moderate to severe dyspareunia; IBSRELA for the treatment of irritable bowel syndrome with constipation in adults; TRELSTAR to treat advanced prostate cancer and for pain associated with endometriosis; ILUVIEN for the treatment of vision loss due to diabetic macular oedema; and NERLYNX to treat early-stage breast cancer. The company also provides Burinex, for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome; PROBUPHINE, to treat opioid addiction; and MOVANTIK for the treatment of opioid-induced constipation. In addition, it offers Vidaza to treat myelodysplastic syndrome; Abraxane for metastatic pancreatic adenocarcinoma; Halaven to treat advanced or metastatic breast cancer; Lenvima for differentiated thyroid cancer, advanced renal cell cancer, and unresectable hepatocellular carcinoma; Ladevina to treat multiple myeloma; Zyvalix for metastatic prostate cancer; Karfib to treat relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; AmBisome and Cresemba to treat fungal infection; and Impavido for leishmaniasis. Further, the company provides Ursofalk to treat biliary cirrhosis; Salofalk for ulcerative colitis; Fibridoner to treat idiopathic pulmonary fibrosis; Toliscrin for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Additionally, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "QC",
        "city": "Montreal",
        "zipcode": "H3Z 3B8",
        "website": "http://www.gud-knight.com",
        "market_cap": "Small Cap"
    },
    "GUFICBIO.NS": {
        "short_name": "GUFIC BIOSCIENCES",
        "long_name": "Gufic Biosciences Limited",
        "summary": "Gufic Biosciences Limited engages in the manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anaesthetics, and immuno suppressants, as well as intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products. The company was founded in 1970 and is based in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400057",
        "website": "http://gufic.com",
        "market_cap": "Micro Cap"
    },
    "H5O.F": {
        "short_name": "MGC PHARMACEUTICALS LTD",
        "long_name": "MGC Pharmaceuticals Limited",
        "summary": "MGC Pharmaceuticals Limited, together with its subsidiaries, produces and supplies phytocannabinoid derived medicines in Australia and Slovenia. It provides pharmaceutical products, such as Tetrinol for the treatment of cachexia; MXOT01GB01 to treat glioblastoma; MXOT02ME01 for the treatment of melanoma cancer; MXOT03PC01 to treat prostate cancer; TopiCann for the topical treatment of eczema and inflamed skin; and InCann, a biactive capsule to treat Chron's and IBS. The company's products under development include CannEpil, which is in Phase IIb clinical trial for the treatment in children and adolescents with refectory epilepsy; CogniCann that is in Phase II clinical trial to treat dementia and Alzheimer's diseases; and ArtemiC, which is in Phase II clinical trial for the treatment COVID-19. It has strategic collaborative partnership agreements Epilepsy Action Australia, Royal Melbourne Institute of Technology, the University of Notre Dame in Western Australia, as well as the National Institute of Biology & University Medical Centre, Ljubljana Slovenia. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is headquartered in West Perth, Australia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Australia",
        "state": "WA",
        "city": "West Perth",
        "zipcode": "6005",
        "website": "http://www.mgcpharma.com.au",
        "market_cap": "Micro Cap"
    },
    "H5P.F": {
        "short_name": "HIKMA PHARMACEUTIC.LS-,10",
        "long_name": "Hikma Pharmaceuticals PLC",
        "summary": "Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment develops, manufactures, and sells generic injectable products primarily for use in hospitals. The Generics segment develops, manufactures, and sells oral and other non-injectable generic products for the retail market. The Branded segment develops, manufactures, markets, and sells branded generics and in-licensed products to retail and hospital markets. The company offers its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, anesthetic, sedative, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "W1S 2HR",
        "website": "http://www.hikma.com",
        "market_cap": "Mid Cap"
    },
    "HAEK.DE": {
        "short_name": "HAEMATO AG  INH O.N.",
        "long_name": "HAEMATO AG",
        "summary": "HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European import medicinal products; and manufactures and distributes its own generic medicinal products. It provides pharmaceuticals in the areas of oncology, HIV/AIDS, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic treatments. The company also develops and commercializes pharmaceutical, medicinal, and medical engineering products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors and hospitals. The company was founded in 1993 and is headquartered in Sch\u00c3\u00b6nefeld, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "GER",
        "market": "de_market",
        "country": "Germany",
        "state": null,
        "city": "Sch\u00c3\u00b6nefeld",
        "zipcode": "12529",
        "website": "http://www.haemato.ag",
        "market_cap": "Micro Cap"
    },
    "HALO.NE": {
        "short_name": "HALO COLLECTIVE INC.",
        "long_name": "Halo Collective Inc.",
        "summary": "Halo Collective Inc. operates as a cannabis cultivation, manufacturing, and distribution company that grows, extracts, and processes cannabis flower, oils, and concentrates in the United States. The company also offers edible products, including single piece chews and a syrup-based drink in California and, Oregon. In addition, it markets branded and private label products. The company sells its cannabis products principally to dispensaries under Hush, Mojave, and Exhale brands. It serves licensed retailers and wholesalers. Halo Collective Inc. has a strategic partnership with High Tide Inc; and with OG DNA Genetics Inc to develop genetics in Oregon. The company was formerly known as Halo Labs Inc. and changed its name to Halo Collective Inc. in January 2021. Halo Collective Inc. was founded in 2016 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NEO",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 2M5",
        "website": "http://www.haloco.com",
        "market_cap": "Micro Cap"
    },
    "HAPP": {
        "short_name": "Happiness Biotech Group Limited",
        "long_name": "Happiness Biotech Group Limited",
        "summary": "Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powder, cordyceps mycelia, ejiao solution, American ginseng, and other products. It also offers a range of ganoderma lucidum products, such as essence oil, cleansing milk, shampoo, shower gel, and nourishing cream products under the Cai Zhi Ning brand, as well as edible fungi. In addition, the company provides disinfectants, non-medical face masks, and COVID-19 anti-body testing kits. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. Happiness Biotech Group Limited was founded in 2004 and is headquartered in Nanping, the People's Republic of China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Nanping",
        "zipcode": "353200",
        "website": "http://www.happ.org.cn",
        "market_cap": "Nano Cap"
    },
    "HARV.CN": {
        "short_name": "HarvestHealth",
        "long_name": "Harvest Health & Recreation Inc.",
        "summary": "Harvest Health and Recreation, Inc., together with its subsidiaries, cultivates, processes, sells, and retails inhalable, ingestible, and topical cannabis products in the United States. The company offers cannabis oil products; inhalables, including flower, dabbable concentrates, pre-filled vaporizer pens, and cartridges; and capsules, tinctures, and cannabis product edibles, including chocolates, gummies, mints, fruit chews, and dissolvable mouth strips under the Avenue, CBX SCIENCES, EVOLAB, ALCHEMY, CHROMA, CO2LORS, GOODSUN, MODERN FLOWER, and ROLL ONE brand names. It also operates retail dispensaries that sell proprietary and third-party cannabis products to patients and customers; and provides support services and financing to a Utah licensed medical cannabis cultivator. Harvest Health and Recreation, Inc. was founded in 2011 and is headquartered in Tempe, Arizona.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "AZ",
        "city": "Tempe",
        "zipcode": "85281",
        "website": "http://www.harvesthoc.com",
        "market_cap": "Small Cap"
    },
    "HBMK": {
        "short_name": "HUBEI MINKANG PHARMACEUTICAL LT",
        "long_name": "Hubei Minkang Pharmaceutical Ltd.",
        "summary": "Hubei Minkang Pharmaceutical Ltd. is engaged in the research, development, manufacture, and marketing of traditional Chinese medicine (TCM) and chemical pharmaceuticals. The company produces 21 products, which include 5 prescription TCM products, 1 chemical or western-style medicine, and 15 over-the-counter (OTC) products in various product types, including pills, tablets, capsules, granules, oral liquids, syrups, and mixtures and injections in approximately 400 formulations and dosages. Its principal products comprise Yinxing Damo Zhusheye, a chemical medication injectable for the prevention and treatment of coronary heart disease; An Ka Huangmin Jiaonang, a chemical medication that relieves cold and flu symptoms, including fever, headache, sore throat, and sneezing; Xumeian Capsule, a prescription TCM medication used for leucopenia; Wei C Yinqiao Pian, an OTC pill used for relieving cold and flu symptoms, such as body aches, cough, fever, headache, and sore throat; and Shuxin Koufouye, a prescription TCM oral medication for promoting blood circulation and relieving chest pain, shortness of breath, and fatigue associated with coronary heart disease. The company sells its products through distributors in the People's Republic of China, the United States, Japan, Vietnam, Malaysia, Singapore, the Philippines, Hong Kong, Indonesia, and various European countries. Hubei Minkang Pharmaceutical Ltd. was founded in 2003 and is based in Singapore.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Singapore",
        "state": null,
        "city": "Singapore",
        "zipcode": "408864",
        "website": "http://www.minkang.com.cn",
        "market_cap": "Micro Cap"
    },
    "HBOR.CN": {
        "short_name": "Harborside",
        "long_name": "Harborside Inc.",
        "summary": "Harborside Inc. cultivates, manufactures, distributes, and sells cannabis and cannabis products. The company owns and operates three retail dispensaries in California and Oregon; and a dispensary under a management services agreement. It also operates a 47 acres of cultivation facility located in Salinas, California. The company sells its products under the Harborside, Harborside Farms, Harborside Farms Reserve, and KEY brands. The company was founded in 2006 and is headquartered in Oakland, California.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "CA",
        "city": "Oakland",
        "zipcode": "94606",
        "website": "http://www.investharborside.com",
        "market_cap": "Nano Cap"
    },
    "HBORF": {
        "short_name": "HARBORSIDE INC",
        "long_name": "Harborside Inc.",
        "summary": "Harborside Inc. cultivates, manufactures, distributes, and sells cannabis and cannabis products. The company owns and operates three retail dispensaries in California and Oregon; and a dispensary under a management services agreement. It also operates a 47 acres of cultivation facility located in Salinas, California. The company sells its products under the Harborside, Harborside Farms, Harborside Farms Reserve, and KEY brands. The company was founded in 2006 and is headquartered in Oakland, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Oakland",
        "zipcode": "94606",
        "website": "http://www.investharborside.com",
        "market_cap": "Nano Cap"
    },
    "HBRM": {
        "short_name": "HERBORIUM GROUP INC",
        "long_name": "Herborium Group, Inc.",
        "summary": "Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. It offers dermatology products, which include AcnEase, herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company also provides sexual health and performance products that are non-prescriptive alternatives to selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, and surgical procedures, including hysterectomy. In addition, it offers energy restoration products, such as Lasting Energy, a herbal supplement to decrease the symptoms associated with hangovers and eliminating jet-lag; and for treating overall depletion of energy due to competitive sports, high levels of stress, and extensive sexual activities, as well as other long term or temporary physical demands. Further, the company provides Liver Activator Series for the treatment of liver damage; ProstAid, a natural product focuses on Benign Prostate Hyperplasia; and CardioVitae, a fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. Herborium Group, Inc. sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "Fort Lee",
        "zipcode": "07024",
        "website": "http://www.herborium.com",
        "market_cap": "Nano Cap"
    },
    "HCANF": {
        "short_name": "HALO COLLECTIVE INC",
        "long_name": "Halo Collective Inc.",
        "summary": "Halo Collective Inc. operates as a cannabis cultivation, manufacturing, and distribution company that grows, extracts, and processes cannabis flower, oils, and concentrates in the United States. The company also offers edible products, including single piece chews and a syrup-based drink in California and, Oregon. In addition, it markets branded and private label products. The company sells its cannabis products principally to dispensaries under Hush, Mojave, and Exhale brands. It serves licensed retailers and wholesalers. Halo Collective Inc. has a strategic partnership with High Tide Inc; and with OG DNA Genetics Inc to develop genetics in Oregon. The company was formerly known as Halo Labs Inc. and changed its name to Halo Collective Inc. in January 2021. Halo Collective Inc. was founded in 2016 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 2M5",
        "website": "http://www.haloco.com",
        "market_cap": "Micro Cap"
    },
    "HEME": {
        "short_name": "HEALTHMED SERVICES LTD",
        "long_name": "Healthmed Services Ltd.",
        "summary": "Healthmed Services Ltd. provides communications technology to provide individuals, companies, and health-provider organizations with telephone and Web-based access to medical advice, information, and products and services. The company was founded in 2000 and is based in Temecula, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Temecula",
        "zipcode": "92590",
        "website": "http://www.healthmedservicesltd.com",
        "market_cap": "Nano Cap"
    },
    "HEMP.F": {
        "short_name": "DT.CANNABIS AG  O.N.",
        "long_name": "Deutsche Cannabis AG",
        "summary": "Deutsche Cannabis AG engages in the acquisition, sale, and management of investments in cannabis industry primarily in Germany. It also focuses on the investment in the renewable energy sector, such as photovoltaics and cogeneration. The company was formerly known as F.A.M.E. AG and changed its name to Deutsche Cannabis AG in December 2014. Deutsche Cannabis AG was founded in 1999 and is based in Hamburg, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Hamburg",
        "zipcode": "22399",
        "website": "http://www.deutschecannabis.com",
        "market_cap": "Nano Cap"
    },
    "HEMP": {
        "short_name": "HEMP INC",
        "long_name": "Hemp, Inc",
        "summary": "Hemp, Inc. focuses on the provision of industrial hemp. The company is involved in processing and farming industrial hemp; extracting hemp CBD oil; and educating and empowering hemp farmers and entrepreneurs with knowledge, processing, infrastructure, and support. It also engages in the sale of hemp accessories, such as extractors, harvesters, storage bags, containers, fertilizer, soil amendments, humidifiers, dehumidifiers, balers, greenhouses, and greenhouse equipment; and drying, trimming, curing, storing, and brokering for other farmers harvesting hemp, as well as provision of research and development, hemp consulting, and educational entertainment services. The company was formerly known as Marijuana, Inc. and changed its name to Hemp, Inc. in June 2012. Hemp, Inc. was founded in 2008 and is based in Las Vegas, Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89123",
        "website": "http://www.hempinc.com",
        "market_cap": "Nano Cap"
    },
    "HERTF": {
        "short_name": "HERITAGE CANNABIS HOLDINGS CORP",
        "long_name": "Heritage Cannabis Holdings Corp.",
        "summary": "Heritage Cannabis Holdings Corp., through its subsidiaries, operates as a cannabinoid company that focuses on the production and sale of medical and recreational hemp-based and cannabis-based products and services in Canada and the United States. It offers extraction services; and focuses on processing, manufacturing, and distributing medical cannabis products and cannabis oils. It provides integrative approach to cannabinoid therapy for healthcare consumers and healthcare practitioners. The company was formerly known as Umbral Energy Corp. and changed its name to Heritage Cannabis Holdings Corp. in January 2018. Heritage Cannabis Holdings Corp. was incorporated in 2007 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5S 1M2",
        "website": "http://www.heritagecann.com",
        "market_cap": "Micro Cap"
    },
    "HESTERBIO.NS": {
        "short_name": "HESTER BIOSCIENCES",
        "long_name": "Hester Biosciences Limited",
        "summary": "Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India. It operates through Poultry healthcare, Animal Healthcare, and Others segments. The Poultry Healthcare segment vaccines for diseases such as fowl pox, Newcastle disease, infectious bronchitis, and others; feed supplements, such as growth tonic, toxin binder, and herbal supplement; disinfectants for farms and equipment; and sanitizers. The Animal Healthcare segment vaccines for large animals against Goat Pox, Peste des Petits Ruminants, and Brucellosis disease; anti-infective, antiparasite, non-steroidal anti-inflammatory, and anthelmintic drugs; food supplements, including growth tonic, mineral mixture, fertility supplement, and bypass fat; farms and equipment disinfectants; and udder management services. It also offers ELISA & PCR diagnostic kits; NDV and IBV ELISA kits for sero-monitoring of poultry; and PCR molecular diagnostic kits for various diseases. The company also exports its products. Hester Biosciences Limited has a collaboration agreement with Indian Institute of Technology Guwahati to develop vaccine against COVID-19. The company was founded in 1987 and is headquartered in Ahmedabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Ahmedabad",
        "zipcode": "380006",
        "website": "http://www.hester.in",
        "market_cap": "Small Cap"
    },
    "HEXO": {
        "short_name": "HEXO Corp.",
        "long_name": "HEXO Corp.",
        "summary": "HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Kanata",
        "zipcode": "K2K 2X2",
        "website": "http://www.hexocorp.com",
        "market_cap": "Small Cap"
    },
    "HEXO.TO": {
        "short_name": "HEXO CORP",
        "long_name": "HEXO Corp.",
        "summary": "HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Kanata",
        "zipcode": "K2K 2X2",
        "website": "http://www.hexocorp.com",
        "market_cap": "Small Cap"
    },
    "HIK.L": {
        "short_name": "HIKMA PHARMACEUTICALS PLC ORD S",
        "long_name": "Hikma Pharmaceuticals PLC",
        "summary": "Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment develops, manufactures, and sells generic injectable products primarily for use in hospitals. The Generics segment develops, manufactures, and sells oral and other non-injectable generic products for the retail market. The Branded segment develops, manufactures, markets, and sells branded generics and in-licensed products to retail and hospital markets. The company offers its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, anesthetic, sedative, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "W1S 2HR",
        "website": "http://www.hikma.com",
        "market_cap": null
    },
    "HIKAL.NS": {
        "short_name": "HIKAL LTD",
        "long_name": "Hikal Limited",
        "summary": "Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, food, animal healthcare, biotech, crop protection, and specialty chemicals and biocides companies. It operates in two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was founded in 1988 and is headquartered in Navi Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Navi Mumbai",
        "zipcode": "400614",
        "website": "http://www.hikal.com",
        "market_cap": "Small Cap"
    },
    "HKMPF": {
        "short_name": "HIKMA PHARMACEUTICALS",
        "long_name": "Hikma Pharmaceuticals PLC",
        "summary": "Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment develops, manufactures, and sells generic injectable products primarily for use in hospitals. The Generics segment develops, manufactures, and sells oral and other non-injectable generic products for the retail market. The Branded segment develops, manufactures, markets, and sells branded generics and in-licensed products to retail and hospital markets. The company offers its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, anesthetic, sedative, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "W1S 2HR",
        "website": "http://www.hikma.com",
        "market_cap": "Mid Cap"
    },
    "HKMPY": {
        "short_name": "HIKMA PHARMACEUTICALS",
        "long_name": "Hikma Pharmaceuticals PLC",
        "summary": "Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment develops, manufactures, and sells generic injectable products primarily for use in hospitals. The Generics segment develops, manufactures, and sells oral and other non-injectable generic products for the retail market. The Branded segment develops, manufactures, markets, and sells branded generics and in-licensed products to retail and hospital markets. The company offers its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, anesthetic, sedative, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "W1S 2HR",
        "website": "http://www.hikma.com",
        "market_cap": "Mid Cap"
    },
    "HLS.TO": {
        "short_name": "HLS THERAPEUTICS INC",
        "long_name": "HLS Therapeutics Inc.",
        "summary": "HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. Its lead product is Clozaril, an atypical antipsychotic used in the treatment of schizophrenia. The company also holds the U.S. marketing rights of Absorica, a commercial stage dermatology product. HLS Therapeutics Inc. has a license agreement with Amarin Corporation plc to register, commercialize, and distribute Vascepa capsules in Canada. The company was founded in 2018 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M9W 6L2",
        "website": "http://www.hlstherapeutics.com",
        "market_cap": "Small Cap"
    },
    "HLTRF": {
        "short_name": "HLS THERAPEUTICS INC",
        "long_name": "HLS Therapeutics Inc.",
        "summary": "HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. Its lead product is Clozaril, an atypical antipsychotic used in the treatment of schizophrenia. The company also holds the U.S. marketing rights of Absorica, a commercial stage dermatology product. HLS Therapeutics Inc. has a license agreement with Amarin Corporation plc to register, commercialize, and distribute Vascepa capsules in Canada. The company was founded in 2018 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M9W 6L2",
        "website": "http://www.hlstherapeutics.com",
        "market_cap": "Small Cap"
    },
    "HLUKF": {
        "short_name": "H.LUNDBECK A/S",
        "long_name": "H. Lundbeck A/S",
        "summary": "H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Onfi for Lennox-Gastaut syndrome; Vyepti for migraine prevention; and Rexulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. The company was founded in 1915 and is headquartered in Valby, Denmark.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Denmark",
        "state": null,
        "city": "Valby",
        "zipcode": "2500",
        "website": "http://www.lundbeck.com",
        "market_cap": "Mid Cap"
    },
    "HLUYY": {
        "short_name": "H.LUNDBECK A/S",
        "long_name": "H. Lundbeck A/S",
        "summary": "H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Onfi for Lennox-Gastaut syndrome; Vyepti for migraine prevention; and Rexulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. The company was founded in 1915 and is headquartered in Valby, Denmark.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Denmark",
        "state": null,
        "city": "Valby",
        "zipcode": "2500",
        "website": "http://www.lundbeck.com",
        "market_cap": "Mid Cap"
    },
    "HM6A.SG": {
        "short_name": "Hypera S.A. Reg.Shs (Spons.ADRs",
        "long_name": "Hypera S.A.",
        "summary": "Hypera S.A. operates as a pharmaceutical company in Brazil. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands; dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. The company also provides nutrition, sweeteners, and vitamin supplement products under the Tamarine, Vitasay 50+, Biot\u00c3\u00b4nico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Qu\u00c3\u00admica, Torsilax, Neosoro, Doralgina, Flavonid, and Histamin brands. It sells its products through distributors and wholesalers. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in S\u00c3\u00a3o Paulo, Brazil.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "Brazil",
        "state": "SP",
        "city": "S\u00c3\u00a3o Paulo",
        "zipcode": "05676-120",
        "website": "http://www.hyperapharma.com.br",
        "market_cap": "Mid Cap"
    },
    "HMPQ": {
        "short_name": "HEMP AMERICANA INC",
        "long_name": "HempAmericana, Inc",
        "summary": "HempAmericana, Inc. researches, develops, and sells products made of industrial hemp in the United States. It provides hemp-based concrete, hemp bags, hemp seeds for consumption, hemp clothing, and hemp rolling paper products. HempAmericana, Inc. was founded in 2014 and is based in New York, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10007",
        "website": "http://www.hempamericana.com",
        "market_cap": "Nano Cap"
    },
    "HN3Q.F": {
        "short_name": "NOVA MENTIS LI. SC. CORP.",
        "long_name": "Nova Mentis Life Science Corp.",
        "summary": "Nova Mentis Life Science Corp., through its subsidiaries, focuses on developing medicinal psychedelics for neuroinflammatory conditions with a focus on autism spectrum disorder. It is also involved in the research and development of psychedelic medicines for metabolic indications, such as obesity and diabetes. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 0A6",
        "website": "http://www.novamentis.ca",
        "market_cap": "Nano Cap"
    },
    "HOB.F": {
        "short_name": "HOLLISTER BIOSCIENCES INC",
        "long_name": "Hollister Biosciences Inc.",
        "summary": "Hollister Biosciences Inc., together with its subsidiaries, manufactures and distributes recreational cannabis and cannabis products in the United States. It offers pre rolls, infused pre rolls, vape formulation, vape cart filling, tinctures, and capsules under HashBone, Purity Petibles, Mighty Med Vape, NanoPure, and Rebel Hemp Company brands, as well as contract manufacturing white label products for other companies. The company has a collaboration with Easyriders to create cannabis products. Hollister Biosciences Inc. based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 4N7",
        "website": "http://www.hollistercannabisco.com",
        "market_cap": "Micro Cap"
    },
    "HOLL.CN": {
        "short_name": "Hollister Bio",
        "long_name": "Hollister Biosciences Inc.",
        "summary": "Hollister Biosciences Inc., together with its subsidiaries, manufactures and distributes recreational cannabis and cannabis products in the United States. It offers pre rolls, infused pre rolls, vape formulation, vape cart filling, tinctures, and capsules under HashBone, Purity Petibles, Mighty Med Vape, NanoPure, and Rebel Hemp Company brands, as well as contract manufacturing white label products for other companies. The company has a collaboration with Easyriders to create cannabis products. Hollister Biosciences Inc. based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 4N7",
        "website": "http://www.hollistercannabisco.com",
        "market_cap": "Micro Cap"
    },
    "HPMM": {
        "short_name": "HEMP NATURALS INC",
        "long_name": "Hemp Naturals, Inc.",
        "summary": "Hemp Naturals, Inc., an early stage company, focuses on researching, developing, acquiring, and selling products made of industrial hemp. The company offers rolling papers through 25 retail outlets, which include gas stations, convenience stores, tobacco shops, and liquor stores. It also intends to offer consumer goods that are made of industrial hemp and/or the non-psychoactive ingredients of the cannabis plant, such as nutritional hemp health supplements, hemp shakes and/or foods, and beauty supply products, as well as hemp clothing. Hemp Naturals, Inc. was incorporated in 2015 and is based in Sunny Isles Beach, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Sunny Isles Beach",
        "zipcode": "33160",
        "website": "http://www.hempofnaturals.com",
        "market_cap": "Nano Cap"
    },
    "HPST": {
        "short_name": "HEMPSTRACT INC",
        "long_name": "Hempstract, Inc.",
        "summary": "Hempstract, Inc. produces and sells cannabidiol (CBD) and cannabigerol solutions in the United States. It offers CBD isolate powder and distillate oil. The company was formerly known as Riverdale Oil and Gas Corporation and changed its name to Hempstract, Inc. in November 2020. Hempstract, Inc. is based in Warden, Washington.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "WA",
        "city": "Warden",
        "zipcode": "98857-0665",
        "website": "http://www.hempstractlabs.com",
        "market_cap": null
    },
    "HPX.F": {
        "short_name": "HISAMITSU PHARMA.",
        "long_name": "Hisamitsu Pharmaceutical Co., Inc.",
        "summary": "Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. The company provides analgesic / anti-inflammatory patches; athlete's foot / ringworm remedy products; allergy-only rhinitis drugs; eye drops; high cholesterol improving drugs; acne remedies; cooling sheets; and supporters for knee, waist, elbow, calf and ankle. It also provides cooling sprays; bactericidal antibacterial spray and deodorant spray; ship fixing sheet; adhesive plasters for magnetic products; skin care products; sweat sheet; massage roller gel and oil spray; thermal equipment, and dietary supplements. The company offers its products under the Salon pass, Salonship, Air Salon Pass, Fatus, Butena Rock, Allegra, Direct pasting, Choleston, Life Cera, Deco Deco Cool, Children Robin Eye Plus. Eye cool, MSM, and other brand names. It sells its products in North America, Central and South America, Asia, Oceania, the Middle East, Africa, and Europe. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Japan",
        "state": null,
        "city": "Tosu",
        "zipcode": "841-0017",
        "website": "http://www.hisamitsu.co.jp",
        "market_cap": "Mid Cap"
    },
    "HQP.SG": {
        "short_name": "KIMIA FARMA TBK",
        "long_name": "PT Kimia Farma (Persero) Tbk",
        "summary": "PT Kimia Farma (Persero) Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia, rest of Asia, Europe, Australia, Africa, and New Zealand. The company operates through Manufacturing, Distribution, Retail, and Other Services segments. It also manufactures and markets chemical, betalactam and non betalactam, antiretroviral, narcotic, hormone contraceptive, powder, oil castor, edible oil, cosmetic, over the counter, personal, and beauty care products, as well as food supplements, active pharmaceutical ingredients, and medical devices. In addition, the company manufactures, markets, distributes, and trades in pharmaceutical products; and operates drug materials plants. As of December 31, 2020, it operated 1,278 retail pharmacy outlets, 451 health clinic outlets, 75 clinical laboratories, 10 optics, 3 beauty clinics, and 24 international retail outlets. The company sells its products to pharmacies, drug stores, hospitals, and free traders through pharmaceutical wholesalers. The company was founded in 1817 and is headquartered in Jakarta, Indonesia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "Indonesia",
        "state": null,
        "city": "Jakarta",
        "zipcode": "10110",
        "website": "http://kimiafarma.co.id",
        "market_cap": "Small Cap"
    },
    "HROW": {
        "short_name": "Harrow Health, Inc.",
        "long_name": "Harrow Health, Inc.",
        "summary": "Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and Visionology, a membership-based online eye health and medication platform. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was founded in 1998 and is headquartered in San Diego, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "TN",
        "city": "Nashville",
        "zipcode": "37205",
        "website": "http://www.harrowinc.com",
        "market_cap": "Micro Cap"
    },
    "HRVOF": {
        "short_name": "HARVEST ONE CANNABIS INC",
        "long_name": "Harvest One Cannabis Inc.",
        "summary": "Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. It operates through two segments, Medical and Nutraceutical, and Consumer. The Medical and Nutraceutical segment is involved in the processing, manufacturing, and distribution of cannabis-based food supplement products. The Consumer segment engages in the marketing, distribution, and product development of liquid sleep shots and sleep powder packets, as well as pain relief creams. Harvest One Cannabis Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3E8",
        "website": "http://www.harvestone.com",
        "market_cap": "Nano Cap"
    },
    "HRVSF": {
        "short_name": "HARVEST HEALTH AND RECREATION I",
        "long_name": "Harvest Health & Recreation Inc.",
        "summary": "Harvest Health and Recreation, Inc., together with its subsidiaries, cultivates, processes, sells, and retails inhalable, ingestible, and topical cannabis products in the United States. The company offers cannabis oil products; inhalables, including flower, dabbable concentrates, pre-filled vaporizer pens, and cartridges; and capsules, tinctures, and cannabis product edibles, including chocolates, gummies, mints, fruit chews, and dissolvable mouth strips under the Avenue, CBX SCIENCES, EVOLAB, ALCHEMY, CHROMA, CO2LORS, GOODSUN, MODERN FLOWER, and ROLL ONE brand names. It also operates retail dispensaries that sell proprietary and third-party cannabis products to patients and customers; and provides support services and financing to a Utah licensed medical cannabis cultivator. Harvest Health and Recreation, Inc. was founded in 2011 and is headquartered in Tempe, Arizona.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "AZ",
        "city": "Tempe",
        "zipcode": "85281",
        "website": "http://www.harvesthoc.com",
        "market_cap": "Small Cap"
    },
    "HSTI": {
        "short_name": "HIGH SIERRA TECHNOLOGIES INC",
        "long_name": "High Sierra Technologies, Inc.",
        "summary": "High Sierra Technologies, Inc. focuses on the development of patents and other products used in the processing of recreational cannabis and industrial hemp. It intends to offer its products for smoking and/or ingestion in various forms. The company is based in Reno, Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Reno",
        "zipcode": "89519",
        "website": null,
        "market_cap": "Micro Cap"
    },
    "HSTRF": {
        "short_name": "HOLLISTER BIOSCIENCES INC",
        "long_name": "Hollister Biosciences Inc.",
        "summary": "Hollister Biosciences Inc., together with its subsidiaries, manufactures and distributes recreational cannabis and cannabis products in the United States. It offers pre rolls, infused pre rolls, vape formulation, vape cart filling, tinctures, and capsules under HashBone, Purity Petibles, Mighty Med Vape, NanoPure, and Rebel Hemp Company brands, as well as contract manufacturing white label products for other companies. The company has a collaboration with Easyriders to create cannabis products. Hollister Biosciences Inc. based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 4N7",
        "website": "http://www.hollistercannabisco.com",
        "market_cap": "Nano Cap"
    },
    "HTSUF": {
        "short_name": "HISAMITSU PHARMACEUTICAL CO INC",
        "long_name": "Hisamitsu Pharmaceutical Co., Inc.",
        "summary": "Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. The company provides analgesic / anti-inflammatory patches; athlete's foot / ringworm remedy products; allergy-only rhinitis drugs; eye drops; high cholesterol improving drugs; acne remedies; cooling sheets; and supporters for knee, waist, elbow, calf and ankle. It also provides cooling sprays; bactericidal antibacterial spray and deodorant spray; ship fixing sheet; adhesive plasters for magnetic products; skin care products; sweat sheet; massage roller gel and oil spray; thermal equipment, and dietary supplements. The company offers its products under the Salon pass, Salonship, Air Salon Pass, Fatus, Butena Rock, Allegra, Direct pasting, Choleston, Life Cera, Deco Deco Cool, Children Robin Eye Plus. Eye cool, MSM, and other brand names. It sells its products in North America, Central and South America, Asia, Oceania, the Middle East, Africa, and Europe. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Japan",
        "state": null,
        "city": "Tosu",
        "zipcode": "841-0017",
        "website": "http://www.hisamitsu.co.jp",
        "market_cap": "Mid Cap"
    },
    "HUGE.CN": {
        "short_name": "FSDPharmaInc",
        "long_name": "FSD Pharma Inc.",
        "summary": "FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological disorders. It has license agreements with Epitech Group SpA.; and with Innovet Italia S.R.L. to develop veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats. The company was founded in 1998 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5X 1A4",
        "website": "http://www.fsdpharma.com",
        "market_cap": "Micro Cap"
    },
    "HUGE": {
        "short_name": "FSD Pharma Inc.",
        "long_name": "FSD Pharma Inc.",
        "summary": "FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological disorders. It has license agreements with Epitech Group SpA.; and with Innovet Italia S.R.L. to develop veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats. The company was founded in 1998 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5X 1A4",
        "website": "http://www.fsdpharma.com",
        "market_cap": "Micro Cap"
    },
    "HUMDF": {
        "short_name": "HUA MEDICINE",
        "long_name": "Hua Medicine (Shanghai) Ltd.",
        "summary": "Hua Medicine (Shanghai) Ltd. operates as a drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes. The company also offers Dorzagliatin in combination with Metformin that is in Phase I clinical trial. In addition, it provides Dorzagliatin in combination with Sitagliptin, Empagli, Pioglitazone, and Insulin for the treatment of Type 2 diabetes that is in pre-clinical stage. Further, the company is developing mGLUR5 for the treatment of Parkinson's disease levodopa-induced dyskinesia or PD-LID. The company was incorporated in 2011 and is headquartered in Shanghai, China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Shanghai",
        "zipcode": "201203",
        "website": "http://www.huamedicine.com",
        "market_cap": "Small Cap"
    },
    "HVT.V": {
        "short_name": "HARVEST ONE CANNABIS INC",
        "long_name": "Harvest One Cannabis Inc.",
        "summary": "Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. It operates through two segments, Medical and Nutraceutical, and Consumer. The Medical and Nutraceutical segment is involved in the processing, manufacturing, and distribution of cannabis-based food supplement products. The Consumer segment engages in the marketing, distribution, and product development of liquid sleep shots and sleep powder packets, as well as pain relief creams. Harvest One Cannabis Inc. is headquartered in Vancouver, Canada.",
        "currency": null,
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3E8",
        "website": "http://www.harvestone.com",
        "market_cap": null
    },
    "HYEX": {
        "short_name": "HEALTHY EXTRACTS INC",
        "long_name": "Healthy Extracts Inc.",
        "summary": "Healthy Extracts Inc., through its subsidiaries, researches, develops, and markets natural plant-based formulations in the United States and internationally. It offers heart health nutritional products; and neuro-products under the KETONOMICS name that enhance brain health, including memory, cognition, focus, and neuro-energy. The company also provides bergamot products in capsule form under the BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, and BergaMet SPORTSHEART products labels. It distributes bergamot products through its website and distribution sites. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is based in Las Vegas, Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89113",
        "website": "http://healthyextractsinc.com",
        "market_cap": "Nano Cap"
    },
    "HYPE3.SA": {
        "short_name": "HYPERA      ON      NM",
        "long_name": "Hypera S.A.",
        "summary": "Hypera S.A. operates as a pharmaceutical company in Brazil. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands; dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. The company also provides nutrition, sweeteners, and vitamin supplement products under the Tamarine, Vitasay 50+, Biot\u00c3\u00b4nico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Qu\u00c3\u00admica, Torsilax, Neosoro, Doralgina, Flavonid, and Histamin brands. It sells its products through distributors and wholesalers. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in S\u00c3\u00a3o Paulo, Brazil.",
        "currency": "BRL",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SAO",
        "market": "br_market",
        "country": "Brazil",
        "state": "SP",
        "city": "S\u00c3\u00a3o Paulo",
        "zipcode": "05676-120",
        "website": "http://www.hyperapharma.com.br",
        "market_cap": "Mid Cap"
    },
    "HYPMY": {
        "short_name": "HYPERA SA",
        "long_name": "Hypera S.A.",
        "summary": "Hypera S.A. operates as a pharmaceutical company in Brazil. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands; dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. The company also provides nutrition, sweeteners, and vitamin supplement products under the Tamarine, Vitasay 50+, Biot\u00c3\u00b4nico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Qu\u00c3\u00admica, Torsilax, Neosoro, Doralgina, Flavonid, and Histamin brands. It sells its products through distributors and wholesalers. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in S\u00c3\u00a3o Paulo, Brazil.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Brazil",
        "state": "SP",
        "city": "S\u00c3\u00a3o Paulo",
        "zipcode": "05676-120",
        "website": "http://www.hyperapharma.com.br",
        "market_cap": "Mid Cap"
    },
    "I76.F": {
        "short_name": "IRONWOOD PHARMA.A DL-,001",
        "long_name": "Ironwood Pharmaceuticals, Inc.",
        "summary": "Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist, which is in pre-clinical development for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "MA",
        "city": "Boston",
        "zipcode": "02110",
        "website": "http://www.ironwoodpharma.com",
        "market_cap": "Small Cap"
    },
    "I7G.F": {
        "short_name": "IPSEN S.A. PORT.  EO 1",
        "long_name": "Ipsen S.A.",
        "summary": "Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Decapeptyl for metastatic prostate cancer, uterine fibroids, precocious puberty, endometriosis, female sterility, and early stage breast cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde for second-line metastatic pancreatic cancer; and Dysport for motor muscular disorders and medical aesthetics. The company also provides NutropinAq for growth failure in children due to growth hormone (GH) deficiency, turner syndrome, and chronic renal failure, as well as GH deficiency in adults; and Increlex for growth failure in children and adolescents. In addition, it offers Smecta for chronic and acute diarrhea, and pain associated with functional bowel diseases; Forlax for constipation; Fortrans/Eziclen for bowel cleansing prior to endoscopy, X-ray examination, and colonic surgery; and Tanakan for cognitive disorders in adults, vertigo of vestibular origin and vestibular rehabilitation, and tinnitus. Further, the company provides Xermelo for the carcinoid syndrome; Cometriq for medullary thyroid cancer; Smebiocta/SmectaFlora Comfort, a food supplement; SmectaGas, a medical device used in the symptomatic treatment of gas-related gastrointestinal disorders and relief of gas-related symptoms; and Etiasa for inflammatory bowel diseases. Additionally, it offers other consumer healthcare products in the gastro-intestinal area, including Buscopan, Clin4000, Prontalgine, Suppositoria Glycerini, Mucothiol, Floractin, and Mucodyne. The company has various agreements with Debiopharm, Exelixis, Galderma, Blueprint Medicines, TerSera Therapeutics, Rhythm Pharmaceuticals, Teijin, Braintree Laboratories, Ethypharm, and Schwabe. Ipsen S.A. was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy SA.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "France",
        "state": null,
        "city": "Boulogne-Billancourt",
        "zipcode": "92650",
        "website": "http://www.ipsen.com",
        "market_cap": "Mid Cap"
    },
    "IAGX": {
        "short_name": "IMAGENETIX INC",
        "long_name": "Imagenetix, Inc.",
        "summary": "Imagenetix, Inc. develops, formulates, and markets proprietary and natural based nutritional supplements, and over-the-counter topical creams and skin care products. Its primary product is Celadrin, a product formulation for joint health. The company also licenses its intellectual property to third parties. Imagenetix, Inc. markets its products through various channels of distribution, including direct and mass marketing companies, nutritional newsletters, and medical and nutritional oriented professionals; medical newsletters; and direct response radio and television. The company was founded in 1996 and is based in San Diego, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "San Diego",
        "zipcode": "92127",
        "website": "http://www.imagenetix.net",
        "market_cap": "Nano Cap"
    },
    "IAN.CN": {
        "short_name": "iAnthus Capital",
        "long_name": "iAnthus Capital Holdings, Inc.",
        "summary": "iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 31 dispensaries and 10 cultivation and/or processing facilities in 9 states. The company is headquartered in New York, New York.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10170",
        "website": "http://www.ianthus.com",
        "market_cap": "Nano Cap"
    },
    "IB3A.F": {
        "short_name": "IONIC BRANDS CORP.",
        "long_name": "Ionic Brands Corp.",
        "summary": "Ionic Brands Corp. provides cannabis related services in Washington and Oregon. The company manufacture and distribute hard goods, such as cartridges, applicators, pens, jars, etc. under the IONIC brand name. The company is headquartered in Tacoma, Washington.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "WA",
        "city": "Tacoma",
        "zipcode": "98402",
        "website": "http://www.ionicbrands.com",
        "market_cap": "Nano Cap"
    },
    "ICAN.CN": {
        "short_name": "IcanicBrCo",
        "long_name": "Icanic Brands Company Inc.",
        "summary": "Icanic Brands Company Inc. provides life enhancement products in Canada. The company owns license for X-Sprays, a brand of life enhancement products administered through an oral spray delivery system. It markets and sells dietary supplements for nonmedical use primarily cannabinoid and cannabis-infused sprays, as well as non-cannabis infused sprays. The company was formerly known as Integrated Cannabis Company, Inc. and changed its name to Icanic Brands Company Inc. in February 2020. Icanic Brands Company Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1H2",
        "website": "http://www.icaninc.com",
        "market_cap": "Micro Cap"
    },
    "ICNAF": {
        "short_name": "ICANIC BRANDS COMPANY INC",
        "long_name": "Icanic Brands Company Inc.",
        "summary": "Icanic Brands Company Inc. provides life enhancement products in Canada. The company owns license for X-Sprays, a brand of life enhancement products administered through an oral spray delivery system. It markets and sells dietary supplements for nonmedical use primarily cannabinoid and cannabis-infused sprays, as well as non-cannabis infused sprays. The company was formerly known as Integrated Cannabis Company, Inc. and changed its name to Icanic Brands Company Inc. in February 2020. Icanic Brands Company Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1H2",
        "website": "http://www.icaninc.com",
        "market_cap": "Micro Cap"
    },
    "IDCN": {
        "short_name": "INDOCAN RESOURCES INC",
        "long_name": "Indocan Resources Inc.",
        "summary": "Indocan Resources Inc., a real estate holding company, invests in coastal vacation rental and commercial properties. The company was incorporated in 1994 and is based in Emerald Isle, North Carolina.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NC",
        "city": "Emerald Isle",
        "zipcode": "28594",
        "website": "http://indocanresources.com",
        "market_cap": "Nano Cap"
    },
    "IDT.AX": {
        "short_name": "IDT AUST FPO",
        "long_name": "IDT Australia Limited",
        "summary": "IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. The company offers analytical method development, stability chambers, and chemistry and microbiology quality control laboratory services, as well as pharmaceutical development services in all dosage forms. Its services also include project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs. In addition, the company offers medical cannabis products; and various contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Boronia",
        "zipcode": "3155",
        "website": "http://www.idtaus.com.au",
        "market_cap": "Nano Cap"
    },
    "IDVR.CN": {
        "short_name": "INDVRBrands",
        "long_name": "INDVR Brands Inc.",
        "summary": "INDVR Brands Inc. focuses on providing management resources, and infrastructure and equipment for the production, cultivation, and dispensary operations of licensed cannabis businesses in the United States. The company offers its products under the Cannabis, The Joint, Incognito by Cannabis, Fire by Cannabis, Cannabis Prime, Fat Face Farms, Honu, and INDVR names. The company was formerly known as Cannabis One Holdings Inc. and changed its name to INDVR Brands Inc. in August 2020. INDVR Brands Inc. is headquartered in Denver, Colorado.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "CO",
        "city": "Denver",
        "zipcode": "80205",
        "website": "http://cannabisone.life",
        "market_cap": "Nano Cap"
    },
    "IGEX": {
        "short_name": "INDO GLOBAL EXCHANGES PTE LTD",
        "long_name": "Indo Global Exchange(s) PTE, Ltd.",
        "summary": "Indo Global Exchange(s) Pte, Ltd. focuses on providing financial market access to customers worldwide. Its platform provides financial market access to approximately 30 equity exchanges for trading in securities and contract for differences. The company is based in Jakarta, Indonesia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Indonesia",
        "state": null,
        "city": "Jakarta",
        "zipcode": "KAV146",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "IGPK": {
        "short_name": "INTEGRATED CANNABIS SOLUTIONS I",
        "long_name": "Integrated Cannabis Solutions, Inc.",
        "summary": "Integrated Cannabis Solutions, Inc. focuses on the growing and processing of hemp in the United States. The company intends to sell processed material in the form of Cannabidiol (CBD) or isolate to manufacturers or pharmaceutical companies for their manufacture, distribution, and sale of CBD related products, such as edibles for human consumption, vitamins, multi-vitamins, and topical products for human use comprises oils, tinctures, creams, oils and salves, and vaping liquids. Further, it is planning to promote and assist in the establishment of a co-op with local farmers for establishing a consistent supply of biomass and enter into long term purchase contracts. The company was formerly known as Integrated Parking Solutions, Inc. and changed its name to Integrated Cannabis Solutions, Inc. in April 2014. Integrated Cannabis Solutions, Inc. was founded in 2003 and is headquartered in Clermont, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Coconut Creek",
        "zipcode": "33073",
        "website": "http://www.igpk.org",
        "market_cap": "Nano Cap"
    },
    "IHL.AX": {
        "short_name": "INHEALTH FPO",
        "long_name": "Incannex Healthcare Limited",
        "summary": "Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's therapeutic products in clinical trials include IHL-42X for obstructive sleep apnea; IHL-216A for traumatic brain injury; IHL-675A for sepsis associated acute respiratory distress syndrome; and IHL-493C for temporomandibular joint dysfunction. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea. Incannex Healthcare Limited has a partnership with Monash Trauma Group at the Department of Neuroscience, Monash University to conduct an in vivo study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited is based in Melbourne, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Melbourne",
        "zipcode": "3000",
        "website": "http://www.incannex.com.au",
        "market_cap": "Micro Cap"
    },
    "IKNK-U.CN": {
        "short_name": "IkanikFarms",
        "long_name": "Ikanik Farms Inc.",
        "summary": "Ikanik Farms Inc. operates as an integrated cannabis cultivator, producer, distributor, and dispensary operator. The company is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 3C2",
        "website": "http://www.iknkbrands.com",
        "market_cap": "Micro Cap"
    },
    "IMCC.CN": {
        "short_name": "IMCannabisCorp",
        "long_name": "IM Cannabis Corp.",
        "summary": "IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers strains under the Roma, Dairy Queen, London, Tel Aviv, Paris, and Pandora Box brands; and CBD oil products under the IMC brand. The company also offers its intellectual property related services to the medical cannabis industry. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Israel",
        "state": null,
        "city": "Tel Aviv",
        "zipcode": null,
        "website": "http://www.imcannabis.com",
        "market_cap": "Micro Cap"
    },
    "IMCC": {
        "short_name": "IM Cannabis Corp.",
        "long_name": "IM Cannabis Corp.",
        "summary": "IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers strains under the Roma, Dairy Queen, London, Tel Aviv, Paris, and Pandora Box brands; and CBD oil products under the IMC brand. The company also offers its intellectual property related services to the medical cannabis industry. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Israel",
        "state": null,
        "city": "Tel Aviv",
        "zipcode": null,
        "website": "http://www.imcannabis.com",
        "market_cap": "Small Cap"
    },
    "INAF.JK": {
        "short_name": "Indofarma Tbk.",
        "long_name": "PT Indofarma (Persero) Tbk",
        "summary": "PT Indofarma (Persero) Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company manufactures, trades in, and distributes medicine and medical devices; extracts and herbals; and operates laboratory. It also provides devices and health services for prevention, control, and treatment of COVID-19. The company also exports its products. PT Indofarma (Persero) Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma (Persero) Tbk is a subsidiary of PT Bio Farma.",
        "currency": "IDR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JKT",
        "market": "id_market",
        "country": "Indonesia",
        "state": null,
        "city": "Bekasi",
        "zipcode": "17530",
        "website": "http://www.indofarma.id",
        "market_cap": "Small Cap"
    },
    "INCR-U.TO": {
        "short_name": "INTERCURE LTD USD",
        "long_name": "InterCure Ltd.",
        "summary": "InterCure Ltd, together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Israel",
        "state": null,
        "city": "Herzliya",
        "zipcode": "4676670",
        "website": "http://www.intercure.co",
        "market_cap": "Small Cap"
    },
    "INCR.TA": {
        "short_name": "INTERCURE LTD",
        "long_name": "InterCure Ltd.",
        "summary": "InterCure Ltd, together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.",
        "currency": "ILA",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TLV",
        "market": "il_market",
        "country": "Israel",
        "state": null,
        "city": "Herzliya",
        "zipcode": "4676670",
        "website": "http://www.intercure.co",
        "market_cap": null
    },
    "INDOCO.NS": {
        "short_name": "INDOCO REMEDIES LT",
        "long_name": "Indoco Remedies Limited",
        "summary": "Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform, Sensodent-KF, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastro intestinal products, such as Carmicide, Cyclopam, Carmicide Drops, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and opthalmological products, such as Renolen, Homide, Tobaren DM, and Mofloren-D. It also provides vitamins/minerals/nutrients that include Methycal, MCBM 69, SM Fibro, Durashape, Trucharge, and Apispur; Urology products, such as Cital, Cital UTI, and Cital-H; Cloben-G and Scabex for derma; ATM for anti-invectives; Otorex for otologicals; Obi X and KG-Low for anti-obesity; Hemsyl for blood related; Dexoren for Opthal/Otologicals; and Vepan, bactogard, and Oxipod for anti-infectives. In addition, the company offers PGVISC eye drops; Aziltence for cardiac therapy; and D-Chiro for gynaec therapy. Further, it provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism, compatibility, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Additionally, the company offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. It serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, and nephrologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400098",
        "website": "http://www.indoco.com",
        "market_cap": "Small Cap"
    },
    "INDSWFTLAB.NS": {
        "short_name": "IND SWIFT LABS",
        "long_name": "Ind-Swift Laboratories Limited",
        "summary": "Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, parkinson disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, anticholinergic, sedative, hypnotic, alcohol abstinence, and antineoplastic, as well as various products for ADHD symptoms. Its impurities portfolio include acamprosate calcium, anastrozole, aripiprazole, aripiprazole, atorvastatin calcium, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide. The company also offers early and late phase drug development, process research and development, contract and API manufacturing, and custom chemicals and synthesis; and analytical development, regulatory support, chemistry, impurity profiling, isolation, discovery, identification and characterization, and project management services. It also exports its products. Ind-Swift Laboratories Limited was founded in 1995 and is based in Manimajra, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Manimajra",
        "zipcode": "160101",
        "website": "http://www.indswiftlabs.com",
        "market_cap": "Micro Cap"
    },
    "INDSWFTLTD.NS": {
        "short_name": "IND SWIFT LTD",
        "long_name": "Ind-Swift Limited",
        "summary": "Ind-Swift Limited, a pharmaceutical company, manufactures and sells finished goods dosages, active pharmaceutical ingredients, and herbal products in India. It has a portfolio of approximately 750 products with presence in therapeutic segments of cardiology, diabetology, anti-depressant, anti-allergic, anti-infective, neurology, and oncology. The company offers medicines for the respiratory, including ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies; a range of medicines for gynecology, pediatrics, dermatology, and GP; and antibiotics, anti-infectives, anti-cold, nutraceuticals, anti-convulsants, analgesics, anti-diarrheal, anti-allergics, anti-inflammatory and anti-ulcer drugs, hypolipidaemic drugs, anti-malarial, enzymes, expectorants, antipsychotics, and anti-depressants for treating common ailments, such as fever, cough, cold, diarrhoea, body ache, and infections. It also provides medicines to government dispensaries, hospitals, and remote and rural areas; and Ayurveda products. The company exports its products to approximately 50 countries. Ind-Swift Limited was founded in 1983 and is based in Chandigarh, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Chandigarh",
        "zipcode": "160002",
        "website": "http://www.indswiftltd.com",
        "market_cap": "Nano Cap"
    },
    "INDV.L": {
        "short_name": "INDIVIOR PLC ORD USD0.10",
        "long_name": "Indivior PLC",
        "summary": "Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company is also involved in finance activities. It operates in approximately 40 countries worldwide. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United States",
        "state": "VA",
        "city": "North Chesterfield",
        "zipcode": "23235",
        "website": "http://www.indivior.com",
        "market_cap": null
    },
    "INIS": {
        "short_name": "INTERNATIONAL ISOTOPES INC",
        "long_name": "International Isotopes Inc.",
        "summary": "International Isotopes, Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through four segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Radiological Services. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. It offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot and pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy and various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals and sodium iodide I-131 generic drug product for medical, industrial, and research applications. The Radiological Services segment provides flood source disposal and gemstones processing services. The company sells its products directly to end users and distributors. International Isotopes, Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "ID",
        "city": "Idaho Falls",
        "zipcode": "83401",
        "website": "http://www.intisoid.com",
        "market_cap": "Micro Cap"
    },
    "INLB": {
        "short_name": "ITEM 9 LABS CORP",
        "long_name": "Item 9 Labs Corp.",
        "summary": "Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers products through licensed dispensaries to consumers in Arizona. The company is headquartered in Phoenix, Arizona.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "AZ",
        "city": "Phoenix",
        "zipcode": "85004",
        "website": "http://www.item9labscorp.com",
        "market_cap": "Micro Cap"
    },
    "INNO.CN": {
        "short_name": "InnoCanPharma",
        "long_name": "InnoCan Pharma Corporation",
        "summary": "InnoCan Pharma Corporation focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in Israel. It engages in the research and development of Covid-19 treatment and other viruses causing lung inflammation, as well as other central nervous system diseases, such as epilepsy and Alzheimer's disease; and CBD loaded liposomes that provides pain relief, and treat epilepsy, other central nervous system disorders, and other indications. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. In addition, it develops SHIR premium CBD facial serum products. The company was incorporated in 2018 and is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2P 0N7",
        "website": "http://innocanpharma.com",
        "market_cap": "Micro Cap"
    },
    "INNPF": {
        "short_name": "INNOCAN PHARMA CORPORATION",
        "long_name": "InnoCan Pharma Corporation",
        "summary": "InnoCan Pharma Corporation focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in Israel. It engages in the research and development of Covid-19 treatment and other viruses causing lung inflammation, as well as other central nervous system diseases, such as epilepsy and Alzheimer's disease; and CBD loaded liposomes that provides pain relief, and treat epilepsy, other central nervous system disorders, and other indications. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. In addition, it develops SHIR premium CBD facial serum products. The company was incorporated in 2018 and is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2P 0N7",
        "website": "http://innocanpharma.com",
        "market_cap": "Micro Cap"
    },
    "INQD": {
        "short_name": "INDOOR HARVEST CORP",
        "long_name": "Indoor Harvest Corp.",
        "summary": "Indoor Harvest Corp. focuses on leveraging technology and planning on vertical farming, building integrated agriculture, controlled environment agriculture, and aeroponic cultivation in the United States. It develops proprietary high pressure aeroponic cultivation system designs, as well as flood and drain, and floating raft designs for cannabis and other agriculture products. The company offers Modular HP-Aeroponics, Low Tide VFRack, and Shallow Raft VFRack platforms under the Indoor Harvest brand. Indoor Harvest Corp. was founded in 2011 and is based in Austin, Texas.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "TX",
        "city": "Austin",
        "zipcode": "78739",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "INSO": {
        "short_name": "INDUSTRY SOURCE CONSULTING INC",
        "long_name": "Industry Source Consulting, Inc.",
        "summary": "Industry Source Consulting, Inc. focuses on providing various management services to the legal cannabis industry in the United States and Canada. The company was formerly known as Vega Biofuels, Inc. Industry Source Consulting, Inc. was founded in 1986 and is based in Norcross, Georgia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "GA",
        "city": "Norcross",
        "zipcode": "30010",
        "website": "http://insoconsulting.com",
        "market_cap": null
    },
    "INTL.TA": {
        "short_name": "INTELICANNA LTD",
        "long_name": "Intelicanna Ltd",
        "summary": "Intelicanna Ltd provides various management consulting services in Israel, the United States, Europe, and internationally. The company offers its services in the areas of corporate strategy, global strategy, marketing strategy, mergers and acquisitions, turnaround management, and innovation strategy; and sales and marketing areas, such as sales and channel management, customer relationship management, customer lifecycle, organization and capabilities, product launch, sales force efficiency, and pricing. It also provides operation and organization services in various areas comprising operational excellence, customer service, organization design, change management, and people capabilities; and services in the areas of manufacturing and quality, including quality management, lean manufacturing, six sigma, capacity planning and OEE, and facility design. In addition, the company offers services in the areas of supply chain comprising strategy and risk management, planning, procurement, distribution and logistics, and reverse logistics and green supply chain; and portfolio management, project management excellence, IT governance, risk management, and design for X methodology. Further, it provides services in the areas of corporate finance, such as financial reporting and cost controlling, financing strategy and financial control, value based management, and financial restructuring services. Additionally, the company offers Tefen AI, an artificial intelligence tool for businesses. It serves various companies in the retail, patient care, life sciences, healthcare, financial services, general manufacturing, aviation and transportation, consumer goods, telecommunications, energy and utilities, public sector, high tech, semiconductors, and legal industries. The company was formerly known as Tefen Industrial Engineering & Management & Systems Analysis and changed its name to Intelicanna Ltd. Intelicanna Ltd was founded in 1982 and is based in Beit-Dagan, Israel.",
        "currency": "ILA",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TLV",
        "market": "il_market",
        "country": "Israel",
        "state": null,
        "city": "Beit Dagan",
        "zipcode": "50200",
        "website": "http://www.tefen.com",
        "market_cap": null
    },
    "INTP": {
        "short_name": "INTEGRATED PHARMACEUTICALS INC",
        "long_name": "Integrated Pharmaceuticals, Inc.",
        "summary": "Integrated Pharmaceuticals, Inc. develops and produces specialty chemicals and nutraceuticals in the United States. It offers compounds and nutraceuticals that have proven therapeutic or nutritional value in humans, plants, and animals. The company also develops technologies for the production of clinically active pharmaceutical compounds, including active small molecules and recombinant DNA technology derived products. In addition, it offers calcium supplements that are used in soft drinks, coffee, tea, soup, dehydrated sauces, and beverages; and fortified bottled water. The company sells its products through distributors and retailers. The company was formerly known as Digital Caddies, Inc. and changed its name to Integrated Pharmaceuticals, Inc. in September 2011. The company was incorporated in 1969 and is based in Fitchburg, Massachusetts.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "MA",
        "city": "Fitchburg",
        "zipcode": "01420",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "INVVY": {
        "short_name": "INDIVIOR PLC",
        "long_name": "Indivior PLC",
        "summary": "Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company is also involved in finance activities. It operates in approximately 40 countries worldwide. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "VA",
        "city": "North Chesterfield",
        "zipcode": "23235",
        "website": "http://www.indivior.com",
        "market_cap": "Small Cap"
    },
    "IOLCP.NS": {
        "short_name": "IOL CHEMICALS&PHAR",
        "long_name": "IOL Chemicals and Pharmaceuticals Limited",
        "summary": "IOL Chemicals and Pharmaceuticals Limited manufactures and sells bulk drugs, and organic and inorganic chemical compounds in India and internationally. It operates through Chemicals and Drugs segments. The company offers active pharmaceutical ingredients, such as ibuprofen, metformin hydrochloride, lamotrigine, fenofibrate, and clopidogrel bi sulphate for use in various therapeutic categories, including pain management, anti-diabetic, anti-hypertensive, anti-convulsants, anti-cholesterol, anti-platelet, etc. It also provides specialty industrial chemicals, which include ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid for use in flexible packaging, pharmaceutical, textile, food processing, pesticide, and paint industries. IOL Chemicals and Pharmaceuticals Limited was founded in 1986 and is headquartered in Ludhiana, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Ludhiana",
        "zipcode": "141003",
        "website": "http://www.iolcp.com",
        "market_cap": "Small Cap"
    },
    "IONC.CN": {
        "short_name": "IonicBrands",
        "long_name": "Ionic Brands Corp.",
        "summary": "Ionic Brands Corp. provides cannabis related services in Washington and Oregon. The company manufacture and distribute hard goods, such as cartridges, applicators, pens, jars, etc. under the IONIC brand name. The company is headquartered in Tacoma, Washington.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "WA",
        "city": "Tacoma",
        "zipcode": "98402",
        "website": "http://www.ionicbrands.com",
        "market_cap": "Nano Cap"
    },
    "IONKF": {
        "short_name": "IONIC BRANDS CORP",
        "long_name": "Ionic Brands Corp.",
        "summary": "Ionic Brands Corp. provides cannabis related services in Washington and Oregon. The company manufacture and distribute hard goods, such as cartridges, applicators, pens, jars, etc. under the IONIC brand name. The company is headquartered in Tacoma, Washington.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "WA",
        "city": "Tacoma",
        "zipcode": "98402",
        "website": "http://www.ionicbrands.com",
        "market_cap": "Nano Cap"
    },
    "IP4.F": {
        "short_name": "INNOCAN PHARMA CORP.",
        "long_name": "InnoCan Pharma Corporation",
        "summary": "InnoCan Pharma Corporation focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in Israel. It engages in the research and development of Covid-19 treatment and other viruses causing lung inflammation, as well as other central nervous system diseases, such as epilepsy and Alzheimer's disease; and CBD loaded liposomes that provides pain relief, and treat epilepsy, other central nervous system disorders, and other indications. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. In addition, it develops SHIR premium CBD facial serum products. The company was incorporated in 2018 and is headquartered in Calgary, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2P 0N7",
        "website": "http://innocanpharma.com",
        "market_cap": "Micro Cap"
    },
    "IPCALAB.NS": {
        "short_name": "IPCA LABORATORIES",
        "long_name": "Ipca Laboratories Limited",
        "summary": "Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. It also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic, cardiology, dermatology, diabetes, fever, gastroenterology, hematology, helminthics, hepatoprotective, immunosuppressant, infectious disease, malarial, neurology, nutraceuticals, ophthalmology, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology, as well as products in various dosage forms comprising oral solids, powders for suspension, and liquid and dry injections. The company exports its products to approximately 100 countries worldwide. It has an agreement with Medicines for Malaria Venture to develop a novel antimalarial co-formulation named Atoguanil. The company was incorporated in 1949 and is based in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400067",
        "website": "http://www.ipca.com",
        "market_cap": "Mid Cap"
    },
    "IPN.PA": {
        "short_name": "IPSEN",
        "long_name": "Ipsen S.A.",
        "summary": "Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Decapeptyl for metastatic prostate cancer, uterine fibroids, precocious puberty, endometriosis, female sterility, and early stage breast cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde for second-line metastatic pancreatic cancer; and Dysport for motor muscular disorders and medical aesthetics. The company also provides NutropinAq for growth failure in children due to growth hormone (GH) deficiency, turner syndrome, and chronic renal failure, as well as GH deficiency in adults; and Increlex for growth failure in children and adolescents. In addition, it offers Smecta for chronic and acute diarrhea, and pain associated with functional bowel diseases; Forlax for constipation; Fortrans/Eziclen for bowel cleansing prior to endoscopy, X-ray examination, and colonic surgery; and Tanakan for cognitive disorders in adults, vertigo of vestibular origin and vestibular rehabilitation, and tinnitus. Further, the company provides Xermelo for the carcinoid syndrome; Cometriq for medullary thyroid cancer; Smebiocta/SmectaFlora Comfort, a food supplement; SmectaGas, a medical device used in the symptomatic treatment of gas-related gastrointestinal disorders and relief of gas-related symptoms; and Etiasa for inflammatory bowel diseases. Additionally, it offers other consumer healthcare products in the gastro-intestinal area, including Buscopan, Clin4000, Prontalgine, Suppositoria Glycerini, Mucothiol, Floractin, and Mucodyne. The company has various agreements with Debiopharm, Exelixis, Galderma, Blueprint Medicines, TerSera Therapeutics, Rhythm Pharmaceuticals, Teijin, Braintree Laboratories, Ethypharm, and Schwabe. Ipsen S.A. was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy SA.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PAR",
        "market": "fr_market",
        "country": "France",
        "state": null,
        "city": "Boulogne-Billancourt",
        "zipcode": "92650",
        "website": "http://www.ipsen.com",
        "market_cap": "Mid Cap"
    },
    "IPN.VI": {
        "short_name": "IPSEN",
        "long_name": "Ipsen S.A.",
        "summary": "Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Decapeptyl for metastatic prostate cancer, uterine fibroids, precocious puberty, endometriosis, female sterility, and early stage breast cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde for second-line metastatic pancreatic cancer; and Dysport for motor muscular disorders and medical aesthetics. The company also provides NutropinAq for growth failure in children due to growth hormone (GH) deficiency, turner syndrome, and chronic renal failure, as well as GH deficiency in adults; and Increlex for growth failure in children and adolescents. In addition, it offers Smecta for chronic and acute diarrhea, and pain associated with functional bowel diseases; Forlax for constipation; Fortrans/Eziclen for bowel cleansing prior to endoscopy, X-ray examination, and colonic surgery; and Tanakan for cognitive disorders in adults, vertigo of vestibular origin and vestibular rehabilitation, and tinnitus. Further, the company provides Xermelo for the carcinoid syndrome; Cometriq for medullary thyroid cancer; Smebiocta/SmectaFlora Comfort, a food supplement; SmectaGas, a medical device used in the symptomatic treatment of gas-related gastrointestinal disorders and relief of gas-related symptoms; and Etiasa for inflammatory bowel diseases. Additionally, it offers other consumer healthcare products in the gastro-intestinal area, including Buscopan, Clin4000, Prontalgine, Suppositoria Glycerini, Mucothiol, Floractin, and Mucodyne. The company has various agreements with Debiopharm, Exelixis, Galderma, Blueprint Medicines, TerSera Therapeutics, Rhythm Pharmaceuticals, Teijin, Braintree Laboratories, Ethypharm, and Schwabe. Ipsen S.A. was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy SA.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VIE",
        "market": "at_market",
        "country": "France",
        "state": null,
        "city": "Boulogne-Billancourt",
        "zipcode": "92650",
        "website": "http://www.ipsen.com",
        "market_cap": "Mid Cap"
    },
    "IPOT.CN": {
        "short_name": "IsracannBiosci",
        "long_name": "Isracann Biosciences Inc.",
        "summary": "Isracann Biosciences Inc., together with its subsidiaries, cultivates and produces medical cannabis in Israel and internationally. It also provides property development, facility design and construction, cultivation and processing, administrative, and technology licensing services. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V7X 1L3",
        "website": "http://www.isracann.com",
        "market_cap": "Nano Cap"
    },
    "IPSEY": {
        "short_name": "IPSEN SA",
        "long_name": "Ipsen S.A.",
        "summary": "Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Decapeptyl for metastatic prostate cancer, uterine fibroids, precocious puberty, endometriosis, female sterility, and early stage breast cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde for second-line metastatic pancreatic cancer; and Dysport for motor muscular disorders and medical aesthetics. The company also provides NutropinAq for growth failure in children due to growth hormone (GH) deficiency, turner syndrome, and chronic renal failure, as well as GH deficiency in adults; and Increlex for growth failure in children and adolescents. In addition, it offers Smecta for chronic and acute diarrhea, and pain associated with functional bowel diseases; Forlax for constipation; Fortrans/Eziclen for bowel cleansing prior to endoscopy, X-ray examination, and colonic surgery; and Tanakan for cognitive disorders in adults, vertigo of vestibular origin and vestibular rehabilitation, and tinnitus. Further, the company provides Xermelo for the carcinoid syndrome; Cometriq for medullary thyroid cancer; Smebiocta/SmectaFlora Comfort, a food supplement; SmectaGas, a medical device used in the symptomatic treatment of gas-related gastrointestinal disorders and relief of gas-related symptoms; and Etiasa for inflammatory bowel diseases. Additionally, it offers other consumer healthcare products in the gastro-intestinal area, including Buscopan, Clin4000, Prontalgine, Suppositoria Glycerini, Mucothiol, Floractin, and Mucodyne. The company has various agreements with Debiopharm, Exelixis, Galderma, Blueprint Medicines, TerSera Therapeutics, Rhythm Pharmaceuticals, Teijin, Braintree Laboratories, Ethypharm, and Schwabe. Ipsen S.A. was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy SA.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "France",
        "state": null,
        "city": "Boulogne-Billancourt",
        "zipcode": "92650",
        "website": "http://www.ipsen.com",
        "market_cap": "Mid Cap"
    },
    "IQ7.F": {
        "short_name": "LEVIATHAN NATURAL PRODUCT",
        "long_name": "Leviathan Natural Products Inc.",
        "summary": "Leviathan Natural Products Inc. engages in cultivating, processing, and distributing of cannabis and hemp products in Canada, the United States, and Colombia. The company was formerly known as Leviathan Cannabis Group Inc. and changed its name to Leviathan Natural Products Inc. in July 2020. Leviathan Natural Products Inc. is headquartered in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 4J6",
        "website": "http://leviathan-naturals.com",
        "market_cap": "Nano Cap"
    },
    "IQI.F": {
        "short_name": "INCANNEX HEALTHCARE LTD.",
        "long_name": "Incannex Healthcare Limited",
        "summary": "Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's therapeutic products in clinical trials include IHL-42X for obstructive sleep apnea; IHL-216A for traumatic brain injury; IHL-675A for sepsis associated acute respiratory distress syndrome; and IHL-493C for temporomandibular joint dysfunction. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea. Incannex Healthcare Limited has a partnership with Monash Trauma Group at the Department of Neuroscience, Monash University to conduct an in vivo study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited is based in Melbourne, Australia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Melbourne",
        "zipcode": "3000",
        "website": "http://www.incannex.com.au",
        "market_cap": "Micro Cap"
    },
    "IRCLF": {
        "short_name": "INTERCURE LTD",
        "long_name": "InterCure Ltd.",
        "summary": "InterCure Ltd, together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Israel",
        "state": null,
        "city": "Herzliya",
        "zipcode": "4676670",
        "website": "http://www.intercure.co",
        "market_cap": "Small Cap"
    },
    "IRWD": {
        "short_name": "Ironwood Pharmaceuticals, Inc.",
        "long_name": "Ironwood Pharmaceuticals, Inc.",
        "summary": "Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist, which is in pre-clinical development for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "MA",
        "city": "Boston",
        "zipcode": "02110",
        "website": "http://www.ironwoodpharma.com",
        "market_cap": "Small Cap"
    },
    "ISCNF": {
        "short_name": "ISRACANN BIOSCIENCES INC",
        "long_name": "Isracann Biosciences Inc.",
        "summary": "Isracann Biosciences Inc., together with its subsidiaries, cultivates and produces medical cannabis in Israel and internationally. It also provides property development, facility design and construction, cultivation and processing, administrative, and technology licensing services. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V7X 1L3",
        "website": "http://www.isracann.com",
        "market_cap": "Nano Cap"
    },
    "ISOLF": {
        "short_name": "ISODIOL INTERNATIONAL INC",
        "long_name": "Isodiol International Inc.",
        "summary": "Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1S4",
        "website": "http://isodiol.com",
        "market_cap": "Nano Cap"
    },
    "ITHUF": {
        "short_name": "IANTHUS CAPITAL HOLDINGS INC",
        "long_name": "iAnthus Capital Holdings, Inc.",
        "summary": "iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 31 dispensaries and 10 cultivation and/or processing facilities in 9 states. The company is headquartered in New York, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10170",
        "website": "http://www.ianthus.com",
        "market_cap": "Nano Cap"
    },
    "IVITF": {
        "short_name": "INVICTUS MD STRATEGIES CORP",
        "long_name": "Invictus MD Strategies Corp.",
        "summary": "Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada. The company operates through two segments, Sale of Cannabis and Fertilizers. It produces and sells medical cannabis; and plant fertilizers, nutrients, and other supplies for hydroponics, as well as operates medical clinics in Alberta. The company was incorporated in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V7X 1L4",
        "website": "http://www.invictus-md.com",
        "market_cap": "Micro Cap"
    },
    "IVIXF": {
        "short_name": "INVION LTD",
        "long_name": "Invion Limited",
        "summary": "Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a chlorophyll-based photosensitizer to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Melbourne",
        "zipcode": "3102",
        "website": "http://www.inviongroup.com",
        "market_cap": "Nano Cap"
    },
    "IVX.AX": {
        "short_name": "INVION FPO",
        "long_name": "Invion Limited",
        "summary": "Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a chlorophyll-based photosensitizer to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Melbourne",
        "zipcode": "3102",
        "website": "http://www.inviongroup.com",
        "market_cap": "Micro Cap"
    },
    "IZQVF": {
        "short_name": "INDIVIOR PLC",
        "long_name": "Indivior PLC",
        "summary": "Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company is also involved in finance activities. It operates in approximately 40 countries worldwide. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "VA",
        "city": "North Chesterfield",
        "zipcode": "23235",
        "website": "http://www.indivior.com",
        "market_cap": "Small Cap"
    },
    "J.CN": {
        "short_name": "LotusVentures",
        "long_name": "Lotus Ventures Inc.",
        "summary": "Lotus Ventures Inc. cultivates and sells cannabis products for medical purpose. The company was incorporated in 2007 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2Y3",
        "website": "http://lotuscannabis.ca",
        "market_cap": "Nano Cap"
    },
    "JAGSNPHARM.NS": {
        "short_name": "JAGSONPAL PHARMACE",
        "long_name": "Jagsonpal Pharmaceuticals Limited",
        "summary": "Jagsonpal Pharmaceuticals Limited develops and manufactures pharmaceuticals products and active pharmaceutical ingredients worldwide. It offers active pharmaceutical ingredients, which include allylestrenol, dextropropoxyphene HCL, dextropropoxyphene napsylate, disulfiram, thiopental sodium, thiopental acid, tolnaftate, and sildenafil citrate, as well as metformin HCL, BP, USP, and EP. The company also provides formulations for various therapeutic categories, such as anabolic steroids, analgesics, anesthetics, anti-allergic, anti-asthamatics, anti-cholinergic agents, anti-convulsants, anti-diabetics, anti-diarrhoeals, anti-emetics, anti-epileptics, anti-fungal agents, anti-gout agents, anti-inflammatory agents, anti-malarials, anti-nauseants, anti-protozoals, anti-pyretic, anti-rheumatic drugs, anti-spasmodic agents, and anti-septic agents. In addition, it offers anti-tubercular drugs, anti-ulcerants, anxiolytics, cardiovascular drugs, corticosteroids, cough syrups, diuretics, drugs for alcohol dependence, GI anti-infectives, haematinics, imaging agents, laxatives, male/female hormones, multivitamins, nutraceuticals, ophthalmic lubricants, oral rehydrating salts, sedative-hypnotics, softgels, systemic anti-infectives, throat pain sprays, tonics, and uterine stimulants. The company sells its products primarily under the Lycored, Maintane, Metadec, Metabol, Doxypal DR, Parvon, and Indocap SR brand names. Jagsonpal Pharmaceuticals Limited was founded in 1964 and is based in New Delhi, India. Jagsonpal Pharmaceuticals Limited is a subsidiary of Aresko Progressive Private Limited.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "New Delhi",
        "zipcode": "110049",
        "website": "http://www.jagsonpal.com",
        "market_cap": "Nano Cap"
    },
    "JBCHEPHARM.NS": {
        "short_name": "J.B.CHEMICALS & PH",
        "long_name": "J. B. Chemicals & Pharmaceuticals Limited",
        "summary": "J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. The company manufactures a range of specialty products that include various pharmaceutical dosage forms. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and medicated and herbal lozenges. The company was founded in 1976 and is headquartered in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400025",
        "website": "http://www.jbcpl.com",
        "market_cap": "Small Cap"
    },
    "JTBK": {
        "short_name": "JETBLACK CORP",
        "long_name": "Jetblack Corp.",
        "summary": "Jetblack Corp., through its subsidiaries, operates in the cannabis industry. The company is in the process of transferring ownership and locations for a Tier 1 Marijuana Producers Licenses with OLCC. The company has finalized an agreement to begin the process of transferring ownership and locations of an Oregon Marijuana Processors License. It also applied for other licenses with OLCC, such as an Oregon Marijuana Wholesale License. Jetblack Corp. was founded in 2002 and is based in Portland, Oregon.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "OR",
        "city": "Portland",
        "zipcode": "97239",
        "website": "http://www.jetblackcorp.com",
        "market_cap": "Nano Cap"
    },
    "JUBLPHARMA.NS": {
        "short_name": "JUBILANT PHARMOVA LTD",
        "long_name": "Jubilant Pharmova Limited",
        "summary": "Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Pharmaceuticals; Drug Discovery & Development Solutions; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile injectables and non-sterile products, active pharmaceutical ingredients, and solid dosage formulations, as well as sale of radiopharmaceuticals through a network of 49 radio pharmacies in the United States. The Drug Discovery & Development Solutions segment provides collaborative research services to pharmaceutical innovators. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune disorders. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is based in Noida, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Noida",
        "zipcode": "201301",
        "website": "http://www.jubilantpharmova.com",
        "market_cap": "Small Cap"
    },
    "JUPW": {
        "short_name": "Jupiter Wellness, Inc.",
        "long_name": "Jupiter Wellness, Inc.",
        "summary": "Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for use in the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CaniSun, a CBD-infused sunscreen; and CaniSkin, a CBD-infused skin care lotion. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Jupiter",
        "zipcode": "33477",
        "website": "http://www.jupiterwellnessinc.com",
        "market_cap": "Micro Cap"
    },
    "JUSH.CN": {
        "short_name": "JushiHdgClassB",
        "long_name": "Jushi Holdings Inc.",
        "summary": "Jushi Holdings Inc., a cannabis and hemp company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of branded cannabis and hemp-derived assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, and Nevada. The company operates 11 retail locations under the BEYOND/HELLO retail brand, which include 8 medical dispensaries in Ardmore, Bristol, Johnstown, Philadelphia, Reading, Scranton, and West Chester, Pennsylvania; and 2 adult-use and medical dispensaries located in Sauget and Normal, Illinois. It also offers hemp-based CBD products under the Nira brand. The company was founded in 2018 and is headquartered in Boca Raton, Florida.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "FL",
        "city": "Boca Raton",
        "zipcode": "33431",
        "website": "http://www.jushico.com",
        "market_cap": "Small Cap"
    },
    "JUSHF": {
        "short_name": "JUSHI HOLDINGS INC",
        "long_name": "Jushi Holdings Inc.",
        "summary": "Jushi Holdings Inc., a cannabis and hemp company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of branded cannabis and hemp-derived assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, and Nevada. The company operates 11 retail locations under the BEYOND/HELLO retail brand, which include 8 medical dispensaries in Ardmore, Bristol, Johnstown, Philadelphia, Reading, Scranton, and West Chester, Pennsylvania; and 2 adult-use and medical dispensaries located in Sauget and Normal, Illinois. It also offers hemp-based CBD products under the Nira brand. The company was founded in 2018 and is headquartered in Boca Raton, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Boca Raton",
        "zipcode": "33431",
        "website": "http://www.jushico.com",
        "market_cap": "Small Cap"
    },
    "JUVA.CN": {
        "short_name": "JuvaLifeInc.",
        "long_name": "Juva Life Inc.",
        "summary": "Juva Life Inc. engages in the cultivation, research, manufacturing, distribution, and sale of pharmacy-grade medical and recreational cannabis products in California. The company was founded in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3E8",
        "website": "http://www.juvalife.com",
        "market_cap": "Micro Cap"
    },
    "JUVAF": {
        "short_name": "JUVA LIFE INC",
        "long_name": "Juva Life Inc.",
        "summary": "Juva Life Inc. engages in the cultivation, research, manufacturing, distribution, and sale of pharmacy-grade medical and recreational cannabis products in California. The company was founded in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3E8",
        "website": "http://www.juvalife.com",
        "market_cap": "Micro Cap"
    },
    "JWCAF": {
        "short_name": "JAMES E WAGNER CULTIVATION CORP",
        "long_name": "James E. Wagner Cultivation Corporation",
        "summary": "James E. Wagner Cultivation Corporation, through its subsidiary, James E. Wagner Cultivation Ltd., engages in the cultivation and sale of medical cannabis in Canada. The company focuses on producing clean, consistent cannabis using a proprietary aeroponic platform named GrowthSTORM. James E. Wagner Cultivation Corporation was founded in 2007 and is headquartered in Kitchener, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Kitchener",
        "zipcode": "N2R 1J4",
        "website": "http://www.jwc.ca",
        "market_cap": "Nano Cap"
    },
    "KA6N.F": {
        "short_name": "KARO PHARMA AB  O.N.",
        "long_name": "Karo Pharma AB (publ)",
        "summary": "Karo Pharma AB (publ) develops and markets prescription drugs, over-the-counter products, medical devices, and hospital supply products for pharmacies and the health care sectors in Sweden, Norway, Denmark, Finland, France, rest of Europe, the United States, and internationally. It offers dermatology products under the Decubal, Fungobase, indy beauty, Lucobase, Mildison, OLIVA, PoxClin, and PROPYLESS brands; intimate care products under the HemoClin, Multi-Gyn, Multi-Mam, Pevaryl, and Scheriproct brand names; and foot care products under the CCS, Cortimyk, Footner, Nailner, Pevaryl, and wortie brands. The company also provides pain, cough, cold products under the Bronkyl, Dolerin, Ibux, Mollipect, Nazamer, nozoil, Paracet, and Viruseptin brand names; prescription drugs under the Burinex, Centyl, Kaleorid, and Selexid brands; and wellness products under the Flux, All\u00c3\u00a9vo, Dosett, Dax, antibac, BAMSE, Betavivo, and Lactocare brands. It sells its products to pharmacies and retailers through direct sales organisations and a network of distributors, as well as online. The company was formerly known as Karo Bio AB (publ) and changed its name to Karo Pharma AB (publ) in March 2016. Karo Pharma AB (publ) was incorporated in 1987 and is based in Stockholm, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "111 22",
        "website": "http://www.karopharma.com",
        "market_cap": "Small Cap"
    },
    "KAEF.JK": {
        "short_name": "Kimia Farma Tbk.",
        "long_name": "PT Kimia Farma (Persero) Tbk",
        "summary": "PT Kimia Farma (Persero) Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia, rest of Asia, Europe, Australia, Africa, and New Zealand. The company operates through Manufacturing, Distribution, Retail, and Other Services segments. It also manufactures and markets chemical, betalactam and non betalactam, antiretroviral, narcotic, hormone contraceptive, powder, oil castor, edible oil, cosmetic, over the counter, personal, and beauty care products, as well as food supplements, active pharmaceutical ingredients, and medical devices. In addition, the company manufactures, markets, distributes, and trades in pharmaceutical products; and operates drug materials plants. As of December 31, 2020, it operated 1,278 retail pharmacy outlets, 451 health clinic outlets, 75 clinical laboratories, 10 optics, 3 beauty clinics, and 24 international retail outlets. The company sells its products to pharmacies, drug stores, hospitals, and free traders through pharmaceutical wholesalers. The company was founded in 1817 and is headquartered in Jakarta, Indonesia.",
        "currency": "IDR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JKT",
        "market": "id_market",
        "country": "Indonesia",
        "state": null,
        "city": "Jakarta",
        "zipcode": "10110",
        "website": "http://kimiafarma.co.id",
        "market_cap": "Small Cap"
    },
    "KALY": {
        "short_name": "KALI INC",
        "long_name": "Kali, Inc.",
        "summary": "Kali, Inc., doing business as Kali-Extracts, Inc., engages in the research and development of cannabis treatments for various illnesses, diseases, and chronic pain as a symptom of various diagnoses. It provides pharmaceuticals, cannabis extracts, and health and wellness products. The company was formerly known as VLOV Inc. and changed its name to Kali, Inc. in February 2016. Kali, Inc. is based in Dallas, Texas.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "TX",
        "city": "Dallas",
        "zipcode": "75225",
        "website": "http://www.kali-extracts.com",
        "market_cap": "Nano Cap"
    },
    "KARO.ST": {
        "short_name": "Karo Pharma AB",
        "long_name": "Karo Pharma AB (publ)",
        "summary": "Karo Pharma AB (publ) develops and markets prescription drugs, over-the-counter products, medical devices, and hospital supply products for pharmacies and the health care sectors in Sweden, Norway, Denmark, Finland, France, rest of Europe, the United States, and internationally. It offers dermatology products under the Decubal, Fungobase, indy beauty, Lucobase, Mildison, OLIVA, PoxClin, and PROPYLESS brands; intimate care products under the HemoClin, Multi-Gyn, Multi-Mam, Pevaryl, and Scheriproct brand names; and foot care products under the CCS, Cortimyk, Footner, Nailner, Pevaryl, and wortie brands. The company also provides pain, cough, cold products under the Bronkyl, Dolerin, Ibux, Mollipect, Nazamer, nozoil, Paracet, and Viruseptin brand names; prescription drugs under the Burinex, Centyl, Kaleorid, and Selexid brands; and wellness products under the Flux, All\u00c3\u00a9vo, Dosett, Dax, antibac, BAMSE, Betavivo, and Lactocare brands. It sells its products to pharmacies and retailers through direct sales organisations and a network of distributors, as well as online. The company was formerly known as Karo Bio AB (publ) and changed its name to Karo Pharma AB (publ) in March 2016. Karo Pharma AB (publ) was incorporated in 1987 and is based in Stockholm, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "111 22",
        "website": "http://www.karopharma.com",
        "market_cap": "Small Cap"
    },
    "KAYS": {
        "short_name": "KAYA HLDGS INC",
        "long_name": "Kaya Holdings, Inc.",
        "summary": "Kaya Holdings, Inc., a vertically integrated legal marijuana enterprise, produces, distributes, and/or sells a range of cannabis products in the United States. The company offers flower, oils, vape cartridges and cannabis infused confections, baked goods, and beverages. It also operates two retail outlets under the Kaya Shack brand name, as well as offers strain specific cannabis cigarettes under the Kaya Buddies name, and strains of cannabis under the Kaya Farms name. The company also provides standing display cases with cannabis intended glassware under the Really Happy Glass brand; and t-shirt designs under the Kaya Gear brand name. The company was formerly known as Alternative Fuels America, Inc. and changed its name to Kaya Holdings, Inc. in April 2015. Kaya Holdings, Inc. was incorporated in 1993 and is headquartered in Fort Lauderdale, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Fort Lauderdale",
        "zipcode": "33304",
        "website": "http://www.kayaholdings.com",
        "market_cap": "Nano Cap"
    },
    "KGKG": {
        "short_name": "KONA GOLD BEVERAGE INC",
        "long_name": "Kona Gold Beverage, Inc.",
        "summary": "Kona Gold Beverage, Inc. develops and sells hemp and cannabidiol (CBD) products in the functional beverage and fitness markets in the United States. The company operates through two segments, Beverages and Distribution. It offers hemp energy drinks and CBD energy water; and alkaline waters, beverages for kids, energy drinks, fruit flavored sodas, low carb lemonade, healthy aloe juice drinks, and CBD-infused jellybeans. The company also sells merchandise and apparel, such as shirts, tanks, hats, and towels. It sells its products primarily to beverage distributors and resellers, retail grocery, smoke shops and specialty stores, wholesalers, merchandisers, vape shops, and convenience stores; and beverage services under the Kona Gold Hemp Energy Drinks, OOH LA LEMIN, and Highdrate names. The company was formerly known as Kona Gold Solutions, Inc. and changed its name to Kona Gold Beverage, Inc. in October 2020. Kona Gold Beverage, Inc. was incorporated in 1997 and is based in Melbourne, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Melbourne",
        "zipcode": "32934",
        "website": "http://www.konagoldhemp.com",
        "market_cap": "Nano Cap"
    },
    "KHRN.V": {
        "short_name": "KHIRON LIFE SCIENCES CORP",
        "long_name": "Khiron Life Sciences Corp.",
        "summary": "Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and CBD (cannabidiol) medical cannabis. It also operates a network of health centers under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2B5",
        "website": "http://www.khiron.ca",
        "market_cap": "Micro Cap"
    },
    "KHRNF": {
        "short_name": "KHIRON LIFE SCIENCES CORP",
        "long_name": "Khiron Life Sciences Corp.",
        "summary": "Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and CBD (cannabidiol) medical cannabis. It also operates a network of health centers under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2B5",
        "website": "http://www.khiron.ca",
        "market_cap": "Micro Cap"
    },
    "KIN": {
        "short_name": "Kindred Biosciences, Inc.",
        "long_name": "Kindred Biosciences, Inc.",
        "summary": "Kindred Biosciences, Inc., a commercial-stage biopharmaceutical company, engages in developing therapies for pets. Its product pipeline focuses on biologics for a range of indications primarily in dogs and cats. The company offers Mirataz, a mirtazapine transdermal ointment for the management of weight loss in cats; and Zimeta, a dipyrone injection for the control of fever in horses. It also develops KIND-016, a monoclonal antibody for the treatment of atopic dermatitis in dogs; KIND-032, a monoclonal antibody targeting interleukin-4 (IL-4) receptor for the treatment of atopic dermatitis in dogs; KIND-025 a canine fusion protein targeting IL-4 and IL-13 for atopic dermatitis in dogs; KIND-030, a monoclonal antibody targeting canine parvovirus for the prophylactic indication in dogs; KIND-509, an antibody for canine inflammatory bowel disease in dogs; KIND-510a, a long-acting feline recombinant erythropoietin being developed for the management of non-regenerative anemia in cats; and KIND-511, an anti-tumor necrosis factor treatment for newborn foals. The company was incorporated in 2012 and is headquartered in Burlingame, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NCM",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Burlingame",
        "zipcode": "94010",
        "website": "http://www.kindredbio.com",
        "market_cap": "Micro Cap"
    },
    "KIP.MI": {
        "short_name": "KOLINPHARMA",
        "long_name": "Kolinpharma S.p.A.",
        "summary": "Kolinpharma S.p.A. operates as a nutraceuticals company. It offers gynecological and orthopedic products. The company was founded in 2013 and is based in Lainate, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "MI",
        "city": "Lainate",
        "zipcode": "20020",
        "website": "http://www.kolinpharma.com",
        "market_cap": "Nano Cap"
    },
    "KIS.F": {
        "short_name": "KISSEI PHARM. LTD",
        "long_name": "Kissei Pharmaceutical Co., Ltd.",
        "summary": "Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products primarily in Japan. It offers Urief and Urief OD tablets for the treatment of dysuria; Glufast, Glubes, and Marizev tablets for type 2 diabetes; Darbepoetin Alfa BS and Epoetin Alfa BS injections for the treatment of renal anemia; Beova tablets for overactive bladder treatment; P-TOL chewable tablets for treating hyperphosphatemia; and Minirin Melt OD tablets for nocturia due to nocturnal polyuria in males, central diabetes insipidus, and nocturnal enuresis resulted from decrease of urine osmolality. The company's products in pipeline include KPS-0373 that has completed Phase III clinical trial to treat spinocerebellar ataxia; CCX168, which has completed Phase III clinical trial for the treatment of microscopic polyangiitis and granulomatosis with polyangiitis; AJM300, which is in Phase III clinical trial to treat ulcerative colitis; R788 that is in Phase III clinical trial to treat chronic idiopathic thrombocytopenic purpura; and MR13A9, which is in Phase III clinical trial to treat uremic pruritus in dialysis patients. It is also developing KLH-2109 for treating endometriosis and uterine fibroids; KDT-3594 for the treatment of Parkinson's disease; Silodosin for dysuria associated with benign prostatic hyperplasia; Mitiglinide for type 2 diabetes mellitus; and Bedoradrine for the treatment of acute exacerbation of asthma. In addition, it develops and sells protein controlled and energy supply foods; and purchases and sells related materials, as well as offers system development and information processing, construction contracting, equipment and facility management, and information gathering and development support services. The company was formerly known as Kissei Yakuhin Kogyo Co., Ltd. and changed its name to Kissei Pharmaceutical Co., Ltd. in October 1964. The company was founded in 1946 and is headquartered in Matsumoto, Japan.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Japan",
        "state": null,
        "city": "Matsumoto",
        "zipcode": "399-8710",
        "website": "http://www.kissei.co.jp",
        "market_cap": "Small Cap"
    },
    "KKPCF": {
        "short_name": "KAKEN PHARMACEUTICAL",
        "long_name": "Kaken Pharmaceutical Co., Ltd.",
        "summary": "Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. It offers pharmaceutical products and medical devices, such as Clenafin, a topical treatment for onychomycosis; Artz, an anti-osteoarthritis agent; Seprafilm, a semitransparent film-type absorbable adhesion barrier, which is applied to damaged tissue; Fiblast, a spray-on drug for the treatment of pressure ulcers and other skin ulcers; Regroth, a medicinal product for periodontal regeneration; and Hernicore for the treatment of lumbar disc herniation. The company also provides Adofeed, a pain- and inflammation-relieving plaster; Ebrantil for the treatment of dysuria and hypertension; Procylin, an oral-use prostaglandin I2 analog; Lipidil, an anti-hyperlipidemia agent; Mentax, an anti-trichophyton agent; and Loxoprofen Na Tape, a pain-relieving and anti-inflammatory plaster. In addition, it offers Ropion, a pain relief injection; and agrochemicals and animal health products, including Polyoxins that is used as fungicide; Pentoxazone, a rice herbicide; and Salinomycin, an anti-coccidial feed additive for chicken. Further, the company is developing BBI-4000 that has completed phase III clinical trial for primary axillary hyperhidrosis; KMW-1, which is in phase III clinical trial for the removal of eschar with thermal burns; KAR for treatment of hide lice infestation; and KP-607, which is in phase II clinical trial for the treatment of onychomycosis. Additionally, it is involved in the rental of Bunkyo Green Court, a commercial complex. The company offers its products under the Mentax Lotrimin Ultra, Mentax Butena, Mentax, Kaifen, Fiblast, and Jublia brands. It has license agreements with Corbus Pharmaceuticals Holdings, Inc. and Arbor Pharmaceuticals, LLC. Kaken Pharmaceutical Co., Ltd. was founded in 1917 and is headquartered in Tokyo, Japan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "113-8650",
        "website": "http://www.kaken.co.jp",
        "market_cap": "Small Cap"
    },
    "KLAR.ST": {
        "short_name": "Klaria Pharma Holding AB",
        "long_name": "Klaria Pharma Holding AB (publ.)",
        "summary": "Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy. The company's clinical phase products include Epinephrine/Adrenaline for the treatment of acute allergic reaction; Naloxone for opioid overdose; and Ketamine for acute pain and depression. It also focuses on the commercialization of cannabis/cannabinoids, including THC and CBD for medical and recreational applications. The company was founded in 2014 and is based in Uppsala, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "754 50",
        "website": "http://www.klaria.com",
        "market_cap": "Micro Cap"
    },
    "KMDA": {
        "short_name": "Kamada Ltd.",
        "long_name": "Kamada Ltd.",
        "summary": "Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. It operates in two segments, Proprietary Products and Distribution. The company offers Glassia for use in chronic augmentation and maintenance therapy in adults with emphysema due to congenital Alpha-1 Antitrypsin (AAT) deficiency. It also provides KamRAB for prophylaxis of rabies disease; KamRho (D) IM to treat prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes Bramitob to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; IVIG 5% for the treatment of various immunodeficiency-related conditions; AeroBika, an OPEP device; Varitect, a varicella zoster immunoglobulin; Zutectra and Hepatect CP for the prevention of hepatitis B virus; Megalotect, a CMV immunoglobulin; and RUCONEST for the treatment of acute angioedema attacks in adults with hereditary angioedema. Further, it distributes Heparin sodium injection to treat thrombo-embolic disorders; Albumin and Albumin 4% for maintenance of blood plasma; and coagulation factors comprising Factor VIII and Factor IX, as well as IXIARO vaccine. It markets its products through strategic partners in the United States, as well as through distributors internationally. Kamada Ltd. has strategic partnerships with Takeda Pharmaceutical Company Limited; PARI GmbH; and Kedrion Biopharma. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Israel",
        "state": null,
        "city": "Rehovot",
        "zipcode": "7670402",
        "website": "http://www.kamada.com",
        "market_cap": "Micro Cap"
    },
    "KMDA.TA": {
        "short_name": "KAMADA LTD",
        "long_name": "Kamada Ltd.",
        "summary": "Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. It operates in two segments, Proprietary Products and Distribution. The company offers Glassia for use in chronic augmentation and maintenance therapy in adults with emphysema due to congenital Alpha-1 Antitrypsin (AAT) deficiency. It also provides KamRAB for prophylaxis of rabies disease; KamRho (D) IM to treat prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes Bramitob to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; IVIG 5% for the treatment of various immunodeficiency-related conditions; AeroBika, an OPEP device; Varitect, a varicella zoster immunoglobulin; Zutectra and Hepatect CP for the prevention of hepatitis B virus; Megalotect, a CMV immunoglobulin; and RUCONEST for the treatment of acute angioedema attacks in adults with hereditary angioedema. Further, it distributes Heparin sodium injection to treat thrombo-embolic disorders; Albumin and Albumin 4% for maintenance of blood plasma; and coagulation factors comprising Factor VIII and Factor IX, as well as IXIARO vaccine. It markets its products through strategic partners in the United States, as well as through distributors internationally. Kamada Ltd. has strategic partnerships with Takeda Pharmaceutical Company Limited; PARI GmbH; and Kedrion Biopharma. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.",
        "currency": "ILA",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TLV",
        "market": "il_market",
        "country": "Israel",
        "state": null,
        "city": "Rehovot",
        "zipcode": "7670402",
        "website": "http://www.kamada.com",
        "market_cap": null
    },
    "KO.V": {
        "short_name": "KIARO HOLDINGS CORP",
        "long_name": "Kiaro Holdings Corp.",
        "summary": "Kiaro Holdings Corp. owns and operates cannabis retail stores in Canada. It also sells through online. The company was founded in 2019 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6A 1K9",
        "website": "http://kiaro.com",
        "market_cap": "Nano Cap"
    },
    "KOAN": {
        "short_name": "RESONATE BLENDS INC",
        "long_name": "Resonate Blends, Inc.",
        "summary": "Resonate Blends, Inc., a cannabis holding company, provides cannabis-based products. It also operates an online mobile marketing platform that provides various offers, discounts, and alerts and events schedules, such as happy hours, trivia night, and other campaigns. The company was formerly known as Textmunication Holdings, Inc. and changed its name to Resonate Blends, Inc. in December 2019. Resonate Blends, Inc. is based in Calabasas, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Calabasas",
        "zipcode": "91302",
        "website": "http://www.resonateblends.com",
        "market_cap": "Nano Cap"
    },
    "KREBSBIO.NS": {
        "short_name": "KREBS BIOCHEM&INDS",
        "long_name": "Krebs Biochemicals & Industries Limited",
        "summary": "Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was founded in 1991 and is headquartered in Hyderabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Hyderabad",
        "zipcode": "500034",
        "website": "http://krebsbiochem.com",
        "market_cap": "Nano Cap"
    },
    "KSPHF": {
        "short_name": "KISSEI PHARMACEUTICAL CO",
        "long_name": "Kissei Pharmaceutical Co., Ltd.",
        "summary": "Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products primarily in Japan. It offers Urief and Urief OD tablets for the treatment of dysuria; Glufast, Glubes, and Marizev tablets for type 2 diabetes; Darbepoetin Alfa BS and Epoetin Alfa BS injections for the treatment of renal anemia; Beova tablets for overactive bladder treatment; P-TOL chewable tablets for treating hyperphosphatemia; and Minirin Melt OD tablets for nocturia due to nocturnal polyuria in males, central diabetes insipidus, and nocturnal enuresis resulted from decrease of urine osmolality. The company's products in pipeline include KPS-0373 that has completed Phase III clinical trial to treat spinocerebellar ataxia; CCX168, which has completed Phase III clinical trial for the treatment of microscopic polyangiitis and granulomatosis with polyangiitis; AJM300, which is in Phase III clinical trial to treat ulcerative colitis; R788 that is in Phase III clinical trial to treat chronic idiopathic thrombocytopenic purpura; and MR13A9, which is in Phase III clinical trial to treat uremic pruritus in dialysis patients. It is also developing KLH-2109 for treating endometriosis and uterine fibroids; KDT-3594 for the treatment of Parkinson's disease; Silodosin for dysuria associated with benign prostatic hyperplasia; Mitiglinide for type 2 diabetes mellitus; and Bedoradrine for the treatment of acute exacerbation of asthma. In addition, it develops and sells protein controlled and energy supply foods; and purchases and sells related materials, as well as offers system development and information processing, construction contracting, equipment and facility management, and information gathering and development support services. The company was formerly known as Kissei Yakuhin Kogyo Co., Ltd. and changed its name to Kissei Pharmaceutical Co., Ltd. in October 1964. The company was founded in 1946 and is headquartered in Matsumoto, Japan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Japan",
        "state": null,
        "city": "Matsumoto",
        "zipcode": "399-8710",
        "website": "http://www.kissei.co.jp",
        "market_cap": "Small Cap"
    },
    "KTNNF": {
        "short_name": "PEAKBIRCH LOGIC INC",
        "long_name": "PeakBirch Logic Inc.",
        "summary": "PeakBirch Logic Inc. engages in the e-commerce sales and delivery of cannabis-related and cannabidiol (CBD) containing products. The company distributes vaporizers, CBD related accessories, and ancillary products for aromatherapy and other applications, as well as CBD tinctures, topicals, edibles, and other products. It sells its products through Namastevapes.com, Everyonedoesit.com, LiftedCBD.com, Leafscience.com, and Lifted.com portals. PeakBirch Logic Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3N6",
        "website": "http://peakbirch.com",
        "market_cap": "Nano Cap"
    },
    "KYH2.F": {
        "short_name": "PEAKBIRCH LOGIC INC.",
        "long_name": "PeakBirch Logic Inc.",
        "summary": "PeakBirch Logic Inc. engages in the e-commerce sales and delivery of cannabis-related and cannabidiol (CBD) containing products. The company distributes vaporizers, CBD related accessories, and ancillary products for aromatherapy and other applications, as well as CBD tinctures, topicals, edibles, and other products. It sells its products through Namastevapes.com, Everyonedoesit.com, LiftedCBD.com, Leafscience.com, and Lifted.com portals. PeakBirch Logic Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3N6",
        "website": "http://peakbirch.com",
        "market_cap": "Nano Cap"
    },
    "L003.F": {
        "short_name": "GLOB.HEALTH CLINICS  O.N.",
        "long_name": "Global Health Clinics Ltd.",
        "summary": "Global Health Clinics Ltd. operates in the cannabis industry. The company operates medical clinics, which guide patients through the process of becoming legal users of medical marijuana. It also operates as a marketing technology company that utilizes a digital platform, which generates leads through storefront kiosks that operates in marijuana dispensaries in British Columbia; and offers sorting, recording, and verification of patient information. The company was formerly known as Leo Resources Inc. and changed its name to Global Health Clinics Ltd. in August 2018. Global Health Clinics Ltd. was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3N6",
        "website": "http://www.globalhealthclinics.co",
        "market_cap": "Nano Cap"
    },
    "L0MA.F": {
        "short_name": "NEXTLEAF SOLUTIONS",
        "long_name": "Nextleaf Solutions Ltd.",
        "summary": "Nextleaf Solutions Ltd., a cannabis extraction technology company, develops and licenses technology for the extraction, distillation, and formulation of cannabinoids in Canada. It also extracts, distills, purifies, delivers, and wholesales CBD oils and THC cannabinoid ingredients; researches and develops cannabis infused products, vapes, ingestible concentrates, and specialty extracts; and provides extraction services. The company was founded in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6B 1A4",
        "website": "http://www.nextleafsolutions.com",
        "market_cap": "Nano Cap"
    },
    "L3D.DE": {
        "short_name": "SYNBIOTIC SE  INH O.N.",
        "long_name": "SynBiotic SE",
        "summary": "SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "GER",
        "market": "de_market",
        "country": "Germany",
        "state": null,
        "city": "Munich",
        "zipcode": "81667",
        "website": "http://www.synbiotic.com",
        "market_cap": "Micro Cap"
    },
    "L3D.DU": {
        "short_name": "SYNBIOTIC SE  INH O.N.",
        "long_name": "SynBiotic SE",
        "summary": "SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "DUS",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Munich",
        "zipcode": "81667",
        "website": "http://www.synbiotic.com",
        "market_cap": "Micro Cap"
    },
    "L3D.F": {
        "short_name": "SYNBIOTIC SE  INH O.N.",
        "long_name": "SynBiotic SE",
        "summary": "SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Munich",
        "zipcode": "81667",
        "website": "http://www.synbiotic.com",
        "market_cap": "Micro Cap"
    },
    "LABB.MX": {
        "short_name": "GENOMMA LAB INTERNACIONAL SAB",
        "long_name": "Genomma Lab Internacional, S.A.B. de C.V.",
        "summary": "Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the research, development, and marketing of pharmaceutical, over the counter, and personal care products in Mexico, the United States, and Latin America. It offers antibacterial products under the Next-AB brand name, including disinfecting wet wipes, alcohol-based hand sanitizers, and antibacterial soaps; razor products under the Groomen brand; anti-flu medicines under the Next brand; HIV testing kits under the OraQuick brand name; and isotonic beverages under the Suerox brand, as well as gold lift creams under the Cicatricure brand. The company also provides shampoos under the Revie, Vanart, and T\u00c3\u00ado Nacho names; and cough and cold medicines under the Tukol brand. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico.",
        "currency": "MXN",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MEX",
        "market": "mx_market",
        "country": "Mexico",
        "state": "DF",
        "city": "Mexico City",
        "zipcode": "01210",
        "website": "http://www.genommalab.com",
        "market_cap": "Small Cap"
    },
    "LABS.TO": {
        "short_name": "MEDIPHARM LABS CORP",
        "long_name": "MediPharm Labs Corp.",
        "summary": "MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates, and advance derivative products in Canada and Australia. It formulates, processes, packages, and distributes cannabis extracts and cannabinoid-based products. The company was founded in 2015 and is headquartered in Barrie, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Barrie",
        "zipcode": "L4N 2L1",
        "website": "http://www.medipharmlabs.com",
        "market_cap": "Micro Cap"
    },
    "LASA.NS": {
        "short_name": "LASA SUPERGENERICS",
        "long_name": "Lasa Supergenerics Limited",
        "summary": "Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers veterinary and other API products, anthelmintic products, animal feed ingredients, and reagents for therapeutic use. The company also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400059",
        "website": "http://lasalabs.com",
        "market_cap": "Nano Cap"
    },
    "LAURUSLABS.NS": {
        "short_name": "LAURUS LABS LTD",
        "long_name": "Laurus Labs Limited",
        "summary": "Laurus Labs Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. It operates through Generics APIs, Generics Finished Dosage Forms (FDF), and Synthesis segments. The Generics APIs segment develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), oncology, hepatitis C, cardiovascular, antidiabetic, anti-asthmatic, gastroenterology, and ophthalmic therapeutic areas. The Generics FDF segment develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, proton pump inhibitors, and central nervous system. The Synthesis segment provides contract development and manufacturing services for pharmaceutical companies. The company also manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. In addition, it offers chemistry, IP development, business support, and related services to the pharmaceutical community. The company was incorporated in 2005 and is based in Hyderabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Hyderabad",
        "zipcode": "500034",
        "website": "http://www.lauruslabs.com",
        "market_cap": "Mid Cap"
    },
    "LAXAF": {
        "short_name": "LAXAI PHARMA LTD",
        "long_name": "Laxai Pharma, Ltd.",
        "summary": "Laxai Pharma, Ltd. offers contract research services in the United States. It provides integrated services across the drug development spectrum. The company focuses its services in the areas of biostatistics, data management (EDC, Hybrid, and Paper), CDISC consulting, medical writing, monitoring, regulatory, drug safety, and related training programs. The company was formerly known as Nexgen Biofuels Ltd. and changed its name to Laxai Pharma, Ltd. in February, 2010. Laxai Pharma, Ltd. is based in Tampa, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Tampa",
        "zipcode": "33647",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "LBM.MI": {
        "short_name": "LABOMAR",
        "long_name": "Labomar S.p.A.",
        "summary": "Labomar S.p.A. researches, develops, manufactures, and sells food supplements, medical devices, cosmetics, and pharmaceutical products in Italy, France, Poland, Spain, North America, and internationally. It offers food supplements for various therapeutic areas, including immune systems, gastroenterology, cough and cold, neurology, oncology, eyesight wellness, sport, dermatology, inside beauty, cardiology, orthopedics, pediatrics, detoxing, and metabolic syndrome; and vitamins, minerals, and antioxidants. The company also provides medical devices for the use in gynaecology, cough and cold, gastroenterology, wound healing, metabolic syndrome, proctology, detoxing, and oral wound care therapeutic areas; and foods for special medical purposes, such as gastroenterology, endocrinology, and dysphagia. In addition, it offers cosmetics for inside beauty, skin cleanser, skincare, haircare, oral wound care, sun care, dermatology, acne rosacea, acne, atopic dertmatitis, and bruises therapeutic areas; and probiotic food supplements. Further, the company provides contract development and manufacturing services. Labomar S.p.A. offers its products in the form of tablets, capsules, liquids, powders, and semi solids. It has a commercial agreement with Bayer for the development and production of the references in various pharmaceutical flavors and forms. The company was founded in 1998 and is headquartered in Istrana, Italy. Labomar S.p.A. is a subsidiary of LBM Holding S.r.l.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "TV",
        "city": "Istrana",
        "zipcode": "31036",
        "website": "http://labomar.com",
        "market_cap": "Micro Cap"
    },
    "LC8A.F": {
        "short_name": "CALLIDITAS THERAP. AD 1/2",
        "long_name": "Calliditas Therapeutics AB (publ)",
        "summary": "Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing pharmaceutical products for patients with unmet medical needs. The company's lead product candidate is Nefecon, a novel oral formulation of budesonide potent local immunosuppressant for the treatment of the autoimmune renal disease IgA nephropathy. Calliditas Therapeutics AB (publ) also intends to take Nefecon through a global Phase 3 study to commercialization. Calliditas Therapeutics AB (publ) was founded in 2004 and is headquartered in Stockholm, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Stockholm",
        "zipcode": "111 22",
        "website": "http://www.calliditas.se",
        "market_cap": "Small Cap"
    },
    "LCI": {
        "short_name": "Lannett Co Inc",
        "long_name": "Lannett Company, Inc.",
        "summary": "Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was founded in 1942 and is headquartered in Philadelphia, Pennsylvania.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "United States",
        "state": "PA",
        "city": "Philadelphia",
        "zipcode": "19136",
        "website": "http://www.lannett.com",
        "market_cap": "Micro Cap"
    },
    "LDB.F": {
        "short_name": "H. LUNDBECK A/S NAM. DK 5",
        "long_name": "H. Lundbeck A/S",
        "summary": "H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Onfi for Lennox-Gastaut syndrome; Vyepti for migraine prevention; and Rexulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. The company was founded in 1915 and is headquartered in Valby, Denmark.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Denmark",
        "state": null,
        "city": "Valby",
        "zipcode": "2500",
        "website": "http://www.lundbeck.com",
        "market_cap": "Mid Cap"
    },
    "LDZA.F": {
        "short_name": "ASPEN PHARMACARE H. NEW",
        "long_name": "Aspen Pharmacare Holdings Limited",
        "summary": "Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anaesthetics and muscle relaxants under the Anaesthetics brand; cytotoxic medicines under the Regional brand; and injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It is also involved in the contract and supply of chemical and biochemical active pharmaceutical ingredients and finished dose form pharmaceuticals for third parties. The company offers products in the form of oral solid dose, injectables, liquids, semi-solids, steriles, biologicals, and active pharmaceutical ingredients. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "South Africa",
        "state": null,
        "city": "Durban",
        "zipcode": null,
        "website": "http://www.aspenpharma.com",
        "market_cap": "Mid Cap"
    },
    "LDZU.F": {
        "short_name": "ASPEN PHAR.UN.ADR /1 O.N.",
        "long_name": "Aspen Pharmacare Holdings Limited",
        "summary": "Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anaesthetics and muscle relaxants under the Anaesthetics brand; cytotoxic medicines under the Regional brand; and injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It is also involved in the contract and supply of chemical and biochemical active pharmaceutical ingredients and finished dose form pharmaceuticals for third parties. The company offers products in the form of oral solid dose, injectables, liquids, semi-solids, steriles, biologicals, and active pharmaceutical ingredients. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "South Africa",
        "state": null,
        "city": "Durban",
        "zipcode": null,
        "website": "http://www.aspenpharma.com",
        "market_cap": "Mid Cap"
    },
    "LGP.AX": {
        "short_name": "LITTLEGRN FPO",
        "long_name": "Little Green Pharma Ltd",
        "summary": "Little Green Pharma Ltd engages in the research and development, cultivation, production, manufacturing, and distribution of medicinal cannabis products in Australia and internationally. It offers a range of medical cannabis preparations in oil formulation under the LGP Natural and LGP Advanced names. The company was founded in 2016 and is headquartered in West Perth, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "WA",
        "city": "West Perth",
        "zipcode": "6005",
        "website": "http://www.littlegreenpharma.com",
        "market_cap": "Micro Cap"
    },
    "LINCOLN.NS": {
        "short_name": "LINCOLN PHARMA LTD",
        "long_name": "Lincoln Pharmaceuticals Limited",
        "summary": "Lincoln Pharmaceuticals Limited manufactures and sells pharmaceutical products in India and internationally. It offers products in the areas of anti-infective, respiratory system, gynecology, cardio and CNS, anti-bacterial, ant-diabetic, anti-malaria, and others areas. The company also trades in pharmaceutical products. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Ahmedabad",
        "zipcode": "380062",
        "website": "http://www.lincolnpharma.com",
        "market_cap": "Micro Cap"
    },
    "LITH": {
        "short_name": "U S LITHIUM CORP",
        "long_name": "BioELife Corp.",
        "summary": "BioELife Corp. operates in cannabinoid market. It offers cannabinoid products, such as combo adult gummies with chirorub, combo tincture with chirorub, intensive relief rub, tinctures, adult gummies, premium pre-rolls, and flowers. The company was formerly known as US Lithium Corp. and changed its name to BioELife Corp. in March 2020. The company was founded in 2006 and is based in Seal Beach, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Seal Beach",
        "zipcode": "90740",
        "website": "http://www.bioelife.com",
        "market_cap": "Nano Cap"
    },
    "LMLLF": {
        "short_name": "PHARMADRUG INC",
        "long_name": "Pharmadrug Inc.",
        "summary": "Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also distributes medical cannabis to pharmacies in Germany and rest of the European Union. In addition, the company engages in the adult use psychedelic retail business; and researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. The company is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5K 1H1",
        "website": "http://www.pharmadrug.co",
        "market_cap": "Nano Cap"
    },
    "LN5.F": {
        "short_name": "LANNETT CO. INC.  DL-,001",
        "long_name": "Lannett Company, Inc.",
        "summary": "Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was founded in 1942 and is headquartered in Philadelphia, Pennsylvania.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "PA",
        "city": "Philadelphia",
        "zipcode": "19136",
        "website": "http://www.lannett.com",
        "market_cap": "Micro Cap"
    },
    "LN5.SG": {
        "short_name": "LANNETT CO. INC. Registered Sha",
        "long_name": "Lannett Company, Inc.",
        "summary": "Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was founded in 1942 and is headquartered in Philadelphia, Pennsylvania.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "United States",
        "state": "PA",
        "city": "Philadelphia",
        "zipcode": "19136",
        "website": "http://www.lannett.com",
        "market_cap": "Micro Cap"
    },
    "LOBE.CN": {
        "short_name": "LobeSciences",
        "long_name": "Lobe Sciences Ltd.",
        "summary": "Lobe Sciences Ltd., a technology and services company, provides real estate, financial, management, intellectual property, and branding support for development of transformational medicine in the United States. The company intends to develop psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications. It also owns acquired brands, intellectual property, and leases office and production premises to a cannabis processor and retailer. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6B 2Z4",
        "website": "http://www.lobesciences.com",
        "market_cap": "Nano Cap"
    },
    "LOVE.V": {
        "short_name": "CANNARA BIOTECH INC",
        "long_name": "Cannara Biotech Inc.",
        "summary": "Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. It also offers hemp based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "QC",
        "city": "Montreal",
        "zipcode": "H4N 3M9",
        "website": "http://cannara.ca",
        "market_cap": "Micro Cap"
    },
    "LOVFF": {
        "short_name": "CANNARA BIOTECH INC",
        "long_name": "Cannara Biotech Inc.",
        "summary": "Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. It also offers hemp based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Montreal, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "QC",
        "city": "Montreal",
        "zipcode": "H4N 3M9",
        "website": "http://cannara.ca",
        "market_cap": "Micro Cap"
    },
    "LOWL.CN": {
        "short_name": "LowellFarms",
        "long_name": "Lowell Farms Inc.",
        "summary": "Lowell Farms Inc., a cannabis company, engages in the cultivation, extraction, processing, manufacturing, branding, packaging, and wholesale distribution of cannabis products to retail dispensaries in California. The company provides flowers, vape pens, oils, extracts, chocolate edibles, mints, gummies, beverages, tinctures, and pre-rolls under the Lowell Herb Co., Lowell Smokes, Cypress Reserve, Flavor Extracts, Kaizen, House Weed, Moon, Altai, Humble Flower, Original Pot Company, CannaStripe, and Acme Elixirs brands. It also offers manufacturing, extraction, and distribution services to third-party cannabis and cannabis branding companies. The company was formerly known as Indus Holdings, Inc. and changed its name to Lowell Farms Inc. in March 2021. Lowell Farms Inc. is headquartered in Salinas, California.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "CA",
        "city": "Salinas",
        "zipcode": "93907",
        "website": "http://www.lowellfarms.com",
        "market_cap": "Nano Cap"
    },
    "LOWLF": {
        "short_name": "LOWELL FARMS INC",
        "long_name": "Lowell Farms Inc.",
        "summary": "Lowell Farms Inc., a cannabis company, engages in the cultivation, extraction, processing, manufacturing, branding, packaging, and wholesale distribution of cannabis products to retail dispensaries in California. The company offers flowers, vape pens, oils, extracts, chocolate edibles, mints, gummies, beverages, tinctures, concentrates, and pre-rolls under the Lowell Herb Co., Lowell Smokes, Cypress Reserve, Flavor Extracts, Kaizen, House Weed, Moon, Altai, Humble Flower, Original Pot Company, CannaStripe, and Acme Elixirs brands. It also provides manufacturing, extraction, and distribution services to third-party cannabis and cannabis branding companies. The company was formerly known as Indus Holdings, Inc. and changed its name to Lowell Farms Inc. in March 2021. Lowell Farms Inc. was founded in 2014 and is headquartered in Salinas, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Salinas",
        "zipcode": "93907",
        "website": "http://www.lowellfarms.com",
        "market_cap": "Nano Cap"
    },
    "LP6.F": {
        "short_name": "LIVZON PHARMAC. GRP H YC1",
        "long_name": "Livzon Pharmaceutical Group Inc.",
        "summary": "Livzon Pharmaceutical Group Inc. engages in the research, development, production, and distribution of pharmaceutical products in the People's Republic of China. Its products include Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitropin for injection to treat anovulation and sufferers; Perospirone Hydrochloride for the treatment of schizophrenia; Anti-viral Granules to treat upper respiratory tract infection and influenza; and Shenqi Fuzheng Injection for the treatment of weakness and tiredness, lassitude, spontaneous sweating, vertigo, and for the patients of lung cancer and stomach cancer. The company also offers active pharmaceutical ingredients (APIs) and intermediates, such as diagnostic kit for IgM/IgG antibody to coronavirus; and diagnostic reagents and equipment, including diagnostic kit for human immunodeficiency virus antibody, diagnostic kit for anti-nuclear antibody panel, and diagnostic kit for tuberculosis specific infected T cells. In addition, it provides biologic products, traditional Chinese drug medicine, biochemical drugs, microbiological preparations, antibiotics, and pharmaceutical raw materials. The company also exports its products. Livzon Pharmaceutical Group Inc. was founded in 1985 and is based in Zhuhai, China.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "China",
        "state": null,
        "city": "Zhuhai",
        "zipcode": "519090",
        "website": "http://www.livzon.com.cn",
        "market_cap": "Mid Cap"
    },
    "LRSV": {
        "short_name": "LINK RESERVATIONS INC",
        "long_name": "Link Reservations Inc.",
        "summary": "Link Reservations Inc., through its subsidiary, produces cannabidiol-based (CBD) products primarily for pets in Europe and the United States. It develops and markets hemp-based CBD products for cats, dogs, and horses. The company was formerly known as Vendum Batteries, Inc. and changed its name to Link Reservations Inc. in May 2015. Link Reservations Inc. was incorporated in 2006 and is based in Kington, the United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Kington",
        "zipcode": "HR5 3DJ",
        "website": "http://www.linkreservationsinc.com",
        "market_cap": "Nano Cap"
    },
    "LTTSF": {
        "short_name": "LOTUS VENTURES INC",
        "long_name": "Lotus Ventures Inc.",
        "summary": "Lotus Ventures Inc. cultivates and sells cannabis products for medical purpose. The company was incorporated in 2007 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2Y3",
        "website": "http://lotuscannabis.ca",
        "market_cap": "Nano Cap"
    },
    "LUFF.CN": {
        "short_name": "LuffEnterprises",
        "long_name": "Luff Enterprises Ltd.",
        "summary": "Luff Enterprises Ltd., a CBD lifestyle company, manufactures and distributes hemp-based cannabinoid wellness products in the United States. The company focuses on formulations leveraging cannabinoids, such as CBG and CBN; and boosts them with superfood ingredients to empower people to realize the potential of everyday life. Its products include tinctures, gummies, topicals, and gel caps. The company was formerly known as Ascent Industries Corp. and changed its name to Luff Enterprises Ltd. in May 2020. Luff Enterprises Ltd. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1X8",
        "website": "http://luffbrands.com",
        "market_cap": "Nano Cap"
    },
    "LUN.CO": {
        "short_name": "H. Lundbeck A/S",
        "long_name": "H. Lundbeck A/S",
        "summary": "H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Onfi for Lennox-Gastaut syndrome; Vyepti for migraine prevention; and Rexulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. The company was founded in 1915 and is headquartered in Valby, Denmark.",
        "currency": "DKK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CPH",
        "market": "dk_market",
        "country": "Denmark",
        "state": null,
        "city": "Valby",
        "zipcode": "2500",
        "website": "http://www.lundbeck.com",
        "market_cap": "Mid Cap"
    },
    "LUN.VI": {
        "short_name": "H LUNDBECK AS",
        "long_name": "H. Lundbeck A/S",
        "summary": "H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Onfi for Lennox-Gastaut syndrome; Vyepti for migraine prevention; and Rexulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. The company was founded in 1915 and is headquartered in Valby, Denmark.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VIE",
        "market": "at_market",
        "country": "Denmark",
        "state": null,
        "city": "Valby",
        "zipcode": "2500",
        "website": "http://www.lundbeck.com",
        "market_cap": "Mid Cap"
    },
    "LUPIN.NS": {
        "short_name": "LUPIN LTD",
        "long_name": "Lupin Limited",
        "summary": "Lupin Limited, a pharmaceutical company, manufactures and distributes a range of branded and generic formulations, biotechnology products, active pharmaceutical ingredients, and specialty products in India, the United States, Japan, and internationally. The company offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastro-intestinal, anti-infective, non-steroidal anti-inflammatory drug therapy, anti-TB, and cephalosporin. It also develops and commercializes various drug delivery platforms; and provides biosimilar products. In addition, the company engages in the provision of the over-the-counter products, and contract manufacturing and supply services; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. Lupin Limited has a licensing, development, and commercialization agreement with Boehringer Ingelheim for Lupin's MEK inhibitor compound (LNP3794) as a potential targeted therapy for patients with cancers. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is based in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400051",
        "website": "http://www.lupin.com",
        "market_cap": "Mid Cap"
    },
    "LV1.AX": {
        "short_name": "LIVEVLIM FPO",
        "long_name": "Live Verdure Ltd",
        "summary": "Live Verdure Ltd develops hemp plant-based solutions in Australia. The company offers hemp seed oil, seed oil capsules, infused manuka honey, honey, drinking chocolate, seed, greens, chai powder, porridge with dried fruit, falafel, health booster, falafel spicy, porridge, flour, food, muesli, protein powder, and falafel lemon and pepper. It distributes its products under the 13 Seeds brand name. The company was formerly known as 13 Seeds Pty Ltd and changed its name to Live Verdure Ltd in October 2020. Live Verdure Ltd was incorporated in 2016 and is based in Melbourne, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Melbourne",
        "zipcode": "3000",
        "website": "http://www.liveverdure.com.au",
        "market_cap": "Nano Cap"
    },
    "LV9.F": {
        "short_name": "LOTUS VENTURES INC.",
        "long_name": "Lotus Ventures Inc.",
        "summary": "Lotus Ventures Inc. cultivates and sells cannabis products for medical purpose. The company was incorporated in 2007 and is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2Y3",
        "website": "http://lotuscannabis.ca",
        "market_cap": "Nano Cap"
    },
    "LVCNF": {
        "short_name": "LEVIATHAN NATURAL PRODUCTS INC",
        "long_name": "Leviathan Natural Products Inc.",
        "summary": "Leviathan Natural Products Inc. engages in cultivating, processing, and distributing of cannabis and hemp products in Canada, the United States, and Colombia. The company was formerly known as Leviathan Cannabis Group Inc. and changed its name to Leviathan Natural Products Inc. in July 2020. Leviathan Natural Products Inc. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 4J6",
        "website": "http://leviathan-naturals.com",
        "market_cap": "Nano Cap"
    },
    "LVGI": {
        "short_name": "LIMITLESS VENTURE GROUP INC",
        "long_name": "Limitless Venture Group Inc.",
        "summary": "Limitless Venture Group Inc., a development stage company, produces, distributes, and markets body care, health, and alcoholic products. The company offers LIMITLESS BODY products, including BODY FRESH, a body wash; MUSCLE BUTTER, a body soothing massage butter; BODY SUGAR, a sugar body scrub; BARE SKIN, a moisturizing shave cream; and GYM SANI-T, a sanitizer. It also provides LIMITLESS HEALTH products, such as Prostaderol, a natural prostate health supplement; LipiRestorin; and Maxtlevelin, a product to increase testosterone levels. In addition, the company offers HempCore health products comprising RELAX, an anxiety relief formula; FIBER UP to remove toxins; HEALTHY HEART, a natural product that promotes cardiovascular health and helps maintain healthy cholesterol levels; BRAIN BOOST, a neurotransmitter boosting formula that assists central nervous system to deliver oxygen and nutrients to the brain; and JOINT RELEIF, an anti-inflammation joint formula used to rebuild, lubricate, and soothe aching joints. Further, it provides ready to drink alcoholic shots that include Haymaker, a vodka with lemon and tea flavors; CoCo-Puff, a vodka with chocolate and Irish cream flavors; Red Headed Slut, a vodka with peach, licorice, and cranberry flavors; Twist, a tequila with lime flavor; and Kamikaze, a vodka with orange liquor and lime flavors. The company was formerly known as Enerbrite Technologies Group Inc. and changed its name to Limitless Venture Group Inc. in February 2013. Limitless Venture Group Inc. is based in Tulsa, Oklahoma.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "OK",
        "city": "Tulsa",
        "zipcode": "74105",
        "website": "http://www.lvginc.com",
        "market_cap": "Micro Cap"
    },
    "LVRLF": {
        "short_name": "CORDOVACANN CORP",
        "long_name": "CordovaCann Corp.",
        "summary": "CordovaCann Corp., a cannabis-focused consumer products company, primarily provides services and investment capital to the processing, production, and retail vertical markets of the cannabis industry. As of March 8, 2021, it operated six stores under the Star Buds cannabis retail store in Alberta, Ontario, and Manitoba. The company was formerly known as LiveReel Media Corporation and changed its name to CordovaCann Corp. in January 2018. CordovaCann Corp. is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5V 0R2",
        "website": "http://www.cordovacann.com",
        "market_cap": "Nano Cap"
    },
    "LVVV": {
        "short_name": "LIVEWIRE ERGOGENICS INC",
        "long_name": "Livewire Ergogenics  Inc.",
        "summary": "LiveWire Ergogenics Inc. focuses on acquiring, managing, and licensing special purpose real estate properties to produce handcrafted and organically grown cannabis products for medical and recreational adult-use in California. The company is based in Anaheim, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Anaheim",
        "zipcode": "92806",
        "website": "http://livewireergogenics.com",
        "market_cap": "Nano Cap"
    },
    "MANGALAM.NS": {
        "short_name": "MANGALAM DRUGS & O",
        "long_name": "Mangalam Drugs & Organics Limited",
        "summary": "Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. Mangalam Drugs & Organics Limited was incorporated in 1972 and is based in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400001",
        "website": "http://www.mangalamdrugs.com",
        "market_cap": "Nano Cap"
    },
    "MB31.F": {
        "short_name": "EXPERION HOLDINGS LTD",
        "long_name": "Experion Holdings Ltd.",
        "summary": "Experion Holdings Ltd., through its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada. Its products are used for adult-use, wellness and therapeutic, and medical applications. Experion Holdings Ltd. offers its products under the Citizen Stash and Kanabe brand names. The company was formerly known as Viridium Pacific Group Ltd. and changed its name to Experion Holdings Ltd. in June 2019. Experion Holdings Ltd. is headquartered in Mission, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Mission",
        "zipcode": "V2V 0A6",
        "website": "http://www.experionwellness.com",
        "market_cap": "Nano Cap"
    },
    "MB8A.F": {
        "short_name": "MOBERG PHARMA AB",
        "long_name": "Moberg Pharma AB (publ)",
        "summary": "Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products for skin diseases in Sweden, the United States, and internationally. It develops MOB-015, which is under Phase III clinical trial for the treatment of nail fungus treatment; and BUPI, a lozenge with bupivacaine intended for pain relief in association with inflammation and ulceration of the oral mucous membranes. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was founded in 2006 and is headquartered in Bromma, Sweden.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Sweden",
        "state": null,
        "city": "Bromma",
        "zipcode": "167 51",
        "website": "http://www.mobergpharma.se",
        "market_cap": "Nano Cap"
    },
    "MCIC": {
        "short_name": "MULTICORP INTL INC",
        "long_name": "Multicorp International, Inc.",
        "summary": "Multicorp International, Inc. engages in the medical business in the United States and internationally. It offers its products and services in the tele-medicine and tele-health sectors. The company also engages in music, television shows and movie production, and Broadway style plays, as well as operates WRSO 810 AM radio station. It was formerly known as XTend Medical Corporation and changed its name to MultiCorp International, Inc. in August 2012. The company is based in Sun Valley, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Sun Valley",
        "zipcode": "91352",
        "website": "http://multicorp.international",
        "market_cap": "Nano Cap"
    },
    "MCOA": {
        "short_name": "MARIJUANA COMPANY OF AMERICA IN",
        "long_name": "Marijuana Company of America, Inc.",
        "summary": "Marijuana Company of America, Inc., together with its subsidiaries, develops, manufactures, markets, and sells hemp and hemp-derived consumer products under the hempSMART brand name in the United States and internationally. The company's hempSMART products include hempSMART Brain, a patented and formulated personal care consumer product that combines hemp-derived cannabidiol (CBD) for brain wellness; hempSMART Pain capsules for relief of minor discomfort with physical activity; hempSMART Pain Cream for muscle relaxation; hempSMART Drops, hemp CBD oil tincture drops; hempSMART Pet Drops for cats and dogs; hempSMART Face, a facial moisturizer; and hempSMART drink mix, an industrial hemp based powderized CBD drink. It also provides financial accounting and bookkeeping, and property management consulting services for operators in states where cannabis and/or hemp is legalized for medicinal and/or recreational use. The company sells its products through its web site and affiliate marketing programs. Marijuana Company of America, Inc. has a strategic collaboration agreement with Eco Innovation Group, Inc. to enhance the company's global cannabis offering. The company was formerly known as Converge Global, Inc. and changed its name to Marijuana Company of America, Inc. in December 2015. Marijuana Company of America, Inc. was incorporated in 1985 and is headquartered in Escondido, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Escondido",
        "zipcode": "92029",
        "website": "http://www.marijuanacompanyofamerica.com",
        "market_cap": "Nano Cap"
    },
    "MDCN": {
        "short_name": "MEDICAN ENTERPRISES INC",
        "long_name": "Medican Enterprises, Inc.",
        "summary": "Medican Enterprises, Inc., a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. The company intends to invest in business of growing, marketing, research and development, training, distribution, and retail sale of medical and recreational marijuana in the United States and Canada. Medican Enterprises, Inc. was founded in 1988 and is headquartered in Las Vegas, Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89120",
        "website": "http://www.medicaninc.com",
        "market_cap": "Nano Cap"
    },
    "MDP.V": {
        "short_name": "MEDEXUS PHARMACEUTICALS INC",
        "long_name": "Medexus Pharmaceuticals Inc.",
        "summary": "Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, which is indicated for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and chronic spontaneous urticaria in patients 2 years of age and older. Its products portfolio also include Cuvposa, which is indicated for sialorrhea in patients aged 3-18 years with neurologic conditions, such as cerebral; Gliolan, an orally administered drug used for the visualization of various brain tumors; and Treosulfan, a conditioning agent used prior to stem cell transplantation. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Verdun, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "QC",
        "city": "Verdun",
        "zipcode": "H3E 1A2",
        "website": "http://www.medexus.com",
        "market_cap": "Micro Cap"
    },
    "MDVL": {
        "short_name": "MedAvail Holdings, Inc.",
        "long_name": "MedAvail Holdings, Inc",
        "summary": "MedAvail Holdings, Inc. operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology. The company provides turnkey services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations. It also operates SpotRx, a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery. MedAvail Holdings, Inc. is based in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NCM",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5N 5M4",
        "website": "http://www.medavail.com",
        "market_cap": "Small Cap"
    },
    "MEDIF": {
        "short_name": "MEDIPHARM LABS CORP",
        "long_name": "MediPharm Labs Corp.",
        "summary": "MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates, and advance derivative products in Canada and Australia. It formulates, processes, packages, and distributes cannabis extracts and cannabinoid-based products. The company was founded in 2015 and is headquartered in Barrie, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Barrie",
        "zipcode": "L4N 2L1",
        "website": "http://www.medipharmlabs.com",
        "market_cap": "Micro Cap"
    },
    "MEDXF": {
        "short_name": "MEDEXUS PHARMACEUTICALS INC",
        "long_name": "Medexus Pharmaceuticals Inc.",
        "summary": "Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, which is indicated for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and chronic spontaneous urticaria in patients 2 years of age and older. Its products portfolio also include Cuvposa, which is indicated for sialorrhea in patients aged 3-18 years with neurologic conditions, such as cerebral; Gliolan, an orally administered drug used for the visualization of various brain tumors; and Treosulfan, a conditioning agent used prior to stem cell transplantation. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Verdun, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "QC",
        "city": "Verdun",
        "zipcode": "H3E 1A2",
        "website": "http://www.medexus.com",
        "market_cap": "Micro Cap"
    },
    "MEGA.BK": {
        "short_name": "MEGA LIFESCIENCES PUBLIC COMPAN",
        "long_name": "Mega Lifesciences Public Company Limited",
        "summary": "Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures, markets, and sells health food supplements, prescription pharmaceutical products, over-the-counter (OTC) products, herbal products, vitamins, and fast moving consumer goods. The company operates through Brands, Distribution, and Original Equipment Manufacture segments. It provides various complementary medicines for bone and joint, children, diabetic, heart, herbal, liver and digestive, skin, slimming, and well-being care, as well as men's and women's care products and sports supplements; gastrointestinal and pain care OTC medicines; and prescription medicines in the areas of iron supplement, anticoagulant, diabetology, cardiology, dermatology, gastroenterology, neurology, pain, osteoporosis, respiratory, urology, oncology, and nephrology. The company also offers logistical and marketing services for the sale of goods manufactured by third parties. In addition, the company engages in the operation of wellness center; and software design, development, and other services business. It operates in the Asia Pacific, the Middle East, Africa, and the Commonwealth of Independent States. The company was incorporated in 1982 and is headquartered in Bangkok, Thailand. Mega Lifesciences Public Company Limited is a subsidiary of Unistretch Limited.",
        "currency": "THB",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SET",
        "market": "th_market",
        "country": "Thailand",
        "state": null,
        "city": "Bangkok",
        "zipcode": "10260",
        "website": "http://www.megawecare.com",
        "market_cap": "Small Cap"
    },
    "MERK.JK": {
        "short_name": "Merck Tbk.",
        "long_name": "PT Merck Tbk",
        "summary": "PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. It operates through three segments: Biopharma, Consumer Health, and Others. The company operates in the healthcare, life science, and performance materials sectors. It offers health care products in the areas of allergies, endocrinology, fertility, general medicine, neuro degenerative diseases, and oncology. The company also engages in discovery, development, manufacturing, and diagnostics of drugs. In addition, it offers liquid crystals and OLED materials for displays, materials for integrated circuits, pigments for coatings or colour cosmetics, and functional materials for energy solutions. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. PT Merck Tbk is a subsidiary of Merck Holding GmbH.",
        "currency": "IDR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JKT",
        "market": "id_market",
        "country": "Indonesia",
        "state": null,
        "city": "Jakarta Timur",
        "zipcode": "13760",
        "website": "http://www.merckgroup.com/id-id",
        "market_cap": "Micro Cap"
    },
    "MFY.F": {
        "short_name": "MOCHIDA PHARM.",
        "long_name": "Mochida Pharmaceutical Co., Ltd.",
        "summary": "Mochida Pharmaceutical Co., Ltd. produces and sells pharmaceuticals, skincare products, and diagnostics solutions in Japan. The company provides cardiovascular, analgesic, gastrointestinal, neurological, anti-infective, antidiabetics, and anticancer products, as well as hormone and biological preparations, and biosimilars; diagnostic reagents, such as reagents for fertility/infertility and other reagents; and face and body care, hair care, and skincare products, as well as dermatology, psychiatry, obstetrics, and gynecology products. It also developing drugs for the treatment of intractable diseases. The company has collaboration agreements with Amarin Corporation plc for the development and commercialization of ethyl icosapentate products; and Gene Techno Science Co., Ltd. to develop new regenerative medicine for the treatment of digestive rare and intractable diseases, such as congenital isolated hypoganglionosis. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "162-0845",
        "website": "http://www.mochida.co.jp",
        "market_cap": "Small Cap"
    },
    "MGCLF": {
        "short_name": "MGC PHARMACEUTICALS LTD",
        "long_name": "MGC Pharmaceuticals Limited",
        "summary": "MGC Pharmaceuticals Limited, together with its subsidiaries, produces and supplies phytocannabinoid derived medicines in Australia and Slovenia. It provides pharmaceutical products, such as Tetrinol for the treatment of cachexia; MXOT01GB01 to treat glioblastoma; MXOT02ME01 for the treatment of melanoma cancer; MXOT03PC01 to treat prostate cancer; TopiCann for the topical treatment of eczema and inflamed skin; and InCann, a biactive capsule to treat Chron's and IBS. The company's products under development include CannEpil, which is in Phase IIb clinical trial for the treatment in children and adolescents with refectory epilepsy; CogniCann that is in Phase II clinical trial to treat dementia and Alzheimer's diseases; and ArtemiC, which is in Phase II clinical trial for the treatment COVID-19. It has strategic collaborative partnership agreements Epilepsy Action Australia, Royal Melbourne Institute of Technology, the University of Notre Dame in Western Australia, as well as the National Institute of Biology & University Medical Centre, Ljubljana Slovenia. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is headquartered in West Perth, Australia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Australia",
        "state": "WA",
        "city": "West Perth",
        "zipcode": "6005",
        "website": "http://www.mgcpharma.com.au",
        "market_cap": "Micro Cap"
    },
    "MGW.NE": {
        "short_name": "MAPLE LEAF GREEN WORLD INC.",
        "long_name": "Maple Leaf Green World Inc.",
        "summary": "Maple Leaf Green World Inc., together with its subsidiaries, focuses on the cannabis and industry in North America. The company was formerly known as Maple Leaf Reforestation Inc. and changed its name to Maple Leaf Green World Inc. in October 2012. Maple Leaf Green World Inc. is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NEO",
        "market": "ca_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2M 1H1",
        "website": "http://www.mlgreenworld.com",
        "market_cap": "Nano Cap"
    },
    "MGWFF": {
        "short_name": "MAPLE LEAF GREEN WORLD INC",
        "long_name": "Maple Leaf Green World Inc.",
        "summary": "Maple Leaf Green World Inc., together with its subsidiaries, focuses on the cannabis and industry in North America. The company was formerly known as Maple Leaf Reforestation Inc. and changed its name to Maple Leaf Green World Inc. in October 2012. Maple Leaf Green World Inc. is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2M 1H1",
        "website": "http://www.mlgreenworld.com",
        "market_cap": "Nano Cap"
    },
    "MITPF": {
        "short_name": "MITHRA PHARMACEUTICALS SA NV",
        "long_name": "Mithra Pharmaceuticals SA",
        "summary": "Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial is a combined oral contraceptive; Donesta, which is in phase III clinical trial for vasomotor menopausal symptoms relief; and PeriNesta, an oral treatment for perimenopause. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications; and Tibelia, a solution for treating menopause and osteoporosis. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Li\u00c3\u00a8ge, Belgium.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Belgium",
        "state": null,
        "city": "Li\u00c3\u00a8ge",
        "zipcode": "4000",
        "website": "http://www.mithra.com",
        "market_cap": "Small Cap"
    },
    "MITRA.BR": {
        "short_name": "MITHRA",
        "long_name": "Mithra Pharmaceuticals SA",
        "summary": "Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial is a combined oral contraceptive; Donesta, which is in phase III clinical trial for vasomotor menopausal symptoms relief; and PeriNesta, an oral treatment for perimenopause. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications; and Tibelia, a solution for treating menopause and osteoporosis. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Li\u00c3\u00a8ge, Belgium.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "BRU",
        "market": "be_market",
        "country": "Belgium",
        "state": null,
        "city": "Li\u00c3\u00a8ge",
        "zipcode": "4000",
        "website": "http://www.mithra.com",
        "market_cap": "Small Cap"
    },
    "MJ.CN": {
        "short_name": "TrueLeaf",
        "long_name": "True Leaf Brands Inc.",
        "summary": "True Leaf Brands Inc. manufactures and distributes hemp-based nutrition for pets. It sells dog chews, dental sticks, and supplement oils under the True Hemp brand name in North America and Europe, as well as through online on Amazon. The company was formerly known as True Leaf Medicine International Ltd. and changed its name to True Leaf Brands Inc. in May 2019. True Leaf Brands Inc. was founded in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vernon",
        "zipcode": "V6E 2E9",
        "website": "http://trueleafbrands.com",
        "market_cap": "Nano Cap"
    },
    "MJAR.CN": {
        "short_name": "MJardinGroupInc",
        "long_name": "MJardin Group, Inc.",
        "summary": "MJardin Group, Inc., through its subsidiaries, cultivates, harvests, processes, and sells cannabis products in Canada and the United States. The company also provides consulting services, including strategic capital and financing, project management services for cultivation, licensure support, facility design, systems implementation, facility and equipment leasing, construction oversight, facility ramp-up, and access to intellectual property held by the company to licensed cannabis operators with cultivation and retail businesses. It owns, manages, or advises on a portfolio of 32 cannabis operations. The company was founded in 2014 and is headquartered in Ontario, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 2V6",
        "website": "http://www.mjardin.com",
        "market_cap": "Nano Cap"
    },
    "MJARF": {
        "short_name": "MJARDIN GROUP INC",
        "long_name": "MJardin Group, Inc.",
        "summary": "MJardin Group, Inc., through its subsidiaries, cultivates, harvests, processes, and sells cannabis products in Canada and the United States. The company also provides consulting services, including strategic capital and financing, project management services for cultivation, licensure support, facility design, systems implementation, facility and equipment leasing, construction oversight, facility ramp-up, and access to intellectual property held by the company to licensed cannabis operators with cultivation and retail businesses. It owns, manages, or advises on a portfolio of 32 cannabis operations. The company was founded in 2014 and is headquartered in Ontario, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 2V6",
        "website": "http://www.mjardin.com",
        "market_cap": "Nano Cap"
    },
    "MJNA": {
        "short_name": "MEDICAL MARIJUANA INC",
        "long_name": "Medical Marijuana, Inc.",
        "summary": "Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It focuses on the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol (CBD) and other products containing CBD-rich hemp oil; treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products; and nonpsychoactive cannabidiol products. The company is also involved in the research and development of new therapeutic agents that are designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants; dietary supplements, skin care products, and prescription-based hemp oil under the Kannaway and HempMeds brands; and proprietary testing, genetics, labeling and packaging, tracking, and production and standardization methods for the medicinal cannabinoid industry. In addition, it offers RSHO oil for the treatment of various illnesses and conditions; and plant-based, non-GMO pet products for health and wellness, play and wear, and environmentally-friendly supplies. Medical Marijuana, Inc. was incorporated in 2005 and is based in San Diego, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "San Diego",
        "zipcode": "92191",
        "website": "http://www.medicalmarijuanainc.com",
        "market_cap": "Micro Cap"
    },
    "MJNE": {
        "short_name": "MJ HOLDINGS INC",
        "long_name": "MJ Holdings, Inc.",
        "summary": "MJ Holdings, Inc. operates in the medical marijuana business in Nevada. It offers cultivation and production management, consulting, and asset and infrastructure development services for the cannabis industry. The company is headquartered in Las Vegas, Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89139",
        "website": "http://www.mjholdingsinc.com",
        "market_cap": "Nano Cap"
    },
    "MJRX.CN": {
        "short_name": "GlobalHealth",
        "long_name": "Global Health Clinics Ltd.",
        "summary": "Global Health Clinics Ltd. operates in the cannabis industry. The company operates medical clinics, which guide patients through the process of becoming legal users of medical marijuana. It also operates as a marketing technology company that utilizes a digital platform, which generates leads through storefront kiosks that operates in marijuana dispensaries in British Columbia; and offers sorting, recording, and verification of patient information. The company was formerly known as Leo Resources Inc. and changed its name to Global Health Clinics Ltd. in August 2018. Global Health Clinics Ltd. was incorporated in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3N6",
        "website": "http://www.globalhealthclinics.co",
        "market_cap": "Nano Cap"
    },
    "MJTV": {
        "short_name": "MICHAEL JAMES ENTERPRISES INC",
        "long_name": "MJ Biotech, Inc.",
        "summary": "MJ Biotech, Inc. produces and distributes medical hemp based CBD infused teas and herbs. It sells its products in wellness stores, as well as through its e-commerce Website. The company was formerly known as Michael James Enterprises, Inc. and changed its name to MJ Biotech, Inc. in April 2017. MJ Biotech, Inc. was founded in 2010 and is based in Boynton Beach, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Boynton Beach",
        "zipcode": "33426",
        "website": "http://www.mjbiotech.us",
        "market_cap": "Nano Cap"
    },
    "MKGAF": {
        "short_name": "MERCK KGAA",
        "long_name": "MERCK Kommanditgesellschaft auf Aktien",
        "summary": "MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd. and Artios Pharma Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. Merck KG.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Germany",
        "state": null,
        "city": "Darmstadt",
        "zipcode": "64293",
        "website": "http://www.merckgroup.com",
        "market_cap": "Large Cap"
    },
    "MKKGY": {
        "short_name": "MERCK KGAA",
        "long_name": "MERCK Kommanditgesellschaft auf Aktien",
        "summary": "MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd. and Artios Pharma Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. Merck KG.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Germany",
        "state": null,
        "city": "Darmstadt",
        "zipcode": "64293",
        "website": "http://www.merckgroup.com",
        "market_cap": "Large Cap"
    },
    "MLCL.CN": {
        "short_name": "MoleculeHldngs",
        "long_name": "Molecule Holdings Inc.",
        "summary": "Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages. The company is based in Lansdowne, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Lansdowne",
        "zipcode": "K0E 1L0",
        "website": "http://www.molecule.ca",
        "market_cap": "Nano Cap"
    },
    "MLGML.PA": {
        "short_name": "GOUR MEDICAL",
        "long_name": "Gour Medical SA",
        "summary": "Gour Medical SA engages in the development and commercialization of veterinary drugs. The company develops various medicines and food supplements to enhance the health of mature pets. Its product portfolio includes Gour-153, a pain product; and Gour-419, an atopic dermatitis product. Gour Medical SA was founded in 2014 and is based in Paris, France.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PAR",
        "market": "fr_market",
        "country": "France",
        "state": null,
        "city": "Paris",
        "zipcode": "75001",
        "website": "http://www.gour-medical.com",
        "market_cap": "Nano Cap"
    },
    "MLZ.F": {
        "short_name": "MEDIPHARM LABS CORP.",
        "long_name": "MediPharm Labs Corp.",
        "summary": "MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates, and advance derivative products in Canada and Australia. It formulates, processes, packages, and distributes cannabis extracts and cannabinoid-based products. The company was founded in 2015 and is headquartered in Barrie, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Barrie",
        "zipcode": "L4N 2L1",
        "website": "http://www.medipharmlabs.com",
        "market_cap": "Micro Cap"
    },
    "MMEN.CN": {
        "short_name": "MedMenInc",
        "long_name": "MedMen Enterprises Inc.",
        "summary": "MedMen Enterprises Inc., through its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, distributes, and retails recreational and medicinal cannabis under the [statemade], LuxLyte, and MedMen Red brand names. It operates 25 retail stores in 6 states. MedMen Enterprises Inc. was founded in 2010 and is headquartered in Culver City, California.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "CA",
        "city": "Culver City",
        "zipcode": "90232",
        "website": "http://www.medmen.com",
        "market_cap": "Micro Cap"
    },
    "MMJ.AX": {
        "short_name": "MMJGROUP FPO",
        "long_name": "MMJ Group Holdings Limited",
        "summary": "MMJ Group Holdings Limited operates as a cannabis investment company worldwide. It owns a portfolio of cannabis sector investments. The company was formerly known as MMJ PhytoTech Limited. MMJ Group Holdings Limited was incorporated in 2014 and is based in Sydney, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Sydney",
        "zipcode": "2000",
        "website": "http://www.mmjgh.com.au",
        "market_cap": "Nano Cap"
    },
    "MMJ.CN": {
        "short_name": "MaticaEnterpr",
        "long_name": "Matica Enterprises Inc.",
        "summary": "Matica Enterprises Inc. engages in the medical marijuana business. It offers IONIC MIST, a spray mist that captures and neutralizes cannabis smoke odours. The company was formerly known as Matica Graphite Inc. and changed its name to Matica Enterprises Inc. in July 2014. Matica Enterprises Inc. is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 1Y2",
        "website": "http://www.maticaenterprises.com",
        "market_cap": "Nano Cap"
    },
    "MMJFF": {
        "short_name": "MATICA ENTERPRISES INC",
        "long_name": "Matica Enterprises Inc.",
        "summary": "Matica Enterprises Inc. engages in the medical marijuana business. It offers IONIC MIST, a spray mist that captures and neutralizes cannabis smoke odours. The company was formerly known as Matica Graphite Inc. and changed its name to Matica Enterprises Inc. in July 2014. Matica Enterprises Inc. is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 1Y2",
        "website": "http://www.maticaenterprises.com",
        "market_cap": "Nano Cap"
    },
    "MMJJF": {
        "short_name": "MMJ GROUP HOLDINGS LTD",
        "long_name": "MMJ Group Holdings Limited",
        "summary": "MMJ Group Holdings Limited operates as a cannabis investment company worldwide. It owns a portfolio of cannabis sector investments. The company was formerly known as MMJ PhytoTech Limited. MMJ Group Holdings Limited was incorporated in 2014 and is based in Sydney, Australia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Sydney",
        "zipcode": "2000",
        "website": "http://www.mmjgh.com.au",
        "market_cap": "Nano Cap"
    },
    "MMNFF": {
        "short_name": "MEDMEN ENTERPRISES INC",
        "long_name": "MedMen Enterprises Inc.",
        "summary": "MedMen Enterprises Inc., through its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, distributes, and retails recreational and medicinal cannabis under the [statemade], LuxLyte, and MedMen Red brand names. It operates 25 retail stores in 6 states. MedMen Enterprises Inc. was founded in 2010 and is headquartered in Culver City, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Culver City",
        "zipcode": "90232",
        "website": "http://www.medmen.com",
        "market_cap": "Micro Cap"
    },
    "MNFSF": {
        "short_name": "MANIFESTSEVEN HOLDINGS CORPORAT",
        "long_name": "ManifestSeven Holdings Corporation",
        "summary": "ManifestSeven Holdings Corporation operates an integrated omnichannel platform for legal cannabis, merging compliant distribution with a retail. It owns and operates retail operations located in various metro markets, including brick-and-mortar dispensaries, local on-demand delivery services, e-commerce, and subscription offerings. The company is headquartered in Irvine, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Irvine",
        "zipcode": "92618",
        "website": "http://www.manifest7.com",
        "market_cap": "Nano Cap"
    },
    "MNKKQ": {
        "short_name": "Mallinckrodt plc",
        "long_name": "Mallinckrodt plc",
        "summary": "Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and gastrointestinal products. It offers Acthar Gel, an injectable drug for rheumatoid arthritis, multiple sclerosis, infantile spasms, systemic lupus erythematosus, polymyositis, and others; INOmax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Ofirmev, an acetaminophen injection; Therakos photopheresis, an immunotherapy treatment platform; and Amitiza for constipation. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; StrataGraft, which is in Phase III and II clinical development for the treatment of burns; MNK-6105 and MNK-6106, an ammonia scavenger for the treatment of hepatic encephalopathy, a neuropsychiatric syndrome associated with hyperammonemia; and SLN500, a ribonucleic acid technology therapy. In addition, it offers specialty generic drugs and active pharmaceutical ingredients. The company markets its branded products to physicians, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with Silence Therapeutics plc for the development and commercialization of ribonucleic acid interference drug targets. The company was founded in 1867 and is based in Dublin, Ireland. On October 12, 2020, Mallinckrodt plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Ireland",
        "state": null,
        "city": "Dublin",
        "zipcode": "15",
        "website": "http://www.mallinckrodt.com",
        "market_cap": "Nano Cap"
    },
    "MNZO": {
        "short_name": "MANZO PHARMACEUTIC INC",
        "long_name": "Manzo Pharmaceuticals, Inc.",
        "summary": "Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. is based in Milford, Pennsylvania.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "PA",
        "city": "Milford",
        "zipcode": "18337",
        "website": "http://www.lactofreedom.com",
        "market_cap": "Nano Cap"
    },
    "MO2.F": {
        "short_name": "MEDCOLCANNA ORGANICS",
        "long_name": "Medcolcanna Organics Inc.",
        "summary": "Medcolcanna Organics Inc. operates as a medical cannabis company in Colombia and Switzerland. The company cultivates, produces, and distributes medicinal cannabis and cannabis derived products, including pharmaceutical, cosmetic, and bulk API products. Medcolcanna Organics Inc. is based in Calgary, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2P 0L6",
        "website": "http://medcolcanna.com",
        "market_cap": "Nano Cap"
    },
    "MOB.ST": {
        "short_name": "Moberg Pharma AB",
        "long_name": "Moberg Pharma AB (publ)",
        "summary": "Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products for skin diseases in Sweden, the United States, and internationally. It develops MOB-015, which is under Phase III clinical trial for the treatment of nail fungus treatment; and BUPI, a lozenge with bupivacaine intended for pain relief in association with inflammation and ulceration of the oral mucous membranes. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was founded in 2006 and is headquartered in Bromma, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Bromma",
        "zipcode": "167 51",
        "website": "http://www.mobergpharma.se",
        "market_cap": "Nano Cap"
    },
    "MOJO.CN": {
        "short_name": "MojaveBrands",
        "long_name": "Mojave Brands Inc.",
        "summary": "Mojave Brands Inc. does not have significant operations. Previously, it was engaged in the manufacturing, processing, and sale of cannabis extracts. The company was formerly known as Mojave Jane Brands Inc. and changed its name to Mojave Brands Inc. in March 2020. Mojave Brands Inc. is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 3P3",
        "website": "http://www.mojavejane.com",
        "market_cap": "Nano Cap"
    },
    "MOREPENLAB.NS": {
        "short_name": "MOREPEN LABORATORI",
        "long_name": "Morepen Laboratories Limited",
        "summary": "Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-hypercholesterolemic, anti-diabetic, and anti-hypertensive; and formulations for antibiotics, gastro-intestinal, CNS, ortho and pain, calcium metabolism, respiratory and anti-allergic, and nutraceuticals and vitamins, as well as diabetes and related complications, and cardiology therapy. It also provides blood glucose and pressure monitors, nebulizers, vaporizers, weighing scales, thermometers, pulse oximeters, massagers and heat therapy, hot water bottles, stethoscopes, sphygmomanometers, ultrasonic nebulizers, fetal Doppler, anti-decubitus air mattress, adult diapers, instant dry under mats, and breathable non-woven tapes. In addition, it provides Burnol for burns and cuts; Forever Young that enhances sexual life, stamina, energy, power, and strength; Lemolate Gold for cold relief; Lemolate- Cough Syrup; Fibre-X Sat-Isabgol, a natural laxative product; Fever-X, a fever reducer; Option72, an emergency contraceptive; Dabgel, an antacid; MoreVital+, a dietary supplement; QuickChek, a pregnancy card; Exygra, a sildenafil citrate; facewashes; Itch Beat for itching; and 2 Kool hair oil. Further, the company offers Active Smile, which is Mouthwash; Dr. Morepen Daily, a health supplement; MTP Kit, a contraception pill; VCalci, a calcium tab; Clean & Pure, an intimate hygiene wash; Liv Healthy, a liver tonic; Head-X for headache; Dr. Morepen Aid, an adhesive first aid dressing; Dr. Morepen Buds, an ear cleaning cotton bud; Cold-EX for cold and cough; Paachan-Arishta, an ayurvedic digestive tonic; and adult nasal spray. Additionally, the company is involved in product contract manufacturing and brand sharing businesses. Morepen Laboratories Limited was founded in 1984 and is based in New Delhi, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "New Delhi",
        "zipcode": "110001",
        "website": "http://www.morepen.com",
        "market_cap": "Small Cap"
    },
    "MOTNF": {
        "short_name": "CLEAN POWER CAPITAL CORP",
        "long_name": "Clean Power Capital Corp.",
        "summary": "Clean Power Capital Corp. is a venture capital firm specializing in investments in early stage, buyouts. It prefers to invest in equity, bridge loans, secured loans, unsecured loans, convertible debentures, warrants and options, joint ventures, partnerships, royalties, streaming investments, net profit interests and other hybrid instruments. It focuses its investments in energy sector, oil and gas equipment and commercial aircraft sector. The firm prefers to invest in securities of private and publicly listed entities that are involved in a variety of industries including renewable energy includes hydrogen & fuel cell technologies, wind power, solar power and geothermal power. The firm invests bio-medical, pharmaceutical, and naturopathic sectors, which may include medical or recreational cannabis. The firm prefers to focus on investing in cannabis enterprises. The firm considers investments in North America. The firm does not invest in Canada and United States. The firm takes control position and majority stake in the companies. Clean Power Capital Corp. was founded in 1980 and is headquartered in Vancouver, Canada with additional offices in Hamilton, Bermuda and London, United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1H2",
        "website": "http://www.cleanpower.capital",
        "market_cap": "Micro Cap"
    },
    "MOVE.NE": {
        "short_name": "CLEAN POWER CAPITAL CORP.",
        "long_name": "Clean Power Capital Corp.",
        "summary": "Clean Power Capital Corp. is a venture capital firm specializing in investments in early stage, buyouts. It prefers to invest in equity, bridge loans, secured loans, unsecured loans, convertible debentures, warrants and options, joint ventures, partnerships, royalties, streaming investments, net profit interests and other hybrid instruments. It focuses its investments in energy sector, oil and gas equipment and commercial aircraft sector. The firm prefers to invest in securities of private and publicly listed entities that are involved in a variety of industries including renewable energy includes hydrogen & fuel cell technologies, wind power, solar power and geothermal power. The firm invests bio-medical, pharmaceutical, and naturopathic sectors, which may include medical or recreational cannabis. The firm prefers to focus on investing in cannabis enterprises. The firm considers investments in North America. The firm does not invest in Canada and United States. The firm takes control position and majority stake in the companies. Clean Power Capital Corp. was founded in 1980 and is headquartered in Vancouver, Canada with additional offices in Hamilton, Bermuda and London, United Kingdom.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NEO",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1H2",
        "website": "http://www.cleanpower.capital",
        "market_cap": "Micro Cap"
    },
    "MPXI.CN": {
        "short_name": "MPXIntlCorp",
        "long_name": "MPX International Corporation",
        "summary": "MPX International Corporation, a cannabis company, focuses on the medical and adult-use cannabis markets in Canada and Switzerland. It focuses on producing and distributing three principal types of products, such as cannabis flowers, cannabis extract and related products, and cannabis derivatives under the Strain Rec and Salus Bioharma brands. The company was founded in 2015 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M2N 6P4",
        "website": "http://mpxinternationalcorp.com",
        "market_cap": "Nano Cap"
    },
    "MPXOF": {
        "short_name": "MPX INTERNATIONAL CORPORATION",
        "long_name": "MPX International Corporation",
        "summary": "MPX International Corporation, a cannabis company, focuses on the medical and adult-use cannabis markets in Canada and Switzerland. It focuses on producing and distributing three principal types of products, such as cannabis flowers, cannabis extract and related products, and cannabis derivatives under the Strain Rec and Salus Bioharma brands. The company was founded in 2015 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M2N 6P4",
        "website": "http://mpxinternationalcorp.com",
        "market_cap": "Nano Cap"
    },
    "MRCK.VI": {
        "short_name": "MERCK KGAA",
        "long_name": "MERCK Kommanditgesellschaft auf Aktien",
        "summary": "MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd. and Artios Pharma Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. Merck KG.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VIE",
        "market": "at_market",
        "country": "Germany",
        "state": null,
        "city": "Darmstadt",
        "zipcode": "64293",
        "website": "http://www.merckgroup.com",
        "market_cap": "Large Cap"
    },
    "MRK.DE": {
        "short_name": "MERCK KGAA O.N.",
        "long_name": "MERCK Kommanditgesellschaft auf Aktien",
        "summary": "MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd. and Artios Pharma Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. Merck KG.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "GER",
        "market": "de_market",
        "country": "Germany",
        "state": null,
        "city": "Darmstadt",
        "zipcode": "64293",
        "website": "http://www.merckgroup.com",
        "market_cap": "Large Cap"
    },
    "MRK.F": {
        "short_name": "MERCK KGAA O.N.",
        "long_name": "MERCK Kommanditgesellschaft auf Aktien",
        "summary": "MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd. and Artios Pharma Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. Merck KG.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Darmstadt",
        "zipcode": "64293",
        "website": "http://www.merckgroup.com",
        "market_cap": "Large Cap"
    },
    "MRK.MI": {
        "short_name": "MERCK",
        "long_name": "MERCK Kommanditgesellschaft auf Aktien",
        "summary": "MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd. and Artios Pharma Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. Merck KG.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Germany",
        "state": null,
        "city": "Darmstadt",
        "zipcode": "64293",
        "website": "http://www.merckgroup.com",
        "market_cap": "Large Cap"
    },
    "MRKC.SG": {
        "short_name": "Merck KGaA Nam.-Akt.(Sp.ADRs) 1",
        "long_name": "MERCK Kommanditgesellschaft auf Aktien",
        "summary": "MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd. and Artios Pharma Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. Merck KG.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Darmstadt",
        "zipcode": "64293",
        "website": "http://www.merckgroup.com",
        "market_cap": "Large Cap"
    },
    "MRMD": {
        "short_name": "MARIMED INC",
        "long_name": "MariMed Inc.",
        "summary": "MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. It offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and drink powder mixes under the brand Kalm Fusion; and natural fruit chews under the Betty's Eddies brand, and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "MA",
        "city": "Norwood",
        "zipcode": "02062",
        "website": "http://www.marimedinc.com",
        "market_cap": "Micro Cap"
    },
    "MRRCF": {
        "short_name": "WAYLAND GROUP CORP",
        "long_name": "Wayland Group Corp.",
        "summary": "Wayland Group Corp. produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally. It offers a range of CBD, balanced, and THC strains under the Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann names. The company was founded in 2013 and is headquartered in Oakville, Canada. Wayland Group Corp. is a subsidiary of Maricann Group Inc.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Oakville",
        "zipcode": "L6H 5S9",
        "website": "http://www.waylandgroup.com",
        "market_cap": "Nano Cap"
    },
    "MRV.TO": {
        "short_name": "NUVO PHARMACEUTICALS INC",
        "long_name": "Nuvo Pharmaceuticals Inc.",
        "summary": "Nuvo Pharmaceuticals Inc. provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticarial; Cambia, a nonsteroidal anti-inflammatory drug for migraine; Suvexx/Treximet migraine medicine; NeoVisc viscosupplement for knee osteoarthritis; and Resultz/FullMarks/LAUSBUB for head lice infestations. The company also provides Bezalip SR for patients with high cholesterol or high levels of triglycerides; Proferrin, an iron supplement for the prevention and treatment of iron deficiency; Fiorinal 1 and Fiorinal C1 for the relief of tension-type headaches; Viskazide and Visken antihypertensive agents; Collatamp G for surgical implantation during surgery; PegaLAX, a laxative for the treatment of occasional constipation and irregularity; Mutaflor, a probiotic for the management and relief of chronic constipation and associated abdominal pain and cramps; MoviPrep for the cleansing of the colon in preparation for colonoscopy; Uracyst for mild to severe GAG layer damage of the urinary bladder; and Soriatane to treat psoriasis and other keratinization disorders. In addition, it offers Pennsaid and Pennsaid 2% topical treatments for osteoarthritic pain; Vimovo for relief of arthritis symptoms; SYNERA/RAPYDAN topical patches used to help prevent pain associated with needle sticks and other superficial skin procedures; Yosprala for the prevention of heart attacks and strokes; and Heated Lidocaine/Tetracaine Patch, a topical patch applied prior to painful medical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was founded in 1983 and is headquartered in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5N 6J5",
        "website": "http://www.miravohealthcare.com",
        "market_cap": "Nano Cap"
    },
    "MRVFF": {
        "short_name": "NUVO PHARMACEUTICALS INC",
        "long_name": "Nuvo Pharmaceuticals Inc.",
        "summary": "Nuvo Pharmaceuticals Inc. provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticarial; Cambia, a nonsteroidal anti-inflammatory drug for migraine; Suvexx/Treximet migraine medicine; NeoVisc viscosupplement for knee osteoarthritis; and Resultz/FullMarks/LAUSBUB for head lice infestations. The company also provides Bezalip SR for patients with high cholesterol or high levels of triglycerides; Proferrin, an iron supplement for the prevention and treatment of iron deficiency; Fiorinal 1 and Fiorinal C1 for the relief of tension-type headaches; Viskazide and Visken antihypertensive agents; Collatamp G for surgical implantation during surgery; PegaLAX, a laxative for the treatment of occasional constipation and irregularity; Mutaflor, a probiotic for the management and relief of chronic constipation and associated abdominal pain and cramps; MoviPrep for the cleansing of the colon in preparation for colonoscopy; Uracyst for mild to severe GAG layer damage of the urinary bladder; and Soriatane to treat psoriasis and other keratinization disorders. In addition, it offers Pennsaid and Pennsaid 2% topical treatments for osteoarthritic pain; Vimovo for relief of arthritis symptoms; SYNERA/RAPYDAN topical patches used to help prevent pain associated with needle sticks and other superficial skin procedures; Yosprala for the prevention of heart attacks and strokes; and Heated Lidocaine/Tetracaine Patch, a topical patch applied prior to painful medical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was founded in 1983 and is headquartered in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5N 6J5",
        "website": "http://www.miravohealthcare.com",
        "market_cap": "Nano Cap"
    },
    "MRVT": {
        "short_name": "MIRAVANT MEDICAL TECHNOLOGY",
        "long_name": "Miravant Medical Technologies Inc.",
        "summary": "Miravant Medical Technologies Inc. operates as a pharmaceutical research and development company. The company develops PhotoPoint, a photodynamic therapy that responds to light destroying cancerous cells; and manufactures light producing and light delivery devices. Its products include PHOTREX for the treatment of wet age-related macular degeneration or AMD; MV9411, a photoreactive drug for the treatment of plaque psoriasis; MV0633 for the treatment of atherosclerosis, atherosclerotic vulnerable plaque, and restenosis; MV2101 for the treatment of vascular access graft disease in hemodialysis patients; and MV6401 for the treatment of solid tumors. Miravant Medical Technologies Inc. was formerly known as PDT, Inc. and changed its name to Miravant Medical Technologies Inc. in September 1997. The company was founded in 1989 and is headquartered in Santa Barbara, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Santa Barbara",
        "zipcode": "93117",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "MSVN.CN": {
        "short_name": "Manifest7Co",
        "long_name": "ManifestSeven Holdings Corporation",
        "summary": "ManifestSeven Holdings Corporation operates an integrated omnichannel platform for legal cannabis, merging compliant distribution with a retail. It owns and operates retail operations located in various metro markets, including brick-and-mortar dispensaries, local on-demand delivery services, e-commerce, and subscription offerings. The company is headquartered in Irvine, California.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "CA",
        "city": "Irvine",
        "zipcode": "92618",
        "website": "http://www.manifest7.com",
        "market_cap": "Nano Cap"
    },
    "MVMD.CN": {
        "short_name": "MountainValley",
        "long_name": "Mountain Valley MD Holdings Inc.",
        "summary": "Mountain Valley MD Holdings Inc., through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company. The company engages in the implementation of its Quicksome oral drug formulation and delivery technologies with the intention of licensing to pharmaceutical, vaccine, and nutraceutical third parties. Its Quicksome desiccation technology utilizes advanced liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into highly efficient product formats that are consumed orally. The company applies its Quicksome technology to its work for the oral delivery of vaccines and pharmaceutical drugs, as well as the development of products for pain management, weight loss, energy, focus, sleep, anxiety, and others. Mountain Valley MD Holdings Inc. is headquartered in Vaughan, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Vaughan",
        "zipcode": "L4K 3Y4",
        "website": "http://www.mountainvalleymd.com",
        "market_cap": "Micro Cap"
    },
    "MVMDF": {
        "short_name": "MOUNTAIN VALLEY MD HOLDINGS INC",
        "long_name": "Mountain Valley MD Holdings Inc.",
        "summary": "Mountain Valley MD Holdings Inc., through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company. The company engages in the implementation of its Quicksome oral drug formulation and delivery technologies with the intention of licensing to pharmaceutical, vaccine, and nutraceutical third parties. Its Quicksome desiccation technology utilizes advanced liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into highly efficient product formats that are consumed orally. The company applies its Quicksome technology to its work for the oral delivery of vaccines and pharmaceutical drugs, as well as the development of products for pain management, weight loss, energy, focus, sleep, anxiety, and others. Mountain Valley MD Holdings Inc. is headquartered in Vaughan, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Vaughan",
        "zipcode": "L4K 3Y4",
        "website": "http://www.mountainvalleymd.com",
        "market_cap": "Micro Cap"
    },
    "MVP.AX": {
        "short_name": "MEDICALDEV FPO",
        "long_name": "Medical Developments International Limited",
        "summary": "Medical Developments International Limited manufactures and distributes pharmaceutical and veterinary products, and medical devices. The company operates through three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management for use in home or in hospitals; Penthrox, a prescription only medicine for pain relief; medical devices; and various veterinary anesthetic machines to veterinarians. The company operates in Australia, New Zealand, the United Kingdom, rest of Europe, Canada, the Middle East, Asia, South Africa, North America, and internationally. Medical Developments International Limited was incorporated in 2003 and is headquartered in Scoresby, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Scoresby",
        "zipcode": "3179",
        "website": "http://medicaldev.com",
        "market_cap": "Micro Cap"
    },
    "MXC.AX": {
        "short_name": "MGC PHARMA FPO",
        "long_name": "MGC Pharmaceuticals Limited",
        "summary": "MGC Pharmaceuticals Limited, together with its subsidiaries, produces and supplies phytocannabinoid derived medicines in Australia and Slovenia. It provides pharmaceutical products, such as Tetrinol for the treatment of cachexia; MXOT01GB01 to treat glioblastoma; MXOT02ME01 for the treatment of melanoma cancer; MXOT03PC01 to treat prostate cancer; TopiCann for the topical treatment of eczema and inflamed skin; and InCann, a biactive capsule to treat Chron's and IBS. The company's products under development include CannEpil, which is in Phase IIb clinical trial for the treatment in children and adolescents with refectory epilepsy; CogniCann that is in Phase II clinical trial to treat dementia and Alzheimer's diseases; and ArtemiC, which is in Phase II clinical trial for the treatment COVID-19. It has strategic collaborative partnership agreements Epilepsy Action Australia, Royal Melbourne Institute of Technology, the University of Notre Dame in Western Australia, as well as the National Institute of Biology & University Medical Centre, Ljubljana Slovenia. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is headquartered in West Perth, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "WA",
        "city": "West Perth",
        "zipcode": "6005",
        "website": "http://www.mgcpharma.com.au",
        "market_cap": "Micro Cap"
    },
    "MXC.L": {
        "short_name": "MGC PHARMACEUTICALS LIMITED ORD",
        "long_name": "MGC Pharmaceuticals Limited",
        "summary": "MGC Pharmaceuticals Limited, together with its subsidiaries, produces and supplies phytocannabinoid derived medicines in Australia and Slovenia. It provides pharmaceutical products, such as Tetrinol for the treatment of cachexia; MXOT01GB01 to treat glioblastoma; MXOT02ME01 for the treatment of melanoma cancer; MXOT03PC01 to treat prostate cancer; TopiCann for the topical treatment of eczema and inflamed skin; and InCann, a biactive capsule to treat Chron's and IBS. The company's products under development include CannEpil, which is in Phase IIb clinical trial for the treatment in children and adolescents with refectory epilepsy; CogniCann that is in Phase II clinical trial to treat dementia and Alzheimer's diseases; and ArtemiC, which is in Phase II clinical trial for the treatment COVID-19. It has strategic collaborative partnership agreements Epilepsy Action Australia, Royal Melbourne Institute of Technology, the University of Notre Dame in Western Australia, as well as the National Institute of Biology & University Medical Centre, Ljubljana Slovenia. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is headquartered in West Perth, Australia.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "Australia",
        "state": "WA",
        "city": "West Perth",
        "zipcode": "6005",
        "website": "http://www.mgcpharma.com.au",
        "market_cap": null
    },
    "MYCO.NE": {
        "short_name": "MYDECINE INNOVATIONS GROUP INC.",
        "long_name": "Mydecine Innovations Group Inc.",
        "summary": "Mydecine Innovations Group Inc. operates as a biopharma and life sciences company which focuses on research, development, acceptance, and commercialization of alternative nature-sourced medicine for treating mental health problems. Its mental health solutions focuses on clinical trials focusing on veterans; emergency medical services (EMS); first responders with a PTSD indication; and drug discovery and delivery mechanisms. The company develops digital health solutions, such as digital therapeutics and quantified mental health solutions. Additionally, it engages in the operation of real estate and farm properties in North America. Mydecine has partnership with Applied Pharmaceutical Innovation for drug development and clinical trial programs. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NEO",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1H2",
        "website": "http://www.mydecine.com",
        "market_cap": "Nano Cap"
    },
    "MYCOF": {
        "short_name": "MYDECINE INNOVATIONS GROUP INC",
        "long_name": "Mydecine Innovations Group Inc.",
        "summary": "Mydecine Innovations Group Inc. operates as a biopharma and life sciences company which focuses on research, development, acceptance, and commercialization of alternative nature-sourced medicine for treating mental health problems. Its mental health solutions focuses on clinical trials focusing on veterans; emergency medical services (EMS); first responders with a PTSD indication; and drug discovery and delivery mechanisms. The company develops digital health solutions, such as digital therapeutics and quantified mental health solutions. Additionally, it engages in the operation of real estate and farm properties in North America. Mydecine has partnership with Applied Pharmaceutical Innovation for drug development and clinical trial programs. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1H2",
        "website": "http://www.mydecine.com",
        "market_cap": "Nano Cap"
    },
    "MYHI": {
        "short_name": "MOUNTAIN HIGH ACQUISITIONS",
        "long_name": "Mountain High Acquisitions Corp.",
        "summary": "Mountain High Acquisitions Corp focuses on the acquisition and development of businesses and other assets within the hemp industry. The company is based in Scottsdale, Arizona.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "AZ",
        "city": "Scottsdale",
        "zipcode": "85254",
        "website": "http://www.mountainhighac.com",
        "market_cap": "Nano Cap"
    },
    "MYM.CN": {
        "short_name": "MYM Nutraceutic",
        "long_name": "MYM Nutraceuticals Inc.",
        "summary": "MYM Nutraceuticals Inc. cultivates, processes, and sells cannabis in Canada. The company was formerly known as My Marijuana Canada Inc. and changed its name to MYM Nutraceuticals Inc. in February 2016. MYM Nutraceuticals Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2M6",
        "website": "http://www.mym.ca",
        "market_cap": "Nano Cap"
    },
    "MYMMF": {
        "short_name": "MYM NUTRACEUTICALS INC",
        "long_name": "MYM Nutraceuticals Inc.",
        "summary": "MYM Nutraceuticals Inc. cultivates, processes, and sells cannabis in Canada. The company was formerly known as My Marijuana Canada Inc. and changed its name to MYM Nutraceuticals Inc. in February 2016. MYM Nutraceuticals Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2M6",
        "website": "http://www.mym.ca",
        "market_cap": "Nano Cap"
    },
    "N4P.L": {
        "short_name": "N4 PHARMA PLC ORD 0.4P",
        "long_name": "N4 Pharma Plc",
        "summary": "N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. The company has a research collaboration with Nanomerics Limited to focus on the different formulations of Nuvec delivery system. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "EC3V 0HR",
        "website": "http://www.n4pharma.com",
        "market_cap": null
    },
    "NAB.CN": {
        "short_name": "NabisHldgs",
        "long_name": "Nabis Holdings Inc.",
        "summary": "Nabis Holdings Inc., formerly known as Innovative Properties Inc., is a principal investment firm specializing in cannabis sector investments. It seeks to invest in the United States. It prefers to take majority stake in its portfolio companies and also prefers sellers to take a significant portion of the consideration in the form of equity. Nabis Holdings Inc. was founded in 2002 and is based in Vancouver, Canada, with additional office in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 3V7",
        "website": "http://www.nabisholdings.com",
        "market_cap": "Nano Cap"
    },
    "NANEXA.ST": {
        "short_name": "Nanexa AB",
        "long_name": "Nanexa AB (publ)",
        "summary": "Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "75450",
        "website": "http://www.nanexa.com",
        "market_cap": "Nano Cap"
    },
    "NATCOPHARM.NS": {
        "short_name": "NATCO PHARMA LTD",
        "long_name": "NATCO Pharma Limited",
        "summary": "NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina and CHF, bosentan, pulmonary arterial hypertension, and others. The company markets its products in approximately 40 countries, including India, the United States, and internationally.NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Hyderabad",
        "zipcode": "500034",
        "website": "http://www.natcopharma.co.in",
        "market_cap": "Mid Cap"
    },
    "NATTO.OL": {
        "short_name": "NATTOPHARMA ASA",
        "long_name": "NattoPharma ASA",
        "summary": "As of March 23, 2021, NattoPharma ASA operates as a subsidiary of Compagnie Des Levures Lesaffre SA.",
        "currency": "NOK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "OSL",
        "market": "no_market",
        "country": "Norway",
        "state": null,
        "city": "Oslo",
        "zipcode": "0283",
        "website": "http://www.nattopharma.com",
        "market_cap": "Micro Cap"
    },
    "NBGV": {
        "short_name": "NEWBRIDGE GLOBAL VENTURES INC",
        "long_name": "NewBridge Global Ventures, Inc.",
        "summary": "NewBridge Global Ventures, Inc., through its subsidiaries, cultivates, manufactures, and distributes medical and recreational cannabis products in California. It also offers consulting services to cultivators, processors, and retail brands, as well as engages in the real estate holding business. The company is based in Alameda, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Alameda",
        "zipcode": "94501",
        "website": "http://www.newbridgegv.com",
        "market_cap": "Nano Cap"
    },
    "NCNNF": {
        "short_name": "48NORTH CANNABIS CORP",
        "long_name": "48North Cannabis Corp.",
        "summary": "48North Cannabis Corp. operates as a cannabis company in the health and wellness market in Canada. The company offers bath salts, intimacy oils, flowers, pre-rolls, body cream and oil, vapes, pressed hash, and accessories under 48North, Apothecanna, First Harvest, Avitas, F8, Trail Mix, and Latitude brands. It also provides LAT, a publication and creative platform that empowers women to connect, engage, and learn through their experiences with cannabis. 48North Cannabis Corp. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 1X9",
        "website": "http://www.48nrth.com",
        "market_cap": "Nano Cap"
    },
    "NDVA.V": {
        "short_name": "INDIVA LIMITED",
        "long_name": "Indiva Limited",
        "summary": "Indiva Limited operates as a licensed producer of cannabis products in Canada. It creates premium pre-rolls, flower, capsules, and edible products, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Ruby Cannabis Sugar, Sapphire Cannabis Salt, Artisan Batch, and other powered by INDIVA products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Ottawa",
        "zipcode": "K1S 5N4",
        "website": "http://www.indiva.com",
        "market_cap": "Nano Cap"
    },
    "NDVAF": {
        "short_name": "INDIVA LIMITED",
        "long_name": "Indiva Limited",
        "summary": "Indiva Limited operates as a licensed producer of cannabis products in Canada. It creates premium pre-rolls, flower, capsules, and edible products, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Ruby Cannabis Sugar, Sapphire Cannabis Salt, Artisan Batch, and other powered by INDIVA products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Ottawa",
        "zipcode": "K1S 5N4",
        "website": "http://www.indiva.com",
        "market_cap": "Nano Cap"
    },
    "NECLIFE.NS": {
        "short_name": "NECTAR LIFESCIENCE",
        "long_name": "Nectar Lifesciences Limited",
        "summary": "Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, it provides a range of diagnostics products; and empty hard gelatin capsules. Further, the company menthol crystals, menthol powders and flakes, peppermint oils, dementholized peppermint oils, and menthone; CIS-3 hexenol, CIS-3-hexenol acetate/leaf acetate, and CIS-3-hexenol butyrate; mentha piperita oils, spearmint oils, distilled mentha oils/commint oils, distilled menthofuran, limonene, 3-octanol, terpenes, alpha pinene, beta pinene, 1.8 cineol, and ISO menthol; and menthone glycerol ketal, menthyl acetate, menthyl lactate, terpineol BP/USP/perfumery, pine oils, terpinolene, terpinen 4 ol, terpinyl acetate, lavendor ketone (3-Octanone), 3 menthyl cyclohexenone, and gamma terpinene. Nectar Lifesciences Limited was founded in 1995 and is headquartered in New Delhi, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "New Delhi",
        "zipcode": "110001",
        "website": "http://www.neclife.com",
        "market_cap": "Micro Cap"
    },
    "NEPT": {
        "short_name": "Neptune Wellness Solutions Inc.",
        "long_name": "Neptune Wellness Solutions Inc.",
        "summary": "Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Forest Remedies and, Ocean Remedies, Neptune Wellness, Mood Ring, and OCEANO3 brands. The company offers turnkey product development and supply chain solutions to businesses and government customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It also provides extraction and purification services from cannabis and hemp biomass; raw material sourcing, formulation, quality control, and quality assurance primarily for omega-3 and hemp-derived ingredients under various delivery forms, such as soft gels, capsules, and liquids; and formulation and manufacturing solutions for value added product forms comprising tinctures, sprays, topicals, vapor products, and edibles and beverages. The company has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "state": "QC",
        "city": "Laval",
        "zipcode": "H7T 0A3",
        "website": "http://neptunecorp.com",
        "market_cap": "Micro Cap"
    },
    "NEPT.TO": {
        "short_name": "NEPTUNE WELLNESS SOLUTIONS INC",
        "long_name": "Neptune Wellness Solutions Inc.",
        "summary": "Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Forest Remedies and, Ocean Remedies, Neptune Wellness, Mood Ring, and OCEANO3 brands. The company offers turnkey product development and supply chain solutions to businesses and government customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It also provides extraction and purification services from cannabis and hemp biomass; raw material sourcing, formulation, quality control, and quality assurance primarily for omega-3 and hemp-derived ingredients under various delivery forms, such as soft gels, capsules, and liquids; and formulation and manufacturing solutions for value added product forms comprising tinctures, sprays, topicals, vapor products, and edibles and beverages. The company has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "QC",
        "city": "Laval",
        "zipcode": "H7T 0A3",
        "website": "http://neptunecorp.com",
        "market_cap": "Micro Cap"
    },
    "NEULANDLAB.NS": {
        "short_name": "NEULAND LABORITIE",
        "long_name": "Neuland Laboratories Limited",
        "summary": "Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Hyderabad",
        "zipcode": "500034",
        "website": "http://www.neulandlabs.com",
        "market_cap": "Small Cap"
    },
    "NEUN": {
        "short_name": "NEUROGENESIS",
        "long_name": "Neurogenesis, Inc.",
        "summary": "Neurogenesis, Inc. manufactures and sells nutritional supplements primarily in the United States. The company offers NeuBecalm'd, a nutritional supplement to reduce the effects of acute and chronic stress factors; NeuBecalm'd Chewables that reduces the effects of stress and enhance focus; and NeuRecover, a nutritional support for the natural replenishment of neurotransmitters depleted by the long-term use of alcohol. It also provides NeuReplenish, a nutritional support for restoring and rebuilding healthy brain chemistry that has been altered or depleted by the long-term use of chemical stimulants; NeuRelieve, a nutritional support for restoring and rebuilding healthy brain chemistry that has been altered or depleted by the long-term use of antianxiety drugs, and to be used in conjunction with professional support during the tapering process; and NeuSlim, which aids in the reduction of cravings (or urges) for simple carbohydrates, to reduce excessive appetite in general, and to assist in healthy moderation of nutritional needs. In addition, the company offers NeuBecalm'd/NeuRelieve Combo, a nutritional support for restoring and rebuilding healthy brain chemistry that has been altered or depleted by the prolonged use of prescription pain pills or from the use of opiate drugs, such as heroin or methadone, as well as used in conjunction with professional support during the tapering process. Neurogenesis, Inc. has a research collaboration with the University of Edinburgh for the development of various platform approaches to enable gene therapies. The company was founded in 1984 and is headquartered in League City, Texas.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "TX",
        "city": "League City",
        "zipcode": "77573",
        "website": "http://www.neurogenesis.com",
        "market_cap": "Nano Cap"
    },
    "NGMC": {
        "short_name": "NEXT GENERATION MGMT CORP",
        "long_name": "Next Generation Management Corp.",
        "summary": "Next Generation Management Corp. operates a medical marijuana dispensary in Hollywood, California. It provides dispensary management services to the medical marijuana industry, including site location selection, dispensary build out, staffing, staff and manager training, security services, and financial advice. It also Dispensary Management Service package, a suite of industry specific software that offers seed to sale controls and regulatory agency compliance featuring the BiotrackTHC application suite. The company was formerly known as Next Generation Energy Corp. and changed its name to Next Generation Management Corp. in June 2014. Next Generation Management Corp. was founded in 1980 and is based in Annandale, Virginia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "VA",
        "city": "Annandale",
        "zipcode": "22003",
        "website": "http://www.nextgenmanagementcorp.com",
        "market_cap": "Nano Cap"
    },
    "NGW.CN": {
        "short_name": "NextGreenWave",
        "long_name": "Next Green Wave Holdings Inc.",
        "summary": "Next Green Wave Holdings Inc. cultivates and distributes medicinal and recreational cannabis in California. It is also involved in the processing, production, and packaging of dry flower, cannabis oils, and concentrates. The company offers its products under the Loki the Dog, Carey Hart, King Louie, Sketchy Tank, Junkyard, SD Cannabis, Thorn St. Brewing, Toy Machine Co, and Junkyard brands. The company was formerly known as Crossgate Capital Corporation and changed its name to Next Green Wave Holdings Inc. in August 2018. Next Green Wave Holdings Inc. was incorporated in 2011 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2E9",
        "website": "http://www.nextgreenwave.com",
        "market_cap": "Micro Cap"
    },
    "NHP.V": {
        "short_name": "LUMIERA HEALTH INC",
        "long_name": "Lumiera Health Inc.",
        "summary": "Lumiera Health Inc. develops and commercializes evidence-based botanical products for the healthcare, bio-agriculture, and organic markets in Canada. It is developing botanical based specialty fertilizers for enhancing plant growth and crop yield; botanical agents to prevent and treat fungal infections of plants; oral and topical botanical agents to manage unmet medical needs, such as fungal infections of nails and skin, women's health, dermatology, and sleep; natural bio stimulants, bio fertilizers, and bio pesticides; specialty fertilizers for use in household plants, lawns and golf courses, urban gardens, nurseries, commercial greenhouses, and indoor cannabis growers; and products for acne and wound healing. The company was formerly known as Mondias Natural Products Inc. and changed its name to Lumiera Health Inc. in November 2020. Lumiera Health Inc. is based in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "QC",
        "city": "Saint-Hubert",
        "zipcode": "J3Y 8K5",
        "website": "http://www.lumiera.ca",
        "market_cap": "Nano Cap"
    },
    "NHPHF": {
        "short_name": "LUMIERA HEALTH INC",
        "long_name": "Lumiera Health Inc.",
        "summary": "Lumiera Health Inc. develops and commercializes evidence-based botanical products for the healthcare, bio-agriculture, and organic markets in Canada. It is developing botanical based specialty fertilizers for enhancing plant growth and crop yield; botanical agents to prevent and treat fungal infections of plants; oral and topical botanical agents to manage unmet medical needs, such as fungal infections of nails and skin, women's health, dermatology, and sleep; natural bio stimulants, bio fertilizers, and bio pesticides; specialty fertilizers for use in household plants, lawns and golf courses, urban gardens, nurseries, commercial greenhouses, and indoor cannabis growers; and products for acne and wound healing. The company was formerly known as Mondias Natural Products Inc. and changed its name to Lumiera Health Inc. in November 2020. Lumiera Health Inc. is based in Montreal, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "QC",
        "city": "Saint-Hubert",
        "zipcode": "J3Y 8K5",
        "website": "http://www.lumiera.ca",
        "market_cap": null
    },
    "NLBS": {
        "short_name": "NUTRALIFE BIOSCIENCES INC",
        "long_name": "NutraLife BioSciences, Inc.",
        "summary": "NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil, topical lotions and oils, massage oils, and internal pet products. The company also offers NutraHemp CBD products, including oral sprays, tinctures, pet drops, pain balms, and face creams; and NutraSpray oral spray products for sleep support and weight loss; and an appetite suppressant, as well as dietary and other products, such as sanitizer products. NutraLife BioSciences, Inc. sells its products through nutralifebiosciences.com, as well as through private label distributors, online retailers, and retail outlets. The company was formerly known as NutraFuels, Inc. and changed its name to NutraLife BioSciences, Inc. in March 2019. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Coconut Creek",
        "zipcode": "33073",
        "website": "http://www.nutralifebiosciences.com",
        "market_cap": "Nano Cap"
    },
    "NLTX": {
        "short_name": "Neoleukin Therapeutics, Inc.",
        "long_name": "Neoleukin Therapeutics, Inc.",
        "summary": "Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "WA",
        "city": "Seattle",
        "zipcode": "98102",
        "website": "http://www.neoleukin.com",
        "market_cap": "Small Cap"
    },
    "NLV.CN": {
        "short_name": "NewLeafVentInc",
        "long_name": "New Leaf Ventures Inc",
        "summary": "New Leaf Ventures Inc. focuses on the extraction, production, and processing of cannabis and related products. The company provides dried flower, oil concentrate, vapor, capsules, and wax under the D\u00c3\u0080M\u00c3\u0080 brand; and outdoor flower and non-connoisseur products under the WEED brand. It also licenses its brands, equipment, and facility to a Washington-based Tier 3 producer/processor focused on cultivating, processing, packaging, and distributing cannabis and cannabis related products. The company was incorporated in 2018 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3E8",
        "website": "http://www.newleafventuresinc.com",
        "market_cap": "Nano Cap"
    },
    "NLVVF": {
        "short_name": "NEW LEAF VENTURES INC",
        "long_name": "New Leaf Ventures Inc",
        "summary": "New Leaf Ventures Inc. focuses on the extraction, production, and processing of cannabis and related products. The company provides dried flower, oil concentrate, vapor, capsules, and wax under the D\u00c3\u0080M\u00c3\u0080 brand; and outdoor flower and non-connoisseur products under the WEED brand. It also licenses its brands, equipment, and facility to a Washington-based Tier 3 producer/processor focused on cultivating, processing, packaging, and distributing cannabis and cannabis related products. The company was incorporated in 2018 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3E8",
        "website": "http://www.newleafventuresinc.com",
        "market_cap": "Nano Cap"
    },
    "NMLSF": {
        "short_name": "NOVA MENTIS LIFE SCIENCE CORP",
        "long_name": "Nova Mentis Life Science Corp.",
        "summary": "Nova Mentis Life Science Corp., through its subsidiaries, focuses on developing medicinal psychedelics for neuroinflammatory conditions with a focus on autism spectrum disorder. It is also involved in the research and development of psychedelic medicines for metabolic indications, such as obesity and diabetes. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 0A6",
        "website": "http://www.novamentis.ca",
        "market_cap": "Nano Cap"
    },
    "NMVA.F": {
        "short_name": "CAPTOR CAPITAL CORP.",
        "long_name": "Captor Capital Corp.",
        "summary": "Captor Capital Corp. engages in the manufacture and retail sale of cannabis products in the United States. It operates two dispensaries under the CHAI Cannabis Co. brand in Santa Cruz and Monterey, California, as well as operates an e-commerce site under the CHAI-brand. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. in June 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 1B6",
        "website": "http://captorcapital.com",
        "market_cap": "Nano Cap"
    },
    "NNRX": {
        "short_name": "NUTRANOMICS INC",
        "long_name": "Nutranomics, Inc.",
        "summary": "Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer's blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing System that improves the absorption of nutrients. In addition, it offers educational services, including various types of analyses, trainings, certifications, and group presentations to individuals and industry professionals. The company distributes its products through sales representatives throughout North America and Asia, as well as through retail stores. Nutranomics, Inc. has a strategic partnership with Terra-Formance, LLC. The company was founded in 1995 and is headquartered in Salt Lake City, Utah.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "UT",
        "city": "Salt Lake City",
        "zipcode": "84020",
        "website": "http://www.nutranomics.com",
        "market_cap": "Nano Cap"
    },
    "NOBDF": {
        "short_name": "NORTH BUD FARMS INC",
        "long_name": "North Bud Farms Inc.",
        "summary": "North Bud Farms Inc., through its subsidiaries, focuses on the production of pharmaceutical-grade cannabis and food grade cannabinoid infused inputs for the pharmaceutical and recreational cannabis markets in Canada. The company was incorporated in 2016 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5J 2T3",
        "website": "http://www.northbud.com",
        "market_cap": "Nano Cap"
    },
    "NOUV": {
        "short_name": "NOUVEAU LIFE PHARMACEUTICALS IN",
        "long_name": "Nouveau Life Pharmaceuticals, Inc.",
        "summary": "Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products. It provides natural alternatives and prescription drugs. The company was formerly known as Hybrid Fuels, Inc. and changed its name to Nouveau Life Pharmaceuticals, Inc. in May 2012. Nouveau Life Pharmaceuticals, Inc. was incorporated in 1998 and is based in Ft. Lauderdale, Florida. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Ft. Lauderdale",
        "zipcode": "33301",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "NOVA.CN": {
        "short_name": "NovaMentisLife",
        "long_name": "Nova Mentis Life Science Corp.",
        "summary": "Nova Mentis Life Science Corp., through its subsidiaries, focuses on developing medicinal psychedelics for neuroinflammatory conditions with a focus on autism spectrum disorder. It is also involved in the research and development of psychedelic medicines for metabolic indications, such as obesity and diabetes. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 0A6",
        "website": "http://www.novamentis.ca",
        "market_cap": "Nano Cap"
    },
    "NOVARTIND.NS": {
        "short_name": "NOVARTIS INDIA",
        "long_name": "Novartis India Limited",
        "summary": "Novartis India Limited primarily trades in drugs and pharmaceuticals. The company offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences. It also provides generics medicines for anti-TB, anti-infective, and gynecology; and tyrosine kinase inhibitor for cancer under Glive brand name, as well as eye care products. The company offers central nervous system products under the Tegrital and Exelon brand name; pain and Inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic Sandimmun, and Neoral brand names. In addition, it provides consignment, clinical research support, and field force support services. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400051",
        "website": "http://www.novartis.in",
        "market_cap": "Micro Cap"
    },
    "NPPNY": {
        "short_name": "NIPPON SHINYAKU CO",
        "long_name": "Nippon Shinyaku Co., Ltd.",
        "summary": "Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Switzerland, and internationally. The company operates through Pharmaceuticals and Functional Food segments. It offers drugs for urological diseases, inflammation and allergies, hematologic malignancies, cardiovascular and metabolic diseases, gastrointestinal disorders, and other diseases. The company's products include Zalutia for urinary disorder caused by benign prostatic; Eviprostat for prostatic hypertrophy; Bladderon for pollakisuria; Estracyt for prostate cancer; Cialis for erectile dysfunction; Vidaza for myelodysplastic syndrome; Cylocide for solid tumor and acute leukemia; CylocideN for relapsed and refractory acute leukemia and malignant lymphoma; Gazyva for humanized anti-CD20 monoclonal antibody; Defiterio sinusoidal obstruction syndrome; and Trisenox and Amnolake for relapsed and refractory acute promyelocytic leukemia. Nippon Shinyaku Co., Ltd.'s products also comprise Uptravi, Adcirca, and Opsumit for pulmonary arterial hypertension; VILTEPSO for muscular dystrophy; Lunabel LD and Lunabel ULD for dysmenorrhea; Erizas, a dry powder inhaler solution for allergic rhinitis; Azunol Gargle liquid, a gargling solution containing azulene; Isobide for oral osmotic diuresis/meniere's disease; Cephadol for vertigo; Livostin for allergic rhinitis and conjunctivitis; Regtect for maintaining alcohol abstinence; and Onetram and Tramal for cancer and chronic pain. In addition, it researches, develops, and markets drugs in the areas of gynecology, otorhinolaryngology, and orthopedics. Further, the company provides functional foods, such as health food ingredients, preservatives, protein preparations, supplements, and spice and condiments. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Japan",
        "state": null,
        "city": "Kyoto",
        "zipcode": "601-8550",
        "website": "http://www.nippon-shinyaku.co.jp",
        "market_cap": "Mid Cap"
    },
    "NRTH.V": {
        "short_name": "48NORTH CANNABIS CORP",
        "long_name": "48North Cannabis Corp.",
        "summary": "48North Cannabis Corp. operates as a cannabis company in the health and wellness market in Canada. The company offers bath salts, intimacy oils, flowers, pre-rolls, body cream and oil, vapes, pressed hash, and accessories under 48North, Apothecanna, First Harvest, Avitas, F8, Trail Mix, and Latitude brands. It also provides LAT, a publication and creative platform that empowers women to connect, engage, and learn through their experiences with cannabis. 48North Cannabis Corp. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 1X9",
        "website": "http://www.48nrth.com",
        "market_cap": "Nano Cap"
    },
    "NRXCF": {
        "short_name": "NEUTRISCI INTL INC",
        "long_name": "NeutriSci International Inc.",
        "summary": "NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada. Its products include Neuenergy, an energy chewable tablet that provides focus and mental clarity; and BluScience, a nutraceutical product. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with Cryopharm Corporation and Nutritional High International Inc. NeutriSci International Inc. was founded in 2009 and is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2G 4X7",
        "website": "http://www.neutrisci.com",
        "market_cap": "Nano Cap"
    },
    "NSVGF": {
        "short_name": "NASS VALLEY GATEWAY LTD.",
        "long_name": "Nass Valley Gateway Ltd.",
        "summary": "Nass Valley Gateway Ltd. operates as a healthcare company in the United States and internationally. It develops and sells hemp based cannabidiol (CBD) products without tetrahydrocannabinol content for internal use, including CBD infused skin, bath, and body care products. The company is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6B 2Z4",
        "website": "http://www.nassvalleygateway.com",
        "market_cap": "Micro Cap"
    },
    "NTU.F": {
        "short_name": "NEPTUNE WELLNESS SOL.",
        "long_name": "Neptune Wellness Solutions Inc.",
        "summary": "Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Forest Remedies and, Ocean Remedies, Neptune Wellness, Mood Ring, and OCEANO3 brands. The company offers turnkey product development and supply chain solutions to businesses and government customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It also provides extraction and purification services from cannabis and hemp biomass; raw material sourcing, formulation, quality control, and quality assurance primarily for omega-3 and hemp-derived ingredients under various delivery forms, such as soft gels, capsules, and liquids; and formulation and manufacturing solutions for value added product forms comprising tinctures, sprays, topicals, vapor products, and edibles and beverages. The company has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "QC",
        "city": "Laval",
        "zipcode": "H7T 0A3",
        "website": "http://neptunecorp.com",
        "market_cap": "Micro Cap"
    },
    "NU.V": {
        "short_name": "NEUTRISCI INTERNATIONAL INC",
        "long_name": "NeutriSci International Inc.",
        "summary": "NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada. Its products include Neuenergy, an energy chewable tablet that provides focus and mental clarity; and BluScience, a nutraceutical product. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with Cryopharm Corporation and Nutritional High International Inc. NeutriSci International Inc. was founded in 2009 and is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2G 4X7",
        "website": "http://www.neutrisci.com",
        "market_cap": "Nano Cap"
    },
    "NUGS": {
        "short_name": "CANNABIS STRATEGIC VENTURES",
        "long_name": "Cannabis Strategic Ventures",
        "summary": "Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Los Angeles",
        "zipcode": "90014",
        "website": "http://www.cannabisstrategic.com",
        "market_cap": "Nano Cap"
    },
    "NUNZ": {
        "short_name": "NUNZIA PHARMACEUTICAL CORPORATI",
        "long_name": "Nunzia Pharmaceutical Corporation",
        "summary": "Nunzia Pharmaceutical Corporation operates as a pharmaceutical and nutraceutical company. It owns the right to manufacture, market, and distribute a drug, NUNZIA that treats autism, fragile X, ADHD, and PTSD. The company was founded in 1986 and is based in Long Beach, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Long Beach",
        "zipcode": "90813",
        "website": "http://www.nunziapharma.com",
        "market_cap": "Small Cap"
    },
    "NVG.CN": {
        "short_name": "NassValley",
        "long_name": "Nass Valley Gateway Ltd.",
        "summary": "Nass Valley Gateway Ltd. operates as a healthcare company in the United States and internationally. It develops and sells hemp based cannabidiol (CBD) products without tetrahydrocannabinol content for internal use, including CBD infused skin, bath, and body care products. The company is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6B 2Z4",
        "website": "http://www.nassvalleygateway.com",
        "market_cap": "Nano Cap"
    },
    "NWPN": {
        "short_name": "NOW CORPORATION",
        "long_name": "The Now Corporation",
        "summary": "The NOW Corporation, a development stage company, operates as an energy development and production company. The company engages in the ownership and operation of 250 KW wind turbine; refurbishment of existing domestic stripper oil wells; and farming, harvesting, and manufacture of hemp products. The company was founded in 1993 and is headquartered in Portland, Oregon.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "OR",
        "city": "Portland",
        "zipcode": "97230",
        "website": "http://www.thenowcorporation.net",
        "market_cap": "Nano Cap"
    },
    "NWYU": {
        "short_name": "NEW YOU INC",
        "long_name": "New You Inc.",
        "summary": "New You, Inc., through its subsidiary, New You LLC, develops and markets cannabidiol (CBD) hemp oil-based products. The company offers DROPS beverage or liquid CBD products; CB2 & CBD 2 Plus, a multi spectrum hemp-extracted CBD and beta-caryophyllene; Drops for pets; Caffe Canna, an organic cannabinoid-infused non-GMO dark roast coffee; and ABSORB, a root and rice flour veggie capsule. It also provides RELEASE; Drops FX, a blend of CBD and Vitamins B3, B6, B9, and B12 for use in drink or liquid; and Drops FX Sleep, a blend of CBD, gamma-amino butyric acid, melatonin, and valerian root; NanoX, a water soluble full spectrum DBD made with Purified Water; and The Cream, a topical skin cream. The company markets and sells its products through multi-level marketing and direct sales force to independent business owners. New You, Inc. is based in Carlsbad, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Carlsbad",
        "zipcode": "92010",
        "website": "http://newyoupro.com",
        "market_cap": "Nano Cap"
    },
    "NXEN": {
        "short_name": "NEXIEN BIOPHARMA INC",
        "long_name": "Nexien BioPharma, Inc.",
        "summary": "Nexien BioPharma, a pharmaceutical company, engages in the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways to address a range of medical conditions and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CO",
        "city": "Glendale",
        "zipcode": "80246",
        "website": "http://www.nexienbiopharma.com",
        "market_cap": "Nano Cap"
    },
    "NXGB": {
        "short_name": "NXGEN BRANDS INC",
        "long_name": "NxGen Brands Inc.",
        "summary": "NxGen Brands Inc., doing business as, LeafyWell, engages in manufacturing, distributing, and marketing various cannabidiol (CBD) supplements. It focuses on offering CBD and hemp derived gummies, oils, vape liquids, pet treats, and other products. The company is based in Davie, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Davie",
        "zipcode": "33314",
        "website": "http://www.leafywell.com",
        "market_cap": null
    },
    "NXGWF": {
        "short_name": "NEXT GREEN WAVE HOLDINGS INC",
        "long_name": "Next Green Wave Holdings Inc.",
        "summary": "Next Green Wave Holdings Inc. cultivates and distributes medicinal and recreational cannabis in California. It is also involved in the processing, production, and packaging of dry flower, cannabis oils, and concentrates. The company offers its products under the Loki the Dog, Carey Hart, King Louie, Sketchy Tank, Junkyard, SD Cannabis, Thorn St. Brewing, Toy Machine Co, and Junkyard brands. The company was formerly known as Crossgate Capital Corporation and changed its name to Next Green Wave Holdings Inc. in August 2018. Next Green Wave Holdings Inc. was incorporated in 2011 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2E9",
        "website": "http://www.nextgreenwave.com",
        "market_cap": "Micro Cap"
    },
    "NXS.AX": {
        "short_name": "NEXTSCIENC FPO",
        "long_name": "Next Science Limited",
        "summary": "Next Science Limited, a medical technology company, researches, develops, and commercializes technologies to eradicate issues in human health caused by biofilms. The company develops its products using its Xbio Technology platform. It offers SURGX, an antimicrobial gel designed to reduce surgical site and post-surgical infections; and BACTISURE, a surgical lavage that is used to wash out the surgery site and Intramedullary canal. The company also provides BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site and post-operative infections. It has strategic partnerships with Montana State University Center for Biofilm Engineering, Mayo Clinic, Texas Tech University Clinical Research Institute, Southwest Regional Wound Care Center, University of Florida Department of Otolaryngology, and Jacksonville Center for Clinical Research. Next Science Limited has operations in the United States and Australia. The company was founded in 2012 and is headquartered in Chatswood, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Chatswood",
        "zipcode": "2067",
        "website": "http://www.nextscience.com",
        "market_cap": "Micro Cap"
    },
    "NXSCF": {
        "short_name": "NEXT SCIENCE LTD",
        "long_name": "Next Science Limited",
        "summary": "Next Science Limited, a medical technology company, researches, develops, and commercializes technologies to eradicate issues in human health caused by biofilms. The company develops its products using its Xbio Technology platform. It offers SURGX, an antimicrobial gel designed to reduce surgical site and post-surgical infections; and BACTISURE, a surgical lavage that is used to wash out the surgery site and Intramedullary canal. The company also provides BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site and post-operative infections. It has strategic partnerships with Montana State University Center for Biofilm Engineering, Mayo Clinic, Texas Tech University Clinical Research Institute, Southwest Regional Wound Care Center, University of Florida Department of Otolaryngology, and Jacksonville Center for Clinical Research. Next Science Limited has operations in the United States and Australia. The company was founded in 2012 and is headquartered in Chatswood, Australia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Chatswood",
        "zipcode": "2067",
        "website": "http://www.nextscience.com",
        "market_cap": "Micro Cap"
    },
    "NXTG.TA": {
        "short_name": "NEXTAGE THERAPEUTI",
        "long_name": "Nextage Therapeutics Ltd",
        "summary": "Nextage Therapeutics Ltd develops and commercializes in-vitro cancer diagnostic products and solutions worldwide. It offers CellDetect, a diagnostic platform for early cancer detection, including bladder cancer, cervical cancer, and prostate cancer. The company also provides BRONJ Test, a test for bisphosphonate-related osteonecrosis of the jaw. In addition, it offers gene expression, and biomarker and histochemical assays for early cancer detection and personalized medicine. Further, the company provides diagnostic solutions for multiple cancer diagnostic applications. The company was formerly known as Micromedic Technologies Ltd and changed its name to Nextage Therapeutics Ltd in August 2020. Nextage Therapeutics Ltd is based in Tel Aviv, Israel.",
        "currency": "ILA",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TLV",
        "market": "il_market",
        "country": "Israel",
        "state": null,
        "city": "Tel Aviv",
        "zipcode": "6158101",
        "website": "http://www.m-medic.com",
        "market_cap": null
    },
    "NZCA.F": {
        "short_name": "PROVEXIS PLC  LS-,001",
        "long_name": "Provexis plc",
        "summary": "Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Reading",
        "zipcode": "RG1 1AZ",
        "website": "http://www.provexis.org",
        "market_cap": "Nano Cap"
    },
    "O1GA.F": {
        "short_name": "THE GREEN ORG.DUTCH.HLDGS",
        "long_name": "The Green Organic Dutchman Holdings Ltd.",
        "summary": "The Green Organic Dutchman Holdings Ltd., through its subsidiaries, produces and sells organic cannabis in Canada. It offers organic cannabis products, such as cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis to retailers or distributors, and federal licensed entities. The Green Organic Dutchman Holdings Ltd. was incorporated in 2016 and is headquartered in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L4V 1E3",
        "website": "http://www.tgod.ca",
        "market_cap": "Micro Cap"
    },
    "O8Z3.F": {
        "short_name": "SONOMA PHARMAC.  DL-,0001",
        "long_name": "Sonoma Pharmaceuticals, Inc.",
        "summary": "Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, a hypochlorous acid (HOCl) based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a product indicated to promote healing through the management of new and old scars resulting from surgical procedures and trauma wounds or burns; SebuDerm, a product indicated to manage and relieve the burning, itching, pain, and distraction associated with seborrhea and seborrheic dermatitis; and Ceramax, a Lipogrid based skin barrier cream for management of dry itchy skin, minor skin irritations, rashes, and inflammation caused by various skin conditions, as well as Loyon for the management of skin scaling. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a line of products designed to stimulate expedited healing by targeting various pathogens, as well as antibiotic-resistant strains that slow natural healing of wounds. In addition, the company offers MicrocynAH and MicrocynVS, which are HOCl-based solutions designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Pediacyn, Epicyn, Gramaderm, and Microdacyn for dermatoses, scar management, and acne; and Sinudox for nasal irrigation, including moistening of cuts, abrasions, and lacerations located in the nasal cavity. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "GA",
        "city": "Woodstock",
        "zipcode": "30102",
        "website": "http://www.sonomapharma.com",
        "market_cap": "Nano Cap"
    },
    "OASM.ST": {
        "short_name": "Oasmia Pharmaceutical AB",
        "long_name": "Oasmia Pharmaceutical AB (publ)",
        "summary": "Oasmia Pharmaceutical AB (publ) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. It focuses on manufacturing formulations based on cytostatics. The company offers Apealea/Paclical for the treatment of ovarian cancer. Its products portfolio includes Docetaxel micellar, a patented formulation that combines XR-17 with docetaxel that has completed pre-clinical trial for the treatment of prostate cancer; and Cantrixil, which has completed Phase I clinical trial for the treatment of ovarian cancer. The company also provides combination therapies, such as XR-19 for various forms of cancer, including ovarian, first-line breast, prostate, and lung cancer. In addition, its animal health product portfolio includes Paccal Vet, a patented formulation of paclitaxel for the treatment of mammary carcinoma; and Doxophos Vet, a patented formulation of doxorubicin for the treatment of lymphoma. Oasmia Pharmaceutical AB (publ) was incorporated in 1988 and is headquartered in Uppsala, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "752 28",
        "website": "http://www.oasmia.com",
        "market_cap": "Micro Cap"
    },
    "OASMY": {
        "short_name": "OASMIA PHARMACEUTICAL AB SPON A",
        "long_name": "Oasmia Pharmaceutical AB (publ)",
        "summary": "Oasmia Pharmaceutical AB (publ) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. It focuses on manufacturing formulations based on cytostatics. The company offers Apealea/Paclical for the treatment of ovarian cancer. Its products portfolio includes Docetaxel micellar, a patented formulation that combines XR-17 with docetaxel that has completed pre-clinical trial for the treatment of prostate cancer; and Cantrixil, which has completed Phase I clinical trial for the treatment of ovarian cancer. The company also provides combination therapies, such as XR-19 for various forms of cancer, including ovarian, first-line breast, prostate, and lung cancer. In addition, its animal health product portfolio includes Paccal Vet, a patented formulation of paclitaxel for the treatment of mammary carcinoma; and Doxophos Vet, a patented formulation of doxorubicin for the treatment of lymphoma. Oasmia Pharmaceutical AB (publ) was incorporated in 1988 and is headquartered in Uppsala, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "752 28",
        "website": "http://www.oasmia.com",
        "market_cap": "Micro Cap"
    },
    "OFSA3.SA": {
        "short_name": "OUROFINO S/AON      NM",
        "long_name": "Ouro Fino Sa\u00fade Animal Participa\u00e7\u00f5es S.A.",
        "summary": "Ouro Fino Sa\u00c3\u00bade Animal Participa\u00c3\u00a7\u00c3\u00b5es S.A., together with its subsidiaries, operates in the animal health industry primarily in Brazil. The company operates through Production Animals, Companion Animals, and International Operations segments. It engages in the manufacture and sale of veterinary products, vaccines, and other products comprising anti-inflammatories, antibiotics, anticoccidials, anti-mastitis, ectoparasiticides, endectocides, endoparasiticides, hemoparasiticides, inoculants, therapeutics, and products for cattle, pigs, poultry, sheep, horses, and goats; and veterinary solutions, such as anesthetics, sedatives, anti-inflammatory, antibiotic, antimicrobial, dermatological, ectoparasiticide, endoparasiticide, dermocosmetic, and otological products for dogs and cats. The company also offers vaccines and other veterinary products for production and companion animals. The company was formerly known as A.H.N.S.P.E. Empreendimentos e Participa\u00c3\u00a7\u00c3\u00b5es S.A. Ouro Fino Sa\u00c3\u00bade Animal Participa\u00c3\u00a7\u00c3\u00b5es S.A. was incorporated in 1987 and is headquartered in Cravinhos, Brazil.",
        "currency": "BRL",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SAO",
        "market": "br_market",
        "country": "Brazil",
        "state": "SP",
        "city": "Cravinhos",
        "zipcode": "14140-000",
        "website": "http://www.ourofinosaudeanimal.com",
        "market_cap": "Small Cap"
    },
    "OGI": {
        "short_name": "Organigram Holdings Inc.",
        "long_name": "OrganiGram Holdings Inc.",
        "summary": "Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "state": "NB",
        "city": "Moncton",
        "zipcode": "E1E 3X3",
        "website": "http://www.organigram.ca",
        "market_cap": "Small Cap"
    },
    "OGI.TO": {
        "short_name": "ORGANIGRAM HOLDINGS INC",
        "long_name": "OrganiGram Holdings Inc.",
        "summary": "Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "NB",
        "city": "Moncton",
        "zipcode": "E1E 3X3",
        "website": "http://www.organigram.ca",
        "market_cap": "Small Cap"
    },
    "OILFF": {
        "short_name": "NEXTLEAF SOLUTIONS LTD",
        "long_name": "Nextleaf Solutions Ltd.",
        "summary": "Nextleaf Solutions Ltd., a cannabis extraction technology company, develops and licenses technology for the extraction, distillation, and formulation of cannabinoids in Canada. It also extracts, distills, purifies, delivers, and wholesales CBD oils and THC cannabinoid ingredients; researches and develops cannabis infused products, vapes, ingestible concentrates, and specialty extracts; and provides extraction services. The company was founded in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6B 1A4",
        "website": "http://www.nextleafsolutions.com",
        "market_cap": "Nano Cap"
    },
    "OILS.CN": {
        "short_name": "NextleafSolns",
        "long_name": "Nextleaf Solutions Ltd.",
        "summary": "Nextleaf Solutions Ltd., a cannabis extraction technology company, develops and licenses technology for the extraction, distillation, and formulation of cannabinoids in Canada. It also extracts, distills, purifies, delivers, and wholesales CBD oils and THC cannabinoid ingredients; researches and develops cannabis infused products, vapes, ingestible concentrates, and specialty extracts; and provides extraction services. The company was founded in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6B 1A4",
        "website": "http://www.nextleafsolutions.com",
        "market_cap": "Nano Cap"
    },
    "OLF1R.RG": {
        "short_name": "Olainfarm",
        "long_name": "AS Olainfarm",
        "summary": "AS Olainfarm manufactures and distributes chemical and pharmaceutical products in Latvia. The company operates through five segments: Medicine Production, Wholesale, Retail, Compression Materials, and Other. It provides over the counter and prescription medicines, including anti-allergy, anti-inflammatory and analgesic, antibacterial, common cold, digestive system, metabolic, antifungal, and antiviral, as well as medicines for cardiovascular health, and digestive and nervous systems; and food supplements. The company also offers active pharmaceutical ingredients (APIs) and intermediates; pharmacovigilance services for patients, physicians, and pharmacists; and QC/QA, regulatory, APIs and intermediates development, final dosage forms development, and contract manufacturing services. In addition, it engages in the sale of medicine and other products to retailers; operation of a pharmacy chain under the Latvijas Aptieka name; production and sale of elastic and compression materials, dietary supplements, herbal infusions, and eco-cosmetics; and provision of travelling, marketing, and public services. The company also exports its products to approximately 60 countries, including the Baltics, Russia, other CIS countries, Europe, Asia, North America, and Australia. AS Olainfarm was founded in 1972 and is based in Olaine, Latvia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "RIS",
        "market": "rg_market",
        "country": "Latvia",
        "state": null,
        "city": "Olaine",
        "zipcode": "2114",
        "website": "http://lv.olainfarm.com",
        "market_cap": "Micro Cap"
    },
    "OMID": {
        "short_name": "OMID HLDGS INC",
        "long_name": "OMID Holdings, Inc.",
        "summary": "OMID Holdings, Inc., a health and wellness company, engages in the manufacture and sale of CBD-based products. The company is based in Phillipsburg, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "Phillipsburg",
        "zipcode": null,
        "website": "http://omidholdingsinc.com",
        "market_cap": null
    },
    "OPTN": {
        "short_name": "OptiNose, Inc.",
        "long_name": "OptiNose, Inc.",
        "summary": "OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase 3b clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "PA",
        "city": "Yardley",
        "zipcode": "19067",
        "website": "http://www.optinose.com",
        "market_cap": "Micro Cap"
    },
    "ORCD.CN": {
        "short_name": "OrchidVentInc",
        "long_name": "Orchid Ventures, Inc.",
        "summary": "Orchid Ventures, Inc. engages in the development, manufacturing, branding, and distribution of cannabis vape products in North America. The company provides cannabis vapor devices, such as kits and cartridges. It offers its products through approximately 200 dispensaries across California and Oregon. The company also licenses its brand and proprietary hardware to licensed manufacturers and distributors. In addition, it designs and sells proprietary and patent pending hardware delivery systems to the Cannabis and CBD industries. Orchid Ventures, Inc. is headquartered in Irvine, California.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "WA",
        "city": "Vancouver",
        "zipcode": "98660",
        "website": "http://www.orchidessentials.com",
        "market_cap": "Nano Cap"
    },
    "ORCHPHARMA.NS": {
        "short_name": "Orchid Pharma Limited",
        "long_name": "Orchid Pharma Limited",
        "summary": "Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of bulk actives, formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company also provides anti-infectives, anti-inflammatory, central nervous system, cardio vascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was founded in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited is a subsidiary of Dhanuka Laboratories Limited.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Chennai",
        "zipcode": "600034",
        "website": "http://www.orchidpharma.com",
        "market_cap": "Small Cap"
    },
    "ORGO": {
        "short_name": "Organogenesis Holdings Inc.",
        "long_name": "Organogenesis Holdings Inc.",
        "summary": "Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic allograft wound covering and surgical barrier for application in the care of chronic and acute wounds or surgical implantation in spine, orthopedic, and sports medicine applications; Apligraf, a bioengineered bi-layered skin substitute for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft, a dermal substitute for the treatment of DFUs; NuShield, a dehydrated placental tissue wound covering and surgical barrier applied to the target tissue to support native healing; and PuraPly Antimicrobial, an antimicrobial barrier skin substitute to treat chronic and acute wounds. Its surgical and sports medicine products comprise NuCel, a surgically implanted allograft used primarily in spinal and orthopedic surgical applications; ReNu, a cryopreserved suspension used to support healing of soft tissues; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company's pipeline products include PuraPly XT and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; Novachor, a chorionic membrane wound covering; TransCyte, a bioengineered tissue for the treatment of partial thickness burns; and Gintuit, a bioengineered bi-layered living cellular tissue for the treatment of mucogingival conditions in adults. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales force and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "MA",
        "city": "Canton",
        "zipcode": "02021",
        "website": "http://organogenesis.com",
        "market_cap": "Mid Cap"
    },
    "ORO.F": {
        "short_name": "CHOOM HOLDINGS INC.",
        "long_name": "Choom Holdings Inc.",
        "summary": "Choom Holdings Inc., through its subsidiaries, engages in the retail of cannabis. As of June 30, 2020, the company operates two medical and two coaching clinics under the name Concord Medical Centre; and 13 retail stores. The company was formerly known as Standard Graphite Corporation and changed its name to Choom Holdings Inc. in November 2017. Choom Holdings Inc. was incorporated in 2006 and is based in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6J 1T5",
        "website": "http://choomholdings.ca",
        "market_cap": "Nano Cap"
    },
    "ORTINLAB.NS": {
        "short_name": "Ortin Laboratories Ltd",
        "long_name": "Ortin Laboratories Limited",
        "summary": "Ortin Laboratories Limited manufactures and trades in pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti biotics-quinolones, anti biotic-pencillins, cephalosporins, and macrolides; and anti anginal and cardio vascular, and antifungal products. The company's formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium preparations, iron preparations, anti arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti retroviral products. In addition, it provides active pharmaceutical ingredient (API) intermediates comprising anti retro viral, anti diabetics, analgesics and antipyretics, anti biotic, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company offers services in the areas of process development, process characterization, analytical research and development, assay development, and product characterization; and diagnostic services, including development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. Ortin Laboratories Limited was founded in 1986 and is based in Hyderabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Hyderabad",
        "zipcode": "500 027",
        "website": "http://www.ortinlabsindia.com",
        "market_cap": "Nano Cap"
    },
    "ORVRD": {
        "short_name": "ORCHID VENTURES INC",
        "long_name": "Orchid Ventures, Inc.",
        "summary": "Orchid Ventures, Inc. engages in the development, manufacturing, branding, and distribution of cannabis vape products in North America. The company provides cannabis vapor devices, such as kits and cartridges. It offers its products through approximately 200 dispensaries across California and Oregon. The company also licenses its brand and proprietary hardware to licensed manufacturers and distributors. In addition, it designs and sells proprietary and patent pending hardware delivery systems to the Cannabis and CBD industries. Orchid Ventures, Inc. is headquartered in Irvine, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "WA",
        "city": "Vancouver",
        "zipcode": "98660",
        "website": "http://www.orchidessentials.com",
        "market_cap": "Nano Cap"
    },
    "ORX.ST": {
        "short_name": "Orexo AB",
        "long_name": "Orexo AB (publ)",
        "summary": "Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar, for the treatment of short-term insomnia. The company's development products comprise OX124, a medication for naloxone rescue; OX125, a medication for nalmefene rescue; and OX338 sublingual tablet formulation of ketorolac for treatment of moderate to severe pain. It is also developing OX-MPI program for the treatment of microvascular diseases in chronic inflammatory conditions. The company's digital therapies comprise deprexis therapy for the treatment of mild to severe depression; vorvida for alcohol use disorder; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "754 50",
        "website": "http://www.orexo.com",
        "market_cap": "Micro Cap"
    },
    "ORXOY": {
        "short_name": "OREXO AB",
        "long_name": "Orexo AB (publ)",
        "summary": "Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar, for the treatment of short-term insomnia. The company's development products comprise OX124, a medication for naloxone rescue; OX125, a medication for nalmefene rescue; and OX338 sublingual tablet formulation of ketorolac for treatment of moderate to severe pain. It is also developing OX-MPI program for the treatment of microvascular diseases in chronic inflammatory conditions. The company's digital therapies comprise deprexis therapy for the treatment of mild to severe depression; vorvida for alcohol use disorder; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Sweden",
        "state": null,
        "city": "Uppsala",
        "zipcode": "754 50",
        "website": "http://www.orexo.com",
        "market_cap": "Micro Cap"
    },
    "OVAT.CN": {
        "short_name": "OvationScience",
        "long_name": "Ovation Science Inc.",
        "summary": "Ovation Science Inc. engages in the production of cannabis or hemp products in Canada. The company's Invisicare is a patented drug delivery technology for use in topical and transdermal skin products containing hemp seed oil and cannabis products under the Ovation brand. It holds sublicenses for cannabis based products in Canada and in the United States; and Lighthouse for licensed dispensaries in the United States. The company was founded in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2T6",
        "website": "http://ovationscience.com",
        "market_cap": "Nano Cap"
    },
    "OVATF": {
        "short_name": "OVATION SCIENCE INC",
        "long_name": "Ovation Science Inc.",
        "summary": "Ovation Science Inc. engages in the production of cannabis or hemp products in Canada. The company's Invisicare is a patented drug delivery technology for use in topical and transdermal skin products containing hemp seed oil and cannabis products under the Ovation brand. It holds sublicenses for cannabis based products in Canada and in the United States; and Lighthouse for licensed dispensaries in the United States. The company was founded in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2T6",
        "website": "http://ovationscience.com",
        "market_cap": "Nano Cap"
    },
    "OWCP": {
        "short_name": "OWC PHARMACEUTICAL RESEARCH COR",
        "long_name": "OWC Pharmaceutical Research Corp.",
        "summary": "OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. The company is also involved in developing cannabis soluble tablet delivery system. In addition, it provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations. The company was formerly known as Dynamic Applications Corp. and changed its name to OWC Pharmaceutical Research Corp. in December 2014. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Ramat Gan, Israel.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Israel",
        "state": null,
        "city": "Ramat Gan",
        "zipcode": "5257334",
        "website": "http://www.owcpharma.com",
        "market_cap": "Nano Cap"
    },
    "OWPC": {
        "short_name": "ONE WORLD PHARMA INC",
        "long_name": "One World Pharma, Inc.",
        "summary": "One World Pharma, Inc. focuses on producing and manufacturing raw cannabis and hemp plant ingredients for medical and industrial uses worldwide. It intends to cultivate, process, and supply crude cannabis oil, distillate, and isolate to customers' specification, as well as hemp plant biomass. The company was founded in 2017 and is headquartered in Las Vegas, Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89118",
        "website": "http://www.oneworldpharma.com",
        "market_cap": "Nano Cap"
    },
    "P1RG34.SA": {
        "short_name": "PERRIGO CO PDRN",
        "long_name": "Perrigo Company plc",
        "summary": "Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, and Dr. Fresh. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations in the United States, as well as pharmaceutical and diagnostic products in Israel. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.",
        "currency": "BRL",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SAO",
        "market": "br_market",
        "country": "Ireland",
        "state": null,
        "city": "Dublin",
        "zipcode": "2",
        "website": "http://www.perrigo.com",
        "market_cap": "Mid Cap"
    },
    "P731.F": {
        "short_name": "MEDEXUS PHARMACEUTIC.",
        "long_name": "Medexus Pharmaceuticals Inc.",
        "summary": "Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, which is indicated for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and chronic spontaneous urticaria in patients 2 years of age and older. Its products portfolio also include Cuvposa, which is indicated for sialorrhea in patients aged 3-18 years with neurologic conditions, such as cerebral; Gliolan, an orally administered drug used for the visualization of various brain tumors; and Treosulfan, a conditioning agent used prior to stem cell transplantation. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Verdun, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "QC",
        "city": "Verdun",
        "zipcode": "H3E 1A2",
        "website": "http://www.medexus.com",
        "market_cap": "Micro Cap"
    },
    "PACR.CN": {
        "short_name": "PacRootsCann",
        "long_name": "Pac Roots Cannabis Corp.",
        "summary": "Pac Roots Cannabis Corp. cultivates and sells marijuana for medicinal purposes. The company was incorporated in 2012 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2E9",
        "website": "http://pacroots.ca",
        "market_cap": "Nano Cap"
    },
    "PAHC": {
        "short_name": "Phibro Animal Health Corporatio",
        "long_name": "Phibro Animal Health Corporation",
        "summary": "Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It also operates in Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NGM",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "Teaneck",
        "zipcode": "07666-6712",
        "website": "http://www.pahc.com",
        "market_cap": "Small Cap"
    },
    "PARNF": {
        "short_name": "PARNELL PHARMACEUTICALS HLDGS L",
        "long_name": "Parnell Pharmaceuticals Holdings Ltd",
        "summary": "Parnell Pharmaceuticals Holdings Ltd, a veterinary pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for improving cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product aids in the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also operates mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Alexandria",
        "zipcode": "2015",
        "website": "http://www.parnell.com",
        "market_cap": "Nano Cap"
    },
    "PB8.F": {
        "short_name": "PHIBRO ANIMAL HEALTH A",
        "long_name": "Phibro Animal Health Corporation",
        "summary": "Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It also operates in Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NJ",
        "city": "Teaneck",
        "zipcode": "07666-6712",
        "website": "http://www.pahc.com",
        "market_cap": "Small Cap"
    },
    "PBIC.CN": {
        "short_name": "Plant-BasedInve",
        "long_name": "Plant-Based Investment Corp.",
        "summary": "Plant-Based Investment Corp. is a principal investment firm. The firm seeks to invest in cannabis industry. It also invests in public cannabis companies. The firm employs fundamental analysis along with a combination of bottom-up and top-down stock picking approach to create its portfolios. Cannabis Growth Opportunity Corporation is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5V 1V6",
        "website": "http://www.pbinvest.ca",
        "market_cap": "Nano Cap"
    },
    "PBP.AX": {
        "short_name": "PROBIOTEC FPO",
        "long_name": "Probiotec Limited",
        "summary": "Probiotec Limited engages in the development, manufacture and sale of pharmaceuticals, consumer health, and nutraceutical products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, and ointments and suspensions; powders and powder blending; and sprays, as well as manufacturing and packaging of finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. In addition, the company provides packing services and formats, including foil, carded and clamshell blister packing, bottle filling, labelling, secondary packaging, and other services for the pharmaceutical, cosmetic, and food industries. Probiotec Limited was incorporated in 1996 and is headquartered in Laverton North, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Laverton North",
        "zipcode": "3026",
        "website": "http://www.probiotec.com.au",
        "market_cap": "Micro Cap"
    },
    "PCLO.V": {
        "short_name": "PHARMACIELO LTD",
        "long_name": "PharmaCielo Ltd.",
        "summary": "PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis oil extracts, tetrahydrocannabinol, and related products to pharmacies, medical clinics, and cosmetic companies. The company also offers telemedicine software. It serves in Canada, Colombia, Italy, and Mexico. The company has a strategic alliance with AssuredTrans Inc. PharmaCielo Ltd. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 2V6",
        "website": "http://www.pharmacielo.com",
        "market_cap": "Micro Cap"
    },
    "PCLOF": {
        "short_name": "PHARMACIELO LTD",
        "long_name": "PharmaCielo Ltd.",
        "summary": "PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis oil extracts, tetrahydrocannabinol, and related products to pharmacies, medical clinics, and cosmetic companies. The company also offers telemedicine software. It serves in Canada, Colombia, Italy, and Mexico. PharmaCielo Ltd. has a strategic alliance with AssuredTrans Inc. PharmaCielo Ltd. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 2E3",
        "website": "http://www.pharmacielo.com",
        "market_cap": "Micro Cap"
    },
    "PCRX": {
        "short_name": "Pacira BioSciences, Inc.",
        "long_name": "Pacira BioSciences, Inc.",
        "summary": "Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a bupivacaine liposome injectable suspension, administered at the time of surgery to control pain and reduce or eliminate the use of opioids for acute postsurgical pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Parsippany, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "Parsippany",
        "zipcode": "07054",
        "website": "http://www.pacira.com",
        "market_cap": "Mid Cap"
    },
    "PCYN": {
        "short_name": "PROCYON CORP",
        "long_name": "Procyon Corporation",
        "summary": "Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems primarily in the United States. The company offers advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions under the AMERIGEL brand name. It also provides Bioactive Collagen products under the HELIX3 brand name. In addition, the company offers wound care products, such as calcium alginate, foam, gauze, and hyrdocolloid dressing products; wound care kits, which include calcium alginate, collagen matrix, collagen powder, foam, and hydrogel wound care kits under the AMERX brand name; and compression garment line products under the EXTREMIT-EASE name. It sells its products through distributors to institutional customers, such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, physicians, and other health care practitioners; and retail customers through direct sales, and internet sales, as well as through independent and retail chain drug stores. Procyon Corporation was incorporated in 1987 and is based in Clearwater, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Clearwater",
        "zipcode": "33756",
        "website": "http://www.procyoncorp.com",
        "market_cap": "Nano Cap"
    },
    "PDPL.NS": {
        "short_name": "PARENTERAL DRUG",
        "long_name": "Parenteral Drugs (India) Limited",
        "summary": "Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anesthesia products. The company also exports its products in Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was founded in 1983 and is based in Indore, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Indore",
        "zipcode": "452001",
        "website": "http://www.pdindia.com",
        "market_cap": "Nano Cap"
    },
    "PEHA.JK": {
        "short_name": "Phapros Tbk.",
        "long_name": "PT Phapros, Tbk",
        "summary": "PT Phapros, Tbk operates in the pharmaceutical and health care industry in Indonesia. The company operates through Over the Counter (OTC), Ethical, Generic Drugs Bearing, and Toll Manufacturing segments. It offers OTC drugs, including Antimo Anak, Livron B Plek, Noza, Hemorogard, Bioron, and others. The company also provides generic drug products for government institutions and hospitals, as well as produces drugs for other pharmaceutical industries; and offers medical devices. PT Phapros, Tbk also exports its products internationally. The company was founded in 1954 and is headquartered in Jakarta, Indonesia. PT Phapros, Tbk operates as a subsidiary of PT Kimia Farma (Persero) Tbk.",
        "currency": "IDR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JKT",
        "market": "id_market",
        "country": "Indonesia",
        "state": null,
        "city": "Jakarta",
        "zipcode": "12950",
        "website": "http://www.phapros.co.id",
        "market_cap": "Micro Cap"
    },
    "PEMTF": {
        "short_name": "THOUGHTFUL BRANDS INC",
        "long_name": "Thoughtful Brands Inc.",
        "summary": "Mota Ventures Corp., together with its subsidiaries, operates in the cannabidiol (CBD) e-commerce business. It provides CBD hemp-oil formulations and cosmetics. The company offers its products under the Nature's Exclusive, First Class, and Sativida brands in the United States and Europe. Mota Ventures Corp. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 3T5",
        "website": "http://www.thoughtful-brands.com",
        "market_cap": "Nano Cap"
    },
    "PETQ": {
        "short_name": "PetIQ, Inc.",
        "long_name": "PetIQ, Inc.",
        "summary": "PetIQ, Inc. operates as a pet medication and wellness company. It operates in two segments, Products and Services. The company offers Rx pet medications, which include heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and co-develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers across 41 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "ID",
        "city": "Eagle",
        "zipcode": "83616",
        "website": "http://www.petiq.com",
        "market_cap": "Small Cap"
    },
    "PEXXF": {
        "short_name": "TEMPO SCAN PACIFIC",
        "long_name": "PT Tempo Scan Pacific Tbk",
        "summary": "PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. It operates through three segments: Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. The company is involved in the construction and rental of buildings; provision of warehousing, freight forwarding, advertising and promotion, research and development, computer systems, and distribution and marketing services; medical devices trading; and manufacture of food supplements, food and beverages, and plastic packaging, as well as consumer products, soaps, and household products. It sells its products under Bodrex, Vidoran, Hemaviton, Oskadon, Bodrexin, Neo rheumacyl, Oskadryl, Contrexyn, Zevit Grow, Wybert, Vitonal, Polaris, and Vitamin IPI brands. The company was formerly known as PT Scanchemie. PT Tempo Scan Pacific Tbk was founded in 1970 and is headquartered in Jakarta, Indonesia. PT Tempo Scan Pacific Tbk is a subsidiary of PT Bogamulia Nagadi.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Indonesia",
        "state": null,
        "city": "Jakarta",
        "zipcode": "12950",
        "website": "http://www.thetempogroup.net",
        "market_cap": "Small Cap"
    },
    "PGHL.NS": {
        "short_name": "PROCTER & GAMBLE HEALTH L",
        "long_name": "Procter & Gamble Health Limited",
        "summary": "Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements, as well as cough and cold products. The company offers its products under the Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. Procter & Gamble Health Limited also exports its pharmaceutical products to Sri Lanka, Nepal, Myanmar, and Maldives. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was founded in 1967 and is headquartered in Mumbai, India. As of June 30, 2020, Procter & Gamble Health Limited operates as a subsidiary of Procter & Gamble Overseas India B.V.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400079",
        "website": "http://www.pghealthindia.com",
        "market_cap": "Small Cap"
    },
    "PGTMF": {
        "short_name": "LUFF ENTERPRISES LTD",
        "long_name": "Luff Enterprises Ltd.",
        "summary": "Luff Enterprises Ltd., a CBD lifestyle company, manufactures and distributes hemp-based cannabinoid wellness products in the United States. The company focuses on formulations leveraging cannabinoids, such as CBG and CBN; and boosts them with superfood ingredients to empower people to realize the potential of everyday life. Its products include tinctures, gummies, topicals, and gel caps. The company was formerly known as Ascent Industries Corp. and changed its name to Luff Enterprises Ltd. in May 2020. Luff Enterprises Ltd. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1X8",
        "website": "http://luffbrands.com",
        "market_cap": "Nano Cap"
    },
    "PHBI": {
        "short_name": "PHARMAGREEN BIOTECH INC",
        "long_name": "Pharmagreen Biotech Inc.",
        "summary": "Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company is headquartered in Coquitlam, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Coquitlam",
        "zipcode": "V3E 3A2",
        "website": "http://www.pharmagreen.ca",
        "market_cap": "Nano Cap"
    },
    "PHCG": {
        "short_name": "PURE HARVEST CORPORATE GROUP",
        "long_name": "Pure Harvest Corporate Group, Inc.",
        "summary": "Pure Harvest Corporate Group, Inc. focuses on the acquisition and operation of licensed medical and recreational marijuana dispensaries, cultivation facilities, and production facilities. It also focuses on providing cannabis and hemp-derived health and wellness products; and applying education, research and development, and technology to various sectors. The company was formerly known as Pure Harvest Cannabis Group, Inc. and changed its name to Pure Harvest Corporate Group, Inc. in June 2020. Pure Harvest Corporate Group, Inc. was founded in 2004 and is based in Greenwood Village, Colorado.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CO",
        "city": "Greenwood Village",
        "zipcode": "80111",
        "website": "http://www.pureharvestgroup.com",
        "market_cap": "Nano Cap"
    },
    "PHE.F": {
        "short_name": "CIPHER PHARMACEUTICALS",
        "long_name": "Cipher Pharmaceuticals Inc.",
        "summary": "Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and Conzip/Durela (CIP- Tramadol), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products also include Trevyent, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for the treatment of onychomycosis; and DTR-001, a tattoo removal cream. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Oakville",
        "zipcode": "L6H 0M2",
        "website": "http://www.cipherpharma.com",
        "market_cap": "Nano Cap"
    },
    "PHN.MI": {
        "short_name": "PHARMANUTRA",
        "long_name": "Pharmanutra S.p.A.",
        "summary": "Pharmanutra S.p.A., a pharmaceutical company, engages in the research, design, development, and marketing of nutraceutical supplements and medical devices in Europe, Asia, the United States, and Africa. The company also manufactures and distributes active ingredients for the pharmaceutical, food, and dietary supplement industry; and develops and distributes drugs, medical devices, OTC products, and nutritional supplements with focus on the pediatric area. Its products primarily include Apportal, Sideral Folic 30, UltraMag, Cetilar, Gestalys DHA, Sideral Forte, CardioSideral, Bonecal, Novomega, and Dikappa2. The company distributes and sells its products through sales representatives and wholesalers to pharmacies and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "PI",
        "city": "Pisa",
        "zipcode": "56122",
        "website": "http://www.pharmanutra.it",
        "market_cap": "Small Cap"
    },
    "PHO.OL": {
        "short_name": "PHOTOCURE ASA",
        "long_name": "Photocure ASA",
        "summary": "Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to license partners, pharmaceutical wholesalers, pharmacies, and hospitals. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway.",
        "currency": "NOK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "OSL",
        "market": "no_market",
        "country": "Norway",
        "state": null,
        "city": "Oslo",
        "zipcode": "0275",
        "website": "http://www.photocure.com",
        "market_cap": "Small Cap"
    },
    "PHS.F": {
        "short_name": "PHOTOCURE ASA  NK-,50",
        "long_name": "Photocure ASA",
        "summary": "Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to license partners, pharmaceutical wholesalers, pharmacies, and hospitals. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Norway",
        "state": null,
        "city": "Oslo",
        "zipcode": "0275",
        "website": "http://www.photocure.com",
        "market_cap": "Small Cap"
    },
    "PIG.F": {
        "short_name": "PERRIGO CO. PLCEO -,001",
        "long_name": "Perrigo Company plc",
        "summary": "Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, and Dr. Fresh. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations in the United States, as well as pharmaceutical and diagnostic products in Israel. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Ireland",
        "state": null,
        "city": "Dublin",
        "zipcode": "2",
        "website": "http://www.perrigo.com",
        "market_cap": "Mid Cap"
    },
    "PILL.CN": {
        "short_name": "CanntabTheraLtd",
        "long_name": "Canntab Therapeutics Limited",
        "summary": "Canntab Therapeutics Limited, a biopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids, tetrahydrocannabinol, and terpenes in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Markham",
        "zipcode": "L3R 5J6",
        "website": "http://canntab.ca",
        "market_cap": "Nano Cap"
    },
    "PKANF": {
        "short_name": "SIMPLY BETTER BRANDS CORP",
        "long_name": "Simply Better Brands Corp.",
        "summary": "PureK Holdings Corp. manufactures and sells hemp based cannabidiol related products in the United States. The company offers tinctures, capsules, gummies, oils, edibles, topicals, sprays, vape pens, pet treats, and bath bombs, as well as tees, hoodies, beanies, caps, and other related products. It distributes its products through e-commerce website PureKana.com, as well as through retail stores, including larger retail chains and small independent retailers; wholesalers; and various brick and mortar retailers. The company was founded in 2017 and is headquartered in Paradise Valley, Arizona. PureK Holdings Corp. is a subsidiary of Heavenly Rx Ltd.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "AZ",
        "city": "Paradise Valley",
        "zipcode": "85253",
        "website": "http://purekana.com",
        "market_cap": "Micro Cap"
    },
    "PKB.CN": {
        "short_name": "PeakbirchLogic",
        "long_name": "PeakBirch Logic Inc.",
        "summary": "PeakBirch Logic Inc. engages in the e-commerce sales and delivery of cannabis-related and cannabidiol (CBD) containing products. The company distributes vaporizers, CBD related accessories, and ancillary products for aromatherapy and other applications, as well as CBD tinctures, topicals, edibles, and other products. It sells its products through Namastevapes.com, Everyonedoesit.com, LiftedCBD.com, Leafscience.com, and Lifted.com portals. PeakBirch Logic Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3N6",
        "website": "http://peakbirch.com",
        "market_cap": "Nano Cap"
    },
    "PKPH": {
        "short_name": "PEAK PHARMACEUTICALS INC",
        "long_name": "Peak Pharmaceuticals, Inc.",
        "summary": "Peak Pharmaceuticals, Inc. operates as a bio\u00c2\u00adpharmaceutical and nutraceutical company in the United States. The company focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. It is involved in the development of over-the-counter, THC\u00c2\u00adfree, hemp based products for human market for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "AZ",
        "city": "Scottsdale",
        "zipcode": "85260",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "PLNHF": {
        "short_name": "PLANET 13 HOLDINGS INC",
        "long_name": "Planet 13 Holdings Inc.",
        "summary": "Planet 13 Holdings Inc., a cannabis company, cultivates, produces, distributes, and markets cannabis and cannabis-infused and related products for medical and retail cannabis markets in Nevada, the United States. It also operates dispensaries that provide cannabis, cannabis extracts, and infused products. In addition, the company provides cardholder process navigation services; individual consultations; compassionate care programs; patient education services; express services; and home delivery services. Further, it operates a coffee shop and pizzeria. The company offers its products under the Planet 13, Medizin, TRENDI, Leaf & Vine, HaHa, and Dreamland Chocolates brands. Planet 13 Holdings Inc. was incorporated in 2002 and is headquartered in Las Vegas, Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89109",
        "website": "http://www.planet13holdings.com",
        "market_cap": "Small Cap"
    },
    "PLNT.CN": {
        "short_name": "BetterPlantSci",
        "long_name": "Better Plant Sciences Inc.",
        "summary": "Better Plant Sciences Inc., through its subsidiaries, develops, markets, and sells of plant-based products for health and wellness. The company offers cosmetic and therapeutic products made of cannabis sativa hemp root oil and essential oils. It also develop and acquire intellectual property for plant-based products. The company offers plant-based skin care products under Urban Juve brand name; cannabis wellness products under Wright & Well and Jack n Jane brands; botanicals, fruit extracts, and spices under the UJ Beverages brand. The company was formerly known as The Yield Growth Corp. and changed its name to Better Plant Sciences Inc. in August 2020. Better Plant Sciences Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6B 2Y5",
        "website": "http://betterplantsciences.com",
        "market_cap": "Nano Cap"
    },
    "PLPRF": {
        "short_name": "PLUS PRODUCTS INC",
        "long_name": "Plus Products Inc.",
        "summary": "Plus Products Inc. develops, manufactures, and sells cannabis products in California. It offers cannabis-infused edibles to the regulated medicinal and adult-use, or recreational markets. The company sells products under the PLUS brand to dispensaries and delivery service customers. Plus Products Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 4N7",
        "website": "http://www.plusproducts.com",
        "market_cap": "Nano Cap"
    },
    "PLSI": {
        "short_name": "PHOENIX LIFE SCIENCES INTL LTD",
        "long_name": "Phoenix Life Sciences International Limited",
        "summary": "Phoenix Life Sciences International Limited operates as a healthcare solutions company in the United States and internationally. The company focuses on advancing research, integrating programs, and manufacturing of products that target and treat diabetes, pain, and cancers, as well as address psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. It offers oral soft gel capsules, thin film dissolvable strips, transdermal patches, sublingual oral sprays, suppositories, and topical creams. The company was formerly known as Stem Bioscience, Inc. and changed its name to Phoenix Life Sciences International Limited in May 2018. Phoenix Life Sciences International Limited was incorporated in 2009 and is headquartered in Las Vegas Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89139",
        "website": "http://www.phoenixlife.co",
        "market_cap": "Nano Cap"
    },
    "PLTH.CN": {
        "short_name": "Planet13Hldgs",
        "long_name": "Planet 13 Holdings Inc.",
        "summary": "Planet 13 Holdings Inc., a cannabis company, cultivates, produces, distributes, and markets cannabis and cannabis-infused and related products for medical and retail cannabis markets in Nevada, the United States. It also operates dispensaries that provide cannabis, cannabis extracts, and infused products. In addition, the company provides cardholder process navigation services; individual consultations; compassionate care programs; patient education services; express services; and home delivery services. Further, it operates a coffee shop and pizzeria. The company offers its products under the Planet 13, Medizin, TRENDI, Leaf & Vine, HaHa, and Dreamland Chocolates brands. Planet 13 Holdings Inc. was incorporated in 2002 and is headquartered in Las Vegas, Nevada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89109",
        "website": "http://www.planet13holdings.com",
        "market_cap": "Small Cap"
    },
    "PLUS.CN": {
        "short_name": "PlusProdnc",
        "long_name": "Plus Products Inc.",
        "summary": "Plus Products Inc. develops, manufactures, and sells cannabis products in California. It offers cannabis-infused edibles to the regulated medicinal and adult-use, or recreational markets. The company sells products under the PLUS brand to dispensaries and delivery service customers. Plus Products Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 4N7",
        "website": "http://www.plusproducts.com",
        "market_cap": "Nano Cap"
    },
    "PLXP": {
        "short_name": "PLx Pharma Inc.",
        "long_name": "PLx Pharma Inc.",
        "summary": "PLx Pharma Inc., a specialty pharmaceutical company, focuses on developing the PLxGuard drug delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system, which provides patients with vascular disease and diabetic patients who are candidates for aspirin therapy based on physician recommendation, with fast, reliable, and predictable platelet inhibition as compared to enteric-coated aspirin, as well as reduces the risk of stomach erosions and ulcers as compared with immediate-release aspirin, after seven days of treatment. Its product pipeline also includes other oral nonsteroidal anti-inflammatory drugs using the PLxGuard drug delivery system, such as PL1200 Ibuprofen 200 mg and PL1200 Ibuprofen 400 mg, which are in Phase I clinical stage for pain and inflammation, as well as PL1100 Ibuprofen 400 mg. PLx Pharma Inc. was founded in 2002 and is headquartered in Sparta, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NCM",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "Sparta",
        "zipcode": "07871",
        "website": "http://plxpharma.com",
        "market_cap": "Micro Cap"
    },
    "PMCN.TA": {
        "short_name": "PHARMOCANN GLOBAL",
        "long_name": "Pharmocann Global Ltd",
        "summary": "Pharmocann Global Ltd engages in cultivation of cannabis for medical purposes. The company was founded in 2008 and is based in Raanana, Israel.",
        "currency": "ILA",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TLV",
        "market": "il_market",
        "country": "Israel",
        "state": null,
        "city": "Raanana",
        "zipcode": "4335810",
        "website": "http://pharmocann.com",
        "market_cap": null
    },
    "PNAX.TA": {
        "short_name": "PANAXIA LABS ISRAE",
        "long_name": "Panaxia Labs Israel Ltd",
        "summary": "Panaxia Pharmaceutical Industries Ltd provides pharmaceutical solutions for patients and physicians. The company offers pharma-grade smokeless cannabis products, such as oral and sublingual tablets, medical oils, concentrations, pastilles, suppositories, topical creams, pain relief creams, and pain relief patches. Panaxia Pharmaceutical Industries Ltd has strategic partnerships with Ultra Health, Salus Biopharma, MPX Bioceutical Corporation, Rafa, Pharmocann, Seach Medical Cannabis Group, TevaAdir, Better, and Cann10. The company was incorporated in 2016 and is based in Lod, Israel.",
        "currency": "ILA",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TLV",
        "market": "il_market",
        "country": "Israel",
        "state": null,
        "city": "Lod",
        "zipcode": "7116002",
        "website": "http://www.panaxia.co.il",
        "market_cap": null
    },
    "POT.CN": {
        "short_name": "PotentVentu",
        "long_name": "Potent Ventures Inc.",
        "summary": "Potent Ventures Inc. sells branded cannabis packaging. It offers its products through Wknd! and Orchard Heights brand name. The company was formerly known as Weekend Unlimited Industries Inc. and changed its name to Potent Ventures Inc. in April 2021. Potent Ventures Inc. is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 3X1",
        "website": "http://www.weekendunlimited.com",
        "market_cap": "Nano Cap"
    },
    "POTN": {
        "short_name": "POTNETWORK HOLDINGS INCOR",
        "long_name": "PotNetwork Holdings, Inc.",
        "summary": "PotNetwork Holdings, Inc., through its subsidiaries, engages in the development and sale of hemp-derived CBD oil products. The company also publishes PotNetwork magazine. It sells its products through distributors and resellers, as well as through its Website. The company is based in Fort Lauderdale, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Fort Lauderdale",
        "zipcode": "33312",
        "website": "http://www.potnetworkholding.com",
        "market_cap": "Nano Cap"
    },
    "PPD": {
        "short_name": "PPD, Inc.",
        "long_name": "PPD, Inc.",
        "summary": "PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "NC",
        "city": "Wilmington",
        "zipcode": "28401-3331",
        "website": "http://www.ppd.com",
        "market_cap": "Large Cap"
    },
    "PPGN.SW": {
        "short_name": "POLYPEPTIDE N",
        "long_name": "PolyPeptide Group AG",
        "summary": "PolyPeptide Group AG operates as a pharmaceutical products contract development and manufacturing organization worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. The company provides GMP compliance and inspection, custom research and development, pre-GMP development, production, quality assurance, quality control, and regulatory support services. It also manufactures and sells peptide-based generics, cosmetic peptides, and individualized peptide therapeutics. The company was founded in 1996 and is based in Zug, Switzerland.",
        "currency": "CHF",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "EBS",
        "market": "ch_market",
        "country": "Switzerland",
        "state": null,
        "city": "Zug",
        "zipcode": "6300",
        "website": "http://www.polypeptide.com",
        "market_cap": null
    },
    "PPII": {
        "short_name": "COENZYME A INC",
        "long_name": "Coenzyme-A Inc.",
        "summary": "Coenzyme-A Inc. formulates and manufactures nutraceutical supplements, and skin and hair care products in the United States and internationally. It offers energy drinks and skin rejuvinating serums, as well as fat management, skin treatment, fatty acid and cholesterol metabolism, and skin rejuvenating products, as well as nutritional formulas for the support of bone, joint, ligament, cartilage, and connective tissue functions. The company also provides sports-specific, women's, and men's formulas, as well as wellness, energy, and body sculpting products. Coenzyme-A Inc. was founded in 1998 and is based in Lynnwood, Washington.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "WA",
        "city": "Lynnwood",
        "zipcode": "98087",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "PRCNF": {
        "short_name": "PURE GLOBAL CANNABIS INC",
        "long_name": "Pure Global Cannabis Inc.",
        "summary": "Pure Global Cannabis Inc. produces cannabis products for the medical and adult-use markets in Canada. The company provides cannabis products, such as dried flower, cannabis oils, soft gels and capsules, seedlings and clones, vape pen cartridges, topicals, sublingual strip/spray, transdermal patch, and edibles and beverages, as well as wellness products. It offers its products under the PureSinse, SPARK Medical Cannabis clinics, and The Great Canadian Hemp Company brands. The company serves medical, pharmaceutical, wellness, health and beauty, natural health, food and beverage, and recreational legal markets. Pure Global Cannabis Inc. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M8V 4G4",
        "website": "http://pureglobal.com",
        "market_cap": "Nano Cap"
    },
    "PRFX": {
        "short_name": "PainReform Ltd.",
        "long_name": "PainReform Ltd.",
        "summary": "PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NCM",
        "market": "us_market",
        "country": "Israel",
        "state": null,
        "city": "Tel Aviv",
        "zipcode": "6745442",
        "website": "http://www.painreform.com",
        "market_cap": "Nano Cap"
    },
    "PRGO": {
        "short_name": "Perrigo Company plc",
        "long_name": "Perrigo Company plc",
        "summary": "Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, and Dr. Fresh. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations in the United States, as well as pharmaceutical and diagnostic products in Israel. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "Ireland",
        "state": null,
        "city": "Dublin",
        "zipcode": "2",
        "website": "http://www.perrigo.com",
        "market_cap": "Mid Cap"
    },
    "PRGO.TA": {
        "short_name": "PERRIGO CO PLC",
        "long_name": "Perrigo Company plc",
        "summary": "Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, and Dr. Fresh. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations in the United States, as well as pharmaceutical and diagnostic products in Israel. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.",
        "currency": "ILA",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TLV",
        "market": "il_market",
        "country": "Ireland",
        "state": null,
        "city": "Dublin",
        "zipcode": "2",
        "website": "http://www.perrigo.com",
        "market_cap": null
    },
    "PROB.ST": {
        "short_name": "Probi AB",
        "long_name": "Probi AB (publ)",
        "summary": "Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. It conducts research primarily in the fields of gastrointestinal and immune health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. The company provides dietary supplement, and food and beverage products in the form of capsules, tablets, chewable tablets, spheres, fast melt sticks, powder, fruit drinks, shots, carbonated beverages, and recovery drinks. It sells its products approximately in 40 countries worldwide. Probi AB (publ) has a collaboration with \u00c3\u0096rebro University for research into exploration of novel, needle free vaccines; and a collaboration with La Trobe University to conduct a clinical trial to investigate the effect of Probi Osteo in an Australian female population. The company was founded in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) is a subsidiary of Symrise AG.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Lund",
        "zipcode": "223 70",
        "website": "http://www.probi.com",
        "market_cap": "Small Cap"
    },
    "PRPH": {
        "short_name": "ProPhase Labs, Inc.",
        "long_name": "ProPhase Labs, Inc.",
        "summary": "ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter (OTC) consumer healthcare products and dietary supplements in the United States. It offers a range of OTC dietary supplements, including Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support product; and Super ProstaFlow+ a supplement to support prostate and urinary health under the TK Supplements brand. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; and offers SARS-CoV-2 (COVID-19) and COVID-19 viral mutation PCR tests through saliva and nasal swab methods, as well as other respiratory pathogen panel testing services, including Influenza A and B, and others. It serves consumer products companies, as well as large national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was incorporated in 1989 and is headquartered in Garden City, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "Garden City",
        "zipcode": "11530",
        "website": "http://www.prophaselabs.com",
        "market_cap": "Micro Cap"
    },
    "PRXTF": {
        "short_name": "PURE EXTRACTS TECHNOLOGIES CORP",
        "long_name": "Pure Extracts Technologies Corp.",
        "summary": "Pure Extracts Technologies Corp. operates as a cannabis and hemp extraction company in British Columbia. It is involved in the production of cannabis, cannabidiol (CBD) oil, hemp, and functional mushrooms extracts. The company also offers various derivative cannabis products, including edible products, such as delta-9-tetrahydrocannabinol infused gummies. It has a collaboration with Dr. Alexander MacGregor to develop CBD infused mushroom wellness products, as well as to research optimum extraction methodologies for psilocybin. The company was formerly known as Big Sky Petroleum Corporation and change its name to Pure Extracts Technologies Corp. in October 2020. Pure Extracts Technologies Corp. was incorporated in 2006 and is headquartered in Pemberton, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Pemberton",
        "zipcode": "V0N 2K0",
        "website": "http://www.pureextractscorp.com",
        "market_cap": "Nano Cap"
    },
    "PSG.DE": {
        "short_name": "PHARMASGP HOLDING SE O.N.",
        "long_name": "PharmaSGP Holding SE",
        "summary": "PharmaSGP Holding SE manufactures non-chemical, over-the-counter drugs, and other healthcare products. The company's pharmaceutical products include RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, and Spain. PharmaSGP Holding SE was founded in 2012 and is based in Gr\u00c3\u00a4felfing, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "GER",
        "market": "de_market",
        "country": "Germany",
        "state": null,
        "city": "Gr\u00c3\u00a4felfing",
        "zipcode": "82166",
        "website": "http://pharmasgp.com",
        "market_cap": "Micro Cap"
    },
    "PSG.F": {
        "short_name": "PHARMASGP HOLDING SE O.N.",
        "long_name": "PharmaSGP Holding SE",
        "summary": "PharmaSGP Holding SE manufactures non-chemical, over-the-counter drugs, and other healthcare products. The company's pharmaceutical products include RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, and Spain. PharmaSGP Holding SE was founded in 2012 and is based in Gr\u00c3\u00a4felfing, Germany.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Germany",
        "state": null,
        "city": "Gr\u00c3\u00a4felfing",
        "zipcode": "82166",
        "website": "http://pharmasgp.com",
        "market_cap": "Micro Cap"
    },
    "PSIQ": {
        "short_name": "PROFILE SOLUTIONS INC",
        "long_name": "Profile Solutions, Inc.",
        "summary": "Profile Solutions, Inc., through its subsidiary, Elite Products International, Inc., manufactures and distributes cannabinoid hemp extracts in the form of edibles, creams, oils, and salves. It offers edibles, such as candies, gummies, cookies, crystal pops, honey and multi-vitamins, oils, tinctures, vapes, creams, and salves, as well as a line of creams and salves for house pets. The company is headquartered in Sunrise, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Sunrise",
        "zipcode": "33351",
        "website": "http://www.profilesolutionsinc.com",
        "market_cap": "Nano Cap"
    },
    "PTLF": {
        "short_name": "PETLIFE PHARMACEUTICALS INC",
        "long_name": "Petlife Pharmaceuticals, Inc.",
        "summary": "Petlife Pharmaceuticals, Inc. engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States. The company's principal product is Vitalzul that inhibits blood vessels formation in solid tumors. It is also developing Vitalzul as a prescription strength oral pharmaceutical, as well as a concentrated intravenous and injectable version for direct administration to a tumor. In addition, the company develops edible dog and cat treats. Petlife Pharmaceuticals, Inc. is based in Los Angeles, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Los Angeles",
        "zipcode": "90046",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "PTPI": {
        "short_name": "Petros Pharmaceuticals, Inc.",
        "long_name": "Petros Pharmaceuticals, Inc.",
        "summary": "Petros Pharmaceuticals, Inc. engages in identifying, acquiring, developing, and commercializing therapeutics for men's health issues in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company develops H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. It also offers prescription medication, such as Stendra for the treatment of male erectile dysfunction; and vacuum erection devices. Petros Pharmaceuticals, Inc. is based in New York, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NCM",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10036",
        "website": "http://www.petrospharma.com",
        "market_cap": "Nano Cap"
    },
    "PU31.F": {
        "short_name": "AGRAFLORA ORGAN. INTL",
        "long_name": "AgraFlora Organics International Inc.",
        "summary": "AgraFlora Organics International Inc. operates in the cannabis industry in Canada and the Republic of Colombia. The company was formerly known as PUF Ventures Inc. and changed its name to AgraFlora Organics International Inc. in November 2018. The company was incorporated in 2004 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2T7",
        "website": "http://agraflora.com",
        "market_cap": "Nano Cap"
    },
    "PULL.CN": {
        "short_name": "PureExtractTech",
        "long_name": "Pure Extracts Technologies Corp.",
        "summary": "Pure Extracts Technologies Corp. operates as a cannabis and hemp extraction company in British Columbia. It is involved in the production of cannabis, cannabidiol (CBD) oil, hemp, and functional mushrooms extracts. The company also offers various derivative cannabis products, including edible products, such as delta-9-tetrahydrocannabinol infused gummies. It has a collaboration with Dr. Alexander MacGregor to develop CBD infused mushroom wellness products, as well as to research optimum extraction methodologies for psilocybin. The company was formerly known as Big Sky Petroleum Corporation and change its name to Pure Extracts Technologies Corp. in October 2020. Pure Extracts Technologies Corp. was incorporated in 2006 and is headquartered in Pemberton, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Pemberton",
        "zipcode": "V0N 2K0",
        "website": "http://www.pureextractscorp.com",
        "market_cap": "Nano Cap"
    },
    "PUX.F": {
        "short_name": "PURE EXTRACTS TECHN. CORP",
        "long_name": "Pure Extracts Technologies Corp.",
        "summary": "Pure Extracts Technologies Corp. operates as a cannabis and hemp extraction company in British Columbia. It is involved in the production of cannabis, cannabidiol (CBD) oil, hemp, and functional mushrooms extracts. The company also offers various derivative cannabis products, including edible products, such as delta-9-tetrahydrocannabinol infused gummies. It has a collaboration with Dr. Alexander MacGregor to develop CBD infused mushroom wellness products, as well as to research optimum extraction methodologies for psilocybin. The company was formerly known as Big Sky Petroleum Corporation and change its name to Pure Extracts Technologies Corp. in October 2020. Pure Extracts Technologies Corp. was incorporated in 2006 and is headquartered in Pemberton, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Pemberton",
        "zipcode": "V0N 2K0",
        "website": "http://www.pureextractscorp.com",
        "market_cap": "Nano Cap"
    },
    "PVTTF": {
        "short_name": "PIVOTAL THERAPEUTI",
        "long_name": "Pivotal Therapeutics Inc.",
        "summary": "Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. Its lead product, VASCAZEN, is a prescription only medical food formulated for clinical dietary management of cardiovascular disease in patients with documented coronary heart disease and who are deficient in blood Omega-3 fatty acids, eicosapentaenoic acid, and docosahexanenoic acid levels. The company also offers OMAZEN for the maintenance of good health through elevating Omega-3 fatty acid levels. In addition, the company develops Benefishial product line for overall health, cardiovascular health, prenatal health, toddler's health, child's health, and pet's health. Further, it is developing PVT-100 indicated for the stabilization of vulnerable plaque in patients undergoing carotid endarterectomy. Pivotal Therapeutics Inc. sells VASCAZEN in the United States and OMAZEN in Canada. The company is headquartered in Woodbridge, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Woodbridge",
        "zipcode": "L4H 0S5",
        "website": "http://www.pivotaltherapeutics.us",
        "market_cap": "Nano Cap"
    },
    "PWR.CN": {
        "short_name": "CaptivaVerde",
        "long_name": "Captiva Verde Wellness Corp.",
        "summary": "Captiva Verde Wellness Corp. operates as a health and wellness company. The company's assets include sustainable real estate communities in California; outdoor organic cannabis cultivation in Canada; premium infused products and consumer retail partnerships across North America; and medical cannabis license product distribution in Mexico. It primarily invests in assets that contain green residential communities, disruptive manufacturing facilities, organic food production, and pharmaceutical products. The company was formerly known as Captiva Verde Land Corp. and changed its name to Captiva Verde Wellness Corp. in May 2021. Captiva Verde Wellness Corp. was incorporated in 2015 and is based in Coquitlam, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Coquitlam",
        "zipcode": "V3J 2L7",
        "website": "http://captivaverdecorp.com",
        "market_cap": "Nano Cap"
    },
    "PXS.L": {
        "short_name": "PROVEXIS PLC ORD 0.1P",
        "long_name": "Provexis plc",
        "summary": "Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Reading",
        "zipcode": "RG1 1AZ",
        "website": "http://www.provexis.org",
        "market_cap": null
    },
    "PYFA.JK": {
        "short_name": "Pyridam Farma Tbk",
        "long_name": "PT Pyridam Farma Tbk",
        "summary": "PT Pyridam Farma Tbk develops, produces, and sells pharmaceuticals, vitamins, supplements, and traditional herbal care products in Indonesia. The company operates in two segments, Pharmaceutical Products and Toll Manufacturing Services, and Medical Equipments. It offers analgesic, antipiretic, anti anemic, anti fungal, anti hypertension, anti parkinsonism, anti rheumatics, anti inflammatory, anti tuberculotic, anti ulcerant and antasida, antibiotic, anticoagulant, anti platelet, fibrinolytic, anticonvulsant, antihistamine, antipsychotic, calcium w/vitamin, central muscle relaxant, cholesterol lowering, and cough and cold remedy products. The company also provides genito-urinary system, eye preparation, hematology, hepatoprotector, immunomodulator, multivitamin and mineral, neurological, nootropic and neurotonic, oral antidiabetics and corticosteroid, peripheral vasodilator and cerebral activator, supplement and adjuvant therapy, anti infective, anti virus, beta-adrenergic agonist bronchodilator, diuretic, hyperuricemia, and gout products, as well as antiemetic and GIT regulators. In addition, it trades in medical equipment. The company was founded in 1976 and is headquartered in Jakarta, Indonesia.",
        "currency": "IDR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JKT",
        "market": "id_market",
        "country": "Indonesia",
        "state": null,
        "city": "Jakarta",
        "zipcode": "11530",
        "website": "http://www.pyridam.com",
        "market_cap": "Nano Cap"
    },
    "PZOO": {
        "short_name": "PAZOO INC",
        "long_name": "Pazoo, Inc.",
        "summary": "Pazoo, Inc. operates as a health and wellness company. It offers laboratory testing services for marijuana. Pazoo, Inc.was formerly known as IUCSS, Inc. and changed its name to Pazoo, Inc. in May 2011. The company was founded in 2010 and is headquartered in East Hanover, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "East Hanover",
        "zipcode": "07936",
        "website": "http://www.pazoo.com",
        "market_cap": "Nano Cap"
    },
    "QA9.F": {
        "short_name": "AUSTRAL.PRIMARY HEMP LTD",
        "long_name": "Australian Primary Hemp Limited",
        "summary": "Australian Primary Hemp Limited manufactures and distributes hemp products under the Australian Primary Hemp brand to retail, wholesale, and white label customers in Australia. The company offers hemp seeds, cold pressed hemp oil, hemp fiber powder, hemp flour, hemp protein powder, hemp and bush balm mint hand sanitizers, hemp boost, hemp balance, and hemp and honey nut bars. It is also involved in the cultivation and production of hemp; handling various areas of hemp seed selection, farming, processing, and distribution; hemp contract packaging; and bulk and retail sale of edible hemp products. The company was founded in 2016 and is headquartered in Geelong, Australia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Australia",
        "state": "VIC",
        "city": "Geelong",
        "zipcode": "3220",
        "website": "http://www.ausprimaryhemp.com.au",
        "market_cap": "Nano Cap"
    },
    "QLI": {
        "short_name": "Qilian International Holding Gr",
        "long_name": "Qilian International Holding Group Limited",
        "summary": "Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivative (TCMD) products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and sausage casings comprising Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties, and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Jiuquan",
        "zipcode": "735000",
        "website": "http://www.qlsyy.net",
        "market_cap": "Micro Cap"
    },
    "QMDT": {
        "short_name": "QUICK-MED TECHNOLOGIES INC",
        "long_name": "Quick-Med Technologies, Inc.",
        "summary": "Quick-Med Technologies, Inc., a life sciences company, focuses on developing and commercializing proprietary broad-based technologies in medical and consumer healthcare markets. It specializes in the research and development of biomedical products and devices for antibacterial applications. The company's core technologies include Novel Intrinsically Micro-Bonded Utility Substrate (NIMBUS), a family of advanced polymers with antimicrobial, hemostatic, and other properties for use in a range of applications; Stay Fresh, a chemical formulation for textiles with a durable antimicrobial agent effective against an array of bacteria; and MultiStat, a family of advanced patented methods and compounds effective in skin therapy applications. It serves government agencies; and healthcare and medical, apparel and textile, and personal care companies. The company was founded in 1997 and is headquartered in Gainesville, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Gainesville",
        "zipcode": "32601",
        "website": "http://www.quickmedtech.com",
        "market_cap": "Nano Cap"
    },
    "R2WA.F": {
        "short_name": "BEXIMCO PHARMA.GDR REGS 1",
        "long_name": "Beximco Pharmaceuticals Limited",
        "summary": "Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesic and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was founded in 1976 and is headquartered in Dhaka, Bangladesh.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Bangladesh",
        "state": null,
        "city": "Dhaka",
        "zipcode": "1205",
        "website": "http://www.beximcopharma.com",
        "market_cap": "Small Cap"
    },
    "R2WA.SG": {
        "short_name": "Beximco Pharmaceuticals Ltd. Re",
        "long_name": "Beximco Pharmaceuticals Limited",
        "summary": "Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesic and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was founded in 1976 and is headquartered in Dhaka, Bangladesh.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "Bangladesh",
        "state": null,
        "city": "Dhaka",
        "zipcode": "1205",
        "website": "http://www.beximcopharma.com",
        "market_cap": "Small Cap"
    },
    "R5X.F": {
        "short_name": "ACELRX PHARMACEUT. DL-,01",
        "long_name": "AcelRx Pharmaceuticals, Inc.",
        "summary": "AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company's lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. It also develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood City, California.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "CA",
        "city": "Redwood City",
        "zipcode": "94063",
        "website": "http://www.acelrx.com",
        "market_cap": "Micro Cap"
    },
    "R9U2.F": {
        "short_name": "GREEN THUMB INDS",
        "long_name": "Green Thumb Industries Inc.",
        "summary": "Green Thumb Industries Inc. manufactures, distributes, and sells various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including concentrates, edibles, and topical and other cannabis products under the Rythm, Dogwalkers, The Feel Collection, incredibles, Dr. Solomon's, Beboe, and other brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of March 25, 2021, it owned and operated 55 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "IL",
        "city": "Chicago",
        "zipcode": "60654",
        "website": "http://www.gtigrows.com",
        "market_cap": "Mid Cap"
    },
    "RAFA": {
        "short_name": "RAFARMA PHARMACEUTICALS INC",
        "long_name": "Rafarma Pharmaceuticals, Inc.",
        "summary": "Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-\u00c3\u009f structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture the first medical cannabis suppositories for patients suffering from inflammatory bowel disease. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company is based in Sandy, Utah with a manufacturing and distribution facility in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "UT",
        "city": "Sandy",
        "zipcode": "84070",
        "website": "http://rafarma.si",
        "market_cap": "Micro Cap"
    },
    "RAH.SG": {
        "short_name": "Recro Pharma Inc. Registered Sh",
        "long_name": "Recro Pharma, Inc.",
        "summary": "Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Malvern, Pennsylvania.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "United States",
        "state": "PA",
        "city": "Malvern",
        "zipcode": "19355",
        "website": "http://www.recrogainesville.com",
        "market_cap": "Micro Cap"
    },
    "RAMM.CN": {
        "short_name": "RammPharma",
        "long_name": "RAMM Pharma Corp.",
        "summary": "RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products. The company offers Epifract\u00c3\u00a1n, a cannabinoid pharmaceutical drug for the treatment of various medical conditions and pathologies; XALEX 10, a prescription pharmaceutical formulation for the treatment of refractory epilepsy; and NettaLife, a cannabis-based product for pets. It also offers cosmetic products, such as cannabipiel nite, cannabipiel body lotion, cannabipiel hair conditioners, cannabipiel liquid soaps, cannabipiel tite, cannabipiel cleaning emulsions, cannabipiel shampoos, cannabipiel lite, and cannbipiel facial tonics. In addition, the company also engages in the agricultural business. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. The company was incorporated in 1987 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 1P1",
        "website": "http://www.rammpharma.com",
        "market_cap": "Micro Cap"
    },
    "RAMMF": {
        "short_name": "RAMM PHARMA CORP",
        "long_name": "RAMM Pharma Corp.",
        "summary": "RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products. The company offers Epifract\u00c3\u00a1n, a cannabinoid pharmaceutical drug for the treatment of various medical conditions and pathologies; XALEX 10, a prescription pharmaceutical formulation for the treatment of refractory epilepsy; and NettaLife, a cannabis-based product for pets. It also offers cosmetic products, such as cannabipiel nite, cannabipiel body lotion, cannabipiel hair conditioners, cannabipiel liquid soaps, cannabipiel tite, cannabipiel cleaning emulsions, cannabipiel shampoos, cannabipiel lite, and cannbipiel facial tonics. In addition, the company also engages in the agricultural business. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. The company was incorporated in 1987 and is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 1P1",
        "website": "http://www.rammpharma.com",
        "market_cap": "Micro Cap"
    },
    "RAP.SW": {
        "short_name": "Rapid Nutrition N",
        "long_name": "Rapid Nutrition PLC",
        "summary": "Rapid Nutrition PLC, a natural healthcare company, researches, develops, and produces a range of life science products. The company offers meal replacement shakes, energy boosting tablets, weight loss tablets, and appetite suppressant powders under the Leisa's Secret brand; and high protein shakes, high fiber bars, organic multivitamins, fat burning shots, and grain granola cereals under the SystemLS brand. It primarily exports its products in Asia, Europe, Africa, the Middle East, North America, and Australia. The company was incorporated in 2001 and is based in London, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "EBS",
        "market": "ch_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "WC1N 3AX",
        "website": "http://www.rnplc.com",
        "market_cap": "Nano Cap"
    },
    "RCMW": {
        "short_name": "RCMW GROUP INC",
        "long_name": "RCMW Group, Inc.",
        "summary": "RCMW Group Inc. produces, manufactures, and distributes hemp-derived phytocannabinoids worldwide. The company was formerly known as Hemp Technology Inc. and changed its name to RCMW Group Inc. in February 2021. RCMW Group Inc. is based in Cheyenne, Wyoming.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "WY",
        "city": "Cheyenne",
        "zipcode": "82009",
        "website": "http://hemptechnologyinc.com",
        "market_cap": "Nano Cap"
    },
    "RD8.F": {
        "short_name": "RADIENT TECHNOLOGIES",
        "long_name": "Radient Technologies Inc.",
        "summary": "Radient Technologies Inc. processes, sells, and distributes cannabis materials in Canada. It offers cannabis oil, standardized cannabinoid ingredients, cannabis extracts, and cannabis formulations. The company also provides extraction services for the extraction, purification and isolation of cannabinoids for third parties. Its ingredients are used in natural food and beverage products, personal care products, and nutraceutical and pharmaceutical products. Radient Technologies Inc. was founded in 2001 and is headquartered in Edmonton, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "AB",
        "city": "Edmonton",
        "zipcode": "T6E 5A6",
        "website": "http://www.radientinc.com",
        "market_cap": "Nano Cap"
    },
    "RDDA.F": {
        "short_name": "DR REDDYS LABS ADR/1 IR 5",
        "long_name": "Dr. Reddy's Laboratories Limited",
        "summary": "Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosage with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. It also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Proprietary Products segment focuses on the research, development, and manufacture of differentiated formulations for dermatology and neurology therapeutic areas. The company also engages in developing therapies in the fields of oncology and inflammation. As of March 31, 2020, it had four late stage projects at various stages of development. The company's therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. It has collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists; and partnership with Department of Biotechnology - Biotechnology Industry Research Assistance Council for Sputnik V vaccine clinical trials in India. The company was founded in 1984 and is headquartered in Hyderabad, India.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "India",
        "state": null,
        "city": "Hyderabad",
        "zipcode": "500034",
        "website": "http://www.drreddys.com",
        "market_cap": "Large Cap"
    },
    "RDDTF": {
        "short_name": "RADIENT TECHNOLOGIES INC",
        "long_name": "Radient Technologies Inc.",
        "summary": "Radient Technologies Inc. processes, sells, and distributes cannabis materials in Canada. It offers cannabis oil, standardized cannabinoid ingredients, cannabis extracts, and cannabis formulations. The company also provides extraction services for the extraction, purification and isolation of cannabinoids for third parties. Its ingredients are used in natural food and beverage products, personal care products, and nutraceutical and pharmaceutical products. Radient Technologies Inc. was founded in 2001 and is headquartered in Edmonton, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "AB",
        "city": "Edmonton",
        "zipcode": "T6E 5A6",
        "website": "http://www.radientinc.com",
        "market_cap": "Nano Cap"
    },
    "RDHL": {
        "short_name": "Redhill Biopharma Ltd.",
        "long_name": "RedHill Biopharma Ltd.",
        "summary": "RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 1/2a study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis, and has completed Phase 2 studies for irritable bowel syndrome with diarrhea; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and Phase 2a study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; and RHB-106, an encapsulated formulation for bowel preparation, which has completed Phase 2a study. The company was incorporated in 2009 and is headquartered in Tel Aviv, Israel.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Israel",
        "state": null,
        "city": "Tel Aviv",
        "zipcode": "6473921",
        "website": "http://www.redhillbio.com",
        "market_cap": "Micro Cap"
    },
    "RDKO.CN": {
        "short_name": "RadikoHldgsCorp",
        "long_name": "Radiko Holdings Corp.",
        "summary": "Radiko Holdings Corp., together with its subsidiaries, focuses on cannabis industries in the United States and internationally. The company also manufactures and distributes a range of cannabis infused edibles and tinctures under the La Vida Verde brand; a range of wholesale flower, packaged flower, pre-rolls, and concentrates under the Skunk Feather brand; a range of cannabis, infused, chocolates, and edible cannabis consumables gummies, and capsules under the name the Blank Brand; and supplements under the Baseline brand. The company was formerly known as International Cannabrands Inc. and changed its name to Radiko Holdings Corp. in July 2020. The company is headquartered in Des Moines, Washington.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "WA",
        "city": "Des Moines",
        "zipcode": "98198",
        "website": "http://www.radikoholdings.com",
        "market_cap": "Nano Cap"
    },
    "RDUS": {
        "short_name": "Radius Health, Inc.",
        "long_name": "Radius Health, Inc.",
        "summary": "Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine and other therapeutics. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a short-wear-time transdermal patch that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone receptor-positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "MA",
        "city": "Boston",
        "zipcode": "02210",
        "website": "http://www.radiuspharm.com",
        "market_cap": "Small Cap"
    },
    "RDY": {
        "short_name": "Dr. Reddy's Laboratories Ltd",
        "long_name": "Dr. Reddy's Laboratories Limited",
        "summary": "Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosage with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. It also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Proprietary Products segment focuses on the research, development, and manufacture of differentiated formulations for dermatology and neurology therapeutic areas. The company also engages in developing therapies in the fields of oncology and inflammation. As of March 31, 2020, it had four late stage projects at various stages of development. The company's therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. It has collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists; and partnership with Department of Biotechnology - Biotechnology Industry Research Assistance Council for Sputnik V vaccine clinical trials in India. The company was founded in 1984 and is headquartered in Hyderabad, India.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "India",
        "state": null,
        "city": "Hyderabad",
        "zipcode": "500034",
        "website": "http://www.drreddys.com",
        "market_cap": "Large Cap"
    },
    "REKA.TA": {
        "short_name": "REKAH PHARMA IND",
        "long_name": "Rekah Pharmaceutical Industry Ltd.",
        "summary": "Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; dermatological preparations; baby products; and vitamins and nutritional supplements. Its portfolio of products comprise approximately 280 drugs used in various medical fields. The company was founded in 1941 and is based in Holon, Israel.",
        "currency": "ILA",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TLV",
        "market": "il_market",
        "country": "Israel",
        "state": null,
        "city": "Holon",
        "zipcode": "5881904",
        "website": "http://www.rekah.co.il",
        "market_cap": null
    },
    "REL.F": {
        "short_name": "SUGARBUD CRAFT GROWERS",
        "long_name": "SugarBud Craft Growers Corp.",
        "summary": "SugarBud Craft Growers Corp. engages in the acquisition, development, production, and distribution of cannabis products in Canada. The company was formerly known as Relentless Resources Ltd. and changed its name to SugarBud Craft Growers Corp. in October 2018. SugarBud Craft Growers Corp. is headquartered in Calgary, Alberta.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2P 0S4",
        "website": "http://www.sugarbud.ca",
        "market_cap": "Nano Cap"
    },
    "REPH": {
        "short_name": "Recro Pharma, Inc.",
        "long_name": "Recro Pharma, Inc.",
        "summary": "Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Malvern, Pennsylvania.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "PA",
        "city": "Malvern",
        "zipcode": "19355",
        "website": "http://www.recrogainesville.com",
        "market_cap": "Micro Cap"
    },
    "RGST": {
        "short_name": "ROGUE STATION COMPANIES INC",
        "long_name": "Rogue Station Companies, Inc.",
        "summary": "NX Uranium, Inc. acquires, explores, and develops uranium and minerals. The company was formerly known as NX Capital Co. and changed its name to NX Uranium, Inc. in September 2014. NX Uranium, Inc. was founded in 2004 and is based in Baton Rouge, Louisiana.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "LA",
        "city": "Baton Rouge",
        "zipcode": "70816",
        "website": "http://www.nxuranium.com",
        "market_cap": "Nano Cap"
    },
    "RICH.BA": {
        "short_name": "LAB RICHMOND",
        "long_name": "Laboratorios Richmond S.A.C.I.F.",
        "summary": "Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antivirals for the treatment of HIV and HCV; oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, cholesterol-lowering, and anti platelet drugs; and psychiatric drugs comprising analgesic, anti psychotic, anti depressive, anti dementia, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company sells its products in Latin America, Africa, Asia, and the Middle East. Laboratorios Richmond S.A.C.I.F. was founded in 1935 and is based in Buenos Aires, Argentina.",
        "currency": "ARS",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "BUE",
        "market": "ar_market",
        "country": "Argentina",
        "state": null,
        "city": "Buenos Aires",
        "zipcode": "C1106ABJ",
        "website": "http://www.richmondlab.com",
        "market_cap": "Micro Cap"
    },
    "RIG2.F": {
        "short_name": "RICHT.GEDE.VEG.GYAR UF100",
        "long_name": "Richter Gedeon Vegy\u00e9szeti Gy\u00e1r Nyilv\u00e1nosan Muk\u00f6do Rt.",
        "summary": "Richter Gedeon Vegy\u00c3\u00a9szeti Gy\u00c3\u00a1r Nyilv\u00c3\u00a1nosan Muk\u00c3\u00b6do Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. The company operates through two segments, Pharmaceuticals, and Wholesale and Retail. It develops and manufactures products in various therapeutic areas, including women's healthcare, cardiovascular, and central nervous system. The company women's healthcare products include contraceptives, endometriosis, fertility, menopause, vaginal infections, and preparations used for the treatment of uterine fibroids. It also offers central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Escapelle and Postinor, an emergency contraceptive pill; Panangin and Folik for pregnancy supplementation; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Groprinosin for antiviral and immunostimulant; Moilec for back and joint pain; Fasconal, a pain relief tablet; Magnezin, a magnesium supplementation; Aflamil, an anti-inflammatory and antirheumatic cream; Oralsept, a sore throat, anti-inflammatory, local anesthetic, and before and after oral surgery spray; Lordestin for allergy; and Curiosin for wound care. Further, it provides financial and accounting, social welfare, portfolio and project management, catering, carriage transportation, engineering, quality control, trading, asset management, and biotechnological services. The company was founded in 1901 and is headquartered in Budapest, Hungary.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Hungary",
        "state": null,
        "city": "Budapest",
        "zipcode": "1103",
        "website": "http://www.richter.hu",
        "market_cap": "Mid Cap"
    },
    "RIV.TO": {
        "short_name": "RIV CAPITAL INC",
        "long_name": "RIV Capital Inc.",
        "summary": "RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, and media and content. The firm also focuses on beverages, capsules and concentrates, edibles, dry flower / pre-rolls, vaporizers and hardware, pet products, and topicals. In agriculture and food sciences firm focuses in invest plant science, soil science, food science, animal science and environmental science. In production firm focuses in Indoor cultivation, greenhouse cultivation, outdoor cultivation, nursery cultivation and fermentation. In processing firm focuses in harvesting, extraction and purification, packaging, food and beverage processing and laboratory testing services. In pharmaceuticals and biotechnology firm focuses in pharmaceutical discovery and development, delivery method (ex: pill, soft gel, tincture), biosynthetic derived cannabinoids and other molecules, medical devices (ex: inhalers) and lab equipment. In consumer products and accessories firm focuses in edibles, beverages, inhalable, cosmetics and cannabis consumption accessories. In retail and distribution firm focuses in licensed brick and mortar retailers, pharmacies, online consumer marketplaces, delivery services, and others. The firm invests in opportunities globally. The firm prefers to invest in check sizes have ranged from CA$1 million ($0.71 million) to $40 million ($28.45 million), but more typical investment range is between CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm is focused on making minority stake investments. Firm employ diverse investment structures including debt, preferred and common equity, and production-linked royalties. RIV Capital Inc. was founded on 2017 and is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5H 3Y2",
        "website": "http://www.rivcapital.com",
        "market_cap": "Micro Cap"
    },
    "RJF.MC": {
        "short_name": "LABORATORIO REIG JOFRE, S.A.",
        "long_name": "Laboratorio Reig Jofre, S.A.",
        "summary": "Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements. The company offers prescription medicines, OTCs, medical devices, and cosmetics. Its products include pharmaceutical technologies products, such as antibiotics, and injectable and other products; specialty pharmacare products, which include skin, hair, and nail health, joint health and pain, women's health, respiratory/ENT, and pediatrics; and consumer healthcare products under the Fort\u00c3\u00a9 Pharma brand. The company also provides CDMO and CMO services. It sells its products directly in 7 countries and through business partners in approximately 70 countries. The company was founded in 1929 and is based in Sant Joan Desp\u00c3\u00ad, Spain. Laboratorio Reig Jofre, S.A. is a subsidiary of Reig Jofre Investments SL.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MCE",
        "market": "es_market",
        "country": "Spain",
        "state": null,
        "city": "Barcelona",
        "zipcode": "08970",
        "website": "http://www.reigjofre.com",
        "market_cap": "Small Cap"
    },
    "RLMD": {
        "short_name": "Relmada Therapeutics, Inc.",
        "long_name": "Relmada Therapeutics, Inc.",
        "summary": "Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, an oral agent, which is in Phase II clinical trial for the treatment of depression, neuropathic pain, and other potential CNS pathological conditions. The company is also developing LevoCap ER, an abuse resistant, sustained release dosage form of the opioid analgesic levorphanol; BuTab, an oral dosage form of the opioid analgesic buprenorphine; and MepiGel, an orphan drug designated topical formulation of the local anesthetic mepivacaine. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in New York, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "New York",
        "zipcode": "10022",
        "website": "http://www.relmada.com",
        "market_cap": "Small Cap"
    },
    "RLS.ST": {
        "short_name": "RLS Global AB",
        "long_name": "RLS Global AB (publ)",
        "summary": "RLS Global AB (publ), a medical technology company, develops and sells products for the treatment of diseases in wound and dental care in Sweden. Its products include ChloraSolv that is used for the treatment of chronic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for treating caries. The company was founded in 1996 and is based in M\u00c3\u00b6lndal, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "M\u00c3\u00b6lndal",
        "zipcode": "431 53",
        "website": "http://rls.global",
        "market_cap": "Nano Cap"
    },
    "RMRK": {
        "short_name": "RIMROCK GOLD CORP",
        "long_name": "Rimrock Gold Corp.",
        "summary": "Rimrock Gold Corp., through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts. The company was incorporated in 2007 and is based in Las Vegas, Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89103",
        "website": "http://www.rimrockgold.com",
        "market_cap": "Nano Cap"
    },
    "RMTI": {
        "short_name": "Rockwell Medical, Inc.",
        "long_name": "Rockwell Medical, Inc.",
        "summary": "Rockwell Medical, Inc. operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "MI",
        "city": "Wixom",
        "zipcode": "48393",
        "website": "http://www.rockwellmed.com",
        "market_cap": "Micro Cap"
    },
    "ROMJ.V": {
        "short_name": "RUBICON ORGANICS INC",
        "long_name": "Rubicon Organics Inc.",
        "summary": "Rubicon Organics Inc. produces and sells organic cannabis in Canada. The company processes organic cannabis at its federally licensed 125,000 square foot facility in Delta, British Columbia and sells under its wholly owned and other licensed brands. Rubicon Organics Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1A5",
        "website": "http://www.rubiconorganics.com",
        "market_cap": "Micro Cap"
    },
    "ROMJF": {
        "short_name": "RUBICON ORGANICS INC",
        "long_name": "Rubicon Organics Inc.",
        "summary": "Rubicon Organics Inc. produces and sells organic cannabis in Canada. The company processes organic cannabis at its federally licensed 125,000 square foot facility in Delta, British Columbia and sells under its wholly owned and other licensed brands. Rubicon Organics Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1A5",
        "website": "http://www.rubiconorganics.com",
        "market_cap": "Micro Cap"
    },
    "ROSE.BA": {
        "short_name": "INSTITUTO ROSENBUC",
        "long_name": "Instituto Rosenbusch S.A.",
        "summary": "Instituto Rosenbusch S.A. researches, develops, manufactures, and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory and nervous complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; vaccines for the prevention of reproductive diseases; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious keratoconjunctivitis. It also provides pharmaceutical products, such as external and internal antiparasitics, endectocides, antimicotics-bacteriostatics, injectable antibiotics, antimastitics, and other chemotherapics, as well as vitamins and minerals. The company was founded in 1917 and is based in Buenos Aires, Argentina.",
        "currency": "ARS",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "BUE",
        "market": "ar_market",
        "country": "Argentina",
        "state": null,
        "city": "Buenos Aires",
        "zipcode": "1136",
        "website": "http://www.rosenbusch.com",
        "market_cap": "Nano Cap"
    },
    "RPGLIFE.NS": {
        "short_name": "RPG LIFE SCIENCES",
        "long_name": "RPG Life Sciences Limited",
        "summary": "RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. It operates through Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients segments. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It also provides generics primarily in the area of immunosuppressant therapy; and finished dosage formulations for various therapies, such as nephrology, oncology, urology, respiratory, vitamins and minerals, gastro intestinal, pain management, cardio-vascular, etc. primarily under the Lomotil, Lomofen+, Naprosyn, Azoran, Aldactone, and Serenace brands. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400030",
        "website": "http://www.rpglifesciences.com",
        "market_cap": "Micro Cap"
    },
    "RPNRF": {
        "short_name": "RAPID NUTRITION PLC",
        "long_name": "Rapid Nutrition PLC",
        "summary": "Rapid Nutrition PLC, a natural healthcare company, researches, develops, and produces a range of life science products. The company offers meal replacement shakes, energy boosting tablets, weight loss tablets, and appetite suppressant powders under the Leisa's Secret brand; and high protein shakes, high fiber bars, organic multivitamins, fat burning shots, and grain granola cereals under the SystemLS brand. It primarily exports its products in Asia, Europe, Africa, the Middle East, North America, and Australia. The company was incorporated in 2001 and is based in London, the United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "WC1N 3AX",
        "website": "http://www.rnplc.com",
        "market_cap": "Nano Cap"
    },
    "RSCI": {
        "short_name": "REDWOOD SCIENTIFIC TECHNOLOGIES",
        "long_name": "Redwood Scientific Technologies, Inc.",
        "summary": "Redwood Scientific Technologies, Inc. develops and markets over-the-counter FDA registered drugs through oral strip delivery technology. The company is based in Claremont, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Claremont",
        "zipcode": "91711",
        "website": "http://www.redwoodscientific.co",
        "market_cap": "Nano Cap"
    },
    "RTI.V": {
        "short_name": "RADIENT TECHNOLOGIES INC",
        "long_name": "Radient Technologies Inc.",
        "summary": "Radient Technologies Inc. processes, sells, and distributes cannabis materials in Canada. It offers cannabis oil, standardized cannabinoid ingredients, cannabis extracts, and cannabis formulations. The company also provides extraction services for the extraction, purification and isolation of cannabinoids for third parties. Its ingredients are used in natural food and beverage products, personal care products, and nutraceutical and pharmaceutical products. Radient Technologies Inc. was founded in 2001 and is headquartered in Edmonton, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "AB",
        "city": "Edmonton",
        "zipcode": "T6E 5A6",
        "website": "http://www.radientinc.com",
        "market_cap": "Nano Cap"
    },
    "RUA.NZ": {
        "short_name": "RUA Bioscience Limited Ordinary",
        "long_name": "Rua Bioscience Limited",
        "summary": "Rua Bioscience Limited, a pharmaceutical company, focuses on the research, cultivation, extraction, and manufacturing parts of the medicinal cannabis supply chain in New Zealand. It also exports bioactive extracts and products internationally. Rua Bioscience Limited has research and commercial partnerships with Crown Research Institutes and Universities Collaboration; Medical Research Institute of New Zealand; and Plant and Food New Zealand. The company was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. Rua Bioscience Limited was founded in 2016 and is based in Gisborne, New Zealand.",
        "currency": "NZD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NZE",
        "market": "nz_market",
        "country": "New Zealand",
        "state": null,
        "city": "Gisborne",
        "zipcode": "4071",
        "website": "http://www.ruabio.com",
        "market_cap": "Nano Cap"
    },
    "RVV.CN": {
        "short_name": "ReviveThera",
        "long_name": "Revive Therapeutics Ltd.",
        "summary": "Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers novel cannabinoid-centric treatments for liver diseases, inflammatory diseases, and skin disorders. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and coronavirus disease; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocybin oral formulations for the treatment of depression, anxiety, etc.; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. Revive Therapeutics Ltd. has a research collaboration agreement with PharmaTher Inc. for the development of psilocybin in the treatment of cancer and the discovery of other uses of undisclosed psychedelic compounds; and with North Carolina State University for the development of a novel biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform, as well as a research agreement with the University of California, San Francisco to explore the use of Bucillamine as a treatment for severe COVID-19. The company was incorporated in 2012 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 1P1",
        "website": "http://www.revivethera.com",
        "market_cap": "Micro Cap"
    },
    "RVVQF": {
        "short_name": "RAVENQUEST BIOMED INC",
        "long_name": "RavenQuest BioMed Inc.",
        "summary": "RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis. It offers its products under the Lore Cannabis and Bloomera brand names. The company was formerly known as Ravencrest Resources Inc. and changed its name to RavenQuest BioMed Inc. in September 2017. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2K3",
        "website": "http://www.rqbglobal.com",
        "market_cap": "Nano Cap"
    },
    "RVVTF": {
        "short_name": "REVIVE THERAPEUTICS LTD",
        "long_name": "Revive Therapeutics Ltd.",
        "summary": "Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers novel cannabinoid-centric treatments for liver diseases, inflammatory diseases, and skin disorders. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and coronavirus disease; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocybin oral formulations for the treatment of depression, anxiety, etc.; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. Revive Therapeutics Ltd. has a research collaboration agreement with PharmaTher Inc. for the development of psilocybin in the treatment of cancer and the discovery of other uses of undisclosed psychedelic compounds; and with North Carolina State University for the development of a novel biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform, as well as a research agreement with the University of California, San Francisco to explore the use of Bucillamine as a treatment for severe COVID-19. The company was incorporated in 2012 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 1P1",
        "website": "http://www.revivethera.com",
        "market_cap": "Micro Cap"
    },
    "RWB.CN": {
        "short_name": "RedWhite&Bloom",
        "long_name": "Red White & Bloom Brands Inc.",
        "summary": "Red White & Bloom Brands Inc. engages in the cultivation and retail of cannabis products primarily in Michigan, Illinois, Massachusetts, California, and Florida. The company is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1H2",
        "website": "http://www.redwhitebloom.com",
        "market_cap": "Micro Cap"
    },
    "RWBYF": {
        "short_name": "RED WHITE & BLOOM BRANDS INC",
        "long_name": "Red White & Bloom Brands Inc.",
        "summary": "Red White & Bloom Brands Inc. engages in the cultivation and retail of cannabis products primarily in Michigan, Illinois, Massachusetts, California, and Florida. The company is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1H2",
        "website": "http://www.redwhitebloom.com",
        "market_cap": "Micro Cap"
    },
    "RWM.F": {
        "short_name": "ROCKWELL MEDICAL INC.",
        "long_name": "Rockwell Medical, Inc.",
        "summary": "Rockwell Medical, Inc. operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "MI",
        "city": "Wixom",
        "zipcode": "48393",
        "website": "http://www.rockwellmed.com",
        "market_cap": "Micro Cap"
    },
    "RX.V": {
        "short_name": "BIOSYENT INC.",
        "long_name": "BioSyent Inc.",
        "summary": "BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX 150, an oral hematinic; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; and FeraMAX Pd Therapeutic 150 for the prevention and treatment of iron deficiency anemia. It also offers Cathejell, a product indicated for surface anesthesia and lubrication during various procedures, including cystoscopy, catheterization, endourethral operation, endoscopy, proctoscopy, rectoscopy, and tracheal intubation, as well as used for the symptomatic treatment of pain in connection with cystitis and urethritis;  ; Aguettant System for pre-filled syringes that are used for various injectable medications in hospital and acute care settings; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by menopause, stress, and chemotherapy; Proktis-M, a rectal suppository for the healing of the anus and rectum; and Cysview, an adjunct to white-light cystoscopy for the detection and management of non-muscle invasive papillary bladder cancer. In addition, it provides Combogesic for moderate acute pain and reduction of fever in adults; Protect-It, a non-chemical food-safe grain insecticide product used as a preventative treatment against insect infestations in stored grains; and Tibella, a hormone replacement therapy to treat vasomotor symptoms due to estrogen deficiency. The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BioSyent Inc. is headquartered in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5N 6M1",
        "website": "http://www.biosyent.com",
        "market_cap": "Micro Cap"
    },
    "RXEI": {
        "short_name": "RXELITE INC",
        "long_name": "RxElite, Inc.",
        "summary": "RxElite, Inc. engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets. Its products include Sterile Liquid Dose products that consist of generic ophthalmic products in unit and multi-dose presentations, sterile unit dose inhalation respiratory products, and injectable drugs. The company, through its subsidiaries, also manufactures active pharmaceutical ingredients for pharmaceutical companies in the United States, Europe, and Asia. Its customers include hospitals and hospital group purchasing organizations, national and regional wholesalers, direct retail pharmacy stocking chains, homecare companies, and outpatient surgery centers and ambulatory care clinics. The company has partnership agreements with Stason Pharmaceuticals, Inc.; Alkem Laboratories Limited; and Zach Systems S.p.A. RxElite is headquartered in Meridian, Idaho. RxElite Inc. operates as a subsidiary of Piramal Healthcare Ltd.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "ID",
        "city": "Meridian",
        "zipcode": "83642",
        "website": "http://www.piramalcriticalcare.com",
        "market_cap": "Nano Cap"
    },
    "S49.F": {
        "short_name": "SUPERNUS PHARMAC.DL -,001",
        "long_name": "Supernus Pharmaceuticals, Inc.",
        "summary": "Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. Its commercial products include Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset epilepsy seizures in adults and children between 6 to 17 years of age. The company's commercial products also comprise APOKYN, a product indicated for the acute intermittent treatment of hypomobility or off episodes in patients with advanced Parkinson's Disease (PD); XADAGO, a product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD experiencing off episodes; and MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and sialorrhea in adults. In addition, its product candidates include SPN-812, which has completed Phase III clinical trials that is used for the treatment of attention deficit hyperactivity disorder (ADHD); SPN-830, a late-stage drug/device combination product candidate for the prevention of off episodes in PD; SPN-817, a novel product candidate in Phase I clinical trials for the treatment of severe epilepsy; and SPN-820, a novel product candidate in Phase I clinical trials for treatment resistant depression. The company markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. It has a development and option agreement with Navitor Pharmaceuticals, Inc. to conduct a Phase II clinical program for NV-5138 in treatment-resistant depression. The company was founded in 2005 and is headquartered in Rockville, Maryland.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "MD",
        "city": "Rockville",
        "zipcode": "20850",
        "website": "http://www.supernus.com",
        "market_cap": "Small Cap"
    },
    "S7C.F": {
        "short_name": "STENOCARE  DK-,08",
        "long_name": "Stenocare A/S",
        "summary": "Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products in the Danish and European markets. It offers medical cannabis oil products. The company was founded in 2017 and is headquartered in Aller\u00c3\u00b8d, Denmark.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Denmark",
        "state": null,
        "city": "Aller\u00c3\u00b8d",
        "zipcode": "3450",
        "website": "http://stenocare.dk",
        "market_cap": "Nano Cap"
    },
    "SAGD": {
        "short_name": "SOUTH AMERICAN GOLD CORP",
        "long_name": "Sativa Growth International",
        "summary": "South American Gold Corp. focuses on acquiring and operating cannabis and tech assets. It provides medical marijuana products. The company was formerly known as Grosvenor Explorations Inc. and changed its name to South American Gold Corp. in October 2010. South American Gold Corp. was founded in 2005 and is based in Las Vegas, Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89123",
        "website": "http://www.sativagrowth.com",
        "market_cap": "Nano Cap"
    },
    "SAKAR.NS": {
        "short_name": "SAKAR HEALTHCARE L",
        "long_name": "Sakar Healthcare Limited",
        "summary": "Sakar Healthcare Limited manufactures and sells pharmaceutical products in India. It offers pharmaceutical products in various forms, such as oral liquid syrups and suspensions, cephalosporin dry powder injections, liquid injectable in ampoules and vials, and lyophilized injections, as well as cephalosporin tablets, and capsules. The company also develops oncology products. It exports its products to approximately 38 countries, including South East Asia, Asia, Africa-Anglo and Francophone, MENA countries, and America. The company was founded in 2004 and is based in Ahmedabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Ahmedabad",
        "zipcode": "380007",
        "website": "http://www.sakarhealthcare.com",
        "market_cap": "Nano Cap"
    },
    "SARSF": {
        "short_name": "CANADA HOUSE WELLNESS GROUP INC",
        "long_name": "Canada House Wellness Group Inc.",
        "summary": "Canada House Wellness Group Inc., through its subsidiaries, provides medical grade cannabis products in Canada. The company offers cannabinoid therapy products and services to patients, as well as owns and operates medicinal cannabis clinics; and a licensed dispensary. It also provides a cloud-based software that links physicians, providers, and patients to data that supports treatment with medical cannabis. The company is headquartered in Pickering, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Pickering",
        "zipcode": "ON L1W",
        "website": "http://www.canadahouse.ca",
        "market_cap": "Nano Cap"
    },
    "SBBC.V": {
        "short_name": "SIMPLY BETTER BRANDS CORP",
        "long_name": "Simply Better Brands Corp.",
        "summary": "PureK Holdings Corp. manufactures and sells hemp based cannabidiol related products in the United States. The company offers tinctures, capsules, gummies, oils, edibles, topicals, sprays, vape pens, pet treats, and bath bombs, as well as tees, hoodies, beanies, caps, and other related products. It distributes its products through e-commerce website PureKana.com, as well as through retail stores, including larger retail chains and small independent retailers; wholesalers; and various brick and mortar retailers. The company was founded in 2017 and is headquartered in Paradise Valley, Arizona. PureK Holdings Corp. is a subsidiary of Heavenly Rx Ltd.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "United States",
        "state": "AZ",
        "city": "Paradise Valley",
        "zipcode": "85253",
        "website": "http://purekana.com",
        "market_cap": "Micro Cap"
    },
    "SBFM": {
        "short_name": "SUNSHINE BIOPHARMA INC",
        "long_name": "Sunshine Biopharma, Inc.",
        "summary": "Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also provides generic prescription drugs for the treatment of breast cancer, prostate cancer, and benign prostatic hyperplasia; and Essential 9, a dietary supplement tablet. Sunshine Biopharma, Inc. has a license agreement with the University of Georgia to advance the development of two anti-coronavirus compounds in parallel with its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. was founded in 2006 and is headquartered in Pointe-Claire, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "QC",
        "city": "Pointe-Claire",
        "zipcode": "H9R 0A5",
        "website": "http://www.sunshinebiopharma.com",
        "market_cap": "Micro Cap"
    },
    "SBUDF": {
        "short_name": "SUGARBUD CRAFT GROWERS CORP",
        "long_name": "SugarBud Craft Growers Corp.",
        "summary": "SugarBud Craft Growers Corp. engages in the acquisition, development, production, and distribution of cannabis products in Canada. The company was formerly known as Relentless Resources Ltd. and changed its name to SugarBud Craft Growers Corp. in October 2018. SugarBud Craft Growers Corp. is headquartered in Calgary, Alberta.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2P 0S4",
        "website": "http://www.sugarbud.ca",
        "market_cap": "Nano Cap"
    },
    "SCNA": {
        "short_name": "SMART CANNABIS CORP",
        "long_name": "Smart Cannabis Corp.",
        "summary": "Smart Cannabis Corp. operates in the agriculture and cannabis industries. The company, through its subsidiary, Next Generation Farming, Inc., provides turnkey, automated, commercial greenhouses systems that improve yields and decrease water consumption for cultivators of organic food and cannabis crops. The company was founded in 2010 and is based in Loomis, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Loomis",
        "zipcode": "95650",
        "website": "http://smartcannabis.com",
        "market_cap": "Micro Cap"
    },
    "SCNNF": {
        "short_name": "SATIVA WELLNESS GROUP INC",
        "long_name": "Sativa Wellness Group Inc.",
        "summary": "Sativa Wellness Group Inc. operates as a CBD wellness company. The company engages in the cultivation and extraction of cannabinoids. It also sells CBD products to wholesale and online retail markets, as well as white label CBD products for third party brands. The company is based in North Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "North Vancouver",
        "zipcode": "V7M 3J3",
        "website": "http://www.sativawellnessgroup.com",
        "market_cap": "Nano Cap"
    },
    "SCU.AX": {
        "short_name": "STEMCELL FPO",
        "long_name": "Stemcell United Limited",
        "summary": "Stemcell United Limited, together with its subsidiaries, engages in the sourcing, producing, marketing, and selling of traditional medicine in Australia, Singapore, Greater China, and Malaysia. The company's products include Cannabis Sativa, an industrial hemp; Dendrobium Officinale Kimura et Migo, an orchid extract; Resina, a Daemonorops Draco Blume extract; and Caulerpa Lentillifera, a sea grape extract. The company has a collaboration agreement with Temasek Polytechnic of Singapore to conduct joint research on the application of plant stem cell technology to the cultivation and commercial farming of seagrapes in Singapore. The company was formerly known as On Q Group Limited and changed its name to Stemcell United Limited in September 2015. Stemcell United Limited was incorporated in 1984 and is headquartered in Sydney, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Sydney",
        "zipcode": "2000",
        "website": "http://www.scu.com.sg",
        "market_cap": "Nano Cap"
    },
    "SCYX": {
        "short_name": "SCYNEXIS, Inc.",
        "long_name": "SCYNEXIS, Inc.",
        "summary": "SCYNEXIS, Inc., a biotechnology company, delivers therapies for the treatment fungal infections in the United States. It is developing its lead product candidate, ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company develops ibrexafungerp, which has completed Phase II clinical trials for the treatment of vulvovaginal candidiasis. It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "Jersey City",
        "zipcode": "07302-6548",
        "website": "http://www.scynexis.com",
        "market_cap": "Micro Cap"
    },
    "SE.CN": {
        "short_name": "SweetEarthHldng",
        "long_name": "Sweet Earth Holdings Corporation",
        "summary": "Sweet Earth Holdings Corporation cultivates, processes, and sells hemp Cannabidiol (CBD) products. The company offers cosmetics products, including hemp hydrating oat and honey facial cleanser, balancing jasmine body oil, hydration cream, salve, lip balm, hydrating cleanser, hand sanitizer, balancing body oil, organic body scrub, rejuvenating salt soak, and muscle recovery rub. It also provides CBD dog treats comprising beef and cheddar potato; turkey and sweet potato; peanut butter crunch; sweet potato cranberry; pumpkin flax; apple carrot oat; and antioxidant blueberry fax. The company is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2Y3",
        "website": "http://www.sweetearthcbd.com",
        "market_cap": "Nano Cap"
    },
    "SECARE.ST": {
        "short_name": "Swedencare AB",
        "long_name": "Swedencare AB (publ)",
        "summary": "Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells pet healthcare products. It offers ProDen PlaqueOff powder, a food supplement for cats and dogs, which reduce the formation of plaque and tartar; ProDen PlaqueOff dental bites, a pet dental product; ProDen PlaqueOff powder cat; ProDen PlaqueOff dental bones for dogs; ProDen PlaqueOff mini dental care bones, a chewy bone for smaller dogs; and ProDen PlaqueOff soft chews for dogs and cats. The company also provides dietary supplements for cats, dogs, and horses under the NutriScience brand, such as Glucosamine and Stomax used to renew joint cartilage, bones, muscles, ligaments, and sinews; ArthriAid for joints and mobility; KalmAid, which helps to calm nervous dogs; and OmegaAid and RevitalAid, a feed supplement used for healthy skin and coat. In addition, it develops and manufactures equine supplements, including Gastrocare used to relieve gastric pain and improve appetite; Equine Gold, which helps horse to thrive; ArthriAid used to aid horse's own natural manufacture of cartilage; and AnxiKalm, a supplement to calm excitable horses. Further, the company provides ProDen PlaqueOff teeth and gums, a natural food supplement to enhance dental hygiene and prevent tartar buildup for human. It distributes its products through pharmacies, veterinary clinics, pet shops, animal hospital, and online. Swedencare AB (publ) was incorporated in 1993 and is headquartered in Malm\u00c3\u00b6, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Malm\u00c3\u00b6",
        "zipcode": "205 12",
        "website": "http://www.swedencare.se",
        "market_cap": "Micro Cap"
    },
    "SEHCF": {
        "short_name": "SWEET EARTH HOLDINGS CORPORATIO",
        "long_name": "Sweet Earth Holdings Corporation",
        "summary": "Sweet Earth Holdings Corporation cultivates, processes, and sells hemp Cannabidiol (CBD) products. The company offers cosmetics products, including hemp hydrating oat and honey facial cleanser, balancing jasmine body oil, hydration cream, salve, lip balm, hydrating cleanser, hand sanitizer, balancing body oil, organic body scrub, rejuvenating salt soak, and muscle recovery rub. It also provides CBD dog treats comprising beef and cheddar potato; turkey and sweet potato; peanut butter crunch; sweet potato cranberry; pumpkin flax; apple carrot oat; and antioxidant blueberry fax. The company is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2Y3",
        "website": "http://www.sweetearthcbd.com",
        "market_cap": "Nano Cap"
    },
    "SEQUENT.NS": {
        "short_name": "SEQUENT SCIENTIFIC",
        "long_name": "Sequent Scientific Limited",
        "summary": "Sequent Scientific Limited operates as an integrated pharmaceutical company in India, Europe, rest of Asia, and internationally. The company offers animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, antibacterial, anthelmintics, anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also provides analytical solutions, including method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. As of September 8, 2020, Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400604",
        "website": "http://www.sequent.in",
        "market_cap": "Small Cap"
    },
    "SESI": {
        "short_name": "SES SOLAR INC",
        "long_name": "SES Solar Inc.",
        "summary": "SES Solar Inc. develops and delivers products in the field of photovoltaic energy in Switzerland. The company offers a range of photovoltaic products, such as solar tiles that comprise standard panels primarily for urban or rural areas, and flat or sloped roofs; and custom/architecturally integrated panels made of glass/glass tedlar, which are used for glazing, light admitting apertures in industrial and residential buildings, as well as for veranda roofs. It also handles project management services from design to completion, as well as provides monitoring (supervision), maintenance, and operation services. The company was founded in 2001 and is based in Plan-les-Ouates, Switzerland. As of November 23, 2010, SES Solar Inc. operates as a subsidiary of Flannel Management S\u00c3\u00a0rl.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Switzerland",
        "state": null,
        "city": "Plan-les-Ouates",
        "zipcode": "1228",
        "website": "http://www.societe-energie-solaire.com",
        "market_cap": "Nano Cap"
    },
    "SFLM": {
        "short_name": "SFLMAVEN CORP",
        "long_name": "SFLMaven, Inc.",
        "summary": "DNA Dynamics, Inc., through its subsidiaries, develops mobile applications and games for smartphones and tablet devices. It develops and publishes games for Apple iPhone/iPad/iPod touch and Android platforms; and develops video games and applications for mobile devices and handheld consoles. The company develops games across seven platforms, including titles for TV brands and intellectual property holders. DNA Dynamics, Inc. was incorporated in 1981 and is headquartered in Leamington Spa, United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Leamington Spa",
        "zipcode": "CV32 5LW",
        "website": "http://www.dnadynamicsinc.com",
        "market_cap": null
    },
    "SFOSF": {
        "short_name": "SHANGHAI FOSUN PHARMACEUTICAL G",
        "long_name": "Shanghai Fosun Pharmaceutical (Group) Co., Ltd.",
        "summary": "Shanghai Fosun Pharmaceutical (Group) Co., Ltd. researches, develops, manufactures, trades, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing and Research and Development, Healthcare Service, Medical Devices and Medical Diagnosis, Pharmaceutical Distribution and Retail, and Other business Operations. It offers pharmaceutical products in the areas of metabolic and digestive system; antitumor; anti-infective; central nervous system drugs; cardiovascular system; blood system; vaccines; and APIs and intermediates. The company also provides medical diagnosis and medical device products in the field of in vitro diagnostics, the products involve clinical chemistry, clinical immunity, molecular diagnostics, gene chip technology, clinical microbiology, and other fields of laboratory medicine. In addition, it offers medical services in various hospitals. The company was formerly known as Shanghai Fosun Industrial Co. Ltd. and changed its name to Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in December 2004. The company was founded in 1994 and is based in Shanghai, China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Shanghai",
        "zipcode": "200233",
        "website": "http://www.fosunpharma.com",
        "market_cap": "Large Cap"
    },
    "SFZN.SW": {
        "short_name": "SIEGFRIED N",
        "long_name": "Siegfried Holding AG",
        "summary": "Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling liquid dosage forms. It offers contract development and manufacturing services, including process and chemical development, analytical development, pilot manufacturing and scale up, and commercial manufacturing. The company also provides APIs and controlled substances focusing on anesthetics, pain/addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.",
        "currency": "CHF",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "EBS",
        "market": "ch_market",
        "country": "Switzerland",
        "state": null,
        "city": "Zofingen",
        "zipcode": "4800",
        "website": "http://www.siegfried.ch",
        "market_cap": "Mid Cap"
    },
    "SGIOF": {
        "short_name": "SHIONOGI & CO",
        "long_name": "Shionogi & Co., Ltd.",
        "summary": "Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. Its primary products Tivicay for HIV treatment; Mulpleta for the treatment of thrombocytopenia; Xofluza, an influenza drug; Symproic for opioid-induced constipation treatment; and Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment. The company also offers antibody detection kits for COVID-19. Shionogi & Co., Ltd. has collaboration agreements with InveniAI, LLC.; Hsiri Therapeutics Inc.; Nagasaki University; Roche Group to develop and commercialize Xofluza; and Nagasaki University and The Kitasato Institute to develop antimalarial drugs and vaccines. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Japan",
        "state": null,
        "city": "Osaka",
        "zipcode": "541-0045",
        "website": "http://www.shionogi.com",
        "market_cap": "Large Cap"
    },
    "SGIOY": {
        "short_name": "SHIONOGI & CO",
        "long_name": "Shionogi & Co., Ltd.",
        "summary": "Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. Its primary products Tivicay for HIV treatment; Mulpleta for the treatment of thrombocytopenia; Xofluza, an influenza drug; Symproic for opioid-induced constipation treatment; and Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment. The company also offers antibody detection kits for COVID-19. Shionogi & Co., Ltd. has collaboration agreements with Hsiri Therapeutics Inc.; Nagasaki University; Roche Group to develop and commercialize Xofluza; and Nagasaki University and The Kitasato Institute to develop antimalarial drugs and vaccines. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Japan",
        "state": null,
        "city": "Osaka",
        "zipcode": "541-0045",
        "website": "http://www.shionogi.com",
        "market_cap": "Large Cap"
    },
    "SH0.F": {
        "short_name": "SHIONOGI + CO. LTD",
        "long_name": "Shionogi & Co., Ltd.",
        "summary": "Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. Its primary products Tivicay for HIV treatment; Mulpleta for the treatment of thrombocytopenia; Xofluza, an influenza drug; Symproic for opioid-induced constipation treatment; and Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment. The company also offers antibody detection kits for COVID-19. Shionogi & Co., Ltd. has collaboration agreements with InveniAI, LLC.; Hsiri Therapeutics Inc.; Nagasaki University; Roche Group to develop and commercialize Xofluza; and Nagasaki University and The Kitasato Institute to develop antimalarial drugs and vaccines. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Japan",
        "state": null,
        "city": "Osaka",
        "zipcode": "541-0045",
        "website": "http://www.shionogi.com",
        "market_cap": "Large Cap"
    },
    "SHE.MI": {
        "short_name": "SHEDIR PHARMA GROUP",
        "long_name": "Shedir Pharma Group S.p.A.",
        "summary": "Shedir Pharma Group S.p.A. operators in the medical and pharmaceutical sector in Italy. It engages in the research and development of nutraceuticals, cosmetics, and medical devices. Its product lines include various pharmaceutical forms, including solid forms, such as capsule, softgel, chewable, and swallowable tablets, as well as buccal tablets powders and granules in sachets; liquid forms comprising oral solutions, drops and sprays for oral use, and sublingual and nasal, single-dose vials and douches; and creams and gels for cosmetic use, as well as topical sprays. The company is based in Naples, Italy.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MIL",
        "market": "it_market",
        "country": "Italy",
        "state": "NA",
        "city": "Naples",
        "zipcode": "80063",
        "website": "http://www.shedirpharma.com",
        "market_cap": "Micro Cap"
    },
    "SHIEF": {
        "short_name": "SHIELD THERAPEUTICS PLC",
        "long_name": "Shield Therapeutics plc",
        "summary": "Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of late-stage pharmaceuticals to treat unmet medical needs. The company's lead product is Ferric Maltol, marketed in the European Union as Feraccru, a non-salt based novel therapy for the treatment of iron deficiency anemia in patients with inflammatory bowel disease. Its advanced pipeline asset is PT20, a novel therapy that has completed its Phase II pivotal study for the treatment of hyperphosphatemia in patients with chronic kidney disease. The company also develops PT30 to treat hypo-allergenic IV iron therapy; and PT40, the first generic version of iron sucrose. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Gateshead",
        "zipcode": "NE8 3DF",
        "website": "http://www.shieldtherapeutics.com",
        "market_cap": "Micro Cap"
    },
    "SHILPAMED.NS": {
        "short_name": "SHILPA MEDICARE",
        "long_name": "Shilpa Medicare Limited",
        "summary": "Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally.. It offers API's for oncology and other therapeutic areas; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the generation and sale of wind power. Shilpa Medicare Limited was founded in 1987 and is headquartered in Raichur, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Raichur",
        "zipcode": "584135",
        "website": "http://www.vbshilpa.com",
        "market_cap": "Small Cap"
    },
    "SHMN": {
        "short_name": "SOHM INC",
        "long_name": "SOHM, Inc.",
        "summary": "SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. It offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. The company also exports its products. SOHM, Inc. was founded in 2005 and is based in Corona, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Corona",
        "zipcode": "92880",
        "website": "http://www.sohm.com",
        "market_cap": "Nano Cap"
    },
    "SIDO.JK": {
        "short_name": "Industri Jamu dan Farmasi Sido ",
        "long_name": "PT Industri Jamu dan Farmasi Sido Muncul Tbk",
        "summary": "PT Industri Jamu dan Farmasi Sido Muncul Tbk provides herbal medicines, cosmetics, and foods and beverages related to health in Indonesia and internationally. The company produces various medicines consisting of ethical products, OTC products, food supplements, and medical herbs. Its products include Anacetine, a medicine to reduce fever; Combicitrine, a medicine for bacteries/worms removal; Berlosid, a medicine for gastric pains; Anabion multivitamins for children; Suprabion multivitamins for adults; and Telon Oil. The company also manufactures herbal extracts, as well as offers confectionary products, energy and health drinks, and other products. In addition, it is involved in commerce and land transportation activities. The company was founded in 1940 and is headquartered in Semarang, Indonesia. PT Industri Jamu dan Farmasi Sido Muncul Tbk is a subsidiary of PT Hotel Candi Baru.",
        "currency": "IDR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JKT",
        "market": "id_market",
        "country": "Indonesia",
        "state": null,
        "city": "Semarang",
        "zipcode": "50134",
        "website": "http://www.sidomuncul.com",
        "market_cap": "Small Cap"
    },
    "SIGO": {
        "short_name": "SUNSET ISLAND GROUP INC",
        "long_name": "Sunset Island Group, Inc.",
        "summary": "Sunset Island Group, Inc., through its subsidiary, VBF Brands, engages in the cultivation of medical cannabis in California, the United States. It also offers consulting and services to clients that operate in the medical marijuana business. Sunset Island Group, Inc. was incorporated in 2005 and is based in San Clemente, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "San Clemente",
        "zipcode": "92672",
        "website": "http://www.sunsetislandgroup.com",
        "market_cap": "Nano Cap"
    },
    "SILO.CN": {
        "short_name": "SiloWellness",
        "long_name": "Silo Wellness Inc.",
        "summary": "FlyOverture Equity Inc. doing business as Silo Wellness, engages in producing plant and fungal-based compounds for natural wellness. It offers psilocybin nasal spray made from cannabis. FlyOverture Equity Inc. was formerly known as Eighteen Fifty Equity, Inc. The company was founded in 2018 and is headquartered in Springfield, Oregon.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "OR",
        "city": "Springfield",
        "zipcode": "97478",
        "website": "http://www.silowellness.com",
        "market_cap": null
    },
    "SKLV": {
        "short_name": "SKYE LIFE VENTURES LTD",
        "long_name": "SKYE Life Ventures Ltd.",
        "summary": "SuperDate Networks Inc. develops dating software application. It matches users through common interests and activities. SuperDate Networks Inc. was founded in 2012 and is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3L2",
        "website": "http://www.thesuperdate.com",
        "market_cap": "Nano Cap"
    },
    "SKYI": {
        "short_name": "SKY CENTURY INVESTMENT INC",
        "long_name": "Sky Century Investment, Inc.",
        "summary": "Sky Century Investment, Inc., a development stage company, intends to find and manage new music talents and bands in China. The company was formerly known as Band Rep Management, Inc. and changed its name to Sky Century Investment, Inc. in May 2017. The company was founded in 2012 and is based in Tsim Sha Tsui, Hong Kong.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Tsim Sha Tsui",
        "zipcode": null,
        "website": "http://skycenturygroup.com",
        "market_cap": "Small Cap"
    },
    "SLDB": {
        "short_name": "Solid Biosciences Inc.",
        "long_name": "Solid Biosciences Inc.",
        "summary": "Solid Biosciences Inc., a life science company, engages in developing therapies for duchenne muscular dystrophy (DMD) in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles. Its portfolio also comprises Anti-LTBP4, a complementary disease modifying program that identifies and develops a monoclonal antibody intended to reduce fibrosis and inflammation by targeting and stabilizing the LTBP4 protein. In addition, the company engages in developing biomarkers and sensors; and Solid Suit program that includes the development of wearable assistive devices that focus on providing functional and therapeutic benefits. Solid Biosciences Inc. has strategic collaboration with Ultragenyx to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "MA",
        "city": "Cambridge",
        "zipcode": "02139",
        "website": "http://www.solidbio.com",
        "market_cap": "Small Cap"
    },
    "SLGWF": {
        "short_name": "SLANG WORLDWIDE INC",
        "long_name": "SLANG Worldwide Inc.",
        "summary": "SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company worldwide. It owns, licenses, and/or markets 11 brands which serve flower, inhalable concentrates, and ingestibles, including edibles and pressed pills. The company was formerly known as Fire Cannabis Inc. and changed its name to SLANG Worldwide Inc. in November 2018. SLANG Worldwide Inc. was incorporated in 2017 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M4M 3G3",
        "website": "http://www.slangww.com",
        "market_cap": "Micro Cap"
    },
    "SLNG.CN": {
        "short_name": "SLANGWorldwide",
        "long_name": "SLANG Worldwide Inc.",
        "summary": "SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company worldwide. It owns, licenses, and/or markets 11 brands which serve flower, inhalable concentrates, and ingestibles, including edibles and pressed pills. The company was formerly known as Fire Cannabis Inc. and changed its name to SLANG Worldwide Inc. in November 2018. SLANG Worldwide Inc. was incorporated in 2017 and is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M4M 3G3",
        "website": "http://www.slangww.com",
        "market_cap": "Micro Cap"
    },
    "SLNX": {
        "short_name": "SOLANBRIDGE GROUP INC",
        "long_name": "Solanbridge Group, Inc.",
        "summary": "Solanbridge Group, Inc. intends to produce and sell medical marijuana in Nova Scotia, Canada. It also focuses on the development and sale of CBD-infused products in Nevada, California, and Colorado. The company was founded in 2000 and is headquartered in The Woodlands, Texas.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "TX",
        "city": "The Woodlands",
        "zipcode": "77380",
        "website": "http://www.solanbridgegroup.com",
        "market_cap": "Nano Cap"
    },
    "SNDL": {
        "short_name": "Sundial Growers Inc.",
        "long_name": "Sundial Growers Inc.",
        "summary": "Sundial Growers Inc. engages in production and marketing of cannabis products for the adult-use market in Canada. It produces and distributes inhalable products, such as flower, pre-rolls, and vapes. The company offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. Sundial Growers Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2R 1P3",
        "website": "http://www.sundialgrowers.com",
        "market_cap": "Small Cap"
    },
    "SNNC": {
        "short_name": "SIBANNAC INC",
        "long_name": "Sibannac, Inc.",
        "summary": "Sibannac, Inc. operates as a media and management services company. It serves businesses with online marketing, advertising, sales tracking, management consulting, and other informational services. The company also provides accounting, and expense and labor management systems to assist in compliance in the regulated industry environment. Sibannac, Inc. is based in Phoenix, Arizona.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "AZ",
        "city": "Phoenix",
        "zipcode": "85016",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "SNNVF": {
        "short_name": "SUNNIVA INC",
        "long_name": "Sunniva Inc.",
        "summary": "Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V7X 1T2",
        "website": "http://www.sunniva.com",
        "market_cap": "Nano Cap"
    },
    "SNOA": {
        "short_name": "Sonoma Pharmaceuticals, Inc.",
        "long_name": "Sonoma Pharmaceuticals, Inc.",
        "summary": "Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, a hypochlorous acid (HOCl) based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a product indicated to promote healing through the management of new and old scars resulting from surgical procedures and trauma wounds or burns; SebuDerm, a product indicated to manage and relieve the burning, itching, pain, and distraction associated with seborrhea and seborrheic dermatitis; and Ceramax, a Lipogrid based skin barrier cream for management of dry itchy skin, minor skin irritations, rashes, and inflammation caused by various skin conditions, as well as Loyon for the management of skin scaling. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a line of products designed to stimulate expedited healing by targeting various pathogens, as well as antibiotic-resistant strains that slow natural healing of wounds. In addition, the company offers MicrocynAH and MicrocynVS, which are HOCl-based solutions designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Pediacyn, Epicyn, Gramaderm, and Microdacyn for dermatoses, scar management, and acne; and Sinudox for nasal irrigation, including moistening of cuts, abrasions, and lacerations located in the nasal cavity. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "GA",
        "city": "Woodstock",
        "zipcode": "30102",
        "website": "http://www.sonomapharma.com",
        "market_cap": "Nano Cap"
    },
    "SOBI.ST": {
        "short_name": "Swedish Orphan Biovitrum AB",
        "long_name": "Swedish Orphan Biovitrum AB (publ)",
        "summary": "Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin associated periodic syndrome, rheumatoid arthritis, and still's disease; Orfadin to treat hereditary tyrosinaemia type-1; and Synagis for serious lower respiratory tract infection. The company It also provides other products, such as Akynzeo, Aloxi, Ammonul, Betapred, Caphosol, Fibclot, IVheBex, and Willfact. In addition, it develops drug substance for ReFacto AF/Xyntha for Pfizer; BIVV001 for haemophilia A; and Nirsevimab for respiratory syncytial virus. The company has a strategic collaboration with Apellis Pharmaceuticals Inc. to develop pegcetacoplan for the treatment of multiple rare diseases, including paroxysmal nocturnal hemoglobinuria. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Solna",
        "zipcode": "112 76",
        "website": "http://www.sobi.com",
        "market_cap": "Mid Cap"
    },
    "SOL.CN": {
        "short_name": "SOLGlobal",
        "long_name": "SOL Global Investments Corp.",
        "summary": "SOL Global Investments Corp. is a principal investment firm with a focus on the biopharmaceutical and cannabis industry in the United States. The company was formerly known as Scythian Biosciences Corp. and changed its name to SOL Global Investments Corp. in October 2018. SOL Global Investments Corp. is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5X 1C9",
        "website": "http://solglobal.com",
        "market_cap": "Micro Cap"
    },
    "SOLARA.NS": {
        "short_name": "SOLARA ACTIVE PHAR",
        "long_name": "Solara Active Pharma Sciences Limited",
        "summary": "Solara Active Pharma Sciences Limited manufactures and sells active pharmaceutical ingredients (API). The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, ant psoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and profiling. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Chennai",
        "zipcode": "600 032",
        "website": "http://www.solara.co.in",
        "market_cap": "Small Cap"
    },
    "SOLCF": {
        "short_name": "SOL GLOBAL INVESTMENTS CORP",
        "long_name": "SOL Global Investments Corp.",
        "summary": "SOL Global Investments Corp. is a principal investment firm with a focus on the biopharmaceutical and cannabis industry in the United States. The company was formerly known as Scythian Biosciences Corp. and changed its name to SOL Global Investments Corp. in October 2018. SOL Global Investments Corp. is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5X 1C9",
        "website": "http://solglobal.com",
        "market_cap": "Micro Cap"
    },
    "SPARC.NS": {
        "short_name": "SUN PHARMA ADV",
        "long_name": "Sun Pharma Advanced Research Company Limited",
        "summary": "Sun Pharma Advanced Research Company Limited engages in the research and development of pharmaceutical products in India and internationally. The company develops new chemical entities or reformulated products based on its proprietary novel drug delivery systems. Its core therapeutic areas of interest include oncology, inflammation, and neurodegenerative diseases, as well as abuse deterrent formulations. The company offers Levetiracetam ER for epilepsy; and Xelpros eye drops for Glaucoma. It is also developing Taclantis for the treatment of cancer; salmeterol-fluticasone dry powder inhaler for use in asthma and COPD; Baclofen GRS for spasticity; Brimonidine OD for glaucoma and ocular hypertension; and SDN-037 steroid eye drops used for the treatment of pain and inflammation following ocular surgery, and other inflammatory ocular conditions. In addition, the company engages in the development of SCO-088, a Bcr\u00c2\u0096Abl kinase inhibitor for treatment resistant chronic myelogenous leukaemia (CML); SDN-021, an abuse deterrent formulation; and SCD-044, a S1P receptor-1 agonist, which uses lymphocyte trafficking to treat auto-immune disorders. Further, it develops SCC\u00c2\u0096138 for Parkinson's disease; SDN\u00c2\u0096118, a formulation for treating depression; SDD-098 to treat acne; and SDE-124, a sub cutaneous injection of GLP-1 receptor agonists, as well as SCO-125 to treat CML. Sun Pharma Advanced Research Company Limited has a collaboration agreement with Bioprojet to develop S1P receptor 1 agonist for autoimmune disorders; and HitGen to identify small molecule leads for targets of interest. The company was incorporated in 2006 and is based in Mumbai, India. Sun Pharma Advanced Research Company Limited is a subsidiary of Shanghvi Finance Pvt. Ltd.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400093",
        "website": "http://www.sparc.life",
        "market_cap": "Small Cap"
    },
    "SPBBF": {
        "short_name": "SPEAKEASY CANNABIS CLUB LTD",
        "long_name": "Speakeasy Cannabis Club Ltd.",
        "summary": "Speakeasy Cannabis Club Ltd. focuses on producing medical cannabis in Canada. It owns approximately 290 acres of land in Rock Creek, British Columbia. The company is headquartered in Rock Creek, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Rock Creek",
        "zipcode": "V0H 1Y0",
        "website": "http://speakeasygrowers.com",
        "market_cap": "Mid Cap"
    },
    "SPLIF": {
        "short_name": "NUTRITIONAL HIGH INTERNATIONAL ",
        "long_name": "Nutritional High International Inc.",
        "summary": "Nutritional High International Inc. manufactures and processes hemp and marijuana-infused cannabis oils, extracts, and edible products for medical and adult recreation use in the United States and Canada. It offers cannabis-based vaping, concentrate, and infused edible products, such as oil vape cartridges, syringes, dab jars, and mints, as well as cannabis infused chocolates under the FL\u00c3\u008f brand name. The company also distributes other branded cannabis products. Nutritional High International Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5K 1H1",
        "website": "http://www.nutritionalhigh.com",
        "market_cap": "Nano Cap"
    },
    "SPR.CN": {
        "short_name": "SproutlyCdaInc",
        "long_name": "Sproutly Canada Inc.",
        "summary": "Sproutly Canada Inc. produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumable markets in Canada. It offers its products under the Caliber brand name. The company is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6B 2T5",
        "website": "http://www.sproutly.ca",
        "market_cap": "Nano Cap"
    },
    "SPRWF": {
        "short_name": "SUPREME CANNABIS CO INC",
        "long_name": "The Supreme Cannabis Company, Inc.",
        "summary": "The Supreme Cannabis Company, Inc. engages in the production of medical cannabis products in Canada. The company was formerly known as Supreme Pharmaceuticals Inc. and changed its name to The Supreme Cannabis Company, Inc. in December 2017. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M6J 2Z7",
        "website": "http://www.supreme.ca",
        "market_cap": "Micro Cap"
    },
    "SRUTF": {
        "short_name": "SPROUTLY CANADA INC",
        "long_name": "Sproutly Canada Inc.",
        "summary": "Sproutly Canada Inc. produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumable markets in Canada. It offers its products under the Caliber brand name. The company is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6B 2T5",
        "website": "http://www.sproutly.ca",
        "market_cap": "Nano Cap"
    },
    "STAR.NS": {
        "short_name": "STRIDES PHARMA SCI",
        "long_name": "Strides Pharma Science Limited",
        "summary": "Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australasia, North America, Europe, Asia, India, and internationally. The company offers pharma generics, including tablets, hard and soft gelatin capsules, sachets, oral liquids, and powders, as well as semi solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Clavicin, Combiart, Solcer, Melonax, Duotab, and Vitafer brands; and drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was founded in 1990 and is headquartered in Bengaluru, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Bengaluru",
        "zipcode": "560076",
        "website": "http://www.strides.com",
        "market_cap": "Small Cap"
    },
    "STAU": {
        "short_name": "STAR NUTRITION INC",
        "long_name": "Star Nutrition, Inc.",
        "summary": "Star Nutrition, Inc. engages in the manufacture of nutritional supplements, vitamins, and other over the counter health care products in the United States. Its products include incredisocks, incredibraces, and incredisoles used for foot and back pain. The company is based in Chico, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Chico",
        "zipcode": "95926-3948",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "STEM.CN": {
        "short_name": "StemHoldingsInc",
        "long_name": "Stem Holdings, Inc.",
        "summary": "Stem Holdings, Inc., together with its subsidiaries, operates as a vertically integrated cannabis operating company. It is involved in manufacture, possession, use, sale, distribution, and branding of cannabis and cannabis-infused products under the laws of the states of Oregon, Nevada, California, Massachusetts, and Oklahoma. As of December 30, 2020, the company had ownership interests in 22 state issued cannabis and hemp licenses, including 10 licenses for cannabis cultivation; 4 licenses for cannabis processing; 1 license for cannabis wholesale distribution; 1 license for hemp production and processing; 5 cannabis dispensary licenses; and 1 license that permits both dispensary and cultivation activities. Stem Holdings, Inc. was founded in 2016 and is headquartered in Boca Raton, Florida.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "FL",
        "city": "Boca Raton",
        "zipcode": "33431",
        "website": "http://www.stemholdings.com",
        "market_cap": "Micro Cap"
    },
    "STENO.CO": {
        "short_name": "STENOCARE A/S",
        "long_name": "Stenocare A/S",
        "summary": "Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products in the Danish and European markets. It offers medical cannabis oil products. The company was founded in 2017 and is headquartered in Aller\u00c3\u00b8d, Denmark.",
        "currency": "DKK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CPH",
        "market": "dk_market",
        "country": "Denmark",
        "state": null,
        "city": "Aller\u00c3\u00b8d",
        "zipcode": "3450",
        "website": "http://stenocare.dk",
        "market_cap": "Nano Cap"
    },
    "STMH": {
        "short_name": "STEM HOLDINGS INC",
        "long_name": "Stem Holdings, Inc.",
        "summary": "Stem Holdings, Inc., together with its subsidiaries, operates as a vertically integrated cannabis operating company. It is involved in manufacture, possession, use, sale, distribution, and branding of cannabis and cannabis-infused products under the laws of the states of Oregon, Nevada, California, Massachusetts, and Oklahoma. As of December 30, 2020, the company had ownership interests in 22 state issued cannabis and hemp licenses, including 10 licenses for cannabis cultivation; 4 licenses for cannabis processing; 1 license for cannabis wholesale distribution; 1 license for hemp production and processing; 5 cannabis dispensary licenses; and 1 license that permits both dispensary and cultivation activities. Stem Holdings, Inc. was founded in 2016 and is headquartered in Boca Raton, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Boca Raton",
        "zipcode": "33431",
        "website": "http://www.stemholdings.com",
        "market_cap": "Micro Cap"
    },
    "STSN": {
        "short_name": "STEMSATION INTERNATIONAL INC",
        "long_name": "Stemsation International, Inc.",
        "summary": "StemSation International, Inc. develops, manufactures, and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body. It offers StemRCM, a dietary supplement that supports stem cells ability to repair, renew, and restore tissues and organ function through healthy stem cell release, circulation, and migration. The company sells its products through independent wellness advocates directly to consumers. StemSation International, Inc. is headquartered in Boca Raton, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Boca Raton",
        "zipcode": "33434",
        "website": "http://www.stemsation.global",
        "market_cap": "Nano Cap"
    },
    "STX.L": {
        "short_name": "SHIELD THERAPEUTICS PLC ORD 1.5",
        "long_name": "Shield Therapeutics plc",
        "summary": "Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of late-stage pharmaceuticals to treat unmet medical needs. The company's lead product is Ferric Maltol, marketed in the European Union as Feraccru, a non-salt based novel therapy for the treatment of iron deficiency anemia in patients with inflammatory bowel disease. Its advanced pipeline asset is PT20, a novel therapy that has completed its Phase II pivotal study for the treatment of hyperphosphatemia in patients with chronic kidney disease. The company also develops PT30 to treat hypo-allergenic IV iron therapy; and PT40, the first generic version of iron sucrose. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Gateshead",
        "zipcode": "NE8 3DF",
        "website": "http://www.shieldtherapeutics.com",
        "market_cap": null
    },
    "SUGR.V": {
        "short_name": "SUGARBUD CRAFT GROWERS CORP",
        "long_name": "SugarBud Craft Growers Corp.",
        "summary": "SugarBud Craft Growers Corp. engages in the acquisition, development, production, and distribution of cannabis products in Canada. The company was formerly known as Relentless Resources Ltd. and changed its name to SugarBud Craft Growers Corp. in October 2018. SugarBud Craft Growers Corp. is headquartered in Calgary, Alberta.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2P 0S4",
        "website": "http://www.sugarbud.ca",
        "market_cap": "Nano Cap"
    },
    "SUNPHARMA.NS": {
        "short_name": "SUN PHARMACEUTICAL",
        "long_name": "Sun Pharmaceutical Industries Limited",
        "summary": "Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, opthalomology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances, as well as over-the-counter products. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400063",
        "website": "http://www.sunpharma.com",
        "market_cap": "Large Cap"
    },
    "SUPN": {
        "short_name": "Supernus Pharmaceuticals, Inc.",
        "long_name": "Supernus Pharmaceuticals, Inc.",
        "summary": "Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. Its commercial products include Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset epilepsy seizures in adults and children between 6 to 17 years of age. The company's commercial products also comprise APOKYN, a product indicated for the acute intermittent treatment of hypomobility or off episodes in patients with advanced Parkinson's Disease (PD); XADAGO, a product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD experiencing off episodes; and MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and sialorrhea in adults. In addition, its product candidates include SPN-812, which has completed Phase III clinical trials that is used for the treatment of attention deficit hyperactivity disorder (ADHD); SPN-830, a late-stage drug/device combination product candidate for the prevention of off episodes in PD; SPN-817, a novel product candidate in Phase I clinical trials for the treatment of severe epilepsy; and SPN-820, a novel product candidate in Phase I clinical trials for treatment resistant depression. The company markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. It has a development and option agreement with Navitor Pharmaceuticals, Inc. to conduct a Phase II clinical program for NV-5138 in treatment-resistant depression. The company was founded in 2005 and is headquartered in Rockville, Maryland.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NGM",
        "market": "us_market",
        "country": "United States",
        "state": "MD",
        "city": "Rockville",
        "zipcode": "20850",
        "website": "http://www.supernus.com",
        "market_cap": "Small Cap"
    },
    "SUVEN.NS": {
        "short_name": "SUVEN LIFE SCIENCE",
        "long_name": "Suven Life Sciences Limited",
        "summary": "Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. It engages in drug discovery and development of new chemical entities (NCE) in central nervous system therapies. The company's product candidates include SUVN-502, which is in Phase II clinical trials for the treatment of Alzheimer's disease; SUVN-G3031, a potent and selective histamine H3 receptor inverse agonist, which has completed Phase I trials for the treatment of sleep and cognitive disorders; SUVN-D4010, a potent, selective, and orally bio-available and brain penetrant 5-HT4 receptor partial agonist, which has completed Phase I trials for the treatment of major depressive disorders; and SUVN-911, a novel, potent, and selective a4\u00c3\u009f2 nicotinic acetylcholine receptor antagonist, which has completed Phase I trials for the treatment of depressive disorders. It is also developing SUVN-I6107 for the treatment of cognitive disorders, SUVN-M8036 for the treatment of psychiatric disorders, SUVN-D1044 for the treatment of gastrointestinal disorders, P2X7 Antagonist for the treatment of pain and inflammation, M4 PAM for the treatment of Psychosis, and 5-HT1A Partial Agonist for the treatment of resistant depression. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was founded in 1989 and is headquartered in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Hyderabad",
        "zipcode": "500034",
        "website": "http://www.suven.com",
        "market_cap": "Micro Cap"
    },
    "SUVENPHAR.NS": {
        "short_name": "Suven Pharmaceuticals Ltd",
        "long_name": "Suven Pharmaceuticals Limited",
        "summary": "Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Hyderabad",
        "zipcode": "500034",
        "website": "http://www.suvenpharm.com",
        "market_cap": "Small Cap"
    },
    "SWEL.CN": {
        "short_name": "SativaWellness",
        "long_name": "Sativa Wellness Group Inc.",
        "summary": "Sativa Wellness Group Inc. operates as a CBD wellness company. The company engages in the cultivation and extraction of cannabinoids. It also sells CBD products to wholesale and online retail markets, as well as white label CBD products for third party brands. The company is based in North Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "North Vancouver",
        "zipcode": "V7M 3J3",
        "website": "http://www.sativawellnessgroup.com",
        "market_cap": "Nano Cap"
    },
    "SWPIF": {
        "short_name": "SAWAI PHARMACEUTICAL",
        "long_name": "Sawai Group Holdings Co., Ltd.",
        "summary": "Sawai Group Holdings Co., Ltd., together with subsidiaries, manufactures, sells, imports, and exports pharmaceutical products in Japan and the United States. The company offers drugs in various formulations, including tablets, oral dispersing tablets, capsules, granules, injections, tapes, ophthalmic/nasal solutions, syrups, etc. in the therapeutic areas of cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, chemotherapeutics, vitamins, anti-cancer, etc. It serves hospitals, general practitioners, and dispensing pharmacies. Sawai Group Holdings Co., Ltd. was founded in 1929 and is headquartered in Osaka, Japan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Japan",
        "state": null,
        "city": "Osaka",
        "zipcode": "532-0003",
        "website": "http://www.sawai.co.jp",
        "market_cap": "Mid Cap"
    },
    "SXTC": {
        "short_name": "China SXT Pharmaceuticals, Inc.",
        "long_name": "China SXT Pharmaceuticals, Inc.",
        "summary": "China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. It offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. The company provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of May 2, 2020, it served 116 pharmaceutical companies, 56 pharmacies, and 76 hospitals. The company was founded in 2005 and is based in Taizhou, China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Taizhou",
        "zipcode": "225300",
        "website": "http://www.sxtchina.com",
        "market_cap": "Nano Cap"
    },
    "SYNCOM.NS": {
        "short_name": "SYNCOM HEALTHCARE",
        "long_name": "Syncom Healthcare Limited",
        "summary": "Syncom Healthcare Limited engages in the manufacture and marketing of pharmaceutical formulations in India and internationally. It also offers nutraceutical products and ayurvedic formulations. The company was incorporated in 2002 and is based in Indore, India. Syncom Healthcare Limited is in corporate insolvency resolution process under the provisions of Section 7 of the Insolvency and Bankruptcy Code, 2016.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Indore",
        "zipcode": "452001",
        "website": "http://www.syncomhealthcare.in",
        "market_cap": "Nano Cap"
    },
    "SYUP": {
        "short_name": "ANBC INC",
        "long_name": "ANBC, INC.",
        "summary": "Shanghai Yutong Pharma, Inc. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People's Republic of China. Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver; Qing-re-jie-du, an oral solution that reduces fever and relieves heat; Sheng-mai-yin, a solution that protects energy and enhances body fluids; Xiao-qing-long, an oral solution that relieves cough and dyspnea; Shen-bao, a syrup for the treatment of impotence and spermatorrhoea; Ban-xia, a syrup that relieves cough; and Gan-mao-zhi-ke, a syrup that relieves flu symptoms, cough, and nasal congestion. It also offers Ban-lan-gen that relieves cold and flu symptoms; Gan-mao-qing-re that relieves minor body aches and pains, and reduces fever; Huang-dan-yin-chen used in the treatment for jaundice infection hepatitis; and Liu-shen-qu for treatment of vomitings and dysentery. It offers its products to distributors on a wholesale basis. The company is based in Shanghai, China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Shanghai",
        "zipcode": "201702",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "T14.SI": {
        "short_name": "Tianjin ZX USD",
        "long_name": "Tianjin Zhong Xin Pharmaceutical Group Corporation Limited",
        "summary": "Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, together with its subsidiaries, manufactures and sells Chinese herbal medicines, proprietary Chinese medicines, chemical raw materials and preparations, and nutritional and health products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals, as well as offers pharmaceutical consultancy services. In addition, it provides logistics, stocks, equipment installation, and medicine processing services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products and biological products under other brands from distributors and sells these to other wholesalers. Tianjin Zhong Xin Pharmaceutical Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SES",
        "market": "sg_market",
        "country": "China",
        "state": null,
        "city": "Tianjin",
        "zipcode": "300193",
        "website": "http://www.zhongxinp.com",
        "market_cap": "Mid Cap"
    },
    "T8RP.F": {
        "short_name": "INDIVA LTD",
        "long_name": "Indiva Limited",
        "summary": "Indiva Limited operates as a licensed producer of cannabis products in Canada. It creates premium pre-rolls, flower, capsules, and edible products, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Ruby Cannabis Sugar, Sapphire Cannabis Salt, Artisan Batch, and other powered by INDIVA products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Ottawa",
        "zipcode": "K1S 5N4",
        "website": "http://www.indiva.com",
        "market_cap": "Nano Cap"
    },
    "TAIPY": {
        "short_name": "TAISHO PHARMACEUTICAL HLDG CO L",
        "long_name": "Taisho Pharmaceutical Holdings Co., Ltd.",
        "summary": "Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) drugs and prescription pharmaceutical products in Japan and internationally. It operates through Self-Medication Operation Group and Prescription Pharmaceutical Operation Group segments. The Self-Medication Operation Group segment offers OTC drugs, quasi-drugs, food products, and general medical and hygiene supplies, such as Lipovitan series of energy drinks; the Pabron series of cold remedies and sinus treatments; the RiUP series of hair re-growth treatment products; the Taisho Kampo series of gastrointestinal treatment products; the Colac series of laxative products; the Naron series and other products for antipyretic analgesics; the Preser series of hemorrhoid treatment products; Hapacol, Efferalgan, Dafalgan, and Tempra for antipyretic analgesics; Counterpain topical anti-inflammatory analgesics; Vitacilina, a dermatological treatment product; and VICKS, a cough suppressant throat lozenges and medicated drops. This segment also engages in the real estate leasing and facility management, and hotel management operations. The Prescription Pharmaceutical Operation Group segment offers ethical drugs, including Edirol, an active vitamin D3 osteoporosis agent; Clarith, a macrolide antibiotic; Palux, a peripheral vasodilator; Bonviva, a bisphosphonate osteoporosis agent; Lusefi, a type 2 diabetes mellitus agent; and LOQOA, a transdermal anti-inflammatory analgesic. This segment has various products under development primarily in therapeutic areas, such as central nervous system, infectious, and metabolic diseases, as well as orthopedic disorders. The company also offers raw materials for pharmaceuticals and quasi-drugs; and supplies health foods and skin care products. Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is headquartered in Tokyo, Japan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "170-8655",
        "website": "http://www.taisho-holdings.co.jp",
        "market_cap": "Mid Cap"
    },
    "TAK": {
        "short_name": "Takeda Pharmaceutical Company L",
        "long_name": "Takeda Pharmaceutical Company Limited",
        "summary": "Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, rest of Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc., Sosei Group Corporation, and LogicBio Therapeutics, Inc.; strategic collaboration with Prometheus Biosciences, Inc; a license and research agreement with The University of Texas MD Anderson Cancer Center; a research collaboration agreements with Enzyre BV and Cerevance; a collaboration agreement with Artisan Bio, Inc.; and a multi-target rare disease collaboration with Evox Therapeutics Ltd., as well as licensing agreement with ProThera Biologics Inc. It also has a strategic alliance with Egle Therapeutics SAS and Evotec SE; a strategic partnership with Neurocrine Biosciences, Inc.; Carmine Therapeutics and HemoShear Therapeutics, LLC; strategic collaboration with KSQ Therapeutics to research, develop, and commercialize immune-based therapies for cancer; and strategic collaboration with Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "103-8668",
        "website": "http://www.takeda.com",
        "market_cap": "Large Cap"
    },
    "TAL.F": {
        "short_name": "TARO PHAR.INDS. IS 0,0001",
        "long_name": "Taro Pharmaceutical Industries Ltd.",
        "summary": "Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprises allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1959 and is based in Haifa Bay, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Israel",
        "state": null,
        "city": "Haifa",
        "zipcode": "2624761",
        "website": "http://www.taro.com",
        "market_cap": "Mid Cap"
    },
    "TARO": {
        "short_name": "Taro Pharmaceutical Industries ",
        "long_name": "Taro Pharmaceutical Industries Ltd.",
        "summary": "Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprises allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1959 and is based in Haifa Bay, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "Israel",
        "state": null,
        "city": "Haifa",
        "zipcode": "2624761",
        "website": "http://www.taro.com",
        "market_cap": "Mid Cap"
    },
    "TBD.F": {
        "short_name": "EMERALD HEALTH THER.",
        "long_name": "Emerald Health Therapeutics, Inc.",
        "summary": "Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1J8",
        "website": "http://emeraldhealth.ca",
        "market_cap": "Nano Cap"
    },
    "TBF1.F": {
        "short_name": "CANNTAB THERAPEUTICS LTD.",
        "long_name": "Canntab Therapeutics Limited",
        "summary": "Canntab Therapeutics Limited, a biopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids, tetrahydrocannabinol, and terpenes in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Markham",
        "zipcode": "L3R 5J6",
        "website": "http://canntab.ca",
        "market_cap": "Nano Cap"
    },
    "TBI.CN": {
        "short_name": "ThoughtfulBran",
        "long_name": "Thoughtful Brands Inc.",
        "summary": "Mota Ventures Corp., together with its subsidiaries, operates in the cannabidiol (CBD) e-commerce business. It provides CBD hemp-oil formulations and cosmetics. The company offers its products under the Nature's Exclusive, First Class, and Sativida brands in the United States and Europe. Mota Ventures Corp. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 3T5",
        "website": "http://www.thoughtful-brands.com",
        "market_cap": "Nano Cap"
    },
    "TCAN.CN": {
        "short_name": "TranscannaHldgs",
        "long_name": "TransCanna Holdings Inc.",
        "summary": "TransCanna Holdings Inc., through its subsidiaries, engages in the management of transportation and distribution services to the cannabis industry in the United States. It provides branding, marketing, transportation, and distribution of cannabis related products for state-licensed operators involved in the cultivation, manufacture, and sale of cannabis in California. The company was founded in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2Y3",
        "website": "http://www.transcanna.com",
        "market_cap": "Nano Cap"
    },
    "TCNAF": {
        "short_name": "TRANSCANNA HOLDINGS INC",
        "long_name": "TransCanna Holdings Inc.",
        "summary": "TransCanna Holdings Inc., through its subsidiaries, engages in the management of transportation and distribution services to the cannabis industry in the United States. It provides branding, marketing, transportation, and distribution of cannabis related products for state-licensed operators involved in the cultivation, manufacture, and sale of cannabis in California. The company was founded in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2Y3",
        "website": "http://www.transcanna.com",
        "market_cap": "Nano Cap"
    },
    "TCNNF": {
        "short_name": "TRULIEVE CANNABIS CORP",
        "long_name": "Trulieve Cannabis Corp.",
        "summary": "Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. As of May 5, 2021, the company operated through 87 dispensaries in the United States. The company is headquartered in Quincy, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Quincy",
        "zipcode": "32351",
        "website": "http://www.trulieve.com",
        "market_cap": "Mid Cap"
    },
    "TED.F": {
        "short_name": "TERRASCEND CORP.",
        "long_name": "TerrAscend Corp.",
        "summary": "TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. The company was incorporated in 2017 and is based in Mississauga, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5C 1W2",
        "website": "http://www.terrascend.com",
        "market_cap": "Small Cap"
    },
    "TEL1.F": {
        "short_name": "SIHUAN PHARMAC.GRP HD-,01",
        "long_name": "Sihuan Pharmaceutical Holdings Group Ltd.",
        "summary": "Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company offers cardio-cerebral vascular system, digestive system, metabolism, anti-infective, respiratory, neurology, and other drugs. It also engages in the marketing of pharmaceutical products; manufacture of pharmaceutical materials and medical instruments; project preparation for the manufacture of pharmaceutical products; promotion of technology, biotechnology, and consulting services; and construction of medical projects, as well as the provision of information support, research and development, business and development, and general hospital and hospital management services. In addition, the company invests in property; constructs environmental protection projects; and wholesales chemical raw materials and medical devices. The company was founded in 2001 and is based in Wanchai, Hong Kong.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Hong Kong",
        "state": null,
        "city": "Wan Chai",
        "zipcode": null,
        "website": "http://www.sihuanpharm.com",
        "market_cap": "Mid Cap"
    },
    "TEQ.CN": {
        "short_name": "Terranueva",
        "long_name": "Terranueva Corporation",
        "summary": "Terranueva Corporation intends to produce cannabis for medical and recreational purposes. The company was incorporated in 2017 and is headquartered in Laval, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "QC",
        "city": "Laval",
        "zipcode": "H7L 2Z9",
        "website": "http://www.terranueva.ca",
        "market_cap": "Nano Cap"
    },
    "TER.CN": {
        "short_name": "TerrAscendCorp",
        "long_name": "TerrAscend Corp.",
        "summary": "TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. The company was incorporated in 2017 and is based in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5C 1W2",
        "website": "http://www.terrascend.com",
        "market_cap": "Small Cap"
    },
    "TEV.F": {
        "short_name": "TEVA PHARMACEUT. SP.ADR",
        "long_name": "Teva Pharmaceutical Industries Limited",
        "summary": "Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Israel",
        "state": null,
        "city": "Petah Tikva",
        "zipcode": "4951033",
        "website": "http://www.tevapharm.com",
        "market_cap": "Large Cap"
    },
    "TEVA": {
        "short_name": "Teva Pharmaceutical Industries ",
        "long_name": "Teva Pharmaceutical Industries Limited",
        "summary": "Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "Israel",
        "state": null,
        "city": "Petah Tikva",
        "zipcode": "4951033",
        "website": "http://www.tevapharm.com",
        "market_cap": "Large Cap"
    },
    "TEVA.TA": {
        "short_name": "TEVA PHARMA IND",
        "long_name": "Teva Pharmaceutical Industries Limited",
        "summary": "Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.",
        "currency": "ILA",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TLV",
        "market": "il_market",
        "country": "Israel",
        "state": null,
        "city": "Petah Tikva",
        "zipcode": "4951033",
        "website": "http://www.tevapharm.com",
        "market_cap": null
    },
    "TEVA.VI": {
        "short_name": "TEVA PHARMACEUTICAL ADR",
        "long_name": "Teva Pharmaceutical Industries Limited",
        "summary": "Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VIE",
        "market": "at_market",
        "country": "Israel",
        "state": null,
        "city": "Petah Tikva",
        "zipcode": "4951033",
        "website": "http://www.tevapharm.com",
        "market_cap": "Large Cap"
    },
    "TEVJF": {
        "short_name": "TEVA PHARMACEUTICAL INDUSTRIES",
        "long_name": "Teva Pharmaceutical Industries Limited",
        "summary": "Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Israel",
        "state": null,
        "city": "Petah Tikva",
        "zipcode": "4951033",
        "website": "http://www.tevapharm.com",
        "market_cap": "Large Cap"
    },
    "TFHD.F": {
        "short_name": "THC BIOMED INTL",
        "long_name": "THC Biomed Intl Ltd.",
        "summary": "THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. The company conducts research and development of products and services related to the medical cannabis industry. It also offers cannabis beverage under the THC KISS brand name, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Kelowna",
        "zipcode": "V1Y 2E1",
        "website": "http://thcbiomed.com",
        "market_cap": "Nano Cap"
    },
    "TGGI": {
        "short_name": "TRANS GLOBAL GROUP INC",
        "long_name": "Trans Global Group, Inc.",
        "summary": "Trans Global Group, Inc., a green company, through its subsidiaries, engages in renewable energy and solar energy sector. It offers products to reduce homeowner's and business' energy consumption, lower their carbon footprint, enhance the efficiency of their energy products, and reduce energy costs. The company also provides general construction services, including building schools, condominiums, town home communities, home renovations and add-ons, housing, and other projects. In addition, it offers bonding and insurance agency services. The company was formerly known as Teletek, Inc. and changed its name to Trans Global Group, Inc. in October 2007. Trans Global Group, Inc. was incorporated in 1979 and is headquartered in Coconut Creek, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Coconut Creek",
        "zipcode": "33073",
        "website": "http://transggi.com",
        "market_cap": "Nano Cap"
    },
    "TGIF.CN": {
        "short_name": "1933IndInc",
        "long_name": "1933 Industries Inc.",
        "summary": "1933 Industries Inc., a cannabis company, engages in the cultivation and production of medical marijuana in the United States and Canada. It operates in AMA and Infused MFG segments. The company operates in the medical and recreational cannabis sectors. It also provides cannabidiol infused products, such as tinctures, lotions, creams, vape pens, cartridges, lip balms, tetrahydrocannabinol concentrates, hemp-seed oils, and capsules under Canna Hemp, Canna Hemp X, Canna Hemp PLUS, Canna Hemp HEMP, and Canna Fused brands; and cannabis flowers and concentrates. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. was incorporated in 2008 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2E9",
        "website": "http://www.1933Industries.com",
        "market_cap": "Nano Cap"
    },
    "TGIFF": {
        "short_name": "1933 INDUSTRIES INC",
        "long_name": "1933 Industries Inc.",
        "summary": "1933 Industries Inc., a cannabis company, engages in the cultivation and production of medical marijuana in the United States and Canada. It operates in AMA and Infused MFG segments. The company operates in the medical and recreational cannabis sectors. It also provides cannabidiol infused products, such as tinctures, lotions, creams, vape pens, cartridges, lip balms, tetrahydrocannabinol concentrates, hemp-seed oils, and capsules under Canna Hemp, Canna Hemp X, Canna Hemp PLUS, Canna Hemp HEMP, and Canna Fused brands; and cannabis flowers and concentrates. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. was incorporated in 2008 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2E9",
        "website": "http://www.1933Industries.com",
        "market_cap": "Nano Cap"
    },
    "TGOD.TO": {
        "short_name": "THE GREEN ORGANIC DUTCHMAN HOLD",
        "long_name": "The Green Organic Dutchman Holdings Ltd.",
        "summary": "The Green Organic Dutchman Holdings Ltd., through its subsidiaries, produces and sells organic cannabis in Canada. It offers organic cannabis products, such as cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis to retailers or distributors, and federal licensed entities. The Green Organic Dutchman Holdings Ltd. was incorporated in 2016 and is headquartered in Mississauga, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L4V 1E3",
        "website": "http://www.tgod.ca",
        "market_cap": "Micro Cap"
    },
    "TGODF": {
        "short_name": "GREEN ORGANIC DUTCHMAN HLDGS LT",
        "long_name": "The Green Organic Dutchman Holdings Ltd.",
        "summary": "The Green Organic Dutchman Holdings Ltd., through its subsidiaries, produces and sells organic cannabis in Canada. It offers organic cannabis products, such as cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis to retailers or distributors, and federal licensed entities. The Green Organic Dutchman Holdings Ltd. was incorporated in 2016 and is headquartered in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L4V 1E3",
        "website": "http://www.tgod.ca",
        "market_cap": "Micro Cap"
    },
    "TGTR.TA": {
        "short_name": "TOGETHER PHARMA",
        "long_name": "Together Pharma Ltd",
        "summary": "Together Pharma Ltd, through its subsidiaries, engages in growing, production, storage, and distribution of medical cannabis products in Israel. The company is based in Ashkelon, Israel.",
        "currency": "ILA",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TLV",
        "market": "il_market",
        "country": "Israel",
        "state": null,
        "city": "Ashkelon",
        "zipcode": "7810001",
        "website": "http://www.together-pharma.com",
        "market_cap": null
    },
    "TH.TO": {
        "short_name": "THERATECHNOLOGIES",
        "long_name": "Theratechnologies Inc.",
        "summary": "Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "QC",
        "city": "Montreal",
        "zipcode": "H3A 1T8",
        "website": "http://www.theratech.com",
        "market_cap": "Small Cap"
    },
    "TH8.F": {
        "short_name": "TRANSCANNA HOLDINGS INC.",
        "long_name": "TransCanna Holdings Inc.",
        "summary": "TransCanna Holdings Inc., through its subsidiaries, engages in the management of transportation and distribution services to the cannabis industry in the United States. It provides branding, marketing, transportation, and distribution of cannabis related products for state-licensed operators involved in the cultivation, manufacture, and sale of cannabis in California. The company was founded in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2Y3",
        "website": "http://www.transcanna.com",
        "market_cap": "Nano Cap"
    },
    "THC.CN": {
        "short_name": "THCBiomed Intl",
        "long_name": "THC Biomed Intl Ltd.",
        "summary": "THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. The company conducts research and development of products and services related to the medical cannabis industry. It also offers cannabis beverage under the THC KISS brand name, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Kelowna",
        "zipcode": "V1Y 2E1",
        "website": "http://thcbiomed.com",
        "market_cap": "Nano Cap"
    },
    "THCT": {
        "short_name": "THC THERAPEUTICS INC",
        "long_name": "THC Therapeutics, Inc.",
        "summary": "THC Therapeutics, Inc. operates in the wellness industry. It is involved in the development of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested cannabis, other herbs, flowers, and tea leaves. The company was formerly known as Millennium Blockchain, Inc. and changed its name to THC Therapeutics, Inc. in September 2018. THC Therapeutics, Inc. was incorporated in 2007 and is based in San Diego, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89135",
        "website": "http://thct.io",
        "market_cap": "Nano Cap"
    },
    "THEMISMED.NS": {
        "short_name": "THEMIS MEDICARE LT",
        "long_name": "Themis Medicare Limited",
        "summary": "Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas, such as anti-infective, antimalarial, anti-tuberculosis, cardiology, health and nutrition, oncology, ophthalmology, and pain management. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1969 and is headquartered in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400104",
        "website": "http://www.themismedicare.com",
        "market_cap": "Micro Cap"
    },
    "THTX": {
        "short_name": "Theratechnologies Inc.",
        "long_name": "Theratechnologies Inc.",
        "summary": "Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "Canada",
        "state": "QC",
        "city": "Montreal",
        "zipcode": "H3A 1T8",
        "website": "http://www.theratech.com",
        "market_cap": "Small Cap"
    },
    "TILT.CN": {
        "short_name": "TILTHldgsInc",
        "long_name": "TILT Holdings Inc.",
        "summary": "TILT Holdings Inc., a vertically-integrated technology and infrastructure company, provides various products and services across the cannabis industry in the United States, Canada, and Europe. It operates through five segments: Cannabis, Technology and Infrastructure, Distribution, Accessories, and Other. The Cannabis segment engages in the production, cultivation, and retail of cannabis products. The Technology and Infrastructure segment offers a range of products and services across the cannabis industry. The Distribution segment provides logistic operations and software solutions throughout the cannabis supply chain. The Accessories segment manufactures and distributes electronic and non-nicotine devices and systems. The Other segment focuses on greenhouse cultivation and CO2 extraction. The company was founded in 2017 and is headquartered in Cambridge, Massachusetts.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "MA",
        "city": "Cambridge",
        "zipcode": "02138",
        "website": "http://www.tiltholdings.com",
        "market_cap": "Micro Cap"
    },
    "TIUM-U.CN": {
        "short_name": "CansortiumInc",
        "long_name": "Cansortium Inc.",
        "summary": "Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. The company engages in the cultivation, processing, retail, and distribution activities. Its medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls, cartridges, and edibles. The company provides its products under the Fluent brand name. Cansortium Inc. was incorporated in 2018 and is headquartered in Miami, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "FL",
        "city": "Miami",
        "zipcode": "33137",
        "website": "http://www.getfluent.com",
        "market_cap": "Micro Cap"
    },
    "TKD.F": {
        "short_name": "TAKEDA PHARM.CO.LTD.",
        "long_name": "Takeda Pharmaceutical Company Limited",
        "summary": "Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, rest of Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc., Sosei Group Corporation, and LogicBio Therapeutics, Inc.; strategic collaboration with Prometheus Biosciences, Inc; a license and research agreement with The University of Texas MD Anderson Cancer Center; a research collaboration agreements with Enzyre BV and Cerevance; a collaboration agreement with Artisan Bio, Inc.; and a multi-target rare disease collaboration with Evox Therapeutics Ltd., as well as licensing agreement with ProThera Biologics Inc. It also has a strategic alliance with Egle Therapeutics SAS and Evotec SE; a strategic partnership with Neurocrine Biosciences, Inc.; Carmine Therapeutics and HemoShear Therapeutics, LLC; strategic collaboration with KSQ Therapeutics to research, develop, and commercialize immune-based therapies for cancer; and strategic collaboration with Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "103-8668",
        "website": "http://www.takeda.com",
        "market_cap": "Large Cap"
    },
    "TKD.VI": {
        "short_name": "TAKEDA PHARMACEUTICAL CO LTD",
        "long_name": "Takeda Pharmaceutical Company Limited",
        "summary": "Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, rest of Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc., Sosei Group Corporation, and LogicBio Therapeutics, Inc.; strategic collaboration with Prometheus Biosciences, Inc; a license and research agreement with The University of Texas MD Anderson Cancer Center; a research collaboration agreements with Enzyre BV and Cerevance; a collaboration agreement with Artisan Bio, Inc.; and a multi-target rare disease collaboration with Evox Therapeutics Ltd., as well as licensing agreement with ProThera Biologics Inc. It also has a strategic alliance with Egle Therapeutics SAS and Evotec SE; a strategic partnership with Neurocrine Biosciences, Inc.; Carmine Therapeutics and HemoShear Therapeutics, LLC; strategic collaboration with KSQ Therapeutics to research, develop, and commercialize immune-based therapies for cancer; and strategic collaboration with Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VIE",
        "market": "at_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "103-8668",
        "website": "http://www.takeda.com",
        "market_cap": "Large Cap"
    },
    "TKDA.F": {
        "short_name": "TAKEDA PHARM.SPON.ADR/1/2",
        "long_name": "Takeda Pharmaceutical Company Limited",
        "summary": "Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, rest of Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc., Sosei Group Corporation, and LogicBio Therapeutics, Inc.; strategic collaboration with Prometheus Biosciences, Inc; a license and research agreement with The University of Texas MD Anderson Cancer Center; a research collaboration agreements with Enzyre BV and Cerevance; a collaboration agreement with Artisan Bio, Inc.; and a multi-target rare disease collaboration with Evox Therapeutics Ltd., as well as licensing agreement with ProThera Biologics Inc. It also has a strategic alliance with Egle Therapeutics SAS and Evotec SE; a strategic partnership with Neurocrine Biosciences, Inc.; Carmine Therapeutics and HemoShear Therapeutics, LLC; strategic collaboration with KSQ Therapeutics to research, develop, and commercialize immune-based therapies for cancer; and strategic collaboration with Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "103-8668",
        "website": "http://www.takeda.com",
        "market_cap": "Large Cap"
    },
    "TKPHF": {
        "short_name": "TAKEDA PHARMACEUTICAL CO LTD",
        "long_name": "Takeda Pharmaceutical Company Limited",
        "summary": "Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, rest of Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc., Sosei Group Corporation, and LogicBio Therapeutics, Inc.; strategic collaboration with Prometheus Biosciences, Inc; a license and research agreement with The University of Texas MD Anderson Cancer Center; a research collaboration agreements with Enzyre BV and Cerevance; a collaboration agreement with Artisan Bio, Inc.; and a multi-target rare disease collaboration with Evox Therapeutics Ltd., as well as licensing agreement with ProThera Biologics Inc. It also has a strategic alliance with Egle Therapeutics SAS and Evotec SE; a strategic partnership with Neurocrine Biosciences, Inc.; Carmine Therapeutics and HemoShear Therapeutics, LLC; strategic collaboration with KSQ Therapeutics to research, develop, and commercialize immune-based therapies for cancer; and strategic collaboration with Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "103-8668",
        "website": "http://www.takeda.com",
        "market_cap": "Large Cap"
    },
    "TKUN.TA": {
        "short_name": "TIKUN OLAM - CANNB",
        "long_name": "Tikun Olam - Cannbit Pharmaceuticals Ltd",
        "summary": "Tikun Olam - Cannbit Pharmaceuticals Ltd engages in the research, development, cultivation, manufacture, marketing, and sale of medical cannabis and related products. The company was incorporated in 1995 and is based in Tel Aviv-Yafo, Israel.",
        "currency": "ILA",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TLV",
        "market": "il_market",
        "country": "Israel",
        "state": null,
        "city": "Tel Aviv-Yafo",
        "zipcode": null,
        "website": "http://tikun-olam.org.il",
        "market_cap": null
    },
    "TLAA.F": {
        "short_name": "TRUE LEAF BRANDS INC.",
        "long_name": "True Leaf Brands Inc.",
        "summary": "True Leaf Brands Inc. manufactures and distributes hemp-based nutrition for pets. It sells dog chews, dental sticks, and supplement oils under the True Hemp brand name in North America and Europe, as well as through online on Amazon. The company was formerly known as True Leaf Medicine International Ltd. and changed its name to True Leaf Brands Inc. in May 2019. True Leaf Brands Inc. was founded in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vernon",
        "zipcode": "V6E 2E9",
        "website": "http://trueleafbrands.com",
        "market_cap": "Nano Cap"
    },
    "TLFE": {
        "short_name": "ELFATO INC",
        "long_name": "Elfato Inc.",
        "summary": "Elfato Inc. focuses on developing canna powder products. Its canna powder is a nano-powder derived from cannabis oil. The company was founded in 1999 and is based in Los Angeles, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Los Angeles",
        "zipcode": "90067",
        "website": "http://canna-powder.com",
        "market_cap": "Nano Cap"
    },
    "TLGT": {
        "short_name": "Teligent, Inc.",
        "long_name": "Teligent, Inc.",
        "summary": "Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The company's topical semi-solid and liquid products are used in various applications that range from cosmetics and cosmeceuticals; and the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. It sells its products through national chain drug stores, drug wholesalers, distributors, and group purchasing organizations. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was incorporated in 1977 and is based in Buena, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "Buena",
        "zipcode": "08310",
        "website": "http://www.teligent.com",
        "market_cap": "Nano Cap"
    },
    "TLLTF": {
        "short_name": "TILT HOLDINGS INC",
        "long_name": "TILT Holdings Inc.",
        "summary": "TILT Holdings Inc., a vertically-integrated technology and infrastructure company, provides various products and services across the cannabis industry in the United States, Canada, and Europe. It operates through five segments: Cannabis, Technology and Infrastructure, Distribution, Accessories, and Other. The Cannabis segment engages in the production, cultivation, and retail of cannabis products. The Technology and Infrastructure segment offers a range of products and services across the cannabis industry. The Distribution segment provides logistic operations and software solutions throughout the cannabis supply chain. The Accessories segment manufactures and distributes electronic and non-nicotine devices and systems. The Other segment focuses on greenhouse cultivation and CO2 extraction. The company was founded in 2017 and is headquartered in Cambridge, Massachusetts.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "MA",
        "city": "Cambridge",
        "zipcode": "02138",
        "website": "http://www.tiltholdings.com",
        "market_cap": "Micro Cap"
    },
    "TMSH": {
        "short_name": "TRANSGLOBAL ASSETS INC",
        "long_name": "TransGlobal Assets Inc.",
        "summary": "TransGlobal Assets Inc., together with its subsidiaries, distributes motor vehicle fuel and tobacco products to retail outlets in the State of Oregon. The company was formerly known as TimeShare Holdings Inc. and changed its name to TransGlobal Assets Inc. in March 2011. TransGlobal Assets Inc. was founded in 2005 and is based in Cheyenne, Wyoming.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "WY",
        "city": "Cheyenne",
        "zipcode": "82001",
        "website": null,
        "market_cap": "Nano Cap"
    },
    "TNPH": {
        "short_name": "TIAN'AN PHARMACEUTICAL COMPANY ",
        "long_name": "Tian'an Pharmaceutical Co., Ltd.",
        "summary": "Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. It also engages in the research and development of biology goods and health care products. The company's pharmaceutical and nutraceutical products include Compound Ginseng capsule, a Chinese medicine preparation that is used to cure and treat prostate gland proliferation; Nizhuanle Yin granule, a Chinese medicine preparation that treats the decomposition or inflammation of the stomach's mucous membrane; and Tianan soft capsule, which is used to adjust high amounts of fat in the blood stream, improve blood vessel ventilation, and soften blood vessels. Its products also include Tianan Pain Relief Capsule, a Chinese medicine preparation, which is under development to cure pain in joints, headache, pain from muscle injury, cancer, and gynecological disorders, as well as general pain. Tian' An Pharmaceutical sells its products to independent distributors, who sell products to pharmacies and drugstores, and hospitals. The company was founded in 2003 and is based in Xi'an, China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Xi'an",
        "zipcode": null,
        "website": null,
        "market_cap": "Nano Cap"
    },
    "TOKI.CN": {
        "short_name": "TreeofKnowledge",
        "long_name": "Tree of Knowledge International Corp.",
        "summary": "Tree of Knowledge International Corp. produces and sells hemp-based cannabidiol (CBD) products. The company offers industrial hemp-derived CBD oil, airless metered pens, capsules, drops, balms, creams, and tinctures. It also operates multidisciplinary specialty pain clinics, which focuses on the treatment of chronic pain, including controlled assessment, authorization, and monitoring of medical cannabis therapy; and develops products for therapeutic purposes, and wellness and natural health product alternatives. In addition, the company distributes and sells hemp-based cannabidiol products. It has a research agreement with the Ryerson University for medical cannabis research and new medical grade products development. The company has operations in the United States, Canada, Europe, and Brazil. Tree of Knowledge International Corp. is based in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M2N 6K7",
        "website": "http://www.tokicorp.com",
        "market_cap": "Nano Cap"
    },
    "TOKIF": {
        "short_name": "TREE OF KNOWLEDGE INTERNATIONAL",
        "long_name": "Tree of Knowledge International Corp.",
        "summary": "Tree of Knowledge International Corp. produces and sells hemp-based cannabidiol (CBD) products. The company offers industrial hemp-derived CBD oil, airless metered pens, capsules, drops, balms, creams, and tinctures. It also operates multidisciplinary specialty pain clinics, which focuses on the treatment of chronic pain, including controlled assessment, authorization, and monitoring of medical cannabis therapy; and develops products for therapeutic purposes, and wellness and natural health product alternatives. In addition, the company distributes and sells hemp-based cannabidiol products. It has a research agreement with the Ryerson University for medical cannabis research and new medical grade products development. The company has operations in the United States, Canada, Europe, and Brazil. Tree of Knowledge International Corp. is based in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M2N 6K7",
        "website": "http://www.tokicorp.com",
        "market_cap": "Nano Cap"
    },
    "TOL.ST": {
        "short_name": "Toleranzia AB",
        "long_name": "Toleranzia AB",
        "summary": "Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate for treating myasthenia gravis, an autoimmune nerve and muscle disease. It also intends to develop TOL3 drug candidate to treat ANCA vasculitis, an autoimmune blood vessel disease. The company is headquartered in Gothenburg, Sweden.",
        "currency": "SEK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STO",
        "market": "se_market",
        "country": "Sweden",
        "state": null,
        "city": "Gothenburg",
        "zipcode": "411 26",
        "website": "http://www.toleranzia.com",
        "market_cap": "Nano Cap"
    },
    "TON.F": {
        "short_name": "TOHO HOLDINGS CO. LTD.",
        "long_name": "Toho Holdings Co., Ltd.",
        "summary": "Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. It sells prescription pharmaceuticals, reagents, medical devices and materials, OTC drugs, and health foods to preventive care, clinical care, community healthcare linkage, and home medical and nursing care, as well as provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. The company also engages in dispensing pharmacy business; manufacture and sale of generic drugs; and site management organization business that assists various medical institutions with clinical trials under contract, as well as sells software to medical institutions. In addition, it provides various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE HeLios and SELENE, a medical care appointment system; Appointment service for first patients, a system to make an appointment via medical institute search engine prior to visiting hospital; ENIFwin, an inventory control system for large hospitals, ENIFvoice SP/ ENIFvoice SP + A/ Core, a supporting system for electronic medication history recording with voice recognition; and ENIF Nurse, an operation support terminal for home-visit nurses; and logistics systems. Toho Holdings Co., Ltd. was founded in 1948 and is headquartered in Tokyo, Japan.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "155-8655",
        "website": "http://www.tohohd.co.jp",
        "market_cap": "Small Cap"
    },
    "TPPRF": {
        "short_name": "TOP STRIKE RES CORP",
        "long_name": "Top Strike Resources Corp.",
        "summary": "Top Strike Resources Corp., doing business as Vencanna Ventures Inc., operates as a merchant capital firm. It provides capital for early-stage global cannabis initiatives, including state compliant opportunities in the United States. The company was formerly known as Colossal Resources Corp. and changed its name to Top Strike Resources Corp. in December 2012. Top Strike Resources Corp. is headquartered in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2P 3H7",
        "website": "http://vencanna.com",
        "market_cap": "Nano Cap"
    },
    "TQ8.F": {
        "short_name": "THERATECHNOLOGIES INC.",
        "long_name": "Theratechnologies Inc.",
        "summary": "Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "QC",
        "city": "Montreal",
        "zipcode": "H3A 1T8",
        "website": "http://www.theratech.com",
        "market_cap": "Small Cap"
    },
    "TRCNF": {
        "short_name": "TRANSNATIONAL CANNABIS LTD",
        "long_name": "TRANSNATIONAL CANNABIS LTD",
        "summary": "TRANSNATIONAL CANNABIS LTD, through its subsidiaries, engages in the cannabis business in Canada and internationally. It holds a license to cultivate, manufacture, supply, hold, import, export, and transport cannabis and derivative products; and engages in procuring and distributing medical cannabis products and cannabis derivatives. The company has strategic partnerships with Green Tree International Inc., Auxly Cananbis Group Inc., Affinity Alpha Unit, Authentic Brands Group, and Biotii Technologies Corp. The company was formerly known as ICC International Cannabis Corp. and changed its name to TRANSNATIONAL CANNABIS LTD in February 2020. TRANSNATIONAL CANNABIS LTD was incorporated in 2006 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1H2",
        "website": "http://www.intlcannabiscorp.com",
        "market_cap": "Nano Cap"
    },
    "TRGM": {
        "short_name": "TARGETED MEDICAL PHARMA INC",
        "long_name": "Targeted Medical Pharma, Inc.",
        "summary": "Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy. The company also provides a proprietary billing process and supporting software (PDRx) that facilitates physician dispensing; provides inventory control; and assists regulatory reporting. In addition, it offers billing and collection services relating to its products on behalf of dispensing physician clients to private insurance and workers' compensation insurance. Targeted Medical Pharma, Inc. distributes its products through a network of distributors and an internal sales force that sells products directly to dispensing physician clients. The company was formerly known as Targeted Medical Foods and changed its name to Targeted Medical Pharma, Inc. in 2006. Targeted Medical Pharma, Inc. was founded in 1996 and is headquartered in Los Angeles, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Los Angeles",
        "zipcode": "90077",
        "website": "http://www.targetedmedicalpharma.com",
        "market_cap": "Nano Cap"
    },
    "TRILC.IS": {
        "short_name": "TURK ILAC SERUM",
        "long_name": "Turk Ilac Ve Serum Sanayi Anonim Sirketi",
        "summary": "Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells human pharmaceuticals and vaccines in Turkey. It offers vaccines, basic IV solutions, premix solutions, hemodialysis solutions, sterile distilled water, diagnostic products, and immunostimulant products. The company was founded in 2010 and is based in Ankara, Turkey.",
        "currency": "TRY",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "IST",
        "market": "tr_market",
        "country": "Turkey",
        "state": null,
        "city": "Ankara",
        "zipcode": "06750",
        "website": "http://www.turkilac.com.tr",
        "market_cap": null
    },
    "TRIP.CN": {
        "short_name": "RedLightHolland",
        "long_name": "Red Light Holland Corp.",
        "summary": "Red Light Holland Corp. engages in the production, cultivation, and sale of magic truffles to the legal recreational market in the Netherlands. It sells its products under the iMicrodose brand name through smart shops operators and an advanced e-commerce platform, iMicrodose.nl. The company was incorporated in 1982 and is based in Toronto, Ontario.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 2V9",
        "website": "http://www.redlighttruffles.com",
        "market_cap": "Micro Cap"
    },
    "TRLFF": {
        "short_name": "TRUE LEAF BRANDS INC",
        "long_name": "True Leaf Brands Inc.",
        "summary": "True Leaf Brands Inc. manufactures and distributes hemp-based nutrition for pets. It sells dog chews, dental sticks, and supplement oils under the True Hemp brand name in North America and Europe, as well as through online on Amazon. The company was formerly known as True Leaf Medicine International Ltd. and changed its name to True Leaf Brands Inc. in May 2019. True Leaf Brands Inc. was founded in 2013 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vernon",
        "zipcode": "V6E 2E9",
        "website": "http://trueleafbrands.com",
        "market_cap": "Nano Cap"
    },
    "TRSSF": {
        "short_name": "TERRASCEND CORP",
        "long_name": "TerrAscend Corp.",
        "summary": "TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. The company was incorporated in 2017 and is based in Mississauga, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Mississauga",
        "zipcode": "L5C 1W2",
        "website": "http://www.terrascend.com",
        "market_cap": "Mid Cap"
    },
    "TRTC": {
        "short_name": "TERRA TECH CORP",
        "long_name": "Terra Tech Corp.",
        "summary": "Terra Tech Corp. cultivates, produces, and retails medical and adult use cannabis products. It offers cannabis-infused baked goods, chocolates, and candies; cannabis-infused topical products, such as lotions, massage oils and balms; clones of marijuana plants; flowers and concentrates; oils, waxes, hash, shatters, and clears under the IVXX brand name; and cartridges, vape pens, and wax products. The company also operates medical marijuana retail and adult use dispensaries under the Bl\u00c3\u00bcm brand in California and Nevada. Terra Tech Corp. was founded in 2010 and is headquartered in Irvine, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Irvine",
        "zipcode": "92614",
        "website": "http://www.terratechcorp.com",
        "market_cap": "Micro Cap"
    },
    "TRUFF": {
        "short_name": "RED LIGHT HOLLAND CORP",
        "long_name": "Red Light Holland Corp.",
        "summary": "Red Light Holland Corp. engages in the production, cultivation, and sale of magic truffles to the legal recreational market in the Netherlands. It sells its products under the iMicrodose brand name through smart shops operators and an advanced e-commerce platform, iMicrodose.nl. The company was incorporated in 1982 and is based in Toronto, Ontario.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5C 2V9",
        "website": "http://www.redlighttruffles.com",
        "market_cap": "Micro Cap"
    },
    "TRUL.CN": {
        "short_name": "TrulieveCannab",
        "long_name": "Trulieve Cannabis Corp.",
        "summary": "Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. As of April 19, 2021, the company operated through 86 dispensaries in the United States. The company is headquartered in Quincy, Florida.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "FL",
        "city": "Quincy",
        "zipcode": "32351",
        "website": "http://www.trulieve.com",
        "market_cap": "Mid Cap"
    },
    "TSMRF": {
        "short_name": "TSUMURA & CO",
        "long_name": "Tsumura & Co.",
        "summary": "Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines, as well as Kampo powdered extracts; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Japan",
        "state": null,
        "city": "Tokyo",
        "zipcode": "107-8521",
        "website": "http://www.tsumura.co.jp",
        "market_cap": "Mid Cap"
    },
    "TSPC.JK": {
        "short_name": "Tempo Scan Pacific Tbk.",
        "long_name": "PT Tempo Scan Pacific Tbk",
        "summary": "PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. It operates through three segments: Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. The company is involved in the construction and rental of buildings; provision of warehousing, freight forwarding, advertising and promotion, research and development, computer systems, and distribution and marketing services; medical devices trading; and manufacture of food supplements, food and beverages, and plastic packaging, as well as consumer products, soaps, and household products. It sells its products under Bodrex, Vidoran, Hemaviton, Oskadon, Bodrexin, Neo rheumacyl, Oskadryl, Contrexyn, Zevit Grow, Wybert, Vitonal, Polaris, and Vitamin IPI brands. The company was formerly known as PT Scanchemie. PT Tempo Scan Pacific Tbk was founded in 1970 and is headquartered in Jakarta, Indonesia. PT Tempo Scan Pacific Tbk is a subsidiary of PT Bogamulia Nagadi.",
        "currency": "IDR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "JKT",
        "market": "id_market",
        "country": "Indonesia",
        "state": null,
        "city": "Jakarta",
        "zipcode": "12950",
        "website": "http://www.thetempogroup.net",
        "market_cap": "Small Cap"
    },
    "TWSI": {
        "short_name": "TRISTAR WELLNESS SOLUTIONS INC",
        "long_name": "Tristar Wellness Solutions Inc.",
        "summary": "TriStar Wellness Solutions, Inc. develops, markets, and sells wound care products. The company also offers skincare and other products under the Beaute de Maman name for pregnant and nursing women; bleeding and wound management products for surgical, health care, consumer, and military markets; and develops and markets Delivery Devise with Invertible Diaphragm, which is a medical applicator for delivering medicants and internal devices within the body without producing injury or damage. In addition, it develops over-the-counter itch suppression products; and develops, manufactures, and markets wound care and infection control medical devices. The company was formerly known as BioPack Environmental Solutions, Inc. and changed its name to TriStar Wellness Solutions, Inc. in January 2013. TriStar Wellness Solutions, Inc. is based in Portland, Oregon. On January 15, 2016, TriStar Wellness Solutions, Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the District of Oregon.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "OR",
        "city": "Portland",
        "zipcode": "97205",
        "website": "http://www.tstarwellness.com",
        "market_cap": "Nano Cap"
    },
    "TXMD": {
        "short_name": "TherapeuticsMD, Inc.",
        "long_name": "TherapeuticsMD, Inc.",
        "summary": "TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17\u00c3\u009f-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-007HR and TX-008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Boca Raton",
        "zipcode": "33431",
        "website": "http://www.therapeuticsmd.com",
        "market_cap": "Small Cap"
    },
    "TYHT": {
        "short_name": "Shineco, Inc.",
        "long_name": "Shineco, Inc.",
        "summary": "Shineco, Inc., through its subsidiaries, produces, distributes, and sells health and well-being focused plant-based products in China. It processes and distributes traditional Chinese herbal medicine products, as well as other pharmaceutical products directly to individual customers. The company also plants, processes, and distributes green and organic vegetables and fruits; and grows, cultivates, and sells yew trees that are used for the production of anti-cancer medication, as well as ornamental bonsai trees for purifying indoor air quality. In addition, it offers logistics services for agricultural products. Further, the company develops, manufactures, and distributes specialized fabrics, textiles, health supplements, and other byproducts derived from an indigenous Chinese plant Apocynum Venetum. The company sells its Chinese medicinal products and western medicines through wholesale customers; and its 13 Ankang retail pharmacies operating under the Sunsimiao Pharmacies name, as well as 66 pharmacies operated by third parties. Shineco, Inc. sells its decoction pieces on the Anhui Bozhou Chinese medicine transaction market to medical materials companies and Chinese patent medicine factories. The company sells its Luobuma textile products online through third party e-commerce websites, as well as through distributors under the Tenethealth brand; and yew trees and agricultural products primarily through its sales personnel, and group and institutional sales. The company was formerly known as Beijing Tenet Jove Technological Development Co., Ltd. and changed its name to Shineco, Inc. in June 2005. Shineco, Inc. was founded in 1997 and is based in Beijing, China.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "China",
        "state": null,
        "city": "Beijing",
        "zipcode": "100176",
        "website": "http://www.tianyiluobuma.com",
        "market_cap": "Micro Cap"
    },
    "UBQU": {
        "short_name": "UBIQUITECH SOFTWARE CORP",
        "long_name": "Ubiquitech Software Corp.",
        "summary": "Ubiquitech Software Corp. develops Internet marketing and sales software solutions in the United States. The company's Internet sales technologies include Blue Crush Monetization System that creates advertising platforms and improves existing platforms to increase sales; InternationalFortune.com, a lead generation portal for currency trading companies, hedge funds, and other asset managers worldwide; and Blue Crush Connect, a social network that rewards and incentivizes customers. It also operates AffiliateCashExpress.com and NeedFunded.com. Ubiquitech Software Corp. was incorporated in 2007 and is based in Denver, Colorado.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CO",
        "city": "Denver",
        "zipcode": "80206",
        "website": "http://ubiquitechsoftware.com",
        "market_cap": "Nano Cap"
    },
    "ULUR": {
        "short_name": "ULURU INC",
        "long_name": "ULURU Inc.",
        "summary": "ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include Aphthasol paste for the treatment of canker sores; OraDisc A for canker sores; and OraDisc B, which is used for the treatment and management of oral pain. ULURU Inc. and is headquartered in Addison, Texas.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "TX",
        "city": "Addison",
        "zipcode": "75001",
        "website": "http://www.uluruinc.info",
        "market_cap": "Nano Cap"
    },
    "UNICHEMLAB.NS": {
        "short_name": "UNICHEM LABS",
        "long_name": "Unichem Laboratories Limited",
        "summary": "Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. It offers pharma products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients. The company was founded in 1944 and is based in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400102",
        "website": "http://www.unichemlabs.com",
        "market_cap": "Small Cap"
    },
    "UNVC": {
        "short_name": "UNIVEC INC",
        "long_name": "Univec, Inc.",
        "summary": "Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers 1 cc AD-syringe for aspirating and non-aspirating applications, which are used for dispensing dosages of allergy, immunization, and insulin medicines. It also manufactures and markets sliding sheath syringes that are designed to protect patients and healthcare workers from needle stick injuries; and bifurcated needle safety syringes, which are used in administering smallpox vaccines in response to bio-terrorist threats. Univec markets its auto-disable syringes and sliding sheath safety syringes to private hospitals, health facilities, and distributors in the United States, as well as to governments of developing countries. In addition, it assists pharmaceutical companies in marketing, fulfillment, and tracking drug samples via an online system connecting pharmacies and managed payment providers. The company was founded in 1992 and is based in Baltimore, Maryland.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "MD",
        "city": "Baltimore",
        "zipcode": "21202",
        "website": "http://www.univec.com",
        "market_cap": "Nano Cap"
    },
    "UPPR": {
        "short_name": "UPPER STREET MARKETING INC",
        "long_name": "Upper Street Marketing Inc.",
        "summary": "Upper Street Marketing Inc. provides liquid conversion water technology for various cannabis and hemp cultivators in the United States and Canada. It also acquires and operates cannabis cultivation, dispensary, and related manufacturing operations. The company is based in Scottsdale, Arizona.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "AZ",
        "city": "Scottsdale",
        "zipcode": null,
        "website": "http://www.upperstreetmarketing.com",
        "market_cap": "Nano Cap"
    },
    "USMJ": {
        "short_name": "NORTH AMERICAN CANNABIS HLDGS I",
        "long_name": "North American Cannabis Holdings, Inc.",
        "summary": "North American Cannabis Holdings, Inc., through its subsidiaries, operates in the legal cannabis market in the United States. It conducts various pilots in the legal cannabis sector in order to explore various high growth potential business opportunities. The company also operates a destination beverage company that enables consumers to interface with staff to learn about the specific benefits of cannabis, and select healthy and refreshing cannabis infused beverages, which include custom blended hemp infused coffee, cold pressed juices, and smoothies. In addition, it offers raw hemp seeds and other hemp infused foods. North American Cannabis Holdings, Inc. was formerly known as Algae International Group, Inc. and changed its name to North American Cannabis Holdings, Inc. in June 2015. The company is based in Farmers Branch, Texas.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "TX",
        "city": "Farmers Branch",
        "zipcode": "75244",
        "website": "http://www.aciconglomerated.com/usmj",
        "market_cap": "Nano Cap"
    },
    "USZ.F": {
        "short_name": "STEMCELL UNITED LTD",
        "long_name": "Stemcell United Limited",
        "summary": "Stemcell United Limited, together with its subsidiaries, engages in the sourcing, producing, marketing, and selling of traditional medicine in Australia, Singapore, Greater China, and Malaysia. The company's products include Cannabis Sativa, an industrial hemp; Dendrobium Officinale Kimura et Migo, an orchid extract; Resina, a Daemonorops Draco Blume extract; and Caulerpa Lentillifera, a sea grape extract. The company has a collaboration agreement with Temasek Polytechnic of Singapore to conduct joint research on the application of plant stem cell technology to the cultivation and commercial farming of seagrapes in Singapore. The company was formerly known as On Q Group Limited and changed its name to Stemcell United Limited in September 2015. Stemcell United Limited was incorporated in 1984 and is headquartered in Sydney, Australia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Sydney",
        "zipcode": "2000",
        "website": "http://www.scu.com.sg",
        "market_cap": "Nano Cap"
    },
    "UU4.F": {
        "short_name": "OLAINFARM",
        "long_name": "AS Olainfarm",
        "summary": "AS Olainfarm manufactures and distributes chemical and pharmaceutical products in Latvia. The company operates through five segments: Medicine Production, Wholesale, Retail, Compression Materials, and Other. It provides over the counter and prescription medicines, including anti-allergy, anti-inflammatory and analgesic, antibacterial, common cold, digestive system, metabolic, antifungal, and antiviral, as well as medicines for cardiovascular health, and digestive and nervous systems; and food supplements. The company also offers active pharmaceutical ingredients (APIs) and intermediates; pharmacovigilance services for patients, physicians, and pharmacists; and QC/QA, regulatory, APIs and intermediates development, final dosage forms development, and contract manufacturing services. In addition, it engages in the sale of medicine and other products to retailers; operation of a pharmacy chain under the Latvijas Aptieka name; production and sale of elastic and compression materials, dietary supplements, herbal infusions, and eco-cosmetics; and provision of travelling, marketing, and public services. The company also exports its products to approximately 60 countries, including the Baltics, Russia, other CIS countries, Europe, Asia, North America, and Australia. AS Olainfarm was founded in 1972 and is based in Olaine, Latvia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Latvia",
        "state": null,
        "city": "Olaine",
        "zipcode": "2114",
        "website": "http://lv.olainfarm.com",
        "market_cap": "Micro Cap"
    },
    "UVP.F": {
        "short_name": "AUSCANN GROUP HLDGS O.N.",
        "long_name": "AusCann Group Holdings Ltd",
        "summary": "AusCann Group Holdings Ltd, a pharmaceutical company, researches, develops, cultivates, produces, and distributes cannabinoid-based pharmaceuticals in Australia and internationally. It offers hard-shell capsules using Neuvis technology for the treatment of chronic neuropathic pain. The company is based in West Perth, Australia.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Australia",
        "state": "WA",
        "city": "West Perth",
        "zipcode": "6005",
        "website": "http://auscann.com.au",
        "market_cap": "Nano Cap"
    },
    "V5D1.F": {
        "short_name": "DELTA 9 CANNABIS",
        "long_name": "Delta 9 Cannabis Inc.",
        "summary": "Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis and related merchandise and devices. As of April 14, 2021, it owned and operated 12 retail stores under the Delta 9 Cannabis Store brand. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "MB",
        "city": "Winnipeg",
        "zipcode": "R3L 2V9",
        "website": "http://www.delta9.ca",
        "market_cap": "Nano Cap"
    },
    "V5D1.SG": {
        "short_name": "Delta 9 Cannabis Inc. Registere",
        "long_name": "Delta 9 Cannabis Inc.",
        "summary": "Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis and related merchandise and devices. As of April 14, 2021, it owned and operated 12 retail stores under the Delta 9 Cannabis Store brand. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "Canada",
        "state": "MB",
        "city": "Winnipeg",
        "zipcode": "R3L 2V9",
        "website": "http://www.delta9.ca",
        "market_cap": "Nano Cap"
    },
    "VAISHALI.NS": {
        "short_name": "Vaishali Pharma Limited",
        "long_name": "Vaishali Pharma Limited",
        "summary": "Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as antibiotics/antibacterial, anti-platelet, laxative, anti-ulcer/enzyme, anti-asthmatic, anti-malarial, anti-cold/anti-allergic/anti-viral, anti-psychotic, anti-fungal, anti-inflammatory/analgesic/anti-pyretic, anti-diabetic, cardiac, vitamins, topical steroids/corticosteroids, and other formulations. In addition, it offers veterinary pharmaceutical, nutraceutical, oncology, herbal, and surgical products. Vaishali Pharma Limited was founded in 1989 and is headquartered in Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400092",
        "website": "http://www.vaishalipharma.com",
        "market_cap": "Nano Cap"
    },
    "VBSCF": {
        "short_name": "VIBE GROWTH CORPORATION",
        "long_name": "Vibe Growth Corporation",
        "summary": "Vibe Growth Corporation engages in the cultivation, production, retail, and distribution of cannabis for recreation and medicinal use in the United States, Canada, and internationally. The company operates through four segments: Dispensaries, Cultivation, Real Estate, and Canada. It operates 5 dispensaries and a cannabis greenhouse cultivation, as well as sells its products online under the Vibe By California brand. The company was formerly known as Vibe Bioscience Ltd. and changed its name to Vibe Growth Corporation in October 2020. Vibe Growth Corporation is headquartered in Sacramento, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Sacramento",
        "zipcode": "95826",
        "website": "http://www.vibebycalifornia.com",
        "market_cap": "Micro Cap"
    },
    "VCBDQ": {
        "short_name": "VITALIBIS INC",
        "long_name": "Vitalibis, Inc.",
        "summary": "Vitalibis, Inc. operates as a technology-based formulator of phytocannabinoid rich hemp products with cannabidiol, along with personal care and nutritional products. The company markets and sells consumer products under the Vitalibis brand. It also sells water soluble phytocannabinoid rich hemp powder. The company was formerly known as Sheng Ying Entertainment Corp. and changed its name to Vitalibis, Inc. in February 2018. Vitalibis, Inc. was founded in 2014 and is based in Las Vegas, Nevada. On June 15, 2020, Vitalibis, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Nevada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "NV",
        "city": "Las Vegas",
        "zipcode": "89169",
        "website": "http://www.vitalibis.com",
        "market_cap": "Nano Cap"
    },
    "VDRM": {
        "short_name": "VIADERMA INC",
        "long_name": "ViaDerma, Inc.",
        "summary": "ViaDerma, Inc. operates as a specialty pharmaceutical company. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as D\u00c3\u00a9cor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. is headquartered in Marina Del Rey, the United States.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Marina Del Rey",
        "zipcode": "90292",
        "website": "http://viadermalicensing.com",
        "market_cap": "Nano Cap"
    },
    "VEGGF": {
        "short_name": "BETTER PLANT SCIENCES INC",
        "long_name": "Better Plant Sciences Inc.",
        "summary": "Better Plant Sciences Inc., through its subsidiaries, develops, markets, and sells of plant-based products for health and wellness. The company offers cosmetic and therapeutic products made of cannabis sativa hemp root oil and essential oils. It also develop and acquire intellectual property for plant-based products. The company offers plant-based skin care products under Urban Juve brand name; cannabis wellness products under Wright & Well and Jack n Jane brands; botanicals, fruit extracts, and spices under the UJ Beverages brand. The company was formerly known as The Yield Growth Corp. and changed its name to Better Plant Sciences Inc. in August 2020. Better Plant Sciences Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6B 2Y5",
        "website": "http://betterplantsciences.com",
        "market_cap": "Nano Cap"
    },
    "VENI.CN": {
        "short_name": "Top Strike",
        "long_name": "Top Strike Resources Corp.",
        "summary": "Top Strike Resources Corp., doing business as Vencanna Ventures Inc., operates as a merchant capital firm. It provides capital for early-stage global cannabis initiatives, including state compliant opportunities in the United States. The company was formerly known as Colossal Resources Corp. and changed its name to Top Strike Resources Corp. in December 2012. Top Strike Resources Corp. is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2P 3H7",
        "website": "http://vencanna.com",
        "market_cap": "Nano Cap"
    },
    "VENUSREM.NS": {
        "short_name": "VENUS REMEDIES LTD",
        "long_name": "Venus Remedies Limited",
        "summary": "Venus Remedies Limited, a pharmaceutical company, manufactures and trades in medicines in India and internationally. The company offers Sterloc, a super oxidized solution; Swachh Guard, an alcohol-based instant hand sanitizer; Trois Spray, a nanotech emulsion; and Trois Tablet to manage acute pain with topical applications. It offers its products in various therapeutic segments comprising analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, cardiac, disinfectant and antiseptic, gastro therapy, hand sanitizers, hormones, iron supplements, neurology, oncology, pain management, respiratory, skin care, stress reliever, urology, vitamins/minerals/nutrients, and wound management. The company was founded in 1989 and is based in Panchkula, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Panchkula",
        "zipcode": "134113",
        "website": "http://www.venusremedies.com",
        "market_cap": "Micro Cap"
    },
    "VETO.PA": {
        "short_name": "VETOQUINOL",
        "long_name": "Vetoquinol SA",
        "summary": "Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of pain management, anti-infective, cardiology-nephrology, care and hygiene, antiparasiticides, behavior, internal medicine, and reproduction for cats, dogs, cattle, and pigs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PAR",
        "market": "fr_market",
        "country": "France",
        "state": null,
        "city": "Lure",
        "zipcode": "70204",
        "website": "http://www.vetoquinol.com",
        "market_cap": "Small Cap"
    },
    "VEXT.CN": {
        "short_name": "VextSciInc",
        "long_name": "Vext Science, Inc.",
        "summary": "Vext Science, Inc., through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States. The company is involved in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. It also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen and Pure Touch Botanicals brands. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2E9",
        "website": "http://www.vapenmj.com",
        "market_cap": "Nano Cap"
    },
    "VEXTF": {
        "short_name": "VEXT SCIENCE INC",
        "long_name": "Vext Science, Inc.",
        "summary": "Vext Science, Inc., through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States. The company is involved in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. It also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen and Pure Touch Botanicals brands. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2E9",
        "website": "http://www.vapenmj.com",
        "market_cap": "Nano Cap"
    },
    "VFRM": {
        "short_name": "VERITAS FARMS INC",
        "long_name": "Veritas Farms, Inc.",
        "summary": "Veritas Farms, Inc. focuses on producing, marketing, and distributing hemp oils and extracts containing phytocannabinoids. The company's products include vegan capsules, gummies, tinctures, lotions, salves, vape oils, cream, and oral syringes. It markets and sells its products under the Veritas Farms brand name, as well as through white label and private label custom formulations for distributors and retailers. The company was formerly known as SanSal Wellness Holdings, Inc. and changed its name to Veritas Farms, Inc. in February 2019. Veritas Farms, Inc. is based in Fort Lauderdale, Florida.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "FL",
        "city": "Fort Lauderdale",
        "zipcode": "33301",
        "website": "http://www.theveritasfarms.com",
        "market_cap": "Nano Cap"
    },
    "VIA.DE": {
        "short_name": "VIATRIS INC.  O.N.",
        "long_name": "Viatris Inc.",
        "summary": "Viatris Inc., a healthcare company, develops, licenses, manufactures, markets, and distributes brand and generic drugs, complex generics, biosimilars, and active pharmaceutical ingredients (APIs) worldwide. The company operates through Developed Markets, Greater China, JANZ, and Emerging Markets segments. It offers drugs in various therapeutic areas, including infectious diseases and non-communicable diseases; HIV/AIDS; and oncology, immunology, endocrinology, ophthalmology, and dermatology, as well as antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas. The company provides medicines, such as Wixela, Inhub, ADVAIR DISKUS, glatiramer acetate injection, Copaxone, and over the counter products in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions; and support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. The company sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, and EpiPen auto-injector; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; Trastuzumab injection; and Celebrex and anti-retrovirals names, as well as offers biosimilars franchises, including Fulphila, Ogivri, and Hulio. Viatris Inc. has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. The company was founded in 1961 and is based in Canonsburg, Pennsylvania.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "GER",
        "market": "de_market",
        "country": "United States",
        "state": "PA",
        "city": "Canonsburg",
        "zipcode": "15317",
        "website": "http://www.viatris.com",
        "market_cap": "Large Cap"
    },
    "VIA.F": {
        "short_name": "VIATRIS INC.  O.N.",
        "long_name": "Viatris Inc.",
        "summary": "Viatris Inc., a healthcare company, develops, licenses, manufactures, markets, and distributes brand and generic drugs, complex generics, biosimilars, and active pharmaceutical ingredients (APIs) worldwide. The company operates through Developed Markets, Greater China, JANZ, and Emerging Markets segments. It offers drugs in various therapeutic areas, including infectious diseases and non-communicable diseases; HIV/AIDS; and oncology, immunology, endocrinology, ophthalmology, and dermatology, as well as antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas. The company provides medicines, such as Wixela, Inhub, ADVAIR DISKUS, glatiramer acetate injection, Copaxone, and over the counter products in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions; and support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. The company sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, and EpiPen auto-injector; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; Trastuzumab injection; and Celebrex and anti-retrovirals names, as well as offers biosimilars franchises, including Fulphila, Ogivri, and Hulio. Viatris Inc. has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. The company was founded in 1961 and is based in Canonsburg, Pennsylvania.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "PA",
        "city": "Canonsburg",
        "zipcode": "15317",
        "website": "http://www.viatris.com",
        "market_cap": "Large Cap"
    },
    "VIBE.CN": {
        "short_name": "Vibe Growth",
        "long_name": "Vibe Growth Corporation",
        "summary": "Vibe Growth Corporation engages in the cultivation, production, retail, and distribution of cannabis for recreation and medicinal use in the United States, Canada, and internationally. The company operates through four segments: Dispensaries, Cultivation, Real Estate, and Canada. It operates 5 dispensaries and a cannabis greenhouse cultivation, as well as sells its products online under the Vibe By California brand. The company was formerly known as Vibe Bioscience Ltd. and changed its name to Vibe Growth Corporation in October 2020. Vibe Growth Corporation is headquartered in Sacramento, California.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "CA",
        "city": "Sacramento",
        "zipcode": "95826",
        "website": "http://www.vibebycalifornia.com",
        "market_cap": "Micro Cap"
    },
    "VIFN.SW": {
        "short_name": "VIFOR N",
        "long_name": "Vifor Pharma AG",
        "summary": "Vifor Pharma AG, a pharmaceutical company, focuses on the development, manufacture, and commercialization of pharmaceutical products in Switzerland, rest of Europe, the United States, and internationally. The company offers Ferinject/Injectafer, a solution of ferric carboxymaltose used for the treatment of iron deficiency and iron deficiency anemia; Maltofer, an oral iron polymaltose complex for infants, children, adolescents, and pregnant woman with iron deficiency; and Mircera, a long-acting erythropoiesis-stimulating agent (ESA) to treat symptomatic anemia associated with the chronic kidney disease (CKD). It also provides Retacrit, a short-acting ESA; Venofer, an intravenous iron sucrose used in the intravenous treatment of iron deficiency; and Velphoro, a non-calcium, iron-based chewable phosphate binder for the treatment of hyperphosphatemia in adults with CKD undergoing dialysis. In addition, the company offers Rayaldee, an orally administered, extended release formulation of calcifediol for the treatment of secondary hyperparathyroidism in patients with CKD; Veltassa for the treatment of hyperkalaemia in CKD and chronic heart failure patients; and Invokana to treat diabetic kidney disease. Further, it developing Vadadustat, an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of anemia due to chronic kidney disease; Avacopan, an orally-administered, highly selective inhibitor of C5aR1 for the treatment of orphan and rare renal diseases; ANG-3777 for the treatment of delayed graft function and cardiac surgery-associated acute kidney injury; Difelikefalin for the treatment for chronic kidney disease-associated pruritus; and VIT-2763 to treat beta-thalassemia. Vifor Pharma AG has a strategic partnership with Fresenius Kabi. The company was formerly known as Galenica AG and changed its name to Vifor Pharma AG in April 2017. Vifor Pharma AG was founded in 1872 and is headquartered in Sankt Gallen, Switzerland.",
        "currency": "CHF",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "EBS",
        "market": "ch_market",
        "country": "Switzerland",
        "state": null,
        "city": "Sankt Gallen",
        "zipcode": "9014",
        "website": "http://www.viforpharma.com",
        "market_cap": "Mid Cap"
    },
    "VIN.CN": {
        "short_name": "VinergyCapital",
        "long_name": "Vinergy Capital Inc.",
        "summary": "Vinergy Capital Inc. does not have significant operations. Previously, it was engaged in the development of cannabis products. The company was formerly known as Vinergy Cannabis Capital Inc. and changed its name to Vinergy Capital Inc. in March 2021. Vinergy Capital Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1T2",
        "website": "http://vinergycapital.com",
        "market_cap": "Nano Cap"
    },
    "VISTN.OL": {
        "short_name": "VISTIN PHARMA ASA",
        "long_name": "Vistin Pharma ASA",
        "summary": "Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin APIs and direct compressive granulates for the pharmaceutical industry. The company was incorporated in 2015 and is headquartered in Oslo, Norway.",
        "currency": "NOK",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "OSL",
        "market": "no_market",
        "country": "Norway",
        "state": null,
        "city": "Oslo",
        "zipcode": "0661",
        "website": "http://www.vistin.com",
        "market_cap": "Micro Cap"
    },
    "VIV.V": {
        "short_name": "AVIVAGEN INC",
        "long_name": "Avivagen Inc.",
        "summary": "Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers products based on its OxC-Beta technology, such as OxC-beta Livestock, a premix for livestock feeds; and Vivamune Health Chews supplements for companion animals. It has operations in Mexico and Latin America. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen Inc.in May 2012. Avivagen Inc. was founded in 2005 and is headquartered in Ottawa, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Ottawa",
        "zipcode": "K1A 0R6",
        "website": "http://www.avivagen.com",
        "market_cap": "Nano Cap"
    },
    "VIVIMEDLAB.NS": {
        "short_name": "VIVIMED LABS LTD",
        "long_name": "Vivimed Labs Limited",
        "summary": "Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India, Mexico, Spain, Hungary, and internationally. It operates in two segments, Specialty Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also offers a range of hair dye intermediates for use in permanent, semi-permanent, and temporary hair colorant systems; oxidation dye couplers and bases to formulate various permanent and demi-permanent shades; direct dyes for semi-permanent formulations; and basic dyes for temporary, semi-permanent, and color-refresher shampoos and conditioners under the Jarocol name. In addition, the company manufactures and markets photochromic dyes under the Reversacol name; and anti-microbial actives for use in a range of applications, including plastics additives and anti-bacterial handwashes. Further, it offers photographic chemicals, such as black and white developers, and antifog additives for use in medical and industrial X-ray imaging, consumer photography, and litho-plate production for the graphic arts industry. Additionally, the company manufactures Favulous for the treatment of mild to moderate cases of Covid-19. Its products are used in home, personal, and industrial care segments. The company was incorporated in 1988 and is based in Hyderabad, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Hyderabad",
        "zipcode": "500034",
        "website": "http://www.vivimedlabs.com",
        "market_cap": "Nano Cap"
    },
    "VIVO.TO": {
        "short_name": "VIVO CANNABIS INC",
        "long_name": "VIVO Cannabis Inc.",
        "summary": "VIVO Cannabis Inc. cultivates, produces, and sells cannabis products for the medical and adult-use markets in Canada, Germany, and Australia. The company offers dried cannabis flower products, pre-rolls and cannabis oils, and other cannabis-derived products; and cannabis-infused chocolates, vapes, kief, live rosin, bubble hash, brick hash, and shatter and wax solvent extracts under the Canna Farms, Beacon Medical, Fireside, Fireside-X, Lumina, and Canadian Bud Collection brands. The company also operates a network of medical cannabis clinics under the Harvest Medicine name. It serves customers through direct and retail sale; and HMED Connect telemedicine platform, an online medical cannabis platform. The company is headquartered in Napanee, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Napanee",
        "zipcode": "K7R 3L2",
        "website": "http://vivocannabis.com",
        "market_cap": "Nano Cap"
    },
    "VIVXF": {
        "short_name": "AVIVAGEN INC",
        "long_name": "Avivagen Inc.",
        "summary": "Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers products based on its OxC-Beta technology, such as OxC-beta Livestock, a premix for livestock feeds; and Vivamune Health Chews supplements for companion animals. It has operations in Mexico and Latin America. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen Inc.in May 2012. Avivagen Inc. was founded in 2005 and is headquartered in Ottawa, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Ottawa",
        "zipcode": "K1A 0R6",
        "website": "http://www.avivagen.com",
        "market_cap": "Nano Cap"
    },
    "VLG.L": {
        "short_name": "VENTURE LIFE GROUP PLC ORD 0.3P",
        "long_name": "Venture Life Group plc",
        "summary": "Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance mental alertness, cognitive function, and mental performance in ageing brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX Original and UltraDEX Sensitive for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and mouth; and Procto-eze for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Bracknell",
        "zipcode": "RG12 2XB",
        "website": "http://www.venture-life.com",
        "market_cap": null
    },
    "VLNCF": {
        "short_name": "THE VALENS COMPANY INC",
        "long_name": "The Valens Company Inc.",
        "summary": "The Valens Company Inc., engages in the development and manufacturing of cannabinoid based products. The company operates through Cannabis Operations and Analytical Testing segments. The Cannabis Operation segment provides extraction, post processing, and white label manufacturing under the standard processing and standard cultivation license issued by Health Canada. The Analytical Testing segment offers testing services for cannabis products under an analytical testing license provided by Health Canada. The company offers CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, formulation, and white-label product development services. Further, it produces dried cannabis and hemp biomass products. Additionally, the company provides range of products, including tinctures, two-piece caps, soft gels, oral sprays and vape pens, as well as beverages, concentrates, topicals, edibles, injectables, natural health products. It also offers analytical testing services to third party licensed producers in the cannabis space. The company offers a CBD-forward iced tea under the BASECAMP; and THC-forward citrus water under the SUMMIT brand names. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5V 2J6",
        "website": "http://www.thevalenscompany.com",
        "market_cap": "Small Cap"
    },
    "VLNS.TO": {
        "short_name": "THE VALENS COMPANYINC",
        "long_name": "The Valens Company Inc.",
        "summary": "The Valens Company Inc., engages in the development and manufacturing of cannabinoid based products. The company operates through Cannabis Operations and Analytical Testing segments. The Cannabis Operation segment provides extraction, post processing, and white label manufacturing under the standard processing and standard cultivation license issued by Health Canada. The Analytical Testing segment offers testing services for cannabis products under an analytical testing license provided by Health Canada. The company offers CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, formulation, and white-label product development services. Further, it produces dried cannabis and hemp biomass products. Additionally, the company provides range of products, including tinctures, two-piece caps, soft gels, oral sprays and vape pens, as well as beverages, concentrates, topicals, edibles, injectables, natural health products. It also offers analytical testing services to third party licensed producers in the cannabis space. The company offers a CBD-forward iced tea under the BASECAMP; and THC-forward citrus water under the SUMMIT brand names. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M5V 2J6",
        "website": "http://www.thevalenscompany.com",
        "market_cap": "Small Cap"
    },
    "VLS.AX": {
        "short_name": "VLSCIENCE FPO",
        "long_name": "Vita Life Sciences Limited",
        "summary": "Vita Life Sciences Limited, a pharmaceutical and healthcare company, engages in formulation, packaging, distribution, and sale of vitamins and supplements. It offers a range of supplements, vitamins, minerals, herbs, and superfoods. The company markets its products through pharmacies and health food stores under the Herbs of Gold, VitaHealth, VitaScience, and VitaLife brands. It operates in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, China, and internationally. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia.",
        "currency": "AUD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASX",
        "market": "au_market",
        "country": "Australia",
        "state": "NSW",
        "city": "Kirrawee",
        "zipcode": "2232",
        "website": "http://www.vitalifesciences.com",
        "market_cap": "Nano Cap"
    },
    "VM.V": {
        "short_name": "VOYAGEUR PHARMACEUTICALS LTD",
        "long_name": "Voyageur Pharmaceuticals Ltd.",
        "summary": "Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the industrial barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is based in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2G 2B3",
        "website": "http://voyageurpharmaceuticals.ca",
        "market_cap": "Nano Cap"
    },
    "VNNYF": {
        "short_name": "VINERGY CAPITAL INC",
        "long_name": "Vinergy Capital Inc.",
        "summary": "Vinergy Capital Inc. does not have significant operations. Previously, it was engaged in the development of cannabis products. The company was formerly known as Vinergy Cannabis Capital Inc. and changed its name to Vinergy Capital Inc. in March 2021. Vinergy Capital Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 1T2",
        "website": "http://vinergycapital.com",
        "market_cap": "Nano Cap"
    },
    "VP2.F": {
        "short_name": "VALEO PHARMA INC.CL.A",
        "long_name": "Valeo Pharma Inc.",
        "summary": "Valeo Pharma Inc., a specialty pharmaceutical company, engages in the acquisition, in-licensing, and commercialization of pharmaceutical products with a primary focus on neurodegenerative diseases, oncology and supportive care, and hospital products. Its products portfolio includes Redesca, a low molecular weight heparin (LMWH) biosimilar to treat and prevent deep vein thrombosis and pulmonary embolism; Hesperco, a capsule that supports the immune system; Onstryv, an oral medication for Parkinson's disease; M-Eslon, a narcotic analgesic for pain management; and Ametop Gel, a tetracaine hydrochloride gel for the percutaneous anesthetic to produce anesthesia of the skin prior to venepuncture or venous cannulation. The company also provides Ethacrynate Sodium, a loop diuretic used to treat high blood pressure and the swelling caused by diseases, such as congestive heart failure, liver failure, and kidney failure; Synacthen Depot, a synthetic adrenocorticotropic hormone to treat multiple sclerosis and nephrotic syndrome; Ondansetron for the prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used for the treatment of Parkinson's disease; and Yondelis, a novel marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. In addition, its product pipeline includes Piperacillin/tazobactam, an injectable antibiotic, as well as various hospital products for anti-fungal, antibiotic, pain management, and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "QC",
        "city": "Kirkland",
        "zipcode": "H9H 4R9",
        "website": "http://www.valeopharma.com",
        "market_cap": "Micro Cap"
    },
    "VP4.F": {
        "short_name": "VISTIN PHARMA ASA  NK 1",
        "long_name": "Vistin Pharma ASA",
        "summary": "Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin APIs and direct compressive granulates for the pharmaceutical industry. The company was incorporated in 2015 and is headquartered in Oslo, Norway.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Norway",
        "state": null,
        "city": "Oslo",
        "zipcode": "0661",
        "website": "http://www.vistin.com",
        "market_cap": "Micro Cap"
    },
    "VPH.CN": {
        "short_name": "ValeoPharma",
        "long_name": "Valeo Pharma Inc.",
        "summary": "Valeo Pharma Inc., a specialty pharmaceutical company, engages in the acquisition, in-licensing, and commercialization of pharmaceutical products with a primary focus on neurodegenerative diseases, oncology and supportive care, and hospital products. Its products portfolio includes Redesca, a low molecular weight heparin (LMWH) biosimilar to treat and prevent deep vein thrombosis and pulmonary embolism; Hesperco, a capsule that supports the immune system; Onstryv, an oral medication for Parkinson's disease; M-Eslon, a narcotic analgesic for pain management; and Ametop Gel, a tetracaine hydrochloride gel for the percutaneous anesthetic to produce anesthesia of the skin prior to venepuncture or venous cannulation. The company also provides Ethacrynate Sodium, a loop diuretic used to treat high blood pressure and the swelling caused by diseases, such as congestive heart failure, liver failure, and kidney failure; Synacthen Depot, a synthetic adrenocorticotropic hormone to treat multiple sclerosis and nephrotic syndrome; Ondansetron for the prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used for the treatment of Parkinson's disease; and Yondelis, a novel marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. In addition, its product pipeline includes Piperacillin/tazobactam, an injectable antibiotic, as well as various hospital products for anti-fungal, antibiotic, pain management, and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "QC",
        "city": "Kirkland",
        "zipcode": "H9H 4R9",
        "website": "http://www.valeopharma.com",
        "market_cap": "Micro Cap"
    },
    "VPHIF": {
        "short_name": "VALEO PHARMA INC",
        "long_name": "Valeo Pharma Inc.",
        "summary": "Valeo Pharma Inc., a specialty pharmaceutical company, engages in the acquisition, in-licensing, and commercialization of pharmaceutical products with a primary focus on neurodegenerative diseases, oncology and supportive care, and hospital products. Its products portfolio includes Redesca, a low molecular weight heparin (LMWH) biosimilar to treat and prevent deep vein thrombosis and pulmonary embolism; Hesperco, a capsule that supports the immune system; Onstryv, an oral medication for Parkinson's disease; M-Eslon, a narcotic analgesic for pain management; and Ametop Gel, a tetracaine hydrochloride gel for the percutaneous anesthetic to produce anesthesia of the skin prior to venepuncture or venous cannulation. The company also provides Ethacrynate Sodium, a loop diuretic used to treat high blood pressure and the swelling caused by diseases, such as congestive heart failure, liver failure, and kidney failure; Synacthen Depot, a synthetic adrenocorticotropic hormone to treat multiple sclerosis and nephrotic syndrome; Ondansetron for the prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used for the treatment of Parkinson's disease; and Yondelis, a novel marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. In addition, its product pipeline includes Piperacillin/tazobactam, an injectable antibiotic, as well as various hospital products for anti-fungal, antibiotic, pain management, and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "QC",
        "city": "Kirkland",
        "zipcode": "H9H 4R9",
        "website": "http://www.valeopharma.com",
        "market_cap": "Micro Cap"
    },
    "VREO.CN": {
        "short_name": "VireoHealth",
        "long_name": "Vireo Health International, Inc.",
        "summary": "Vireo Health International Inc. operates as a physician-led cannabis company in the United States. It cultivates cannabis; manufactures pharmaceutical-grade cannabis extracts; and sells its products through its network of Green Goods and other retail locations, and third-party dispensaries. The company grows and/or processes cannabis in eight markets and operates 16 dispensaries. Vireo Health International Inc. is headquartered in Minneapolis, Minnesota.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "MN",
        "city": "Minneapolis",
        "zipcode": "55408",
        "website": "http://www.vireohealth.com",
        "market_cap": "Micro Cap"
    },
    "VREOF": {
        "short_name": "VIREO HEALTH INTERNATIONAL INC",
        "long_name": "Goodness Growth Holdings, Inc.",
        "summary": "Vireo Health International Inc. operates as a physician-led cannabis company in the United States. It cultivates cannabis; manufactures pharmaceutical-grade cannabis extracts; and sells its products through its network of Green Goods and other retail locations, and third-party dispensaries. The company grows and/or processes cannabis in eight markets and operates 16 dispensaries. Vireo Health International Inc. is headquartered in Minneapolis, Minnesota.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "MN",
        "city": "Minneapolis",
        "zipcode": "55408",
        "website": "http://www.vireohealth.com",
        "market_cap": "Micro Cap"
    },
    "VRNO.CN": {
        "short_name": "Verano Holdings",
        "long_name": "Verano Holdings Corp.",
        "summary": "Verano Holdings Corp. operates as a vertically-integrated multi-state cannabis operator in the United States. The company produces and sells a suite of cannabis products under the portfolio of consumer brands, including Encore, Avexia, M\u00c3\u009cV, and Verano. It designs, builds, and operates dispensaries under the Zen Leaf and M\u00c3\u009cV retail brands that delivers a cannabis shopping experience in medical and adult-use markets. The company also holds, operates, manages, consults, licenses, and/or controls licenses/permits in the states of Illinois, Florida, Arizona, New Jersey, Pennsylvania, Ohio, Maryland, Massachusetts, Nevada, Michigan, Arkansas, California, Missouri, and West Virginia; and engages in the wholesale of cannabis consumer packaged goods. Verano Holdings Corp. was founded in 2017 and is headquartered in Chicago, Illinois.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "United States",
        "state": "IL",
        "city": "Chicago",
        "zipcode": "60654",
        "website": "http://www.verano.com",
        "market_cap": null
    },
    "VRNOF": {
        "short_name": "VERANO HOLDINGS CORP",
        "long_name": "Verano Holdings Corp.",
        "summary": "Verano Holdings Corp. operates as a vertically-integrated multi-state cannabis operator in the United States. The company produces and sells a suite of cannabis products under the portfolio of consumer brands, including Verano, Avexia, Encore, and M\u00c3\u009cV. It designs, builds, and operates dispensaries under the Zen Leaf and M\u00c3\u009cV retail brands that delivers a cannabis shopping experience in medical and adult-use markets. The company also holds, operates, manages, consults, licenses, and/or controls licenses/permits in the states of Illinois, Maryland, New Jersey, Massachusetts, Nevada, Ohio, Pennsylvania, Michigan, Arkansas, California, Missouri, and West Virginia; and engages in the wholesale of cannabis consumer packaged goods. Verano Holdings Corp. was founded in 2017 and is headquartered in Chicago, Illinois.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "IL",
        "city": "Chicago",
        "zipcode": "60654",
        "website": "http://www.verano.com",
        "market_cap": null
    },
    "VTRS": {
        "short_name": "Viatris Inc.",
        "long_name": "Viatris Inc.",
        "summary": "Viatris Inc., a healthcare company, develops, licenses, manufactures, markets, and distributes brand and generic drugs, complex generics, biosimilars, and active pharmaceutical ingredients (APIs) worldwide. The company operates through Developed Markets, Greater China, JANZ, and Emerging Markets segments. It offers drugs in various therapeutic areas, including infectious diseases and non-communicable diseases; HIV/AIDS; and oncology, immunology, endocrinology, ophthalmology, and dermatology, as well as antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas. The company provides medicines, such as Wixela, Inhub, ADVAIR DISKUS, glatiramer acetate injection, Copaxone, and over the counter products in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions; and support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. The company sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, and EpiPen auto-injector; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; Trastuzumab injection; and Celebrex and anti-retrovirals names, as well as offers biosimilars franchises, including Fulphila, Ogivri, and Hulio. Viatris Inc. has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. The company was founded in 1961 and is based in Canonsburg, Pennsylvania.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United States",
        "state": "PA",
        "city": "Canonsburg",
        "zipcode": "15317",
        "website": "http://www.viatris.com",
        "market_cap": "Large Cap"
    },
    "VV5.F": {
        "short_name": "VEXT SCIENCE INC.",
        "long_name": "Vext Science, Inc.",
        "summary": "Vext Science, Inc., through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States. The company is involved in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. It also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen and Pure Touch Botanicals brands. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 2E9",
        "website": "http://www.vapenmj.com",
        "market_cap": "Nano Cap"
    },
    "VVCIF": {
        "short_name": "VIVO CANNABIS INC",
        "long_name": "VIVO Cannabis Inc.",
        "summary": "VIVO Cannabis Inc. cultivates, produces, and sells cannabis products for the medical and adult-use markets in Canada, Germany, and Australia. The company offers dried cannabis flower products, pre-rolls and cannabis oils, and other cannabis-derived products; and cannabis-infused chocolates, vapes, kief, live rosin, bubble hash, brick hash, and shatter and wax solvent extracts under the Canna Farms, Beacon Medical, Fireside, Fireside-X, Lumina, and Canadian Bud Collection brands. The company also operates a network of medical cannabis clinics under the Harvest Medicine name. It serves customers through direct and retail sale; and HMED Connect telemedicine platform, an online medical cannabis platform. The company is headquartered in Napanee, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Napanee",
        "zipcode": "K7R 3L2",
        "website": "http://vivocannabis.com",
        "market_cap": "Nano Cap"
    },
    "VYYRF": {
        "short_name": "VOYAGEUR PHARMACEUTICALS LTD",
        "long_name": "Voyageur Pharmaceuticals Ltd.",
        "summary": "Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the industrial barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is based in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2G 2B3",
        "website": "http://voyageurpharmaceuticals.ca",
        "market_cap": "Nano Cap"
    },
    "WANBURY.NS": {
        "short_name": "WANBURY LTD",
        "long_name": "Wanbury Limited",
        "summary": "Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Navi Mumbai",
        "zipcode": "400703",
        "website": "http://www.wanbury.com",
        "market_cap": "Nano Cap"
    },
    "WDDMF": {
        "short_name": "WEEDMD INC",
        "long_name": "WeedMD Inc.",
        "summary": "WeedMD Inc. produces, distributes, and sells medical-grade cannabis in Canada. It offers dried cannabis, cannabis plants and seeds, cannabis oil, edibles, extracts and topicals, and others, as well as cannabis flower products. The company sells its products directly to medical patients and strategic relationships across the seniors' market, as well as through supply agreements with Shoppers Drug Mart and six provincial distribution agencies under the Color Cannabis, Saturday, Starseed, and WeedMD brand names. WeedMD Inc. is headquartered in Aylmer, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "ON",
        "city": "Aylmer",
        "zipcode": "N5H 2M8",
        "website": "http://www.weedmd.com",
        "market_cap": "Micro Cap"
    },
    "WEED.TO": {
        "short_name": "CANOPY GROWTH CORPORATION",
        "long_name": "Canopy Growth Corporation",
        "summary": "Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. As of February 14, 2020, it operated 28 cannabis retail stores under the Tweed or Tokyo Smoke name. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Smiths Falls",
        "zipcode": "K7A 0A8",
        "website": "http://www.canopygrowth.com",
        "market_cap": "Mid Cap"
    },
    "WKULF": {
        "short_name": "POTENT VENTURES INC",
        "long_name": "Potent Ventures Inc.",
        "summary": "Potent Ventures Inc. sells branded cannabis packaging. It offers its products through Wknd! and Orchard Heights brand name. The company was formerly known as Weekend Unlimited Industries Inc. and changed its name to Potent Ventures Inc. in April 2021. Potent Ventures Inc. is based in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6E 3X1",
        "website": "http://www.weekendunlimited.com",
        "market_cap": "Nano Cap"
    },
    "WLDFF": {
        "short_name": "WILDFLOWER BRANDS INC",
        "long_name": "Wildflower Brands Inc.",
        "summary": "Wildflower Brands Inc. develops, designs, and sells branded products in the cannabis in Washington and California. It offers a line of hemp derived CBD+ wellness products, including CBD based topicals, soaps, tinctures, capsules, and vaporizers. The company also provides bundle box kit. The company offers its products online and through retailers. The company was formerly known as Wildflower Marijuana Inc. and changed its name to Wildflower Brands Inc. in April 2018. Wildflower Brands Inc. is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6H 3Y4",
        "website": "http://www.wildflowerbrands.co",
        "market_cap": "Nano Cap"
    },
    "WLLW.TO": {
        "short_name": "WILLOW BIOSCIENCES INC",
        "long_name": "Willow Biosciences Inc.",
        "summary": "Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. is headquartered in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2R 0Y6",
        "website": "http://www.willowbio.com",
        "market_cap": "Micro Cap"
    },
    "WLNS.CN": {
        "short_name": "DiscoverWell",
        "long_name": "Discover Wellness Solutions Inc.",
        "summary": "Discover Wellness Solutions Inc., a development stage company, cultivates, produces, processes, and sells cannabis in various forms. The company was formerly known as RMMI Corp. and changed its name to Discover Wellness Solutions Inc. in January 2021. Discover Wellness Solutions Inc. was incorporated in 2018 and is based in Calgary, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2P 0Y3",
        "website": "http://www.discoverwellnesssolutions.ca",
        "market_cap": "Nano Cap"
    },
    "WLNSF": {
        "short_name": "DISCOVER WELLNESS SOLUTIONS INC",
        "long_name": "Discover Wellness Solutions Inc.",
        "summary": "Discover Wellness Solutions Inc., a development stage company, cultivates, produces, processes, and sells cannabis in various forms. The company was formerly known as RMMI Corp. and changed its name to Discover Wellness Solutions Inc. in January 2021. Discover Wellness Solutions Inc. was incorporated in 2018 and is based in Calgary, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "AB",
        "city": "Calgary",
        "zipcode": "T2P 0Y3",
        "website": "http://www.discoverwellnesssolutions.ca",
        "market_cap": "Nano Cap"
    },
    "WMD.V": {
        "short_name": "WEEDMD INC",
        "long_name": "WeedMD Inc.",
        "summary": "WeedMD Inc. produces, distributes, and sells medical-grade cannabis in Canada. It offers dried cannabis, cannabis plants and seeds, cannabis oil, edibles, extracts and topicals, and others, as well as cannabis flower products. The company sells its products directly to medical patients and strategic relationships across the seniors' market, as well as through supply agreements with Shoppers Drug Mart and six provincial distribution agencies under the Color Cannabis, Saturday, Starseed, and WeedMD brand names. WeedMD Inc. is headquartered in Aylmer, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VAN",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Aylmer",
        "zipcode": "N5H 2M8",
        "website": "http://www.weedmd.com",
        "market_cap": "Micro Cap"
    },
    "WOCKPHARMA.NS": {
        "short_name": "WOCKHARDT",
        "long_name": "Wockhardt Limited",
        "summary": "Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines in India, the United States, Europe, and internationally. It provides pharmaceutical products in the therapeutic areas of anti-infective, cardiology, dermatology, diabetology, neurology, pain management, respiratory, and other areas. The company offers generic products that comprise injectables, including cephalosporins and non-cephalosporins; molecules; and value-added generics. Its biopharmaceutical products include Glaritus, an insulin analog; Wosulin, an r-DNA insulin; Wepox, a recombinant erythropoietin that is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. The company also provides contract manufacturing services for sterile injectables, lyophilisation, and other dosage forms; and research services. It develops various molecules primarily in the area of anti-infectives, which include WCK 771 and WCK 2349 that is in Phase II human clinical trials for the treatment of staphylococcal infections; and WCK 5222, WCK 4282, WCK 4873, and WCK 6777 lead molecules, which are under pre-clinical trials. The company was incorporated in 1999 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited.",
        "currency": "INR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NSI",
        "market": "in_market",
        "country": "India",
        "state": null,
        "city": "Mumbai",
        "zipcode": "400051",
        "website": "http://www.wockhardt.com",
        "market_cap": "Small Cap"
    },
    "WOWU": {
        "short_name": "WOWI INC",
        "long_name": "WOWI, Inc.",
        "summary": "WOWI, Inc., an early-stage company, engages in the business of licensing technology and intellectual property to operators and businesses in the legal cannabis industry in the United States. The company also provides packaging and labeling, as well as equipment and real property leasing services to various companies. In addition, it offers a plethora of consulting services, including proper business structure and management services in the legal cannabis space serving cultivations, growers, extractors, and dispensaries that operate legally in states that has legal medicinal and/or recreational legislation. The company is headquartered in Centennial, Colorado.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CO",
        "city": "Centennial",
        "zipcode": "80112",
        "website": "http://worldofweedinc.com",
        "market_cap": "Nano Cap"
    },
    "WPHM": {
        "short_name": "WINSTON PHARMACEUTICALS INC",
        "long_name": "Winston Pharmaceuticals, Inc.",
        "summary": "Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management. It focuses on pain indications, such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo-and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease, as well as niche indications. Winston Pharmaceuticals, Inc. was formerly known as Winston Laboratories, Inc. and changed its name to Winston Pharmaceuticals, Inc. in November 2008. The company was incorporated in 1998 and is headquartered in Vernon Hills, Illinois.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "IL",
        "city": "Vernon Hills",
        "zipcode": "60061",
        "website": "http://www.winstonlabs.com",
        "market_cap": "Nano Cap"
    },
    "WRHLF": {
        "short_name": "LOVE HEMP GROUP PLC",
        "long_name": "Love Hemp Group Plc",
        "summary": "Love Hemp Group Plc formerly known as World High Life Limited, is a private equity and venture capital firm specializing in acquisition, early stage and mature companies. It may invest as debt or equity, in either quoted or unquoted securities, and made by direct acquisition of an interest in companies, partnerships or joint ventures, or direct interests in projects, or by way of licensing arrangements. It typically invests in companies operating in the Cannabidiol (CBD) wellness and medicinal cannabis, hemp including the industrial hemp with focus on therapeutic cannabis derivatives including nutraceuticals, dietary supplements and cosmetic products. The firm also seeks to invest in the cultivation of cannabis and hemp, the manufacture and distribution of medicinal cannabis, hemp and CBD products, pharmacology commercialization of medicinal cannabis, hemp and CBD, professional prescription by practitioners and after care as it relates to medicinal cannabis, statistical management, laboratory testing and compliance in respect of medicinal cannabis, hemp and CBD sectors, and the development of CBD within the wellness sector including retail products such as patches, topical ointments, tinctures, beverages, powdered supplements as well as vaping capsules, e-liquids and oils. The firm typically invests in Europe, Canada, Africa and South America, Israel and Asia. The firm will hold investments for the medium to long term, although where opportunities exist for shorter-term investments, it may undertake such investments. The firm typically acquire control in certain situations, although it may also consider acquiring non-controlling positions. The firm seeks to take majority stake. World High Life Plc was founded on 30th January 2019 and is based in London, United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "W1B 4DE",
        "website": "http://www.worldhighlife.uk",
        "market_cap": "Nano Cap"
    },
    "WSRC": {
        "short_name": "WESTERN SIERRA RESOURCE CORP",
        "long_name": "Western Sierra Resource Corporation",
        "summary": "Western Sierra Resource Corporation engages in the formulation, manufacture, infusion, packaging, and distribution of high-quality CBD products and other products derived from industrial hemp. Its products include creams, salves, ointments, tinctures, beverages, organic jams, and other health and wellness products. The company was formerly known as Western Sierra Mining Corp. and changed its name to Western Sierra Resource Corporation in September 2018. The company was founded in 1907 and is based in Lake Havasu City, Arizona. Western Sierra Resource Corporation is a subsidiary of Matchaah Holdings, Inc.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "AZ",
        "city": "Lake Havasu City",
        "zipcode": "86403",
        "website": "http://westernsierraresource.com",
        "market_cap": "Nano Cap"
    },
    "WUHN": {
        "short_name": "WUHAN GENERAL GROUP CHINA INC",
        "long_name": "Wuhan General Group (China), Inc.",
        "summary": "Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "QC",
        "city": "Pointe-Claire",
        "zipcode": "H9R 0A5",
        "website": "http://wuhn.org",
        "market_cap": "Nano Cap"
    },
    "XCX.CN": {
        "short_name": "AMPAlterMedPro",
        "long_name": "AMP Alternative Medical Products Inc.",
        "summary": "AMP Alternative Medical Products Inc., through its subsidiaries, operates in the medical cannabis industry. It imports and sells EU-GMP medical cannabis for patients in Germany. The company was formerly known as AMP German Cannabis Group Inc. and changed its name to AMP Alternative Medical Products Inc. in February 2021. AMP Alternative Medical Products Inc. is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 3L2",
        "website": "http://www.amp-eu.com",
        "market_cap": "Nano Cap"
    },
    "XIN.F": {
        "short_name": "SHANDONG XINHUA PHA.H YC1",
        "long_name": "Shandong Xinhua Pharmaceutical Company Limited",
        "summary": "Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical Bulk Drugs, Preparations, and Chemical Intermediates and Other products. It offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for central nervous system diseases; and other drugs under the brand of Xinhua. The company also provides prepared Chinese herbal medicine for decoction, traditional Chinese medicines, chemical raw materials, chemical preparations, antibiotics, biochemical medicines, chemical bulk drugs, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc. In addition, it offers raw materials and intermediates, powders for injection and tablets, and bulk pharmaceutical and intermediates; tablets, hard capsules, granules, and dry suspension; imports and exports goods and technologies; designs medical projects; develops and sells real estate; and health products research and development activities. Additionally, the company engages in the certification and import and export business; electrical equipment engineering; and installation and testing of chemical equipment and electrical equipment, as well as sales of mechanical, hardware, and electrical equipment. It also provides contract manufacturing services of APIs and pharmaceutical intermediates, as well as OTC and generic products; and internet data services, internet sales, and internet information services for pharmaceuticals and medical devices, etc. The company operates in the People's Republic of China, the Americas, Europe, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "China",
        "state": null,
        "city": "Zibo",
        "zipcode": "255086",
        "website": "http://www.xhzy.com",
        "market_cap": "Small Cap"
    },
    "XLY.TO": {
        "short_name": "AUXLY CANNABIS GROUP INC",
        "long_name": "Auxly Cannabis Group Inc.",
        "summary": "Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. The company engages in the cultivation of cannabis; and development and distribution of cannabis products. It offers products, such as soft chews, vape cartridges, vape pens, pre-rolled cannabis, chocolates, and cannabis oil spray and oil drops through retail stores under the Kolab Project, Foray, and Dosecan brand names. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "ON",
        "city": "Toronto",
        "zipcode": "M6J 0C2",
        "website": "http://auxly.com",
        "market_cap": "Micro Cap"
    },
    "XPHY.CN": {
        "short_name": "XPhytoThera",
        "long_name": "XPhyto Therapeutics Corp.",
        "summary": "XPhyto Therapeutics Corp., through its subsidiaries, operates as a biopharma, diagnostics, and cannabis science company in Canada and Germany. It is involved in the production, cultivation, extraction, isolation, formulation, delivery, and sale of medicinal cannabis. The company also provides contract development and consulting services. XPhyto Therapeutics Corp. has development, technology purchase and license agreement with 3a-Diagnostics GmbH for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a's pathogen specific biosensors and XPhyto's oral dissolvable drug delivery platform. XPhyto Therapeutics Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6J 3B1",
        "website": "http://www.xphyto.com",
        "market_cap": "Micro Cap"
    },
    "XPHYF": {
        "short_name": "XPHYTO THERAPEUTICS CORP",
        "long_name": "XPhyto Therapeutics Corp.",
        "summary": "XPhyto Therapeutics Corp., through its subsidiaries, operates as a biopharma, diagnostics, and cannabis science company in Canada and Germany. It is involved in the production, cultivation, extraction, isolation, formulation, delivery, and sale of medicinal cannabis. The company also provides contract development and consulting services. XPhyto Therapeutics Corp. has development, technology purchase and license agreement with 3a-Diagnostics GmbH for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a's pathogen specific biosensors and XPhyto's oral dissolvable drug delivery platform. XPhyto Therapeutics Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6J 3B1",
        "website": "http://www.xphyto.com",
        "market_cap": "Micro Cap"
    },
    "XQJ.F": {
        "short_name": "CHINA PHARMA HLDGS DL-001",
        "long_name": "China Pharma Holdings, Inc.",
        "summary": "China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. was founded in 1993 and is based in Haikou, the People's Republic of China.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "China",
        "state": null,
        "city": "Haikou",
        "zipcode": "570216",
        "website": "http://www.chinapharmaholdings.com",
        "market_cap": "Nano Cap"
    },
    "XTRX.CN": {
        "short_name": "PhytoExtraction",
        "long_name": "Phyto Extractions Inc.",
        "summary": "Adastra Labs Holdings Ltd. operates as a cannabis extraction and processing solutions company. It also offers third party analytical testing services, such as white labelling, contract processing, and cannabis testing. The company is based in Langley, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "CNQ",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Langley",
        "zipcode": "V4W 3X8",
        "website": "http://www.adastralabs.ca",
        "market_cap": "Nano Cap"
    },
    "XXII": {
        "short_name": "22nd Century Group, Inc.",
        "long_name": "22nd Century Group, Inc.",
        "summary": "22nd Century Group, Inc., a biotechnology company, develops plant-based solutions for the life science, consumer product, and pharmaceutical markets. It develops very low nicotine content tobacco and cigarette products under the Moonlight and Moonlight Menthol names; and SPECTRUM research cigarettes for use in independent clinical studies. 22nd Century Group, Inc. has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASE",
        "market": "us_market",
        "country": "United States",
        "state": "NY",
        "city": "Williamsville",
        "zipcode": "14221",
        "website": "http://www.xxiicentury.com",
        "market_cap": "Small Cap"
    },
    "YBAO": {
        "short_name": "YBCC INC",
        "long_name": "YBCC, Inc.",
        "summary": "YBCC, Inc. does not have significant operations. The company focuses on the acquisition of or merger with an existing company. Previously, it was engaged in the bio-science manufacture and research business. The company is based in Walnut, California.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United States",
        "state": "CA",
        "city": "Walnut",
        "zipcode": "91789",
        "website": "http://www.ybccinc.com",
        "market_cap": "Nano Cap"
    },
    "YCBD": {
        "short_name": "cbdMD, Inc.",
        "long_name": "cbdMD, Inc.",
        "summary": "cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. It owns and operates consumer hemp-based CBD brands, such as cbdMD and Paw CBD. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. It distributes its products through its e-commerce Website, third party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was founded in 2015 and is headquartered in Charlotte, North Carolina.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASE",
        "market": "us_market",
        "country": "United States",
        "state": "NC",
        "city": "Charlotte",
        "zipcode": "28217",
        "website": "http://www.cbdmd.com",
        "market_cap": "Micro Cap"
    },
    "YG3.F": {
        "short_name": "BETTER PLANT SCIENCES INC",
        "long_name": "Better Plant Sciences Inc.",
        "summary": "Better Plant Sciences Inc., through its subsidiaries, develops, markets, and sells of plant-based products for health and wellness. The company offers cosmetic and therapeutic products made of cannabis sativa hemp root oil and essential oils. It also develop and acquire intellectual property for plant-based products. The company offers plant-based skin care products under Urban Juve brand name; cannabis wellness products under Wright & Well and Jack n Jane brands; botanicals, fruit extracts, and spices under the UJ Beverages brand. The company was formerly known as The Yield Growth Corp. and changed its name to Better Plant Sciences Inc. in August 2020. Better Plant Sciences Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6B 2Y5",
        "website": "http://betterplantsciences.com",
        "market_cap": "Nano Cap"
    },
    "Z1TS34.SA": {
        "short_name": "ZOETIS INC  DRN",
        "long_name": "Zoetis Inc.",
        "summary": "Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; Dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.",
        "currency": "BRL",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SAO",
        "market": "br_market",
        "country": "United States",
        "state": "NJ",
        "city": "Parsippany",
        "zipcode": "07054",
        "website": "http://www.zoetis.com",
        "market_cap": "Large Cap"
    },
    "ZBISF": {
        "short_name": "ZENABIS GLOBAL INC",
        "long_name": "Zenabis Global Inc.",
        "summary": "Zenabis Global Inc. engages in the cultivation and sale of medical and adult-use recreational cannabis in Canada and internationally. The company produces and markets strains of dried cannabis under the Zenabis, Namaste, and Re-\u00c3\u00bcp brands; and various oil-based cannabis products. It has 111,200 kg of licensed cannabis cultivation space in three licensed facilities in Canada. The company is headquartered in Vancouver, Canada.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2X8",
        "website": "http://www.zenabis.com",
        "market_cap": "Micro Cap"
    },
    "ZENA.TO": {
        "short_name": "ZENABIS GLOBAL INC",
        "long_name": "Zenabis Global Inc.",
        "summary": "Zenabis Global Inc. engages in the cultivation and sale of medical and adult-use recreational cannabis in Canada and internationally. The company produces and markets strains of dried cannabis under the Zenabis, Namaste, and Re-\u00c3\u00bcp brands; and various oil-based cannabis products. It has 111,200 kg of licensed cannabis cultivation space in three licensed facilities in Canada. The company is headquartered in Vancouver, Canada.",
        "currency": "CAD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "TOR",
        "market": "ca_market",
        "country": "Canada",
        "state": "BC",
        "city": "Vancouver",
        "zipcode": "V6C 2X8",
        "website": "http://www.zenabis.com",
        "market_cap": "Micro Cap"
    },
    "ZOE.DE": {
        "short_name": "ZOETIS INC. CL.A  DL -,01",
        "long_name": "Zoetis Inc.",
        "summary": "Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; Dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "GER",
        "market": "de_market",
        "country": "United States",
        "state": "NJ",
        "city": "Parsippany",
        "zipcode": "07054",
        "website": "http://www.zoetis.com",
        "market_cap": "Large Cap"
    },
    "ZOE.F": {
        "short_name": "ZOETIS INC. CL.A  DL -,01",
        "long_name": "Zoetis Inc.",
        "summary": "Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; Dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United States",
        "state": "NJ",
        "city": "Parsippany",
        "zipcode": "07054",
        "website": "http://www.zoetis.com",
        "market_cap": "Large Cap"
    },
    "ZOE.L": {
        "short_name": "ZOETIC INTERNATIONAL PLC ORD 1P",
        "long_name": "Zoetic International Plc",
        "summary": "Zoetic International Plc, a vertically integrated CBD company, researches, develops, produces, and sells cannabidiol (CBD) consumer products and other hemp derivatives in the United States and the United Kingdom. The company offers oral CBD tinctures and CBD gummies, as well as softgel, massage oil, and skincare products. Its CBD products are used for pharmaceutical and tobacco replacement applications. The company was formerly known as Highlands Natural Resources plc and changed its name to Zoetic International Plc in September 2019. Zoetic International Plc was founded in 2014 and is headquartered in London, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "W1W 8DH",
        "website": "http://zoeticinternational.com",
        "market_cap": null
    },
    "ZOEIF": {
        "short_name": "ZOETIC INTERNATIONAL PLC",
        "long_name": "Zoetic International Plc",
        "summary": "Zoetic International Plc, a vertically integrated CBD company, researches, develops, produces, and sells cannabidiol (CBD) consumer products and other hemp derivatives in the United States and the United Kingdom. The company offers oral CBD tinctures and CBD gummies, as well as softgel, massage oil, and skincare products. Its CBD products are used for pharmaceutical and tobacco replacement applications. The company was formerly known as Highlands Natural Resources plc and changed its name to Zoetic International Plc in September 2019. Zoetic International Plc was founded in 2014 and is headquartered in London, the United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "W1W 8DH",
        "website": "http://zoeticinternational.com",
        "market_cap": "Micro Cap"
    },
    "ZOM": {
        "short_name": "Zomedica Corp.",
        "long_name": "Zomedica Corp.",
        "summary": "Zomedica Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies. The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. It has a collaboration agreement with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "ASE",
        "market": "us_market",
        "country": "United States",
        "state": "MI",
        "city": "Ann Arbor",
        "zipcode": "48108",
        "website": "http://zomedica.com",
        "market_cap": "Small Cap"
    },
    "ZOTS.VI": {
        "short_name": "ZOETIS INC",
        "long_name": "Zoetis Inc.",
        "summary": "Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; Dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "VIE",
        "market": "at_market",
        "country": "United States",
        "state": "NJ",
        "city": "Parsippany",
        "zipcode": "07054",
        "website": "http://www.zoetis.com",
        "market_cap": "Large Cap"
    },
    "ZTS.MX": {
        "short_name": "ZOETIS INC",
        "long_name": "Zoetis Inc.",
        "summary": "Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; Dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.",
        "currency": "MXN",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "MEX",
        "market": "mx_market",
        "country": "United States",
        "state": "NJ",
        "city": "Parsippany",
        "zipcode": "07054",
        "website": "http://www.zoetis.com",
        "market_cap": "Large Cap"
    },
    "ZTS": {
        "short_name": "Zoetis Inc.",
        "long_name": "Zoetis Inc.",
        "summary": "Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; Dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "United States",
        "state": "NJ",
        "city": "Parsippany",
        "zipcode": "07054",
        "website": "http://www.zoetis.com",
        "market_cap": "Large Cap"
    },
    "ZYNE": {
        "short_name": "Zynerba Pharmaceuticals, Inc.",
        "long_name": "Zynerba Pharmaceuticals, Inc.",
        "summary": "Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It improves the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "NGM",
        "market": "us_market",
        "country": "United States",
        "state": "PA",
        "city": "Devon",
        "zipcode": "19333",
        "website": "http://zynerba.com",
        "market_cap": "Micro Cap"
    }
}